{
  "total_chunks": 1326,
  "processing_timestamp": "2025-06-28T15:28:32.739857",
  "chunk_size": 600,
  "chunk_overlap": 100,
  "chunks": [
    {
      "id": "chunk_0",
      "text": "For most women, menopause is marked by the end of monthly menstruation (also known as a \nmenstrual period or ‘period’) due to loss of ovarian follicular function. This means that the \novaries stop releasing eggs for fertilization. \nThe regularity and length of the menstrual cycle varies across a woman’s reproductive life span, \nbut the age at which natural menopause occurs is generally between 45 and 55 years for women \nworldwide. \nNatural menopause is deemed to have occurred after 12 consecutive months without \nmenstruation for which there is no other obvious physiological or pathological cause and in the \nabsence of clinical intervention.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 648,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 648,
      "word_count": 101,
      "start_pos": 0,
      "end_pos": 648,
      "chunk_index": 0,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.265242"
    },
    {
      "id": "chunk_1",
      "text": "s no other obvious physiological or pathological cause and in the \nabsence of clinical intervention. \nSome women experience menopause earlier (before 40 years of age). This premature menopause \nmay be because of certain chromosomal abnormalities, autoimmune disorders or other unknown \ncauses. \nIt is not possible to predict when an individual woman will experience menopause, although \nthere are associations between the age at menopause and certain demographic, health and genetic \nfactors.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 492,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 492,
      "word_count": 70,
      "start_pos": 548,
      "end_pos": 1040,
      "chunk_index": 1,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.265242"
    },
    {
      "id": "chunk_2",
      "text": "are associations between the age at menopause and certain demographic, health and genetic \nfactors. \nMenopause can also be induced as a consequence of surgical procedures that involve removal of \nboth ovaries or medical interventions that cause cessation of ovarian function (for example \nradiation therapy or chemotherapy). \nMany women have already stopped menstruating before menopause, for example those who \nhave had certain surgical procedures (hysterectomy or surgical removal of their uterine lining) as \nwell as those using certain hormonal contraceptives and other medicines that cause infrequent or \nabsent periods.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 626,
          "overlap_percentage": 100.16000000000001
        }
      ],
      "primary_page": 1,
      "char_count": 625,
      "word_count": 88,
      "start_pos": 940,
      "end_pos": 1566,
      "chunk_index": 2,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.265242"
    },
    {
      "id": "chunk_3",
      "text": "using certain hormonal contraceptives and other medicines that cause infrequent or \nabsent periods. They may still experience other changes related to the menopausal transition. \nChanges associated with menopause \nThe hormonal changes associated with menopause can affect physical, emotional, mental and \nsocial well-being. The symptoms experienced during and following the menopausal transition \nvary substantially from person to person. Some have few if any symptoms. For others, symptoms \ncan be severe and affect daily activities and quality of life. Some can experience symptoms for \nseveral years. \nSymptoms associated with menopause include: \n●​ hot flushes and night sweats.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 683,
          "overlap_percentage": 100.1466275659824
        }
      ],
      "primary_page": 1,
      "char_count": 682,
      "word_count": 95,
      "start_pos": 1466,
      "end_pos": 2149,
      "chunk_index": 3,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.265242"
    },
    {
      "id": "chunk_4",
      "text": "s for \nseveral years. \nSymptoms associated with menopause include: \n●​ hot flushes and night sweats. Hot flushes refer to a sudden feeling of heat in the face, \nneck and chest, often accompanied by flushing of the skin, perspiration (sweating), \npalpitations and acute feelings of physical discomfort which can last several minutes; \n●​ changes in the regularity and flow of the menstrual cycle, culminating in cessation of \nmenstruation; \n●​ vaginal dryness, pain during sexual intercourse and incontinence; \n●​ difficulty sleeping/insomnia; and \n●​ changes in mood, depression and anxiety. \nBody composition and cardiovascular risk can also be affected.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 655,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 655,
      "word_count": 96,
      "start_pos": 2049,
      "end_pos": 2704,
      "chunk_index": 4,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.265242"
    },
    {
      "id": "chunk_5",
      "text": "ges in mood, depression and anxiety. \nBody composition and cardiovascular risk can also be affected. Women’s advantage over men in \nterms of cardiovascular disease gradually disappears with the significant decline in oestrogen\n\nlevels after menopause. Menopause can also result in the weakening of the pelvic support \nstructures, increasing the risk of pelvic organ prolapse. Loss of bone density at menopause is a \nsignificant contributor to higher rates of osteoporosis and fractures. \nThere are a variety of non-hormonal and hormonal interventions that can help alleviate \nsymptoms of menopause.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 226,
          "overlap_percentage": 37.79264214046823
        },
        {
          "page_number": 2,
          "overlap_chars": 370,
          "overlap_percentage": 61.87290969899666
        }
      ],
      "primary_page": 1,
      "char_count": 598,
      "word_count": 87,
      "start_pos": 2604,
      "end_pos": 3202,
      "chunk_index": 5,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.265242"
    },
    {
      "id": "chunk_6",
      "text": "a variety of non-hormonal and hormonal interventions that can help alleviate \nsymptoms of menopause. Symptoms that impact on health and well-being should be discussed \nwith a health-care provider to identify available management options, with consideration of \nmedical history, values, and preferences. \nPregnancy is still possible during perimenopause. Contraception is recommended to avoid \nunintended pregnancy until after 12 consecutive months without menstruation. Pregnancy after \nmenopause is unlikely without fertility treatment that involves the use of donor eggs or \npreviously frozen embryos.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 603,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 603,
      "word_count": 80,
      "start_pos": 3102,
      "end_pos": 3705,
      "chunk_index": 6,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.265242"
    },
    {
      "id": "chunk_7",
      "text": "ikely without fertility treatment that involves the use of donor eggs or \npreviously frozen embryos. \nDuring perimenopause and following menopause, it is still possible to acquire sexually \ntransmitted infections (STIs), including HIV, through unprotected sexual contact, including oral, \nanal and vaginal sex. The thinning of the vaginal wall after menopause increases the chances of \nlesions and tears, thereby increasing the risk of HIV transmission during vaginal sex. \nThe importance of understanding menopause \nIt is critical to see menopause as just one point in a continuum of life stages.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 597,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 597,
      "word_count": 88,
      "start_pos": 3605,
      "end_pos": 4202,
      "chunk_index": 7,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.265242"
    },
    {
      "id": "chunk_8",
      "text": "standing menopause \nIt is critical to see menopause as just one point in a continuum of life stages. A woman’s health \nstatus entering the perimenopausal period will largely be determined by prior health and \nreproductive history, lifestyle and environmental factors. Perimenopausal and postmenopausal \nsymptoms can be disruptive to personal and professional lives, and changes associated with \nmenopause will affect a woman’s health as she ages. Therefore, perimenopausal care plays an \nimportant role in the promotion of healthy ageing and quality of life. \nMenopause can be an important transition from a social perspective, as well as a biological one.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 656,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 656,
      "word_count": 98,
      "start_pos": 4102,
      "end_pos": 4758,
      "chunk_index": 8,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.265242"
    },
    {
      "id": "chunk_9",
      "text": "e. \nMenopause can be an important transition from a social perspective, as well as a biological one. \nSocially, a women’s experience of menopause may be influenced by gender norms, familial and \nsociocultural factors, including how female ageing and the menopausal transition are viewed in \nher culture. \nThe global population of postmenopausal women is growing. In 2021, women aged 50 and over \naccounted for 26% of all women and girls globally. This was up from 22% 10 years earlier (1). \nAdditionally, women are living longer. Globally, a woman aged 60 years in 2019 could expect to \nlive on average another 21 years (2).",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 624,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 624,
      "word_count": 102,
      "start_pos": 4658,
      "end_pos": 5282,
      "chunk_index": 9,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.265242"
    },
    {
      "id": "chunk_10",
      "text": "nger. Globally, a woman aged 60 years in 2019 could expect to \nlive on average another 21 years (2). \nMenopause can offer an important opportunity to reassess one’s health, lifestyle, and goals. \nPublic health challenges related to menopause \nPerimenopausal women need access to quality health services and communities and systems that \ncan support them. Unfortunately, both awareness and access to menopause-related information \nand services remain a significant challenge in most countries. Menopause is often not discussed \nwithin families, communities, workplaces, or health-care settings.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 593,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 593,
      "word_count": 83,
      "start_pos": 5182,
      "end_pos": 5775,
      "chunk_index": 10,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.265242"
    },
    {
      "id": "chunk_11",
      "text": "Menopause is often not discussed \nwithin families, communities, workplaces, or health-care settings.\n\nWomen may not know that symptoms they experience are related to menopause, or that there are \ncounselling and treatment options that can help alleviate discomfort. Those experiencing \nmenopausal symptoms may feel embarrassed or ashamed to draw attention to their experiences \nand ask for support. \nHealth-care providers may not be trained to recognize perimenopausal and post-menopausal \nsymptoms and counsel patients on treatment options and staying healthy after the menopausal \ntransition. Menopause currently receives limited attention in the training curricula for many \nhealth-care workers.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 100,
          "overlap_percentage": 14.326647564469914
        },
        {
          "page_number": 3,
          "overlap_chars": 596,
          "overlap_percentage": 85.38681948424069
        }
      ],
      "primary_page": 2,
      "char_count": 698,
      "word_count": 94,
      "start_pos": 5675,
      "end_pos": 6373,
      "chunk_index": 11,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.265242"
    },
    {
      "id": "chunk_12",
      "text": "opause currently receives limited attention in the training curricula for many \nhealth-care workers. \nThe sexual well-being of menopausal women is overlooked in many countries. This means that \ncommon gynaecological effects of menopause, including vaginal dryness and pain during \nintercourse, may go unaddressed. Similarly, older women may not consider themselves at risk of \nsexually transmitted infections, including HIV (3), or may not be counselled by their providers to \npractice safer sex or get tested.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 510,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 3,
      "char_count": 510,
      "word_count": 73,
      "start_pos": 6273,
      "end_pos": 6783,
      "chunk_index": 12,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.265242"
    },
    {
      "id": "chunk_13",
      "text": "including HIV (3), or may not be counselled by their providers to \npractice safer sex or get tested. \nMany governments do not have health polices and financing for the inclusion of \nmenopause-related diagnosis, counselling, and treatment services as part of their routinely \navailable services. Menopause-related services are a particular challenge in settings where there \nare often other urgent and competing priorities for health funding. \nWHO response \nWHO considers that social, psychological and physical health support during the menopausal \ntransition and after menopause should be an integral part of health care.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 622,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 3,
      "char_count": 622,
      "word_count": 90,
      "start_pos": 6683,
      "end_pos": 7305,
      "chunk_index": 13,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_14",
      "text": "ort during the menopausal \ntransition and after menopause should be an integral part of health care. WHO is committed to \nincreasing understanding of menopause by: \n●​ raising awareness of menopause and its impact on women at individual and societal \nlevels, as well as on countries’ health and socioeconomic development; \n●​ advocating for the inclusion of diagnosis, treatment and counselling related to \nmanagement of menopausal symptoms as part of universal health coverage; \n●​ promoting the inclusion of training on menopause and treatment options in pre-service \ncurricula for health workers;",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 600,
          "overlap_percentage": 100.1669449081803
        }
      ],
      "primary_page": 3,
      "char_count": 599,
      "word_count": 88,
      "start_pos": 7205,
      "end_pos": 7805,
      "chunk_index": 14,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_15",
      "text": "lusion of training on menopause and treatment options in pre-service \ncurricula for health workers; and \n●​ emphasizing a life course approach to health and well-being (including sexual health and \nwell-being), by ensuring that women have access to appropriate health information and \nservices to promote healthy ageing and a high quality of life before, during and after \nmenopause. \n \nNotes \n1) Whilst most personal experiences with menopause relate to cisgender women (who were born \nfemale and identify as female), transgender men and some people who identify as neither men \nnor women also experience menopause.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 616,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 3,
      "char_count": 616,
      "word_count": 92,
      "start_pos": 7705,
      "end_pos": 8321,
      "chunk_index": 15,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_16",
      "text": "), transgender men and some people who identify as neither men \nnor women also experience menopause. \nThis fact sheet refers to “women” in alignment with the available data, which does not routinely \nidentify gender identity. There is a paucity of readily available data on trans and gender diverse\n\nexperiences of menopause. Trans and gender diverse people have unique age-related health \nneeds that clinicians should consider, including referral to specialist services when necessary.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 298,
          "overlap_percentage": 61.31687242798354
        },
        {
          "page_number": 4,
          "overlap_chars": 186,
          "overlap_percentage": 38.2716049382716
        }
      ],
      "primary_page": 3,
      "char_count": 486,
      "word_count": 72,
      "start_pos": 8221,
      "end_pos": 8707,
      "chunk_index": 16,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_17",
      "text": "th \nneeds that clinicians should consider, including referral to specialist services when necessary. \n2) Although menopause is not a disease, this fact sheet refers to the perimenopausal and \npostmenopausal experiences of women as symptoms because they can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 325,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 325,
      "word_count": 49,
      "start_pos": 8607,
      "end_pos": 8934,
      "chunk_index": 17,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_18",
      "text": "as symptoms because they can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 98,
          "overlap_percentage": 101.03092783505154
        }
      ],
      "primary_page": 4,
      "char_count": 97,
      "word_count": 17,
      "start_pos": 8834,
      "end_pos": 8934,
      "chunk_index": 18,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_19",
      "text": "as symptoms because they can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 97,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 97,
      "word_count": 17,
      "start_pos": 8835,
      "end_pos": 8934,
      "chunk_index": 19,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_20",
      "text": "s symptoms because they can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 96,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 96,
      "word_count": 17,
      "start_pos": 8836,
      "end_pos": 8934,
      "chunk_index": 20,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_21",
      "text": "symptoms because they can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 95,
          "overlap_percentage": 101.06382978723406
        }
      ],
      "primary_page": 4,
      "char_count": 94,
      "word_count": 16,
      "start_pos": 8837,
      "end_pos": 8934,
      "chunk_index": 21,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_22",
      "text": "symptoms because they can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 94,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 94,
      "word_count": 16,
      "start_pos": 8838,
      "end_pos": 8934,
      "chunk_index": 22,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_23",
      "text": "ymptoms because they can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 93,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 93,
      "word_count": 16,
      "start_pos": 8839,
      "end_pos": 8934,
      "chunk_index": 23,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_24",
      "text": "mptoms because they can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 92,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 92,
      "word_count": 16,
      "start_pos": 8840,
      "end_pos": 8934,
      "chunk_index": 24,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_25",
      "text": "ptoms because they can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 91,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 91,
      "word_count": 16,
      "start_pos": 8841,
      "end_pos": 8934,
      "chunk_index": 25,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_26",
      "text": "toms because they can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 90,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 90,
      "word_count": 16,
      "start_pos": 8842,
      "end_pos": 8934,
      "chunk_index": 26,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_27",
      "text": "oms because they can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 89,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 89,
      "word_count": 16,
      "start_pos": 8843,
      "end_pos": 8934,
      "chunk_index": 27,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_28",
      "text": "ms because they can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 88,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 88,
      "word_count": 16,
      "start_pos": 8844,
      "end_pos": 8934,
      "chunk_index": 28,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_29",
      "text": "s because they can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 87,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 87,
      "word_count": 16,
      "start_pos": 8845,
      "end_pos": 8934,
      "chunk_index": 29,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_30",
      "text": "because they can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 86,
          "overlap_percentage": 101.17647058823529
        }
      ],
      "primary_page": 4,
      "char_count": 85,
      "word_count": 15,
      "start_pos": 8846,
      "end_pos": 8934,
      "chunk_index": 30,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_31",
      "text": "because they can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 85,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 85,
      "word_count": 15,
      "start_pos": 8847,
      "end_pos": 8934,
      "chunk_index": 31,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_32",
      "text": "ecause they can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 84,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 84,
      "word_count": 15,
      "start_pos": 8848,
      "end_pos": 8934,
      "chunk_index": 32,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_33",
      "text": "cause they can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 83,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 83,
      "word_count": 15,
      "start_pos": 8849,
      "end_pos": 8934,
      "chunk_index": 33,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_34",
      "text": "ause they can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 82,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 82,
      "word_count": 15,
      "start_pos": 8850,
      "end_pos": 8934,
      "chunk_index": 34,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_35",
      "text": "use they can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 81,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 81,
      "word_count": 15,
      "start_pos": 8851,
      "end_pos": 8934,
      "chunk_index": 35,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_36",
      "text": "se they can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 80,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 80,
      "word_count": 15,
      "start_pos": 8852,
      "end_pos": 8934,
      "chunk_index": 36,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_37",
      "text": "e they can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 79,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 79,
      "word_count": 15,
      "start_pos": 8853,
      "end_pos": 8934,
      "chunk_index": 37,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_38",
      "text": "they can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 78,
          "overlap_percentage": 101.29870129870129
        }
      ],
      "primary_page": 4,
      "char_count": 77,
      "word_count": 14,
      "start_pos": 8854,
      "end_pos": 8934,
      "chunk_index": 38,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_39",
      "text": "they can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 77,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 77,
      "word_count": 14,
      "start_pos": 8855,
      "end_pos": 8934,
      "chunk_index": 39,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_40",
      "text": "hey can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 76,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 76,
      "word_count": 14,
      "start_pos": 8856,
      "end_pos": 8934,
      "chunk_index": 40,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_41",
      "text": "ey can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 75,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 75,
      "word_count": 14,
      "start_pos": 8857,
      "end_pos": 8934,
      "chunk_index": 41,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_42",
      "text": "y can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 74,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 74,
      "word_count": 14,
      "start_pos": 8858,
      "end_pos": 8934,
      "chunk_index": 42,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_43",
      "text": "can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 73,
          "overlap_percentage": 101.38888888888889
        }
      ],
      "primary_page": 4,
      "char_count": 72,
      "word_count": 13,
      "start_pos": 8859,
      "end_pos": 8934,
      "chunk_index": 43,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_44",
      "text": "can result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 72,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 72,
      "word_count": 13,
      "start_pos": 8860,
      "end_pos": 8934,
      "chunk_index": 44,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_45",
      "text": "an result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 71,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 71,
      "word_count": 13,
      "start_pos": 8861,
      "end_pos": 8934,
      "chunk_index": 45,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_46",
      "text": "n result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 70,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 70,
      "word_count": 13,
      "start_pos": 8862,
      "end_pos": 8934,
      "chunk_index": 46,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_47",
      "text": "result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 69,
          "overlap_percentage": 101.47058823529412
        }
      ],
      "primary_page": 4,
      "char_count": 68,
      "word_count": 12,
      "start_pos": 8863,
      "end_pos": 8934,
      "chunk_index": 47,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_48",
      "text": "result in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 68,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 68,
      "word_count": 12,
      "start_pos": 8864,
      "end_pos": 8934,
      "chunk_index": 48,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_49",
      "text": "esult in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 67,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 67,
      "word_count": 12,
      "start_pos": 8865,
      "end_pos": 8934,
      "chunk_index": 49,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_50",
      "text": "sult in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 66,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 66,
      "word_count": 12,
      "start_pos": 8866,
      "end_pos": 8934,
      "chunk_index": 50,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_51",
      "text": "ult in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 65,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 65,
      "word_count": 12,
      "start_pos": 8867,
      "end_pos": 8934,
      "chunk_index": 51,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_52",
      "text": "lt in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 64,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 64,
      "word_count": 12,
      "start_pos": 8868,
      "end_pos": 8934,
      "chunk_index": 52,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_53",
      "text": "t in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 63,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 63,
      "word_count": 12,
      "start_pos": 8869,
      "end_pos": 8934,
      "chunk_index": 53,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_54",
      "text": "in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 62,
          "overlap_percentage": 101.63934426229508
        }
      ],
      "primary_page": 4,
      "char_count": 61,
      "word_count": 11,
      "start_pos": 8870,
      "end_pos": 8934,
      "chunk_index": 54,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_55",
      "text": "in a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 61,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 61,
      "word_count": 11,
      "start_pos": 8871,
      "end_pos": 8934,
      "chunk_index": 55,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_56",
      "text": "n a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 60,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 60,
      "word_count": 11,
      "start_pos": 8872,
      "end_pos": 8934,
      "chunk_index": 56,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_57",
      "text": "a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 59,
          "overlap_percentage": 101.72413793103448
        }
      ],
      "primary_page": 4,
      "char_count": 58,
      "word_count": 10,
      "start_pos": 8873,
      "end_pos": 8934,
      "chunk_index": 57,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_58",
      "text": "a level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 58,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 58,
      "word_count": 10,
      "start_pos": 8874,
      "end_pos": 8934,
      "chunk_index": 58,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_59",
      "text": "level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 57,
          "overlap_percentage": 101.78571428571428
        }
      ],
      "primary_page": 4,
      "char_count": 56,
      "word_count": 9,
      "start_pos": 8875,
      "end_pos": 8934,
      "chunk_index": 59,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_60",
      "text": "level of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 56,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 56,
      "word_count": 9,
      "start_pos": 8876,
      "end_pos": 8934,
      "chunk_index": 60,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_61",
      "text": "evel of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 55,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 55,
      "word_count": 9,
      "start_pos": 8877,
      "end_pos": 8934,
      "chunk_index": 61,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_62",
      "text": "vel of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 54,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 54,
      "word_count": 9,
      "start_pos": 8878,
      "end_pos": 8934,
      "chunk_index": 62,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_63",
      "text": "el of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 53,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 53,
      "word_count": 9,
      "start_pos": 8879,
      "end_pos": 8934,
      "chunk_index": 63,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_64",
      "text": "l of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 52,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 52,
      "word_count": 9,
      "start_pos": 8880,
      "end_pos": 8934,
      "chunk_index": 64,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_65",
      "text": "of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 51,
          "overlap_percentage": 102.0
        }
      ],
      "primary_page": 4,
      "char_count": 50,
      "word_count": 8,
      "start_pos": 8881,
      "end_pos": 8934,
      "chunk_index": 65,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_66",
      "text": "of \ndiscomfort that affects their quality of life.",
      "doc_title": "1_Menopause",
      "doc_filename": "1_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\1_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 50,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 50,
      "word_count": 8,
      "start_pos": 8882,
      "end_pos": 8934,
      "chunk_index": 66,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.266242"
    },
    {
      "id": "chunk_0",
      "text": "55\n\nClinical Practice Guidelines on Menopause: *An Executive Summary \nand Recommendations: Indian Menopause Society 2019–2020\nMeeta Meeta, Leela Digumarti1, Neelam Agarwal2, Nirmala Vaze3, Rashmi Shah4, Sonia Malik5\nGynecologist, Co-Director and Chief Consultant, Tanvir Hospital, Hyderabad, Telangana, 1Gynecologist, Homi Bhabha Cancer Hospital \nand Research Centre, Aganampudi, Visakhapatnam, Andhra Pradesh, 2Obs Gynae, Postgraduate Institute of Medical Education & \nResearch, Chandigarh, 3Consultant Obstetrician/Gynaecologist, Counselar Breast, Gynae Cancer & Menopause, Nagpur, \n4Gynecologist,",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 600,
          "overlap_percentage": 100.1669449081803
        }
      ],
      "primary_page": 1,
      "char_count": 599,
      "word_count": 68,
      "start_pos": 0,
      "end_pos": 600,
      "chunk_index": 0,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.385485"
    },
    {
      "id": "chunk_1",
      "text": "ant Obstetrician/Gynaecologist, Counselar Breast, Gynae Cancer & Menopause, Nagpur, \n4Gynecologist, Ex Senior Deputy Director, National Institute for Research in Reproductive Health (ICMR), Mumbai, \n5Gynecologist, Director and HOD, Southend Fertility & IVF Centre, New Delhi, India\nExternal Review Board: Anita Gadgil, Dayasagar, G. R. Sridhar, Hema Divakar, P. K. Shah, Rakesh Sahay, Sanjay Kalra, Vishal Tandon.\nResource Faculty: Alka Kumar, Anil Mahajan, Anita Kant, Anita Shah, Anu Vij, Archana Tripathi, Asha Kapadia, Ashok Khurana, \nAtul Munshi, Bhavana Sheth, Bipasa Sen, C. H. Trivedi, Chellamma V. K., Choranur Ambuja, Duru Shah, G. Nagamani, \nGurava A. Reddy, H. P.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 675,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 675,
      "word_count": 96,
      "start_pos": 500,
      "end_pos": 1175,
      "chunk_index": 1,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_2",
      "text": "en, C. H. Trivedi, Chellamma V. K., Choranur Ambuja, Duru Shah, G. Nagamani, \nGurava A. Reddy, H. P. Pattanaik, Jaideep Malhotra, Jaishree Gajraj, Jignesh Shah, Jyothi Unni, Jyoti Hak, Jyoti M. Shah, \nKaushal Chundawat, Lakshm Ratna, Lakshmi Seshadri, Leela Digumarti, Madhukar Reddy, Mala Raj, Mandakini Parihar, \nManinder Ahuja, Manjit Kaur Mohi, Meeta Meeta, Monica Chauhan, Muzammil S. Shaikh, Navneet Magon, Navneet Takkar, \nNeelam Agarwal, Nidhi Gupta, Nila A. Mohile, Nirmala Vaze, Phagun N. Shah, Preeti D. Galvankar, Pushpa Sethi, Rajesh S.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 549,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 549,
      "word_count": 81,
      "start_pos": 1075,
      "end_pos": 1624,
      "chunk_index": 2,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_3",
      "text": "hi Gupta, Nila A. Mohile, Nirmala Vaze, Phagun N. Shah, Preeti D. Galvankar, Pushpa Sethi, Rajesh S. Kumar, \nRama Vaidya, Ranu Patni, Rashmi Shah, Rekha Sharma, Renu Makwana, Rita Shah, Rohit Shetty, Roza Olyai, Saroj Srivastava, \nSeema Sharma, Shailender Singh, Sharad Kumar, Sharmila Pimple, Sheela V. Mane, Shobhana Mohandas, Sonal Bathla, Sonia Malik, \nSudha Sharma, Sudhakar Krishnamurti, Sunila Khandelwal, Surendra Shastri, Sushmita Dave, Suvarna Khadilkar, Tanvir, Tripti Nagaria, \nUrvashi Prasad Jha, Urvashi Yavalkar, Usha Rani Poli, Vandana Bansal, Yashodhara Pradeep.\nAddress for correspondence: Dr.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 611,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 611,
      "word_count": 84,
      "start_pos": 1524,
      "end_pos": 2135,
      "chunk_index": 3,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_4",
      "text": "rvashi Yavalkar, Usha Rani Poli, Vandana Bansal, Yashodhara Pradeep.\nAddress for correspondence: Dr. Meeta Meeta, \nDepartment of Obstetrics and Gynaecology, Tanvir \nHospital, Kamalapuri Colony, Hyderabad, Telangana, India. \nE‑mail: drmeeta919@gmail.com\nfor menopause or impending menopause and \nassociated with low estradiol levels. Anti‑Mullerian \nhormone becomes undetectable, inhibin levels fall, \nand antral follicular count and ovarian volume \ndecrease at menopause. Menstrual irregularity is the \nonly objective marker to define and establish the \nmenopause transition.[2]\nTerminology\n3.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 593,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 593,
      "word_count": 73,
      "start_pos": 2035,
      "end_pos": 2628,
      "chunk_index": 4,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_5",
      "text": "y is the \nonly objective marker to define and establish the \nmenopause transition.[2]\nTerminology\n3. Natural or spontaneous menopause: It is recognized \nto have occurred after 12 months of amenorrhea, \nfor which there are no obvious pathological and \nphysiological causes. It occurs due to the depletion of \nGuidelines\n*This is a short summary and recommendations from \nthe detailed monogram on Clinical Practice Guidelines \non Menopause, available at the Indian Menopause \nSociety Website: www.indianmenopausesociety.org.\nSection I\nGeneral Considerations\n1. Menopause is a transition phase from the reproductive \nto the nonreproductive phase in a woman’s life.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 661,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 661,
      "word_count": 94,
      "start_pos": 2528,
      "end_pos": 3189,
      "chunk_index": 5,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_6",
      "text": "nopause is a transition phase from the reproductive \nto the nonreproductive phase in a woman’s life. It is \nnature’s protective phenomenon against reproductive \nmorbidity and mortality in the aging population. It \nsets the stage for aging and accelerates the process of \nnoncommunicable disorders\n2. Menopause is diagnosed retrospectively by history. \nMarkers for diagnosis of menopause are preferably \nrestricted for use in special situations and for fertility \nissues. Levels of follicle‑stimulating hormone (FSH) \n>10 IU/L are indicative of declining ovarian function.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 571,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 571,
      "word_count": 80,
      "start_pos": 3089,
      "end_pos": 3660,
      "chunk_index": 6,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_7",
      "text": "Levels of follicle‑stimulating hormone (FSH) \n>10 IU/L are indicative of declining ovarian function. \nFSH levels  >20 IU/L are diagnostic of ovarian \ninsufficiency in the perimenopausal age group with \nvasomotor symptoms  (VMS), even in the absence \nof cessation of menstruation.[1] FSH level  >40 IU/L \ndone at least 4  weeks apart is a reliable marker \nThis is an open access journal, and articles are distributed under the terms of the Creative \nCommons Attribution‑NonCommercial‑ShareAlike 4.0 License, which allows others to \nremix, tweak, and build upon the work non‑commercially, as long as appropriate credit is \ngiven and the new creations are licensed under the identical terms.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 688,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 688,
      "word_count": 102,
      "start_pos": 3560,
      "end_pos": 4248,
      "chunk_index": 7,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_8",
      "text": "s long as appropriate credit is \ngiven and the new creations are licensed under the identical terms.\nFor reprints contact: WKHLRPMedknow_reprints@wolterskluwer.com\nHow to cite this article:  Meeta M, Digumarti L, Agarwal N, Vaze N, Shah R, \nMalik S. Clinical practice guidelines on menopause: *An executive summary \nand recommendations: Indian menopause society 2019–2020. J Mid-life \nHealth 2020;11:55-95.\nAccess this article online\nQuick Response Code:\nWebsite: www.jmidlifehealth.org\nDOI: 10.4103/jmh.JMH_137_20\nSubmitted: 25‑Jun‑2020\nRevised: 10-Jul-2020\nAccepted: 14‑Ju1‑2020\nPublished: 10-Aug-2020\n\nMeeta, et al.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 603,
          "overlap_percentage": 97.57281553398059
        },
        {
          "page_number": 2,
          "overlap_chars": 13,
          "overlap_percentage": 2.103559870550162
        }
      ],
      "primary_page": 1,
      "char_count": 618,
      "word_count": 78,
      "start_pos": 4148,
      "end_pos": 4766,
      "chunk_index": 8,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_9",
      "text": "mitted: 25‑Jun‑2020\nRevised: 10-Jul-2020\nAccepted: 14‑Ju1‑2020\nPublished: 10-Aug-2020\n\nMeeta, et al.: Guidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\novarian follicles, resulting in near‑complete, but natural \ndiminution of ovarian hormone secretion. There is no \nindependent biological marker for menopause[3]\n4. Premenopause: It is often used to refer the entire \nreproductive period, up to the final menstrual \nperiod (FMP).\n5. Perimenopause: It is the period immediately before \nand up to 1  year after the FMP. It may last for \n3–5  years.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 85,
          "overlap_percentage": 14.333895446880272
        },
        {
          "page_number": 2,
          "overlap_chars": 506,
          "overlap_percentage": 85.32883642495784
        }
      ],
      "primary_page": 1,
      "char_count": 593,
      "word_count": 88,
      "start_pos": 4666,
      "end_pos": 5259,
      "chunk_index": 9,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_10",
      "text": ": It is the period immediately before \nand up to 1  year after the FMP. It may last for \n3–5  years. The characteristics are increased blood \nlevels of FSH, anovulatory cycles, significantly \nreduced fertility and erratic menstrual periods, and \nonset of symptoms. This term is used interchangeably \nwith menopause transition[4,5]\n6. Menopause transition or perimenopause begins on an \naverage 4 years before the FMP and is characterized \nby irregular menstrual cycles, endocrine changes, \nand symptoms such as hot flashes that may affect a \nwoman’s quality of life (QOL). It may be considered \nas a biological marker for chronic disease.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 638,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 638,
      "word_count": 99,
      "start_pos": 5159,
      "end_pos": 5797,
      "chunk_index": 10,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_11",
      "text": "a \nwoman’s quality of life (QOL). It may be considered \nas a biological marker for chronic disease. The \nbiology and symptomatology of menopause are \nblurred due to its relationship to the underlying \naging process. Long‑term effects on bone and heart \nhave been related to estrogen deficiency. It is the \nterm coined by the Stages of Reproductive Ageing \nWorkshop  (STRAW) group, and during this period, \ndisturbed menstrual cycle and endocrine changes \nare observed. Anklesaria’s staging of menopause has \nbeen adopted by the Indian Menopause Society (IMS) \nafter modification[5‑7]\n7. Climacteric: Literally, it means the rungs of a \nladder.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 644,
          "overlap_percentage": 100.15552099533438
        }
      ],
      "primary_page": 2,
      "char_count": 643,
      "word_count": 97,
      "start_pos": 5697,
      "end_pos": 6341,
      "chunk_index": 11,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_12",
      "text": "e Society (IMS) \nafter modification[5‑7]\n7. Climacteric: Literally, it means the rungs of a \nladder. It is interchangeable with perimenopause \nand menopause transition. When associated with \nsymptoms, it is termed as the climacteric syndrome. \nThis term is preferably not to be used in scientific \npapers[4]\n8. Postmenopause: It is the span of time dating from \nthe FMP, regardless of whether the menopause was \nspontaneous or iatrogenic[4]\n9. Senescence: It is the period after the age of 60 years[3]\n10. Premature menopause/premature ovarian insufficiency \n(POI): POI is replacing the term premature \nmenopause.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 613,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 613,
      "word_count": 91,
      "start_pos": 6241,
      "end_pos": 6854,
      "chunk_index": 12,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_13",
      "text": "re menopause/premature ovarian insufficiency \n(POI): POI is replacing the term premature \nmenopause. POI is described as amenorrhea due to \nloss of ovarian function before the age of 40 years. It \nis a state of female hypergonadotropic hypogonadism. \nIt can manifest as primary amenorrhea with \nonset before menarche or secondary amenorrhea. \nStatistically, it is defined as spontaneous menopause \noccurring below two standard deviations (SDs) below \nthe mean estimated age for the reference population \nfor 5% level of significance. The estimated average \nage of menopause in India is reported to be 46 years; \nhence, we may consider POI as occurring below \nthe age of 38  years.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 680,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 680,
      "word_count": 104,
      "start_pos": 6754,
      "end_pos": 7434,
      "chunk_index": 13,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_14",
      "text": "ia is reported to be 46 years; \nhence, we may consider POI as occurring below \nthe age of 38  years. However, we do need to have \npopulation‑based studies to derive at these cutoff \nvalues. The European Society of Human Reproduction \nand Embryology  (ESHRE 2015) laid the following \ndiagnostic criteria for POI‑oligomenorrhea/amenorrhea \nfor at least 4 months and an elevated FSH level \n>25 IU/l on two occasions >4 weeks apart.[8]\n11. Induced menopause: It is cessation of menstruation \nthat follows bilateral oophorectomy or iatrogenic \nablation of ovarian function[4]\n12.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 574,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 574,
      "word_count": 88,
      "start_pos": 7334,
      "end_pos": 7908,
      "chunk_index": 14,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_15",
      "text": "menstruation \nthat follows bilateral oophorectomy or iatrogenic \nablation of ovarian function[4]\n12. Temporary menopause: It is a term preferably not to \nbe used since the definition of menopause is complete \ncessation of menstruation. Rarely, ovarian function is \ninterrupted for a period of time and later resumes[4]\n13. Early menopause: It is the time span between the \nspontaneous or iatrogenic menopause occurring \nbetween the age of 40 years and the accepted typical \nage of menopause for a given population. The \nconsensus from various guidelines is to treat with \nhormone replacement therapy  (HRT) till the age of \nmenopause\n14.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 637,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 637,
      "word_count": 97,
      "start_pos": 7808,
      "end_pos": 8445,
      "chunk_index": 15,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_16",
      "text": "rious guidelines is to treat with \nhormone replacement therapy  (HRT) till the age of \nmenopause\n14. Delayed menopause: It is not defined but may be \nimportant in terms of increased problems associated \nwith the hyperestrogenism and is used in this \nguideline. It is two SDs above from the natural \naverage age of menopause in a given population. \nWe may consider it to be beyond 54  years. \nPopulation‑based studies are needed to derive at \nthese cutoff values\n15. Postmenopausal bleeding  (PMB): It is bleeding \nthat occurs 12 months after the last normal period.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 565,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 565,
      "word_count": 92,
      "start_pos": 8345,
      "end_pos": 8910,
      "chunk_index": 16,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_17",
      "text": "Postmenopausal bleeding  (PMB): It is bleeding \nthat occurs 12 months after the last normal period. \nHowever, it is recommended that any vaginal \nbleeding that occurs 6 months after the last period \n(presumed menopause) should be investigated\n16. Staging \nsystem: \nThe \nstaging \nsystem \nof \na \nphysiological event is to improve comparability of \nstrategies and facilitate clinical decision‑making. In \n1997, Ankelesaria in India published a simple clinical \nmethod of staging of menopause to understand \nand deal with the problems of the transition phase \nand beyond.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 568,
          "overlap_percentage": 100.1763668430335
        }
      ],
      "primary_page": 2,
      "char_count": 567,
      "word_count": 83,
      "start_pos": 8810,
      "end_pos": 9378,
      "chunk_index": 17,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_18",
      "text": "staging of menopause to understand \nand deal with the problems of the transition phase \nand beyond.[6,7] STRAW  (2001) aimed to classify \nthe woman’s life in three phases:  (1) reproductive, \n(2) menopause transition, and  (3) postmenopause \nbased on the menstrual cycle, endocrine parameters, \nand ovarian reserve markers. This was applicable \nonly to healthy women. The 2012 STRAW  +  10 \nprovides a greater clarity for menstrual pattern and \nis applicable to most women, except for those with \nPOI[9,10]\n17. India, with a population of 1.2  billion people, is \nthe second largest emerging economy and second \nmost populated country in the world.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 649,
          "overlap_percentage": 100.15432098765432
        }
      ],
      "primary_page": 2,
      "char_count": 648,
      "word_count": 99,
      "start_pos": 9278,
      "end_pos": 9927,
      "chunk_index": 18,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_19",
      "text": "ion people, is \nthe second largest emerging economy and second \nmost populated country in the world. According to \nthe latest World Health Organization  (WHO) data \npublished in 2018, the life expectancy in India for a\n\nMeeta, et al.: Guidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\nfemale is 70.3 years, expected to increase to 77 years \nby \n2050. \nNoncommunicable \ndiseases \naccount \nfor 60% of the total deaths in India. Currently, \napproximately 10% of India’s population, i.e., more \nthan 100 million, is aged over 50 years[11]\n18. The estimated mean age of menopause is 46 years in \nIndia and is lower than that of the Caucasians.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 218,
          "overlap_percentage": 31.824817518248178
        },
        {
          "page_number": 3,
          "overlap_chars": 465,
          "overlap_percentage": 67.88321167883211
        }
      ],
      "primary_page": 2,
      "char_count": 685,
      "word_count": 113,
      "start_pos": 9827,
      "end_pos": 10512,
      "chunk_index": 19,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_20",
      "text": "The estimated mean age of menopause is 46 years in \nIndia and is lower than that of the Caucasians.[12‑28] \nFrom the available Indian data, it is hypothesized \nthat an early age of menopause predisposes a \nwoman to chronic health disorders a decade \nearlier than a Caucasian woman. It is reported \nthat osteoporotic fractures occur 10–20  years \nearlier in Indians compared to Caucasians.[29,30] \nThe first myocardial infarction  (MI) attack occurs \nin 4.4% of Asian women at a younger age than \nin European women.[31] In India, type  2 diabetes \nmellitus  (T2DM) occurs a decade earlier than the \nCaucasians.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 610,
          "overlap_percentage": 100.16420361247948
        }
      ],
      "primary_page": 3,
      "char_count": 609,
      "word_count": 96,
      "start_pos": 10412,
      "end_pos": 11022,
      "chunk_index": 20,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_21",
      "text": "omen.[31] In India, type  2 diabetes \nmellitus  (T2DM) occurs a decade earlier than the \nCaucasians.[32] Breast cancer is the most common \ncancer in Indian women, and the incidence peaks \nbefore the age of 50 years[33]\n19. The overall prevalence of hypertension in India \nwas 29.8%. Significant differences in hypertension \nprevalence were noted between rural and urban parts, \ni.e., 27.6% and 33.8%, respectively. Only 25% of \nrural and 38% of urban Indians are being treated \nfor hypertension. The burden of cardiovascular \ndisease  (CVD) in India is projected to increase by \n115% from 1990 to 2020[34] and cerebrovascular \nincidence by 104%.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 645,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 3,
      "char_count": 645,
      "word_count": 99,
      "start_pos": 10922,
      "end_pos": 11567,
      "chunk_index": 21,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_22",
      "text": "ndia is projected to increase by \n115% from 1990 to 2020[34] and cerebrovascular \nincidence by 104%.[35] The migrant population from \nthe Indian subcontinent in the UK is known to be \nat a significantly higher risk of developing diabetes \nand CVD.[36] The mean bone mineral density (BMD) \nin India is about two SDs lower than in women in \nthe Western population.[29] The prevalence of low \nbone mass is to the extent of 40% from the age of \n40 years and increases to more than 62% by the age \nof 60 years and 80% by the age of 65 years.[37‑42] The \nabove facts indicate the need to have well‑planned \ncost‑effective systems in place to promote a healthy \nand an active aging population.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 686,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 3,
      "char_count": 686,
      "word_count": 120,
      "start_pos": 11467,
      "end_pos": 12153,
      "chunk_index": 22,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_23",
      "text": "well‑planned \ncost‑effective systems in place to promote a healthy \nand an active aging population.\nIndividualized Plan for Menopause\n20. Each woman needs an individualized health plan \nmanagement. It is most important to distinguish \nbetween a symptomatic and an asymptomatic \nmenopausal woman.[43] Women may present at \nthe menopausal clinic with menstrual problems, \nmenopausal symptoms, or request for a general health \ncheckup or as an opportunistic contact to be picked \nup by the health professional [Flowcharts 1 and 2].[44]\nSection II\nSymptoms of Menopause, Issues Related \nto Menopause Transition, and Aging\nFertility\n21.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 632,
          "overlap_percentage": 100.15847860538827
        }
      ],
      "primary_page": 3,
      "char_count": 631,
      "word_count": 91,
      "start_pos": 12053,
      "end_pos": 12685,
      "chunk_index": 23,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_24",
      "text": "]\nSection II\nSymptoms of Menopause, Issues Related \nto Menopause Transition, and Aging\nFertility\n21. After the age of 30  years, if a woman does not \nconceive naturally within 6 months, the couple \nshould have an infertility workup (Grade B)\n22. In women with a single ovary, previous ovarian \nsurgery, poor response to gonadotropins, previous \nexposure \nto \nchemotherapy \nor \nradiation, \nor \nunexplained infertility, they should undergo ovarian \nreserve testing even before the age of 30 years, and \nin all women, it is done beyond more than or equal \nto 30 years (Grade B)\n23.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 578,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 3,
      "char_count": 578,
      "word_count": 94,
      "start_pos": 12585,
      "end_pos": 13163,
      "chunk_index": 24,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_25",
      "text": "age of 30 years, and \nin all women, it is done beyond more than or equal \nto 30 years (Grade B)\n23. In women aged >40 years who do not conceive within \n1–2  cycles of controlled ovarian hyperstimulation, \nin  vitro fertilization  (IVF) should be considered \n(Grade B)\n24. The only effective treatment for ovarian aging \nis oocyte donation. A  woman with decreased \novarian reserve should be offered oocyte donation \nas an option, for pregnancy rates associated with \nthis treatment are significantly higher than those \nassociated with controlled ovarian hyperstimulation \nor IVF with a woman’s own eggs (Grade B)\n25.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 617,
          "overlap_percentage": 100.16233766233766
        }
      ],
      "primary_page": 3,
      "char_count": 616,
      "word_count": 99,
      "start_pos": 13063,
      "end_pos": 13680,
      "chunk_index": 25,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_26",
      "text": "e \nassociated with controlled ovarian hyperstimulation \nor IVF with a woman’s own eggs (Grade B)\n25. The \nrisk \nof \nspontaneous \npregnancy \nloss \nand \nchromosomal abnormalities increases with age, and the \ncouple needs to be counseled on this aspect (Grade B)\n26. Preconception counseling with an emphasis on \noptimal general health and screening for medical \nconditions, such as hypertension, diabetes, and \npregnancy‑related risks, should be addressed for \nwomen aged >40 years (Grade B).",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 490,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 3,
      "char_count": 490,
      "word_count": 72,
      "start_pos": 13580,
      "end_pos": 14070,
      "chunk_index": 26,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_27",
      "text": "on, diabetes, and \npregnancy‑related risks, should be addressed for \nwomen aged >40 years (Grade B).\n UNINTENDED PREGNANCY, DECLINING FERTILITY, MENSTRUAL PROBLEMS\nVASOMOTOR\nGENITOURINARY\nNEUROPSYCHIATRIC\nSKIN, EYE, EAR, AND ORAL CAVITY\nSYMPTOMS\nSKELETOMUSCULAR\nSEXUAL\nFAT DEPOSITION\nFlowchart 2: Issues in symptomatic women\nMenopause + Aging \nAsymptomatic\nPreventive health\nSymptomatic\nFlowchart 1: The physician’s role and approach\n\nMeeta, et al.: Guidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\nContraception\n27. Pregnancies in the elderly women are associated \nwith higher maternal and perinatal morbidity \nand mortality.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 433,
          "overlap_percentage": 64.2433234421365
        },
        {
          "page_number": 4,
          "overlap_chars": 239,
          "overlap_percentage": 35.459940652818986
        }
      ],
      "primary_page": 3,
      "char_count": 674,
      "word_count": 91,
      "start_pos": 13970,
      "end_pos": 14644,
      "chunk_index": 27,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_28",
      "text": "es in the elderly women are associated \nwith higher maternal and perinatal morbidity \nand mortality. There is an increased risk of fetal \nmalformations. This can also lead to psychological \nand potential domestic and social consequences\n28. The annual risk of deaths associated with using no \nmethod of contraception far exceeds that for use of \nany method among all age groups [Table 1][45]\n29. Pattern of contraception use in the age group of \n15–49 years is shown in Table 2[46]\n30. Sterilization is a highly effective, safe, and single \nact; the case‑fatality rate with tubectomy is \n1–2/100,000 procedures. However, it is a permanent \nmethod.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 647,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 647,
      "word_count": 103,
      "start_pos": 14544,
      "end_pos": 15191,
      "chunk_index": 28,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_29",
      "text": "he case‑fatality rate with tubectomy is \n1–2/100,000 procedures. However, it is a permanent \nmethod. Vasectomy is even safer except for minor \ncomplications (Grade A)\n31. Oral contraceptive pills  (OCPs) are effective, \neasy to use, and reversible. Low‑dose OCPs have \nnoncontraceptive health benefits with an increased \nsafety profile (Grade A)[47‑49]\n32. For women above the age of 35 years, careful personal \nand family history, and accurate measurement of \nblood pressure  (BP), breast examination, screening \nfor diabetes, and lipid profile should be performed \n(Grade A)[50]\n33.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 584,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 584,
      "word_count": 84,
      "start_pos": 15091,
      "end_pos": 15675,
      "chunk_index": 29,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_30",
      "text": "reast examination, screening \nfor diabetes, and lipid profile should be performed \n(Grade A)[50]\n33. Healthy \nwomen \nof \nnormal \nweight, \nnonusers \nof tobacco, and doing well on a combination \ncontraceptive pill can continue this method until the \nage of menopause and up to a year or 2 years later, \nafter analyzing its risks and benefits (Grade B)\n34. If OCPs are continued before major surgery, heparin \nprophylaxis may be considered (Grade B)\n35. Depot medroxyprogesterone acetate  (DMPA) is \nassociated with bone loss, which returns to normal, \nafter stopping DMPA. Yet, the caution needs to be \nexercised in women at a high risk of osteoporosis.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 651,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 651,
      "word_count": 103,
      "start_pos": 15575,
      "end_pos": 16226,
      "chunk_index": 30,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_31",
      "text": "fter stopping DMPA. Yet, the caution needs to be \nexercised in women at a high risk of osteoporosis. \nShort‑ or long‑term use of DMPA in healthy women \nshould not be considered as an indication for dual \nX‑ray energy absorptiometry or other tests that assess \nBMD (Grade C)\n36. Change over from OCPs to hormone therapy  (HT) \nis carried out at an arbitrary age of 45–50  years, if \nserum FSH: luteinzing hormone ratio of  >1; low \nestradiol  <20 pg/mL; FSH  >30 IU/L done twice \n6 weeks apart[51]\n37. Progesterone‑only contraceptive is an ideal method \nin women with a history of venous thromboembolism \n(VTE) and gallstones. Limitations are erratic and \nscanty \nperiods.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 671,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 671,
      "word_count": 110,
      "start_pos": 16126,
      "end_pos": 16797,
      "chunk_index": 31,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_32",
      "text": "story of venous thromboembolism \n(VTE) and gallstones. Limitations are erratic and \nscanty \nperiods. \nThe \nlevonorgestrel–intrauterine \nsystem, apart from being used as a contraception, is \nan effective HT for heavy menstrual bleeding and \nfor treating bleeding disturbances associated with \nendometrial hyperplasia (EH) (Grade B)\n38. Intrauterine contraceptive devices are effective but \nsometimes can cause menorrhagia and dysmenorrhea \n(Grade B)\n39. Emergency contraception is an effective emergency \nmethod, but it is not as effective and consistent as \nthe use of other contraceptive (Grade C).\nPerimenopausal bleeding\n40.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 627,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 627,
      "word_count": 85,
      "start_pos": 16697,
      "end_pos": 17324,
      "chunk_index": 32,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_33",
      "text": "s effective and consistent as \nthe use of other contraceptive (Grade C).\nPerimenopausal bleeding\n40. It \nis \nsuggested \nto \nincorporate \nthe \nuse \nof \nPALM‑COEIN  (polyp, adenomyosis, leiomyoma, \nmalignancy and hyperplasia, coagulopathy, ovulatory \ndysfunction, endometrial, iatrogenic, and not yet \nclassified) \nclassification \nfor \nabnormal \nuterine \nbleeding (AUB)[52]\n41. The common causes are anovulatory bleeding, \nleiomyoma, endometrial polyp, EH, and endometrial \ncancer (EC)[53]\n42. Endometrial tissue sampling may be performed in \npatients with AUB who are older than 40  years \n(Grade C). Office hysteroscopy is the preferred \nmethod \nfor \ntissue \nsampling.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 668,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 668,
      "word_count": 88,
      "start_pos": 17224,
      "end_pos": 17892,
      "chunk_index": 33,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_34",
      "text": "lder than 40  years \n(Grade C). Office hysteroscopy is the preferred \nmethod \nfor \ntissue \nsampling. \nBlind \nsampling \nprocedures are justified if an abnormality is \nsymmetrically “panuterine.” Directed biopsies are \npreferable, in cases of focal lesions[54]\n43. Pipelle is a safe, accurate, noninvasive, and \ncost‑effective outpatient procedure and may be \noffered to women at low risk of cancer.[55] It has a low \nsensitivity for detecting other intracavitary lesions, \nincluding polyps and submucosal fibroids, and small \nlesions may be missed. Hysteroscopy directed biopsy \nis the gold standard\n44. A meta‑analysis by van Hanegem et  al.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 641,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 641,
      "word_count": 93,
      "start_pos": 17792,
      "end_pos": 18433,
      "chunk_index": 34,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_35",
      "text": "issed. Hysteroscopy directed biopsy \nis the gold standard\n44. A meta‑analysis by van Hanegem et  al., 2016 \nconcluded that a positive test result of endometrial \nTable 1: Mortality rates\nAge\n35‑39 years\n40‑44 years\nNo method Contraception\n11.7/100,000 women\n20.6/100,000\nWith oral contraceptive pills\n1/10,000 women\n1.9/100,000\nTable 2: Unmet need for family planning, and percentage \nof women currently married women and sexually active \nwomen 15‑49 years who use any contraceptive method\nCriteria\nNumbers in percentages\nTotal unmet need in %\n13%\nUnmet need for spacing in %\n6%\nNot using any method\n47%\nFemale sterilisation\n37%\nMale sterilisation\n0.3%\nPill/Injectables\n4.1%/0.2%\nIUD/PPIUD\n1.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 692,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 692,
      "word_count": 104,
      "start_pos": 18333,
      "end_pos": 19025,
      "chunk_index": 35,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_36",
      "text": "method\n47%\nFemale sterilisation\n37%\nMale sterilisation\n0.3%\nPill/Injectables\n4.1%/0.2%\nIUD/PPIUD\n1.5%\nCondom ;male/female\n5.6%/0.1%\nRhythm/withdrawal\n3.5%/2.3%\nIUD ‑ Intrauterine device; PPIUD ‑ Postpartum Intrauterine device\n\nMeeta, et al.: Guidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\nsampling is very accurate in diagnosing endometrial \n(pre) cancer or endometrial disease. However, \nendometrial sampling is not very accurate in ruling \nout endometrial (pre) cancer and endometrial \ndisease, and therefore, further diagnostic workup \nfor focal pathology is warranted, after a benign \nresult of endometrial sampling in high‑risk women.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 226,
          "overlap_percentage": 32.801161103047896
        },
        {
          "page_number": 5,
          "overlap_chars": 462,
          "overlap_percentage": 67.05370101596516
        }
      ],
      "primary_page": 4,
      "char_count": 689,
      "word_count": 93,
      "start_pos": 18925,
      "end_pos": 19615,
      "chunk_index": 36,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_37",
      "text": "for focal pathology is warranted, after a benign \nresult of endometrial sampling in high‑risk women. \nEndometrial sampling methods show good specificity \n(98%–100%), but the sensitivity is low (76%–90%)[56]\n45. Transvaginal ultrasonography  (TVS) is the primary \nscreening test for AUB, and magnetic resonance \nimaging  (MRI) should be considered when the \ndiagnosis is inconclusive (Grade C)\n46. Persistent bleeding with a previous benign pathology, \nsuch as proliferative endometrium, requires further \ntesting to rule out focal endometrial pathology or a \nstructural pathology, such as a polyp or leiomyoma \n(Grade B)\n47.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 624,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 624,
      "word_count": 88,
      "start_pos": 19515,
      "end_pos": 20139,
      "chunk_index": 37,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_38",
      "text": "focal endometrial pathology or a \nstructural pathology, such as a polyp or leiomyoma \n(Grade B)\n47. Management depends on the cause, the cost–\nbenefit analysis of therapy, and the patient’s choice \n(Grade C).\nPostmenopausal bleeding\n48. PMB is defined as uterine bleeding occurring after \nat least 1 year of amenorrhea. Its incidence is about \n10%–15%[57]\n49. Women with PMB have a 10%–15% chance \nof having EC. Conversely, 90% of EC in the \npostmenopausal period presents with PMB. Hence, \nimmediate evaluation is required[58]\n50. The common cause of PMB is due to atrophic \nchanges in the vagina and the endometrium[59]\n51.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 626,
          "overlap_percentage": 100.16000000000001
        }
      ],
      "primary_page": 5,
      "char_count": 625,
      "word_count": 100,
      "start_pos": 20039,
      "end_pos": 20665,
      "chunk_index": 38,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_39",
      "text": "8]\n50. The common cause of PMB is due to atrophic \nchanges in the vagina and the endometrium[59]\n51. A detailed clinical and drug history is important as \nsome over‑the‑counter drugs such as “ginseng” can \ncause PMB\n52. A thorough clinical examination is carried out to \nrule out cervical, vulval, and vaginal cancer, atrophic \nvaginitis, and urinary and anal causes for bleeding\n53. Women with PMB may be assessed initially \nwith TVS and an endometrial biopsy (Grade A)\n54. Endometrial thickness is measured as the maximum \nanteroposterior thickness of the endometrial echo on \na long‑axis transvaginal view of the uterus\n55.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 626,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 626,
      "word_count": 101,
      "start_pos": 20565,
      "end_pos": 21191,
      "chunk_index": 39,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_40",
      "text": "nteroposterior thickness of the endometrial echo on \na long‑axis transvaginal view of the uterus\n55. Women with PMB with an endometrial thickness \nof  ≤3–4 mm in the transvaginal scan do not require \nendometrial sampling unless they are at a high risk for \nEC or bleeding is episodic. In an asymptomatic early \npostmenopausal woman, an endometrial thickness \nof >11 should prompt an endometrial biopsy[60]\n56. An endometrial thickness of  more than 3–5 mm in \nTVS consider endometrial sampling. The sensitivity \nfor detecting EC at 3 mm is 98%, at 4 mm is 95%, \nand at 5 mm is 90%.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 581,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 581,
      "word_count": 98,
      "start_pos": 21091,
      "end_pos": 21672,
      "chunk_index": 40,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_41",
      "text": "ial sampling. The sensitivity \nfor detecting EC at 3 mm is 98%, at 4 mm is 95%, \nand at 5 mm is 90%. In women with homogeneous \nand normal morphology, those on MHT, and \nhypertensive medication, the acceptable combined \nthickness is 6 mm[61]\n57. A focal increased echogenicity or a diffuse \nheterogeneity in the endometrium even in a thin \nendometrium warrants further investigations\n58. Outpatient endometrial sampling devices such as \nPipelle in low‑risk woman and with global pathology \nmay be used. Outpatient hysteroscopy is the preferred \nmethod for endometrial sampling\n59.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 580,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 580,
      "word_count": 91,
      "start_pos": 21572,
      "end_pos": 22152,
      "chunk_index": 41,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_42",
      "text": "athology \nmay be used. Outpatient hysteroscopy is the preferred \nmethod for endometrial sampling\n59. If the endometrial biopsy tissue is reported as \ninsufficient for diagnosis, and endometrial thickness \non TVS is <4 mm, follow‑up is sufficient. Recurrent \nepisode warrants further investigations\n60. Saline infusion sonography and three‑dimensional \n(3D) USG play a limited role in PMB evaluation.\nQuality of life\n61. The WHO defines QOL as an individual’s perception \nof their position in life in the context of the culture \nand value system in which they live and in relation to \ntheir goals, expectations, standards, and concerns.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 635,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 635,
      "word_count": 96,
      "start_pos": 22052,
      "end_pos": 22687,
      "chunk_index": 42,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_43",
      "text": "ue system in which they live and in relation to \ntheir goals, expectations, standards, and concerns.[62] \nThe two terms in common usage are global QOL and \nhealth‑related QOL  (HRQOL). The WHO‑several \nquestionnaires are used to assess the HRQOL\n62. QOL as it relates to menopausal women is usually \nreferring to HRQOL, taking into account a woman’s \nsymptoms.[63] Commonly used are Menopause Rating \nScale, Greene Climacteric Scale, Women’s Health \nQuestionnaire, and Utian QOL Scale\n63. When evaluating drug therapies, besides safety and \nefficacy, it is important to know the effect of drug on \nQOL\n64.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 605,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 605,
      "word_count": 94,
      "start_pos": 22587,
      "end_pos": 23192,
      "chunk_index": 43,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_44",
      "text": "drug therapies, besides safety and \nefficacy, it is important to know the effect of drug on \nQOL\n64. Some studies show that menopausal hormone therapy \n(MHT) significantly improves overall measures of QOL \nin symptomatic women at menopause\n65. Some studies show that low‑dose MHT significantly \nimproves overall measures of QOL. MHT had mixed \neffects on QOL among older women from the Heart \nand Estrogen or Progestin Replacement Study trial, \nwhereas the Women’s Health Initiative  (WHI) Trial \nInvestigators found that estrogen plus progestin did \nnot have a clinically meaningful effect on HRQOL\n66. An Indian study has shown an improvement in QOL \nin women receiving tibolone.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 681,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 681,
      "word_count": 105,
      "start_pos": 23092,
      "end_pos": 23773,
      "chunk_index": 44,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_45",
      "text": "ul effect on HRQOL\n66. An Indian study has shown an improvement in QOL \nin women receiving tibolone.[64]\nSymptoms of menopause\nThe symptom complex can be divided into VMS, \nsomatic symptom, genitourinary syndrome of menopause \n(GSM), and neuropsychiatric symptom.\n67. Menstrual cycle: Shortening of cycles that occurs \nin the late reproductive years is a clinical marker \nfor the onset of menopause. Later, there is usually a \nlengthening of the intermenstrual interval, and some \nmay have sudden amenorrhea.\n\nMeeta, et al.: Guidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\n68.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 508,
          "overlap_percentage": 81.28
        },
        {
          "page_number": 6,
          "overlap_chars": 115,
          "overlap_percentage": 18.4
        }
      ],
      "primary_page": 5,
      "char_count": 625,
      "word_count": 97,
      "start_pos": 23673,
      "end_pos": 24298,
      "chunk_index": 45,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_46",
      "text": "Guidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\n68. VMS\n• In a multicenter hospital, urban‑based study \nconducted by the IMS, the incidence of VMS \nwas found to be 75%.[11] There is a wide variation \nin the prevalence of symptom reporting, ranging \nfrom 19% to 75% from various studies conducted \nin India.[20,21,65] The prevalence in the UK Asians \nwas reported as 71%[66] and in the Australian \nIndians as 33%[67]\n• VMSs present as hot flushes, cold sweats, and \nnight sweats. VMS may be reported in the \nmenopause transition, reaches the maximum \nintensity during the first 2 years’ postmenopause, \nand then declines over time.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 679,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 6,
      "char_count": 679,
      "word_count": 111,
      "start_pos": 24198,
      "end_pos": 24877,
      "chunk_index": 46,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_47",
      "text": "eaches the maximum \nintensity during the first 2 years’ postmenopause, \nand then declines over time. VMS generally \nlasts for 6 months to 2 years although some may \nexperience for 10  years or longer. We need to \nexclude other causes of flushing before planning \ntreatment\n• Grading of VMS is important to plan management, \nfollow‑up, and for research.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 352,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 6,
      "char_count": 352,
      "word_count": 57,
      "start_pos": 24777,
      "end_pos": 25129,
      "chunk_index": 47,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_48",
      "text": "planning \ntreatment\n• Grading of VMS is important to plan management, \nfollow‑up, and for research. Grades of hot flushes \nare classified as mild feeling of heat without \nsweating; moderate feeling of heat with sweating; \nand severe feeling of heat with sweating and \npalpitation that disrupt usual activity[68]\n• Lifestyle modifications may be recommended to \nreduce mild VMS (Grade B)\n• The most effective treatment for VMS is MHT \n(Grade A)\n• Low‑dose OCPs if not contraindicated may \nbe used at menopause transition phase for \ncontraception and relief of symptoms (Grade A)\n• Nonhormonal prescription agents may relieve \nVMS but have their own side effects.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 662,
          "overlap_percentage": 100.15128593040848
        }
      ],
      "primary_page": 6,
      "char_count": 661,
      "word_count": 104,
      "start_pos": 25029,
      "end_pos": 25691,
      "chunk_index": 48,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_49",
      "text": "mptoms (Grade A)\n• Nonhormonal prescription agents may relieve \nVMS but have their own side effects. These can \nbe considered when MHT is contraindicated or \nnot desired (Grade B)\n• Complementary and alternative treatments should \nbe advised with caution as the data are still \ninsufficient, \nespecially \nin \nmoderate‑to‑severe \nVMS (Grade B).\n69. Somatic\n• Joint aches and pain are the commonly reported \nsymptoms among women at midlife.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 438,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 6,
      "char_count": 438,
      "word_count": 67,
      "start_pos": 25591,
      "end_pos": 26029,
      "chunk_index": 49,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_50",
      "text": "e B).\n69. Somatic\n• Joint aches and pain are the commonly reported \nsymptoms among women at midlife. While \nwomen who are obese or depressed are more \nlikely to experience joint pain, there also \nappears to be an association with menopausal \nstatus, with peri‑  and post‑menopausal women \nexperiencing \nmore \njoint \npain \nthan \nwith \npremenopausal women\n• Body composition  –  Although women typically \ngain weight during midlife, it does not appear to \nbe due to menopausal status or stage. In the early \npostmenopausal years, women typically gain \nabdominal fat mass and lose lean mass[69]\n• Skin changes  – The collagen content of the skin \nand bones is reduced by estrogen deficiency.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 688,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 6,
      "char_count": 688,
      "word_count": 110,
      "start_pos": 25929,
      "end_pos": 26617,
      "chunk_index": 50,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_51",
      "text": "69]\n• Skin changes  – The collagen content of the skin \nand bones is reduced by estrogen deficiency. \nDecreased cutaneous collagen may lead to \nincreased aging and wrinkling of the skin, frontal \nbalding, and hirsutism[70]\n• Balance – Impaired balance in the postmenopausal \nwomen may be a central effect of estrogen \ndeficiency additional to aging. Problems with \nbalance may play a role in the incidence of \nforearm fractures in women.\n70. GSM\n• The prevalence of urogenital symptoms in the \npostmenopause in the IMS study was 15%. It \npresents as vaginal dryness in 32%, pruritus \nvulvae in 10%–17%, and dyspareunia and urinary \nurgency in 10%.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 647,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 6,
      "char_count": 647,
      "word_count": 105,
      "start_pos": 26517,
      "end_pos": 27164,
      "chunk_index": 51,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_52",
      "text": "as vaginal dryness in 32%, pruritus \nvulvae in 10%–17%, and dyspareunia and urinary \nurgency in 10%. It is due to urogenital atrophy as \na result of declining estrogen levels and may also \npresent as recurrent urinary tract infections.[11,71] \nAlthough it effects the QOL, women in general \ndo not complain about it; hence, suggestive \nquestions need to be posed during history‑taking\n• Physical signs of vulvovaginal atrophy are variable \nand include reduced vulval fat, reduced vaginal \nrugae, and blood flow, leading to a pale appearance; \na change from moderately acidic range (pH 3.5–5.0) \nto a neutral range (pH 6.0–8.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 624,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 6,
      "char_count": 624,
      "word_count": 98,
      "start_pos": 27064,
      "end_pos": 27688,
      "chunk_index": 52,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_53",
      "text": "pale appearance; \na change from moderately acidic range (pH 3.5–5.0) \nto a neutral range (pH 6.0–8.0) in the vaginal pH; \nthere is a shift in the vaginal maturation index\n• Vaginal lubricants can be recommended for \nthe \nsubjective \nsymptom \nimprovement \nof \ndyspareunia (Grade B)\n• Vaginal moisturizers can be offered for vaginal \ndryness and dyspareunia (Grade B)\n• Local estrogen therapy  (ET) is the first line of \nmanagement, the only contraindication being \nactive estrogen dependant tumors (Grade A)\n• Lifestyle modification, bladder drill, and pelvic \nfloor exercises are recommended for urinary \nincontinence (Grade B).\n71.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 633,
          "overlap_percentage": 100.15822784810126
        }
      ],
      "primary_page": 6,
      "char_count": 632,
      "word_count": 95,
      "start_pos": 27588,
      "end_pos": 28221,
      "chunk_index": 53,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_54",
      "text": "bladder drill, and pelvic \nfloor exercises are recommended for urinary \nincontinence (Grade B).\n71. Sexual problems\n• A woman’s sexual response to her partner is \nsignificantly related to her baseline feelings \nfor the partner, their relationship qualities, and \npartner’s age and health\n• Sexual dysfunction is multifactorial and needs to \nbe addressed accordingly[72]\n• Vaginal atrophy with aging may lead to \ndyspareunia causing sexual dysfunction, which is \ncorrected by local ET\n• Acquired sexual desire disorder in some women \nresponds to testosterone therapy. Formulations of \ntestosterone for use in women are not available in \nIndia.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 643,
          "overlap_percentage": 100.15576323987538
        }
      ],
      "primary_page": 6,
      "char_count": 642,
      "word_count": 95,
      "start_pos": 28121,
      "end_pos": 28764,
      "chunk_index": 54,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_55",
      "text": "to testosterone therapy. Formulations of \ntestosterone for use in women are not available in \nIndia. Testosterone preparations meant for males \nshould not be prescribed for women. Tibolone is\n\nMeeta, et al.: Guidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\na good option since it contains androgenic activity \nand can be used to treat libido problems.\nCentral nervous system\n72. Dementia\n• In 2010, there are 3.7 million Indians with \ndementia, consisting of 2.1 million women and \n1.5 million men, and the total societal costs \nis about 14,700 crore. While the numbers are \nexpected to double by 2030, costs would increase \nthree times.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 191,
          "overlap_percentage": 27.883211678832115
        },
        {
          "page_number": 7,
          "overlap_chars": 492,
          "overlap_percentage": 71.82481751824817
        }
      ],
      "primary_page": 6,
      "char_count": 685,
      "word_count": 110,
      "start_pos": 28664,
      "end_pos": 29349,
      "chunk_index": 55,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_56",
      "text": "14,700 crore. While the numbers are \nexpected to double by 2030, costs would increase \nthree times. The prevalence of dementia is 0.6%–\n3.5% in rural India and 0.9%–4.8% in urban \nIndia[73]\n• The \ncore \nmental \nfunctions \nare \nmemory, \ncommunication and language, ability to focus and \npay attention, reasoning and judgment, activities \nof daily living, and visual perception.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 377,
          "overlap_percentage": 100.2659574468085
        }
      ],
      "primary_page": 7,
      "char_count": 376,
      "word_count": 57,
      "start_pos": 29249,
      "end_pos": 29626,
      "chunk_index": 56,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_57",
      "text": "ocus and \npay attention, reasoning and judgment, activities \nof daily living, and visual perception. Impairment \nof any two functions is suggestive of dementia\n• Many dementias are progressive; early diagnosis \nallows a person to get the maximum benefit from \navailable treatments and provides an opportunity \nto plan for the future\n• Factors that increase the risk of dementia are \nfamily history, genetic factor apolipoprotein E, \nmild cognitive impairment, CVD risk factors, \nphysical \ninactivity, \ndiabetes, \nhypertension, \ndyslipidemia, \nsmoking, \nobesity, \nautoimmune \ndiseases, depression and",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 600,
          "overlap_percentage": 100.1669449081803
        }
      ],
      "primary_page": 7,
      "char_count": 599,
      "word_count": 82,
      "start_pos": 29526,
      "end_pos": 30126,
      "chunk_index": 57,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_58",
      "text": "diabetes, \nhypertension, \ndyslipidemia, \nsmoking, \nobesity, \nautoimmune \ndiseases, depression and stress, social engagement \nand diet, head trauma and traumatic brain injury, \nand age (Grade B)\n• An objective marker is the examination of \ncerebrospinal fluid for amyloid‑beta or tau‑protein \nand phosphorylated tau‑protein concentration.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 339,
          "overlap_percentage": 100.59347181008901
        }
      ],
      "primary_page": 7,
      "char_count": 337,
      "word_count": 42,
      "start_pos": 30026,
      "end_pos": 30365,
      "chunk_index": 58,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_59",
      "text": "cerebrospinal fluid for amyloid‑beta or tau‑protein \nand phosphorylated tau‑protein concentration. \nThey have a sensitivity between 94% and 100% \n(Grade A)\n• ET is not currently recommended for reducing risk \nof dementia developing in the postmenopausal \nwomen or retarding the progress of diagnosed \nAlzheimer’s disease (Grade A)\n• For best preservation of memory and cognition, \nwomen should be advised about the importance \nof good overall health, good cardiac and vascular \nhealth, exercise, maintenance of active mind, \navoidance of excessive alcohol consumption, \nand measures to reduce risk of diabetes and \nhypertension.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 630,
          "overlap_percentage": 100.31847133757962
        }
      ],
      "primary_page": 7,
      "char_count": 628,
      "word_count": 89,
      "start_pos": 30265,
      "end_pos": 30895,
      "chunk_index": 59,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_60",
      "text": "idance of excessive alcohol consumption, \nand measures to reduce risk of diabetes and \nhypertension. At present, MHT is not indicated \nfor neuroprotection\n• Introduction \nof \naccessible \ndiagnostic \nand \nearly‑stage dementia care services, such as \nmemory clinics, is recommended.\n73. Depression\n• There is a significant increased risk of new‑onset \ndepression in women during the menopausal \ntransition compared with their premenopausal \nyears. In a within‑woman, 8‑year, longitudinal \nstudy to determine the risk factors for depressive \ndisorders, \na \ndiagnosis \nof \ndepression \nwas \n2.5 times more likely to occur in the menopausal \ntransition compared with when a woman was \npremenopausal.\n74.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 697,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 7,
      "char_count": 697,
      "word_count": 98,
      "start_pos": 30795,
      "end_pos": 31492,
      "chunk_index": 60,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_61",
      "text": "ore likely to occur in the menopausal \ntransition compared with when a woman was \npremenopausal.\n74. Cognitive changes\n \nEvidence supports the relation of estrogen to \ncognitive function; women face problems with \nmemory loss and difficulty in concentration at \nmenopause transition. A  definitive role of MHT for \ntreating cognitive symptoms without VMS is lacking.\n75. Sleep\n• In a study conducted in the UK Asians, sleep \nproblems were noted in 32%. A  large study of \nover  9000 older adults aged  >65  years found \nthat 42% of participants reported difficulty in \ninitiating and maintaining sleep.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 602,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 7,
      "char_count": 602,
      "word_count": 93,
      "start_pos": 31392,
      "end_pos": 31994,
      "chunk_index": 61,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_62",
      "text": ">65  years found \nthat 42% of participants reported difficulty in \ninitiating and maintaining sleep.[74] The estimate \nof the prevalence of sleep disorders in India, by \nthe WHO extrapolated data from the US data, is \n156,628,027 in 1,065,070,607 population\n• A detailed assessment of menopausal symptoms \nshould always include questions about sleep \npattern.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 359,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 7,
      "char_count": 359,
      "word_count": 52,
      "start_pos": 31894,
      "end_pos": 32253,
      "chunk_index": 62,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_63",
      "text": "A detailed assessment of menopausal symptoms \nshould always include questions about sleep \npattern. Sleep questionnaires or sleep diaries can \nbe useful to assess sleep in detail (Grade B)\n• Adverse lifestyle factors, social factors, and \nrisk factors should be considered and treated \naccordingly (Grade C)\n• If insomnia is identified, medical or psychiatric \ncauses of insomnia should be ruled out, and \nif present, it should be treated accordingly.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 452,
          "overlap_percentage": 100.22172949002217
        }
      ],
      "primary_page": 7,
      "char_count": 451,
      "word_count": 68,
      "start_pos": 32153,
      "end_pos": 32605,
      "chunk_index": 63,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_64",
      "text": "chiatric \ncauses of insomnia should be ruled out, and \nif present, it should be treated accordingly. If \nspecific neurological or breathing disorders are \nsuspected, further investigations and referrals to \nspecialists should be initiated (Grade B)\n• Sleep \nhygiene \nmeasures \nand \nlifestyle \nmodifications should be recommended as the \nfirst‑line treatment. Psychological treatments, \nsuch as cognitive behavioral therapy, should also \nbe considered (Grade B)\n• If insomnia is resistant to lifestyle modifications, \nthen hypnotics, benzodiazepines, or melatonin \nagonists can be used in the short term, but there \nis no definite or convincing evidence to suggest \nits efficacy.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 678,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 7,
      "char_count": 678,
      "word_count": 95,
      "start_pos": 32505,
      "end_pos": 33183,
      "chunk_index": 64,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_65",
      "text": "e used in the short term, but there \nis no definite or convincing evidence to suggest \nits efficacy. These should only be prescribed by \nsupervision or after liaison with psychiatrists or \nsleep experts (Grade C)\n• No recommendations can be made about the \nuse of herbal remedies for insomnia as there \nis insufficient evidence. Mind–body therapies \nsuch as yoga and tai chi have some evidence \nbut need further rigorous studies to prove its \neffectiveness (Grade D)\n\nMeeta, et al.: Guidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\nSkeletomuscular system\n76.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 466,
          "overlap_percentage": 76.89768976897689
        },
        {
          "page_number": 8,
          "overlap_chars": 138,
          "overlap_percentage": 22.772277227722775
        }
      ],
      "primary_page": 7,
      "char_count": 606,
      "word_count": 98,
      "start_pos": 33083,
      "end_pos": 33689,
      "chunk_index": 65,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_66",
      "text": "Journal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\nSkeletomuscular system\n76. Osteoporosis: Refer Clinical Practice Guidelines on \nPostmenopausal Osteoporosis: An executive summary \nand recommendations: Indian Menopause Society.\n77. Osteoarthritis\n• The prevalence of osteoarthritis in India as \nreported from community dwellers in a small \nstudy conducted in Delhi was 47.3%, and in \nothers, it is reported to be between 22% and \n39%[75‑77]\n• Age, weight, female sex, quadriceps weakness, \nand overloading of the knee joint  are the main \ncontributors than menopause per se in the \nincidence of osteoarthritis.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 634,
          "overlap_percentage": 100.15797788309638
        }
      ],
      "primary_page": 8,
      "char_count": 633,
      "word_count": 93,
      "start_pos": 33589,
      "end_pos": 34223,
      "chunk_index": 66,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_67",
      "text": "he knee joint  are the main \ncontributors than menopause per se in the \nincidence of osteoarthritis. Those contributing \nfactors should be addressed on a priority basis\n• Epidemiological studies of a potential role for \nestrogens in osteoarthritis showed two very \ndifferent findings. First, estrogen deprivation \nat the menopause seems to be associated with \nincreases in the frequency of knee, hip, and \nfinger osteoarthritis and in the severity of hip \nosteoarthritis.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 471,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 8,
      "char_count": 471,
      "word_count": 70,
      "start_pos": 34123,
      "end_pos": 34594,
      "chunk_index": 67,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_68",
      "text": "n the frequency of knee, hip, and \nfinger osteoarthritis and in the severity of hip \nosteoarthritis. Second, MHT for the menopause \nmay decrease the incidence and progression of \nhip and knee osteoarthritis\n• The identification of the estrogen receptors (ERs) \nin normal and osteoarthritic cartilage and the \neffects of 17‑beta‑estradiol on cartilage in  vivo \nin animals and in vitro confirm that the cartilage \nresponds to estrogens. Finally, this response is \ndose dependent: physiological doses  (as with \nMHT) are protective and higher dosages are \ndeleterious\n• Once osteoarthritis sets in, there is no protection \nfrom MHT and osteoarthritis takes its own course.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 670,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 8,
      "char_count": 670,
      "word_count": 101,
      "start_pos": 34494,
      "end_pos": 35164,
      "chunk_index": 68,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_69",
      "text": "ce osteoarthritis sets in, there is no protection \nfrom MHT and osteoarthritis takes its own course. \nIn such cases, osteoarthritis should be treated on \nits own merits\n• Age, weight, female sex, quadriceps weakness, \nand overloading of the knee joint are the main \ncontributors than menopause per se in the \nincidence of osteoarthritis. Those contributing \nfactors should be addressed on a priority basis\n• First two stages of osteoarthritis can be addressed \nby lifestyle modification, pharmacotherapy, and \nphysical therapy (Grade A).",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 537,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 8,
      "char_count": 537,
      "word_count": 81,
      "start_pos": 35064,
      "end_pos": 35601,
      "chunk_index": 69,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_70",
      "text": "ritis can be addressed \nby lifestyle modification, pharmacotherapy, and \nphysical therapy (Grade A). A  Cochrane review \nfound that about 60% of the patients achieved \nat least 50% improvement in pain with topical \nnonsteroidal \nanti‑inflammatory \ndrugs, \nwhich \nwas comparable to the effect obtained with oral \nformulations and slightly better than that observed \nwith topical placebo.\n• Third and fourth stages need surgical intervention, \nfor which total knee replacement is the gold \nstandard (Grade B).\n78. CVD.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 516,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 8,
      "char_count": 516,
      "word_count": 75,
      "start_pos": 35501,
      "end_pos": 36017,
      "chunk_index": 70,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_71",
      "text": "d surgical intervention, \nfor which total knee replacement is the gold \nstandard (Grade B).\n78. CVD.\nPrevention and management\n• Lifestyle interventions (Grade A)\n• Encourage optimal BP  <120/80 mmHg through \nlifestyle approaches (Grade A)\n• Pharmacotherapy if BP  ≥140/90 mmHg to avoid \nend‑organ damage, more so in diabetes (Grade A)\n• Use thiazide diuretics, unless there is an absolute \ncontraindication\n• Optimal lipid targets  (Grade A)  –  Low‑density \nlipoprotein \n(LDL) \n<100 \nmg/dL, \nhigh‑density \nlipoprotein \n(HDL) \n>50 \nmg/dL, \ntriglycerides \n<150 mg/dL, non‑HDL cholesterol <100 mg/dL",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 600,
          "overlap_percentage": 100.33444816053512
        }
      ],
      "primary_page": 8,
      "char_count": 598,
      "word_count": 85,
      "start_pos": 35917,
      "end_pos": 36517,
      "chunk_index": 71,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_72",
      "text": "ensity \nlipoprotein \n(HDL) \n>50 \nmg/dL, \ntriglycerides \n<150 mg/dL, non‑HDL cholesterol <100 mg/dL \n(Grade A)\n• Women at high risk: Initiate statin if LDL >100 mg/dL \n(Grade A)\n• Women at intermediate risk: Initiate statin if \nLDL >130 mg/dL (Grade A)\n• Lifestyle approaches and pharmacotherapy to achieve \nnear‑normal glycosylated hemoglobin  (HbA1C  <7%) \nin women with diabetes (Grade A)\n• Aspirin in high‑risk women  (75–162 mg/day) \n(Grade A)\n• Routine use of aspirin in women <65 years of age is \nnot recommended for MI prevention (Grade C)\n• MHT is not indicated solely for primary or secondar",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 8,
      "char_count": 600,
      "word_count": 96,
      "start_pos": 36417,
      "end_pos": 37017,
      "chunk_index": 72,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_73",
      "text": "s \nnot recommended for MI prevention (Grade C)\n• MHT is not indicated solely for primary or secondary \ncardioprotection\n• A 2015 Cochrane review of randomized controlled \ntrial (RCT) data found that MHT initiated fewer than \n10 years after menopause onset lowered coronary heart \ndisease (CHD) in the postmenopausal women (relative \nrisk [RR], 0.52). It also found a reduction in all‑cause \nmortality  (RR, 0.70), no increased risk of stroke, but \nan increased risk of VTE  (RR, 1.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 481,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 8,
      "char_count": 481,
      "word_count": 77,
      "start_pos": 36917,
      "end_pos": 37398,
      "chunk_index": 73,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_74",
      "text": "ll‑cause \nmortality  (RR, 0.70), no increased risk of stroke, but \nan increased risk of VTE  (RR, 1.74), similar to the \nfindings of an earlier meta‑analysis of studies in women \nwho initiated MHT within 10 years of menopause onset \nor in women aged younger than 60 years (Grade A)\n• Do not use antioxidant supplements for CVD \nprevention (Grade C)\n• Do not use folic acid, with or without B6 or \nB12 supplements for CVD prevention (Grade C).\n79. Metabolic syndrome: Insulin resistance (IR)\n \nThe prevalence reported in India at perimenopause is \n22.2%, rising to 32.2%–48% at postmenopause.[78,79] It \nis 1.5–2 times more common in women than in men\n80.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 654,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 8,
      "char_count": 654,
      "word_count": 109,
      "start_pos": 37298,
      "end_pos": 37952,
      "chunk_index": 74,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_75",
      "text": "rising to 32.2%–48% at postmenopause.[78,79] It \nis 1.5–2 times more common in women than in men\n80. The metabolic syndrome is also known as IR \nsyndrome and syndrome X, and an average of 40% \nof the Indian women are affected\n81. Clinical conditions associated with IR include \nT2DM, CVD, polycystic ovary syndrome  (PCOS), \nnonalcoholic fatty liver, obstructive sleep apnea, and \ncertain cancers. It is also a prominent feature of the\n\nMeeta, et al.: Guidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\nmetabolic syndrome\n82.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 435,
          "overlap_percentage": 76.18213660245185
        },
        {
          "page_number": 9,
          "overlap_chars": 134,
          "overlap_percentage": 23.46760070052539
        }
      ],
      "primary_page": 8,
      "char_count": 571,
      "word_count": 92,
      "start_pos": 37852,
      "end_pos": 38423,
      "chunk_index": 75,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_76",
      "text": "ause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\nmetabolic syndrome\n82. Diagnosis \nof \nmetabolic \nsyndrome: \nNational \nCholesterol Education Program Adult Treatment \nPanel III (NCEP ATO III 2005 revision); abdominal \nobesity defined as >35 inche in females; serum \ntriglycerides >150 mg/dL; BP >130/85 mm Hg; and \nfasting plasma glucose >110 mg/dL  –  any three out \nof the five criteria\n83. Effect of MHT: A  meta‑analysis of pooled data \nfrom 107 trials concluded that MHT reduced IR, \nabdominal obesity, new‑onset diabetes, lipids, BP, \nadhesion molecules, and procoagulant factors in \nwomen without diabetes and reduced fasting glucose \nand IR in women with diabetes.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 9,
          "overlap_chars": 700,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 9,
      "char_count": 700,
      "word_count": 106,
      "start_pos": 38323,
      "end_pos": 39023,
      "chunk_index": 76,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_77",
      "text": "ulant factors in \nwomen without diabetes and reduced fasting glucose \nand IR in women with diabetes. The effects were \ndiminished by the addition of progestin (Grade A)\n84.The basis of dietary recommendations is to \nreduce exposure to insulin both as a result of \ndietary stimulus and through decreased IR (Grade \nB). We should advocate exercise as it improves \ninsulin sensitivity, aiming for a minimum of \n30 min of moderate physical activity/exercise per \nday\n85. Indications for the intervention by body mass \nindex (BMI) category are shown in Table 3[79]\n86. Abdominal \nobesity \nbased \non \nthe \nwaist \ncircumference[79] is shown in Table 4\n87.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 9,
          "overlap_chars": 648,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 9,
      "char_count": 648,
      "word_count": 103,
      "start_pos": 38923,
      "end_pos": 39571,
      "chunk_index": 77,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.386485"
    },
    {
      "id": "chunk_78",
      "text": "Table 3[79]\n86. Abdominal \nobesity \nbased \non \nthe \nwaist \ncircumference[79] is shown in Table 4\n87. DM\n• India has 63 million people with diabetes and \nis second largest in numbers. The prevalence \nrate of diabetes in the last 30  years has \nincreased from 2.3% in urban and 1.2% in rural \nareas  (1971) to 15%–20% in urban and 10% in \nrural areas (2012)\n• The prevalence of diabetes in women in the age \ngroup of 15–49  years was 10.5% in the urban \npopulation and 7.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 9,
          "overlap_chars": 469,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 9,
      "char_count": 469,
      "word_count": 85,
      "start_pos": 39471,
      "end_pos": 39940,
      "chunk_index": 78,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_79",
      "text": "nce of diabetes in women in the age \ngroup of 15–49  years was 10.5% in the urban \npopulation and 7.5% in the rural, based on the \ndata from the National Family Health Survey, \n2015‑2016 (NFHS‑4)\n• The prevalence in hospital‑based multicenter study \nby the IMS in the postmenopausal woman was 12%\n• In India, T2DM occurs a decade earlier than the \nCaucasians. More than 50% of the subjects are \nundiagnosed[80]\n• Screening: Opportunistic screening for all women \nabove the age of 30  years, every 3  years for \nyounger women with risk factors  (Grade C), \nshould be done.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 9,
          "overlap_chars": 571,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 9,
      "char_count": 571,
      "word_count": 97,
      "start_pos": 39840,
      "end_pos": 40411,
      "chunk_index": 79,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_80",
      "text": "e age of 30  years, every 3  years for \nyounger women with risk factors  (Grade C), \nshould be done. Diabetic women should be \nscreened for hypertension, dyslipidemia, and \nmicroalbuminuria and undergo yearly eye check\n• Laboratory test for screening: The best test is a \nfasting plasma glucose or nonfasting HbA1c.[81] \nIf fasting blood glucose is normal at <100 mg/dL \nor HbA1c  <5.7%, retesting should be done at \n3‑year intervals. If the fasting blood glucose is \n100–125 mg/dL or HbA1C is 5.7%–6.4%, repeat \ntesting should be done in 1–3‑year intervals. \nPrediabetes should be defined if the fasting blood \nglucose is 100–125 mg/dL or HbA1c is 5.7%–\n6.4%.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 9,
          "overlap_chars": 660,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 9,
      "char_count": 660,
      "word_count": 106,
      "start_pos": 40311,
      "end_pos": 40971,
      "chunk_index": 80,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_81",
      "text": "Prediabetes should be defined if the fasting blood \nglucose is 100–125 mg/dL or HbA1c is 5.7%–\n6.4%.\n• The goal in management is to maintain the \nHbA1c around  <7% and control risk factors for \nCVD\n• It may be indicated to evaluate the endometrium \nby transvaginal scan before starting MHT.\n88. Thyroid disease\n• The prevalence from hospital‑based data in the \npostmenopausal women for hypothyroid in India \nis 3%–7%[82]\n• Hypothyroidism is much more common in older \nthan younger individuals\n• Symptoms \nand \nsigns \ninclude \nlethargy, \nconstipation, \ndry \nskin, \nalopecia, \nmemory \nimpairment, and depression.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 9,
          "overlap_chars": 610,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 9,
      "char_count": 610,
      "word_count": 94,
      "start_pos": 40871,
      "end_pos": 41481,
      "chunk_index": 81,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_82",
      "text": "signs \ninclude \nlethargy, \nconstipation, \ndry \nskin, \nalopecia, \nmemory \nimpairment, and depression. The individual is \noften obese and may have elevated cholesterol\n• The \nprevalence \nof \nhypothyroidism \nis \napproximately \n5% \nin \notherwise \nhealthy \nindividuals. Thyroid‑stimulating hormone  (TSH) \nis a good screening test.\nTable 3: Body mass index in kg/m2 category and management\nCategory and intervention\nCategory\nWHO\nIndian\nIntervention\nUnder weight\n<18.5\n<18\nEncourage balanced diet and exercise\nHealthy\n18.5‑24.9\n18.0‑22.9\nEncourage balanced diet and exercise\nOverweight\n25.0‑29.9\n23.0‑24.9\nLifestyle (diet, exercise and behavior therapy)\nObese Grade I\n>30.0‑34.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 9,
          "overlap_chars": 671,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 9,
      "char_count": 671,
      "word_count": 88,
      "start_pos": 41381,
      "end_pos": 42052,
      "chunk_index": 82,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_83",
      "text": "erweight\n25.0‑29.9\n23.0‑24.9\nLifestyle (diet, exercise and behavior therapy)\nObese Grade I\n>30.0‑34.9\n>25\nLifestyle, lifestyle plus drug therapy if comorbidities* exist\nObesity Grade II\n35.0‑39.9\nLifestyle plus drug therapy: If comorbidities* exist, bariatric surgery\nObese Grade III\n≥40\nLifestyle, drug therapy, and bariatric surgery\n*Comorbidities: Hypertension, diabetes, and hyperlipidemia. WHO: World Health Organization\nTable 4: Obesity as defined by waist circumference\nWHO\nIndian Management\n>80 cm\n>72 cm Action line 1 ‑ Avoid weight gain or lose weight\n>88 cm\n>80 cm Action line 2 ‑ Supervised weight management\nWHO: World Health Organization\n\nMeeta, et al.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 9,
          "overlap_chars": 651,
          "overlap_percentage": 97.74774774774775
        },
        {
          "page_number": 10,
          "overlap_chars": 13,
          "overlap_percentage": 1.951951951951952
        }
      ],
      "primary_page": 9,
      "char_count": 666,
      "word_count": 97,
      "start_pos": 41952,
      "end_pos": 42618,
      "chunk_index": 83,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_84",
      "text": "cm\n>80 cm Action line 2 ‑ Supervised weight management\nWHO: World Health Organization\n\nMeeta, et al.: Guidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\n89. Anemia\n \nAnemia is common in the elderly people in India. \nThe overall prevalence of anemia was 68.7%.[83] \nThe prevalence of iron deficiency anemia, Vitamin \nB12 deficiency, and folate deficiency is common and \nshould be an integral part of the management of \nmenopause.\n90. Eye\n• Blindness was more likely with increasing age \nand decreasing socioeconomic status, in female \nsubjects and in rural areas. The causes of \nblindness were easily treatable in 60.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 9,
          "overlap_chars": 85,
          "overlap_percentage": 12.83987915407855
        },
        {
          "page_number": 10,
          "overlap_chars": 575,
          "overlap_percentage": 86.85800604229608
        }
      ],
      "primary_page": 9,
      "char_count": 662,
      "word_count": 106,
      "start_pos": 42518,
      "end_pos": 43180,
      "chunk_index": 84,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_85",
      "text": "tatus, in female \nsubjects and in rural areas. The causes of \nblindness were easily treatable in 60.3% (cataract, \n44%; refractive error, 16.3%).[84] Preventable \ncorneal disease, glaucoma, complications of \ncataract surgery, and amblyopia caused another \n19% of the blindness [Table 5][85]\n• Blindness due to primary angle‑closure glaucoma \nis potentially avoidable if this condition is \ndetected early and peripheral iridotomy or \niridectomy is performed. This requires the \ndetection of occludable angles, which lead to \nprimary angle‑closure glaucoma, using slit‑lamp \nexamination and gonioscopy.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 10,
      "char_count": 600,
      "word_count": 81,
      "start_pos": 43080,
      "end_pos": 43680,
      "chunk_index": 85,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_86",
      "text": "angles, which lead to \nprimary angle‑closure glaucoma, using slit‑lamp \nexamination and gonioscopy. Blindness due to \nprimary open‑angle glaucoma is more difficult \nto \nprevent \nand \nmedication \nin \nopen‑angle \nglaucoma could prevent the progression of the \ndisease (Grade A)\n• There is increased risk of dry eye in both genders \nwith age due to decreased tear production. \nThe incidence is more in women than in men. \nMenopause also contributes to the ocular surface \nimpairment due to hormonal imbalance\n• MHT after menopause, especially unopposed \nET, has been implicated to cause the dry eye \n(Grade B).\n91.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 612,
          "overlap_percentage": 100.16366612111294
        }
      ],
      "primary_page": 10,
      "char_count": 611,
      "word_count": 94,
      "start_pos": 43580,
      "end_pos": 44192,
      "chunk_index": 86,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_87",
      "text": "after menopause, especially unopposed \nET, has been implicated to cause the dry eye \n(Grade B).\n91. Prevention of blindness\n• Improvement in the quality of cataract surgery \nand increase in the number of surgeries on \npersons blind in both eyes\n• Effective screening to detect the refractive error \nblindness and provision of spectacles\n• Initiation of long‑term strategies to prevent \ncorneal and glaucoma blindness\n• Effective control of diabetes and yearly eye \ncheckup to prevent diabetic retinopathy.\nCancers\n92.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 518,
          "overlap_percentage": 100.19342359767892
        }
      ],
      "primary_page": 10,
      "char_count": 517,
      "word_count": 79,
      "start_pos": 44092,
      "end_pos": 44610,
      "chunk_index": 87,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_88",
      "text": "• Effective control of diabetes and yearly eye \ncheckup to prevent diabetic retinopathy.\nCancers\n92. A \npopulation‑based \nstudy \n(Million \nDeath \nStudy Cancer Mortality in India: A  Nationally \nRepresentative Survey, 2012) revealed that 1 in 22 \nmen or women aged 30  years alive today in rural \nIndia is likely to die of cancer before 70 years of age \nbased on the rates of actual deaths and in the absence \nof other disorders. In urban areas, the risks are 1 in \n20 for men and 1 in 24 for women.[86,87]\nBreast cancer\n93. Breast cancer in India is now the most common \ncancer in most cities and second most common in the \nrural areas.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 636,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 10,
      "char_count": 636,
      "word_count": 112,
      "start_pos": 44510,
      "end_pos": 45146,
      "chunk_index": 88,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_89",
      "text": "r in India is now the most common \ncancer in most cities and second most common in the \nrural areas. In 2012, it is estimated that approximately \n145,000 new patients were diagnosed with breast \ncancer in India, and nearly 70,000 women died of \nthe disease. The data from Atlas Project suggest that \nbreast cancer in urban areas of India is three times \nhigher than in rural parts of the country[88‑90]\n94. More younger women are getting diagnosed with \nbreast cancer. 25  years back, 69% of the patients \nwere above 50 years of age. At present, almost 48% \nof patients are below 50  years age.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 594,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 10,
      "char_count": 594,
      "word_count": 104,
      "start_pos": 45046,
      "end_pos": 45640,
      "chunk_index": 89,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_90",
      "text": "e patients \nwere above 50 years of age. At present, almost 48% \nof patients are below 50  years age. Breast cancers \nin the young are hormone positive in 48%; the rest \nare negative and tend to be more aggressive. Indian \nwomen are more likely to develop breast cancer at \nearlier ages than their Western counterparts[91,92]\n95. In the United States, 89 women out of 100 are likely \nto survive for 5 years after breast cancer. In India, a \nrough estimate is not even 60% and present late in \nStage III[93,94]\n96.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 512,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 10,
      "char_count": 512,
      "word_count": 91,
      "start_pos": 45540,
      "end_pos": 46052,
      "chunk_index": 90,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_91",
      "text": "breast cancer. In India, a \nrough estimate is not even 60% and present late in \nStage III[93,94]\n96. Nonmodifiable risk factors for breast cancer are age, \nfamily history, benign breast disease, BRCA  (breast \ncancer) 1 or 2 carriers, early menarche  (<12  years), \nlate age at menopause (after age 55 years), increased \nbreast density, and a chest irradiation between ages \nof 25 and 55 years\n97. Modifiable risk factors are age at first child, \nbreastfeeding, parity, obesity, physical activity, and \nmenopausal HT.\nScreening in breast cancer\n98. The debate about value of screening continues. There \nis no organized, systematic, government‑funded \nscreening program for breast cancer in India.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 696,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 10,
      "char_count": 696,
      "word_count": 106,
      "start_pos": 45952,
      "end_pos": 46648,
      "chunk_index": 91,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_92",
      "text": "There \nis no organized, systematic, government‑funded \nscreening program for breast cancer in India. \nThe screening in developing countries can be \nregarded as “opportunistic screening.” There are no \nevidence‑based guidelines for breast cancer screening \nin India at present\n99. There are no validated breast screening tools in India. \nThe 5‑year NCI or IBIS breast cancer risk assessment \nis arrived at and classified as low, intermediate, or \nhigh. These tools are simple to implement in the \npopulation. The limitation is that they have not being \nTable 5: Causes of blindness\nDisease\nPercentage of contribution (%)\nCataract\n62.6\nRefractive error\n19.7\nGlaucoma\n5.8\nCorneal pathologies\n0.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 691,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 10,
      "char_count": 691,
      "word_count": 103,
      "start_pos": 46548,
      "end_pos": 47239,
      "chunk_index": 92,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_93",
      "text": "rcentage of contribution (%)\nCataract\n62.6\nRefractive error\n19.7\nGlaucoma\n5.8\nCorneal pathologies\n0.9\nOther causes\n11.00\n\nMeeta, et al.: Guidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\nvalidated in the Indian population. MHT needs to be \navoided in the moderate and high risk category.\n100. Methods\n \nBreast cancer screening includes three methods of \nearly detection (Grade C).\n• Breast self‑examination (BSE) monthly starting in \nthe 20s\n• Clinical breast examination  (CBE) every 3  years \nstarting in the 20s till 39 and annually thereafter\n• Mammography screening  (annually) starting at \nthe age of 40 years.\n101.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 120,
          "overlap_percentage": 17.964071856287426
        },
        {
          "page_number": 11,
          "overlap_chars": 546,
          "overlap_percentage": 81.73652694610777
        }
      ],
      "primary_page": 10,
      "char_count": 668,
      "word_count": 104,
      "start_pos": 47139,
      "end_pos": 47807,
      "chunk_index": 93,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_94",
      "text": "9 and annually thereafter\n• Mammography screening  (annually) starting at \nthe age of 40 years.\n101. BSE\n• BSE is performed by the woman herself and \ninvolves examination of the breast, skin, and \naxillae – based on the palpations by her hands\n• The woman should examine the look and feel of \nher breasts as well as any signs, symptoms, or \nchanges to the breasts\n• BSE is recommended so that women understand their \nbreasts for detecting any suspicious changes over time\n• Initially, \nBSE \nshould \nbe \nperformed \nvery \nfrequently and regularly so that a woman \nunderstands the physiological changes",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 600,
          "overlap_percentage": 100.1669449081803
        }
      ],
      "primary_page": 11,
      "char_count": 599,
      "word_count": 100,
      "start_pos": 47707,
      "end_pos": 48307,
      "chunk_index": 94,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_95",
      "text": "e \nperformed \nvery \nfrequently and regularly so that a woman \nunderstands the physiological changes that occur \nduring the different phases of menstrual cycle and \nthen continue monthly around 7th or 8th day of \ncycle. They are encouraged to report any recent \nor persistent changes\n• Nodular and lumpy feel of the breasts and \nincreased pain and tenderness, which is a \nphysiological finding before menstruation, needs \nto be explained to the patient\n• Women can be taught to examine the breasts in \nany of the following ways in supine as well as \nstanding positions.\n102.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 573,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 11,
      "char_count": 573,
      "word_count": 94,
      "start_pos": 48207,
      "end_pos": 48780,
      "chunk_index": 95,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_96",
      "text": "to examine the breasts in \nany of the following ways in supine as well as \nstanding positions.\n102. CBE\n• CBE and increasing awareness of breast cancer \nare viable alternative in view of limited healthcare \nresources \nand \nadvanced \nstage \nof \ndisease \ndistribution for Indian women aged 50 years\n• Early results of trial by the WHO in India (Journal \nof the National Cancer Institute  [JNCI 2011]) \nand studies for cost‑effectiveness of screening in \nIndian women support that CBE is an effective \nway and survival can be improved by up to 16% \nat half the cost[93]\n• For women between 50 and 70  y",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 600,
          "overlap_percentage": 100.1669449081803
        }
      ],
      "primary_page": 11,
      "char_count": 599,
      "word_count": 103,
      "start_pos": 48680,
      "end_pos": 49280,
      "chunk_index": 96,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_97",
      "text": "way and survival can be improved by up to 16% \nat half the cost[93]\n• For women between 50 and 70  years of age, \nannual CBE and selective use of mammography, \nonce in 3  years, in high‑risk groups, determined \nby the above‑mentioned criteria have been found \nto be equally effective (JNCI 2011)\n• CBE is performed by a clinician or other \nhealth professional and involves a systematic \nexamination of the breast skin and tissue\n• The health professional is looking for signs and \nsymptoms or if any changes occur, including \ndevelopment of a lump or swelling, skin irritation \nor dimpling, nipple pa",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 11,
      "char_count": 600,
      "word_count": 102,
      "start_pos": 49180,
      "end_pos": 49780,
      "chunk_index": 97,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_98",
      "text": "changes occur, including \ndevelopment of a lump or swelling, skin irritation \nor dimpling, nipple pain or retraction  (turning \ninward), redness or scaliness of the nipple or \nbreast skin, or a discharge other than breast milk\n• CBE should include all the four quadrants of \nthe breast and the central nipple areola complex \nfollowed by examination of the axilla and \nsupraclavicular fossae\n• Fibroadenoma, a benign condition, feels as a \nfirm and freely mobile swelling, characteristically \ndescribed as a “mouse in the breast,” whereas an \nirregular hard painless lump is a characteristic of \nmalig",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 11,
      "char_count": 600,
      "word_count": 93,
      "start_pos": 49680,
      "end_pos": 50280,
      "chunk_index": 98,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_99",
      "text": "d as a “mouse in the breast,” whereas an \nirregular hard painless lump is a characteristic of \nmalignancy\n• These findings are generalized and all lumps may \nnot classically fit into these descriptions\n• Normal breasts may feel lumpy and tender before \nmenstruation, especially if felt with the tips \nof the fingers; hence, the use of a flat hand is \nrecommended.\n103.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 368,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 11,
      "char_count": 368,
      "word_count": 62,
      "start_pos": 50180,
      "end_pos": 50548,
      "chunk_index": 99,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_100",
      "text": "specially if felt with the tips \nof the fingers; hence, the use of a flat hand is \nrecommended.\n103. Mammogram\n• In India, breast cancer incidence peaks before \nthe age of 50  years, and a recent review of the \nevidence in younger women  (aged 39–49  years), \nbased on eight trials conducted between 2001 and \n2008, suggests that mammography screening is \nalso beneficial in this younger age group\n• An approximate 12%–15% reduction in breast \ncancer mortality is associated with mammography \nscreening for women aged 40–69 years[94]\n• Imitations \nof \nmammography \nin \ndeveloping \ncountries are economic constraints and quality \nassurance.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 639,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 11,
      "char_count": 639,
      "word_count": 99,
      "start_pos": 50448,
      "end_pos": 51087,
      "chunk_index": 100,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_101",
      "text": "tations \nof \nmammography \nin \ndeveloping \ncountries are economic constraints and quality \nassurance. \nCost‑affectivity \nand \nfalse‑positive \nrates are the other limitations in the use of \nmammography in India\n• The decision to perform mammography should \nbe determined with shared decision‑making about \nrisks and benefits and by individual patient values\n104.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 360,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 11,
      "char_count": 360,
      "word_count": 49,
      "start_pos": 50987,
      "end_pos": 51347,
      "chunk_index": 101,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_102",
      "text": "termined with shared decision‑making about \nrisks and benefits and by individual patient values\n104. MRI\n• Currently, MRI screening in combination with \nmammography is targeted to high‑risk patients, \nwhich includes:\n• BRCA 1 or 2 mutation carriers\n• Untested women who have a first‑degree relative \nwith a BRCA 1 or 2 mutation\n• Life time risk of breast cancer of 20%–25% or \nmore\n• Received radiation treatment to the chest between \nages of 10 and 30 years\n• Women with silicon implants.\n105. \u0007Role of positron‑emission tomography  (PET) \nimaging\n\nMeeta, et al.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 548,
          "overlap_percentage": 97.33570159857904
        },
        {
          "page_number": 12,
          "overlap_chars": 13,
          "overlap_percentage": 2.3090586145648313
        }
      ],
      "primary_page": 11,
      "char_count": 563,
      "word_count": 92,
      "start_pos": 51247,
      "end_pos": 51810,
      "chunk_index": 102,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_103",
      "text": "men with silicon implants.\n105. \u0007Role of positron‑emission tomography  (PET) \nimaging\n\nMeeta, et al.: Guidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\n \n \u0007PET has currently a limited role in breast cancer, \ndue to its low sensitivity, and is not recommended \nin most of the cases, especially in early disease. \nThe most useful application of PET or computed \ntomography \nis \nmonitoring \nthe \nchanges \nin \n18‑fludeoxyglucose uptake during chemotherapy to \ndetect an early response to treatment.\n106.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 85,
          "overlap_percentage": 15.567765567765568
        },
        {
          "page_number": 12,
          "overlap_chars": 459,
          "overlap_percentage": 84.06593406593407
        }
      ],
      "primary_page": 11,
      "char_count": 546,
      "word_count": 83,
      "start_pos": 51710,
      "end_pos": 52256,
      "chunk_index": 103,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_104",
      "text": "s \nin \n18‑fludeoxyglucose uptake during chemotherapy to \ndetect an early response to treatment.\n106. Breast cancer prevention\n• The risk of breast cancer may be lowered to some \nextent by lifestyle changes, working on modifiable \nrisk factors, and diligent use of MHT\n• The best way to protect one’s self is through early \ndetection\nPrevention in high‑risk population\n107. \u0007Indications of risk reducing surgery, mastectomy, \nsalpingo‑oophorectomy, \nand \nchemoprevention \ncan be discussed with experts. The decision is \nindividualized.\nCancer cervix\n108. \u0007The number of new cases of cervical cancer \ndetected in India is 96,922 every year.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 638,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 12,
      "char_count": 638,
      "word_count": 95,
      "start_pos": 52156,
      "end_pos": 52794,
      "chunk_index": 104,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_105",
      "text": "cer cervix\n108. \u0007The number of new cases of cervical cancer \ndetected in India is 96,922 every year. Deaths due \nto cervical cancer in India are 60,078/year[95]\n109. \u0007Opportunistic screening coverage varied from 6.9% \nin Kerala to 0.006% and 0.002% in the western \nstate of Maharashtra and southern state of Tamil \nNadu, respectively[96]\n110. \u0007India contributes to over  25% of the disease \nburden and more than 26% of the deaths due to \ncervical cancer, worldwide. More than 75% of the \ncases presenting in the late stage of the disease \nrender poor prospects for survival and cure. About \n134,420 new case are being diagnosed every \nyear[97]\n111.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 648,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 12,
      "char_count": 648,
      "word_count": 106,
      "start_pos": 52694,
      "end_pos": 53342,
      "chunk_index": 105,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_106",
      "text": "or prospects for survival and cure. About \n134,420 new case are being diagnosed every \nyear[97]\n111. \u0007Risk factors are human papilloma virus  (HPV), \nsexual intercourse at an early age, multiple sexual \npartners, sexual partners who have had multiple \npartners, HIV‑positive status, and smoking\n112. Screening tests available\n• Visual inspection\n• Visual inspection with acetic acid (VIA)\n• Visual inspection with Lugol’s iodine\n• Papanicolaou (PAP) smear both conventional and \nliquid‑based cytology\n• HPV‑DNA testing\n• Cervicography\n• Polar probe.\n113. \u0007The first three are useful at community and \nlow‑resource setting\n114.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 626,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 12,
      "char_count": 626,
      "word_count": 92,
      "start_pos": 53242,
      "end_pos": 53868,
      "chunk_index": 106,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_107",
      "text": "cography\n• Polar probe.\n113. \u0007The first three are useful at community and \nlow‑resource setting\n114. \u0007Cost‑effectiveness studies on VIA screening also \nsuggest that, once in a lifetime, screening at the age \nof 35 years involving one or two visits reduced the \nlifetime risk of cancer by approximately 25%–36%. \nThe relative risk further decreased by 40% with \ntwo rounds of screenings  (at 35 and 45  years of \nage).[98]\nScreening at different levels of care\n115.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 464,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 12,
      "char_count": 464,
      "word_count": 75,
      "start_pos": 53768,
      "end_pos": 54232,
      "chunk_index": 107,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_108",
      "text": "rounds of screenings  (at 35 and 45  years of \nage).[98]\nScreening at different levels of care\n115. Primary care (rural/urban)\n• Cytology‑based screening has made little impact \nin developing countries due to relatively high \nfalse‑negative rate and lack of organized screening \nprogram and referral pattern\n• Several studies have shown the benefit of a \nsingle‑visit approach in the form of “see and treat,” \nwhich involves VIA followed by cryotherapy. \nThis unique approach is based on the principle \nthat the screening test should provide rapid and \naccurate results and the treatment modality \nshould be appropriate, adequate, and effective.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 646,
          "overlap_percentage": 100.15503875968992
        }
      ],
      "primary_page": 12,
      "char_count": 645,
      "word_count": 97,
      "start_pos": 54132,
      "end_pos": 54778,
      "chunk_index": 108,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_109",
      "text": "id and \naccurate results and the treatment modality \nshould be appropriate, adequate, and effective. \nVIA and cryotherapy satisfied these criteria and \nyielded satisfying results. A  randomized trial in \nSouth India done by Sankaranarayanan et  al., \nin 2007, has shown 25% reduction in cervical \ncancer incidence and 35% reduction in mortality \ncompared to control with VIA and cryotherapy.[98] \nThis approach is useful in primary care level to \nmake the screening program more cost‑effective.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 494,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 12,
      "char_count": 494,
      "word_count": 72,
      "start_pos": 54678,
      "end_pos": 55172,
      "chunk_index": 109,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_110",
      "text": "] \nThis approach is useful in primary care level to \nmake the screening program more cost‑effective. \nThis can be carried out both by physicians and by \ntrained nurses and midwives[99‑105]\n• Colposcopy: For diagnostic confirmation with \nguided biopsies in screen‑positive women, post \nany primary screening method adopted. Because \nof hormonal changes, many postmenopausal \nwomen will have an unsatisfactory colposcopy.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 419,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 12,
      "char_count": 419,
      "word_count": 59,
      "start_pos": 55072,
      "end_pos": 55491,
      "chunk_index": 110,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_111",
      "text": "ed. Because \nof hormonal changes, many postmenopausal \nwomen will have an unsatisfactory colposcopy. \nEstrogen treatment  (estrogen cream application \nintravaginally each evening for 2  weeks and \nstopped 1 week before repeat cytology) will cause \nenough ectropion of the endocervical cells to \nresult in a satisfactory examination\n• HPV \ntesting \nalso \nhas \nbeen \ntried \nin \na \nscreen‑and‑treat approach. A few studies reported \nscreening with HPV DNA testing followed by \ncryotherapy. However, it has two limitations: \ntime and infrastructure required for the current \nHPV testing and a lack of consensus about \nappropriate follow‑up for test positives and also \ntreatment strategy.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 684,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 12,
      "char_count": 684,
      "word_count": 97,
      "start_pos": 55391,
      "end_pos": 56075,
      "chunk_index": 111,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_112",
      "text": "nd a lack of consensus about \nappropriate follow‑up for test positives and also \ntreatment strategy. Hence, in some other studies, \nTable 6: Screening at different levels of cancer cervix\nLevel of care \nIntervention\nPrimary\nVIA + cryotherapy/HPV + cryotherapy\nSecondary\nPAP±HPV cotesting\nTertiary\nPAP±HPV cotesting\nPap: Papanicolaou, HPV: Human papilloma virus, VIA: Visual \ninspection with acetic acid\n\nMeeta, et al.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 402,
          "overlap_percentage": 96.40287769784173
        },
        {
          "page_number": 13,
          "overlap_chars": 13,
          "overlap_percentage": 3.117505995203837
        }
      ],
      "primary_page": 12,
      "char_count": 417,
      "word_count": 60,
      "start_pos": 55975,
      "end_pos": 56392,
      "chunk_index": 112,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_113",
      "text": "p: Papanicolaou, HPV: Human papilloma virus, VIA: Visual \ninspection with acetic acid\n\nMeeta, et al.: Guidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\nHPV DNA‑positive women had VIA followed by \ncryotherapy if VIA was positive\n• Some \nstudies \nsuggest \nthat \ncryotherapy \nis \nprotective against the future development of \ncervical disease among women with current HPV \ninfection. Because of this, and due to the low \nmorbidity of cryotherapy, the occasional treatment \nof screen‑positive women without confirmed \ncervical disease is acceptable.\n116.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 85,
          "overlap_percentage": 14.237855946398659
        },
        {
          "page_number": 13,
          "overlap_chars": 510,
          "overlap_percentage": 85.42713567839196
        }
      ],
      "primary_page": 12,
      "char_count": 597,
      "word_count": 88,
      "start_pos": 56292,
      "end_pos": 56889,
      "chunk_index": 113,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_114",
      "text": "casional treatment \nof screen‑positive women without confirmed \ncervical disease is acceptable.\n116. Secondary and tertiary level\n \nPAP smear and HPV‑DNA testing are being used \ncommonly at secondary and tertiary care level.\n117. \u0007Screening \ntechniques’ \nrecommendations \nfrom \ndifferent organizations may be applicable at different \nsettings both in rural and in urban [Table 6]\n118. \u0007HPV co‑testing is to be performed only if the \nwoman crosses 30 years of age as most of the HPV \ninfection clears by then with natural immunity. \nIf both PAP and HPV are negative, the screening \ninterval can be increased, which again becomes \ncost‑effective\n119.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 648,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 13,
      "char_count": 648,
      "word_count": 98,
      "start_pos": 56789,
      "end_pos": 57437,
      "chunk_index": 114,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_115",
      "text": "HPV are negative, the screening \ninterval can be increased, which again becomes \ncost‑effective\n119. \u0007Colposcopy: For diagnostic confirmation with \nguided biopsies in screen‑positive women, post \nany primary screening method adopted. Because of \nhormonal changes, many postmenopausal women \nwill have an unsatisfactory colposcopy. Estrogen \ntreatment (estrogen cream application intravaginally \neach evening for 2  weeks and stopped 1  week \nbefore repeat cytology) will cause enough ectropion \nof the endocervical cells to result in a satisfactory \nexamination\n120. \u0007Screening \nrecommendations \nfrom \ndifferent \norganizations are presented in Table 7\n121.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 656,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 13,
      "char_count": 656,
      "word_count": 86,
      "start_pos": 57337,
      "end_pos": 57993,
      "chunk_index": 115,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_116",
      "text": "ation\n120. \u0007Screening \nrecommendations \nfrom \ndifferent \norganizations are presented in Table 7\n121. \u0007Women with negative PAP and positive HPV \ntesting can be either rescreened with co‑testing in \n1 year or with a test specific for type of HPV\n122. \u0007All these screening methods may be sometimes \ninconclusive in the menopausal women whose \ntransformation zone is inside the cervical canal \nor due to atrophic changes. Hence, choosing the \nappropriate test is important.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 469,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 13,
      "char_count": 469,
      "word_count": 72,
      "start_pos": 57893,
      "end_pos": 58362,
      "chunk_index": 116,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_117",
      "text": "the cervical canal \nor due to atrophic changes. Hence, choosing the \nappropriate test is important.\n• High‑risk  (oncogenic) HPV DNA testing could \nbe adopted for appropriate triage management \nof postmenopausal women with unequivocal \ncytology results\n• HPV DNA testing is indicated in postcolposcopy \nmanagement of women of any age with \ninitial cytological result of atypical glandular \ncells \n(or \natypical \nsquamous \ncells \ncannot \nexclude‑high‑grade \nsquamous \nintraepithelial \nlesion in initial workup does not identify a \nhigh‑grade lesion)\n• If a low‑cost and rapid HPV is available, this may \nbe used as primary screening test every 5  years \nup to the age of 65  years.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 681,
          "overlap_percentage": 100.1470588235294
        }
      ],
      "primary_page": 13,
      "char_count": 680,
      "word_count": 102,
      "start_pos": 58262,
      "end_pos": 58943,
      "chunk_index": 117,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_118",
      "text": "s available, this may \nbe used as primary screening test every 5  years \nup to the age of 65  years. With HPV testing as \nthe primary screening method, PAP or VIA testing \ncan be used to triage to evaluate those with \nHPV‑positive test results to plan for appropriate \ntreatment options\n• Above recommendation holds true for women \nseeking opportunistic services in apex and \nsecondary care levels in public and private sector \nhealth facilities where good‑quality PAP cytology \nservices and molecular testing for HPV‑DNA are \navailable\n• In the absence of organized cervix cancer \nscreening for the",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 600,
          "overlap_percentage": 100.1669449081803
        }
      ],
      "primary_page": 13,
      "char_count": 599,
      "word_count": 96,
      "start_pos": 58843,
      "end_pos": 59443,
      "chunk_index": 118,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_119",
      "text": "r testing for HPV‑DNA are \navailable\n• In the absence of organized cervix cancer \nscreening for the vast women population in rural \nand urban areas, once in a lifetime, screening by \nco‑testing by combined use of cervical cytology \nand high‑risk HPV‑DNA testing would be \nappropriate [Table 7].\nPrimary prevention\n123. \u0007Women should be educated early on to think \nof cervical cancer as an extension of a sexually \ntransmitted disease\n124.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 438,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 13,
      "char_count": 438,
      "word_count": 70,
      "start_pos": 59343,
      "end_pos": 59781,
      "chunk_index": 119,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_120",
      "text": "ucated early on to think \nof cervical cancer as an extension of a sexually \ntransmitted disease\n124. \u0007Behavioral changes to reduce the risk of cervical \ncancer include limiting the number of sexual \nTable 7: Screening recommendations from different organizations\nAge (years)\nUSPSTF\nACS/ASCCP\n30‑65\nCo‑testing with PAP + HPV every 5 years (preferred) \nPAP alone every 3 years (acceptable) (Grade A)\nSame as USPSTF Recommendations\n>65\nScreening not recommended in women who have \nhad adequate prior screening and or not high risk for \ncervical cancer (Grade D)\nAdequate prior negative screening no hist",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 13,
      "char_count": 600,
      "word_count": 93,
      "start_pos": 59681,
      "end_pos": 60281,
      "chunk_index": 120,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_121",
      "text": "eening and or not high risk for \ncervical cancer (Grade D)\nAdequate prior negative screening no history \nof high‑grade CIN in the last 20 years, no \nscreening should not be resumed even a \nwoman reports having a new sexual partner\nPosthysterectomy, \nartificial menopause\nNo screening if hysterectomy with removal of the \ncervix is performed for benign lesions and no history \nof high‑grade CIN (Grade D)\nNo screening if hysterectomy is performed \nwith no history of high‑grade CIN\nHPV vaccinated\nScreening as per the age\nScreening as per age\nUSPSTF: United States Preventive Services Task Force, ACS:",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 13,
      "char_count": 600,
      "word_count": 96,
      "start_pos": 60181,
      "end_pos": 60781,
      "chunk_index": 121,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_122",
      "text": "ening as per the age\nScreening as per age\nUSPSTF: United States Preventive Services Task Force, ACS: American Cancer Society, ASSCP: American Society for Colposcopic and \nCervical Pathology, CIN: Cervical intraepithelial neoplasia, PAP: Papinocolau, HPV: Human papilloma virus\n\nMeeta, et al.: Guidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\npartners, delaying initial age of sexual intercourse, \nand avoiding sexually transmitted disease. The \nassociation of cigarette smoking with cervical \ncancer should also be emphasized\n125. \u0007An HPV vaccine needs to be promoted, especially \nin the age group of 9 years to the age of first sexual \ndebut.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 276,
          "overlap_percentage": 39.94211287988423
        },
        {
          "page_number": 14,
          "overlap_chars": 413,
          "overlap_percentage": 59.7684515195369
        }
      ],
      "primary_page": 13,
      "char_count": 691,
      "word_count": 104,
      "start_pos": 60681,
      "end_pos": 61372,
      "chunk_index": 122,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_123",
      "text": "ine needs to be promoted, especially \nin the age group of 9 years to the age of first sexual \ndebut. Data from a large placebo‑controlled trial \nshowed that the vaccine reduced the incidence of \nboth HPV‑16 infection and HPV‑16‑related cervical \nintraepithelial neoplasia.[106]\nEndometrial cancer\n126. \u0007Indian incidence of EC is 4.3/100,000 as per \nthe Delhi population‑based cancer registry. EC \ncommonly occurs in the postmenopausal women[107]\n127. \u0007Overall morbidity and mortality of EC are low \nbecause most patients present at an early stage \nbecause of abnormal bleeding or PMB\n128.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 588,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 14,
      "char_count": 588,
      "word_count": 89,
      "start_pos": 61272,
      "end_pos": 61860,
      "chunk_index": 123,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_124",
      "text": "C are low \nbecause most patients present at an early stage \nbecause of abnormal bleeding or PMB\n128. \u0007Risk factors\n• Factors that increase the risk of EC are those \nassociated with increase in endogenous ET or HT \nwith estrogens\n• A strong modifiable risk factor is increasing \nobesity; the relative risk of EC with obesity is \n3 in women 9.5 -22 kg overweight and 10 in \nwomen more than 22 kg overweight\n• Women taking tamoxifen for more than 2  years \nhave a 2.3‑fold to 7.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 475,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 14,
      "char_count": 475,
      "word_count": 87,
      "start_pos": 61760,
      "end_pos": 62235,
      "chunk_index": 124,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_125",
      "text": "en more than 22 kg overweight\n• Women taking tamoxifen for more than 2  years \nhave a 2.3‑fold to 7.5‑fold relative risk of EC[108]\n• Adenomatous hyperplasia and EH are the \ncommon precursors of endometrial carcinoma\n• Unopposed ET in women with an intact uterus \nincreases the risk of EC 2–10‑fold, and the risk \nincreases with the duration of use\n• The lifetime risk of EC for women with hereditary \nnonpolyposis colorectal cancer (HNPCC) and for \nwomen who are at high risk for HNPCC is as \nhigh as 60%[109]\n• Cyclic or continuous progestin given along with \nestrogens reduces the risk of EC.\n129. \u0007There is no evidence that screening by USG or \nendometrial biopsy reduces mortality from EC.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 694,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 14,
      "char_count": 694,
      "word_count": 119,
      "start_pos": 62135,
      "end_pos": 62829,
      "chunk_index": 125,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_126",
      "text": ".\n129. \u0007There is no evidence that screening by USG or \nendometrial biopsy reduces mortality from EC. \nMost cases of EC (85%) are diagnosed at low stage \nbecause of symptoms, and the survival rates are \nhigh[110]\n130. \u0007There is no indication that screening for EC is \nwarranted for women who have no identified risk \nfactors[111]\n131. \u0007It is recommended that, at the time of menopause, \nwomen at average risk should be informed about \nthe risks and symptoms of EC and strongly \nencouraged to report any unexpected bleeding or \nspotting\n132.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 539,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 14,
      "char_count": 539,
      "word_count": 90,
      "start_pos": 62729,
      "end_pos": 63268,
      "chunk_index": 126,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_127",
      "text": "isks and symptoms of EC and strongly \nencouraged to report any unexpected bleeding or \nspotting\n132. \u0007For those with increased risk and special situations, \nsuch as on MHT (tibolone sequential MHT), genetic \nrisk, and tamoxifen therapy, they should have a \nfollow‑up and complete diagnostic evaluation as \nneeded. Regular screening for high‑risk group for \nEC has not been fully evaluated\n133. \u0007Women diagnosed with EC should have the benefit \nof multidisciplinary team approach.\nEndometrial hyperplasia\n134.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 508,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 14,
      "char_count": 508,
      "word_count": 75,
      "start_pos": 63168,
      "end_pos": 63676,
      "chunk_index": 127,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_128",
      "text": "ed with EC should have the benefit \nof multidisciplinary team approach.\nEndometrial hyperplasia\n134. \u0007Definition: EH is a pathological condition that most \noften results from persistent, prolonged exposure of \nunopposed estrogenic  (endogenous production or \nexogenous administration of estrogens) stimulation \nof the endometrium. It is known to be precursor of \nEC\n135.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 370,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 14,
      "char_count": 370,
      "word_count": 51,
      "start_pos": 63576,
      "end_pos": 63946,
      "chunk_index": 128,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_129",
      "text": "dministration of estrogens) stimulation \nof the endometrium. It is known to be precursor of \nEC\n135. \u0007There are two methods of classifying EH:\n• The 2014 WHO EH classification system has \nonly two categories  –  hyperplasia without \natypia (nonneoplastic) and atypical hyperplasia \n(endometrial intraepithelial neoplasm [EIN])[112]\n• The EIN classification system defines two classes \nof endometrial changes: benign and intraepithelial \nneoplasia[113]\n136. \u0007EH is a histologic diagnosis made based upon the \nresults of evaluation of an endometrial biopsy, \nendometrial curettage sample, or hysterectomy \nspecimen\n137.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 617,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 14,
      "char_count": 617,
      "word_count": 85,
      "start_pos": 63846,
      "end_pos": 64463,
      "chunk_index": 129,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_130",
      "text": "f evaluation of an endometrial biopsy, \nendometrial curettage sample, or hysterectomy \nspecimen\n137. \u0007Clinical significance: EH is of clinical significance \nbecause it is often a precursor lesion to Type I \nendometrioid adenocarcinoma of the endometrium. \nEndometrial stripe thickness and age were the \nstrongest predictors of concurrent endometrial \ncancer at time of hysterectomy for EIN. An \nendometrial stripe of  ≥2 cm was associated \nwith 4.0  times the odds of concurrent EC  (95% \nconfidence interval, 1.5–10.0), controlling for age\n138.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 545,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 14,
      "char_count": 545,
      "word_count": 78,
      "start_pos": 64363,
      "end_pos": 64908,
      "chunk_index": 130,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_131",
      "text": "4.0  times the odds of concurrent EC  (95% \nconfidence interval, 1.5–10.0), controlling for age\n138. \u0007Management\n• All management strategies should also be \naccompanied by the removal of the extrinsic \nor intrinsic source of unopposed estrogen since \nexcess exposure to estrogen is a main etiology of \nendometrial neoplasia\n• Conservative management: if the risk of an \noccult cancer or progression to cancer is low and \nthe inciting factor that resulted in endometrial \nproliferation has been eliminated  (e.g.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 511,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 14,
      "char_count": 511,
      "word_count": 77,
      "start_pos": 64808,
      "end_pos": 65319,
      "chunk_index": 131,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_132",
      "text": "low and \nthe inciting factor that resulted in endometrial \nproliferation has been eliminated  (e.g., patient \nwith anovulation, now corrected, who had \ndeveloped simple hyperplasia without atypia) \nand requires vigilant follow‑up with two negative \nbiopsies 6 months apart[114]\n• Benign EH:  (1) Conservative with use of \ncontinuous progesterones and follow‑up (2) \nSurgical—total \nhysterectomy \n(TH) \nwhen \nassociated with high‑risk factors, postmenopause\n• EIN: TH with bilateral salpingo‑opherctomy\n\nMeeta, et al.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 502,
          "overlap_percentage": 97.28682170542635
        },
        {
          "page_number": 15,
          "overlap_chars": 13,
          "overlap_percentage": 2.5193798449612403
        }
      ],
      "primary_page": 14,
      "char_count": 516,
      "word_count": 68,
      "start_pos": 65219,
      "end_pos": 65736,
      "chunk_index": 132,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_133",
      "text": "ed with high‑risk factors, postmenopause\n• EIN: TH with bilateral salpingo‑opherctomy\n\nMeeta, et al.: Guidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\n(BSOP) for EIN provides definitive assessment of \na possible concurrent carcinoma and effectively \ntreats premalignant lesions in a postmenopausal \nwoman. In premenopausal women, decision \nregarding BSOP needs to be individualized. \nSupracervical hysterectomy, morcellation, and \nendometrial ablation are unacceptable for the \ntreatment of EIN.[115]\nCancer ovary\n139. \u0007The general or lifetime risk of ovarian cancer is \n1.4%\n140.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 85,
          "overlap_percentage": 13.535031847133757
        },
        {
          "page_number": 15,
          "overlap_chars": 541,
          "overlap_percentage": 86.14649681528662
        }
      ],
      "primary_page": 14,
      "char_count": 628,
      "word_count": 87,
      "start_pos": 65636,
      "end_pos": 66264,
      "chunk_index": 133,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_134",
      "text": "eatment of EIN.[115]\nCancer ovary\n139. \u0007The general or lifetime risk of ovarian cancer is \n1.4%\n140. \u0007The most common sign of ovarian cancer is \nenlargement of the abdomen caused by the \naccumulation of fluid or a large ovarian mass\n141. \u0007However, many women have bloating or weight gain \nin the abdominal area, making this sign nonspecific\n142. \u0007In \nwomen \naged \nover \nyears, \ndigestive \ndisturbances that persist and cannot be explained \nby any other cause indicate the need for a thorough \nevaluation for ovarian cancer, including a carefully \nperformed pelvic examination and ultrasound (US)\n143.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 15,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 15,
      "char_count": 600,
      "word_count": 95,
      "start_pos": 66164,
      "end_pos": 66764,
      "chunk_index": 134,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_135",
      "text": "ion for ovarian cancer, including a carefully \nperformed pelvic examination and ultrasound (US)\n143. \u0007Risk factors\n• A first‑degree relative with ovarian cancer \n(mother, sister, or daughter)\n• Personal history of breast cancer <40 years or age\n• Personal history of breast cancer  <50  years or \nage and one or more close relative with breast \nor ovary cancer at any age; two or more close \nrelative with breast cancer  <50  years of age or \novarian cancer at any age.\n144. \u0007Screening\n• No screening guidelines are available for mass \nscreening for ovarian cancer.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 15,
          "overlap_chars": 565,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 15,
      "char_count": 565,
      "word_count": 93,
      "start_pos": 66664,
      "end_pos": 67229,
      "chunk_index": 135,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_136",
      "text": "age.\n144. \u0007Screening\n• No screening guidelines are available for mass \nscreening for ovarian cancer. Recommendation \nfor screening is dependent on the risk status of \nwomen[116]\n• A heightened awareness of the symptoms of \nearly ovarian cancers on the parts of the patients \nand practitioners may help reduce the delay in \ndiagnosis and hopefully result in an improvement \nin the outcome of some progress\n• For general population, annual pelvic examination, \nPAP smear, and transvaginal sonography are \nrecommended as a part of postmenopausal surveillance\n145.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 15,
          "overlap_chars": 560,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 15,
      "char_count": 560,
      "word_count": 85,
      "start_pos": 67129,
      "end_pos": 67689,
      "chunk_index": 136,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_137",
      "text": "AP smear, and transvaginal sonography are \nrecommended as a part of postmenopausal surveillance\n145. \u0007Primary prevention: Limited data are available \non the efficacy of prophylactic oophorectomy in \ndecreasing the risk of ovarian cancer in mutation \ncarriers. Still, it is recommended that prophylactic \nsurgery be considered in BRCA mutation carriers \nwho have completed childbearing.\nVulvar cancer\n146. \u0007Epidemiology: Cancer of the vulva is a rare \ndisease that accounts for approximately 5% of \ngynecological cancers. The median age of onset is \napproximately 65–70 years for invasive cancer and \napproximately 45–50 years for carcinoma in situ\n147.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 15,
          "overlap_chars": 652,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 15,
      "char_count": 652,
      "word_count": 94,
      "start_pos": 67589,
      "end_pos": 68241,
      "chunk_index": 137,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_138",
      "text": "roximately 65–70 years for invasive cancer and \napproximately 45–50 years for carcinoma in situ\n147. \u0007Risk factors for vulvar cancer including HPV, \nprevious genital warts, greater number of sexual \npartners, current smoking, abnormal PAP smear, \ndiabetes, obesity, chronic vulvar pruritus, and poor \npersonal hygiene have also been suggested as \ncontributing to risk\n148. \u0007Protected intercourse, monogamy, and adequate \nhygiene of the external genitalia protect against \nvulvar cancer\n149. \u0007Prevention and detection: The prevention of vulvar \ncancer rests in the avoidance of risk factors and \napplication of protective factors as summarized \nabove.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 15,
          "overlap_chars": 650,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 15,
      "char_count": 650,
      "word_count": 91,
      "start_pos": 68141,
      "end_pos": 68791,
      "chunk_index": 138,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_139",
      "text": "rests in the avoidance of risk factors and \napplication of protective factors as summarized \nabove. Annual examinations should be performed \nto check for vulvar cancer. High‑risk patients \nshould be examined every 6 months. White lesions \nand chronic ulcerative lesions should be biopsied \nfor evaluation.\nStomach cancer\n150. \u0007According to the GLOBOCAN 2018 data, in \nwomen aged 30–69 years, the fourth most common \nfatal cancer was stomach (14.1%). Stomach cancer \nrates were higher in rural than in urban areas \nof India due to increased prevalence of chronic \nHelicobacter pylori infection. Treating for H. pylori \nmay prevent stomach cancer\n151.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 15,
          "overlap_chars": 650,
          "overlap_percentage": 100.15408320493067
        }
      ],
      "primary_page": 15,
      "char_count": 649,
      "word_count": 98,
      "start_pos": 68691,
      "end_pos": 69341,
      "chunk_index": 139,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_140",
      "text": "e of chronic \nHelicobacter pylori infection. Treating for H. pylori \nmay prevent stomach cancer\n151. \u0007Million Death Study Cancer Mortality in India: \nA  Nationally Representative Survey 2012: This \nmay include stomach and primary liver cancer. \nThe prevalence of hepatitis B virus  (HBV) in \nIndia was  <1.9% in 72,000 pregnant women aged \n15–49 years who were tested in 2002\n152. \u0007Nearly, 37% of all female cancer deaths were \nfrom \ninfection‑related \ncervical, \nstomach, \nand liver cancers and 18.3% were from \ntobacco‑related \ncancers. \nThis \nunderscores \nthe importance of vaccination and control of \ninfection. Vaccination against HBV would \nreduce future liver cancer deaths and cirrhosis.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 15,
          "overlap_chars": 695,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 15,
      "char_count": 695,
      "word_count": 101,
      "start_pos": 69241,
      "end_pos": 69936,
      "chunk_index": 140,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_141",
      "text": "ntrol of \ninfection. Vaccination against HBV would \nreduce future liver cancer deaths and cirrhosis. \nUse of tobacco in pan and beedi should be \nstrongly discouraged.\nHyperandrogenism at menopause\n153. \u0007Postmenopause is a state of relative androgen \nexcess in relation to estrogen; the postmenopausal \novary \nremains \nhormonally \nactive, \nsecreting \nsignificant amounts of androgens and relatively \nfewer estrogens years after menopause\n154. \u0007There is no consensus regarding specific clinical \nand hormonal indices and/or imaging modalities \nrequired for diagnostic certainty[117]\n\nMeeta, et al.: Guidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\n155.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 15,
          "overlap_chars": 580,
          "overlap_percentage": 83.0945558739255
        },
        {
          "page_number": 16,
          "overlap_chars": 116,
          "overlap_percentage": 16.6189111747851
        }
      ],
      "primary_page": 15,
      "char_count": 698,
      "word_count": 97,
      "start_pos": 69836,
      "end_pos": 70534,
      "chunk_index": 141,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_142",
      "text": "uidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\n155. \u0007Hyperandrogenism in the postmenopausal women \ncan \nbe \ngenerally \ncategorized as \nfunctional/\nnontumorous or tumorous\n156. \u0007The \ncauses \nof \nfunctional \nhyperandrogenism, \nsuch as PCOS and nonclassic congenital adrenal \nhyperplasia, \nare \nclinically \nmanifested \nbefore \nmenopause\n157. \u0007Androgen‑secreting neoplasm should be suspected \nin cases of clitoromegaly  (clitoral size  >1.5 cm \n×  2.5 cm) and other signs of virilization even \nif symptom progression is not rapid.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 575,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 16,
      "char_count": 575,
      "word_count": 79,
      "start_pos": 70434,
      "end_pos": 71009,
      "chunk_index": 142,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_143",
      "text": "size  >1.5 cm \n×  2.5 cm) and other signs of virilization even \nif symptom progression is not rapid. Very high \nserum \ntestosterone \n(>150–200 \nng/dL) \nand/or \nDHEAS (>6000 ng/mL) levels are indicative of \nan androgen‑secreting tumor of the ovarian and \nadrenal origin, respectively\n158. \u0007The \nlong‑term \nsequelae \nof \nnontumorous \nhyperandrogenism in the postmenopausal women \nin respect to cardiovascular morbidity and mortality \nare not known.[117]\nPolycystic ovary syndrome at menopause\n159. \u0007Increased androgen secretion by the ovarian theca \ncells is a primary defect in PCOS and may persist \nas hyperandrogenism in a subset of the population\n160.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 653,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 16,
      "char_count": 653,
      "word_count": 95,
      "start_pos": 70909,
      "end_pos": 71562,
      "chunk_index": 143,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_144",
      "text": "is a primary defect in PCOS and may persist \nas hyperandrogenism in a subset of the population\n160. \u0007Androgen excess favors the development of \nabdominal \nadiposity, \nIR, \nand \ncompensatory \nhyperinsulinism, \nand \nthis \nfurther \nincreases \nandrogens, leading to a vicious circle that \npredisposes these women to metabolic dysfunction \nand cardiovascular risk[118]\n161. \u0007Menopausal transition does not seem to be \nassociated with worsening of cardiometabolic \nprofile in PCOS patients. This may be related to \nthe improvement in phenotypic features of PCOS \nwith aging. The phenotype of PCOS plays an \nimportant role in determining the cardiometabolic \nrisk in patients with the syndrome[119]\n162.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 697,
          "overlap_percentage": 100.14367816091954
        }
      ],
      "primary_page": 16,
      "char_count": 696,
      "word_count": 100,
      "start_pos": 71462,
      "end_pos": 72159,
      "chunk_index": 144,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_145",
      "text": "an \nimportant role in determining the cardiometabolic \nrisk in patients with the syndrome[119]\n162. \u0007Population‑based, longitudinal studies examining \ncardiometabolic morbidity and mortality in women \nwith PCOS are lacking\n163. \u0007Identifying clinical and biochemical characteristics \nof PCOS in the postmenopausal period may \nprovide a reliable method for following women to \nhelp define the true cardiovascular morbidity and \nmortality\n164. \u0007As a part of menopause workup, vigilance is needed \nin women with hyperandrogenism and PCOS or a \nhistory of PCOS as this forms an additional risk \nfactor for cancers.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 610,
          "overlap_percentage": 100.16420361247948
        }
      ],
      "primary_page": 16,
      "char_count": 609,
      "word_count": 87,
      "start_pos": 72059,
      "end_pos": 72669,
      "chunk_index": 145,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_146",
      "text": "yperandrogenism and PCOS or a \nhistory of PCOS as this forms an additional risk \nfactor for cancers. Persistent thickened endometrium \nand/or risk factors including prolonged amenorrhea, \nabnormal vaginal bleeding, or excess weight need \nto be investigated[117]\n165. \u0007Therapeutic \nstrategies \ncurrently \nin \nuse \nfor \nPCOS, \nincluding \nlifestyle \nmodification, \noral \ncontraceptives  (OCs), antiandrogens, and insulin \nsensitizers, are used throughout the lifespan such \nthat these women enter menopause with a healthy \nmetabolic profile.\nEndometriosis and menopause\n166. \u0007Endometriosis in the postmenopausal women is a \nrare condition\n167.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 640,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 16,
      "char_count": 640,
      "word_count": 84,
      "start_pos": 72569,
      "end_pos": 73209,
      "chunk_index": 146,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_147",
      "text": "ndometriosis and menopause\n166. \u0007Endometriosis in the postmenopausal women is a \nrare condition\n167. \u0007Postmenopausal endometriosis may have a greater \ntendency to spread and involve extragonadal organs \nand structures that may develop into constrictive \nand/or obstructive lesions[120]\n168. \u0007Surgical treatment is the first‑line therapy to exclude \nmalignancy case of postmenopausal endometriosis, \nbut drug treatment may be an option in case of \npain recurrence after surgery[121]\n169. \u0007In a Cochrane review, authors concluded that MHT \nmay increase the risk of endometriosis symptoms \nand disease recurrence after surgically induced \nmenopause.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 646,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 16,
      "char_count": 646,
      "word_count": 88,
      "start_pos": 73109,
      "end_pos": 73755,
      "chunk_index": 147,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_148",
      "text": "ease the risk of endometriosis symptoms \nand disease recurrence after surgically induced \nmenopause. The current data are, however, insufficient \nto justify not administering HRT for symptomatic \nwomen after surgically induced menopause[122]\n170. \u0007The evidence is currently insufficient to support \nany conclusions about the optimal MHT regimen \nfor women with endometriosis. Few data suggest \na higher malignancy risk with estrogen‑only MHT \ncompared with combined MHT[121]\n171. \u0007Postmenopausal women should be conscientiously \nevaluated before initiating MHT. Patients with \nendometriosis receiving MHT should be monitored \nregularly for pain recurrence.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 656,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 16,
      "char_count": 656,
      "word_count": 86,
      "start_pos": 73655,
      "end_pos": 74311,
      "chunk_index": 148,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_149",
      "text": "MHT. Patients with \nendometriosis receiving MHT should be monitored \nregularly for pain recurrence.\nFibroid and menopause\n• Fibroids are benign tumors that probably arise from \na somatic myometrial stem cell. They have ERs \nand progesterone receptors  (PRs). After menopause, \nfibroids generally shrink, and some may become \ncalcified due to the loss of estrogen\n• Malignant transformation into sarcoma is possible \nbut exceedingly rare (around 1/2000)[123]\n• At menopause transition, depending on the patient’s \nsymptoms and age, fibroids can be managed \nexpectantly, medically, radiologically, or",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 600,
          "overlap_percentage": 100.33444816053512
        }
      ],
      "primary_page": 16,
      "char_count": 598,
      "word_count": 84,
      "start_pos": 74211,
      "end_pos": 74811,
      "chunk_index": 149,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_150",
      "text": "he patient’s \nsymptoms and age, fibroids can be managed \nexpectantly, medically, radiologically, or surgically\n• MHT \nuse \nin \nthe \nmenopausal \nwomen \nwith \nasymptomatic fibroid demonstrates variable effects \non the volume and size of uterine fibroids\n• Some combination estrogen and progestin therapy \nmay increase in size of preexisting myomas and \nincrease in frequency of new myoma formation, \nespecially with higher doses of MPA (5 mg/day). Use \nthe lowest possible dose of progestin with estrogen\n• The use of tibolone for menopausal symptoms is \ngenerally associated with fewer episodes of irregular \nspotting and no significant changes in volume or size\n\nMeeta, et al.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 661,
          "overlap_percentage": 97.7810650887574
        },
        {
          "page_number": 17,
          "overlap_chars": 13,
          "overlap_percentage": 1.9230769230769231
        }
      ],
      "primary_page": 16,
      "char_count": 676,
      "word_count": 102,
      "start_pos": 74711,
      "end_pos": 75387,
      "chunk_index": 150,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_151",
      "text": "th fewer episodes of irregular \nspotting and no significant changes in volume or size\n\nMeeta, et al.: Guidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\nof myoma compared with estrogen, progestin therapy\n• Raloxifene appears to be relatively safe for \nmenopausal women at risk of osteoporosis or breast \ncancer, who present with asymptomatic fibroids\n• If on MHT, periodic follow‑ups with an ultrasound \nevery 3 months for appearance of symptoms and \ngrowth of myoma are advisable in the initial year.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 85,
          "overlap_percentage": 15.539305301645337
        },
        {
          "page_number": 17,
          "overlap_chars": 460,
          "overlap_percentage": 84.09506398537478
        }
      ],
      "primary_page": 16,
      "char_count": 547,
      "word_count": 88,
      "start_pos": 75287,
      "end_pos": 75834,
      "chunk_index": 151,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_152",
      "text": "d \nevery 3 months for appearance of symptoms and \ngrowth of myoma are advisable in the initial year.\nSection III\nAbnormal Menopause\nPremature ovarian insufficiency\n• The NFHS of 2015-16 collected information from \na sample of more than 90,000 married women \naged between 15 and 49  years and covering 99% \nof the India’s population living in 26 states; 3.7% \nof the women are already in menopause by the \nage of 30–34  years; and the incidence rises to 8% \nfor the age bracket of 35–39  years. At the age of \n48–49 years, 55.8% of the women are amenorrheic.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 557,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 17,
      "char_count": 557,
      "word_count": 97,
      "start_pos": 75734,
      "end_pos": 76291,
      "chunk_index": 152,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_153",
      "text": "for the age bracket of 35–39  years. At the age of \n48–49 years, 55.8% of the women are amenorrheic. \nIt is probably an overestimate for the study that \ndid not differentiate between natural, surgical, or \nsecondary causes\n• Menopause occurring at an age less than 2 SD below \nthe mean estimated age for the reference population \nis called as POI. It is a spectrum ranging from occult \nto overt POI\n• Conventionally, the diagnosis of overt POI is more \nlikely if there is amenorrhea of 3–4 months and \nserum FSH levels >40 IU/mL (that is the menopause \nrange) repeated a month apart accompanied by \nlow estradiol levels.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 620,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 17,
      "char_count": 620,
      "word_count": 107,
      "start_pos": 76191,
      "end_pos": 76811,
      "chunk_index": 153,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_154",
      "text": "40 IU/mL (that is the menopause \nrange) repeated a month apart accompanied by \nlow estradiol levels. The ESHRE 2015 guidelines \nrecommend these diagnostic criteria for POI:  (1) \nthe presence of menstrual disturbance such as \noligomenorrhea or amenorrhea for at least 4 months \nand (2) an elevated FSH level  >25 IU/L on two \noccasions at least 4 weeks apart (Grade C)\n• Appropriate counseling, lifestyle modification, and \nHT form the mainstay of treatment. HT should be \nstarted as early as possible in women with POI and \ncontinued till the age of natural menopause.[124,125] \nOCs may be used.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 596,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 17,
      "char_count": 596,
      "word_count": 96,
      "start_pos": 76711,
      "end_pos": 77307,
      "chunk_index": 154,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_155",
      "text": "sible in women with POI and \ncontinued till the age of natural menopause.[124,125] \nOCs may be used.[126] However, emerging evidence \nsuggests that physiological dose of HT is superior \nto hormone contraceptives. Androgen replacement \nmay be considered for women with persistent fatigue \nand loss of libido, in spite of estrogen replacement.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 341,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 17,
      "char_count": 341,
      "word_count": 50,
      "start_pos": 77207,
      "end_pos": 77548,
      "chunk_index": 155,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_156",
      "text": "considered for women with persistent fatigue \nand loss of libido, in spite of estrogen replacement. \nCounsel women that HT is not a contraceptive, and \nerratic ovulation and pregnancy may occur in POI\n• There is no evidence that HT increases risk of breast \ncancer, CVD, or dementia, over and above that \nfound in menstruating women with a normally timed \nmenopause\n• Women with untreated premature menopause are \nat increased risk of developing osteoporosis, CVD, \ndementia, cognitive decline, and Parkinson’s and \nall‑cause mortality[127‑129]\n• Women receiving chemotherapy or radiotherapy \n(pelvi",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 600,
          "overlap_percentage": 100.1669449081803
        }
      ],
      "primary_page": 17,
      "char_count": 599,
      "word_count": 89,
      "start_pos": 77448,
      "end_pos": 78048,
      "chunk_index": 156,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_157",
      "text": "Parkinson’s and \nall‑cause mortality[127‑129]\n• Women receiving chemotherapy or radiotherapy \n(pelvis) should be cautioned about iatrogenic \npremature menopause\n• Premenopausal hysterectomy alone may cause early \nmenopause[130,131]\nIatrogenic menopause\n• The exact prevalence of surgical menopause is not \nknown but varies from rural to urban areas and \nacross states\n• A significant number of hysterectomies along with \nbilateral oophorectomies are performed at a young \nage.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 476,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 17,
      "char_count": 476,
      "word_count": 64,
      "start_pos": 77948,
      "end_pos": 78424,
      "chunk_index": 157,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_158",
      "text": "ificant number of hysterectomies along with \nbilateral oophorectomies are performed at a young \nage. This trend of unwarranted hysterectomies \nand surgical castration for fear of cancer by the \nprofessional and the women should be discouraged\n• The physicians should have appropriate knowledge \nto recognize menopausal symptoms and whenever \nin doubt should get the tests done (FSH >40 IU/mL, \nE2 <20 pg/mL)\n• Women who need oophorectomy before menopause \nshould be counseled about the risk of surgical \nmenopause\n• Routine MHT is not recommended for surgical \nmenopause in a postmenopausal woman as",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 600,
          "overlap_percentage": 100.1669449081803
        }
      ],
      "primary_page": 17,
      "char_count": 599,
      "word_count": 91,
      "start_pos": 78324,
      "end_pos": 78924,
      "chunk_index": 158,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_159",
      "text": "al \nmenopause\n• Routine MHT is not recommended for surgical \nmenopause in a postmenopausal woman as the \nprimary prevention for chronic conditions\n• MHT should be considered in women aged <50 years \nwho have undergone surgical menopause\n• Results of the WHI studies in older women do \nnot apply to women with early menopause, and \nobservational evidence suggests benefit with the use \nof HT taken up to the average age of menopause\n• Younger women may require higher doses for \nsymptom relief or protection against bone loss\n• HT may have a beneficial effect on BP when \ncompared with a combined OC\n• HT has bone protection effect.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 631,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 17,
      "char_count": 631,
      "word_count": 108,
      "start_pos": 78824,
      "end_pos": 79455,
      "chunk_index": 159,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_160",
      "text": "ay have a beneficial effect on BP when \ncompared with a combined OC\n• HT has bone protection effect. Combined OCs may \nprotect bone depending on the estrogen status of the \nwoman.[125,126]\nSection IV\nClinical Evaluation\nGeneral considerations\n172. \u0007Clinical examination includes a holistic approach to \nhealth, rather than simply looking for the features \nof menopause in isolation; this leads to diagnose \nthe latent and overt noncommunicable diseases \nNCD.[132‑135] The age‑related factors, lifestyle, and \nsocioeconomic status need to be evaluated the \nwoman and plan the management strategies\n173. \u0007A detailed history, followed by general and physical\n\nMeeta, et al.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 655,
          "overlap_percentage": 97.76119402985076
        },
        {
          "page_number": 18,
          "overlap_chars": 13,
          "overlap_percentage": 1.9402985074626864
        }
      ],
      "primary_page": 17,
      "char_count": 670,
      "word_count": 99,
      "start_pos": 79355,
      "end_pos": 80025,
      "chunk_index": 160,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_161",
      "text": "the management strategies\n173. \u0007A detailed history, followed by general and physical\n\nMeeta, et al.: Guidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\nexamination, and assessment and categorization for \nrisk of disease is done based on history and by using \nvalidated tools described below which are simple and \ncan be easily incorporated in practice. These help in \nindividualizing and plan long‑term management for \nthe midlife woman [Refer Appendix 1]\n174. \u0007Menopause‑related symptoms may be documented \nusing the menopause rating scale [Refer Appendix 2]\n175.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 85,
          "overlap_percentage": 13.934426229508196
        },
        {
          "page_number": 18,
          "overlap_chars": 524,
          "overlap_percentage": 85.90163934426229
        }
      ],
      "primary_page": 17,
      "char_count": 610,
      "word_count": 92,
      "start_pos": 79925,
      "end_pos": 80536,
      "chunk_index": 161,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_162",
      "text": "nopause‑related symptoms may be documented \nusing the menopause rating scale [Refer Appendix 2]\n175. \u0007Breast: A  woman may be categorized of her risk for \ndeveloping invasive breast cancer by Gail Model, the \nlimitation being that it has not being validated in India \n([URL] [Refer Appendix 3]\n176. \u0007CVD: 10‑year probability risk of MI/stroke – based on \nthe WHO SEAR, WHO/ISH Risk Prediction Charts \nfor India – uses the SEAR D. They are simple to use \nby the paramedics and the clinician ([URL]\nint›ncds›management›WHO_ISH_Risk_Prediction_) \n[Refer Appendix 4]\n177. \u0007Skeletal health: Risk assessment for osteoporosis \nmay be done by OSTA/SCORE/FRAX (http//www.\nshef.ac.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 671,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 18,
      "char_count": 671,
      "word_count": 100,
      "start_pos": 80436,
      "end_pos": 81107,
      "chunk_index": 162,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_163",
      "text": "eletal health: Risk assessment for osteoporosis \nmay be done by OSTA/SCORE/FRAX (http//www.\nshef.ac.uk/FRAX) [Refer Appendix 5]\n178. \u0007Muscle health is assessed by the SARC‑F, a 5‑item \nquestionnaire [Refer Appendix 6]\n \nResults for risk assessment for diseases are \ndocumented in Table 8\n179. \u0007Examination can be broadly divided into three \nmain categories: general physical including BMI \nand waist circumference, breast examination, and \npelvic examination\n180. \u0007Recommended laboratory tests include complete \nblood picture, urine test routine, fasting glucose \nlevel/Hb1Ac, lipid profile, serum TSH, stool \nfor occult blood, PAP smear, vaginal pH, TVS, \nmammogram, or US\n181.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 678,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 18,
      "char_count": 678,
      "word_count": 94,
      "start_pos": 81007,
      "end_pos": 81685,
      "chunk_index": 163,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_164",
      "text": "ipid profile, serum TSH, stool \nfor occult blood, PAP smear, vaginal pH, TVS, \nmammogram, or US\n181. \u0007Investigations given in Table  9 should be chosen \njudiciously depending on the women’s history and \nexamination\n182. \u0007Dental and eye checkup should also be done.\nSection V\nManagement Options\n183. \u0007Classifying a woman into the following categories: \nIt is helpful in planning management (adapted and \nmodified from Morris Notelovitz)\n \n\u0007The information obtained from the MRS scale \nand health status obtained from the risk screening \nresults aids in classifying the women into two major \ngroups.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 597,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 18,
      "char_count": 597,
      "word_count": 91,
      "start_pos": 81585,
      "end_pos": 82182,
      "chunk_index": 164,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_165",
      "text": "atus obtained from the risk screening \nresults aids in classifying the women into two major \ngroups.\n \nGroup 1-Women with no menopausal symptoms \n(VMS)\n \nGroup 2-Women with menopausal symptoms\n \n\u0007In \npractise \n, \ncharting \nout \nan \nindividualised \nmanagement plan becomes simple.\n \nGroup 1-Women with no VMS\n \n• \u0007Healthy, no VMS - institute preventive care \n \n• \u0007Healthy with risk factors for disease, no VMS \n—-institute preventive health care \n \n• \u0007Women with latent disease, no VMS- institute \npreventive health care, treat the disease \n \n• \u0007Women with comorbidities, no VMS-institute \npreventive",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 600,
          "overlap_percentage": 100.1669449081803
        }
      ],
      "primary_page": 18,
      "char_count": 599,
      "word_count": 86,
      "start_pos": 82082,
      "end_pos": 82682,
      "chunk_index": 165,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_166",
      "text": "ventive health care, treat the disease \n \n• \u0007Women with comorbidities, no VMS-institute \npreventive health care, treat the disease \n \nGroup 2-Women with menopausal symptoms \n \n• \u0007Healthy with VMS - institute preventive health \ncare, treat with MHT \n \n• \u0007Healthy with risk factors for disease, with VMS \n-institute \npreventive \nhealth \ncare, \nrisk-benefit \nanalysis before therapeutic intervention \n \n• \u0007Women with latent diseases, with VMS —-institute \npreventive health care, risk benefit analysis before \ntherapeutic intervention \n \n• \u0007Women with comorbidities, with VMS - institute \npreventive health care, treat the disease, risk-benefit analysis \nbefore therapeutic intervention.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 684,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 18,
      "char_count": 684,
      "word_count": 89,
      "start_pos": 82582,
      "end_pos": 83266,
      "chunk_index": 166,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_167",
      "text": "preventive health care, treat the disease, risk-benefit analysis \nbefore therapeutic intervention. [Refer Appendix 7]\nCounseling\n184. \u0007Today, the art of medical counseling and translating \nthe statistics in simple language is an important \npart of the consultation\n185. \u0007The objectives of counseling include addressing \nwomen’s \nquestions \nand \nconcerns, \nproviding \npatient’s education, and enhancing the patient’s \nconfidence in decision‑making.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 449,
          "overlap_percentage": 100.44742729306489
        }
      ],
      "primary_page": 18,
      "char_count": 447,
      "word_count": 57,
      "start_pos": 83166,
      "end_pos": 83615,
      "chunk_index": 167,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_168",
      "text": "ncerns, \nproviding \npatient’s education, and enhancing the patient’s \nconfidence in decision‑making. If a therapy is \nchosen, the patient and clinician should agree on \nthe goals, risks, and benefits, whether they are \nshort term  (menopause symptom relief), long \nterm (primary or secondary prevention of diseases \nassociated with aging), or both[136‑138]\n186. \u0007Classification of frequency of drug reactions \naccording to the WHO and the Council for \nInternational Organisations of Medical Sciences is \npresented in Table  10.[139] This tool is effective in \ncounseling the woman on the risks of MHT.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 601,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 18,
      "char_count": 601,
      "word_count": 87,
      "start_pos": 83515,
      "end_pos": 84116,
      "chunk_index": 168,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_169",
      "text": "s \npresented in Table  10.[139] This tool is effective in \ncounseling the woman on the risks of MHT.\nTable 8: Comprehensive chart for grading the health \nstatus of an individual based on tools for invasive breast \ncancer, CVD and Skeletomuscular health \nTool\n5/10‑Year \nrisk score\nLifetime \nrisk score\nStatus\nInvasive breast Cancer Gail\nWHO/ISH\nOSTA/SCORE/FRAX\nSARC‑F\nWHO: World Health Organization, FRAX: Fracture Risk \nAssessment Tool\n\nMeeta, et al.: Guidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\nDietary prescription\n187. \u0007The National Institute of Nutrition plan for an adult \nsedentary woman is a good strategy for healthy \nliving [Table 11].",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 436,
          "overlap_percentage": 62.46418338108882
        },
        {
          "page_number": 19,
          "overlap_chars": 260,
          "overlap_percentage": 37.249283667621775
        }
      ],
      "primary_page": 18,
      "char_count": 698,
      "word_count": 107,
      "start_pos": 84016,
      "end_pos": 84714,
      "chunk_index": 169,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_170",
      "text": "e of Nutrition plan for an adult \nsedentary woman is a good strategy for healthy \nliving [Table 11].[140]\nExercise prescription\n188. \u0007Physical exercise helps maintain a healthy weight, \nimproves bone density, coordination and balance, \nmuscle strength and joint mobility, lipid profiles, \ngenitourinary problems, relieves depression, and \ninduces sleep\n189. \u0007Social interactions, either in an exercise program \nor otherwise, help the postmenopausal women \nto improve mood, relieve depression, and relieve \nanxieties\n190. \u0007Euphoria created with activity promotes QOL.\nImmunization prescription\n191.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 597,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 19,
      "char_count": 597,
      "word_count": 80,
      "start_pos": 84614,
      "end_pos": 85211,
      "chunk_index": 170,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_171",
      "text": "relieve \nanxieties\n190. \u0007Euphoria created with activity promotes QOL.\nImmunization prescription\n191. \u0007Hepatitis B vaccination is indicated for all \nunvaccinated adults at risk for HBV infection and \nall adults seeking protection from HBV infection \nincluding postexposure prophylaxis. Prevaccination \nscreening in general population has not been found \nto be cost‑effective in India (Grade B)[141]\n192. \u0007The Expert Group of Association of Physicians \nof India recommends vaccination of the entire \ncommunity at risk during an outbreak situation \n(Grade B)[141]\n193. \u0007Two doses of varicella vaccine are strongly \nrecommended in adults at increased risk for \nexposure of varicella (Grade B).",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 689,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 19,
      "char_count": 689,
      "word_count": 97,
      "start_pos": 85111,
      "end_pos": 85800,
      "chunk_index": 171,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_172",
      "text": "vaccine are strongly \nrecommended in adults at increased risk for \nexposure of varicella (Grade B).[142]\nPharmacotherapy\nComplementary and alternative therapies\n194. \u0007Nonhormonal prescription agents may relieve \nVMS but have their own side effects. These can \nbe considered when MHT is contraindicated or not \ndesired (Grade A). Complementary and alternative \ntreatments should be advised with caution as the \ndata are still insufficient, especially in moderate-to-\nsevere VMS.\n195. \u0007These are not as effective as MHT and include \ndrugs used as antidepressants and anticonvulsants, \ni.e., the selective serotonin reuptake inhibitors/ \nserotonin-norepinephrine \nreuptake \ninhibitors.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 683,
          "overlap_percentage": 100.1466275659824
        }
      ],
      "primary_page": 19,
      "char_count": 682,
      "word_count": 91,
      "start_pos": 85700,
      "end_pos": 86383,
      "chunk_index": 172,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_173",
      "text": "i.e., the selective serotonin reuptake inhibitors/ \nserotonin-norepinephrine \nreuptake \ninhibitors. \nFor women with insomnia as the predominant \nsymptom, choose gabapentin, and for women \nwith predominance of mood disorders, prefer \nTable 9: Tests performed solely on indication\nTest\nIndication\nFSH\nPremature ovarian insufficiency, women on contraceptive pills, women who had hysterectomy, doubt as to the \ncause of secondary amenorrhea or hot flushes, women on patches to rule out accumulation, fertility\nEstradiol\nPremature ovarian insufficiency, women on contraceptive pills, women who had hyster",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 600,
          "overlap_percentage": 100.1669449081803
        }
      ],
      "primary_page": 19,
      "char_count": 599,
      "word_count": 80,
      "start_pos": 86283,
      "end_pos": 86883,
      "chunk_index": 173,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_174",
      "text": "tility\nEstradiol\nPremature ovarian insufficiency, women on contraceptive pills, women who had hysterectomy, doubt as to the \ncause of secondary amenorrhea or hot flushes\nTests to assess increased \nrisk of thrombosis\nWhere there is relevant past or family history, women with previous history of unexplained thromoembolic \nepisodes antithrombin III, Tissue factor pathway inhibitor activity, protein C and protein S are to be estimated.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 435,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 19,
      "char_count": 435,
      "word_count": 63,
      "start_pos": 86783,
      "end_pos": 87218,
      "chunk_index": 174,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_175",
      "text": "thrombin III, Tissue factor pathway inhibitor activity, protein C and protein S are to be estimated. \nLupus anticoagulant, anticardiolipin antibodies should also be assessed\nEndometrial biopsy\nPostmenopausal bleeding, recent irregular bleeding, previous use of unopposed estrogen in the presence of uterus\nBone mass measurement For specific indication (Refer Flowchart 2)\nLFT\nWhen relevant as with suspected liver disease or recent history of liver disease\nUrodynamic study\nTo diagnose and differentiate on the severity and type of Incontinence before planning surgery\nECG, 2D Echo\nCVD assessment\nVag",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 19,
      "char_count": 600,
      "word_count": 86,
      "start_pos": 87118,
      "end_pos": 87718,
      "chunk_index": 175,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_176",
      "text": "ate on the severity and type of Incontinence before planning surgery\nECG, 2D Echo\nCVD assessment\nVaginal pH, VMI\nVaginal atrophy\n25, OH Vitamin D\nRule out secondary causes of osteoporosis\nFSH: Follicle‑stimulating hormone, LFT Liver function tests, ECG: Electrocardiogram, 2D Echo: Two‑dimensional echocardiography, \nCVD: Cardiovascular disease, VMI: Vaginal saturation index\nTable 10: Council for International Organisations of \nMedical Sciences definitions are as follows which can be \neasily communicated to the lay person\nTerm\nn\nColloquial\nVery common\n 1/1 to 1/10\nA person in family\nCommon\n1/10",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 600,
          "overlap_percentage": 100.1669449081803
        }
      ],
      "primary_page": 19,
      "char_count": 599,
      "word_count": 87,
      "start_pos": 87618,
      "end_pos": 88218,
      "chunk_index": 176,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_177",
      "text": "nicated to the lay person\nTerm\nn\nColloquial\nVery common\n 1/1 to 1/10\nA person in family\nCommon\n1/10 to 1/100\nA person in street\nUncommon\n1/100 to 1/1000\nA person in village\nRare\n1/1000 to 1/10000\nA person in a small town\nVery rare\nLess than 1/10000\nA person in a large town\nTable 11: Nutrition plan for an adult sedentary women\nFood source\ng/day\nCereals and millets\nPulses (vegetarian)\nNonvegetarian\nVegetables\nFruits\nDairy products\n0.3\nFats and oils\nSugar\nSalt\nWater\n8‑10 glasses\n\nMeeta, et al.: Guidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\nfluoxetine and paroxetine.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 480,
          "overlap_percentage": 77.41935483870968
        },
        {
          "page_number": 20,
          "overlap_chars": 138,
          "overlap_percentage": 22.258064516129032
        }
      ],
      "primary_page": 19,
      "char_count": 620,
      "word_count": 107,
      "start_pos": 88118,
      "end_pos": 88738,
      "chunk_index": 177,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_178",
      "text": "Journal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\nfluoxetine and paroxetine.[143] In breast cancer \npatients, fluoxetine and paroxetine should not \nbe used as they inhibit the effect of tamoxifen.\n[144] In women with dyslipidemia, fluoxetine and \ncitalopram exert the most favorable effect on the \nlipid profie\n196. \u0007Awareness \nshould \nbe \ncreated \nregarding \nthe \nphytoestrogens and lycopene‑rich foods in the \nIndian diet[145,146] (Grade C)\n197. \u0007It is recommended to validate the effects of locally \nused herbs in the Indian context, according to the \nmodern medicine, and prescribe them rationally \nusing clinical research tools and well‑designed \nand documented RCTs.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 696,
          "overlap_percentage": 100.14388489208632
        }
      ],
      "primary_page": 20,
      "char_count": 695,
      "word_count": 102,
      "start_pos": 88638,
      "end_pos": 89334,
      "chunk_index": 178,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_179",
      "text": "and prescribe them rationally \nusing clinical research tools and well‑designed \nand documented RCTs. While prescribing or \nrecommending herbs, it would be essential to fully \ninform the women that very little human data are \navailable on the usefulness of these formulations \nand side effects of the herbs have not been studied. \nIt is important to read labels to determine isoflavone \ncontent and to warn them that in India, there are no \nregulations to ensure the content or quality of such \nproducts (Grade C).[147]\nIndian data are sparse on the use of MHT; hence, this \nsection is based on the guidelines developed by various \nsocieties.[8,147-151]\nMenopausal Hormone Therapy\nTerminology\n198.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 696,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 20,
      "char_count": 696,
      "word_count": 108,
      "start_pos": 89234,
      "end_pos": 89930,
      "chunk_index": 179,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.387485"
    },
    {
      "id": "chunk_180",
      "text": "e guidelines developed by various \nsocieties.[8,147-151]\nMenopausal Hormone Therapy\nTerminology\n198. \u0007MHT \ncovers \ntherapies \nincluding \nestrogens, \nprogestogens, combined therapies, androgens, and \ntibolone\n \nTerminology used in MHT: ET-estrogen therapy: \nEPT-estrogenprogesterone therapy: AT-androgen \ntherapy:SERMs-selective estrogen receptor modulators \n(raloxifene and bazedoxifene): Gonadomimetics- \ntibolone, which contains estrogen, progestogen, and \nandrogen activity\n199.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 481,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 20,
      "char_count": 481,
      "word_count": 48,
      "start_pos": 89830,
      "end_pos": 90311,
      "chunk_index": 180,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_181",
      "text": "ifene): Gonadomimetics- \ntibolone, which contains estrogen, progestogen, and \nandrogen activity\n199. \u0007Three indications for postmenopausal HT, which \nhave constantly withstood the test of time, \nderived from the results of various clinical \ntrials are the beneficial effects of estrogens on \nsymptom relief, urogenital atrophy, and bone. \nHormone thearpy is indicated in POI and early \nmenopause \n200.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 401,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 20,
      "char_count": 401,
      "word_count": 55,
      "start_pos": 90211,
      "end_pos": 90612,
      "chunk_index": 181,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_182",
      "text": "elief, urogenital atrophy, and bone. \nHormone thearpy is indicated in POI and early \nmenopause \n200. \u0007Contraindications for MHT: Active endometrial \nand gynecological hormone‑dependent cancers, \nactive breast cancer, high risk for breast cancer, \nsevere active liver disease with impaired/\nabnormal liver function, venous thrombosis, \nestablished CVD and at severe increased risk \nof CVD, known or suspected pregnancy, and \nundiagnosed and abnormal vaginal bleeding.\nPatient characteristics that may be favorable for \nestrogen/androgen combination\n201.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 552,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 20,
      "char_count": 552,
      "word_count": 72,
      "start_pos": 90512,
      "end_pos": 91064,
      "chunk_index": 182,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_183",
      "text": "inal bleeding.\nPatient characteristics that may be favorable for \nestrogen/androgen combination\n201. Surgical menopause with continued VMS despite \nestrogen replacement, decreased well‑being despite \nestrogen replacement, and acquired sexual desire \ndysfunction.\nIndications for hormone therapy\nVasomotor symptoms\n202. \u0007The most effective treatment for VMS is MHT at \nmenopause transition  (Grade A). Progesterones \nor low‑dose OCPs may be used at menopause \ntransition phase for relief of symptoms.\nGenitourinary syndrome of menopause\n203. \u0007Vaginal ET is most effective in the treatment of \nurogenital atrophy. Low‑dose vaginal preparations \nare as effective as systemic therapy.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 680,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 20,
      "char_count": 680,
      "word_count": 90,
      "start_pos": 90964,
      "end_pos": 91644,
      "chunk_index": 183,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_184",
      "text": "eatment of \nurogenital atrophy. Low‑dose vaginal preparations \nare as effective as systemic therapy. Some women \non oral ET may require additional local therapy\n204. \u0007Treatment should be started early to prevent \nirreversible atrophic changes and may need \nlong‑term treatment to maintain benefits. Regular \nsexual activity, including vaginal coitus, should be \nencouraged to maintain vaginal health (Grade A)\n205. \u0007Recurrent attacks of atrophic vaginitis require the \nuse of the smallest effective dose over a period of \ntime. After control of acute symptoms, the dose \nof local estrogen can be tapered for long‑term \nmaintenance therapy.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 639,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 20,
      "char_count": 639,
      "word_count": 93,
      "start_pos": 91544,
      "end_pos": 92183,
      "chunk_index": 184,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_185",
      "text": "ol of acute symptoms, the dose \nof local estrogen can be tapered for long‑term \nmaintenance therapy. Treatment may be continued \nindefinitely although safety data from studies do \nnot go beyond 1 year (Grade C)\n206. \u0007Limited data are available on the use of vaginal \nET in women with breast cancer and EC. Lifestyle \nmanagement and nonhormonal treatments would \nbe the first option, but, in resistant cases, joint \nconsultation with the oncologist and counseling \nof the woman is done before prescribing vaginal \nestrogen. The preferred therapy may be low dose \nwith low‑potency agent like estriol\n207.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 602,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 20,
      "char_count": 602,
      "word_count": 95,
      "start_pos": 92083,
      "end_pos": 92685,
      "chunk_index": 185,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_186",
      "text": "g vaginal \nestrogen. The preferred therapy may be low dose \nwith low‑potency agent like estriol\n207. \u0007Recurrent urinary tract in this age after ruling out \nother causes may benefit from the local application \nof ET (Grade A)\n208. \u0007Progesterone supplement for endometrial protection \nis not needed along with the use of vaginal \nestrogen (Grade C)\n209. \u0007Endometrial surveillance is not necessary in \nlow‑risk \nasymptomatic \nwoman. \nUnscheduled \nbleeding should be investigated by transvaginal US \nand endometrial biopsy (Grade A)\n210. \u0007Low‑dose vaginal estrogen formulations reported \nno incidence of increase in CHD, stroke, and \nVTE.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 634,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 20,
      "char_count": 634,
      "word_count": 93,
      "start_pos": 92585,
      "end_pos": 93219,
      "chunk_index": 186,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_187",
      "text": "\u0007Low‑dose vaginal estrogen formulations reported \nno incidence of increase in CHD, stroke, and \nVTE. There are no contraindications for use in \nnonestrogen‑dependent cancers (Grade A).\n\nMeeta, et al.: Guidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\nOsteoporosis\n211. \u0007All preparations including low‑dose, nonoral routes \nof estrogen are effective in preserving bone mass\n \nEstrogen–progesterone therapy (EPT) or ET may be \nused for the prevention and treatment of osteoporosis \nin the early postmenopause in symptomatic women \nunless there is a contraindication.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 184,
          "overlap_percentage": 30.11456628477905
        },
        {
          "page_number": 21,
          "overlap_chars": 425,
          "overlap_percentage": 69.55810147299509
        }
      ],
      "primary_page": 20,
      "char_count": 611,
      "word_count": 87,
      "start_pos": 93119,
      "end_pos": 93730,
      "chunk_index": 187,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_188",
      "text": "f osteoporosis \nin the early postmenopause in symptomatic women \nunless there is a contraindication. ET/EPT prevents \nall osteoporotic fractures even in low‑risk population; \nit increases lumbar spine BMD up to 7.6% and \nfemoral neck BMD up to 4.5% over  3  years. It \nreduces the risk of spine, hip, and other osteoporotic \nfractures by 33%–40% (Grade A).\n212. \u0007MHT should not be started solely for bone \nprotection after 10  years of menopause. Extended \nuse of MHT in women with reduced bone mass is \nan option after considering the risk–benefit analysis \ncompared to the other available therapies for \nosteoporosis (Grade B)\n213.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 633,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 633,
      "word_count": 100,
      "start_pos": 93630,
      "end_pos": 94263,
      "chunk_index": 188,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_189",
      "text": "he risk–benefit analysis \ncompared to the other available therapies for \nosteoporosis (Grade B)\n213. \u0007POI: HT should be offered to women with POI and \nearly menopause (and it can be recommended until \nthe age of natural menopause) (Grade B)\n214. \u0007Depression: Estrogen may be prescribed to enhance \nmood in women with depressive symptoms after \nruling out other causes. The effect appears to be \ngreater for perimenopausal symptomatic women \nthan for postmenopausal women (Grade A).\nHormone therapy use in disease\n215. \u0007In women with hypertriglyceridemia (>400 mg/dL), \nobesity, history of deep vein thrombosis, and tobacco \nusers, nonoral route should be preferred (Grade B).",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 675,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 675,
      "word_count": 102,
      "start_pos": 94163,
      "end_pos": 94838,
      "chunk_index": 189,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_190",
      "text": "y, history of deep vein thrombosis, and tobacco \nusers, nonoral route should be preferred (Grade B).\n \nFor \nwomen \nat \nmoderate \nrisk \nof \nCVD, \nobservational data suggest transdermal rather than \noral estrogen, with micronized progesterone or \ndydrogesterone for those with a uterus. Non‑HTs \nare advised for symptomatic women who are at \nhigh risk (>10% 10‑year risk) for CVD.\n216. \u0007MHT has a favorable effect on glucose metabolism, \nboth in women with and without T2DM, while it \nmay delay the onset of T2DM\n217. \u0007MHT in women with T2DM should be administered \naccording to their risk of CVD.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 595,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 595,
      "word_count": 96,
      "start_pos": 94738,
      "end_pos": 95333,
      "chunk_index": 190,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_191",
      "text": "e onset of T2DM\n217. \u0007MHT in women with T2DM should be administered \naccording to their risk of CVD. In women with \nT2DM and low CVD risk, oral estrogens may \nbe preferred, while transdermal 17 β‑estradiol is \npreferred for women with T2DM and coexistent \nCVD risk factors, such as obesity. Progestogen \nwith neutral effects on glucose metabolism should \nbe used, such as progesterone and dydrogesterone\n218. \u0007Women who have low to moderate of breast \ncancer may be prescribed MHT according to their \nneed after a detailed history, examination, and \ncounseling. They should be provided information \nabout breast cancer risk with MHT as per evidence\n219.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 653,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 653,
      "word_count": 105,
      "start_pos": 95233,
      "end_pos": 95886,
      "chunk_index": 191,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_192",
      "text": "nseling. They should be provided information \nabout breast cancer risk with MHT as per evidence\n219. \u0007Women at moderate risk of breast cancer,a benifit risk \nanalysis and the choice of MHT should be discussed\n220. \u0007In women with high risk and breast cancer \nsurvivors, it is recommended to use non MHT\n221. \u0007HT does not appear to influence the clinical pattern \nof benign breast disease in a postmenopausal \nwoman (Grade C).\nPreexisting \ncancers \nand \nmenopausal \nhormone \ntherapy (Grade C)\n222.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 495,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 495,
      "word_count": 80,
      "start_pos": 95786,
      "end_pos": 96281,
      "chunk_index": 192,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_193",
      "text": "tmenopausal \nwoman (Grade C).\nPreexisting \ncancers \nand \nmenopausal \nhormone \ntherapy (Grade C)\n222. \u0007MHT is neutral – Low‑grade, early‑stage EC type I, \ncervical adenocarcinoma, epithelial ovarian cancer, \ngerm cell tumors, hematological malignancies, local \ncutaneous malignant melanoma, colorectal cancer, \nhepatocellular cancer BRCA 1/2 mutation carriers \nwithout cancer, most types of ovarian cancer, \nsquamous cell carcinomas of cervix, vaginal and \nvulvar squamous cell carcinoma, prolactinoma, \nkidney cancer, pancreatic cancer, and thyroid cancer\n223.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 560,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 560,
      "word_count": 71,
      "start_pos": 96181,
      "end_pos": 96741,
      "chunk_index": 193,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_194",
      "text": "ar squamous cell carcinoma, prolactinoma, \nkidney cancer, pancreatic cancer, and thyroid cancer\n223. \u0007MHT \nis \nrelatively \ncontraindicated \n– \nLeiomyosarcoma, EC type II, advanced metastatic \nmalignant melanoma, lung cancer, gastric cancer, \nand bladder cancer\n224. \u0007MHT is contraindicated – Breast cancer, endometrial \nstromal sarcoma, uterine carcinosarcoma, ovarian \ncancer \n(estrogen‑dependent \ngranulosa \ncell, \nlow‑grade serous, and Sertoli–Leydig, endometroid \ntypes of ovarian tumors), adenocarcinoma of \nthe cervix meningioma, glioma, and hormone \nreceptor‑positive gastric and bladder cancer\n225.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 606,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 606,
      "word_count": 73,
      "start_pos": 96641,
      "end_pos": 97247,
      "chunk_index": 194,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_195",
      "text": "ma of \nthe cervix meningioma, glioma, and hormone \nreceptor‑positive gastric and bladder cancer\n225. \u0007Low‑dose, local vaginal ET may be an option for \nthe treatment of vaginal dryness related to hormone \ndeficiency after certain types of cancers, even if \nsystemic MHT is not recommended.\nPrecautions\n226. \nProgesterone in adequate dose and duration \nshould be supplemented along with oral estrogens in \nwomen with uterus (Grade A)\n227. \u0007Estrogen alone is given in hysterectomized women \n(Grade A)\n228. \u0007Progesterone supplement for endometrial protection \nis not needed along with the use of vaginal estrogen \n(Grade C)\n229.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 624,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 624,
      "word_count": 94,
      "start_pos": 97147,
      "end_pos": 97771,
      "chunk_index": 195,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_196",
      "text": "ent for endometrial protection \nis not needed along with the use of vaginal estrogen \n(Grade C)\n229. \u0007Investigations are needed, if bleeding starts at the \nstart of progesterone therapy in cyclical regimens, \nor there is a change in the duration or intensity of \nblood flow which is not normal for that woman. \nInvestigations are needed, if bleeding is heavy or \ncontinuous and continues after 6–12 months of use \nwith continuous combined regimens, and in women \nwith a high risk for uterine cancer\n230. \u0007Pre‑MHT workup and annual follow‑up are essential \nwhen prescribing MHT. A  full gynecological\n\nMeeta, et al.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 599,
          "overlap_percentage": 97.55700325732899
        },
        {
          "page_number": 22,
          "overlap_chars": 13,
          "overlap_percentage": 2.1172638436482085
        }
      ],
      "primary_page": 21,
      "char_count": 614,
      "word_count": 99,
      "start_pos": 97671,
      "end_pos": 98285,
      "chunk_index": 196,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_197",
      "text": "orkup and annual follow‑up are essential \nwhen prescribing MHT. A  full gynecological\n\nMeeta, et al.: Guidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\nassessment is mandatory before starting MHT \nand at regular intervals thereafter. SBE is advised \nmonthly. Mammogram or the breast US, where \navailable, should be carried out 1–3  yearly if the \ninitial mammogram is normal (Grade C)\n231. \u0007The dose and duration of use of MHT should be \nindividualized, and a risk–benefit assessment is \ncarried out annually. Follow‑up after 1 month, 3 \nmonths, 6 months and then annually (Grade C)\n232.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 85,
          "overlap_percentage": 13.406940063091483
        },
        {
          "page_number": 22,
          "overlap_chars": 547,
          "overlap_percentage": 86.2776025236593
        }
      ],
      "primary_page": 21,
      "char_count": 634,
      "word_count": 101,
      "start_pos": 98185,
      "end_pos": 98819,
      "chunk_index": 197,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_198",
      "text": "carried out annually. Follow‑up after 1 month, 3 \nmonths, 6 months and then annually (Grade C)\n232. \u0007Regimens\n• Continuous‑cyclic regimen, estrogen is used \nevery day, with progesterone added cyclically \nfor 10–14  days during each month. Progestogen \nis started on day 1 or day 15 each month. This \nregimen is suitable for women at perimenopause\n• Uterine bleeding occurs in about 80% of women \nwhen \nprogestogen \nis \nwithdrawn, \nalthough \nbleeding can begin 1–2 days earlier, depending on \nthe type and dose of progestogen used\n• In \nthe \ncontinuous‑combined \nEPT \nregimen, \nfixed doses of estrogen and progesterone are \nadministered every day.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 22,
          "overlap_chars": 647,
          "overlap_percentage": 100.15479876160991
        }
      ],
      "primary_page": 22,
      "char_count": 646,
      "word_count": 100,
      "start_pos": 98719,
      "end_pos": 99366,
      "chunk_index": 198,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_199",
      "text": "nuous‑combined \nEPT \nregimen, \nfixed doses of estrogen and progesterone are \nadministered every day. It is the treatment of \nchoice at postmenopause\n• Approximately \n40% \nincidence \nof \nirregular \nspotting or bleeding in the first 6 months\n• Estrogen alone is prescribed in hysterectomized \nwoman. Progesterone is added along with \nestrogens in hysterectomized woman in cases \nof endometriosis, endometrial ablation, and \nsupracervical hysterectomy.\n233. Routes\n• Estrogen: Oral, transdermal , and vaginal\n• Progestogen: Oral, vaginal, and intrauterine \nlevonorgestrel system.\n234. Duration of use\n235.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 22,
          "overlap_chars": 602,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 22,
      "char_count": 602,
      "word_count": 83,
      "start_pos": 99266,
      "end_pos": 99868,
      "chunk_index": 199,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_200",
      "text": "nal\n• Progestogen: Oral, vaginal, and intrauterine \nlevonorgestrel system.\n234. Duration of use\n235. \u0007POI: HT can be prescribed up to the natural age \nof menopause; further continuation of therapy is a \nshared decision between the woman and the physician \naccording to the indication and the need (Grade C)\n236. \u0007Natural menopause: Safety data on EPT with \nCEE  +  MPA use are 3–5  years, and with ET, \nsafety data are 7  years of treatment with 20 years \nfollow‑up.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 22,
          "overlap_chars": 466,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 22,
      "char_count": 466,
      "word_count": 78,
      "start_pos": 99768,
      "end_pos": 100234,
      "chunk_index": 200,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_201",
      "text": "PA use are 3–5  years, and with ET, \nsafety data are 7  years of treatment with 20 years \nfollow‑up. Role of extended use of HT is a shared \ndecision between the woman and the physician \nand may be considered in cases of recurrence \nof symptoms after stopping therapy, in case of \nmanagement of osteoporosis when other therapies \nare contraindicated (Grade A)\n237. \u0007Stopping MHT may be abrupt or the dose and \nduration may be tapered off gradually (Grade C).\nPotency and nonoral routes\n238. \u0007Minimum effective dose is the principle to be \nfollowed while prescribing MHT. The potency \nneeded by the woman may change over time.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 22,
          "overlap_chars": 625,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 22,
      "char_count": 625,
      "word_count": 106,
      "start_pos": 100134,
      "end_pos": 100759,
      "chunk_index": 201,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_202",
      "text": "nciple to be \nfollowed while prescribing MHT. The potency \nneeded by the woman may change over time. \nAfter starting standard‑dose therapy, dose can be \nlowered and maintained accordingly. Low‑dose and \nultralow‑dose therapies are effective in relieving \nsymptoms and maintaining bone mass\n239. \u0007Transdermal estrogen has a neutral effect on \ntriglycerides, \nCRP, \nand \nsex \nhormone‑binding \nglobulin and is preferable for use in women with \nhypertriglyceridemia, obesity, glucose intolerance, \nhigh risk of deep vein thrombosis, and tobacco users.\nConclusions on the Risks and Benefits \nof \nSystemic \nand \nLocal \nHormone \nTherapy‑Based on Available Evidence\n240.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 22,
          "overlap_chars": 662,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 22,
      "char_count": 662,
      "word_count": 92,
      "start_pos": 100659,
      "end_pos": 101321,
      "chunk_index": 202,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_203",
      "text": "the Risks and Benefits \nof \nSystemic \nand \nLocal \nHormone \nTherapy‑Based on Available Evidence\n240. \u0007MHT may be given to women below the age of \n60 years or within 10 years of menopause, and the \nrisks are rare.\nRisks of systemic therapy\n241. \u0007The risks of MHT may be explained to the woman \nin terms defined by CIOMS. Refer Table 12.\nCoronary heart disease\n242. \u0007Systemic therapy is not to be used for primary \nor secondary prevention of CHD.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 22,
          "overlap_chars": 444,
          "overlap_percentage": 100.22573363431151
        }
      ],
      "primary_page": 22,
      "char_count": 443,
      "word_count": 78,
      "start_pos": 101221,
      "end_pos": 101665,
      "chunk_index": 203,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_204",
      "text": "heart disease\n242. \u0007Systemic therapy is not to be used for primary \nor secondary prevention of CHD. At any age, \navoid MHT in women at high risk of CVD or in \nestablished CVD\nTable 12: Based on the Women’s Health Initiative, number of excess events on hormone therapy versus placebo per \n10,000 women per year of hormone therapy\nDisease\nEstrogen\nWHO/CIOMS definition of risk\nEstrogen + progesterone\nWHO/CIOMS definition of risk\nVenous \nthromboembolism\nRare \nRare \nStroke\nRare \nRare \nBreast cancer\nRare \nCardiovascular \ndisease\nRare \nUse between the age group of 50‑59 years. CIOMS: Council for International Organisations of Medical Sciences, WHO: World Health \nOrganization\n\nMeeta, et al.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 22,
          "overlap_chars": 675,
          "overlap_percentage": 97.96806966618288
        },
        {
          "page_number": 23,
          "overlap_chars": 13,
          "overlap_percentage": 1.8867924528301887
        }
      ],
      "primary_page": 22,
      "char_count": 689,
      "word_count": 107,
      "start_pos": 101565,
      "end_pos": 102255,
      "chunk_index": 204,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_205",
      "text": "for International Organisations of Medical Sciences, WHO: World Health \nOrganization\n\nMeeta, et al.: Guidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\n243. \u0007ET may be cardioprotective, if started around the \ntime of menopause “window of opportunity” in \na healthy woman. It reduces the risk of diabetes \nand has positive effects on the lipid profile and \nmetabolic syndrome\n244. \u0007Less than 60  years old, recently menopausal and \nwithout evidence of CVD, at mild‑to‑moderate \nrisk of CVD, the initiation of MHT does not cause \nearly harm and may reduce morbidity and mortality \nfrom CHD.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 22,
          "overlap_chars": 85,
          "overlap_percentage": 13.406940063091483
        },
        {
          "page_number": 23,
          "overlap_chars": 548,
          "overlap_percentage": 86.43533123028391
        }
      ],
      "primary_page": 22,
      "char_count": 634,
      "word_count": 100,
      "start_pos": 102155,
      "end_pos": 102790,
      "chunk_index": 205,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_206",
      "text": ", the initiation of MHT does not cause \nearly harm and may reduce morbidity and mortality \nfrom CHD. At moderate‑risk women, if indicated, \ntransdermal MHT is preferable\n245. \u0007MHT beyond the age of 60 years should be decided \nas a part of the overall risk–benefit analysis.\nVenous thromboembolism\n246. \u0007The risk of VTE is increased by smoking, increasing \nage, obesity, and oral MHT. VTE risk is as high as \n29/10,000 woman‑years during pregnancy and 300–\n400/10,000 woman‑years in the postpartum period\n247. \u0007HT increases VTE risk by twofold  (Grade A). \nTransdermal ET and the natural progesterones \nmay not have an effect. Population screening for \nthrombophilia is not indicated before MHT use.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 23,
          "overlap_chars": 698,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 23,
      "char_count": 698,
      "word_count": 111,
      "start_pos": 102690,
      "end_pos": 103388,
      "chunk_index": 206,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_207",
      "text": "es \nmay not have an effect. Population screening for \nthrombophilia is not indicated before MHT use.\nStroke\n248. \u0007Unlike CHD, the timing hypothesis does not appear \nto apply to the risk of stroke, most likely because \nthe risk of stroke is probably due to thrombotic \nrather than atherosclerotic mechanisms. Hence, \nliterature is suggestive of an increased risk of \nstroke with oral MHT, there is a dose‑dependent \nrelationship, and the event rate is extremely low, \nespecially in younger women\n249. \u0007Standard‑dose oral MHT increased stroke risk by \nabout one‑third in generally healthy postmenopausal \nwomen (Grade B)\n250.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 23,
          "overlap_chars": 623,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 23,
      "char_count": 623,
      "word_count": 96,
      "start_pos": 103288,
      "end_pos": 103911,
      "chunk_index": 207,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_208",
      "text": "increased stroke risk by \nabout one‑third in generally healthy postmenopausal \nwomen (Grade B)\n250. \u0007The risk increases with estrogen dose, age, and \nBMI and is greater during the first years of therapy. \nThe absolute risk is 1.5 more cases/10,000 women \nper year at the age of 50–54 years, 2.2 at the age of \n59 years, 2.8 at the age of 60–64 years\n251. \u0007Low‑dose ET, transdermal route may not increase \nthe risk of stroke (Grade C).\nMHT and breast cancer\n252. \u0007MHT may not initiate breast cancer and may have \npromotional effect on hormone receptor breast cancer \nin susceptible women. Tumors in MHT used women \nare usually ER‑positive and lobular type (Level C)\n253.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 23,
          "overlap_chars": 670,
          "overlap_percentage": 100.14947683109119
        }
      ],
      "primary_page": 23,
      "char_count": 669,
      "word_count": 114,
      "start_pos": 103811,
      "end_pos": 104481,
      "chunk_index": 208,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_209",
      "text": "susceptible women. Tumors in MHT used women \nare usually ER‑positive and lobular type (Level C)\n253. \u0007The increased risk for breast cancer attributable to \nMHT is less than 1 per 1000 women per year of \nuse in the age group of 50–59 years. This increased \nrisk is similar or lower than those associated with \ncommon lifestyle factors, such as reduced physical \nactivity, obesity, and alcohol consumption\n254. \u0007Losing weight and keeping it off were associated \nwith lower breast cancer risk for women aged \n50  years and over in The Nurses’ Health Study \n(1980–2014; n  =  73,196) and The Health \nProfessionals \nFollow‑Up \nStudy \n(1986–2014; \nn = 38,366)\n255.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 23,
          "overlap_chars": 658,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 23,
      "char_count": 658,
      "word_count": 107,
      "start_pos": 104381,
      "end_pos": 105039,
      "chunk_index": 209,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_210",
      "text": "0–2014; n  =  73,196) and The Health \nProfessionals \nFollow‑Up \nStudy \n(1986–2014; \nn = 38,366)\n255. \u0007The effect of MHT on breast cancer risk may \ndepend on the type of MHT, dose, duration of use, \nregimen, route of administration, prior exposure, \nand individual characteristics\n256. \u0007Avoid MHT in women with severe risk for breast \ncancer and in breast cancer survivors.\nEstrogen alone\n257. \u0007In the WHI trial,prior randomized use of CEE alone \ncompared with placebo, among women who had a \nprevious hysterectomy, was significantly associated \nwith lower breast cancer incidence and lower breast \ncancer mortality[151]\n258.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 23,
          "overlap_chars": 624,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 23,
      "char_count": 624,
      "word_count": 95,
      "start_pos": 104939,
      "end_pos": 105563,
      "chunk_index": 210,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_211",
      "text": "ficantly associated \nwith lower breast cancer incidence and lower breast \ncancer mortality[151]\n258. \u0007For women who are BRCA positive and have \nundergone risk reducing BSOP, observational data \nsuggest that the use of systemic HT to the median \nage of menopause aimed to decrease health risks \nassociated with premature loss of estrogen does \nnot increase breast cancer risk. Decisions are on an \nindividual basis.\nEstrogen plus progesterone\n259.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 23,
          "overlap_chars": 446,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 23,
      "char_count": 446,
      "word_count": 67,
      "start_pos": 105463,
      "end_pos": 105909,
      "chunk_index": 211,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_212",
      "text": "increase breast cancer risk. Decisions are on an \nindividual basis.\nEstrogen plus progesterone\n259. \u0007In the WHI trial,prior randomized use of CEE \nplus MPA, compared with placebo, among women \nwho had an intact uterus, was significantly \nassociated with a higher breast cancer incidence \nbut no significant difference in breast cancer \nmortality[151]\n260. \u0007Emerging data from two independent studies \nreport that progesterone  (micronized progesterone/\ndydrogesterone) with estrogen may not increase the \nrisk if given for less than 5 years (Level C)\n261. \u0007The risk returns to approximately that of nonusers \nwithin 3 years of cessation (Level B).\nGallbladder\n262.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 23,
          "overlap_chars": 665,
          "overlap_percentage": 100.15060240963855
        }
      ],
      "primary_page": 23,
      "char_count": 664,
      "word_count": 98,
      "start_pos": 105809,
      "end_pos": 106474,
      "chunk_index": 212,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_213",
      "text": "k returns to approximately that of nonusers \nwithin 3 years of cessation (Level B).\nGallbladder\n262. \u0007Risk \nof \ngallstones, \ncholecystitis, \nand \ncholecystectomy \nis \nincreased \nwith \noral \nestrogen‑alone and combination MHT\n263. \u0007Observational studies report lower risk with \ntransdermal MHT than with oral and with \noral estradiol compared with CEE, but neither \nobservation is confirmed in RCTs.\nBenefits of systemic therapy\nThe absolute benefits of MHT are given in Table 13.\nOther possible benefits\n• MHT significantly reduces the diagnosis of new‑onset \nT2DM\n\nMeeta, et al.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 23,
          "overlap_chars": 564,
          "overlap_percentage": 97.40932642487047
        },
        {
          "page_number": 24,
          "overlap_chars": 13,
          "overlap_percentage": 2.2452504317789295
        }
      ],
      "primary_page": 23,
      "char_count": 579,
      "word_count": 85,
      "start_pos": 106374,
      "end_pos": 106953,
      "chunk_index": 213,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_214",
      "text": "Other possible benefits\n• MHT significantly reduces the diagnosis of new‑onset \nT2DM\n\nMeeta, et al.: Guidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\n• MHT may help reduce the abdominal adipose tissue \nand the weight gains that are often associated with \nthe menopause transition and thus help in reducing \nthe emergence of new onset of metabolic syndrome\n• Estrogens \nmay \nhave \na \nprotective \neffect \non \nosteoarthritis (Grade B)\n• Estrogen benefits verbal memory over the short \nperiod when initiated soon after surgical menopause \n(Grade B)\n• MHT",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 23,
          "overlap_chars": 85,
          "overlap_percentage": 14.214046822742473
        },
        {
          "page_number": 24,
          "overlap_chars": 513,
          "overlap_percentage": 85.78595317725753
        }
      ],
      "primary_page": 23,
      "char_count": 598,
      "word_count": 95,
      "start_pos": 106853,
      "end_pos": 107453,
      "chunk_index": 214,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_215",
      "text": "verbal memory over the short \nperiod when initiated soon after surgical menopause \n(Grade B)\n• MHT reduces the neovascular macular lesions (Grade C)\n• MHT use has shown to reduce colorectal cancers\n• MHT in the early menopausal period improves QOL \nby its effects on VSMs and urogenital symptoms and \nimprovement on sleep and mood.\nBenefits and risks of local therapy\n• Local therapy is indicated when the woman suffers \nonly from urogenital atrophy\n• Vaginal ET is most effective in the treatment of \nurogenital atrophy. Low‑dose vaginal preparations \nare as effective as systemic therapy.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 24,
          "overlap_chars": 591,
          "overlap_percentage": 100.16949152542374
        }
      ],
      "primary_page": 24,
      "char_count": 590,
      "word_count": 95,
      "start_pos": 107353,
      "end_pos": 107944,
      "chunk_index": 215,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_216",
      "text": "eatment of \nurogenital atrophy. Low‑dose vaginal preparations \nare as effective as systemic therapy. Some women on \noral ET may require additional local therapy\n• Low‑dose vaginal estrogen formulations reported \nno incidence of increase in CHD, stroke, and \nVTE. There are no contraindications for use in \nnonhormone‑dependent cancers.\nAndrogens\n264. \u0007Available data are of low quality and conflicting \nregarding the risk of breast cancer relating to use of \nandrogens (Grade D)\n265. \u0007Androgen replacement for use in women is not \navailable in India.\nRaloxifene\n266. \u0007It decreases the risk of development of breast \ncancer.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 24,
          "overlap_chars": 623,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 24,
      "char_count": 623,
      "word_count": 93,
      "start_pos": 107844,
      "end_pos": 108467,
      "chunk_index": 216,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_217",
      "text": "is not \navailable in India.\nRaloxifene\n266. \u0007It decreases the risk of development of breast \ncancer. The indication for use is postmenopausal \nosteoporosis especially in women at high risk for \nbreast cancer given in a dose of 60mg/day\n267. \u0007Tissue \nselective \nestrogen \ncomplex: \nNewer \nformulations of combination therapy of estrogen \nand selective ER modulators are soon to be \navailable.\nTibolone\n268. \u0007Tibolone is a selective tissue estrogenic activity \nregulator. It is a synthetic steroid compound, which \nhas estrogenic, progestogenic, and androgenic \nproperties. It has an estrogenic effect on bone, \ninhibiting bone resorption by reducing osteoclastic \nactivity\n269.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 24,
          "overlap_chars": 676,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 24,
      "char_count": 676,
      "word_count": 97,
      "start_pos": 108367,
      "end_pos": 109043,
      "chunk_index": 217,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_218",
      "text": "as an estrogenic effect on bone, \ninhibiting bone resorption by reducing osteoclastic \nactivity\n269. \u0007Tibolone is effective in treating VMS and improves \nurogenital atrophy (Grade A)\n270. \u0007It improves mood and libido (Grade B)\n271. \u0007It is prescribed in a single daily dose of 2.5 mg \norally. A lower dose of 1.25 mg has been found to \nbe equally effective for most indications, including \nosteoporosis. It should be prescribed 1  year after \namenorrhea (Grade A).\nUse of oral contraceptives during the menopausal \ntransition\n272.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 24,
          "overlap_chars": 529,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 24,
      "char_count": 529,
      "word_count": 84,
      "start_pos": 108943,
      "end_pos": 109472,
      "chunk_index": 218,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_219",
      "text": "year after \namenorrhea (Grade A).\nUse of oral contraceptives during the menopausal \ntransition\n272. \u0007A low‑dose estrogen OC is an option, unless \ncontraindicated for perimenopausal  (40–50  years) \nwomen who seek relief of menopausal symptoms, \nalso desire contraception, and may need control of \nbleeding when it is heavy. A continuous 3‑monthly \nregimen may be beneficial to control VMS.\nSection VI\nEconomics of Menopause Management\n273. \u0007Indian healthcare system is one of the most \nprivatized systems where government spends \nmuch less and individual has to pay for health \ninsurance[152]\n274. \u0007Insurance may be described as a social device to \nreduce or eliminate the risk of life and property.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 24,
          "overlap_chars": 700,
          "overlap_percentage": 100.14306151645206
        }
      ],
      "primary_page": 24,
      "char_count": 699,
      "word_count": 106,
      "start_pos": 109372,
      "end_pos": 110072,
      "chunk_index": 219,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_220",
      "text": "Insurance may be described as a social device to \nreduce or eliminate the risk of life and property. \nUnder the plan of insurance, many people associate \nthemselves by sharing risk, attached to individual \ninsurance plan that covers only healthcare costs \nand is called health insurance\n275. \u0007It is indeed very important to enroll in any of \nthe good health insurance schemes for a secure \nfuture. Healthcare insurance provides a cushion \nagainst medical emergencies. Most companies stop \nenrolment after 65–70  years of age. Menopause \nmanagement has significant direct and indirect \ncosts\n276.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 24,
          "overlap_chars": 595,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 24,
      "char_count": 595,
      "word_count": 91,
      "start_pos": 109972,
      "end_pos": 110567,
      "chunk_index": 220,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_221",
      "text": "ent after 65–70  years of age. Menopause \nmanagement has significant direct and indirect \ncosts\n276. \u0007Direct costs include physician’s visits, specialist’s \nvisit, and traditional pharmacotherapy or alternative \nand complementary medicine modality\n277. \u0007Indirect \ncosts \ninclude \nlaboratory \ntesting, \nmanagement of adverse events, loss of productivity \nat home and at work, and treatment of associated \nmedical disorders\n278.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 24,
          "overlap_chars": 426,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 24,
      "char_count": 426,
      "word_count": 56,
      "start_pos": 110467,
      "end_pos": 110893,
      "chunk_index": 221,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_222",
      "text": "ents, loss of productivity \nat home and at work, and treatment of associated \nmedical disorders\n278. \u0007Various groups of molecules are available for \nprevention \nand \ntreatment \nof \nosteopenia \nand \nTable 13: Based on WHI: number of less events on ET \nand EPT versus placebo per 10,000 women per year of \nHT use between the age group of 50 years and 59 years\nDisease\nNumber of less events with ET\nHeart Disease\nBreast Cancer\nDisease\nNumber of less events with E / EPT\nOverall Mortality\nFractures\nColorectal cancer\n\nMeeta, et al.: Guidelines on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\nosteoporosis.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 24,
          "overlap_chars": 512,
          "overlap_percentage": 80.12519561815337
        },
        {
          "page_number": 25,
          "overlap_chars": 125,
          "overlap_percentage": 19.561815336463223
        }
      ],
      "primary_page": 24,
      "char_count": 639,
      "word_count": 107,
      "start_pos": 110793,
      "end_pos": 111432,
      "chunk_index": 222,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_223",
      "text": "on menopause\nJournal of Mid-life Health  ¦  Volume 11  ¦  Issue 2  ¦  April-June 2020\nosteoporosis. Cost of therapy varies according to the \nindication whether they are prescribed for prevention \nor treatment of osteopenia or osteoporosis\n279. \u0007Menopause is a critical window of opportunity \nfor preventing and reducing risk for CVD and \nmaintaining skeletomuscular and urogenital health. \nThe importance of lifestyle counseling for smoking \ncessation, diet modification, and physical activity \nin the menopausal women has to be emphasized. \nAdopting a healthy lifestyle is cost effective.\n280.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 595,
          "overlap_percentage": 100.16835016835017
        }
      ],
      "primary_page": 25,
      "char_count": 594,
      "word_count": 86,
      "start_pos": 111332,
      "end_pos": 111927,
      "chunk_index": 223,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_224",
      "text": "in the menopausal women has to be emphasized. \nAdopting a healthy lifestyle is cost effective.\n280. \u0007Establishing menopause clinics at primary and \nspecialized centers would help in implementing \nthe concept of critical window of opportunity at \nmenopause.[153]\nFinancial support and sponsorship\nNil.\nConflicts of interest\nThere are no conflicts of interest.\nReferences\n1. \nde Carvalho  BR, Gomes Sobrinho  DB, Damasceno Vieira AD, \net al. Ovarian reserve assessment for infertility investigation. \nObstet Gynecol 2012;2012:576385.\n2. \nFritz  MA, Speroff  L. Menopause and the perimenopausal \ntransition. In: Speroff  L, Glass  RH, Kase  NG, editors.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 651,
          "overlap_percentage": 100.15384615384615
        }
      ],
      "primary_page": 25,
      "char_count": 650,
      "word_count": 91,
      "start_pos": 111827,
      "end_pos": 112478,
      "chunk_index": 224,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_225",
      "text": "roff  L. Menopause and the perimenopausal \ntransition. In: Speroff  L, Glass  RH, Kase  NG, editors. Clinical \nGynecological Endocrinology and Infertility. 8th ed. Philadelphia, \nPA, USA: Lippincott Williams & Wilkins; 2011. p. 681.\n3. \nResearch on the menopause in the 1990s. Report of a WHO \nScientific Group. World Health Organ Tech Rep Ser 1996;866:1‑07.\n4. \nUtian \nWH. \nThe \nInternational \nMenopause \nSociety \nmenopause‑related \nterminology \ndefinitions. \nClimacteric \n1999;2:284‑6.\n5. \nSherman  S. Defining the menopausal transition. Am J Med \n2005;118:3S‑7S.\n6. \nAnklesaria BS, Soneji RM. Staging, symptoms and urological \nproblems in the climacteric. In: Krishna UR, Shah D (Eds).",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 688,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 688,
      "word_count": 95,
      "start_pos": 112378,
      "end_pos": 113066,
      "chunk_index": 225,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_226",
      "text": "eji RM. Staging, symptoms and urological \nproblems in the climacteric. In: Krishna UR, Shah D (Eds). \nMenopause Obstetrics and Gynecology in Perspective, 1st \nedition. Chennai: Orient Longman Pvt Ltd; 1996. p. 13.\n7. \nAnklesaria  BS. The staging of menopause. In: Kumar  P, \nMalhotra N, editors. Jeffcoate’s Principles of Gynecology. 7th ed. \nNew  Delhi, India: Jaypee Brothers Medical Publishers; 2008. \np. 862‑4.\n8. \nStuenkel CA, Davis SR, Gompel A, Lumsden MA, Murad MH, \nPinkerton  JV, et  al. Treatment of symptoms of the menopause: \nAn endocrine society clinical practice guideline. J  Clin \nEndocrinol Metab 2015;100:3975‑4011.\n9.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 637,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 637,
      "word_count": 94,
      "start_pos": 112966,
      "end_pos": 113603,
      "chunk_index": 226,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_227",
      "text": "An endocrine society clinical practice guideline. J  Clin \nEndocrinol Metab 2015;100:3975‑4011.\n9. \nSoules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, \net  al. Executive summary: Stages of reproductive aging \nworkshop  (STRAW) Park City, Utah, July, 2001. Menopause \n2001;8:402‑7.\n10. Harlow  SD, Gass  M, Hall  JE, Lobo  R, Maki  P, Rebar  RW, \net  al. Executive summary of the Stages of Reproductive Aging \nWorkshop + 10: Addressing the unfinished agenda of staging \nreproductive aging. Fertil Steril 2012;97:843‑51.\n11. Government of India: Ministry of Home Affairs 2011, Office of the \nRegistrar General & Census Commissioner, India; 2011.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 656,
          "overlap_percentage": 100.3058103975535
        }
      ],
      "primary_page": 25,
      "char_count": 654,
      "word_count": 97,
      "start_pos": 113503,
      "end_pos": 114159,
      "chunk_index": 227,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_228",
      "text": "Ministry of Home Affairs 2011, Office of the \nRegistrar General & Census Commissioner, India; 2011. Available \nfrom: [URL] [Last accessed on 2020 Jul 10].\n12. Sharma  S, Tandon  VR, Mahajan  A. Menopausal symptoms in \nurban women. J K Sci J Med Educ Res 2007;9:13‑7.\n13. Singh M. Early age of natural menopause in India, a biological \nmarker for early preventive health programs. Climacteric \n2012;15:581‑6.\n14. Singh  L, Ahuja  S. Trend of menopause among the women of \nPunjab. Anthropol Anz 1980;38:297‑300.\n15. Sengupta  S, Gogoi  G. Menarche and menopause among the \nKai‑  barta women of Dibrugarh, Assam. J  Assam Sci Soc \n1993;35:113‑9.\n16. Kulkarni  VS, Joshi  M.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 671,
          "overlap_percentage": 100.1492537313433
        }
      ],
      "primary_page": 25,
      "char_count": 670,
      "word_count": 106,
      "start_pos": 114059,
      "end_pos": 114730,
      "chunk_index": 228,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_229",
      "text": "Kai‑  barta women of Dibrugarh, Assam. J  Assam Sci Soc \n1993;35:113‑9.\n16. Kulkarni  VS, Joshi  M. Reproductive life of two endogamous \ngroups of Maharashtra. Man India 1979;59:71‑90.\n17. Kar  RK, Mahanta  S. Menarche and menopause among the \nwomen of Arunachal Pradesh. Indian J Phys Anthro Hum Genet \n1975;1:51‑7.\n18. Balgir RS. Age at menarche and menopause among the Sikligars \nof Punjab. J Indian Med Assoc 1985;83:195‑7.\n19. Sharma  N, Singh  R. Age at menarche and menopause of \nBrahmins and Choudhary females of Kangra valley. Proceedings \nof International Symposium on Human Growth. Patiala India; \n1980.\n20. Gosh  AK, Kumari  S. Effect of menarcheal age on fertility.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 679,
          "overlap_percentage": 100.14749262536873
        }
      ],
      "primary_page": 25,
      "char_count": 678,
      "word_count": 105,
      "start_pos": 114630,
      "end_pos": 115309,
      "chunk_index": 229,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_230",
      "text": "Human Growth. Patiala India; \n1980.\n20. Gosh  AK, Kumari  S. Effect of menarcheal age on fertility. \nJ Indian Anthropol Soc 1973;8:165‑72.\n21. Singh A, Arora AK. Prole of menopausal women in rural North \nIndia. Climacteric 2005;8:177‑84.\n22. Shah R, Kalgutkar S, Savardekar L, Chitlange S, Iddya U, \nBaliah D. Menopausal symptoms in urban Indian women. \nObstet Gynaecol Today 2004;IX:667-70.\n23. Bagga A. Age and symptomatology of menopause: A case study. \nObstet Gynaecol Today 2004;11:660‑6.\n24. Rakshit S. Reproductive life of Maharashtrian Brahmin women. \nMan India 1962;56:65‑70.\n25. Sengupta  S, Rjkhowa  M. Menarche and menopause in Ahom \nwomen of Dibrogarh in Assam. J Hum Ecol 1996;7:211‑3.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 700,
          "overlap_percentage": 100.14306151645206
        }
      ],
      "primary_page": 25,
      "char_count": 699,
      "word_count": 105,
      "start_pos": 115209,
      "end_pos": 115909,
      "chunk_index": 230,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_231",
      "text": "S, Rjkhowa  M. Menarche and menopause in Ahom \nwomen of Dibrogarh in Assam. J Hum Ecol 1996;7:211‑3.\n26. Kaw D, Khanna B, Vasishtha K. Factors that influence the age at \nnatural menopause. J Obstet Gynaecol India 1994;44:273‑7.\n27. Mastana  SS. Age at menopause among the Lobanas of North \nWest India. J Hum Ecol 1996;7:151‑3.\n28. Kriplani  A, Banerjee  K. An overview of age of onset of \nmenopause in Northern India. Maturitas 2005;52:199‑204.\n29. Shatrugna V, Kulkarni  B, Kumar  PA, Rani  KU, Balakrishna  N. \nBone status of Indian women from a low‑income group \nand its relationship to the nutritional status. Osteoporos Int \n2005;16:1827‑35.\n30. Gupta  A.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 660,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 660,
      "word_count": 105,
      "start_pos": 115809,
      "end_pos": 116469,
      "chunk_index": 231,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_232",
      "text": "roup \nand its relationship to the nutritional status. Osteoporos Int \n2005;16:1827‑35.\n30. Gupta  A. Osteoporosis in India the nutritional hypothesis. In: \nMithal A, Rao DS, Zaidi M, editors. Metabolic Bone Disorders. \nLucknow, UP, India: Hindustani Book Depot; 1998. p. 115.\n31. Yusuf S, Hawken S, Ounpuu S,Dans T, Avezum A, Lanas F \nEffect of potentially modifiable risk factors associated with \nmyocardial infarction in 52 countries (the INTERHEART study): \ncase-control study. Lancet. 2004;364(9438):937-952.\n32. Ramachandran  A, Ma  RC, Snehalatha  C. Diabetes in Asia. \nLancet 2010;375:408‑18.\n33.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 603,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 603,
      "word_count": 85,
      "start_pos": 116369,
      "end_pos": 116972,
      "chunk_index": 232,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_233",
      "text": ":937-952.\n32. Ramachandran  A, Ma  RC, Snehalatha  C. Diabetes in Asia. \nLancet 2010;375:408‑18.\n33. International Agency for Research on Cancer: GLOBOCAN \n2012: Estimated Cancer Incidence, Mortality and Prevalence \nWorldwide; 2012. Available from: [URL]\nfact_sheets_cancer.aspx. [Last accessed on 2020 Jul 10].\n34. Yusuf  S, Reddy  S, Ounpuu  S, Anand  S. Global burden of \ncardiovascular diseases: Part I: General considerations, the \nepidemiologic transition, risk factors, and impact of urbanization. \nCirculation 2001;104:2746‑53.\n35. Das  SK, Banerjee  TK, Biswas  A, Roy  T, Raut  DK, \nMukherjee  CS, et  al.",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 615,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 615,
      "word_count": 84,
      "start_pos": 116872,
      "end_pos": 117487,
      "chunk_index": 233,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_234",
      "text": "on 2001;104:2746‑53.\n35. Das  SK, Banerjee  TK, Biswas  A, Roy  T, Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 140,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 140,
      "word_count": 22,
      "start_pos": 117387,
      "end_pos": 117529,
      "chunk_index": 234,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_235",
      "text": "TK, Biswas  A, Roy  T, Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 98,
          "overlap_percentage": 102.08333333333333
        }
      ],
      "primary_page": 25,
      "char_count": 96,
      "word_count": 16,
      "start_pos": 117429,
      "end_pos": 117529,
      "chunk_index": 235,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_236",
      "text": "TK, Biswas  A, Roy  T, Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 97,
          "overlap_percentage": 101.04166666666667
        }
      ],
      "primary_page": 25,
      "char_count": 96,
      "word_count": 16,
      "start_pos": 117430,
      "end_pos": 117529,
      "chunk_index": 236,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_237",
      "text": "TK, Biswas  A, Roy  T, Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 96,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 96,
      "word_count": 16,
      "start_pos": 117431,
      "end_pos": 117529,
      "chunk_index": 237,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_238",
      "text": "K, Biswas  A, Roy  T, Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 95,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 95,
      "word_count": 16,
      "start_pos": 117432,
      "end_pos": 117529,
      "chunk_index": 238,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_239",
      "text": ", Biswas  A, Roy  T, Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 94,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 94,
      "word_count": 16,
      "start_pos": 117433,
      "end_pos": 117529,
      "chunk_index": 239,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_240",
      "text": "Biswas  A, Roy  T, Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 93,
          "overlap_percentage": 101.08695652173914
        }
      ],
      "primary_page": 25,
      "char_count": 92,
      "word_count": 15,
      "start_pos": 117434,
      "end_pos": 117529,
      "chunk_index": 240,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_241",
      "text": "Biswas  A, Roy  T, Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 92,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 92,
      "word_count": 15,
      "start_pos": 117435,
      "end_pos": 117529,
      "chunk_index": 241,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_242",
      "text": "iswas  A, Roy  T, Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 91,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 91,
      "word_count": 15,
      "start_pos": 117436,
      "end_pos": 117529,
      "chunk_index": 242,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_243",
      "text": "swas  A, Roy  T, Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 90,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 90,
      "word_count": 15,
      "start_pos": 117437,
      "end_pos": 117529,
      "chunk_index": 243,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_244",
      "text": "was  A, Roy  T, Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 89,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 89,
      "word_count": 15,
      "start_pos": 117438,
      "end_pos": 117529,
      "chunk_index": 244,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_245",
      "text": "as  A, Roy  T, Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 88,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 88,
      "word_count": 15,
      "start_pos": 117439,
      "end_pos": 117529,
      "chunk_index": 245,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_246",
      "text": "s  A, Roy  T, Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 87,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 87,
      "word_count": 15,
      "start_pos": 117440,
      "end_pos": 117529,
      "chunk_index": 246,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_247",
      "text": "A, Roy  T, Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 86,
          "overlap_percentage": 102.38095238095238
        }
      ],
      "primary_page": 25,
      "char_count": 84,
      "word_count": 14,
      "start_pos": 117441,
      "end_pos": 117529,
      "chunk_index": 247,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_248",
      "text": "A, Roy  T, Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 85,
          "overlap_percentage": 101.19047619047619
        }
      ],
      "primary_page": 25,
      "char_count": 84,
      "word_count": 14,
      "start_pos": 117442,
      "end_pos": 117529,
      "chunk_index": 248,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_249",
      "text": "A, Roy  T, Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 84,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 84,
      "word_count": 14,
      "start_pos": 117443,
      "end_pos": 117529,
      "chunk_index": 249,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_250",
      "text": ", Roy  T, Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 83,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 83,
      "word_count": 14,
      "start_pos": 117444,
      "end_pos": 117529,
      "chunk_index": 250,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_251",
      "text": "Roy  T, Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 82,
          "overlap_percentage": 101.23456790123457
        }
      ],
      "primary_page": 25,
      "char_count": 81,
      "word_count": 13,
      "start_pos": 117445,
      "end_pos": 117529,
      "chunk_index": 251,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_252",
      "text": "Roy  T, Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 81,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 81,
      "word_count": 13,
      "start_pos": 117446,
      "end_pos": 117529,
      "chunk_index": 252,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_253",
      "text": "oy  T, Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 80,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 80,
      "word_count": 13,
      "start_pos": 117447,
      "end_pos": 117529,
      "chunk_index": 253,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_254",
      "text": "y  T, Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 79,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 79,
      "word_count": 13,
      "start_pos": 117448,
      "end_pos": 117529,
      "chunk_index": 254,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_255",
      "text": "T, Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 78,
          "overlap_percentage": 102.63157894736842
        }
      ],
      "primary_page": 25,
      "char_count": 76,
      "word_count": 12,
      "start_pos": 117449,
      "end_pos": 117529,
      "chunk_index": 255,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_256",
      "text": "T, Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 77,
          "overlap_percentage": 101.3157894736842
        }
      ],
      "primary_page": 25,
      "char_count": 76,
      "word_count": 12,
      "start_pos": 117450,
      "end_pos": 117529,
      "chunk_index": 256,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_257",
      "text": "T, Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 76,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 76,
      "word_count": 12,
      "start_pos": 117451,
      "end_pos": 117529,
      "chunk_index": 257,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_258",
      "text": ", Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 75,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 75,
      "word_count": 12,
      "start_pos": 117452,
      "end_pos": 117529,
      "chunk_index": 258,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_259",
      "text": "Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 74,
          "overlap_percentage": 101.36986301369863
        }
      ],
      "primary_page": 25,
      "char_count": 73,
      "word_count": 11,
      "start_pos": 117453,
      "end_pos": 117529,
      "chunk_index": 259,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_260",
      "text": "Raut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 73,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 73,
      "word_count": 11,
      "start_pos": 117454,
      "end_pos": 117529,
      "chunk_index": 260,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_261",
      "text": "aut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 72,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 72,
      "word_count": 11,
      "start_pos": 117455,
      "end_pos": 117529,
      "chunk_index": 261,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_262",
      "text": "ut  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 71,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 71,
      "word_count": 11,
      "start_pos": 117456,
      "end_pos": 117529,
      "chunk_index": 262,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_263",
      "text": "t  DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 70,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 70,
      "word_count": 11,
      "start_pos": 117457,
      "end_pos": 117529,
      "chunk_index": 263,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_264",
      "text": "DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 69,
          "overlap_percentage": 102.98507462686568
        }
      ],
      "primary_page": 25,
      "char_count": 67,
      "word_count": 10,
      "start_pos": 117458,
      "end_pos": 117529,
      "chunk_index": 264,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_265",
      "text": "DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 68,
          "overlap_percentage": 101.49253731343283
        }
      ],
      "primary_page": 25,
      "char_count": 67,
      "word_count": 10,
      "start_pos": 117459,
      "end_pos": 117529,
      "chunk_index": 265,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_266",
      "text": "DK, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 67,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 67,
      "word_count": 10,
      "start_pos": 117460,
      "end_pos": 117529,
      "chunk_index": 266,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_267",
      "text": "K, \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 66,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 66,
      "word_count": 10,
      "start_pos": 117461,
      "end_pos": 117529,
      "chunk_index": 267,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_268",
      "text": ", \nMukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 65,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 65,
      "word_count": 10,
      "start_pos": 117462,
      "end_pos": 117529,
      "chunk_index": 268,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_269",
      "text": "Mukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 64,
          "overlap_percentage": 103.2258064516129
        }
      ],
      "primary_page": 25,
      "char_count": 62,
      "word_count": 9,
      "start_pos": 117463,
      "end_pos": 117529,
      "chunk_index": 269,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_270",
      "text": "Mukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 63,
          "overlap_percentage": 101.61290322580645
        }
      ],
      "primary_page": 25,
      "char_count": 62,
      "word_count": 9,
      "start_pos": 117464,
      "end_pos": 117529,
      "chunk_index": 270,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_271",
      "text": "Mukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 62,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 62,
      "word_count": 9,
      "start_pos": 117465,
      "end_pos": 117529,
      "chunk_index": 271,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_272",
      "text": "ukherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 61,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 61,
      "word_count": 9,
      "start_pos": 117466,
      "end_pos": 117529,
      "chunk_index": 272,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_273",
      "text": "kherjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 60,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 60,
      "word_count": 9,
      "start_pos": 117467,
      "end_pos": 117529,
      "chunk_index": 273,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_274",
      "text": "herjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 59,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 59,
      "word_count": 9,
      "start_pos": 117468,
      "end_pos": 117529,
      "chunk_index": 274,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_275",
      "text": "erjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 58,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 58,
      "word_count": 9,
      "start_pos": 117469,
      "end_pos": 117529,
      "chunk_index": 275,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_276",
      "text": "rjee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 57,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 57,
      "word_count": 9,
      "start_pos": 117470,
      "end_pos": 117529,
      "chunk_index": 276,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_277",
      "text": "jee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 56,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 56,
      "word_count": 9,
      "start_pos": 117471,
      "end_pos": 117529,
      "chunk_index": 277,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_278",
      "text": "ee  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 55,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 55,
      "word_count": 9,
      "start_pos": 117472,
      "end_pos": 117529,
      "chunk_index": 278,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_279",
      "text": "e  CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 54,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 54,
      "word_count": 9,
      "start_pos": 117473,
      "end_pos": 117529,
      "chunk_index": 279,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_280",
      "text": "CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 53,
          "overlap_percentage": 103.921568627451
        }
      ],
      "primary_page": 25,
      "char_count": 51,
      "word_count": 8,
      "start_pos": 117474,
      "end_pos": 117529,
      "chunk_index": 280,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_281",
      "text": "CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 52,
          "overlap_percentage": 101.96078431372548
        }
      ],
      "primary_page": 25,
      "char_count": 51,
      "word_count": 8,
      "start_pos": 117475,
      "end_pos": 117529,
      "chunk_index": 281,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_282",
      "text": "CS, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 51,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 51,
      "word_count": 8,
      "start_pos": 117476,
      "end_pos": 117529,
      "chunk_index": 282,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_283",
      "text": "S, et  al. A  prospective community‑based study of",
      "doc_title": "2_Clinical_Practice_Guidelines_on_Menopause",
      "doc_filename": "2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\2_Clinical_Practice_Guidelines_on_Menopause.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 50,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 50,
      "word_count": 8,
      "start_pos": 117477,
      "end_pos": 117529,
      "chunk_index": 283,
      "total_doc_pages": 25,
      "extraction_timestamp": "2025-06-28T15:28:32.388486"
    },
    {
      "id": "chunk_0",
      "text": "The Endocrine Society recommends that women with a uterus who decide to undergo \nmenopausal hormone therapy with estrogen and progestogen be informed about risks and \nbenefits, including the possible increased risk of breast cancer during and after discontinuing \ntreatment. Health care providers should advise all women, including those taking menopausal \nhormone therapy, to follow guidelines for breast cancer screening. \n​\nTransdermal estrogen therapy by patch, gel or spray is recommended for women who \nrequest menopausal hormone therapy and have an increased risk of venous \nthromboembolism7mdash;a disease that includes deep vein thrombosis.",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 649,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 649,
      "word_count": 91,
      "start_pos": 0,
      "end_pos": 649,
      "chunk_index": 0,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_1",
      "text": "ave an increased risk of venous \nthromboembolism7mdash;a disease that includes deep vein thrombosis. \n​\nProgestogen treatment prevents uterine cancer in women taking estrogen for hot flash \nrelief. For women who have undergone a hysterectomy, it is not necessary. \n​\nIf a woman on menopausal hormone therapy experiences persistent unscheduled vaginal \nbleeding, she should be evaluated to rule out endometrial cancer or hyperplasia.",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 432,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 432,
      "word_count": 62,
      "start_pos": 549,
      "end_pos": 981,
      "chunk_index": 1,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_2",
      "text": "nscheduled vaginal \nbleeding, she should be evaluated to rule out endometrial cancer or hyperplasia. \n​\nMedications called selective serotonin reuptake inhibitors (SSRIs), \nserotonin-norepinephrine reuptake inhibitors (SNRIs), gabapentin or pregabalin are \nrecommended for women who want medication to manage moderate to severe hot \nflashes, but either prefer not to take hormone therapy or have significant risk factors that \nmake hormone therapy inadvisable.",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 460,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 460,
      "word_count": 61,
      "start_pos": 881,
      "end_pos": 1341,
      "chunk_index": 2,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_3",
      "text": "not to take hormone therapy or have significant risk factors that \nmake hormone therapy inadvisable. \n​\nLow-dose vaginal estrogen therapy is recommended to treat women for genitourinary \nsymptoms of menopause, such as burning and irritation of the genitalia, dryness, \ndiscomfort or pain with intercourse; and urinary urgency or recurrent infections. This \ntreatment should only be used in women without a history of estrogen-dependent cancers. \nSummary of Recommendations \n- 1.0 Diagnosis and symptoms of menopause \n​\n1.1 We suggest diagnosing menopause based on the clinical criteria of the menstrual \ncycle. (2|⊕⊕⚪⚪) \n​\n1.",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 625,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 625,
      "word_count": 92,
      "start_pos": 1241,
      "end_pos": 1866,
      "chunk_index": 3,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_4",
      "text": "suggest diagnosing menopause based on the clinical criteria of the menstrual \ncycle. (2|⊕⊕⚪⚪) \n​\n1.2 If establishing a diagnosis of menopause is necessary for patient management in \nwomen having undergone a hysterectomy without bilateral oophorectomy or presenting \nwith a menstrual history that is inadequate to ascertain menopausal status, we suggest \nmaking a presumptive diagnosis of menopause based on the presence of vasomotor \nsymptoms (VMS) and, when indicated, laboratory testing that includes replicate measures \nof FSH and serum estradiol. (2|⊕⊕⚪⚪) \n- 2.0 Health considerations for all menopausal women \n​\n2.",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 620,
          "overlap_percentage": 100.16155088852989
        }
      ],
      "primary_page": 1,
      "char_count": 619,
      "word_count": 89,
      "start_pos": 1766,
      "end_pos": 2386,
      "chunk_index": 4,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_5",
      "text": "es \nof FSH and serum estradiol. (2|⊕⊕⚪⚪) \n- 2.0 Health considerations for all menopausal women \n​\n2.1 When women present during the menopausal transition, we suggest using this \nopportunity to address bone health, smoking cessation, alcohol use, cardiovascular risk \nassessment and management, and cancer screening and prevention. (Ungraded best \npractice statement) \n- 3.0 Hormone therapy for menopausal symptom relief \n​\n3.1 Estrogen and progestogen therapy3.",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 461,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 461,
      "word_count": 65,
      "start_pos": 2286,
      "end_pos": 2747,
      "chunk_index": 5,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_6",
      "text": "ment) \n- 3.0 Hormone therapy for menopausal symptom relief \n​\n3.1 Estrogen and progestogen therapy3.1a For menopausal women < 60 years of age or < \n10 years past menopause with bothersome VMS (with or without additional climacteric\n\nsymptoms) who do not have contraindications or excess cardiovascular or breast cancer \nrisks and are willing to take menopausal hormone therapy (MHT), we suggest initiating \nestrogen therapy (ET) for those without a uterus and estrogen plus progestogen therapy \n(EPT) for those with a uterus. (2|⊕⊕⚪⚪) \n​\nCardiovascular risk \n​\n3.",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 231,
          "overlap_percentage": 41.03019538188277
        },
        {
          "page_number": 2,
          "overlap_chars": 330,
          "overlap_percentage": 58.614564831261106
        }
      ],
      "primary_page": 1,
      "char_count": 563,
      "word_count": 87,
      "start_pos": 2647,
      "end_pos": 3210,
      "chunk_index": 6,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_7",
      "text": "rogen plus progestogen therapy \n(EPT) for those with a uterus. (2|⊕⊕⚪⚪) \n​\nCardiovascular risk \n​\n3.1b For women < age 60 or < 10 years past menopause onset considering MHT for \nmenopausal symptom relief, we suggest evaluating the baseline risk of cardiovascular \ndisease (CVD) and taking this risk into consideration when advising for or against MHT \nand when selecting type, dose, and route of administration. (2|⊕⊕⚪⚪) \n​\n3.1c For women at high risk of CVD, we suggest initiating nonhormonal therapies to \nalleviate bothersome VMS (with or without climacteric symptoms) over MHT. \n(2|⊕⊕⚪⚪) \n​\n3.",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 597,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 597,
      "word_count": 94,
      "start_pos": 3110,
      "end_pos": 3707,
      "chunk_index": 7,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_8",
      "text": "rapies to \nalleviate bothersome VMS (with or without climacteric symptoms) over MHT. \n(2|⊕⊕⚪⚪) \n​\n3.1d For women with moderate risk of CVD, we suggest transdermal estradiol as \nfirst-line treatment, alone for women without a uterus or combined with micronized \nprogesterone (or another progestogen that does not adversely modify metabolic \nparameters) for women with a uterus, because these preparations have less untoward \neffect on blood pressure, triglycerides, and carbohydrate metabolism. (2|⊕⊕⚪⚪) \n​\nVenous thromboembolic events3.",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 536,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 536,
      "word_count": 74,
      "start_pos": 3607,
      "end_pos": 4143,
      "chunk_index": 8,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_9",
      "text": "ood pressure, triglycerides, and carbohydrate metabolism. (2|⊕⊕⚪⚪) \n​\nVenous thromboembolic events3.1e For women at increased risk of venous \nthromboembolism (VTE) who request MHT, we recommend a nonoral route of ET at the \nlowest effective dose, if not contraindicated (1|⊕⊕○○); for women with a uterus, we \nrecommend a progestogen (for example, progesterone and dydrogestone) that is neutral \non coagulation parameters. (1|⊕⊕⊕⚪) \n​\nBreast cancer3.",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 449,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 449,
      "word_count": 63,
      "start_pos": 4043,
      "end_pos": 4492,
      "chunk_index": 9,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_10",
      "text": "ogesterone and dydrogestone) that is neutral \non coagulation parameters. (1|⊕⊕⊕⚪) \n​\nBreast cancer3.1f For women considering MHT for menopausal symptom relief, we \nsuggest evaluating the baseline risk of breast cancer and taking this risk into \nconsideration when advising for or against MHT and when selecting type, dose, and route \nof administration. (2|⊕⊕⚪⚪) \n​\n3.1g For women at high or intermediate risk of breast cancer considering MHT for \nmenopausal symptom relief, we suggest nonhormonal therapies over MHT to alleviate \nbothersome VMS. (2|⊕⊕⚪⚪) \n​\nTailoring MHT3.",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 573,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 573,
      "word_count": 84,
      "start_pos": 4392,
      "end_pos": 4965,
      "chunk_index": 10,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_11",
      "text": "we suggest nonhormonal therapies over MHT to alleviate \nbothersome VMS. (2|⊕⊕⚪⚪) \n​\nTailoring MHT3.1h We suggest a shared decision-making approach to decide about the \nchoice of formulation, starting dose, the route of administration of MHT, and how to \ntailor MHT to each woman's individual situation, risks, and treatment goals. (Ungraded \nbest practice statement) \n​\nCustom-compounded hormones3.1i We recommend using MHT preparations approved \nby the US Food and Drug Administration (FDA) and comparable regulating bodies \noutside the United States and recommend against the use of custom-compounded \nhormones. (Ungraded best practice statement) \n​\n3.",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 655,
          "overlap_percentage": 100.15290519877675
        }
      ],
      "primary_page": 2,
      "char_count": 654,
      "word_count": 92,
      "start_pos": 4865,
      "end_pos": 5520,
      "chunk_index": 11,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_12",
      "text": "d recommend against the use of custom-compounded \nhormones. (Ungraded best practice statement) \n​\n3.2 Conjugated equine estrogens with bazedoxifene3.2 For symptomatic postmenopausal \nwomen with a uterus and without contraindications, we suggest the combination of\n\nconjugated equine estrogens (CEE)/bazedoxifene (BZA) (where available) as an option \nfor relief of VMS and prevention of bone loss. (2|⊕⊕⊕⚪) \n​\n3.3 Tibolone3.3a For women with bothersome VMS and climacteric symptoms and \nwithout contraindications, we suggest tibolone (in countries where available) as an \nalternative to MHT. (2|⊕⊕⚪⚪) \n​\n3.3b We recommend against adding tibolone to other forms of MHT. (1|⊕⊕⚪⚪) \n​\n3.",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 263,
          "overlap_percentage": 38.56304985337243
        },
        {
          "page_number": 3,
          "overlap_chars": 417,
          "overlap_percentage": 61.14369501466276
        }
      ],
      "primary_page": 2,
      "char_count": 682,
      "word_count": 96,
      "start_pos": 5420,
      "end_pos": 6102,
      "chunk_index": 12,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_13",
      "text": "to MHT. (2|⊕⊕⚪⚪) \n​\n3.3b We recommend against adding tibolone to other forms of MHT. (1|⊕⊕⚪⚪) \n​\n3.3c We recommend against using tibolone in women with a history of breast cancer. \n(1|⊕⊕⚪⚪) \n​\n3.4 Clinical management of patients taking hormone therapies​\nMonitoring during therapy3.4a For women with persistent unscheduled bleeding while \ntaking MHT, we recommend evaluation to rule out pelvic pathology, most importantly, \nendometrial hyperplasia and cancer. (1|⊕⊕⊕⚪) \n​\n3.4b We recommend informing women about the possible increased risk of breast cancer \nduring and after discontinuing EPT and emphasizing the importance of adhering to \nage-appropriate breast cancer screening. (1|⊕⊕⊕⚪) \n​\n3.",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 696,
          "overlap_percentage": 100.14388489208632
        }
      ],
      "primary_page": 3,
      "char_count": 695,
      "word_count": 101,
      "start_pos": 6002,
      "end_pos": 6698,
      "chunk_index": 13,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_14",
      "text": "d emphasizing the importance of adhering to \nage-appropriate breast cancer screening. (1|⊕⊕⊕⚪) \n​\n3.4c We suggest that the decision to continue MHT be revisited at least annually, \ntargeting the shortest total duration of MHT consistent with the treatment goals and \nevolving risk assessment of the individual woman. (Ungraded best practice statement) \n​\n3.4d For young women with primary ovarian insufficiency (POI), premature or early \nmenopause, without contraindications, we suggest taking MHT until the time of \nanticipated natural menopause, when the advisability of continuing MHT can be \nreassessed. (2|⊕⊕⚪⚪) \n​\nStopping considerations3.",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 645,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 3,
      "char_count": 645,
      "word_count": 91,
      "start_pos": 6598,
      "end_pos": 7243,
      "chunk_index": 14,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_15",
      "text": "e, when the advisability of continuing MHT can be \nreassessed. (2|⊕⊕⚪⚪) \n​\nStopping considerations3.4e For women preparing to discontinue MHT, we suggest a \nshared decision-making approach to elicit individual preference about adopting a gradual \ntaper vs abrupt discontinuation. (2|⊕⊕⚪⚪) \n- 4.0 Nonhormonal therapies for VMS \n​\n4.0 For postmenopausal women with mild or less bothersome hot flashes, we suggest a \nseries of steps that do not involve medication, such as turning down the thermostat, \ndressing in layers, avoiding alcohol and spicy foods, and reducing obesity and stress. \n(2|⊕⊕⚪⚪) \n​\n4.1 Nonhormonal prescription therapies for VMS4.",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 648,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 3,
      "char_count": 648,
      "word_count": 95,
      "start_pos": 7143,
      "end_pos": 7791,
      "chunk_index": 15,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_16",
      "text": "oods, and reducing obesity and stress. \n(2|⊕⊕⚪⚪) \n​\n4.1 Nonhormonal prescription therapies for VMS4.1a For women seeking \npharmacological management for moderate to severe VMS for whom MHT is \ncontraindicated, or who choose not to take MHT, we recommend selective serotonin \nreuptake inhibitors (SSRIs)/serotonin-norepinephrine reuptake inhibitors (SNRIs) or \ngabapentin or pregabalin (if there are no contraindications). (1|⊕⊕⊕⚪) \n​\n4.1b For those women seeking relief of moderate to severe VMS who are not responding \nto or tolerating the nonhormonal prescription therapies, SSRIs/SNRIs or gabapentin or \npregabalin, we suggest a trial of clonidine (if there are no contraindications).",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 687,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 3,
      "char_count": 687,
      "word_count": 95,
      "start_pos": 7691,
      "end_pos": 8378,
      "chunk_index": 16,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_17",
      "text": "s or gabapentin or \npregabalin, we suggest a trial of clonidine (if there are no contraindications). (2|⊕⊕⚪⚪) \n​\n4.2 Over-the-counter and alternative nonhormonal therapies for VMS4.2 For women \nseeking relief of VMS with over-the-counter (OTC) or complementary medicine\n\ntherapies, we suggest counseling regarding the lack of consistent evidence for benefit for \nbotanicals, black cohosh, omega-3-fatty acids, red clover, vitamin E, and mind/body \nalternatives including anxiety control, acupuncture, paced breathing, and hypnosis. \n(2|⊕⊕⚪⚪) \n- 5.0 Treatment of genitourinary syndrome of menopause \n​\n5.1 Vaginal moisturizers and lubricants5.",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 269,
          "overlap_percentage": 41.90031152647975
        },
        {
          "page_number": 4,
          "overlap_chars": 371,
          "overlap_percentage": 57.78816199376947
        }
      ],
      "primary_page": 3,
      "char_count": 642,
      "word_count": 86,
      "start_pos": 8278,
      "end_pos": 8920,
      "chunk_index": 17,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_18",
      "text": "- 5.0 Treatment of genitourinary syndrome of menopause \n​\n5.1 Vaginal moisturizers and lubricants5.1a For postmenopausal women with symptoms \nof vulvovaginal atrophy (VVA), we suggest a trial of vaginal moisturizers to be used at \nleast twice weekly. (2|⊕⊕○○) \n​\n5.1b For women who do not produce sufficient vaginal secretions for comfortable sexual \nactivity, we suggest vaginal lubricants. (2|⊕⊕○○) \n​\n5.2 Vaginal estrogen therapies5.",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 437,
          "overlap_percentage": 100.22935779816513
        }
      ],
      "primary_page": 4,
      "char_count": 436,
      "word_count": 63,
      "start_pos": 8820,
      "end_pos": 9257,
      "chunk_index": 18,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_19",
      "text": "rtable sexual \nactivity, we suggest vaginal lubricants. (2|⊕⊕○○) \n​\n5.2 Vaginal estrogen therapies5.2a For women without a history of hormone- (estrogen) \ndependent cancers who are seeking relief from symptoms of genitourinary syndrome of \nmenopause (GSM) (including VVA) that persist despite using vaginal lubricants and \nmoisturizers, we recommend low-dose vaginal ET. (1|⊕⊕⊕⚪) \n​\nPractice statement5.2b In women with a history of breast or endometrial cancer, who \npresent with symptomatic GSM (including VVA), that does not respond to nonhormonal \ntherapies, we suggest a shared decision-making approach that includes the treating \noncologist to discuss using low-dose vaginal ET.",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 684,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 684,
      "word_count": 95,
      "start_pos": 9157,
      "end_pos": 9841,
      "chunk_index": 19,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_20",
      "text": "ecision-making approach that includes the treating \noncologist to discuss using low-dose vaginal ET. (Ungraded best practice statement) \n​\n5.2c For women taking raloxifene, without a history of hormone- (estrogen) dependent \ncancers, who develop symptoms of GSM (including VVA) that do not respond to \nnonhormonal therapies, we suggest adding low-dose vaginal ET. (2|⊕⊕⚪⚪) \n​\n5.2d For women using low-dose vaginal ET, we suggest against adding a progestogen (ie, \nno need for adding progestogen to prevent endometrial hyperplasia). (2|⊕⚪⚪⚪) \n​\n5.2e For women using vaginal ET who report postmenopausal bleeding or spotting, we \nrecommend prompt evaluation for endometrial pathology. (1|⊕⊕⚪⚪) \n​\n5.",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 697,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 697,
      "word_count": 100,
      "start_pos": 9741,
      "end_pos": 10438,
      "chunk_index": 20,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_21",
      "text": "usal bleeding or spotting, we \nrecommend prompt evaluation for endometrial pathology. (1|⊕⊕⚪⚪) \n​\n5.3 Ospemifene5.3a For treatment of moderate to severe dyspareunia associated with \nvaginal atrophy in postmenopausal women without contraindications, we suggest a trial \nof ospemifene. (2|⊕⊕⊕⚪) \n​\n5.3b For women with a history of breast cancer presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 414,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 414,
      "word_count": 56,
      "start_pos": 10338,
      "end_pos": 10754,
      "chunk_index": 21,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_22",
      "text": "a history of breast cancer presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 98,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 98,
      "word_count": 13,
      "start_pos": 10654,
      "end_pos": 10754,
      "chunk_index": 22,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_23",
      "text": "history of breast cancer presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 97,
          "overlap_percentage": 101.04166666666667
        }
      ],
      "primary_page": 4,
      "char_count": 96,
      "word_count": 12,
      "start_pos": 10655,
      "end_pos": 10754,
      "chunk_index": 23,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_24",
      "text": "history of breast cancer presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 96,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 96,
      "word_count": 12,
      "start_pos": 10656,
      "end_pos": 10754,
      "chunk_index": 24,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_25",
      "text": "istory of breast cancer presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 95,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 95,
      "word_count": 12,
      "start_pos": 10657,
      "end_pos": 10754,
      "chunk_index": 25,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_26",
      "text": "story of breast cancer presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 94,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 94,
      "word_count": 12,
      "start_pos": 10658,
      "end_pos": 10754,
      "chunk_index": 26,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_27",
      "text": "tory of breast cancer presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 93,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 93,
      "word_count": 12,
      "start_pos": 10659,
      "end_pos": 10754,
      "chunk_index": 27,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_28",
      "text": "ory of breast cancer presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 92,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 92,
      "word_count": 12,
      "start_pos": 10660,
      "end_pos": 10754,
      "chunk_index": 28,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_29",
      "text": "ry of breast cancer presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 91,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 91,
      "word_count": 12,
      "start_pos": 10661,
      "end_pos": 10754,
      "chunk_index": 29,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_30",
      "text": "y of breast cancer presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 90,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 90,
      "word_count": 12,
      "start_pos": 10662,
      "end_pos": 10754,
      "chunk_index": 30,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_31",
      "text": "of breast cancer presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 89,
          "overlap_percentage": 101.13636363636364
        }
      ],
      "primary_page": 4,
      "char_count": 88,
      "word_count": 11,
      "start_pos": 10663,
      "end_pos": 10754,
      "chunk_index": 31,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_32",
      "text": "of breast cancer presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 88,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 88,
      "word_count": 11,
      "start_pos": 10664,
      "end_pos": 10754,
      "chunk_index": 32,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_33",
      "text": "f breast cancer presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 87,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 87,
      "word_count": 11,
      "start_pos": 10665,
      "end_pos": 10754,
      "chunk_index": 33,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_34",
      "text": "breast cancer presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 86,
          "overlap_percentage": 101.17647058823529
        }
      ],
      "primary_page": 4,
      "char_count": 85,
      "word_count": 10,
      "start_pos": 10666,
      "end_pos": 10754,
      "chunk_index": 34,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_35",
      "text": "breast cancer presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 85,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 85,
      "word_count": 10,
      "start_pos": 10667,
      "end_pos": 10754,
      "chunk_index": 35,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_36",
      "text": "reast cancer presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 84,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 84,
      "word_count": 10,
      "start_pos": 10668,
      "end_pos": 10754,
      "chunk_index": 36,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_37",
      "text": "east cancer presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 83,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 83,
      "word_count": 10,
      "start_pos": 10669,
      "end_pos": 10754,
      "chunk_index": 37,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_38",
      "text": "ast cancer presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 82,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 82,
      "word_count": 10,
      "start_pos": 10670,
      "end_pos": 10754,
      "chunk_index": 38,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_39",
      "text": "st cancer presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 81,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 81,
      "word_count": 10,
      "start_pos": 10671,
      "end_pos": 10754,
      "chunk_index": 39,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_40",
      "text": "t cancer presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 80,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 80,
      "word_count": 10,
      "start_pos": 10672,
      "end_pos": 10754,
      "chunk_index": 40,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_41",
      "text": "cancer presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 79,
          "overlap_percentage": 101.28205128205127
        }
      ],
      "primary_page": 4,
      "char_count": 78,
      "word_count": 9,
      "start_pos": 10673,
      "end_pos": 10754,
      "chunk_index": 41,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_42",
      "text": "cancer presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 78,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 78,
      "word_count": 9,
      "start_pos": 10674,
      "end_pos": 10754,
      "chunk_index": 42,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_43",
      "text": "ancer presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 77,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 77,
      "word_count": 9,
      "start_pos": 10675,
      "end_pos": 10754,
      "chunk_index": 43,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_44",
      "text": "ncer presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 76,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 76,
      "word_count": 9,
      "start_pos": 10676,
      "end_pos": 10754,
      "chunk_index": 44,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_45",
      "text": "cer presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 75,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 75,
      "word_count": 9,
      "start_pos": 10677,
      "end_pos": 10754,
      "chunk_index": 45,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_46",
      "text": "er presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 74,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 74,
      "word_count": 9,
      "start_pos": 10678,
      "end_pos": 10754,
      "chunk_index": 46,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_47",
      "text": "r presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 73,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 73,
      "word_count": 9,
      "start_pos": 10679,
      "end_pos": 10754,
      "chunk_index": 47,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_48",
      "text": "presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 72,
          "overlap_percentage": 101.40845070422534
        }
      ],
      "primary_page": 4,
      "char_count": 71,
      "word_count": 8,
      "start_pos": 10680,
      "end_pos": 10754,
      "chunk_index": 48,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_49",
      "text": "presenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 71,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 71,
      "word_count": 8,
      "start_pos": 10681,
      "end_pos": 10754,
      "chunk_index": 49,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_50",
      "text": "resenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 70,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 70,
      "word_count": 8,
      "start_pos": 10682,
      "end_pos": 10754,
      "chunk_index": 50,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_51",
      "text": "esenting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 69,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 69,
      "word_count": 8,
      "start_pos": 10683,
      "end_pos": 10754,
      "chunk_index": 51,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_52",
      "text": "senting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 68,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 68,
      "word_count": 8,
      "start_pos": 10684,
      "end_pos": 10754,
      "chunk_index": 52,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_53",
      "text": "enting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 67,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 67,
      "word_count": 8,
      "start_pos": 10685,
      "end_pos": 10754,
      "chunk_index": 53,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_54",
      "text": "nting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 66,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 66,
      "word_count": 8,
      "start_pos": 10686,
      "end_pos": 10754,
      "chunk_index": 54,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_55",
      "text": "ting with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 65,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 65,
      "word_count": 8,
      "start_pos": 10687,
      "end_pos": 10754,
      "chunk_index": 55,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_56",
      "text": "ing with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 64,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 64,
      "word_count": 8,
      "start_pos": 10688,
      "end_pos": 10754,
      "chunk_index": 56,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_57",
      "text": "ng with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 63,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 63,
      "word_count": 8,
      "start_pos": 10689,
      "end_pos": 10754,
      "chunk_index": 57,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_58",
      "text": "g with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 62,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 62,
      "word_count": 8,
      "start_pos": 10690,
      "end_pos": 10754,
      "chunk_index": 58,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_59",
      "text": "with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 61,
          "overlap_percentage": 101.66666666666666
        }
      ],
      "primary_page": 4,
      "char_count": 60,
      "word_count": 7,
      "start_pos": 10691,
      "end_pos": 10754,
      "chunk_index": 59,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_60",
      "text": "with dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 60,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 60,
      "word_count": 7,
      "start_pos": 10692,
      "end_pos": 10754,
      "chunk_index": 60,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_61",
      "text": "ith dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 59,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 59,
      "word_count": 7,
      "start_pos": 10693,
      "end_pos": 10754,
      "chunk_index": 61,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_62",
      "text": "th dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 58,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 58,
      "word_count": 7,
      "start_pos": 10694,
      "end_pos": 10754,
      "chunk_index": 62,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_63",
      "text": "h dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 57,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 57,
      "word_count": 7,
      "start_pos": 10695,
      "end_pos": 10754,
      "chunk_index": 63,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_64",
      "text": "dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 56,
          "overlap_percentage": 101.81818181818181
        }
      ],
      "primary_page": 4,
      "char_count": 55,
      "word_count": 6,
      "start_pos": 10696,
      "end_pos": 10754,
      "chunk_index": 64,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_65",
      "text": "dyspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 55,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 55,
      "word_count": 6,
      "start_pos": 10697,
      "end_pos": 10754,
      "chunk_index": 65,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_66",
      "text": "yspareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 54,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 54,
      "word_count": 6,
      "start_pos": 10698,
      "end_pos": 10754,
      "chunk_index": 66,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_67",
      "text": "spareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 53,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 53,
      "word_count": 6,
      "start_pos": 10699,
      "end_pos": 10754,
      "chunk_index": 67,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_68",
      "text": "pareunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 52,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 52,
      "word_count": 6,
      "start_pos": 10700,
      "end_pos": 10754,
      "chunk_index": 68,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_69",
      "text": "areunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 51,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 51,
      "word_count": 6,
      "start_pos": 10701,
      "end_pos": 10754,
      "chunk_index": 69,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_70",
      "text": "reunia, we \nrecommend against ospemifene. (1|⊕⚪⚪⚪)",
      "doc_title": "3_Treatment_of_the_Symptoms_of_Menopause",
      "doc_filename": "3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\3_Treatment_of_the_Symptoms_of_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 50,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 50,
      "word_count": 6,
      "start_pos": 10702,
      "end_pos": 10754,
      "chunk_index": 70,
      "total_doc_pages": 4,
      "extraction_timestamp": "2025-06-28T15:28:32.407485"
    },
    {
      "id": "chunk_0",
      "text": "Evidence and consensus-based clinical practice guidelines \nfor management of overweight and obesity in midlife \nwomen: An AIIMS-DST initiative\nPiyush Ranjan1, Naval K. Vikram1, Archana Kumari2, Sakshi Chopra3, \nAmbuja Choranur4, Yashodhara Pradeep5, Manju Puri6, Anita Malhotra7, \nManinder Ahuja8, Meeta9, Achla Batra10, Geetha Balsarkar11, \nDeepti Goswami12, Kiran Guleria13, Siddharth Sarkar14, Garima Kachhawa2, \nAditi Verma3, M Krishna Kumari15, Jagmeet Madan16, Anjali Dabral17, \nSandhya Kamath18, Asmita Muthal Rathore19, Raman Kumar20, \nSrikumar Venkataraman21, Gaurishankar Kaloiya22, Neerja Bhatla2, \nS.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 612,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 612,
      "word_count": 73,
      "start_pos": 0,
      "end_pos": 612,
      "chunk_index": 0,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_1",
      "text": "thal Rathore19, Raman Kumar20, \nSrikumar Venkataraman21, Gaurishankar Kaloiya22, Neerja Bhatla2, \nS. Shantha Kumari23, Upendra Baitha1, Anupam Prakash24, \nMangesh Tiwaskar25, Kamlesh Tewary26, Anoop Misra27, Randeep Guleria28\n1Department of Medicine, All India Institute of Medical Sciences, New Delhi, India, 2Department of Obstetrics and Gynaecology, \nAll India Institute of Medical Sciences, New Delhi, India, 3Department of Home Science, University of Delhi, New Delhi, India, \n4President, Indian Menopause Society, Former Professor and Head, Department of Obstetrics and Gynaecology, Osmania Med",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 600,
      "word_count": 76,
      "start_pos": 512,
      "end_pos": 1112,
      "chunk_index": 1,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_2",
      "text": "Menopause Society, Former Professor and Head, Department of Obstetrics and Gynaecology, Osmania Medical \nCollege, Hyderabad, India, 5Era Medical College and University, Ex Professor and Head Department of Obstetrics and Gynaecology, \nRML Institute of Medical Sciences, KGMU, Lucknow, Vice President Elect, FOGSI, Ex Vice President, IMS, India, 6Head, Department \nof Obstetrics and Gynaecology, LHMC and SSK Hospital, New Delhi, India, 7Food and Nutrition, Department of Home Science, \nVice-Principal, Lakshmibai College, University of Delhi, New Delhi, India, 8President, Society of Meaningful Life",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 600,
          "overlap_percentage": 100.33444816053512
        }
      ],
      "primary_page": 1,
      "char_count": 598,
      "word_count": 80,
      "start_pos": 1012,
      "end_pos": 1612,
      "chunk_index": 2,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_3",
      "text": ", Lakshmibai College, University of Delhi, New Delhi, India, 8President, Society of Meaningful Life Management, \nAssociate Editor, Journal of Midlife Health, India, 9Indian Menopause Society, Editor-in-Chief, Journal of Mid-Life Health, India, \n10President, Association of Obstetricians and Gynaecologists of Delhi (AOGD), Professor, Department of Obstetrics and Gynaecology, \nVMMC and Safdarjung Hospital, New Delhi, India, 11Department of Obstetrics and Gynaecology Seth G. S.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 478,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 478,
      "word_count": 61,
      "start_pos": 1512,
      "end_pos": 1990,
      "chunk_index": 3,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_4",
      "text": "MMC and Safdarjung Hospital, New Delhi, India, 11Department of Obstetrics and Gynaecology Seth G. S. Medical College, \nMumbai, India, 12Director Professor, Department of Obstetrics and Gynaecology, Maulana Azad Medical College, New Delhi, India, \n13Department of Obstetrics and Gynaecology, University College of Medical Sciences, New Delhi, India, 14Department of Psychiatry \nand NDDTC, All India Institute of Medical Sciences, New Delhi, India, 15Apollo Medical College, Hyderabad, India, 16National \nPresident, Indian Dietetic Association, India, 17Head, Department of Obstetrics and Gynaecology,",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 600,
          "overlap_percentage": 100.1669449081803
        }
      ],
      "primary_page": 1,
      "char_count": 599,
      "word_count": 77,
      "start_pos": 1890,
      "end_pos": 2490,
      "chunk_index": 4,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_5",
      "text": "l \nPresident, Indian Dietetic Association, India, 17Head, Department of Obstetrics and Gynaecology, VMMC and Safdarjung Hospital, \nNew Delhi, India, 18Ex-Professor of Medicine and Dean, Seth G S Medical College and KEM Hospital, Mumbai, and LT Municipal \nMedical College and General Hospital, Mumbai, India, 19Director Professor and Head, Department of Obstetrics and Gynaecology, \nMaulana Azad Medical College, New Delhi, India, 20President, Academy of Family Physicians of India, India, 21Department of \nPhysical Medicine and Rehabilitation, All India Institute of Medical Sciences, New Delhi, Indi",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 600,
      "word_count": 82,
      "start_pos": 2390,
      "end_pos": 2990,
      "chunk_index": 5,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_6",
      "text": "t of \nPhysical Medicine and Rehabilitation, All India Institute of Medical Sciences, New Delhi, India, 22Clinical Psychology, Department \nof Psychiatry, All India Institute of Medical Sciences, New Delhi, India, 23President, The Federation of Obstetric and Gynaecological \nSocieties of India, India, 24Department of Medicine, LHMC and SSK Hospital, New Delhi, India, 25Secretary, Association of the \nPhysicians of India, India, 26President, Association of the Physicians of India, India, 27Chairman, Fortis-C-DOC Centre of Excellence \nfor Diabetes, Metabolic Diseases and Endocrinology, Chairman, Nat",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 600,
      "word_count": 79,
      "start_pos": 2890,
      "end_pos": 3490,
      "chunk_index": 6,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_7",
      "text": "Fortis-C-DOC Centre of Excellence \nfor Diabetes, Metabolic Diseases and Endocrinology, Chairman, National Diabetes, Obesity and Cholesterol Foundation (N-DOC) and \nPresident, Diabetes Foundation (India), New Delhi, India, 28Director, All India Institute of Medical Sciences, New Delhi, India\nReview Article\nAccess this article online\nQuick Response Code:\nWebsite: \nwww.jfmpc.com\nDOI: \n10.4103/jfmpc.jfmpc_51_22\nAddress for correspondence: Dr. Naval K. Vikram, \nProfessor, Department of Medicine, All India Institute of Medical \nSciences, Ansari Nagar, New Delhi - 110 029, India. \nE-mail: navalvikram@gmail.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 607,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 607,
      "word_count": 76,
      "start_pos": 3390,
      "end_pos": 3997,
      "chunk_index": 7,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_8",
      "text": "nstitute of Medical \nSciences, Ansari Nagar, New Delhi - 110 029, India. \nE-mail: navalvikram@gmail.com\nHow to cite this article: Ranjan P, Vikram NK, Kumari A, Chopra S, \nChoranur A, Pradeep Y, et al. Evidence and consensus-based clinical \npractice guidelines for management of overweight and obesity in \nmidlife women: An AIIMS-DST initiative. J Family Med Prim Care \n2022;11:7549-601.\nThis is an open access journal, and articles are distributed under the terms of the Creative \nCommons Attribution-NonCommercial-ShareAlike 4.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 529,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 529,
      "word_count": 76,
      "start_pos": 3897,
      "end_pos": 4426,
      "chunk_index": 8,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_9",
      "text": "les are distributed under the terms of the Creative \nCommons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to \nremix, tweak, and build upon the work non-commercially, as long as appropriate credit is \ngiven and the new creations are licensed under the identical terms.\nFor reprints contact: WKHLRPMedknow_reprints@wolterskluwer.com\nReceived: 07-01-2022 \n \nRevised: 23-01-2022\nAccepted: 31-01-2022 \n \nPublished: 17-01-2023\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nIntroduction\nObesity is a clinical and public health epidemic.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 445,
          "overlap_percentage": 67.93893129770993
        },
        {
          "page_number": 2,
          "overlap_chars": 208,
          "overlap_percentage": 31.755725190839694
        }
      ],
      "primary_page": 1,
      "char_count": 655,
      "word_count": 87,
      "start_pos": 4326,
      "end_pos": 4981,
      "chunk_index": 9,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_10",
      "text": "ume 11  :  Issue 12  :  December 2022\nIntroduction\nObesity is a clinical and public health epidemic. In most \npopulations, women contribute more to the prevalence of obesity \nin adults than their male counterparts. The biopsychosocial \nchanges experienced during various stages of the reproductive \ncycle might implicate excessive weight gain in women.[1] One such \nhigh-risk reproductive stage for gaining weight is the menopause \ntransition experienced during midlife.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 470,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 470,
      "word_count": 67,
      "start_pos": 4881,
      "end_pos": 5351,
      "chunk_index": 10,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_11",
      "text": "-risk reproductive stage for gaining weight is the menopause \ntransition experienced during midlife. In addition to biological \ntransition, midlife women experience changes in their everyday \nlifestyle-related habits in a way that might promote unhealthy \neating habits, sedentary lifestyles, and distress in the face of \nhousehold and work responsibilities.[2] Further, weight gain \npromotes menopausal symptom severity, making it difficult to \nmaintain healthy lifestyle-related behaviours and health-related \nquality of life.[3]\nThe introduction of corrective lifestyle-related habits has \nproven beneficial in managing weight and menopausal \nhealth.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 653,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 653,
      "word_count": 83,
      "start_pos": 5251,
      "end_pos": 5904,
      "chunk_index": 11,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_12",
      "text": "orrective lifestyle-related habits has \nproven beneficial in managing weight and menopausal \nhealth.[4] Corrective lifestyle habits such as healthy dietary \nbehaviour, physically active lifestyle, and psychological well-being \nare necessary for successful weight management. Most midlife \nwomen lack the motivation to initiate corrective practices as they \nprioritise their roles as mothers, homemakers, and workers over \ntheir own health. Besides, factors including poor musculoskeletal \nhealth, limited physical function, menstrual irregularities, and \npsychological distress interfere with adopting healthy lifestyle \npractices.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 631,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 631,
      "word_count": 76,
      "start_pos": 5804,
      "end_pos": 6435,
      "chunk_index": 12,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_13",
      "text": "al irregularities, and \npsychological distress interfere with adopting healthy lifestyle \npractices.[5] Considering these factors, it becomes necessary to \nincorporate strategies to address midlife-specific barriers while \nmanaging obesity in this group of women to initiate and sustain \nweight loss efforts.\nGenerally, midlife women receive generic weight management \nadvice from healthcare professionals.[6] This advice is less \nactionable, so it rarely contributes towards correcting the \nexisting lifestyle-related behaviours in midlife women. In \ncontrast, comprehensive obesity care also lacks specificity to \naddress issues faced by midlife women in managing weight \nand overall health.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 693,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 693,
      "word_count": 89,
      "start_pos": 6335,
      "end_pos": 7028,
      "chunk_index": 13,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_14",
      "text": "lacks specificity to \naddress issues faced by midlife women in managing weight \nand overall health. This care can be provided by a team of \nclinicians such as gynaecologists, physicians, and allied healthcare \nprofessionals, including nutritionists and exercise physiologists. \nThe availability of such a team in the healthcare setting might \nbe limited, especially in developing countries.[7] This underscores \nthe need for the development of evidence and consensus-based \nrecommendations related to diet, physical activity, and behaviour, \nwhich can be used by clinicians and/or any other healthcare \nprovider for opportunistic management of overweight and \nobesity in midlife women.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 686,
          "overlap_percentage": 100.14598540145985
        }
      ],
      "primary_page": 2,
      "char_count": 685,
      "word_count": 95,
      "start_pos": 6928,
      "end_pos": 7614,
      "chunk_index": 14,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_15",
      "text": "other healthcare \nprovider for opportunistic management of overweight and \nobesity in midlife women.\nMethods\nThe development and validation of the guideline were initiated \nto address the need for protocolised weight management \nmeasures specific to midlife women that can be implemented \nin day-to-day clinical practice at different healthcare settings. \nThe guidelines were developed in two phases using standardised \nmethodology as per the National Health and Medical Research \nCouncil (NHMRC): (i) development of recommendations and \n(ii) validation of the developed recommendations.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 587,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 587,
      "word_count": 79,
      "start_pos": 7514,
      "end_pos": 8101,
      "chunk_index": 15,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_16",
      "text": "l (NHMRC): (i) development of recommendations and \n(ii) validation of the developed recommendations. Firstly, an \nexhaustive list of key clinical questions through literature search, \nexpert opinion, and Delphi method was identified to be addressed \nby the guideline. In Phase I, a systematic review of the evidence, \ngrading, and expert opinion were undertaken to formulate clinical \npractice recommendations for each clinical question. In Phase \nII, the clinical practice recommendations were peer-reviewed \nand validated using the Delphi method and graded using the \nGRADE approach via the experts participating in the Guideline \nDevelopment Group (GDG).",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 657,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 657,
      "word_count": 92,
      "start_pos": 8001,
      "end_pos": 8658,
      "chunk_index": 16,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_17",
      "text": "d using the \nGRADE approach via the experts participating in the Guideline \nDevelopment Group (GDG).\nGuideline Development Group (GDG)\nExpert representatives from multidisciplinary fields including \nmedicine, gynecology, psychology, psychiatry, physical medicine \nand rehabilitation, nutrition, and exercise physiology were part of \nthe GDG.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 341,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 341,
      "word_count": 42,
      "start_pos": 8558,
      "end_pos": 8899,
      "chunk_index": 17,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_18",
      "text": "ry, physical medicine \nand rehabilitation, nutrition, and exercise physiology were part of \nthe GDG. Further, chairperson and field experts from prominent \nnational organisations such as the Department of Science and \nTechnology, the Federation of Obstetric and Gynaecological \nSocieties of India, Indian Menopause Society, Association of \nPhysicians of India, Academy of Family Physicians of India, \nAssociation of Obstetricians & Gynaecologists of Delhi, Indian \nDietetic Association, and the Indian Society of Clinical Nutrition \nalso participated in the GDG. From academia, senior professors \nacross five leading medical colleges of the country participated \nin the proceedings of GDGs.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 690,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 690,
      "word_count": 94,
      "start_pos": 8799,
      "end_pos": 9489,
      "chunk_index": 18,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_19",
      "text": "ssors \nacross five leading medical colleges of the country participated \nin the proceedings of GDGs. The role and responsibilities of \na member of the GDG included finalisation and prioritisation \nof key clinical questions to be addressed in guideline, review of \nthe available evidence, providing expert opinion, development \nof the recommendation for each clinical question, validation \nof the developed recommendations, and grading of the final \nrecommendations.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 465,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 465,
      "word_count": 65,
      "start_pos": 9389,
      "end_pos": 9854,
      "chunk_index": 19,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_20",
      "text": "l question, validation \nof the developed recommendations, and grading of the final \nrecommendations.\nDevelopment and prioritization of key clinical \nquestion\nInitially, a series of exploratory focus group discussions were \nconducted to identify the risk factors, barriers, and facilitators \nfor appropriate weight management among midlife women.[8] \nSecondly, a comprehensive, valid and reliable screening tool was \ndesigned to evaluate the lifestyle-related practices and barriers \nfaced in maintaining healthy eating, physical activity, and sleep \npractices.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 560,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 560,
      "word_count": 72,
      "start_pos": 9754,
      "end_pos": 10314,
      "chunk_index": 20,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_21",
      "text": "ractices and barriers \nfaced in maintaining healthy eating, physical activity, and sleep \npractices. Finally, a cross-sectional survey on 504 midlife women \nwas conducted to identify the daily lifestyle-related patterns and \ntheir association with menopausal symptom severity. These steps \nguided the team in identifying key critical areas that should be \naddressed for appropriate weight management in midlife women. \nIn addition, an exhaustive literature review was conducted to \ndetermine key clinical areas of interest for translation into key \nclinical questions.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 568,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 568,
      "word_count": 78,
      "start_pos": 10214,
      "end_pos": 10782,
      "chunk_index": 21,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_22",
      "text": "conducted to \ndetermine key clinical areas of interest for translation into key \nclinical questions. Based on the stages of weight management, \na comprehensive list of key clinical questions was classified into \nfour domains: (i) initiation of discussion for weight management, \n(ii) screening and risk assessment of the target population, (iii) \nmanagement of weight, and (iv) follow-up for weight sustenance. \nA series of online meetings with GDG were organised to\n\nRanjan, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 466,
          "overlap_percentage": 96.6804979253112
        },
        {
          "page_number": 3,
          "overlap_chars": 14,
          "overlap_percentage": 2.904564315352697
        }
      ],
      "primary_page": 2,
      "char_count": 482,
      "word_count": 72,
      "start_pos": 10682,
      "end_pos": 11164,
      "chunk_index": 22,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_23",
      "text": "ow-up for weight sustenance. \nA series of online meetings with GDG were organised to\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nprioritise and finalise the list of key clinical questions that can \nbe addressed in this guideline document. The list of key clinical \nquestions was peer-reviewed for its necessity in clinical practice, \nrelevance, face, and content validity under two levels. At the first \nlevel review, key clinical questions were reviewed, modified, and \nfinalised by a group of four to five topic-specific experts.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 84,
          "overlap_percentage": 13.249211356466878
        },
        {
          "page_number": 3,
          "overlap_chars": 548,
          "overlap_percentage": 86.43533123028391
        }
      ],
      "primary_page": 2,
      "char_count": 634,
      "word_count": 99,
      "start_pos": 11064,
      "end_pos": 11698,
      "chunk_index": 23,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_24",
      "text": "questions were reviewed, modified, and \nfinalised by a group of four to five topic-specific experts. The \nmodified clinical questions were subjected to a second-level \npeer-review done by a larger group of experts, including experts \nfrom different disciplines, journal editors, and senior professors \nfrom leading organisations. Finally, 19 key clinical questions were \nprioritised for appropriate midlife health care.\nReview of evidence to answer the clinical questions\nTo develop the recommendations, an exhaustive and systematic \nliterature review was conducted independently for each clinical \nquestion.\nSearch for evidence: A search string was developed for each \nclinical question.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 688,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 3,
      "char_count": 688,
      "word_count": 94,
      "start_pos": 11598,
      "end_pos": 12286,
      "chunk_index": 24,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_25",
      "text": "clinical \nquestion.\nSearch for evidence: A search string was developed for each \nclinical question. The keywords related to each clinical question \nwere identified through initial literature search, recommendations \nfrom experts, and discussion amongst the evidence review team. \nThree electronic databases (PubMed, Wiley, and Cochrane) were \nsearched to extract relevant evidence.\nSelection criteria: Studies published in peer-reviewed English-\nlanguage journals and on human participants were selected. \nMethodological filters related to the study design were not \napplied at this stage to ensure an extensive and exhaustive search.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 635,
          "overlap_percentage": 100.15772870662461
        }
      ],
      "primary_page": 3,
      "char_count": 634,
      "word_count": 85,
      "start_pos": 12186,
      "end_pos": 12821,
      "chunk_index": 25,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_26",
      "text": "ed to the study design were not \napplied at this stage to ensure an extensive and exhaustive search. \nThe evidence team further performed the title, abstract, and \nfull-text screening of articles. Any disagreements on selecting \na manuscript were resolved by consensus among the evidence \nteam members.\nEligibility criteria:\nInclusion Criteria: Existing practice guidelines, position statement, \nconsensus statement, systematic reviews on weight management \nand menopausal health and randomised control trials (RCT), \nexperimental and observational studies recruiting midlife women \nat different menopausal stages, i.e. perimenopause, menopause, \nor post-menopause were included.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 679,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 3,
      "char_count": 679,
      "word_count": 88,
      "start_pos": 12721,
      "end_pos": 13400,
      "chunk_index": 26,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_27",
      "text": "en \nat different menopausal stages, i.e. perimenopause, menopause, \nor post-menopause were included.\nExclusion Criteria: Studies reported in non-English language, \npublished in non-peer-reviewed journals, and with limited access \nwere excluded.\nData extraction and synthesis: The following study characteristics \nwere extracted: year of publication, country, author, study design, \nsample size, and sample characteristics specific to the clinical \nquestion. The findings of the studies were reported in tables to \nform a write-up for a summary statement.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 554,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 3,
      "char_count": 554,
      "word_count": 73,
      "start_pos": 13300,
      "end_pos": 13854,
      "chunk_index": 27,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_28",
      "text": "on. The findings of the studies were reported in tables to \nform a write-up for a summary statement.\nDevelopment of clinical practice recommendations\nThe extracted high-quality data for each clinical question \nwas presented with a summary of evidence supplemented \nby a narrative table. The evidence was circulated amongst \nTable 1: Quality of evidence\nQuality of evidence\nDescription\nI\nHigh‑quality evidence\nBased on evidence gathered from the literature search, there is substantial certainty that the true effect lies within the estimated \neffect.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 550,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 3,
      "char_count": 550,
      "word_count": 81,
      "start_pos": 13754,
      "end_pos": 14304,
      "chunk_index": 28,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_29",
      "text": "ature search, there is substantial certainty that the true effect lies within the estimated \neffect.\nThe high‑quality evidence will include:\n(i) Well‑designed and executed randomised control trials (RCTs) consisting of adequate randomisation, allocation and \nblinding, sufficient power and intention‑to‑treat analysis, and adequate measures for follow‑up\n(ii) Meta‑analysis including high‑quality RCTs is also included\n(iii) Previously published good quality recommendations/consensus statements and/or position statements were given by an \norganisation or working group consisting of experts in that field.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 607,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 3,
      "char_count": 607,
      "word_count": 77,
      "start_pos": 14204,
      "end_pos": 14811,
      "chunk_index": 29,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_30",
      "text": "tion statements were given by an \norganisation or working group consisting of experts in that field. The quality of the recommendations should be established \non the basis of the Appraisal Guideline for Research and Evaluation[6]\nII\nModerate quality evidence\nBased on evidence gathered from the literature search, it is possible that the true effect lies close to the estimated effect.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 385,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 3,
      "char_count": 385,
      "word_count": 60,
      "start_pos": 14711,
      "end_pos": 15096,
      "chunk_index": 30,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_31",
      "text": "from the literature search, it is possible that the true effect lies close to the estimated effect.\nThe moderate‑quality evidence includes:\n(i) Well‑designed and executed RCTs with minor methodological limitations impacting the confidence in the estimated effect\n(ii) Quasi‑randomised trials with good methodological quality\n(iii) Systematic and meta‑analysis of low‑quality RCTs with limited quality \nIII\nLow‑quality evidence\nBased on the evidence gathered from the literature search, there is little certainty that the true effect is close to the estimated effect.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 567,
          "overlap_percentage": 100.17667844522968
        }
      ],
      "primary_page": 3,
      "char_count": 566,
      "word_count": 80,
      "start_pos": 14996,
      "end_pos": 15563,
      "chunk_index": 31,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_32",
      "text": "literature search, there is little certainty that the true effect is close to the estimated effect.\nThe low quality of evidence includes:\n(i) Well‑designed and executed RCTs with major methodological limitations affecting the confidence in estimated effect.\n(ii) Well‑designed and executed non‑randomised trials including intervention studies, cohort, and quasi‑experimental studies, \ncase‑control studies with minor methodological limitations\n(ii) Observational studies with minor methodological limitations\nIV\nExpert opinion\nVery uncertain that the true effect is close to the estimated effect.\nBased on clinical experience, reasoning, and suggestions.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 655,
          "overlap_percentage": 100.15290519877675
        }
      ],
      "primary_page": 3,
      "char_count": 654,
      "word_count": 85,
      "start_pos": 15463,
      "end_pos": 16118,
      "chunk_index": 32,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_33",
      "text": "e effect is close to the estimated effect.\nBased on clinical experience, reasoning, and suggestions.\nThere might be a small net benefit from the suggestion. Based on the feasibility, healthcare providers may incorporate the \nsuggestion for weight management.\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nthe experts for evaluation to form necessary clinical practice \nrecommendations.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 258,
          "overlap_percentage": 53.086419753086425
        },
        {
          "page_number": 4,
          "overlap_chars": 226,
          "overlap_percentage": 46.50205761316872
        }
      ],
      "primary_page": 3,
      "char_count": 486,
      "word_count": 72,
      "start_pos": 16018,
      "end_pos": 16504,
      "chunk_index": 33,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_34",
      "text": "2  :  December 2022\nthe experts for evaluation to form necessary clinical practice \nrecommendations. Experts were given the training to develop \nrecommendations through online meetings on the following \ncriteria: reviewing evidence, formulating evidence-based \nrecommendations, providing expert opinion, reaching a \nconsensus whenever there is a lack of evidence, and grading the \nrecommendation based on quality. This led to the development \nof two types of recommendations that is, Recommendations \nBased on Evidence (RBE) and Recommendations Based \non Opinion (RBO). The developed recommendations were \nsubjected to a two-level peer-review process.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 651,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 651,
      "word_count": 87,
      "start_pos": 16404,
      "end_pos": 17055,
      "chunk_index": 34,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_35",
      "text": "on Opinion (RBO). The developed recommendations were \nsubjected to a two-level peer-review process. The first review \nwas conducted by a small group of topic-specific experts, and \nthe second review with a large group of experts, including field \nexperts, academicians and journal editors.\nGRADE approach\nThe Grading of Recommendations, Assessment, Development, \nand Evaluation (GRADE) evidence profile was constructed to \ndetermine the quality of evidence obtained for clinical questions \n[Tables 1 and 2]. Four grades: high, moderate, low, and very low \nwere used to rate the quality of evidence.[9]\nResults\nSection I: Initiation of discussion for weight \nmanagement\n1.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 672,
          "overlap_percentage": 100.14903129657229
        }
      ],
      "primary_page": 4,
      "char_count": 671,
      "word_count": 97,
      "start_pos": 16955,
      "end_pos": 17627,
      "chunk_index": 35,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_36",
      "text": "te the quality of evidence.[9]\nResults\nSection I: Initiation of discussion for weight \nmanagement\n1.1 When should a healthcare provider initiate structured \ncounselling regarding weight management in midlife \nwomen?\nBackground\nThe menopausal transition is marked by the onset of irregularity \nin the menstrual cycle and menopausal symptoms, including hot \nflushes, physical decline, and emotional volatility.[2,10] In midlife, \nchronological ageing coupled with menopausal transition leads \nto several biological changes predisposing women to weight \ngain. The independent and interactive contribution of increasing \nage and menopausal transition remains debatable.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 665,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 665,
      "word_count": 86,
      "start_pos": 17527,
      "end_pos": 18192,
      "chunk_index": 36,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_37",
      "text": "pendent and interactive contribution of increasing \nage and menopausal transition remains debatable. Nevertheless, \nboth these factors impact the daily lifestyle behaviours, including \neating, activity, and sleep habits of midlife women in a way \nthat might make them prone to excessive weight gain.[6] There \nis a need to understand at which stage during the menopausal \ntransition should weight gain be identified as a potential detriment \nto the overall health and quality of life. Identifying these critical \nphases during midlife can help in the early initiation of weight \nmanagement support by the healthcare provider.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 625,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 625,
      "word_count": 92,
      "start_pos": 18092,
      "end_pos": 18717,
      "chunk_index": 37,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_38",
      "text": "g midlife can help in the early initiation of weight \nmanagement support by the healthcare provider.\nSummary of evidence\nIn India, the mean age of initiation of the menopausal transition \nis 44 years, whereas 46 years is the mean age at menopause, which \nis lower than Caucasian women.[11] Similar findings are reported \nby a systematic review reporting that the age at menopause \nwas 46.24 ± 3.38 years in Indian women.[12]Further, the mean \nage of early menopause due to premature ovarian insufficiency \nwas 38 years, and late menopause was beyond 54 years. Some \nstudies reported a positive association of menopause with an \noverall increase in body weight status.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 667,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 667,
      "word_count": 107,
      "start_pos": 18617,
      "end_pos": 19284,
      "chunk_index": 38,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_39",
      "text": "tudies reported a positive association of menopause with an \noverall increase in body weight status.[13,14] However, a direct \nassociation of the overall increase in the weight status with \nhormonal changes during the menopausal transition could not \nbe established. Menopause transition was related to an increase \nin visceral adiposity.[15,16] Women experienced a steady increase \nin weight and body fat during perimenopause and menopausal \nphases. During the menopausal transition, the accelerated gain \nin fat mass doubled, whereas a decline in lean muscle mass \nwas observed. The rate of change in the body weight and fat \naccumulation stabilised before initiation of the post-menopausal \nphase.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 700,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 700,
      "word_count": 101,
      "start_pos": 19184,
      "end_pos": 19884,
      "chunk_index": 39,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_40",
      "text": "in the body weight and fat \naccumulation stabilised before initiation of the post-menopausal \nphase.[17] Postmenopausal women with overweight and obesity \nhave shown greater circulating estrogen levels than non-obese \ncounterparts. This increase in estrogen is contributed by the \nperipheral aromatisation of the androgens in adipose tissues. \nIt was previously hypothesised that excessive circulating \nestrogen levels are beneficial for maintaining menopausal and \nmetabolic health. However, recent studies found out that the \nincrease in estrogen levels is not associated with the protective \ncardiometabolic effects.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 619,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 619,
      "word_count": 81,
      "start_pos": 19784,
      "end_pos": 20403,
      "chunk_index": 40,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_41",
      "text": "hat the \nincrease in estrogen levels is not associated with the protective \ncardiometabolic effects.[16]\nTable 2: Grades for the strength of recommendation\nStrength of recommendation\nDescription\nA\nStrong recommendation:\nQuantum of benefit expected >>> Resource requirement/logistic needs\nCertainly, the net benefits, (i.e. the benefits in comparison to resources required/logistics needed for the \nservice/intervention) outweigh the resource requirement for achieving optimal weight loss outcome.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 496,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 496,
      "word_count": 63,
      "start_pos": 20303,
      "end_pos": 20799,
      "chunk_index": 41,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_42",
      "text": "service/intervention) outweigh the resource requirement for achieving optimal weight loss outcome.\nClinicians and allied healthcare providers should universally adopt these recommendations as a standard practice \nto prevent and manage overweight and obesity in women at an individual, clinical, and public health level. \nB\nModerate recommendation:\nQuantum of benefit expected >> Resource requirement/logistic needs\nIt is moderately certain that the net benefit from the recommendation is moderate to substantial.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 514,
          "overlap_percentage": 100.390625
        }
      ],
      "primary_page": 4,
      "char_count": 512,
      "word_count": 68,
      "start_pos": 20699,
      "end_pos": 21213,
      "chunk_index": 42,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_43",
      "text": "ds\nIt is moderately certain that the net benefit from the recommendation is moderate to substantial.\nThese recommendations might not be a mandatory part of a standard weight management clinical practice; \nhowever, their implementation can prove beneficial in attaining significant weight loss outcomes. The \nimplementation of these recommendations should be as per an individual’s preference, values, and settings. \nC\nWeak recommendation:\nQuantum of benefit expected > = < Resource requirement/logistic needs\nIt is at least certain that there might be a small net benefit from the recommendation.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 596,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 596,
      "word_count": 87,
      "start_pos": 21113,
      "end_pos": 21709,
      "chunk_index": 43,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_44",
      "text": "gistic needs\nIt is at least certain that there might be a small net benefit from the recommendation.\nThese recommendations should be incorporated on the basis of resource availability, feasibility, \ncost‑effectiveness and acceptability in the weight management program.\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nClinical practice recommendations\nNo. Recommendations\nGrade\n1.1.1  Opportunistic screening and management of obesity \nshould be delivered all through the lifespan of a woman.\nIV\nA\n1.1.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 269,
          "overlap_percentage": 44.75873544093178
        },
        {
          "page_number": 5,
          "overlap_chars": 330,
          "overlap_percentage": 54.90848585690515
        }
      ],
      "primary_page": 4,
      "char_count": 601,
      "word_count": 88,
      "start_pos": 21609,
      "end_pos": 22210,
      "chunk_index": 44,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_45",
      "text": "eening and management of obesity \nshould be delivered all through the lifespan of a woman.\nIV\nA\n1.1.2 In the late 30s, before menopause transition, women should \nbe counselled about the added risk of menopause‑related \nweight gain and body fat distribution. Opportunistic \nscreening and management of obesity should be continued.\nII\nA/B\n1.1.3 In the early 40s, when women experience menopausal \ntransition, intensive customised weight management \ncounselling should be given.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 475,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 475,
      "word_count": 70,
      "start_pos": 22110,
      "end_pos": 22585,
      "chunk_index": 45,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_46",
      "text": "erience menopausal \ntransition, intensive customised weight management \ncounselling should be given. The emphasis should be on \ncorrective lifestyle behaviour and handling health issues \nspecific to menopausal transition such as menopausal \nsymptoms, sleep disturbances, psychological distress, bone \nand joint health and other comorbidities.\nII\nA\nDiscussion\nThere is a lack of consistent literature on the independent and \ninteractive nature of chronological ageing and menopausal \ntransition on the weight status of menopausal women. Considering \nthe mean age at menopause as 46 years, it is crucial to engage midlife \nwomen in weight regulation before menopausal transition.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 677,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 677,
      "word_count": 93,
      "start_pos": 22485,
      "end_pos": 23162,
      "chunk_index": 46,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_47",
      "text": "46 years, it is crucial to engage midlife \nwomen in weight regulation before menopausal transition.[11] Ideally, \nopportunistic screening and management should be delivered \nacross the women’s lifespan (as presented in Table 1.1.1). Similarly, \nas per the Anklesaria staging menopausal system, at stage 1 during \nthe perimenopausal phase, the advice should be shared to create \nawareness and manage obesity and other menopause-related health \nrisks amongst midlife women.[18] In the later 30s, women should be \nmade aware of experiencing a probable increase in their weight and \ntotal body fat status with the onset of the menopausal transition.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 646,
          "overlap_percentage": 100.15503875968992
        }
      ],
      "primary_page": 5,
      "char_count": 645,
      "word_count": 95,
      "start_pos": 23062,
      "end_pos": 23708,
      "chunk_index": 47,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_48",
      "text": "ble increase in their weight and \ntotal body fat status with the onset of the menopausal transition. \nAt this phase, the healthcare providers should counsel women \nregarding the changes in the menstrual cycle and its probable \nassociation with weight gain. Because the age at menopause can \nvary amongst women belonging to different population groups, \nthe experts have given a dual strength of recommendation to this \nclinical practice. In the late 40s, an opportunistic screening of weight \nand health status, followed by customised weight management, \nshould be initiated and continued with the aim of achieving normal \nweight status.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 637,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 637,
      "word_count": 97,
      "start_pos": 23608,
      "end_pos": 24245,
      "chunk_index": 48,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_49",
      "text": "ight management, \nshould be initiated and continued with the aim of achieving normal \nweight status. The healthcare provider should advise dietary and \nphysical activity modifications using behavioural techniques for \nmanaging weight. In addition, other menopause-related health \nissues, including psychological distress, sarcopenia, and bone health, \nshould also be addressed during weight management. It should \nbe noted that the evidence for the recommendations mentioned \nabove is derived mainly from studies on midlife women in the \nwest.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 543,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 543,
      "word_count": 74,
      "start_pos": 24145,
      "end_pos": 24688,
      "chunk_index": 49,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.652695"
    },
    {
      "id": "chunk_50",
      "text": "r the recommendations mentioned \nabove is derived mainly from studies on midlife women in the \nwest. To our knowledge, there are no longitudinal studies that \nassess the changes in weight status and body composition during \nthe menopausal transition in midlife women from India. The \nassociation of menopausal transition (independent of chronological \nageing) and weight status needs to be assessed for the engagement \nof Indian women in weight-management practices.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 466,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 466,
      "word_count": 68,
      "start_pos": 24588,
      "end_pos": 25054,
      "chunk_index": 50,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_51",
      "text": "ight status needs to be assessed for the engagement \nof Indian women in weight-management practices. Thus, the \nrecommendations should be revisited and revised every 5 to 10 \nyears in the face of new evidence on the age of menopause in \nIndian women, changes in body composition during menopausal \ntransition, and effective weight management practices.\n1.2: What are the components of knowledge, attitude \nand practice (KAP) that should be evaluated to plan a \npersonalised weight management intervention in midlife \nwomen?\nBackground\nThe successful management of obesity and other lifestyle-related \ndisorders depends on adopting behavioural techniques for \nTable 1.1.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 669,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 669,
      "word_count": 97,
      "start_pos": 24954,
      "end_pos": 25623,
      "chunk_index": 51,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_52",
      "text": "ty and other lifestyle-related \ndisorders depends on adopting behavioural techniques for \nTable 1.1.1: Opportunistic screening and management of weight during reproductive stages\nReproductive stage\nKey opportunities to screen and discuss weight\nAdolescents\nEngagement in school, family, and community‑based health education programs\nScreening of adolescent visiting regarding other health conditions for weight status (as a vital clinical sign) at \nclinical set‑ups (Criteria: overweight: BMI ≥85th percentile, obese: <95th percentile)\nAdolescent girls presenting with obesity‑related complications s",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 600,
      "word_count": 75,
      "start_pos": 25523,
      "end_pos": 26123,
      "chunk_index": 52,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_53",
      "text": "ercentile, obese: <95th percentile)\nAdolescent girls presenting with obesity‑related complications such as polycystic ovary syndrome (PCOS) and \nmetabolic disorder should be enrolled in a multidisciplinary program\nPregnancy and delivery\nWeight counselling during regular antenatal check‑up\nGynaecologists should counsel women regarding postpartum weight retention and its health risk\nEncouraging women to enrol in post‑delivery weight management program\nPostpartum\nPost‑delivery weight management programs as part of future gynaecologist visits\nPromotion of breastfeeding as a preventive strategy for",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 600,
      "word_count": 75,
      "start_pos": 26023,
      "end_pos": 26623,
      "chunk_index": 53,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_54",
      "text": "grams as part of future gynaecologist visits\nPromotion of breastfeeding as a preventive strategy for post-partum weight gain\nPaediatrician involved in immunisation of child should reinforce weight management\nSupport groups: Discussion weight control during post‑pregnancy \nPremenopausal\nScreening of women at clinical set‑ups for weight status (as a vital clinical sign)\nEngagement in community and workplace weight management programs\nReferring women with obesity and associated metabolic complications to specialist or multidisciplinary teams \nMenopausal transition\nScreening midlife women at diffe",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 600,
      "word_count": 78,
      "start_pos": 26523,
      "end_pos": 27123,
      "chunk_index": 54,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_55",
      "text": "ons to specialist or multidisciplinary teams \nMenopausal transition\nScreening midlife women at different clinical departments such as medicine, obstetrics and gynaecology, \northopaedics, physical medicine and rehabilitation, and endocrinology\nEngagement in community and workplace‑specific healthcare intervention\nProvision of screening at religious centres\nReferring women with obesity and associated metabolic complications to specialist or multidisciplinary teams \nPost‑menopausal\nScreening of midlife women at different clinical departments such as geriatric medicine, obstetrics and \ngynaecology",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 600,
      "word_count": 70,
      "start_pos": 27023,
      "end_pos": 27623,
      "chunk_index": 55,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_56",
      "text": "life women at different clinical departments such as geriatric medicine, obstetrics and \ngynaecology, orthopaedics, physical medicine and rehabilitation, and endocrinology\nEngagement in community‑based healthcare intervention\nReferring women with obesity and associated metabolic complications to specialist or multidisciplinary teams\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\ncorrecting eating, activity, and other lifestyle-related habits.[19] The \nbehavioural practices are motivated by pre-existing knowledge \nand attitude of an individual.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 334,
          "overlap_percentage": 51.463790446841294
        },
        {
          "page_number": 6,
          "overlap_chars": 313,
          "overlap_percentage": 48.228043143297384
        }
      ],
      "primary_page": 5,
      "char_count": 649,
      "word_count": 82,
      "start_pos": 27523,
      "end_pos": 28172,
      "chunk_index": 56,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_57",
      "text": "] The \nbehavioural practices are motivated by pre-existing knowledge \nand attitude of an individual. In the literature, knowledge is \ndefined as information and skills acquired using experience and \neducation. Attitude is a value, belief, and feeling that predisposes \nan individual towards a particular behaviour and behavioural \npractices are habits and patterns associated with the maintenance \nof weight status.[20,21] KAP assessment is common in lifestyle-\nrelated diseases in clinical and community settings.[22] The clinician \nneeds to understand the KAP of midlife women that promotes \nobesity.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 602,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 6,
      "char_count": 602,
      "word_count": 84,
      "start_pos": 28072,
      "end_pos": 28674,
      "chunk_index": 57,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_58",
      "text": "ty settings.[22] The clinician \nneeds to understand the KAP of midlife women that promotes \nobesity. The KAP of core components associated with obesity \nin midlife women should include lifestyle practices, menopausal \nsymptoms, bone health, and psychological distress.[2] Generally, \nthe KAP can be assessed before the initiation of lifestyle \nmanagement to identify the risk factors specific to middle-aged \nwomen that the clinician should attempt to modify during weight \nmanagement. A few qualitative studies and cross-sectional \nsurveys have independently assessed KAP for different obesity-\nrelated factors in midlife women.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 629,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 6,
      "char_count": 629,
      "word_count": 87,
      "start_pos": 28574,
      "end_pos": 29203,
      "chunk_index": 58,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_59",
      "text": "al \nsurveys have independently assessed KAP for different obesity-\nrelated factors in midlife women.[23-25] In qualitative studies, the \ninfluence of social, cultural, and economic constructs on obesity-\nrelated behaviours has been highlighted. Across cross-sectional \nstudies, KAP was assessed using self-developed or validated \nquestionnaires that rate an individual’s competence in the three \ndomains and correlate with weight and metabolic status.[26-28] \nA comprehensive assessment of KAP on lifestyle practices, \nmenopausal symptoms, bone health, and psychological distress \nas risk factors for obesity in midlife is lacking in the current \nliterature.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 658,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 6,
      "char_count": 658,
      "word_count": 87,
      "start_pos": 29103,
      "end_pos": 29761,
      "chunk_index": 59,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_60",
      "text": "sychological distress \nas risk factors for obesity in midlife is lacking in the current \nliterature. Hence, this clinical question addressed the present \nevidence on KAP of critical components associated with the \nmanagement of obesity in midlife women to deliver women-\ncentric management of obesity.\nSummary of evidence\nThe critical components evaluated for the initiation of management \nof obesity in midlife women included: weight and health-related \nmeasures, menopausal symptoms, bone health and psychological \ndistress. The KAP of these components is considered necessary for \ncustomising the weight management regime for a midlife woman.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 645,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 6,
      "char_count": 645,
      "word_count": 91,
      "start_pos": 29661,
      "end_pos": 30306,
      "chunk_index": 60,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_61",
      "text": "omponents is considered necessary for \ncustomising the weight management regime for a midlife woman.\n[24,28-30] For weight and lifestyle-related parameters, women reported \na lack of knowledge regarding corrective weight-related practices, \nlack of time, social eating, indulging in high-fat, sugar, and salt \nfoods (HFSS), and reduced daily activity, led to obesity.[31,32]Four \nstudies reported the interplay between the menopausal symptoms \nseverity and psychological distress, leading to the consumption of \nenergy-dense foods and limited physical activity in midlife women. \nThe difficulty in sleeping due to hot flashes and mood disorders \nwas associated with weight gain in midlife women.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 695,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 6,
      "char_count": 695,
      "word_count": 95,
      "start_pos": 30206,
      "end_pos": 30901,
      "chunk_index": 61,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_62",
      "text": "in sleeping due to hot flashes and mood disorders \nwas associated with weight gain in midlife women.[33-35] Menopause \nled joint pain was the primary reason for limited participation \nin dedicated physical activity. Moreover, women had limited \nknowledge regarding age-related osteoporosis and measures that \ncan be taken to maintain bone health such as getting a regular \nbone check-up, consuming foods rich in calcium, and consulting \ndoctors for guidance on supplementation such as vitamin D and \ncalcium for bone health.[27,30] In addition to limited knowledge, \nmost women prioritised their roles as homemakers, working \nwomen and child care providers over their own health issues.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 686,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 6,
      "char_count": 686,
      "word_count": 101,
      "start_pos": 30801,
      "end_pos": 31487,
      "chunk_index": 62,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_63",
      "text": "sed their roles as homemakers, working \nwomen and child care providers over their own health issues.[36,37] \nThis self-sacrificing attitude coupled with limited support from \nfamily and friends in maintaining health-related behaviours in \ntheir day-to-day lifestyle should also be addressed for maintaining \ncontinuous and sustainable efforts for weight management and \nallied comorbidities.[24,36]\nClinical practice recommendations\nNo. Recommendations\nGrade\n1.2.1 Assessment of KAP related to risk factors and consequences \nof obesity on the holistic health of women is recommended.\nIII\nA\n1.2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 594,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 6,
      "char_count": 594,
      "word_count": 80,
      "start_pos": 31387,
      "end_pos": 31981,
      "chunk_index": 63,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_64",
      "text": "risk factors and consequences \nof obesity on the holistic health of women is recommended.\nIII\nA\n1.2.2  Different modalities for weight management, barriers, and \nfacilitators in their implementation should be evaluated and \naccounted for in the management plan. \nIII\nB\nDiscussion\nA comprehensive assessment of KAP should be done to identify \nkey areas that the interventionist should attempt to modify during \nlifestyle intervention to achieve clinically significant weight loss. \nThe recommendations were based on well-known, lifestyle and \nmidlife-related risk factors experienced during the menopausal \ntransition.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 617,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 6,
      "char_count": 617,
      "word_count": 85,
      "start_pos": 31881,
      "end_pos": 32498,
      "chunk_index": 64,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_65",
      "text": "ll-known, lifestyle and \nmidlife-related risk factors experienced during the menopausal \ntransition. However, the evidence was from independent studies \non a particular risk factor (e.g., diet, mental health, joint health \netc.). There were no data on a comprehensive assessment of \nKAP related to risk factors of obesity in midlife women, which \nwould be relevant to guide future clinical and research practice. \nBesides, the effectiveness of KAP in providing customised \nweight management advice for achieving significant weight loss \nshould be assessed using longitudinal studies or RCTs in future \nresearch.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 611,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 6,
      "char_count": 611,
      "word_count": 87,
      "start_pos": 32398,
      "end_pos": 33009,
      "chunk_index": 65,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_66",
      "text": "significant weight loss \nshould be assessed using longitudinal studies or RCTs in future \nresearch. Considering the importance of KAP in customising \nweight management approaches in midlife women, experts \nagreed that a comprehensive assessment of KAP as a component \nof risk assessment of obesity in midlife women should be \nincorporated into clinical practice (shown in Table 1.2.1). Based \non available resources in the healthcare or community setting, \nhealthcare professionals can assess KAP via history taking, \ngroup discussions and/or interview schedule with a structured \nquestionnaire. The key questions that can be assessed in resource-\nconstrained settings are presented in Table 1.2.2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 699,
          "overlap_percentage": 100.14326647564471
        }
      ],
      "primary_page": 6,
      "char_count": 698,
      "word_count": 99,
      "start_pos": 32909,
      "end_pos": 33608,
      "chunk_index": 66,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_67",
      "text": "e key questions that can be assessed in resource-\nconstrained settings are presented in Table 1.2.2.\n1.3 Which healthcare providers can be involved in \nthe management of overweight and obesity in midlife \nwomen?\nBackground\nObesity is a complex and multisystem disorder.[38]According to the \ninternational guidelines, preventive and curative obesity treatment \nshould be delivered to individuals across the healthcare system.[39] \nThe comprehensive treatment of obesity and allied complications \nrequires a multicomponent and multidisciplinary approach.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 552,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 6,
      "char_count": 552,
      "word_count": 73,
      "start_pos": 33508,
      "end_pos": 34060,
      "chunk_index": 67,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_68",
      "text": "tment of obesity and allied complications \nrequires a multicomponent and multidisciplinary approach. A \nmultidisciplinary approach manages treatment components \nwith the help of different healthcare professionals including a \nprimary care physician, family physician and/or a gynaecologist \nwith expertise in pharmacotherapy, an exercise physiologist, \na dietitian, and a psychologist to provide comprehensive \nweight management counselling.[40] Despite the consensus on \npromoting multicomponent and multidisciplinary approaches\n\nRanjan, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 529,
          "overlap_percentage": 97.06422018348624
        },
        {
          "page_number": 7,
          "overlap_chars": 14,
          "overlap_percentage": 2.5688073394495414
        }
      ],
      "primary_page": 6,
      "char_count": 545,
      "word_count": 65,
      "start_pos": 33960,
      "end_pos": 34505,
      "chunk_index": 68,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_69",
      "text": "Despite the consensus on \npromoting multicomponent and multidisciplinary approaches\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\namongst obesity experts, there are no specific guidelines or \nposition statements on the operationalisation of these treatment \nmodalities in daily clinical practice.[41] The limited application of \nmultidisciplinary approaches can be due to limited healthcare \nresources such as a low doctor-to-patient ratio, time constraints, \nlack of auxiliary healthcare teams, and infrastructure, especially \nin developing countries.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 84,
          "overlap_percentage": 12.863705972434916
        },
        {
          "page_number": 7,
          "overlap_chars": 568,
          "overlap_percentage": 86.98315467075038
        }
      ],
      "primary_page": 6,
      "char_count": 653,
      "word_count": 87,
      "start_pos": 34405,
      "end_pos": 35059,
      "chunk_index": 69,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_70",
      "text": "aints, \nlack of auxiliary healthcare teams, and infrastructure, especially \nin developing countries.[42] Considering the challenges in the \nmanagement of obesity in healthcare settings, it becomes essential \nto identify the roles and responsibilities of clinicians and allied \nhealthcare professionals that can make multidisciplinary teams. \nFurthermore, these teams should be educated and trained to equip \nhealthcare professionals to assess obesity risk, provide brief weight \ncounselling advice, and referrals specialists at healthcare centres.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 547,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 7,
      "char_count": 547,
      "word_count": 70,
      "start_pos": 34959,
      "end_pos": 35506,
      "chunk_index": 70,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_71",
      "text": "ity risk, provide brief weight \ncounselling advice, and referrals specialists at healthcare centres.[43]\nSummary of evidence\nThe comprehensive management of overweight and obesity \nincludes three key components: diet, physical activity and \nbehavioural strategies. In 29 pertinent weight-loss trials, the \ntreatment modalities were managed by either a multidisciplinary \nteam, a core team of two healthcare professionals or single-\nhandedly by a dietitian. In seven studies, a qualified dietitian \nprovided lifestyle counselling to the participants to manage \ntheir weight.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 573,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 7,
      "char_count": 573,
      "word_count": 77,
      "start_pos": 35406,
      "end_pos": 35979,
      "chunk_index": 71,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_72",
      "text": ", a qualified dietitian \nprovided lifestyle counselling to the participants to manage \ntheir weight.[44-46] As per 11 studies, weight management teams \ncommonly consist of two healthcare professionals from different \nspecialities. Out of 11 studies, nine studies opted for a team of \ndietitians and exercise experts such as physiotherapists, exercise \nphysiologists, exercise specialists or personal trainers for weight \nmanagement.[47-49] In three studies, lifestyle advice was coupled \nwith behavioural techniques counselled by a team of dietitians \nand behaviour management experts such as psychologists, \nbehaviour science experts or clinical health psychologists.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 668,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 7,
      "char_count": 668,
      "word_count": 88,
      "start_pos": 35879,
      "end_pos": 36547,
      "chunk_index": 72,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_73",
      "text": "nagement experts such as psychologists, \nbehaviour science experts or clinical health psychologists.[50-52] It \nwas observed that dietitians are an essential component of all the \ncore teams. Nine studies reported that a multidisciplinary team \nconsisting of a dietitian, exercise physiologist, and behavioural \ntherapist were a part of a comprehensive weight management \nprogram.[53-55]\nClinical practice recommendations\nNo. Recommendation\nGrade\n1.3.1 The protocolised weight management module should be \nimplemented by any healthcare worker who encounters \na woman in her midlife for routine screening or specific \nhealth conditions.\nIV\nA\n1.3.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 645,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 7,
      "char_count": 645,
      "word_count": 87,
      "start_pos": 36447,
      "end_pos": 37092,
      "chunk_index": 73,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_74",
      "text": "o encounters \na woman in her midlife for routine screening or specific \nhealth conditions.\nIV\nA\n1.3.2 Wherever feasible, a multi‑disciplinary team consisting \nof primary care physicians, clinicians, dietitians, and \nexercise physiologists/physiotherapists should be involved \nin weight management of midlife women. Specialists \nincluding psychologists/psychiatrists, endocrinologist and \northopedicians should be involved, whenever indicated.\nI\nA\n1.3.3 All healthcare workers should be empowered with the \nknowledge and skills for the prevention, diagnosis and \ntreatment of obesity in midlife women.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 7,
      "char_count": 600,
      "word_count": 77,
      "start_pos": 36992,
      "end_pos": 37592,
      "chunk_index": 74,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_75",
      "text": "the \nknowledge and skills for the prevention, diagnosis and \ntreatment of obesity in midlife women.\nIV\nB\nDiscussion\nThe effective management of weight in healthcare settings \nrequires a multidisciplinary team. Despite the importance of \nmultidisciplinary teams, the onus of effective preventive and \ncurative obesity care lies on all the healthcare professionals \nwho encounter midlife women with overweight and obesity. \nOften, midlife women meet primary care physicians and family \nTable 1.2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 495,
          "overlap_percentage": 100.20242914979758
        }
      ],
      "primary_page": 7,
      "char_count": 494,
      "word_count": 70,
      "start_pos": 37492,
      "end_pos": 37987,
      "chunk_index": 75,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_76",
      "text": "th overweight and obesity. \nOften, midlife women meet primary care physicians and family \nTable 1.2.1: KAP regarding obesity, associated risk factors for weight gain, and appropriate weight management in \nmidlife women\nKnowledge \nAttitude\nPractice\nKnowledge associated with vegetables \nand fruit consumption\nAwareness of weight gain and health\nOsteoporosis and its complications\nCalcium‑rich dietary sources\nPerceived benefits of exercise, adequate \ncalcium intake, regular physical activity, \ndairy intake\nManagement of menopausal symptoms\nContraception use and weight gain\nEasy to gain weight but d",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 7,
      "char_count": 600,
      "word_count": 81,
      "start_pos": 37887,
      "end_pos": 38487,
      "chunk_index": 76,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_77",
      "text": "intake\nManagement of menopausal symptoms\nContraception use and weight gain\nEasy to gain weight but difficult to lose\nDissatisfaction with one’s appearance\nBody shape concerns\nSelf‑rated physical health\nAttitude towards menopause\nHealth motivation\nSedentary lifestyle\nNot engaging in any exercise\nEating during socialisation\nHigh calorie and fat intake\nHaving limited free time to manage diet and exercise\nLimited dairy intake\nStress‑eating\nRegular health check‑ups\nRegular visits to the gynaecologist\nMaintaining menopausal hygiene\nSelf‑management of menopausal symptoms \nTable 1.2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 582,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 7,
      "char_count": 582,
      "word_count": 78,
      "start_pos": 38387,
      "end_pos": 38969,
      "chunk_index": 77,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_78",
      "text": "the gynaecologist\nMaintaining menopausal hygiene\nSelf‑management of menopausal symptoms \nTable 1.2.2: Questions for assessment of KAP regarding \nobesity in midlife women\nDomains\nKey questions that can be enquired while initiating \nclinical management\nKnowledge\nHow can obesity cause health‑related complications in \nmidlife women?\nWhat are the common menopausal symptoms and how can \nyou manage them?\nWhat is the importance of bone health during the \nmenopausal phase?\nWhat lifestyle modifications should you incorporate into \nyour daily routine to avoid weight gain?\nAttitude \nHow motivated are you",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 600,
          "overlap_percentage": 100.1669449081803
        }
      ],
      "primary_page": 7,
      "char_count": 599,
      "word_count": 84,
      "start_pos": 38869,
      "end_pos": 39469,
      "chunk_index": 78,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_79",
      "text": "hould you incorporate into \nyour daily routine to avoid weight gain?\nAttitude \nHow motivated are you to participate in a weight \nmanagement program at this stage of your life?\nHow ready are you to change your current dietary and \nphysical activity habits at this point in time?\nHow do you feel about your menopausal health during the \ntransition?\nPractice\nWhat are the different food items that you usually consume \nin a day?\nWhat kind of activities do you participate in on a regular day?\nHow do you maintain your bone health?\nWhat are common measures that you adopt for the \nmanagement of menopausa",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 7,
      "char_count": 600,
      "word_count": 103,
      "start_pos": 39369,
      "end_pos": 39969,
      "chunk_index": 79,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_80",
      "text": "maintain your bone health?\nWhat are common measures that you adopt for the \nmanagement of menopausal symptoms?\nHow do you cope with emotional distress?\n*These questions should be asked as an opportunity to initiate discussion. Healthcare providers should \nsupplement the information received from these questions with appropriate facts through objective \ndiagnosis and assessment, if and when required.\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nphysicians as the first point of contact in the healthcare system.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 403,
          "overlap_percentage": 65.42207792207793
        },
        {
          "page_number": 8,
          "overlap_chars": 212,
          "overlap_percentage": 34.41558441558442
        }
      ],
      "primary_page": 7,
      "char_count": 616,
      "word_count": 92,
      "start_pos": 39869,
      "end_pos": 40486,
      "chunk_index": 80,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_81",
      "text": "11  :  Issue 12  :  December 2022\nphysicians as the first point of contact in the healthcare system. \nThe incorporation of family care physicians as a part of the core \nweight management team or an extended weight management \nteam is vital for initiating effective management at the healthcare \nlevel. In literature, dietitians-led weight management was most \ncommonly observed across weight-loss trials. The inclusion of \ndietitians in core weight management teams and/or frequent \nreferrals to dietitians can be helpful to impart detailed lifestyle \nmodification counselling that might not be feasible for a general \npractitioner or gynaecologist in a busy outpatient setting.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 678,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 8,
      "char_count": 678,
      "word_count": 100,
      "start_pos": 40386,
      "end_pos": 41064,
      "chunk_index": 81,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_82",
      "text": "hat might not be feasible for a general \npractitioner or gynaecologist in a busy outpatient setting. Experts \nbelieve further attempts can be made based on the available \nhealthcare resources to involve specialists and clinicians such \nas exercise physiologists, psychologists, and orthopaedics who \nhave decisive roles in obesity management in midlife women. \nConsidering the limited healthcare resources in developing \ncountries such as India, a dedicated multidisciplinary approach \ncan be limited to established tertiary healthcare set-ups.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 544,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 8,
      "char_count": 544,
      "word_count": 74,
      "start_pos": 40964,
      "end_pos": 41508,
      "chunk_index": 82,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_83",
      "text": ", a dedicated multidisciplinary approach \ncan be limited to established tertiary healthcare set-ups. Experts \nsuggest that interprofessional education and training sessions to \ndiscuss professional attitudes, skills and barriers faced in everyday \nclinical practice for obesity management can be the first step \nto mitigate this resource constraint. Every healthcare provider \nshould be trained in opportunistic screening and generalised \nmanagement of obesity in midlife women.\n1.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 481,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 8,
      "char_count": 481,
      "word_count": 64,
      "start_pos": 41408,
      "end_pos": 41889,
      "chunk_index": 83,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_84",
      "text": "ld be trained in opportunistic screening and generalised \nmanagement of obesity in midlife women.\n1.4: What could be the effective ways of delivering \npertinent information to midlife women regarding the \nmanagement of overweight and obesity?\nBackground\nHealth promotion counselling is a feasible, cost-effective and \nlong-term solution for the effective management of obesity. The \nNational Health and Medical Research Council (NHMRC) (2013) \nrecommendations refer to the importance of health promotion \nand lifestyle advice to identify, assist and treat individuals with \nobesity.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 582,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 8,
      "char_count": 582,
      "word_count": 80,
      "start_pos": 41789,
      "end_pos": 42371,
      "chunk_index": 84,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_85",
      "text": "e of health promotion \nand lifestyle advice to identify, assist and treat individuals with \nobesity.[56] The lifestyle counselling paradigm has evolved over \nthe years from personalised counselling sessions to web-based \ninterventions.[57,58]Personalised counselling can be defined as \none-to-one counselling sessions with trained healthcare providers \nfocused on managing an individual’s weight-related issues.[59] \nGroup counselling provides an opportunity to discuss and share \nsimilar weight-related concerns amongst a group of participants \nin the presence of trained healthcare professionals in a real social \nsetting.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 624,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 8,
      "char_count": 624,
      "word_count": 79,
      "start_pos": 42271,
      "end_pos": 42895,
      "chunk_index": 85,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_86",
      "text": "roup of participants \nin the presence of trained healthcare professionals in a real social \nsetting.[60]In the current clinical practice, the traditional one-to-\none counselling is supplemented with web-based interventions \nthat help in improving compliance to the lifestyle advice by \nproviding personalised feedback and addressing challenges \nin real-time.[61]Web-based counselling utilises technological \ncomponents such as the internet, mobile application and \nonline social support groups to counsel women on weight-\nrelated issues.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 537,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 8,
      "char_count": 537,
      "word_count": 69,
      "start_pos": 42795,
      "end_pos": 43332,
      "chunk_index": 86,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_87",
      "text": "et, mobile application and \nonline social support groups to counsel women on weight-\nrelated issues.[62] Nowadays, web-based counselling techniques \nhave replaced the non-digital formats for nutrition education \nconsisting of patient education material such as pamphlets, \nbrochures, and e-newsletters. However, there is limited \nevidence on the mode of lifestyle counselling (independent or \nin combination) that will effectively manage weight in midlife \nwomen.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 463,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 8,
      "char_count": 463,
      "word_count": 61,
      "start_pos": 43232,
      "end_pos": 43695,
      "chunk_index": 87,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_88",
      "text": "counselling (independent or \nin combination) that will effectively manage weight in midlife \nwomen. Further, healthcare professionals need to understand \nthe most effective and promising way of delivering information \nfor counselling on weight management components (diet, \nphysical activity and behaviour) for widespread acceptance of \nadvice. To date, the role of different counselling techniques and \nmodalities of communication in improving odds of achieving \nsuccessful weight loss and prevention of weight gain remains \nunclear.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 535,
          "overlap_percentage": 100.18726591760299
        }
      ],
      "primary_page": 8,
      "char_count": 534,
      "word_count": 71,
      "start_pos": 43595,
      "end_pos": 44130,
      "chunk_index": 88,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_89",
      "text": "improving odds of achieving \nsuccessful weight loss and prevention of weight gain remains \nunclear. Hence, this clinical question was undertaken to identify \nthe most promising ways of counselling and delivery of patient \neducation advice for effective management of obesity in clinical \nand community settings.\nSummary of evidence\nThe pertinent studies identified used a range of counselling \ntechniques, including personalised counselling sessions, group \ncounselling, telephonic counselling sessions, or a combination \nto achieve significant weight loss.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 558,
          "overlap_percentage": 100.17953321364452
        }
      ],
      "primary_page": 8,
      "char_count": 557,
      "word_count": 74,
      "start_pos": 44030,
      "end_pos": 44588,
      "chunk_index": 89,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_90",
      "text": "counselling, telephonic counselling sessions, or a combination \nto achieve significant weight loss. A systematic review \ncomparing the role of group and individualised counselling for \nweight management reported that group counselling led by a \npsychologist was more effective for female participants.[63] It was \nalso reported that in-person and more frequent contact were \nnot associated with more significant weight loss.[64]In addition \nto these techniques, web-based counselling sessions were also \nopted for weight management.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 533,
          "overlap_percentage": 100.18796992481202
        }
      ],
      "primary_page": 8,
      "char_count": 532,
      "word_count": 71,
      "start_pos": 44488,
      "end_pos": 45021,
      "chunk_index": 90,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_91",
      "text": "ddition \nto these techniques, web-based counselling sessions were also \nopted for weight management. Four meta-analysis and systematic \nreviews assessed the role of technology-based interventions \nsuggesting different web-based interventions were minimally \neffective in weight management. In comparison to traditional \npersonalised counselling techniques, the efficacy of the web-\nbased intervention was inconsistent.[65] A recent systematic review \nsuggested that web-supported video conferencing sessions are \neffective in maintaining physical activity.[58]\nIn addition to counselling, various forms of nutrition education \nmaterial have been used across trials to facilitate weight loss.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 691,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 8,
      "char_count": 691,
      "word_count": 85,
      "start_pos": 44921,
      "end_pos": 45612,
      "chunk_index": 91,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_92",
      "text": "rious forms of nutrition education \nmaterial have been used across trials to facilitate weight loss. \nEducation material such as printed material, exercise videos \nand mobile application for self-monitoring is available.[44,66,67] \nA systematic review has reported that dietary counselling was \nmostly given as verbal advice coupled with handouts/brochures. \nThere were no referrals for comprehensive weight management \nto the dietitians. Three-fourth of the participants were advised \nto walk for physical activity without providing any tailor-made \nactivity plan.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 565,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 8,
      "char_count": 565,
      "word_count": 75,
      "start_pos": 45512,
      "end_pos": 46077,
      "chunk_index": 92,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_93",
      "text": "ipants were advised \nto walk for physical activity without providing any tailor-made \nactivity plan.[68] It was suggested that a toolkit approach should \nbe undertaken, including evidence-based and practical dietary, \nphysical activity, and behavioural advice.\nClinical practice recommendations\nNo. Recommendations\nGrade\n1.4.1 A combination of face‑to‑face and technology‑supported \ndistance counselling should be planned for the management \nof weight in midlife women with overweight and obesity.\nIV\nA\n1.4.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 507,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 8,
      "char_count": 507,
      "word_count": 67,
      "start_pos": 45977,
      "end_pos": 46484,
      "chunk_index": 93,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_94",
      "text": "uld be planned for the management \nof weight in midlife women with overweight and obesity.\nIV\nA\n1.4.2 Internet and mobile‑based applications should be used \nproactively for improving compliance by enhancing patient \neducation, motivation, self‑monitoring, personalised \nfeedback, and managing challenges faced in appropriate \nweight management practices.\nII\nA\n1.4.3 A toolkit consisting of education material apprising midlife \nwomen about menopausal transition and its impact on weight \nstatus and key management strategies can be developed to be \ndistributed and utilised across healthcare settings.\nIV\nB\n\nRanjan, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 606,
          "overlap_percentage": 97.42765273311898
        },
        {
          "page_number": 9,
          "overlap_chars": 14,
          "overlap_percentage": 2.2508038585209005
        }
      ],
      "primary_page": 8,
      "char_count": 622,
      "word_count": 87,
      "start_pos": 46384,
      "end_pos": 47006,
      "chunk_index": 94,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_95",
      "text": "es can be developed to be \ndistributed and utilised across healthcare settings.\nIV\nB\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nTable 1.4.1: Advantages and disadvantages of counselling techniques\nCounseling technique\nAdvantage\nDisadvantage \nIndividualised counseling \nOne‑on‑one attention\nIntense and comprehensive therapy\nFocused and tailored treatment\nPersonalised feedback\nHigh level of confidentiality\nMore expensive\nLack of social support\nRequires human resource\nTime intensive\nGroup counsel",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 84,
          "overlap_percentage": 14.000000000000002
        },
        {
          "page_number": 9,
          "overlap_chars": 514,
          "overlap_percentage": 85.66666666666667
        }
      ],
      "primary_page": 8,
      "char_count": 600,
      "word_count": 81,
      "start_pos": 46906,
      "end_pos": 47506,
      "chunk_index": 95,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_96",
      "text": "entiality\nMore expensive\nLack of social support\nRequires human resource\nTime intensive\nGroup counseling\nCost‑effective\nSocial support\nResource‑saving\nNew perspectives and diversity in opinion\nSocial support\nRequires space\nLimited opportunities for managing more specific \nindividual needs\nLess confidentiality and trust\nHesitancy\nLess focus and attention towards each individual\nWeb‑based counseling \nCost‑effective\nTime‑efficient\nEnhanced availability and easy accessibility\nImproved adherence\nLong‑term efficacy\nPrivacy and anonymity\nClose contact with a healthcare professional at any \ntime\nImprov",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 9,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 9,
      "char_count": 600,
      "word_count": 74,
      "start_pos": 47406,
      "end_pos": 48006,
      "chunk_index": 96,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_97",
      "text": "term efficacy\nPrivacy and anonymity\nClose contact with a healthcare professional at any \ntime\nImproved discretion and comfort\nReduced barriers related to patient disengagement, \ngeographical distance, socioeconomic status\nLimited opportunities for attending to more specific \nindividual needs\nData security issues\nLack of non‑verbal signals\nNeed of technology\nLow need or desire for in‑person contact\nMass awareness\nCater to a broad‑range audience\nCost‑effective\nTime‑saving\nSocial support\nBridge geographical distance\nAnonymity\nLack of non‑verbal signals\nNeed of technology\nLack of effectiveness\nNo long‑term effect\nLess opportunity for individual needs \nTable 1.4.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 9,
          "overlap_chars": 666,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 9,
      "char_count": 666,
      "word_count": 89,
      "start_pos": 47906,
      "end_pos": 48572,
      "chunk_index": 97,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_98",
      "text": "chnology\nLack of effectiveness\nNo long‑term effect\nLess opportunity for individual needs \nTable 1.4.2: Advantages and disadvantages of various modes used for counseling\nModes used for counselling \nAdvantages\nDisadvantages\nPosters, brochure, pamphlet \nand leaflets\nCost‑effective\nEasy to distribute\nTime‑saving\nConnect with the target audience\nInformative\nNo long‑term effect\nPresentations and videos\nBroad population reach\nInformative\nEasily accessible\nCost‑effective\nLimited interaction\nRequires time for planning and content \nSocial media\nEasy access\nMore flexibility\nAnonymity\nCost‑effective\nWider",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 9,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 9,
      "char_count": 600,
      "word_count": 75,
      "start_pos": 48472,
      "end_pos": 49072,
      "chunk_index": 98,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_99",
      "text": "e for planning and content \nSocial media\nEasy access\nMore flexibility\nAnonymity\nCost‑effective\nWider reachability\nUser friendly\nLanguage friendly\nLacks social‑emotional connection\nAvailability and varied understanding of \ntechnology\nLacks feedback and follow‑up\nE‑counselling tools: websites, \ne-mail, group chat \nAccessible\nConvenient\nCater to masses as well as individuals\nBridge geographical distance\nIncreased follow‑up\nTime‑delayed format\nAbsence of visual and vocal cues\nGreater potential for misinterpretation\nVaried understanding of technology \nVideo conferencing\nAccessible\nConvenient\nReal‑t",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 9,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 9,
      "char_count": 600,
      "word_count": 73,
      "start_pos": 48972,
      "end_pos": 49572,
      "chunk_index": 99,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_100",
      "text": "isinterpretation\nVaried understanding of technology \nVideo conferencing\nAccessible\nConvenient\nReal‑time\nMore privacy\nBridge geographical distance \nAvailability of technology\nDecreased sense of intimacy\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nDiscussion\nA combined counselling regime consisting of individualised and \ninternet-based distance counselling sessions can help to improve \nthe odds of achieving weight loss success in the general population \nand midlife women.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 9,
          "overlap_chars": 201,
          "overlap_percentage": 34.835355285961874
        },
        {
          "page_number": 10,
          "overlap_chars": 374,
          "overlap_percentage": 64.81802426343154
        }
      ],
      "primary_page": 9,
      "char_count": 577,
      "word_count": 77,
      "start_pos": 49472,
      "end_pos": 50049,
      "chunk_index": 100,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_101",
      "text": "to improve \nthe odds of achieving weight loss success in the general population \nand midlife women. Experts believed that healthcare providers \nshould decide the mode of counselling based on several factors, \nincluding infrastructure, availability of resources, the expertise of \nthe healthcare provider, clinician to patient ratio, and characteristics \nof the patient attending healthcare settings. It is important to note \nthe advantages and disadvantages of each counselling method, \neducation tools to customise the weight management approach \n(as depicted in Table 1.4.1 and 1.4.2).",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 588,
          "overlap_percentage": 100.17035775127768
        }
      ],
      "primary_page": 10,
      "char_count": 587,
      "word_count": 82,
      "start_pos": 49949,
      "end_pos": 50537,
      "chunk_index": 101,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_102",
      "text": "education tools to customise the weight management approach \n(as depicted in Table 1.4.1 and 1.4.2). The experts recommended \na uniform toolkit approach to provide nutrition, physical activity \nand behavioural strategies for management of weight in midlife \nwomen across health care settings. This toolkit should include \nhealth education material that can be easily used for counselling by \nallied healthcare professionals, especially in rural settings. Currently, \nsocial media has been identified as an upcoming cost-effective tool \nfor increasing patient engagement, health promotion and social \nsupport at an individual and community level.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 645,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 10,
      "char_count": 645,
      "word_count": 89,
      "start_pos": 50437,
      "end_pos": 51082,
      "chunk_index": 102,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_103",
      "text": "asing patient engagement, health promotion and social \nsupport at an individual and community level.[69]\nSection II: Screening and risk assessment of midlife \nwomen\n2.1: What BMI cut-off and other anthropometric \nparameters should determine the need to initiate weight \nmanagement intervention in midlife women?\nBackground\nBody mass index (BMI) is a universally accepted method for \ndiagnosing overweight and obesity.[70] BMI is an index of weight \nand height, expressed as kg/m2. Ideally, BMI is used as a measure \nof adiposity.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 529,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 10,
      "char_count": 529,
      "word_count": 78,
      "start_pos": 50982,
      "end_pos": 51511,
      "chunk_index": 103,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_104",
      "text": "an index of weight \nand height, expressed as kg/m2. Ideally, BMI is used as a measure \nof adiposity. The internationally accepted BMI cut-offs and \ncorresponding components of body weight (body fat, muscle mass \nand total water) are known to vary in different ethnic communities.[71] \nBecause the internationally accepted BMI cut-offs are based on \ndata from the western population, ethnic variation in BMI cut-offs \nfor Asian Indians should be addressed. In addition to BMI, other \nanthropometric parameters such as waist and hip circumference \nand their ratios such as waist to height ratio (WHtR) and waist to \nhip ratio (WHR) can be used for the assessment of generalised and \ncentral obesity.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 697,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 10,
      "char_count": 697,
      "word_count": 109,
      "start_pos": 51411,
      "end_pos": 52108,
      "chunk_index": 104,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_105",
      "text": "R) and waist to \nhip ratio (WHR) can be used for the assessment of generalised and \ncentral obesity. Waist circumference and its ratios are important \nanthropometric parameters associated with visceral adiposity \nand cardiometabolic health.[72] In resource-rich settings, methods \nsuch as Bioelectric Impedence Analysis (BIA) and Dual X-ray \nAbsorptiometry (DEXA) can be used for objective assessment \nof total body fat, skeletal and lean muscle mass.[73]The choice of \nanthropometric measure opted for diagnosis is dependent on several \nfactors including technical know-how, availability of instruments, \nhealthcare personnel, infrastructure, and the clinician to patient \nratio.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 680,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 10,
      "char_count": 680,
      "word_count": 91,
      "start_pos": 52008,
      "end_pos": 52688,
      "chunk_index": 105,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_106",
      "text": "lability of instruments, \nhealthcare personnel, infrastructure, and the clinician to patient \nratio. It is important to identify anthropometric parameters, which \nare simple, feasible, cost-effective and efficacious in identifying \ngeneralised and central obesity status in clinical practice.\nSummary of evidence\nThe optimum BMI coupled with waist circumference cut-off has \nbeen identified across the literature to diagnose overweight and \nobesity. Globally, for the categorization of BMI, World Health \nOrganisation (WHO) suggests an individual with a cut-off of \n25–29.9 kg/m2 as overweight and ≥ 30 kg/m2 as obese.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 618,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 10,
      "char_count": 618,
      "word_count": 85,
      "start_pos": 52588,
      "end_pos": 53206,
      "chunk_index": 106,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_107",
      "text": "(WHO) suggests an individual with a cut-off of \n25–29.9 kg/m2 as overweight and ≥ 30 kg/m2 as obese. It was \nidentified that the globally recommended cut-off for defining \noverweight and obesity should be lowered in different Asian \npopulation groups due to ethnic variation in the total body \nfat and fat-free mass. The Indian Consensus Group (2009) \nrecommended a cut-off value of 23–24.9 kg/m2 as an indicator \nof overweight individuals and ≥25 kg/m2 as an indicator for \nobese individuals.[74] Across literature on lifestyle modification \nin menopausal women, the BMI range was 23–45 kg/m2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 594,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 10,
      "char_count": 594,
      "word_count": 92,
      "start_pos": 53106,
      "end_pos": 53700,
      "chunk_index": 107,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_108",
      "text": "74] Across literature on lifestyle modification \nin menopausal women, the BMI range was 23–45 kg/m2.[75-77]\nIn addition to BMI, the consensus statement from a working \ngroup reported that waist circumference should be made a vital \nsign for clinical assessment.[72]According to the WHO, women \nwith waist circumference > 88 cm can be at risk of at least one \ncardiometabolic risk factor.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 387,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 10,
      "char_count": 387,
      "word_count": 60,
      "start_pos": 53600,
      "end_pos": 53987,
      "chunk_index": 108,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_109",
      "text": "women \nwith waist circumference > 88 cm can be at risk of at least one \ncardiometabolic risk factor.[78]For Asian Indians, a woman > \n80 cm waist circumference should seek help from a healthcare \npractitioner for management of obesity-related risk factors and \nwomen with waist circumference > 72 cm should avoid gaining \nweight and incorporate physical activity to avoid having any \ncardiometabolic risk factor in later life.[74]We found six trials that \nassessed the waist circumference at the baseline. Out of which, \nfour studies defined the waist circumference cut-off as 80 cm and \ntwo studies defined waist circumference cut-off as 88 cm.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 645,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 10,
      "char_count": 645,
      "word_count": 100,
      "start_pos": 53887,
      "end_pos": 54532,
      "chunk_index": 109,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_110",
      "text": "waist circumference cut-off as 80 cm and \ntwo studies defined waist circumference cut-off as 88 cm.[79-82] We \nfound three studies assessing baseline total body fat for midlife \nwomen enrolling in lifestyle modification intervention, with a \ncut-off of more than 32% in one study[83] and more than 35% \nin one RCT and systematic review. Only four studies assessed \nthe total body fat percentage at the baseline in midlife women \nundergoing weight loss intervention.[75,79,83]\nClinical practice recommendations\nNo. Recommendations\nGrade\n2.1.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 541,
          "overlap_percentage": 100.18518518518518
        }
      ],
      "primary_page": 10,
      "char_count": 540,
      "word_count": 79,
      "start_pos": 54432,
      "end_pos": 54973,
      "chunk_index": 110,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_111",
      "text": "weight loss intervention.[75,79,83]\nClinical practice recommendations\nNo. Recommendations\nGrade\n2.1.1 BMI and waist circumference should be used independently \nfor population‑ and clinic‑based cardiometabolic risk \nstratification and other obesity‑related diseases.\nI\nA\n2.1.2 For initiating a weight management intervention, the class \nof generalised obesity should be identified according to the \nBMI‑cut‑off:\n18.5‑22.9 kg/m2: Normal weight\n23.0‑24.9 kg/m2: Overweight\n≥25 kg/m2: Obesity\nI\nA\n2.1.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 497,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 10,
      "char_count": 497,
      "word_count": 63,
      "start_pos": 54873,
      "end_pos": 55370,
      "chunk_index": 111,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_112",
      "text": "BMI‑cut‑off:\n18.5‑22.9 kg/m2: Normal weight\n23.0‑24.9 kg/m2: Overweight\n≥25 kg/m2: Obesity\nI\nA\n2.1.3 For initiating weight management intervention, the cut‑off \nfor waist circumference should be as below:\nWaist Circumference less than or equal to 72 cm: normal\nWaist Circumference more than 72 cm but <80 cm: \nassociated with one cardiometabolic risk factor-initiate \nweight management advice\nWaist Circumference more than 80 cm: associated with \ncardiometabolic comorbidities-initiate intensive weight \nmanagement\nI\nA\nDiscussion\nWe found robust evidence that suggests that BMI and waist \ncircumfere",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 600,
          "overlap_percentage": 100.1669449081803
        }
      ],
      "primary_page": 10,
      "char_count": 599,
      "word_count": 83,
      "start_pos": 55270,
      "end_pos": 55870,
      "chunk_index": 112,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_113",
      "text": "ght \nmanagement\nI\nA\nDiscussion\nWe found robust evidence that suggests that BMI and waist \ncircumference are associated with risk of general and abdominal \nadiposity, cardiometabolic risk and obesity-related diseases. The\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nuniversally recommended BMI values for overweight (≥ 25 kg/m2) \nand obesity (≥ 30 kg/m2) were established on the basis of morbidity \nand mortality data from the white adult population.[70] In Asian \nIndians, higher body fat and higher cardiometabolic comorbidities \nare observed at a lower BMI status.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 220,
          "overlap_percentage": 32.884902840059794
        },
        {
          "page_number": 11,
          "overlap_chars": 447,
          "overlap_percentage": 66.81614349775785
        }
      ],
      "primary_page": 10,
      "char_count": 669,
      "word_count": 101,
      "start_pos": 55770,
      "end_pos": 56439,
      "chunk_index": 113,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_114",
      "text": "dians, higher body fat and higher cardiometabolic comorbidities \nare observed at a lower BMI status.[84] This raises concerns in \nclinical practice as these individuals who are metabolically obese \nand predisposed to developing hyperlipidaemia, diabetes, blood \npressure and atherosclerosis are misclassified as individuals with \nnormal BMI. Considering a greater cardiometabolic risk at a \nlower BMI, a revision of the BMI cut-off for Asian Indians was \nsuggested by national recommendation bodies as 23–24.9 kg/m2 \nfor overweight and 25 kg/m2 or more as obese.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 562,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 11,
      "char_count": 562,
      "word_count": 81,
      "start_pos": 56339,
      "end_pos": 56901,
      "chunk_index": 114,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_115",
      "text": "ed by national recommendation bodies as 23–24.9 kg/m2 \nfor overweight and 25 kg/m2 or more as obese. It should be noted \nthat clinicians and healthcare providers should classify midlife \nwomen according to the Asian Indian specifications in their daily \nclinical practice, rather than the internationally accepted guidelines.\nIn addition to BMI, waist circumference should be utilised in \nthe assessment of generalised and abdominal obesity, especially \nto identify women who are metabolically obese presenting \nwith normal weight (MONW) in clinical settings.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 559,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 11,
      "char_count": 559,
      "word_count": 80,
      "start_pos": 56801,
      "end_pos": 57360,
      "chunk_index": 115,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_116",
      "text": "entify women who are metabolically obese presenting \nwith normal weight (MONW) in clinical settings. These \nanthropometric parameters can be used to screen women at high \nrisk of cardiometabolic disease and obesity-related disorders for \ntimely initiation of treatment. Considering the importance of \nwaist circumference in assessing cardiometabolic risk factors in \nan individual, a consensus on cut-offs of waist circumference \nin the adult population was recommended. For women, a \nwaist circumference of more than 88 cm was considered as an \nindicator of cardiometabolic risk.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 580,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 11,
      "char_count": 580,
      "word_count": 82,
      "start_pos": 57260,
      "end_pos": 57840,
      "chunk_index": 116,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_117",
      "text": ", a \nwaist circumference of more than 88 cm was considered as an \nindicator of cardiometabolic risk.[78,85] In Asian women, a waist \ncircumference of 80 cm was considered appropriate in identifying \ncardiovascular risk factors in comparison to 88 cm, which was \ninternationally accepted.[74] Furthermore, ratios such as WtHR \nand WHR are used as an indicator of metabolic health. Evidence \nsuggests that waist circumference alone is a vital responsive \nclinical sign of cardiometabolic health in comparison to WHR.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 514,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 11,
      "char_count": 514,
      "word_count": 77,
      "start_pos": 57740,
      "end_pos": 58254,
      "chunk_index": 117,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_118",
      "text": "umference alone is a vital responsive \nclinical sign of cardiometabolic health in comparison to WHR.[72]\nExperts suggested that measurement of anthropometric \nparameters BMI and waist circumference should be made a \npart of routine clinical practice as a vital clinical sign for health \nassessment of midlife women.\nIn addition, clinicians should also stratify treatment at different \nBMI cut-offs for optimal utilization of resources for diagnosis \nand treatment. The intensity of weight management advice \nshould be in accordance with deviation from the ideal weight \nand waist circumference.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 594,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 11,
      "char_count": 594,
      "word_count": 85,
      "start_pos": 58154,
      "end_pos": 58748,
      "chunk_index": 118,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_119",
      "text": "ement advice \nshould be in accordance with deviation from the ideal weight \nand waist circumference. The use of pharmacotherapy should \nbe incorporated in the treatment only as per indications by \nthe treating clinician. In addition to cut-offs, the availability \nof resources should also be noted while planning obesity care, \nespecially in resource-constrained settings such as anganwadi, \ncommunity clinics and primary healthcare centres (PHC).\n2.2: How should dietary practices of midlife women be \nevaluated?\nBackground\nThe assessment of lifestyle-related risk factors is an important step \nin managing weight in midlife women.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 632,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 11,
      "char_count": 632,
      "word_count": 90,
      "start_pos": 58648,
      "end_pos": 59280,
      "chunk_index": 119,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_120",
      "text": "essment of lifestyle-related risk factors is an important step \nin managing weight in midlife women. In clinical practice, a detailed \ndietary history consisting of current caloric intake, adequacy of \nmacronutrient composition (carbohydrate, protein and fat), \nconsumption of HFSS foods, meal pattern, portion size, eating \nout, and nutritional deficiencies is a common method of dietary \nassessment.[86] For an objective assessment in terms of quantity \nand quality, traditional methods such as twenty-four-hour recall \nand food frequency questionnaires (FFQ) can be administered \nby trained healthcare professionals.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 619,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 11,
      "char_count": 619,
      "word_count": 83,
      "start_pos": 59180,
      "end_pos": 59799,
      "chunk_index": 120,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_121",
      "text": "l \nand food frequency questionnaires (FFQ) can be administered \nby trained healthcare professionals.[87] In addition, most weight-\nloss trials administered valid and reliable questionnaires to \nassess different aspects of eating behaviour.[45,88-90] The choice \nof the assessment method depends on a number of factors \nsuch as the aim of assessment, the expertise of the healthcare \nprovider, availability of time, participant burden, infrastructure \nand method of interpretation of collected information. It is \ncommonly observed that a majority of clinicians are involved in \ngeneral dietary management as a part of midlife care.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 631,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 11,
      "char_count": 631,
      "word_count": 89,
      "start_pos": 59699,
      "end_pos": 60330,
      "chunk_index": 121,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_122",
      "text": "that a majority of clinicians are involved in \ngeneral dietary management as a part of midlife care.[2] It becomes \nimportant to identify simple, practical and cost-effective ways for \ndietary assessment, which can facilitate holistic dietary counselling, \nespecially in resource-constrained settings with limited or no \navailability of a nutritionist or a dietitian.\nSummary of evidence\nA total of 15 instruments were identified for dietary assessment \nof the individuals participating in weight-loss interventions. Only \none study assessed the dietary quality using the healthy eating \nindex (HEI)-2010.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 605,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 11,
      "char_count": 605,
      "word_count": 84,
      "start_pos": 60230,
      "end_pos": 60835,
      "chunk_index": 122,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_123",
      "text": "erventions. Only \none study assessed the dietary quality using the healthy eating \nindex (HEI)-2010.[91] The usual dietary intake of the participants \nwas most commonly assessed at baseline in weight loss trials. A \ntotal of nine studies assessed usual dietary intake by administering \n24-hour dietary recall (three weekdays and one weekend)[92] \nWomen’s Health Initiative FFQ,[89] Vioscreen (an electronic \nFFQ),[44] four-day food record [48] and dietary food logs.[83] The \nfrequency, type and distribution of meals were assessed via a \nmeal pattern assessment grid in two studies.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 583,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 11,
      "char_count": 583,
      "word_count": 84,
      "start_pos": 60735,
      "end_pos": 61318,
      "chunk_index": 123,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_124",
      "text": "cy, type and distribution of meals were assessed via a \nmeal pattern assessment grid in two studies.[49,89]The frequency \nof intake of HFSS foods was assessed using two scales including \nfat-related intake questionnaires,[93] and Connor Diet Habit \nSurvey.[94]The eating behaviour was assessed via a 51-item valid \nand reliable Three-Factor Eating Behavior Questionnaire(TFEQ) \nmeasuring three domains: Cognitive Restraint, Disinhibition, \nand Hunger on a four-point Likert scale.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 480,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 11,
      "char_count": 480,
      "word_count": 64,
      "start_pos": 61218,
      "end_pos": 61698,
      "chunk_index": 124,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_125",
      "text": "asuring three domains: Cognitive Restraint, Disinhibition, \nand Hunger on a four-point Likert scale.[88,95,96] Only two studies \nmeasured the barriers faced in maintaining healthy eating in an \ninterview schedule to assess the factors such as emotional eating, \ndaily mechanics of healthy eating and lack of social support on \na five-point Likert scale.[97,98]\nClinical practice recommendations\nNo.\nRecommendations\nGrade\n2.2.1 The detailed dietary evaluation should include an \nassessment of the usual meal pattern (including the number \nof food items consumed) and dietary habits (including \nskipping meals, typical frequency of HFSS usual frequency \nof eating out, emotional/stressful eating).",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 695,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 11,
      "char_count": 695,
      "word_count": 95,
      "start_pos": 61598,
      "end_pos": 62293,
      "chunk_index": 125,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_126",
      "text": "ipping meals, typical frequency of HFSS usual frequency \nof eating out, emotional/stressful eating). \nI\nA\n2.2.2 Twenty‑four‑hour dietary recall and food frequency \nquestionnaire for 3  days  (2  weekdays and 1  weekend) \nshould be used for dietary evaluation, if feasible. Energy, \nmacronutrient, fibre intake should subsequently be calculated. \nAlternatively, a short validated questionnaire can be used.*\nII\nB\nContd...\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\n2.2.3 Dietary intake of foods rich in protein, iron, and calcium \nshould also be assessed while taking dietary history.\nIV\nB\n2.2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 420,
          "overlap_percentage": 60.258249641319935
        },
        {
          "page_number": 12,
          "overlap_chars": 275,
          "overlap_percentage": 39.45480631276901
        }
      ],
      "primary_page": 11,
      "char_count": 697,
      "word_count": 104,
      "start_pos": 62193,
      "end_pos": 62890,
      "chunk_index": 126,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_127",
      "text": "rich in protein, iron, and calcium \nshould also be assessed while taking dietary history.\nIV\nB\n2.2.4 The barriers faced by midlife women to maintain a healthy \ndiet in their daily lifestyle should be enquired. \nIV\nB\n*Refer to Annexure 4.\nDiscussion\nThe recommendations were based on guidelines, position \nstatements and RCTs in the general population and midlife \nwomen for the management of overweight and obesity.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 416,
          "overlap_percentage": 100.2409638554217
        }
      ],
      "primary_page": 12,
      "char_count": 415,
      "word_count": 66,
      "start_pos": 62790,
      "end_pos": 63206,
      "chunk_index": 127,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_128",
      "text": "and RCTs in the general population and midlife \nwomen for the management of overweight and obesity. The \nevidence suggests that assessment of current caloric intake, \ndietary habits related to health risks (such as sarcopenic obesity, \ncardiometabolic distress, osteoarthritis), and micronutrient \ndeficiencies is a crucial step in the dietary management for weight \nloss in midlife women.[99,100]Ideally, midlife women should be \nreferred to dietitians and/or nutritionists to assess current dietary \nintake using a 24-h dietary recall method coupled with FFQ.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 562,
          "overlap_percentage": 100.17825311942958
        }
      ],
      "primary_page": 12,
      "char_count": 561,
      "word_count": 78,
      "start_pos": 63106,
      "end_pos": 63668,
      "chunk_index": 128,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_129",
      "text": "nutritionists to assess current dietary \nintake using a 24-h dietary recall method coupled with FFQ. For \nclinicians and researchers interested in utilizing traditional tools \nfor dietary assessment, a detailed description of available tools \nwith their advantages and disadvantages is presented in Table \n2.2.1. However, these methods suffer from practical limitations \nsuch as the need for technical knowledge, are time-consuming, \nand are difficult to interpret, especially in resource-constrained \nsettings. Experts believed that a detailed dietary history should be \nconsidered a simple, practical and feasible assessment method in \ndaily clinical practice.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 662,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 12,
      "char_count": 662,
      "word_count": 89,
      "start_pos": 63568,
      "end_pos": 64230,
      "chunk_index": 129,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_130",
      "text": "hould be \nconsidered a simple, practical and feasible assessment method in \ndaily clinical practice. For ease of practice, the details on specific \npoints to be considered while taking the dietary history are \npresented in [Table 2.2.2]. Considering the resource availability, \npractitioners can opt for a combination of methods for dietary \nassessment that can provide them with complete information \non current dietary practices in midlife women. Special attention \nshould be given to assessing the regular consumption of foods \nrich in protein, iron, and calcium.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 566,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 12,
      "char_count": 566,
      "word_count": 83,
      "start_pos": 64130,
      "end_pos": 64696,
      "chunk_index": 130,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_131",
      "text": "should be given to assessing the regular consumption of foods \nrich in protein, iron, and calcium. Healthcare practitioners can \nassess the intake of foods rich in protein and other micronutrients \nin two ways: (i) quantitatively via 24-h dietary recall method or a \nsemi-quantitative FFQ and/or (ii) qualitatively via dietary history. \nIn the presence of any clinical symptoms related to micronutrient \ndeficiencies, a detailed clinical history, assessment of clinical signs \nand confirmatory laboratory tests (if feasible) should be planned \nunder the guidance of a clinician.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 580,
          "overlap_percentage": 100.34602076124568
        }
      ],
      "primary_page": 12,
      "char_count": 578,
      "word_count": 84,
      "start_pos": 64596,
      "end_pos": 65176,
      "chunk_index": 131,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_132",
      "text": "nd confirmatory laboratory tests (if feasible) should be planned \nunder the guidance of a clinician. Diet diversity can also be checked \nvia an easy to administer checklist like the FIGO Nutrition checklist \nconsisting of six questions on consumption of food groups to \nassess the dietary quality. This checklist can be completed before \nthe doctor's appointment at the outpatient setting.[101] This checklist \ncan be customised and validated for Indian midlife women.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 468,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 12,
      "char_count": 468,
      "word_count": 70,
      "start_pos": 65076,
      "end_pos": 65544,
      "chunk_index": 132,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_133",
      "text": "e outpatient setting.[101] This checklist \ncan be customised and validated for Indian midlife women.\nMidlife women presenting with signs and symptoms of iron \ndeficiency anaemia can be assessed through (i) examination of \nclinical signs and symptoms like pallor of eyelids, tongue, nail \nbeds and palms and (ii) prescribing a complete blood count \nincluding assessment of haemoglobin (Hb), mean corpuscular \nhaemoglobin (MCH), mean cell haemoglobin concentration \n(MCHC), and mean corpuscular volume (MCV) as a preliminary \npredictive test.[102]The blood level of serum ferritin is considered \nthe most appropriate test for assessing iron deficiency anaemia.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 658,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 12,
      "char_count": 658,
      "word_count": 92,
      "start_pos": 65444,
      "end_pos": 66102,
      "chunk_index": 133,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_134",
      "text": "el of serum ferritin is considered \nthe most appropriate test for assessing iron deficiency anaemia.[103] \nThe cut-off values for the assessment of iron deficiency anaemia \nare given in [annexure 1].\nThere are no reliable biochemical status markers for the \nassessment of calcium deficiency in adults.[104]In a resource-\nTable 2.2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 331,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 12,
      "char_count": 331,
      "word_count": 49,
      "start_pos": 66002,
      "end_pos": 66333,
      "chunk_index": 134,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_135",
      "text": "al status markers for the \nassessment of calcium deficiency in adults.[104]In a resource-\nTable 2.2.1: Advantages and disadvantages of traditional tools used for dietary assessment\nTools/Description\nAdvantages\nDisadvantages\n24‑h recall\n(Retrospective assessment method of dietary \nintake over 24 h)\nPrecise method if interviewed efficiently\nLess burden on the respondent\nSensitive to ethnicity\nCaptures eating habits such as meal \npattern, preparation methods\nAdministered skilled interviewer\nRecall bias\nTime‑consuming\nAccuracy depends on respondent’s literacy and ability \nto describe the food and",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 600,
          "overlap_percentage": 100.1669449081803
        }
      ],
      "primary_page": 12,
      "char_count": 599,
      "word_count": 79,
      "start_pos": 66233,
      "end_pos": 66833,
      "chunk_index": 135,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_136",
      "text": "bias\nTime‑consuming\nAccuracy depends on respondent’s literacy and ability \nto describe the food and portion size\nFood frequency questionnaire\n(Retrospective method\nAssessment of frequency of foods \nconsumption over time)\nTypes:\nQualitative: Frequency of food consumed only\nSemi‑quantitative: Frequency along with portion \nsize consumed, for example, small, average, large\nQuantitative: Portion size enquired\nHelpful for long term dietary intake \nestimation\nCapture food diversity, specific nutrient or \nfood group\nLess burden on researcher and participant\nCost‑efficient\nMore accurate and culture‑spe",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 12,
      "char_count": 600,
      "word_count": 78,
      "start_pos": 66733,
      "end_pos": 67333,
      "chunk_index": 136,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_137",
      "text": "r \nfood group\nLess burden on researcher and participant\nCost‑efficient\nMore accurate and culture‑specific\nLess intensive analysis \nRelies on participant’s memory\nChances of misreporting\nMay lead to underreporting if the food list is not \ncomprehensive \nFood diary/records\n(Record of all food items consumed\nAmount of food consumed is either estimated \nor weighed) \nMore accurate\nDetailed information on dietary intake\nGood estimates of short term total \ndietary intake and total nutrient intake\nLittle reliance on participants’ memory\nCost‑effective \nHigh participant burden\nApplicable for trained/literate participant\nLabour intensive.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 636,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 12,
      "char_count": 636,
      "word_count": 86,
      "start_pos": 67233,
      "end_pos": 67869,
      "chunk_index": 137,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_138",
      "text": "ost‑effective \nHigh participant burden\nApplicable for trained/literate participant\nLabour intensive. Time‑consuming analysis\nChances of misreporting\nEstimated food diaries rely on one’s ability to describe \nportion size\nSemi-quantitative weighed food record\n(Portion sizes quantified (weight of foods \nconsumed in a day/estimation using household \nmeasures))\nDirect and simple recording of all \nconsumed foods\nDoes not rely on respondent's memory\nHigh participant burden\nAccuracy depends on the motivation of the respondent\nRequires literate/trained participants\nTime-consuming\nCan lead to undertreatment\n\nRanjan, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 604,
          "overlap_percentage": 97.41935483870968
        },
        {
          "page_number": 13,
          "overlap_chars": 14,
          "overlap_percentage": 2.258064516129032
        }
      ],
      "primary_page": 12,
      "char_count": 620,
      "word_count": 79,
      "start_pos": 67769,
      "end_pos": 68389,
      "chunk_index": 138,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_139",
      "text": "ent\nRequires literate/trained participants\nTime-consuming\nCan lead to undertreatment\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nconstrained setting with limited possibilities of performing \na 24-hour recall for assessment of calcium intake, the daily \ndietary calcium intake can be assessed using a feasible National \nOsteoporosis Foundation (NOF) tool (as shown in Annexure \n2).[105]The adequacy of calcium intake can be assessed by \ncomparing the calculated daily dietary calcium intake with \nthe recommended daily allowance (RDA).",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 84,
          "overlap_percentage": 13.186813186813188
        },
        {
          "page_number": 13,
          "overlap_chars": 551,
          "overlap_percentage": 86.49921507064364
        }
      ],
      "primary_page": 12,
      "char_count": 637,
      "word_count": 90,
      "start_pos": 68289,
      "end_pos": 68926,
      "chunk_index": 139,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_140",
      "text": "comparing the calculated daily dietary calcium intake with \nthe recommended daily allowance (RDA). In addition, \nVitamin D deficiency can be assessed by testing the serum \n25-hydroxyvitamin D concentrations, especially in midlife \nwomen presenting with joint and bone-related issues.[104]The \ncut-offs for the assessment of vitamin D deficiency in adults \nare presented in Annexure 3.[106]\nThe final step in dietary assessment is to ascertain the barriers \nfaced by midlife women in managing healthy eating practices in \ntheir day-to-day life. These barriers should be considered for \nproviding personlised dietary modification advice.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 637,
          "overlap_percentage": 100.31496062992127
        }
      ],
      "primary_page": 13,
      "char_count": 635,
      "word_count": 88,
      "start_pos": 68826,
      "end_pos": 69463,
      "chunk_index": 140,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_141",
      "text": "ay life. These barriers should be considered for \nproviding personlised dietary modification advice. A valid and \nreliable questionnaire for assessing dietary practices and barriers \nto healthy eating in Indian midlife women can be accessed from \n[Annexure 4].\n2.3: How should the level of daily physical activity of \nmidlife women be evaluated?\nBackground\nThe assessment of daily physical activity status is important \nfor determining the total caloric deficit required for achieving \nweight loss in midlife women. Daily activity assessment is aimed \nat calculating caloric expenditure.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 587,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 13,
      "char_count": 587,
      "word_count": 84,
      "start_pos": 69363,
      "end_pos": 69950,
      "chunk_index": 141,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_142",
      "text": "eight loss in midlife women. Daily activity assessment is aimed \nat calculating caloric expenditure. Daily physical activity can \nbe comprehensively assessed under the following domains: \nexercise, occupational, household-related, leisure-related and \nsedentary activities.[107]Physical activity is defined as ‘bodily \nmovement generated due to contraction of the muscle \nthat raises the energy expenditure above resting metabolic \nequivalents (METs)’. It is generally characterised by type, \nintensity, and duration. Exercise is a sub-category of activity \nthat is planned, structured and repeated for maintaining physical \nfitness.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 633,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 13,
      "char_count": 633,
      "word_count": 80,
      "start_pos": 69850,
      "end_pos": 70483,
      "chunk_index": 142,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_143",
      "text": "ub-category of activity \nthat is planned, structured and repeated for maintaining physical \nfitness.[108] Sedentary activities are defined as “any activity \nwith an energy expenditure of ≤ 1.5 metabolic equivalents \n(METs) while in a sitting, reclining and lying posture”.[109] \nSeveral methods have been used for objective assessment \n(accelerometers, heart rate monitors, mobile applications) and \nsubjective assessment (detailed activity history, physical activity \nquestionnaires and activity monitoring applications).[51,110-113] \nThe choice of assessment method in healthcare settings \ndepends on efficacy and ease of use with respect to available \ntime, expertise, and economics.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 686,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 13,
      "char_count": 686,
      "word_count": 88,
      "start_pos": 70383,
      "end_pos": 71069,
      "chunk_index": 143,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_144",
      "text": "ings \ndepends on efficacy and ease of use with respect to available \ntime, expertise, and economics. In most healthcare settings, \nclinicians primarily engage midlife women in considering \nan active lifestyle. It is important to identify concise, valid \nand reliable assessment methods that can be taken up by the \nclinicians and other healthcare professionals for a time-bound \nand comprehensive assessment of daily physical activity.\nSummary of evidence\nAcross weight-loss trials, daily physical activity was assessed \nusing objective, subjective and a combination of both measures.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 584,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 13,
      "char_count": 584,
      "word_count": 83,
      "start_pos": 70969,
      "end_pos": 71553,
      "chunk_index": 144,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_145",
      "text": "aily physical activity was assessed \nusing objective, subjective and a combination of both measures. \nObjective measures included an accelerometer and pedometer \nworn on the wrist, waist or hip to calculate the mean physical \nactivity as MET values.[90,111,112] In subjective measures, a total \nof ten questionnaires were used to assess the total physical \nactivity across different domains such as leisure, occupational, \nhousehold chores, and sitting and screen time.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 469,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 13,
      "char_count": 469,
      "word_count": 67,
      "start_pos": 71453,
      "end_pos": 71922,
      "chunk_index": 145,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_146",
      "text": "oss different domains such as leisure, occupational, \nhousehold chores, and sitting and screen time. Five studies \nassessed physical activity using a combination of objective \nmeasures such as accelerometer and subjective measures such \nas Stanford 7 day Physical Activity Recall, International Physical \nActivity Questionnaire (IPAQ), and Minnesota Physical Activity \nQuestionnaire.[110,114,115] The questionnaires evaluating both \nsedentariness and activity status are IPAQ and Modifiable \nActivity Questionnaire (MAQ).",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 521,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 13,
      "char_count": 521,
      "word_count": 64,
      "start_pos": 71822,
      "end_pos": 72343,
      "chunk_index": 146,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_147",
      "text": "ating both \nsedentariness and activity status are IPAQ and Modifiable \nActivity Questionnaire (MAQ).[113,116] Other domain-specific \nactivity questionnaires are the Leisure-Time Physical Activity \nQuestionnaire and Allied Dunbar National Fitness Survey for \nleisure-related physical activity and work and non-work activity \nby Stanford Physical Activity Recall.[50,117] Sedentariness was \nmeasured using low level physical activity recall and Sitting \nQuestionnaire.[118] The assessment can be reported as continuous \nscores (mean MET values per day or week) or categorical scores \nas low, moderate and high activity according to the cut-off MET \nvalues per day.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 662,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 13,
      "char_count": 662,
      "word_count": 87,
      "start_pos": 72243,
      "end_pos": 72905,
      "chunk_index": 147,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_148",
      "text": "categorical scores \nas low, moderate and high activity according to the cut-off MET \nvalues per day.\nIt was also observed that physical activity assessment should \nbe done for activities that are specific to geographical, social \nand cultural constructs. Considering this, the physical activity \nassessment scale for the western population might not correctly \nmeasure the level of physical activity in midlife women in India. \nMPAQ is a recall measure specifically developed and validated \nin the Indian population to measure both the level of physical \nactivity in different domains and sedentariness.[119] Although, the \napplication of this measure in a busy outpatient setting is still \nlimited.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 699,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 13,
      "char_count": 699,
      "word_count": 103,
      "start_pos": 72805,
      "end_pos": 73504,
      "chunk_index": 148,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_149",
      "text": "ess.[119] Although, the \napplication of this measure in a busy outpatient setting is still \nlimited. There is limited evidence on short and comprehensive \nphysical activity assessment tools that can measure the level of \nphysical activity as well as barriers faced by midlife women in \nmanaging daily physical activity.\nTable 2.2.2: Important points of consideration while \ntaking a comprehensive dietary history\nType of diet: Amount and quality of usual calorie intake should be \nassessed\nMeal pattern: Assess eating habits in terms of frequency and timings of \nthe meal consumptions. Unhealthy eating habits such as meal skipping \nhabits, longer meal gaps and energy‑dense meals should be marked.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 698,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 13,
      "char_count": 698,
      "word_count": 105,
      "start_pos": 73404,
      "end_pos": 74102,
      "chunk_index": 149,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_150",
      "text": "ting habits such as meal skipping \nhabits, longer meal gaps and energy‑dense meals should be marked.\nPortion size: Estimation of accurate food portions. Identify large portion \nsize, energy‑dense products and second helpings.\nMacronutrient intake: The proportion of fat, protein, fat and fibre intake \nshould be noted.\nProtein intake: Daily consumption of adequate portions of foods high in \nprotein including legumes, meats, dairy and nuts.\nFat intake: Consumption of fried, processed foods and bakery products \nshould be asked along with frequency and portion size. The amount and \nquality of oil on a daily basis should also be noted.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 637,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 13,
      "char_count": 637,
      "word_count": 97,
      "start_pos": 74002,
      "end_pos": 74639,
      "chunk_index": 150,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_151",
      "text": "th frequency and portion size. The amount and \nquality of oil on a daily basis should also be noted.\nFibre intake: Fiber intake includes fruits and vegetables, whole grains and \nlegumes and nuts and seeds.\nMeal preparation: Method of cooking, intake of processed and \nconvenience food items should also be assessed.\nEating out habits: Frequency and quality of food consumed outside the \nhome.\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nClinical practice recommendations\nNo.\nRecommendations\nGrade\n2.3.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 392,
          "overlap_percentage": 64.90066225165563
        },
        {
          "page_number": 14,
          "overlap_chars": 210,
          "overlap_percentage": 34.7682119205298
        }
      ],
      "primary_page": 13,
      "char_count": 604,
      "word_count": 94,
      "start_pos": 74539,
      "end_pos": 75143,
      "chunk_index": 151,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_152",
      "text": "e 11  :  Issue 12  :  December 2022\nClinical practice recommendations\nNo.\nRecommendations\nGrade\n2.3.1\nThe detailed physical activity evaluation should include \nan assessment of dedicated physical exercise, domestic, \nwork‑related, leisure‑related, transport‑related and \nsedentary activities (screen and sitting time). \nI\nB\n2.3.2\nMadras Diabetes Research Foundation‑ Physical \nActivity Questionnaire (MPAQ) should be used for the \nevaluation of physical activity, if feasible. Alternatively, a \nshort validated questionnaire can be used.*\nII\nB/C\n2.3.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 550,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 14,
      "char_count": 550,
      "word_count": 72,
      "start_pos": 75043,
      "end_pos": 75593,
      "chunk_index": 152,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_153",
      "text": "cal activity, if feasible. Alternatively, a \nshort validated questionnaire can be used.*\nII\nB/C\n2.3.3\nEvaluation of the adequacy of physical exercise should \nbe done by assessing: type of exercise (stretching/\nstrengthening/aerobics/balance), intensity (light/\nmoderate/vigorous), frequency (number of days per \nweek) and duration (number of minutes per day).\nIV\nB\n2.3.4\nSpecial attention should be given to assess the number \nof sedentary hours (especially, screen and sitting time) \nspent during the day.\nIV\nA\n2.3.5\nMidlife women should be encouraged to discuss the \nbarriers faced by them in maintaining an active lifestyle.\nIV\nA\n*Refer to Annexure 2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 654,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 14,
      "char_count": 654,
      "word_count": 98,
      "start_pos": 75493,
      "end_pos": 76147,
      "chunk_index": 153,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_154",
      "text": "o discuss the \nbarriers faced by them in maintaining an active lifestyle.\nIV\nA\n*Refer to Annexure 2.\nDiscussion\nPhysical activity assessment should be made a standard step in \nroutine care to design and promote strategies to maintain an active \nlifestyle.[120] The recommendations on baseline assessment of \nphysical activity status in midlife women are derived from lifestyle \nmodification RCTs aiming at achieving weight loss. The two \nmethods identified for physical activity assessment are objective \n(activity monitors: accelerometer, pedometer) and subjective \nmethods (questionnaires and activity history).",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 613,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 14,
      "char_count": 613,
      "word_count": 85,
      "start_pos": 76047,
      "end_pos": 76660,
      "chunk_index": 154,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_155",
      "text": "y monitors: accelerometer, pedometer) and subjective \nmethods (questionnaires and activity history). In public health \nand clinical settings, subjective methods including self-reported \nPA questionnaires, daily activity logs and activity history schedules \nare commonly used to assess the level of daily activities. There is \nevidence that comprehensive assessment of daily activities across \ndomains including physical activity, household chores, work, \ntransport and sedentary activities is crucial to assess the total daily \ncaloric expenditure.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 548,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 14,
      "char_count": 548,
      "word_count": 70,
      "start_pos": 76560,
      "end_pos": 77108,
      "chunk_index": 155,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_156",
      "text": "work, \ntransport and sedentary activities is crucial to assess the total daily \ncaloric expenditure.[80] Experts believed that healthcare practitioners \nshould consider the feasibility of the assessment approach before \nincluding it in daily clinical practice. Based on resource availability, the \nassessment can be done using three possible methods of assessment: \nMPAQ, comprehensive questionnaire and/or detailed activity \nhistory. It is important to integrate the physical activity assessment \ninto clinical practice.[121] If the application of the questionnaires is \nnot feasible, some important points of consideration while taking \nactivity history in midlife women are presented in [Table 2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 699,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 14,
      "char_count": 699,
      "word_count": 94,
      "start_pos": 77008,
      "end_pos": 77707,
      "chunk_index": 156,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_157",
      "text": "t points of consideration while taking \nactivity history in midlife women are presented in [Table 2.3.1].\nConsidering the effect of dedicated activity in maintaining \ncardiometabolic, bone and cognitive health in midlife women, a \ndetailed investigation focusing on the type of exercise (stretching/ \nstrengthening/aerobics/balance), frequency of participation \n(number of days in a week) and duration of involvement (in \nminutes) is also recommended (as presented in Figure 2.3.1). \nExperts suggested that the participation of midlife women in \nhousehold chores might be limited due to the shifting of the \nhousehold-related responsibilities to younger women.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 660,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 14,
      "char_count": 660,
      "word_count": 91,
      "start_pos": 77607,
      "end_pos": 78267,
      "chunk_index": 157,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_158",
      "text": "es might be limited due to the shifting of the \nhousehold-related responsibilities to younger women. Hence, it is \nimportant to assess the daily sitting and screen time as two main \nindicators of sedentary behaviours in this group of women.[122]\nThe application of objective methods of physical activity \nassessment such as wearable activity monitors (WAM) are more \ncommonly used for self-monitoring of daily activity status. A \nnumber of technology-driven and consumer-oriented WAMs \n(e.g. Fitbit) and mobile applications are available for assessment \nof the number of steps taken per day. However, it is challenging \nfor these methods to assess the intensity of physical activity.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 683,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 14,
      "char_count": 683,
      "word_count": 102,
      "start_pos": 78167,
      "end_pos": 78850,
      "chunk_index": 158,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_159",
      "text": "per day. However, it is challenging \nfor these methods to assess the intensity of physical activity.[123] \nThe major limitation of this method is that it cannot assess \nphysical activity compliance in accordance with the international \nactivity guidelines of moderate-intensity physical activity.[121]\nExperts believed that assessment of barriers faced in managing \ndaily physical activity can help practitioners to devise a \ncustomised women-centric activity plan. A comprehensive tool \nfor assessment of daily physical activity and barriers associated \nwith maintaining daily activities in Indian midlife women is given \nin Annexure 4.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 637,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 14,
      "char_count": 637,
      "word_count": 88,
      "start_pos": 78750,
      "end_pos": 79387,
      "chunk_index": 159,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_160",
      "text": "riers associated \nwith maintaining daily activities in Indian midlife women is given \nin Annexure 4.\nThere is limited literature on comprehensive and practical tools that \ncan be integrated into the clinical workflow with a limited burden \non healthcare practitioners and patients. In current literature, the \ntools only account for the assessment of aerobic activity. As per \nthe international recommendations for advising comprehensive \nphysical activity, muscle strengthening and flexibility should be \nincorporated twice a week.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 532,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 14,
      "char_count": 532,
      "word_count": 74,
      "start_pos": 79287,
      "end_pos": 79819,
      "chunk_index": 160,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_161",
      "text": "nsive \nphysical activity, muscle strengthening and flexibility should be \nincorporated twice a week. Clinicians should include questions \nsuch as ‘How many times in a week do you engage in muscle-\nstrengthening exercises such as bodyweight resistance?’ and ‘How \nmany times do you participate in flexibility exercises such as \nstretching and yoga?’ in their routine assessment schedule.\nTable 2.3.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 397,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 14,
      "char_count": 397,
      "word_count": 58,
      "start_pos": 79719,
      "end_pos": 80116,
      "chunk_index": 161,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.653695"
    },
    {
      "id": "chunk_162",
      "text": "lexibility exercises such as \nstretching and yoga?’ in their routine assessment schedule.\nTable 2.3.1: Important points to be considered for \nphysical activity assessment\nDedicated exercise (moderate to vigorous‑intensity activity; such as \nyoga, aerobics, resistance or strength training exercises for 150 min/\nweek):\n•How often do you engage in dedicated physical activity in a week?\n•How much time duration do you dedicate to participate in exercise?\n•What types of exercises do you include in dedicated physical activity?\nHousehold activities (cooking, cleaning, mopping, gardening, child care \netc.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 603,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 14,
      "char_count": 603,
      "word_count": 85,
      "start_pos": 80016,
      "end_pos": 80619,
      "chunk_index": 162,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_163",
      "text": "ted physical activity?\nHousehold activities (cooking, cleaning, mopping, gardening, child care \netc.):\n•How often do you participate in household chores in a week?\n•What household chores do you usually do on a regular day?\n•How much time do you spend doing household chores in a day?\nOccupation‑related activities (manual tasks, sitting task, walking, \nworking on a laptop, carrying or lifting objects):\n•How many hours in a day do you usually spend doing sedentary \nwork‑related activities (sitting and screen time)?\nTransport‑related activities (self‑driving, cycling and walking from one \nplace to",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 14,
      "char_count": 600,
      "word_count": 89,
      "start_pos": 80519,
      "end_pos": 81119,
      "chunk_index": 163,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_164",
      "text": "and screen time)?\nTransport‑related activities (self‑driving, cycling and walking from one \nplace to another):\n•What kind of transport do you usually opt for while travelling from \none place to another?\n•How much time do you usually spend travelling?\nLeisure time activities (discretional or recreational activities including \nhobbies, walking, gardening):\n•What type of activities do you usually do in your free time?\n•How much time do you usually spend on leisure activities?\nSedentary habits (includes such as sitting, reclining or lying posture, \nwatching TV, playing video games, or using the computer):\n•How much is your daily screen and sitting time?\n\nRanjan, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 657,
          "overlap_percentage": 97.6225854383358
        },
        {
          "page_number": 15,
          "overlap_chars": 14,
          "overlap_percentage": 2.080237741456166
        }
      ],
      "primary_page": 14,
      "char_count": 673,
      "word_count": 102,
      "start_pos": 81019,
      "end_pos": 81692,
      "chunk_index": 164,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_165",
      "text": "ideo games, or using the computer):\n•How much is your daily screen and sitting time?\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\n2.4: How psychological and behavioural health should \nbe evaluated in midlife women being engaged in the \nmanagement of overweight and obesity?\nBackground\nThe question is important as psychological and behavioural health \nattributes may have an implication as it drives adherence and \ncompliance amongst midlife women engaged in the management \nof overweight and obesity.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 84,
          "overlap_percentage": 13.930348258706468
        },
        {
          "page_number": 15,
          "overlap_chars": 517,
          "overlap_percentage": 85.7379767827529
        }
      ],
      "primary_page": 14,
      "char_count": 603,
      "word_count": 92,
      "start_pos": 81592,
      "end_pos": 82195,
      "chunk_index": 165,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_166",
      "text": "dherence and \ncompliance amongst midlife women engaged in the management \nof overweight and obesity. The presence of diagnosed psychiatric \ndisorders and clearly discernible psychological attributes may \nlimit the ability of the woman to engage in structured weight-loss \ninterventions. Behaviours such as stress and emotional eating \nmay have an impact on the weight-loss trajectory or an increased \nprobability to regain the initially lost weight. Thus, addressing \npsychological and behavioural health may be an important \nconsideration in women who undergo weight-loss interventions.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 15,
          "overlap_chars": 587,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 15,
      "char_count": 587,
      "word_count": 80,
      "start_pos": 82095,
      "end_pos": 82682,
      "chunk_index": 166,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_167",
      "text": "ehavioural health may be an important \nconsideration in women who undergo weight-loss interventions.\nThe context of psychological and behavioural health holds \nimportance as mental distress in midlife is common, especially \ndepression and anxiety. Personality profile, stress appraisal and \nstress coping mechanisms may also influence adherence and \noutcome of weight management efforts. Moreover, eating \ndisorders such as binge eating and food addiction may impair \nsystematic efforts at weight loss by increasing proclivity towards \nsugar or fat-rich foods, which may lead to weight gain, or may \nimpair weight reduction measures.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 15,
          "overlap_chars": 633,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 15,
      "char_count": 633,
      "word_count": 88,
      "start_pos": 82582,
      "end_pos": 83215,
      "chunk_index": 167,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_168",
      "text": "s \nsugar or fat-rich foods, which may lead to weight gain, or may \nimpair weight reduction measures. Considering the role of \npsychological health in weight management, the assessment of \npsychological and behavioural health is of importance.\nSummary of evidence\nPsychological symptoms such as depression, anxiety, distress, \ndeteriorated sleep and decline in cognitive abilities have \nbeen found to be significantly associated with middle-aged \nwomen.[124-127] Literature has also revealed that these symptoms \nbecome even worse from the perimenopausal to the post-\nmenopausal transition period.[128]Several psychiatric disorders \nare also associated with an increase in weight.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 15,
          "overlap_chars": 679,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 15,
      "char_count": 679,
      "word_count": 92,
      "start_pos": 83115,
      "end_pos": 83794,
      "chunk_index": 168,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_169",
      "text": "ransition period.[128]Several psychiatric disorders \nare also associated with an increase in weight. Common \npsychiatric disorders such as anxiety and depressive disorders \ncan be associated with obesity. A meta-analysis of cross-sectional \nstudies found anxiety disorders to be associated with 1.4 times \nthe risk of obesity (95% confidence intervals of odds ratio \nranging from 1.2 to 1.6).[129] Similarly, another meta-analysis \nsuggested that the presence of depressive disorder was associated \nwith greater odds of developing obesity in later life. Although \ncontrolling for baseline BMI and other factors, it was seen that \nthose with depression had 1.18 times the risk of developing \nobesity.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 15,
          "overlap_chars": 699,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 15,
      "char_count": 699,
      "word_count": 99,
      "start_pos": 83694,
      "end_pos": 84393,
      "chunk_index": 169,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_170",
      "text": "her factors, it was seen that \nthose with depression had 1.18 times the risk of developing \nobesity.[130] Binge eating disorder is also associated with 3 to 6 \ntimes the risk of obesity as compared to those without any eating \ndisorder.[131] Night-eating syndrome is also associated with obesity \nas per observational studies.[131] It has been seen that the use of \npsychotropic medications is also associated with obesity and \nweight gain. Different psychotropic medications have different \npropensities to cause weight gain. Among the antidepressants, \namitriptyline, mirtazapine, and paroxetine are associated with \ngreater weight gain as compared to other medications.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 15,
          "overlap_chars": 672,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 15,
      "char_count": 672,
      "word_count": 97,
      "start_pos": 84293,
      "end_pos": 84965,
      "chunk_index": 170,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_171",
      "text": "rtazapine, and paroxetine are associated with \ngreater weight gain as compared to other medications.[132]\nSimilarly, antipsychotics are associated with weight gain, with \nclozapine and olanzapine being associated with the highest risk \nof weight gain.[133]\nPsychological factors and psychiatric issues can have an \nimpact on weight loss management, affecting the outcome of \nindividuals undergoing weight-loss interventions. It has been \nseen that baseline mental health correlates with weight change \nin family physician-led interventions for weight management.[134]\nAnother study found that women with significant weight loss \n(more than 10%) were more likely to have lower depression at \nbaseline.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 15,
          "overlap_chars": 700,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 15,
      "char_count": 700,
      "word_count": 95,
      "start_pos": 84865,
      "end_pos": 85565,
      "chunk_index": 171,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_172",
      "text": "ith significant weight loss \n(more than 10%) were more likely to have lower depression at \nbaseline.[135] Similarly, other studies have found psychological \nissues to be predictors of impaired outcomes of weight-loss \ninterventions.[136,137] Depression is common among individuals \nwith obesity and RCTs have addressed comorbid depression \nand obesity (RAINBOW trial and the Be Active Trial).[138,139] \nFurthermore, certain weight management interventions \nhave addressed psychological issues as a component of their \noverall strategy.[137,140] Thus, psychological issues are a relevant \nconsideration for weight management.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 15,
          "overlap_chars": 624,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 15,
      "char_count": 624,
      "word_count": 80,
      "start_pos": 85465,
      "end_pos": 86089,
      "chunk_index": 172,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_173",
      "text": "l strategy.[137,140] Thus, psychological issues are a relevant \nconsideration for weight management.\nThe literature search resulted in 22 tools to evaluate psychological \nand behavioural health in midlife women engaged in managing \ntheir weight. Several tools with good psychometric properties are \navailable to assess these psychological and behavioural changes. \nHowever, the limitation in using these tools is that they need \nto be administered by trained psychologists or mental health \nprofessionals. Therefore, it is necessary to identify the tools which \nare validated and can be self -administered.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 15,
          "overlap_chars": 606,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 15,
      "char_count": 606,
      "word_count": 85,
      "start_pos": 85989,
      "end_pos": 86595,
      "chunk_index": 173,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_174",
      "text": "Therefore, it is necessary to identify the tools which \nare validated and can be self -administered. The Menopause-\nSpecific Quality of Life (MENQOL) scale, Menopause Rating \nScale (MRS), Women’s Health Questionnaire (WHQ), history \ntaking and self-developed validated questionnaire are some of \nthe tools which assess psychological domains including mood \ndisorders, sleep quality, cognitive impairment and somatic \nsymptoms. Two questionnaires specific to female sexual \nfunctionality were found to be the Female Sexual Distress Scale-\nRevised (FSDS-R) and Female Sexual Function Index (FSFI).",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 15,
          "overlap_chars": 595,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 15,
      "char_count": 595,
      "word_count": 81,
      "start_pos": 86495,
      "end_pos": 87090,
      "chunk_index": 174,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_175",
      "text": "nd to be the Female Sexual Distress Scale-\nRevised (FSDS-R) and Female Sexual Function Index (FSFI).[141]\nThe Attitudes Toward Menopause Scale (ATMS) can be used to \nassess the overall perception towards the menopausal symptoms \nwhich is directly correlated with the quality of life. Evaluating \nthese domains will help us identify the problematic psychological, \nFigure 2.3.1: Key components of physical activity assessment\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nsocial, emotional and behavioural domains and cater to the needs \nof these women in the management of obesity.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 15,
          "overlap_chars": 424,
          "overlap_percentage": 62.17008797653959
        },
        {
          "page_number": 16,
          "overlap_chars": 256,
          "overlap_percentage": 37.5366568914956
        }
      ],
      "primary_page": 15,
      "char_count": 682,
      "word_count": 103,
      "start_pos": 86990,
      "end_pos": 87672,
      "chunk_index": 175,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_176",
      "text": "otional and behavioural domains and cater to the needs \nof these women in the management of obesity.\nClinical practice recommendations\nNo. Recommendations\nGrade\n2.4.1 Assessment should include inquiry into the presence of a \ndiagnosed psychiatric disorder, especially depression, anxiety \nor eating disorder. \nII\nA\n2.4.2 If there is clinical suspicion, DASS‑21 can be used as an \ninitial screening tool for the assessment of depression, \nanxiety and stress.*\nI\nB\n2.4.3 In case a diagnosed psychiatric disorder is present, then the \ncurrent condition of the psychiatric disorder and use of \npsychotropic medications should be asked for by the weight \nmanagement team.\nI\nA\n2.4.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 675,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 16,
      "char_count": 675,
      "word_count": 103,
      "start_pos": 87572,
      "end_pos": 88247,
      "chunk_index": 176,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_177",
      "text": "er and use of \npsychotropic medications should be asked for by the weight \nmanagement team.\nI\nA\n2.4.4 The referral to a mental health professional should be \nconsidered if:\nDietary history reveals abnormal eating practices to cope \nwith stress.\nThere is a sudden lack of motivation for weight reduction.\nThere are persistent interpersonal difficulties with the \nweight management team.\nDASS‑21 score indicates the possibility of depression, \nanxiety or stress.\nThere is a history of diagnosed psychiatric disorders.\nThere is clinical suspicion of a known psychiatric disorder.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 576,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 16,
      "char_count": 576,
      "word_count": 86,
      "start_pos": 88147,
      "end_pos": 88723,
      "chunk_index": 177,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_178",
      "text": "ory of diagnosed psychiatric disorders.\nThere is clinical suspicion of a known psychiatric disorder.\nIV\nA\n*Refer to Annexure 5\nDiscussion\nThe clinical practice recommendations are based upon the \npragmatic assessment of feasibility, along with the clinical \nrelevance of the assessment. We suggest only one aspect of \npsychological and behavioural health should be routinely asked by \nanyone/any team providing intervention for weight management: \nenquiring about the history of psychiatric disorder and the \nmedications being taken for the same. In cases with suspicion, \nthe primary screening tool should be DASS-21 screening \ndepression, anxiety or stress (refer to Annexure 5).",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 681,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 16,
      "char_count": 681,
      "word_count": 98,
      "start_pos": 88623,
      "end_pos": 89304,
      "chunk_index": 178,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_179",
      "text": "ary screening tool should be DASS-21 screening \ndepression, anxiety or stress (refer to Annexure 5). The presence \nof a psychiatric disorder is not a contraindication for weight \nloss management intervention; however, this information can \nprovide insights into a few issues: whether the disorder is likely \nto impair efforts at weight loss (depression can be associated \nwith poor energy, lack of interest and altered eating patterns), \nor whether the psychotropics being used have an impact on the \nweight (antidepressants such as mirtazapine and antipsychotics \nsuch as olanzapine can increase weight).",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 605,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 16,
      "char_count": 605,
      "word_count": 89,
      "start_pos": 89204,
      "end_pos": 89809,
      "chunk_index": 179,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_180",
      "text": "ht (antidepressants such as mirtazapine and antipsychotics \nsuch as olanzapine can increase weight).\nStress eating presents a unique challenge in weight management \nintervention and hence should be evaluated by a mental \nhealth professional. Such an evaluation can facilitate the \nimplementation of alternate stress management techniques that \nmay help to better deal with stress. Similarly, the presence of \nsignificant anxiety or depression may indicate an undiagnosed \npsychiatric illness, sudden lack of motivation for weight \nmanagement may indicate adjustment difficulties or the onset \nof an illness, and persistent/recurrent interpersonal issues may \nindicate personality problems.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 689,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 16,
      "char_count": 689,
      "word_count": 92,
      "start_pos": 89709,
      "end_pos": 90398,
      "chunk_index": 180,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_181",
      "text": "et \nof an illness, and persistent/recurrent interpersonal issues may \nindicate personality problems. All these may be evaluated better \nby a mental health professional.\nGood psychological functioning can help midlife women to \nbetter engage with the interventions for weight loss management. \nHowever, the presence of a psychiatric disorder or significant \npsychological issues may adversely affect the engagement into \nintervention, continued efforts at weight management, and \noverall outcomes of the intervention.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 516,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 16,
      "char_count": 516,
      "word_count": 69,
      "start_pos": 90298,
      "end_pos": 90814,
      "chunk_index": 181,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_182",
      "text": "to \nintervention, continued efforts at weight management, and \noverall outcomes of the intervention. Clinicians and experts \nproviding interventions for weight management in midlife \nwomen need to be sensitised to the need to consider mental \nhealth aspects, which may have an influence on weight gain and \nmay impair the efforts at weight loss. Thus, routinely asking \nfor mental health history can help in appropriate assessment, \nwithout significantly increasing the time/depth of assessment.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 495,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 16,
      "char_count": 495,
      "word_count": 71,
      "start_pos": 90714,
      "end_pos": 91209,
      "chunk_index": 182,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_183",
      "text": "can help in appropriate assessment, \nwithout significantly increasing the time/depth of assessment. \nWhere major issues are identified as above, a more detailed \nassessment by a mental health professional can be done to help \nin ascertaining the mental health problem(s) and for suggesting \nameliorative measures. Such assessment is likely to be required in \na minority of the cases and may help to improve the outcomes \nof the midlife women attempting to lose weight.\n2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 472,
          "overlap_percentage": 100.21231422505308
        }
      ],
      "primary_page": 16,
      "char_count": 471,
      "word_count": 73,
      "start_pos": 91109,
      "end_pos": 91581,
      "chunk_index": 183,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_184",
      "text": "f the cases and may help to improve the outcomes \nof the midlife women attempting to lose weight.\n2.5: What are the important comorbid conditions \n(cardiometabolic and other medical conditions) that \nshould be evaluated before initiating management of \noverweight and obesity?\nBackground\nWeight gain is an important concern among women in their \nmidlife years. In addition to weight gain, midlife women are \npredisposed to cardiometabolic comorbidities and obesity-related \ncomplications.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 488,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 16,
      "char_count": 488,
      "word_count": 69,
      "start_pos": 91481,
      "end_pos": 91969,
      "chunk_index": 184,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_185",
      "text": "midlife women are \npredisposed to cardiometabolic comorbidities and obesity-related \ncomplications.[6,142,143] In the Study of Women’s Health Across \nthe Nation (SWAN) study, the chances of cardiometabolic \ncomorbidities including diabetes, hypertension, dyslipidaemia are \nincreased as women undergo menopausal transition.[144] Other \nobesity-related comorbidities includes non-fatty alcoholic liver \n(NAFLD), sleep apnoea, polycystic ovary syndrome (PCOS), \ninfertility and osteoarthritis.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 492,
          "overlap_percentage": 100.20366598778003
        }
      ],
      "primary_page": 16,
      "char_count": 491,
      "word_count": 54,
      "start_pos": 91869,
      "end_pos": 92361,
      "chunk_index": 185,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_186",
      "text": "lic liver \n(NAFLD), sleep apnoea, polycystic ovary syndrome (PCOS), \ninfertility and osteoarthritis.[145] Studies suggest that midlife-\nspecific factors such as low estrogen deficiency, limited activity, \npoor dietary habits (low protein and calcium intake) and low \nvitamin D levels contribute to conditions such as poor bone \ndensity, reduced muscle mass and strength, which consequently \nlead to osteoporosis and sarcopenia.[146,147] Although there is a \nneed to assess and understand the cumulative role of comorbid \nconditions in weight management, such a comprehensive \napproach is rarely used in healthcare settings.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 623,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 16,
      "char_count": 623,
      "word_count": 86,
      "start_pos": 92261,
      "end_pos": 92884,
      "chunk_index": 186,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_187",
      "text": "nditions in weight management, such a comprehensive \napproach is rarely used in healthcare settings.[148] It becomes \ncrucial to assess the consequence of comorbid conditions on \nachieving significant weight loss. The introduction of timely \nscreening, diagnosis and action for prevention and treatment \nof allied comorbidities will help in improving the overall quality \nof life in later years.\nSummary of evidence\nAcross the literature, weight gain has been associated with \na number of comorbid conditions ranging from metabolic, \nmental, musculoskeletal and other obesity-related disorders.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 594,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 16,
      "char_count": 594,
      "word_count": 82,
      "start_pos": 92784,
      "end_pos": 93378,
      "chunk_index": 187,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_188",
      "text": "bid conditions ranging from metabolic, \nmental, musculoskeletal and other obesity-related disorders. Out \nof 23 studies, nine studies reported a positive correlation of \nclustering of one or more components of metabolic syndrome \n(elevated lipid profile, insulin resistance and high blood pressure, \nand elevated inflammatory markers) with weight gain, total\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nbody fat and central adiposity.[142,149-151] A higher incidence of \ncardiovascular events was observed in six studies among obese \nmenopausal women.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 358,
          "overlap_percentage": 54.74006116207951
        },
        {
          "page_number": 17,
          "overlap_chars": 294,
          "overlap_percentage": 44.95412844036697
        }
      ],
      "primary_page": 16,
      "char_count": 654,
      "word_count": 92,
      "start_pos": 93278,
      "end_pos": 93932,
      "chunk_index": 188,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_189",
      "text": "igher incidence of \ncardiovascular events was observed in six studies among obese \nmenopausal women.[152-154]\nBesides weight gain and fat accumulation, women in midlife are \nalso subjected to declining lean mass, bone health and muscle \nstrength leading to musculoskeletal diseases such as sarcopenia \nand osteoporosis. In addition, factors such as chronological \nageing, post-menopausal status, perceived barriers for exercise \nand limited consumption of calcium-rich foods were also \npositively associated with osteoporosis.[155,156] Studies report a \npositive correlation between central obesity and increased risk of \nfractures especially hip fracture among menopausal women.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 679,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 17,
      "char_count": 679,
      "word_count": 88,
      "start_pos": 93832,
      "end_pos": 94511,
      "chunk_index": 189,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_190",
      "text": "een central obesity and increased risk of \nfractures especially hip fracture among menopausal women.[157]\nClinical practice recommendations\nNo.\nRecommendations\nGrade\n2.5.1 In midlife women, lifestyle intervention should be initiated \nif they have any known cardiometabolic risk factors (such \nas abnormal blood sugar, increased blood pressure, \ndyslipidaemia) or obesity‑related complications (such as \nnon‑alcoholic fatty liver and sleep apnoea).\nI\nA\nDiscussion\nWeight gain during menopausal transition is associated with a \nrange of non-communicable chronic conditions.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 571,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 17,
      "char_count": 571,
      "word_count": 74,
      "start_pos": 94411,
      "end_pos": 94982,
      "chunk_index": 190,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_191",
      "text": "ain during menopausal transition is associated with a \nrange of non-communicable chronic conditions.[2] We identified \nsome important comorbid conditions that are generally \nassociated with obesity in midlife women: metabolic syndrome, \ndiabetes, cardiovascular diseases such as heart attack and stroke, \nosteoporosis, osteoarthritis and sarcopenia.[158,159] It can be \nnoted that multifactorial risk factors specific to midlife such as \nhormonal and physiological changes coupled with unhealthy \nlifestyle habits make these women prone to weight gain and \nconsequently to increased cardiometabolic risk as compared to \nother reproductive phases.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 646,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 17,
      "char_count": 646,
      "word_count": 84,
      "start_pos": 94882,
      "end_pos": 95528,
      "chunk_index": 191,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_192",
      "text": "gain and \nconsequently to increased cardiometabolic risk as compared to \nother reproductive phases.[160] The guidelines for screening of \ncardiovascular risk factors in adults can be referred from the \nAmerican Heart Association Task Force on Clinical Practice \nGuidelines available from [URL]\ndoi/10.1161/CIR.0000000000000678.[161]\nApart from cardiovascular diseases, women suffer from sarcopenic \nobesity marked by a reduction in muscle mass coupled with an \nincrease in fat mass leading to reduced physical performance.[162] \nPoor bone mass and decreased bone mineral density also contribute \nto compromised mobility and physical functionality interfering \nwith daily life activities.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 688,
          "overlap_percentage": 100.14556040756915
        }
      ],
      "primary_page": 17,
      "char_count": 687,
      "word_count": 90,
      "start_pos": 95428,
      "end_pos": 96116,
      "chunk_index": 192,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_193",
      "text": "tribute \nto compromised mobility and physical functionality interfering \nwith daily life activities.[147] Factors such as consumption of a diet \nlow in protein and calcium, long-term physical inactivity and low \nexposure to sunlight are some factors related to musculoskeletal \nconditions.[163,164]According to the Asian Working Group for \nSarcopenia (AWGS) Criteria, if feasible, bioelectric impedance \ncan be used for assessing muscle strength and muscle mass. In \naddition, a detailed history of fractures, dietary habits, physical \nactivity level, and alcohol consumption should also be taken.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 597,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 17,
      "char_count": 597,
      "word_count": 81,
      "start_pos": 96016,
      "end_pos": 96613,
      "chunk_index": 193,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_194",
      "text": "f fractures, dietary habits, physical \nactivity level, and alcohol consumption should also be taken. The \nconsensus on diagnosis and management of sarcopenia in adults \nas per the AWGS working group is available at [URL]\nncbi.nlm.nih.gov/32033882/.[163]\nIn a resource-rich setting, bone health can be assessed using \na Dual-energy X-ray machine (DXA) or vertebral imaging.[105] \nFurthermore, the clinical practice guidelines on screening and \nmanagement of osteoporosis in midlife women are available at \n[URL]\n2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 513,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 17,
      "char_count": 513,
      "word_count": 72,
      "start_pos": 96513,
      "end_pos": 97026,
      "chunk_index": 194,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_195",
      "text": "guidelines on screening and \nmanagement of osteoporosis in midlife women are available at \n[URL]\n2.6: How should menopause-related symptoms be \nevaluated in midlife women being engaged in the \nmanagement of overweight and obesity?\nBackground\nMenopause is a transition from a reproductive to a non-\nreproductive phase marked by the emergence of specific \nsymptoms. The changes in menstrual cyclicity as a symptom is \na clinical marker of the onset of the menopause transition at \nthe later stages of the reproductive cycle.[165]The menopausal \nsymptoms can be categorised as physical, psychological, \nvasomotor, genitourinary, and sexual symptoms.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 647,
          "overlap_percentage": 100.15479876160991
        }
      ],
      "primary_page": 17,
      "char_count": 646,
      "word_count": 93,
      "start_pos": 96926,
      "end_pos": 97573,
      "chunk_index": 195,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_196",
      "text": "ptoms can be categorised as physical, psychological, \nvasomotor, genitourinary, and sexual symptoms. There can be \nvariation in the type, frequency, and severity of menopausal \nsymptoms experienced by midlife women. Vasomotor symptoms \nare considered as primary symptoms of menopause causing \nhot and cold sweats, especially in the upper body.[164] Somatic \nsymptoms include musculoskeletal pains, which are associated \nwith the menopausal transition status. Often, musculoskeletal \npain is associated with BMI, fatigue, sleep disturbance, mood \ndisorder, anxiety and stress.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 575,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 17,
      "char_count": 575,
      "word_count": 76,
      "start_pos": 97473,
      "end_pos": 98048,
      "chunk_index": 196,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_197",
      "text": "eletal \npain is associated with BMI, fatigue, sleep disturbance, mood \ndisorder, anxiety and stress.[166] Further, the biological decline in \novarian function is also associated with psychological distress \nleading to episodes of mood disturbances, irritability, anxiety, \ndepression and poor sleep, especially during the menopausal \ntransition.[165,167]Both vasomotor symptoms and psychological \ndistress lead to poor sleep quality in menopausal women.[168]\nAcross the literature, menopausal symptoms have been associated \nwith lifestyle-related practices in a way that can promote \noverweight and obesity in midlife women.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 624,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 17,
      "char_count": 624,
      "word_count": 80,
      "start_pos": 97948,
      "end_pos": 98572,
      "chunk_index": 197,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_198",
      "text": "with lifestyle-related practices in a way that can promote \noverweight and obesity in midlife women. Women with higher \ntotal menopausal symptom severity scores are known to have a \nhigher caloric intake, especially from HFSS foods. It has been \nobserved that midlife women having joint issues have limited \nparticipation in physical activity leading to weight gain over \ntime.[169] Similarly, women reporting higher vasomotor symptom \nseverity often report greater sleep disturbances and emotional \nvolatility.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 511,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 17,
      "char_count": 511,
      "word_count": 72,
      "start_pos": 98472,
      "end_pos": 98983,
      "chunk_index": 198,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_199",
      "text": "igher vasomotor symptom \nseverity often report greater sleep disturbances and emotional \nvolatility.[170] Considering the association between menopausal \nsymptom severity with the key lifestyle practices associated with \nweight gain in menopausal women, an assessment of menopausal \nsymptom severity should be undertaken by clinicians, especially in \nsymptomatic women. The assessment should be done objectively \nto classify menopausal women into mild, moderate and severe \ncategories.[171]\nSummary of evidence\nAcross the literature, a total of seven questionnaires assessing \nthe menopausal-related symptoms in middle-aged women were \nidentified.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 647,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 17,
      "char_count": 647,
      "word_count": 82,
      "start_pos": 98883,
      "end_pos": 99530,
      "chunk_index": 199,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_200",
      "text": "ven questionnaires assessing \nthe menopausal-related symptoms in middle-aged women were \nidentified. The identified questionnaires are condition-specific \nquestionnaires that assess symptoms experienced by middle-aged \nwomen undergoing menopausal transition. All the questionnaires \ncan be self-administered to examine menopausal symptoms. \nFive questionnaires measured menopause-specific symptoms\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nincluding vasomotor, physical, psychological, urogenital, and \nsexual symptoms.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 397,
          "overlap_percentage": 63.62179487179487
        },
        {
          "page_number": 18,
          "overlap_chars": 225,
          "overlap_percentage": 36.05769230769231
        }
      ],
      "primary_page": 17,
      "char_count": 624,
      "word_count": 74,
      "start_pos": 99430,
      "end_pos": 100054,
      "chunk_index": 200,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_201",
      "text": "12  :  December 2022\nincluding vasomotor, physical, psychological, urogenital, and \nsexual symptoms. Other symptoms such as cognitive impairment, \nbody image issues, sleep disorder, perceived loss of control, \nand numbness were assessed in three questionnaires: Women’s \nHealth Questionnaire (36-items), Menopause Symptoms \nSeverity Inventory (38-items), and Self-developed validated \nquestionnaire (41-items).[35,172,173] On the basis of severity, the \nsymptoms were rated on a Likert-scale response scale ranging \nfrom not severe (lowest score) to maximum severity (highest \nscores).",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 585,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 18,
      "char_count": 585,
      "word_count": 73,
      "start_pos": 99954,
      "end_pos": 100539,
      "chunk_index": 201,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_202",
      "text": "-scale response scale ranging \nfrom not severe (lowest score) to maximum severity (highest \nscores). Questionnaires such as Menopause Specific Quality of \nLife calculated domain-wise scores, whereas Menopause Rating \nScale, Greene Climacteric scale and Kupperman’s index calculated \ntotal scores for all the menopausal symptoms.[174-177] The higher \nscores indicate severe menopausal symptoms and lower scores \nindicate mild menopausal symptoms.\nThese questionnaires are concise, valid and reliable measures for \nassessment of menopause symptoms severity in women. There \nis a lack of menopause symptom assessment scales specific to \nmiddle-aged Indian women.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 659,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 18,
      "char_count": 659,
      "word_count": 87,
      "start_pos": 100439,
      "end_pos": 101098,
      "chunk_index": 202,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_203",
      "text": "omen. There \nis a lack of menopause symptom assessment scales specific to \nmiddle-aged Indian women. There is a need for the development \nand validation of simple, practical, and feasible tools to assess \nmenopausal symptom severity in Indian women.\nClinical practice recommendations\nNo.\nRecommendations\nGrade\n2.6.1 Menopause Rating Scale (MRS) may be used for evaluation of \nmenopausal symptoms which includes physical, psychological, \nvasomotor, genitourinary and sexual domains.*\nI\nB\n2.6.2 The impact of menopausal symptoms severity on \nweight‑related behaviours (diet, physical activity and sleep) \nshould also be assessed.\nIV\nA\n*Refer to Annexure 6.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 654,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 18,
      "char_count": 654,
      "word_count": 93,
      "start_pos": 100998,
      "end_pos": 101652,
      "chunk_index": 203,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_204",
      "text": "behaviours (diet, physical activity and sleep) \nshould also be assessed.\nIV\nA\n*Refer to Annexure 6.\nDiscussion\nMenopause is retrospectively diagnosed considering menstrual \nirregularities. The assessment of menopause using biochemical \nparameter follicle-stimulating hormone (FSH) is initiated in \nspecial cases or during infertility.[165] Further, the severity of \nmenopausal symptoms can be assessed using a number of \ndeveloped and validated questionnaires. Often, these scales \nassess menopause symptom severity in relation to the overall life \nquality in midlife women.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 575,
          "overlap_percentage": 100.17421602787458
        }
      ],
      "primary_page": 18,
      "char_count": 574,
      "word_count": 76,
      "start_pos": 101552,
      "end_pos": 102127,
      "chunk_index": 204,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_205",
      "text": "scales \nassess menopause symptom severity in relation to the overall life \nquality in midlife women. The commonly used scales includes \nMenopause Rating Scale (MRS), Greene’s Climacteric Scale, \nand Menopause Specific Quality of Life (MENQOL).[172,174,175]\nAccording to the Practice Guideline on Menopause, MRS is the \nrecommended self-administered tool for screening of the severity \nof the menopausal symptoms in midlife Indian women (refer \nto Annexure 6).[11] The MRS is also translated and validated in \nHindi language for easier administration in Indian women.[178] \nHowever, the integration of MRS in clinical practice for the \nmanagement of weight in midlife women is still lacking.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 690,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 18,
      "char_count": 690,
      "word_count": 99,
      "start_pos": 102027,
      "end_pos": 102717,
      "chunk_index": 205,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_206",
      "text": "gration of MRS in clinical practice for the \nmanagement of weight in midlife women is still lacking. An \nadapted version of MRS in Indian women is also given as a part \nof a comprehensive assessment tool for an overall assessment \nof menopausal symptoms and lifestyle-related factors for \nappropriate weight management in Indian women (shown in \nAnnexure 4). According to the WHO, the categorization of the \nmenopause symptom severity in midlife women is decided on \nthe percentage of menopausal symptoms and can range from \nno problem (0-4%) to complete problem (95–100%).\nSection III: Management of overweight and obesity\n3.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 626,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 18,
      "char_count": 626,
      "word_count": 98,
      "start_pos": 102617,
      "end_pos": 103243,
      "chunk_index": 206,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_207",
      "text": "o problem (0-4%) to complete problem (95–100%).\nSection III: Management of overweight and obesity\n3.1: How stepwise weight loss goals should be set for \nmidlife women being engaged in the management of \noverweight and obesity?\nBackground\nGoal setting is a common behaviour change strategy that is \nconsidered a fundamental component of successful weight loss \nintervention.[179] Weight loss goals should be patient-centric, \nrealistic, practical and mutually set with the help of a healthcare \nprovider. Generally, a weight loss goal is set in terms of absolute \nor percentage reduction from baseline weight at the end of the \nintervention.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 640,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 18,
      "char_count": 640,
      "word_count": 96,
      "start_pos": 103143,
      "end_pos": 103783,
      "chunk_index": 207,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_208",
      "text": "in terms of absolute \nor percentage reduction from baseline weight at the end of the \nintervention.[78] In addition to weight loss, incorporation of \ncorrective lifestyle habits and improvement in cardiometabolic, \nmenopausal and overall health should also be considered while \nsetting weight loss goals in midlife women. The S.T.A.R.T \ncriteria (Specificity, Timing, Acquisition, Rewards and feedback, \nand Tools) is considered useful for promoting health behaviour \nchange to set goals that are specific, timely, self-determined, and \nsupported by self-monitoring tools, feedback and rewards.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 595,
          "overlap_percentage": 100.16835016835017
        }
      ],
      "primary_page": 18,
      "char_count": 594,
      "word_count": 81,
      "start_pos": 103683,
      "end_pos": 104278,
      "chunk_index": 208,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_209",
      "text": "re specific, timely, self-determined, and \nsupported by self-monitoring tools, feedback and rewards.[179] \nThis can help in directing the midlife woman’s attention and \nefforts in defining relevant strategies for accomplishing her future \nweight and health goals.[180] However, the nature of weight loss \ngoals for initiating lifestyle modification intervention and its \nassociation with achieving therapeutic weight loss has not been \nsystematically explored. Hence, we undertook this question of \nclinical relevance to understand the type of weight loss and health \ngoals that should be set for midlife women and their association \nwith achieving weight loss success.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 669,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 18,
      "char_count": 669,
      "word_count": 93,
      "start_pos": 104178,
      "end_pos": 104847,
      "chunk_index": 209,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_210",
      "text": "oals that should be set for midlife women and their association \nwith achieving weight loss success.\nSummary of evidence\nAcross trials, weight loss goals were defined in terms of lost \nweight, improvement in cardiometabolic risk factors and \nmenopausal symptom severity. The American Heart Association \n(AHA) guidelines suggested that a modest weight loss goal of \n5–10% should be initially targeted for individuals seeking weight \nloss treatment. A modest weight loss of 5–10% was related to \nimprovements in cardiometabolic risk factors and other obesity-\nrelated disorders. Most RCTs also aimed at reducing 5–10% in \na duration of 6–12 months.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 646,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 18,
      "char_count": 646,
      "word_count": 97,
      "start_pos": 104747,
      "end_pos": 105393,
      "chunk_index": 210,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_211",
      "text": "er obesity-\nrelated disorders. Most RCTs also aimed at reducing 5–10% in \na duration of 6–12 months.[53,76,90] Similar consistent findings \nwere reported in four systematic reviews where the achievement \nof 5–10% weight loss was associated with improvement in \nhypertension, hyperlipidaemia, and blood glucose fasting.[181-183]\nAny further improvement in weight correlated with graded \nimprovement in obesity-related diseases such as non-fatty liver \ndisease, and sleep apnoea. Weight loss was also associated with \nimprovement in polycystic ovary disease, regularity of menstrual \ncycle and fertility in women.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 611,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 18,
      "char_count": 611,
      "word_count": 83,
      "start_pos": 105293,
      "end_pos": 105904,
      "chunk_index": 211,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_212",
      "text": "ith \nimprovement in polycystic ovary disease, regularity of menstrual \ncycle and fertility in women.[182]A limited number of experimental \nstudies reported that a weight loss of 10% can be associated with a \nreduction in menopause-related hot flushes.[46,184] The improvement \nin other comorbidities such as depression, mobility, sexual \ndysfunction, and urinary stress incontinence and overall quality of\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nlife was also associated with a reduction of 5–10% body weight.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 405,
          "overlap_percentage": 65.74675324675324
        },
        {
          "page_number": 19,
          "overlap_chars": 209,
          "overlap_percentage": 33.92857142857143
        }
      ],
      "primary_page": 18,
      "char_count": 616,
      "word_count": 90,
      "start_pos": 105804,
      "end_pos": 106420,
      "chunk_index": 212,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_213",
      "text": "me 11  :  Issue 12  :  December 2022\nlife was also associated with a reduction of 5–10% body weight. \nThe further reduction of body weight correlates with a graded \nimprovement in cardiometabolic and obesity-related disease status.\nIn addition to quantitative weight loss goals, attention should \nbe given to setting realistic and patient-centric goals.[78,182] The \nweight loss goals should also be discussed with the woman in \nthe context of any competing priorities in the woman’s everyday \nlife that might hinder the achievement of the set goal. The \nwoman’s readiness to achieve the weight and health goal can \nalso be ascertained before initiating a comprehensive lifestyle \nmanagement program.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 700,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 19,
      "char_count": 700,
      "word_count": 106,
      "start_pos": 106320,
      "end_pos": 107020,
      "chunk_index": 213,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_214",
      "text": "ealth goal can \nalso be ascertained before initiating a comprehensive lifestyle \nmanagement program.[78]\nClinical practice recommendations\nNo.\nRecommendations\nGrade\n3.1.1  Healthcare providers should assess the readiness to \nengage in weight loss attempts by changing the current \ndiet and physical activity using behavioural modification.\nIV\nA\n3.1.2  Realistic and sustainable patient‑centric weight loss goals \nshould be established after a detailed discussion with the \nmidlife woman.\nIf feasible, family members should be involved and \nsimilar health goals should be planned for them. \nIV\nA\n3.1.3\nOverweight and obese women should be advised to \nreduce body weight to a normal BMI (18.5‑22.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 694,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 19,
      "char_count": 694,
      "word_count": 99,
      "start_pos": 106920,
      "end_pos": 107614,
      "chunk_index": 214,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_215",
      "text": "3.1.3\nOverweight and obese women should be advised to \nreduce body weight to a normal BMI (18.5‑22.5 kg/m2).\nI\nA\n3.1.4  A step‑wise body‑weight loss goal should be set with a \ntarget weight loss of 0.5 kg per week attaining a weight \nloss goal of 5‑10% of baseline body weight over a period \nof 6 months (clinically significant weight loss).\nI\nA\nDiscussion\nThe recommended weight loss goals for midlife women seeking \nlifestyle modification treatment for weight loss are similar to \nprevious recommendations for the adult population.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 534,
          "overlap_percentage": 100.187617260788
        }
      ],
      "primary_page": 19,
      "char_count": 533,
      "word_count": 87,
      "start_pos": 107514,
      "end_pos": 108048,
      "chunk_index": 215,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_216",
      "text": "ication treatment for weight loss are similar to \nprevious recommendations for the adult population.[78,86] Initially, \nthe readiness to change existing lifestyle-related behaviours, \nespecially dietary and physical activity behaviours to lose weight \nshould be assessed in midlife women. The transtheoretical model \n(TTM) of health behaviour change defines the ‘readiness of \nchange’ across five stages: pre-contemplation, contemplation, \npreparation, action, and maintenance (as shown in Figure 3.1.1). \nGenerally, the proportion of population at-risk is 40% in pre-\ncontemplation, 40% in contemplation and 20% in the action \nstage.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 634,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 19,
      "char_count": 634,
      "word_count": 84,
      "start_pos": 107948,
      "end_pos": 108582,
      "chunk_index": 216,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_217",
      "text": "population at-risk is 40% in pre-\ncontemplation, 40% in contemplation and 20% in the action \nstage.[185]An early understanding of the readiness and motivation \nto change can help clinicians and healthcare professionals in \ndevising customised weight loss and health goals. For example: \nat the precontemplation stage, providing education on the \nconsequences of weight gain in later life can be an optimum \ngoal. At the contemplation stage, setting personal weight and \nhealth goals can be set in detailed discussion with the healthcare \nprovider.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 548,
          "overlap_percentage": 100.18281535648994
        }
      ],
      "primary_page": 19,
      "char_count": 547,
      "word_count": 81,
      "start_pos": 108482,
      "end_pos": 109030,
      "chunk_index": 217,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_218",
      "text": "g personal weight and \nhealth goals can be set in detailed discussion with the healthcare \nprovider. Across the literature, a modest and realistic weight \nloss goal of 5-10% reduction from baseline body weight in 6 \nmonths is recommended as it has significant clinical benefits. \nFor setting sustainable goals, healthcare providers should \neducate women that a target of 0.5-1 kg weight loss per week \nshould be undertaken.[186] Ideally, the weight management efforts \nshould be continued till the midlife woman has achieved the \nideal weight status. Furthermore, healthcare providers should \ndiscuss lifelong weight management efforts for the sustenance \nof appropriate weight in the long term.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 695,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 19,
      "char_count": 695,
      "word_count": 103,
      "start_pos": 108930,
      "end_pos": 109625,
      "chunk_index": 218,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_219",
      "text": "scuss lifelong weight management efforts for the sustenance \nof appropriate weight in the long term.[86] It should be noted \nthat goal setting is an important component of the behavioural \nstrategy for weight management. Currently, there is a lack \nof well-designed interventions assessing goal pursuits (goal \nsetting and goal striving) amongst adults participating in weight \nloss programs.[187] Furthermore, across weight loss literature, goal \nsetting is considered as an initial step rather than an ongoing \nprocess.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 521,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 19,
      "char_count": 521,
      "word_count": 74,
      "start_pos": 109525,
      "end_pos": 110046,
      "chunk_index": 219,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_220",
      "text": "ght loss literature, goal \nsetting is considered as an initial step rather than an ongoing \nprocess. Goal setting as a process includes finalizing weight loss \ngoals, and reflecting on and receiving feedback from healthcare \nproviders to successfully achieve the initially set goals during the \nlifestyle modification intervention. In addition, customization of \nweight loss plans to manage the barriers faced by the participant \nduring the intervention should be incorporated as a part of \ngoal striving.[179,188]The incorporation of goal pursuit can help \nto achieve and sustain therapeutic weight loss.\n3.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 608,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 19,
      "char_count": 608,
      "word_count": 88,
      "start_pos": 109946,
      "end_pos": 110554,
      "chunk_index": 220,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_221",
      "text": "9,188]The incorporation of goal pursuit can help \nto achieve and sustain therapeutic weight loss.\n3.2: What type of dietary recommendations should be \nadvised for improving weight loss, anthropometric and \nmetabolic health outcomes?\nBackground\nDietary modification is the cornerstone of weight management. \nDietary modification aims at reducing the caloric intake for \ncreating a negative calorie balance to produce weight loss.[189] Other \ndietary recommendations include having a balanced diet, adequate \nprotein intake, consumption of fruits and vegetables and limiting \nconsumption of calorie-dense foods with a high proportion of \nfat, salt, and sugar to improve the quality of the meals.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 693,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 19,
      "char_count": 693,
      "word_count": 97,
      "start_pos": 110454,
      "end_pos": 111147,
      "chunk_index": 221,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_222",
      "text": "rie-dense foods with a high proportion of \nfat, salt, and sugar to improve the quality of the meals.[190] Further, \nimprovements in the meal pattern in terms of number, type, \nfrequency and portions size of meals is also recommended.[191] \nAcross the literature, different dietary modification techniques \nhave been recommended for achieving weight loss, improving the \nFigure 3.1.1: Trans-theoretical model (TTM)\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\ncardiometabolic profile and menopausal health in midlife women.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 413,
          "overlap_percentage": 66.18589743589743
        },
        {
          "page_number": 20,
          "overlap_chars": 209,
          "overlap_percentage": 33.493589743589745
        }
      ],
      "primary_page": 19,
      "char_count": 624,
      "word_count": 91,
      "start_pos": 111047,
      "end_pos": 111671,
      "chunk_index": 222,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_223",
      "text": "me 11  :  Issue 12  :  December 2022\ncardiometabolic profile and menopausal health in midlife women. \nThe understanding of a comprehensive dietary intervention that \ncan prove effective in managing weight, metabolic and menopausal \nhealth in midlife women is still lacking. Moreover, the dietary \ninterventions recommended across weight-loss trials can be mostly \nprescribed by trained healthcare professionals such as registered \ndietitians and nutritionists. The availability of trained professionals \nacross healthcare settings in developing countries such as India might \nbe difficult.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 589,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 20,
      "char_count": 589,
      "word_count": 79,
      "start_pos": 111571,
      "end_pos": 112160,
      "chunk_index": 223,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_224",
      "text": "professionals \nacross healthcare settings in developing countries such as India might \nbe difficult. There is a need for simple, practical and technically \nfeasible recommendations that can be prescribed by healthcare \nprofessionals during patient encounters across healthcare settings. \nHence, this clinical question was undertaken to identify effective \ndietary strategies for weight management in midlife Indian women.\nSummary of evidence\nDietary interventions for managing overweight and obesity in \nmidlife women were prescribed for an average duration of 6 \nmonths; ranging from 21 days to 48 months across trials.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 620,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 20,
      "char_count": 620,
      "word_count": 86,
      "start_pos": 112060,
      "end_pos": 112680,
      "chunk_index": 224,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_225",
      "text": "re prescribed for an average duration of 6 \nmonths; ranging from 21 days to 48 months across trials.[94,192] \nThe dietary interventions aims to achieve weight loss by creating \na negative calorie balance. In all the dietary interventions, \ncalorie restriction (500 kcal per day) from the baseline intake \nwas prescribed after the estimation of an individual’s energy \nrequirement.[114] Studies also specified the daily energy intake \nranging from 1000–2000 kcal.[76,192] The ad libitum approaches of \nenergy restriction were not prescribed, but lower caloric intake \nwas prescribed by manipulation of macronutrient composition.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 627,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 20,
      "char_count": 627,
      "word_count": 89,
      "start_pos": 112580,
      "end_pos": 113207,
      "chunk_index": 225,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_226",
      "text": "t prescribed, but lower caloric intake \nwas prescribed by manipulation of macronutrient composition. \nA number of dietary approaches including macronutrient \nmanipulation with caloric restriction were recommended: AHA \nstyle diet (fat <30% of total calories, <10% from saturated fat), \nVery Low-Calorie Diet, Low Carbohydrate, Glycemic-Load and \nFat Diet, Mediterranean Diet and High Protein Diet.[78] The \nmost common dietary interventions were based on a calorie-\nrestricted diet with the following macronutrient composition: \ncarbohydrate 50%-60%, fats 30%, and protein 10%-20%. In a \nlow carbohydrate diet, carbohydrate intake ranged from 5-15% \nof the total calories.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 672,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 20,
      "char_count": 672,
      "word_count": 91,
      "start_pos": 113107,
      "end_pos": 113779,
      "chunk_index": 226,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_227",
      "text": "10%-20%. In a \nlow carbohydrate diet, carbohydrate intake ranged from 5-15% \nof the total calories.[66,83] The prescription on the incorporation of \nhigh dietary fibre (soluble and insoluble) foods was incorporated \nin four RCTs and one experimental study. A dietary fibre intake \nof 20 to 30 grams per day was prescribed from whole grains, \nnuts, oilseeds, fruits and vegetables. The average protein intake \nof 10-20% was prescribed in most diets with the focus on \nthe consumption of at least one serving of lean meat sources \nin non-vegetarian diets.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 554,
          "overlap_percentage": 100.18083182640144
        }
      ],
      "primary_page": 20,
      "char_count": 553,
      "word_count": 87,
      "start_pos": 113679,
      "end_pos": 114233,
      "chunk_index": 227,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_228",
      "text": "the focus on \nthe consumption of at least one serving of lean meat sources \nin non-vegetarian diets.[193] Low Calorie, High Protein diet \n(25-30% of energy) was prescribed in three studies with the \nfocus on the consumption of lean meats, non-fat dairy, nuts \nand pulses.[83,192,194]Low-fat diets are defined as diets with less \nthan 30% of total energy intake from fats were prescribed in \nsix trials.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 402,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 20,
      "char_count": 402,
      "word_count": 64,
      "start_pos": 114133,
      "end_pos": 114535,
      "chunk_index": 228,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_229",
      "text": "efined as diets with less \nthan 30% of total energy intake from fats were prescribed in \nsix trials. In addition, two studies reported Mediterranean style \ndiet prescribing daily consumption limit of different fatty acids \nbased on the proportion of total fat intake: saturated fats (<7%), \npolyunsaturated fatty acids (PUFA) (9%), monounsaturated fatty \nacids (MUFA) (20%), and cholesterol intake < 1% per day.[77,80] \nOther dietary prescriptions were based on recommended country-\nspecific healthy dietary patterns (Dietary Recommendations for \nAmericans) and landmark weight loss trials (Diabetes Prevention \nProgram and Look AHEAD) focusing on improving the overall \ndietary quality.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 687,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 20,
      "char_count": 687,
      "word_count": 96,
      "start_pos": 114435,
      "end_pos": 115122,
      "chunk_index": 229,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_230",
      "text": "ls (Diabetes Prevention \nProgram and Look AHEAD) focusing on improving the overall \ndietary quality.[50,195] These prescriptions were limited to healthy \neating practices such as consumption of lean protein, limited \nfat, salt and sugar (≤10 g) intake and consumption of fruits \nand vegetables. Two trials assessed ways of calorie restriction \nvia intermittent fasting with continuous calorie restriction as an \napproach for the management of weight and other biochemical \nparameters.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 484,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 20,
      "char_count": 484,
      "word_count": 68,
      "start_pos": 115022,
      "end_pos": 115506,
      "chunk_index": 230,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_231",
      "text": "calorie restriction as an \napproach for the management of weight and other biochemical \nparameters.[45,196] Only two studies focused on providing education \non healthy dietary practices such as meal pattern, portion size, \nEatwell plate, emotional eating, reading food labels as strategies for \nmanagement of weight in midlife women.[49,110]In midlife women, \ndietary management included supplementation of phytoestrogen \nfrom soy-based products, omega-3 for essential fatty acid, and \ncalcium and vitamin D for weight management.[75,83,113]\nClinical practice recommendations\nNo.\nRecommendations\nGrade\n3.2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 607,
          "overlap_percentage": 100.16501650165017
        }
      ],
      "primary_page": 20,
      "char_count": 606,
      "word_count": 78,
      "start_pos": 115406,
      "end_pos": 116013,
      "chunk_index": 231,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_232",
      "text": "D for weight management.[75,83,113]\nClinical practice recommendations\nNo.\nRecommendations\nGrade\n3.2.1\nAn individualised diet plan should be recommended \nconsidering eating preferences, food habits and health \nstatus of the patient.\nI\nA\n3.2.2\nThe meal pattern should be spread throughout the day \npreferably involving three major meals and two snacks.\nII\nA\n3.2.3\nThe daily dietary calorie intake should be based on the \nbaseline caloric intake and level of physical activity of \nthe midlife woman.\nI\nA\n3.2.4\nThe diet plan should incorporate an energy deficit of \n500 kcal per day to achieve a weight loss of 0.5 kg body \nweight per week.\nI\nA\n3.2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 645,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 20,
      "char_count": 645,
      "word_count": 105,
      "start_pos": 115913,
      "end_pos": 116558,
      "chunk_index": 232,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_233",
      "text": "ergy deficit of \n500 kcal per day to achieve a weight loss of 0.5 kg body \nweight per week.\nI\nA\n3.2.5\nRestricted carbohydrate, good quality fat and a high \nprotein diet is recommended for midlife women.\nII\nA\n3.2.6\nWomen should be counselled to consume foods rich in \nprotein, calcium and iron in their daily diet to meet the \nestimated average requirement (EAR).\nI\nA\n3.2.7\nDietary fibre intake of 20‑30 grams per day should be \nprescribed from whole grains, legumes, nuts, oilseeds, \nfruits and vegetables.\nI\nA\n3.2.8\nRestricted consumption of food products high in fat, \nsugar and salt (HFSS) should be emphasised. Salt intake \nshould be limited to <5 g/day.\nI\nA\n3.2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 667,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 20,
      "char_count": 667,
      "word_count": 116,
      "start_pos": 116458,
      "end_pos": 117125,
      "chunk_index": 233,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_234",
      "text": "t, \nsugar and salt (HFSS) should be emphasised. Salt intake \nshould be limited to <5 g/day.\nI\nA\n3.2.9\nDietary intake of foods rich in phytoestrogen from the \nIndian diet should be encouraged. \nII\nC\nDiscussion\nThe dietary recommendations in midlife women are based on \nthe principles of caloric restriction, balanced diet and healthy \neating practices. The caloric restrictions should be individualised \nby accounting for the current dietary and activity habits, \ncomorbidities and previous dieting attempts. A daily caloric \nrestriction of 500–750 kcal is optimum for losing 0.5-1 kg weight \nper week.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 601,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 20,
      "char_count": 601,
      "word_count": 92,
      "start_pos": 117025,
      "end_pos": 117626,
      "chunk_index": 234,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_235",
      "text": "empts. A daily caloric \nrestriction of 500–750 kcal is optimum for losing 0.5-1 kg weight \nper week.[197] Generally, in clinical practice, a hypocaloric balanced \ndiet of around 1000-1200 kcal is prescribed in adult women.[2,194] \nA total of 15-30% caloric restriction with respect to habitual \ncaloric intake is optimum for weight loss. However, clinicians \nshould note that patients often underreport caloric intake and \noverestimate caloric expenditure.\nThe caloric restriction should be translated into optimum \nmacronutrient manipulation. In the current literature, different\n\nRanjan, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 580,
          "overlap_percentage": 97.31543624161074
        },
        {
          "page_number": 21,
          "overlap_chars": 14,
          "overlap_percentage": 2.348993288590604
        }
      ],
      "primary_page": 20,
      "char_count": 596,
      "word_count": 83,
      "start_pos": 117526,
      "end_pos": 118122,
      "chunk_index": 235,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_236",
      "text": "lated into optimum \nmacronutrient manipulation. In the current literature, different\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\ndiets based on acceptable macronutrient distribution range \nare low carbohydrate (45–55%), high protein (10–35%), low \nfat (20–30%) and low glycaemic index diet.[66,83,192] There is \ninconsistent evidence that these diets are beneficial over the \nhypocaloric balanced diet. However, these diets have been shown \nto improve the cardiometabolic risk factors such as dyslipidaemia, \ntype 2 diabetes and blood pressure.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 84,
          "overlap_percentage": 12.982998454404946
        },
        {
          "page_number": 21,
          "overlap_chars": 561,
          "overlap_percentage": 86.70788253477589
        }
      ],
      "primary_page": 20,
      "char_count": 647,
      "word_count": 91,
      "start_pos": 118022,
      "end_pos": 118669,
      "chunk_index": 236,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_237",
      "text": "improve the cardiometabolic risk factors such as dyslipidaemia, \ntype 2 diabetes and blood pressure. In some cases, the total \ncarbohydrates should be restricted (<26% per 2000 kcal caloric \nintake) and complex carbohydrates with a low glycaemic index \nshould be incorporated.[198] The targeted daily fibre intake should \nbe around 30 grams from fruits and vegetables (4-5 servings per \nday), legumes (1-2 servings), nuts and oilseeds (1–2 servings) \nand whole-grain flour. Special attention should be given to \nadequate protein intake as per the estimated average requirement \nfor maintaining optimum muscle and bone health in midlife \nwomen.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 643,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 643,
      "word_count": 94,
      "start_pos": 118569,
      "end_pos": 119212,
      "chunk_index": 237,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_238",
      "text": "the estimated average requirement \nfor maintaining optimum muscle and bone health in midlife \nwomen.[199] A very low-calorie diet (500–800 kcal) might lead to \nmicronutrient deficiency in the long term. These diets should \npreferably be recommended by trained healthcare professionals \nsuch as nutritionists and dietitians.\nHealthcare providers should consider personal and cultural food \nhabits while prescribing any dietary modification. Fixing the meal \npattern can also be helpful in avoiding fasting and feeding cycles \nthroughout the day. For the main meals, these women should \nbe encouraged to adjust the servings of the foods according \nto the ‘EatWell’ plate.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 669,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 669,
      "word_count": 96,
      "start_pos": 119112,
      "end_pos": 119781,
      "chunk_index": 238,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_239",
      "text": "e women should \nbe encouraged to adjust the servings of the foods according \nto the ‘EatWell’ plate.[200]The caloric manipulation should be \nsupplemented with generic advice on healthy eating behaviours. \nSome generic advice can be: limit the consumption of HFSS, \navoid skipping meals, adequate intake of water, decrease the \nportion size, avoid eating out, and manage episodes of emotional \neating.[189]\nIn addition, the consumption of micronutrients should be \nrecommended in accordance with the estimated average \nrequirement (EAR).",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 536,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 536,
      "word_count": 76,
      "start_pos": 119681,
      "end_pos": 120217,
      "chunk_index": 239,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_240",
      "text": "f micronutrients should be \nrecommended in accordance with the estimated average \nrequirement (EAR). The daily intake of iron (29 mg), calcium (1000 \nmg) and other B-complex vitamins should be planned from dietary \nsources available in Indian diets (refer to Annexure 7).[199]The \ndietary sources of iron, calcium and phytoestrogen are presented in \nAnnexure 8. If women are found deficient, supplementations can \nbe recommended as per clinical indications. The detailed clinical \npractice guideline for iron deficiency anaemia in women (age > \n15 years) can be accessed from:[URL]\npdf/programmes/child-health/guidelines/Control-of-Iron-\nDeficiency-Anaemia.pdf.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 661,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 661,
      "word_count": 87,
      "start_pos": 120117,
      "end_pos": 120778,
      "chunk_index": 240,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_241",
      "text": "accessed from:[URL]\npdf/programmes/child-health/guidelines/Control-of-Iron-\nDeficiency-Anaemia.pdf.[201] Considering the practical limitations \nfor the consumption of Vitamin D from natural dietary sources, \nVitamin D supplementations can be recommended in cases of \ndeficiency as per clinical recommendations under the guidance \nof a clinician. The detailed clinical practice recommendations \non the management of micronutrient deficiency (calcium and \nvitamin D) in midlife women are available from [URL]\nncbi.nlm.nih.gov/33281419/.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 535,
          "overlap_percentage": 100.18726591760299
        }
      ],
      "primary_page": 21,
      "char_count": 534,
      "word_count": 61,
      "start_pos": 120678,
      "end_pos": 121213,
      "chunk_index": 241,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_242",
      "text": "iency (calcium and \nvitamin D) in midlife women are available from [URL]\nncbi.nlm.nih.gov/33281419/.[164] Women suffering from severe \nmenopausal symptoms can also be prescribed supplementations \nof phytoestrogen from natural sources, especially soy-based \nproducts.[202]The reinforcement of healthy eating habits during \nintervention is important for the long-term sustenance of weight \nloss.\n3.3: What type of physical activity recommendations should \nbe advised for improving weight loss, anthropometric and \nmetabolic health outcomes?\nBackground\nPhysical activity is defined as all movements that can lead to \ncaloric expenditure.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 634,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 634,
      "word_count": 81,
      "start_pos": 121113,
      "end_pos": 121747,
      "chunk_index": 242,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_243",
      "text": "mes?\nBackground\nPhysical activity is defined as all movements that can lead to \ncaloric expenditure.[203]The caloric expenditure is important \nfor creating an energy deficit required to produce a reduction \nin weight. Generally, women with overweight and obesity are \nrecommended to incorporate exercise in their daily regime to \nincrease the caloric deficit. Exercise is structured and planned \nphysical activity.[204] The midlife women can be suggested different \ntypes of exercises including aerobic exercise for maintaining \ncardiometabolic health, strength training for increasing bone \nand muscle mass and balance exercises for maintaining posture \nand flexibility.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 671,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 671,
      "word_count": 91,
      "start_pos": 121647,
      "end_pos": 122318,
      "chunk_index": 243,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_244",
      "text": "for increasing bone \nand muscle mass and balance exercises for maintaining posture \nand flexibility.[205-207] Healthcare providers should recommend the \ntype, intensity, duration and frequency of exercise in a patient-\ncentric, simple and feasible manner.[208] Further, the activity \nrecommendations should be menopause friendly, i.e. it should \nnot aggravate any menopausal symptoms such as vasomotor \nsymptoms or joint pains. It is important to understand the \neffective combination of exercises that can help in producing \nsignificant weight loss.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 550,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 550,
      "word_count": 75,
      "start_pos": 122218,
      "end_pos": 122768,
      "chunk_index": 244,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_245",
      "text": "erstand the \neffective combination of exercises that can help in producing \nsignificant weight loss. In current literature, the effectiveness of \nindependent exercise and/or a combination of exercise regimes \nin producing significant weight loss in midlife women is lacking. \nHence, this clinical question was undertaken to identify the type \nand nature of exercises that can help in improving weight loss \nand overall health-related outcomes in midlife women.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 460,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 460,
      "word_count": 66,
      "start_pos": 122668,
      "end_pos": 123128,
      "chunk_index": 245,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_246",
      "text": "rcises that can help in improving weight loss \nand overall health-related outcomes in midlife women.\nSummary of evidence\nPhysical activity prescriptions for midlife women to \nmanage overweight and obesity were based on pre-existing \nrecommendations from the American College of Sports Medicine \nand National Strength and Conditioning Guidelines.[79,205]Most \nstudies recommend different types of physical activity in \ncollaboration with caloric restrictions for managing weight in \nmidlife women. The total duration of interventions ranged \nfrom 10 weeks to 18 months.[209,210] During the intervention, \nan average of three exercise sessions were planned in a week.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 665,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 665,
      "word_count": 91,
      "start_pos": 123028,
      "end_pos": 123693,
      "chunk_index": 246,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_247",
      "text": "hs.[209,210] During the intervention, \nan average of three exercise sessions were planned in a week. \nOnly one study planned a stepwise increase in the number of \nsessions ranging from three sessions per week to five sessions \nper week.[51]Exercise sessions were planned in a phasic manner \nstarting with a warm-up, exercise and cool down.[207] The duration \nof the exercise sessions varied from 50 to 65 min, except for one \nstudy which reported 90-minute walking sessions.[53] Studies have \nrecommended different activities including aerobics, resistance \ntraining and endurance, stretching, and combined exercise \ncircuits.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 626,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 626,
      "word_count": 90,
      "start_pos": 123593,
      "end_pos": 124219,
      "chunk_index": 247,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_248",
      "text": "including aerobics, resistance \ntraining and endurance, stretching, and combined exercise \ncircuits. Six trials recommended moderate (60-70% Heart Rate \nMaximum (HRmax) to vigorous (70-80% HRmax) intensity \naerobic exercises including walking, nordic walking, jogging, \nswimming, bicycling, ergo cycling, treadmill and video-based \naerobic exercise only one trial focused on moderate (HRmax \n50-75%) intensity endurance exercises including upper limb, \nspine-stabilizing, deep muscle-forming, lower limb and balance-\nadjusting exercises.[79] Three studies focused on the role of \nresistance training of all major muscle groups and core exercises.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 646,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 646,
      "word_count": 81,
      "start_pos": 124119,
      "end_pos": 124765,
      "chunk_index": 248,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_249",
      "text": "e studies focused on the role of \nresistance training of all major muscle groups and core exercises. \nThe resistance training included different types of exercises such\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nas leg press, leg extensions, calf raises, chest press, lateral pull-\ndowns, shoulder press and triceps extension.[194,205,211]Five trials \ncustomised exercise circuits for management of weight in midlife \nwomen.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 168,
          "overlap_percentage": 31.818181818181817
        },
        {
          "page_number": 22,
          "overlap_chars": 358,
          "overlap_percentage": 67.8030303030303
        }
      ],
      "primary_page": 21,
      "char_count": 528,
      "word_count": 78,
      "start_pos": 124665,
      "end_pos": 125193,
      "chunk_index": 249,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_250",
      "text": "n.[194,205,211]Five trials \ncustomised exercise circuits for management of weight in midlife \nwomen. The following exercise circuits were recommended: \naerobics and resistance exercises, high-intensity interval training \n(HIIT) and resistance exercises, walking and weight-bearing \nexercises.[51,79,207]The aim of these circuits was to reduce the total \nbody fat and visceral fat (especially HIIT), improve lean muscle \nmass, bone mineral density, physical capacity and maximum range \nof oxygen (VO2 max). Only one trial reported the importance of \naerobic exercises in managing distress, hot flushes as climacteric \nsymptoms and health-related overall quality of life (HRQoL).",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 22,
          "overlap_chars": 677,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 22,
      "char_count": 677,
      "word_count": 89,
      "start_pos": 125093,
      "end_pos": 125770,
      "chunk_index": 250,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_251",
      "text": "g distress, hot flushes as climacteric \nsymptoms and health-related overall quality of life (HRQoL).[212] \nAn experimental study reported that involvement in 60 min of \ndaily physical activity helps in improving climacteric symptoms \nand psychological distress.[213] Social support from coaches in \nmaintaining regular engagement in physical activity did not \ncontribute to an increased frequency of engagement in physical \nactivity.[214]\nClinical practice recommendations\nNo.\nRecommendations\nGrade\n3.3.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 22,
          "overlap_chars": 503,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 22,
      "char_count": 503,
      "word_count": 65,
      "start_pos": 125670,
      "end_pos": 126173,
      "chunk_index": 251,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_252",
      "text": "agement in physical \nactivity.[214]\nClinical practice recommendations\nNo.\nRecommendations\nGrade\n3.3.1\nMidlife women should be encouraged to avoid a \nsedentary lifestyle as far as possible by ensuring \nparticipation in dedicated exercise, household‑related, \nwork‑related and leisure‑related physical activities.\nII\nA\n3.3.2\nA stepwise progressive and personalised physical \nexercise regime based on body weight, presence of \ncardiometabolic risk factors, bone, muscle and joint \nhealth should be prescribed.\nII\nA\n3.3.3\nThe barriers and facilitators for adopting different \ntypes of physical exercise should also be considered \nwhile prescribing a physical exercise regime. \nIV\nA\n3.3.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 22,
          "overlap_chars": 682,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 22,
      "char_count": 682,
      "word_count": 92,
      "start_pos": 126073,
      "end_pos": 126755,
      "chunk_index": 252,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_253",
      "text": "hysical exercise should also be considered \nwhile prescribing a physical exercise regime. \nIV\nA\n3.3.4\nWomen should be encouraged to incorporate up to \n300 min/week of moderate‑intensity aerobic physical \nactivity or 150 min/week of high‑intensity aerobic \nphysical activity or an identical combination of \nmoderate and high‑intensity exercise.\nI\nA\n3.3.5\nPreferably, daily 60 min of physical activity should \nbe recommended including a combination of \nmoderate‑intensity aerobic exercise (30 min moderate \nintensity), muscle strengthening engaging major muscle \ngroup or balance exercise (15 min), work‑related and/\nor household‑related activities (15 min).\nI\nB\n3.3.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 22,
          "overlap_chars": 665,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 22,
      "char_count": 665,
      "word_count": 92,
      "start_pos": 126655,
      "end_pos": 127320,
      "chunk_index": 253,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_254",
      "text": "p or balance exercise (15 min), work‑related and/\nor household‑related activities (15 min).\nI\nB\n3.3.6\nWomen can participate in moderate‑intensity aerobic \nactivities in short bouts (10‑15 min) throughout the day \n(2‑3 times).\nII\nB\n3.3.7\nThe talk test should be used for self‑monitoring the \nintensity of aerobic activities.\nI\nA\n3.3.8\nYogic practices (including physically intensive yoga) \ncan be prescribed for weight management and overall \nwell‑being in midlife women.\nIII\nA\nDiscussion\nA personalised, progressive and stepwise exercise regime \nshould be planned by the healthcare provider.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 22,
          "overlap_chars": 591,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 22,
      "char_count": 591,
      "word_count": 87,
      "start_pos": 127220,
      "end_pos": 127811,
      "chunk_index": 254,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_255",
      "text": "ersonalised, progressive and stepwise exercise regime \nshould be planned by the healthcare provider. According to the \nAustralian pre-exercise screening guide, factors such as cardio-\nrespiratory health, musculoskeletal strength, and pre-existing \nclinical conditions should be assessed before recommending an \nexercise regime.[215] The recommendations are derived from RCTs \nthat incorporate both dietary restrictions and physical activity \nfor weight regulation. Most studies comparing exercise alone vs \nexercise and diet as components of weight loss intervention report \nthat exercise alone results in minimal weight loss.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 22,
          "overlap_chars": 626,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 22,
      "char_count": 626,
      "word_count": 81,
      "start_pos": 127711,
      "end_pos": 128337,
      "chunk_index": 255,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_256",
      "text": "s components of weight loss intervention report \nthat exercise alone results in minimal weight loss. According to the \nposition statement from the American College of Sports Medicine \nand American Diabetes Association, “up to 60 min/day physical \nactivity alone is required to produce weight loss”.[216] Similarly, \nclinical recommendations from the American Academy of \nClinical Endocrinologists (AACE) and the American College of \nEndocrinology also state that 150 minutes of moderate-intensity \naerobic exercise improves weight loss outcomes and improvement \nin intensity and duration can lead to improved weight and fat \nloss.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 22,
          "overlap_chars": 630,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 22,
      "char_count": 630,
      "word_count": 88,
      "start_pos": 128237,
      "end_pos": 128867,
      "chunk_index": 256,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_257",
      "text": "loss outcomes and improvement \nin intensity and duration can lead to improved weight and fat \nloss.[217] The intensity of aerobic exercises can be assessed using \nthe talk test: comfortable speech denotes light intensity, speech \nwith some difficulty denotes moderate intensity and speech limited \nto phrases denotes vigorous intensity.[218] Besides, resistance \nand weight-bearing exercises are recommended twice a week \nfor enhancing muscle and bone mass. It should be noted that \nexercise should be done for all major muscle groups, preferably \nwith the help of a trainer.[219] The overall muscle functioning \ncan also be improved with the help of stretching and flexibility \nexercises.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 22,
          "overlap_chars": 690,
          "overlap_percentage": 100.14513788098694
        }
      ],
      "primary_page": 22,
      "char_count": 689,
      "word_count": 101,
      "start_pos": 128767,
      "end_pos": 129457,
      "chunk_index": 257,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_258",
      "text": "all muscle functioning \ncan also be improved with the help of stretching and flexibility \nexercises. Regular practice of yogic postures (asanas) can also \nhelp in improving flexibility. Midlife women can undertake yoga \nconsisting of postures (asanas), controlled breathing (pranayama) \nand meditation (dhyana) for maintaining physical, mental and \nemotional well-being.[220]\nA comprehensive exercise regime including moderate-intensity \naerobic, resistance and flexibility exercises should be planned for \noverall weight loss and health benefits.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 22,
          "overlap_chars": 547,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 22,
      "char_count": 547,
      "word_count": 70,
      "start_pos": 129357,
      "end_pos": 129904,
      "chunk_index": 258,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_259",
      "text": "resistance and flexibility exercises should be planned for \noverall weight loss and health benefits. For example: initiating \nwarm-up (5–10 min) with stretching to ensure flexibility, engaging \nin moderate-intensity aerobic exercises (30–45 min) for increasing \nheart rate and improving cardiometabolic health, followed by \nresistance exercises (15–20 min) for muscle and bone strength \nand cool down (5–10 min) to relax the muscles.[219] Different \nactivities that can be planned in each exercise category are \npresented in (Table 3.3.1).\nThe management of exercise should also include mitigating \nbarriers faced by midlife women to ensure optimum engagement \nin physical activity.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 22,
          "overlap_chars": 682,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 22,
      "char_count": 682,
      "word_count": 95,
      "start_pos": 129804,
      "end_pos": 130486,
      "chunk_index": 259,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_260",
      "text": "lude mitigating \nbarriers faced by midlife women to ensure optimum engagement \nin physical activity. Healthcare providers should ensure regular \nTable 3.3.1: Different types of activities that can be \nplanned in exercise categories\nAerobics/endurance exercises: Physical exercises that lead to increased \nheart rate and oxygen consumption.\nExamples: walking, running, cycling, swimming, jumping, etc.\nStrength exercise/resistance training: These exercises help in \nincreasing muscle strength, carried out against an opposing force and/or \none’s body weight.\nExamples: weight lifting, using resistance bands, arm curls, etc.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 22,
          "overlap_chars": 623,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 22,
      "char_count": 623,
      "word_count": 81,
      "start_pos": 130386,
      "end_pos": 131009,
      "chunk_index": 260,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.654695"
    },
    {
      "id": "chunk_261",
      "text": "g force and/or \none’s body weight.\nExamples: weight lifting, using resistance bands, arm curls, etc.\nBalance exercise: These exercises help in improving and maintaining \nbalance.\nExamples: Yoga asana, Tai chi\nFlexibility exercises: Flexibility exercises help in keeping your muscles \nelastic and flexible and joints moving.\nExample: Yoga, Tai‑chi, pilates, stretching\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nfollow-up to understand women-centric barriers in managing \nphysical activity.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 22,
          "overlap_chars": 367,
          "overlap_percentage": 61.88870151770658
        },
        {
          "page_number": 23,
          "overlap_chars": 224,
          "overlap_percentage": 37.77403035413153
        }
      ],
      "primary_page": 22,
      "char_count": 593,
      "word_count": 83,
      "start_pos": 130909,
      "end_pos": 131502,
      "chunk_index": 261,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_262",
      "text": "12  :  December 2022\nfollow-up to understand women-centric barriers in managing \nphysical activity.\nIn current literature, the effect of ‘exercise alone’ interventions \non achieving significant weight loss and cardiometabolic \noutcomes is still lacking. Furthermore, the effect of exercise \nintensity, frequency and duration on weight loss outcomes can \nbe explored for devising better exercise regimes for weight loss \nin midlife women.\n3.4: What are the behaviour modification techniques that \nshould be incorporated in weight-management advice?\nBackground\nLifestyle modification for weight management focuses on \nchanges in dietary habits, physical activity patterns and \nbehavioural counselling.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 23,
          "overlap_chars": 700,
          "overlap_percentage": 100.14306151645206
        }
      ],
      "primary_page": 23,
      "char_count": 699,
      "word_count": 92,
      "start_pos": 131402,
      "end_pos": 132102,
      "chunk_index": 262,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_263",
      "text": "ment focuses on \nchanges in dietary habits, physical activity patterns and \nbehavioural counselling. While incorporating dietary and activity-\nrelated modifications, women face a range of barriers associated \nwith adoption and long-term compliance consequently leading \nto unsuccessful outcomes.[221] It is important to empower \npatients with behavioural modification skills which may help \nthem to overcome their challenges in adopting healthy lifestyle \nmodifications.[222] Behavioural modification techniques can \nplay a pivotal role in restructuring an individuals’ lifestyle \nhabits.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 23,
          "overlap_chars": 588,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 23,
      "char_count": 588,
      "word_count": 74,
      "start_pos": 132002,
      "end_pos": 132590,
      "chunk_index": 263,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_264",
      "text": "modification techniques can \nplay a pivotal role in restructuring an individuals’ lifestyle \nhabits.[223]These behavioural modification strategies can be \ninculcated with the help of a behavioural specialist and/or \npsychologist in collaboration with a multidisciplinary team of \ndoctors, nutritionists and exercise specialists.[224] Some of the \neffective strategies suggested in the literature include goal-\nsetting, self-monitoring, coping strategies, stimulus control, \ncognitive restructuring, and relapse prevention.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 23,
          "overlap_chars": 522,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 23,
      "char_count": 522,
      "word_count": 62,
      "start_pos": 132490,
      "end_pos": 133012,
      "chunk_index": 264,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_265",
      "text": "f-monitoring, coping strategies, stimulus control, \ncognitive restructuring, and relapse prevention.[54,115,225,226] \nMidlife women should be educated to apply these behavioural \nstrategies to mitigate the challenges they face while trying to \nincorporate healthy lifestyle practices. However, there is a lack \nof comprehensive list of behavioural strategies established \nparticularly for addressing issues faced by midlife women. Hence, \neffective behavioural strategies should be identified to counsel \nwomen in midlife during the weight management process.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 23,
          "overlap_chars": 559,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 23,
      "char_count": 559,
      "word_count": 70,
      "start_pos": 132912,
      "end_pos": 133471,
      "chunk_index": 265,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_266",
      "text": "l strategies should be identified to counsel \nwomen in midlife during the weight management process.\nSummary of evidence\nComprehensive weight management in midlife women \nwas based on three components: diet, physical activity and \nbehavioural modification recommendations. The behavioural \nintervention can be delivered via web-based, group-based and \nindividualised sessions for a duration ranging from 3 months to \n60 months.[54,225,227] These sessions were delivered by nutritionists, \ndoctors and behavioural therapists. Only one study had a \nmultidisciplinary team for behavioural weight loss counselling.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 23,
          "overlap_chars": 610,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 23,
      "char_count": 610,
      "word_count": 80,
      "start_pos": 133371,
      "end_pos": 133981,
      "chunk_index": 266,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_267",
      "text": "al therapists. Only one study had a \nmultidisciplinary team for behavioural weight loss counselling.[228] \nA number of behavioural strategies were recommended to \nenhance compliance to dietary and activity advice in the long \nterm: goal setting, motivational interviewing, self-monitoring, \npositive reinforcement, thought process, coping skills, problem-\nsolving, and social support. During the initiation of weight \nmanagement, goal setting was used as a behavioural strategy to \nset realistic and practical weight reduction goals.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 23,
          "overlap_chars": 533,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 23,
      "char_count": 533,
      "word_count": 71,
      "start_pos": 133881,
      "end_pos": 134414,
      "chunk_index": 267,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_268",
      "text": "l setting was used as a behavioural strategy to \nset realistic and practical weight reduction goals.[54,55,229]During the \nintervention, motivational interviewing as a technique was used \nto advise healthy eating behaviours including fibre consumption \nand activity habits including completing 10,000 steps.[48,115] \nDietitian-led counselling sessions or seminars were planned for \nimprovement in eating behaviours such as reading labels, eating \nout, coping skills for emotional eating, recipe substitution, and \nselection of foods.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 23,
          "overlap_chars": 533,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 23,
      "char_count": 533,
      "word_count": 69,
      "start_pos": 134314,
      "end_pos": 134847,
      "chunk_index": 268,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_269",
      "text": "bels, eating \nout, coping skills for emotional eating, recipe substitution, and \nselection of foods.[226,227,230]At follow-up, self-monitoring of \ndiet, activity and weight was the most common behavioural \nstrategy that was adopted for managing corrective eating and \nactivity.[54,55,118,229]\nAcross the literature, web-based behavioural lifestyle modification \nin midlife women produced significant weight reduction \nup to -1.34 kg over 12 months.[225] On-site exercise sessions \nunder the supervision of a trained interventionist resulted in \ngreater weight loss than those produced by usual care (limited \nprovision of dietary or activity advice and/or educational \nmaterials).",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 23,
          "overlap_chars": 680,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 23,
      "char_count": 680,
      "word_count": 88,
      "start_pos": 134747,
      "end_pos": 135427,
      "chunk_index": 269,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_270",
      "text": "uced by usual care (limited \nprovision of dietary or activity advice and/or educational \nmaterials).[46,116,230] Only three studies reported a significant \nreduction in the visceral adipose tissue observed as a reduction \nin waist circumference.[116,226] Limited studies assessed changes \nin metabolic parameters such as blood pressure, HbA1c, serum \ninsulin, C-peptide, and HOMA-IR leading to inconclusive \nevidence on the role of comprehensive behavioural lifestyle \nintervention on improvement in metabolic status.[225,230]\nClinical practice recommendations\nNo.\nRecommendations\nGrade\n3.4.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 23,
          "overlap_chars": 591,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 23,
      "char_count": 591,
      "word_count": 74,
      "start_pos": 135327,
      "end_pos": 135918,
      "chunk_index": 270,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_271",
      "text": "ement in metabolic status.[225,230]\nClinical practice recommendations\nNo.\nRecommendations\nGrade\n3.4.1 Behaviour modification techniques such as realistic goal \nsetting, motivational interviewing, and self‑monitoring \nstrategies should be used.\nII\nB\n3.4.2 Women should be trained regarding problem‑solving skills \nsuch as defining problems, creating solutions and opting \nfor the best possible choice.\nII\nB/C\n3.4.3 Cognitive restructuring skills such as identifying, challenging, \nand correcting the negative thoughts and emotions related \nto weight management should be imparted.\nII\nB/C\n3.4.4 Feedback on the accomplishments, achievements and \nscope for better progress should be given regularly.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 23,
          "overlap_chars": 696,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 23,
      "char_count": 696,
      "word_count": 91,
      "start_pos": 135818,
      "end_pos": 136514,
      "chunk_index": 271,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_272",
      "text": "dback on the accomplishments, achievements and \nscope for better progress should be given regularly.\nII\nB\nDiscussion\nThe recommendations derived from the current systematic \nreviews and RCTs reveal that behavioural modification strategies \nhave a crucial role in weight management programs.[115,225,228]\nAcross the literature, a number of behavioural techniques were \nidentified at different stages of weight management. Strategies \nsuch as setting realistic goals and motivational interviewing \nduring initiation; problem-solving and cognitive restructuring \nduring the intervention; self-monitoring and relapse prevention \nduring the follow-up have proven to be effective.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 23,
          "overlap_chars": 674,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 23,
      "char_count": 674,
      "word_count": 86,
      "start_pos": 136414,
      "end_pos": 137088,
      "chunk_index": 272,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_273",
      "text": "ervention; self-monitoring and relapse prevention \nduring the follow-up have proven to be effective.[54,229] Initially, \nwhen patients are confronted with the need to change lifestyle-\nrelated behaviour they might face some ambivalence in \nincorporating this behaviour change. Healthcare providers can \nresolve this ambivalence through motivational interviewing, \nreflective listening and asking open-ended questions to stimulate \ninvolvement towards a behaviour change.[231]The counselling of \nproblem-solving skills provides patients with an opportunity to \ndiscuss barriers experienced in day-to-day life for maintaining \ncorrective dietary and activity behaviour.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 23,
          "overlap_chars": 667,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 23,
      "char_count": 667,
      "word_count": 81,
      "start_pos": 136988,
      "end_pos": 137655,
      "chunk_index": 273,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_274",
      "text": "barriers experienced in day-to-day life for maintaining \ncorrective dietary and activity behaviour.[55,230] Problem solving\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nskills include identifying the problem, finding possible solutions \nand adopting the best solution that can help in sustaining the \ncorrective lifestyle habits for a long time period.[232] During \nfollow-up sessions, self-monitoring of weight, diet and activity \nstatus should also be included as a key component for maintaining \nweight loss.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 23,
          "overlap_chars": 124,
          "overlap_percentage": 20.22838499184339
        },
        {
          "page_number": 24,
          "overlap_chars": 488,
          "overlap_percentage": 79.6084828711256
        }
      ],
      "primary_page": 23,
      "char_count": 613,
      "word_count": 87,
      "start_pos": 137555,
      "end_pos": 138169,
      "chunk_index": 274,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_275",
      "text": ", diet and activity \nstatus should also be included as a key component for maintaining \nweight loss. Thus, a combination of behavioural approaches can \nbe used in addition to lifestyle intervention for successful and \nsustainable weight loss outcomes.\nIn clinical settings, weight loss programs focus only on \nprescribing corrective dietary and physical activity behaviours as \nprimary modalities of weight loss. Healthcare providers should \nalso consider incorporating behavioural modification strategies \nas an important modality of successful weight loss outcome.[223] \nIdeally, behavioural strategies should be advised by a trained \nbehavioural therapist and/or psychologist.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 24,
          "overlap_chars": 679,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 24,
      "char_count": 679,
      "word_count": 91,
      "start_pos": 138069,
      "end_pos": 138748,
      "chunk_index": 275,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_276",
      "text": "y, behavioural strategies should be advised by a trained \nbehavioural therapist and/or psychologist. Often in healthcare \nsettings, there is limited availability of dedicated behavioural \ntherapists for weight management. Other healthcare providers \nshould also be trained in providing preliminary behavioural \nstrategies to mitigate barriers faced by midlife women for \nsustainable weight loss.\n3.5: What is the role of menopausal hormone therapy \n(MHT) in a weight management program for midlife \nwomen?\nBackground\nMenopausal hormone therapy (MHT) is an effective treatment \nfor the management of menopausal symptoms, especially for \nvasomotor and genitourinary symptoms.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 24,
          "overlap_chars": 673,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 24,
      "char_count": 673,
      "word_count": 90,
      "start_pos": 138648,
      "end_pos": 139321,
      "chunk_index": 276,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_277",
      "text": "nt \nfor the management of menopausal symptoms, especially for \nvasomotor and genitourinary symptoms. MHT is indicated in \nwomen with oestrogen deficiency. It is a systematic treatment \nwith a group of preparations consisting of oestrogen and/or \ntibolone.[233] Almost 600 million women-years of MHT use have \nbeen reported in the period between 1970-2019.[234] Because there \nis high utilisation of MHT during the menopausal transition, it \nbecomes important to understand its role in maintaining weight \nand health in midlife women. There is inconsistent literature \non the effect of MHT use on body fat and changes in its \ndistribution.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 24,
          "overlap_chars": 638,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 24,
      "char_count": 638,
      "word_count": 95,
      "start_pos": 139221,
      "end_pos": 139859,
      "chunk_index": 277,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_278",
      "text": "e is inconsistent literature \non the effect of MHT use on body fat and changes in its \ndistribution.[235] Besides, accelerated decline in lean muscle mass \nleading to sarcopenia has been associated with the menopausal \ntransition. In midlife women using MHT, no positive or \ndetrimental impact on muscle mass can be observed in the \nliterature. In addition to alleviating menopausal symptoms, the \npossible health effects of MHT have been inconsistently reported \nacross the literature.[236] Due to inconsistencies in literature it \nis important to realise the effect of MHT on weight status in \nmidlife women undergoing lifestyle interventions.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 24,
          "overlap_chars": 645,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 24,
      "char_count": 645,
      "word_count": 96,
      "start_pos": 139759,
      "end_pos": 140404,
      "chunk_index": 278,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_279",
      "text": "to realise the effect of MHT on weight status in \nmidlife women undergoing lifestyle interventions. Hence, this \nclinical question was undertaken to understand the role of MHT \nin managing weight status, body composition and metabolic \nparameters in midlife women.\nSummary of evidence\nMHT has been evaluated in the management of osteoporosis, \ncognitive function, emotional volatility, sleep disturbances, \ncardiometabolic disorders and sexual dysfunction, especially in \nearly menopausal women in the age group of 40 - 45 years.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 24,
          "overlap_chars": 530,
          "overlap_percentage": 100.1890359168242
        }
      ],
      "primary_page": 24,
      "char_count": 529,
      "word_count": 76,
      "start_pos": 140304,
      "end_pos": 140834,
      "chunk_index": 279,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_280",
      "text": "ers and sexual dysfunction, especially in \nearly menopausal women in the age group of 40 - 45 years.[237,238]\nThe International Menopause Society recommends customising \nand prescribing the lowest dose of hormone replacement drugs \nafter considering the severity of menopausal symptoms, age \nof onset of menopause, family and personal history, route of \nadministration and woman’s preference.[238] In comparison to a \nconventional dose, low MHT doses led to a reduction in the levels \nof low-density lipoprotein (LDL), triglycerides and an increase \nin high-density lipoprotein (HDL). In addition, no effect on \nweight and corresponding BMI was observed in comparison to \nplacebo.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 24,
          "overlap_chars": 680,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 24,
      "char_count": 680,
      "word_count": 98,
      "start_pos": 140734,
      "end_pos": 141414,
      "chunk_index": 280,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_281",
      "text": "DL). In addition, no effect on \nweight and corresponding BMI was observed in comparison to \nplacebo.[239,240] Only one prospective experimental study reported \na reduction in body weight, fat mass and waist to hip ratio on \nthe administration of oestradiol valerate plus dienogest at 6 and \n12 months.[241]Similar inconsistencies have been reported on the \nprotective role of MHT in the management of metabolic risk \nfactors such as blood glucose, blood pressure, and serum lipid \nlevel in midlife women administered MHT in comparison to \nplacebo.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 24,
          "overlap_chars": 547,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 24,
      "char_count": 547,
      "word_count": 83,
      "start_pos": 141314,
      "end_pos": 141861,
      "chunk_index": 281,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_282",
      "text": "blood pressure, and serum lipid \nlevel in midlife women administered MHT in comparison to \nplacebo.[242,243]This calls for more research in this area of midlife \nhealth to provide conclusive recommendations on the impact of \nMHT on the body composition of midlife women.\nClinical practice recommendations\nNo.\nRecommendations\nGrade\n3.5.1\nMenopausal Hormone Therapy (MHT) is not indicated \nsolely for weight management in midlife women.\nII\nA\n3.5.2\nWeight management by lifestyle interventions may help \nin improving the overall well‑being of midlife women \nwith menopausal symptoms.\nII\nA\nDiscussion\nThe recommendations suggest that MHT is not solely prescribed \nfor weight management in midlife women.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 24,
          "overlap_chars": 700,
          "overlap_percentage": 100.14306151645206
        }
      ],
      "primary_page": 24,
      "char_count": 699,
      "word_count": 101,
      "start_pos": 141761,
      "end_pos": 142461,
      "chunk_index": 282,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_283",
      "text": "e recommendations suggest that MHT is not solely prescribed \nfor weight management in midlife women. Experts believe that \nMHT is indicated in women with severe menopausal symptoms. \nThe menopausal symptoms are known to impact the daily lifestyle \nof midlife women in a way that promotes weight gain. MHT \nshould be primarily prescribed to manage menopausal symptoms \nseverity, which in turn might improve the adherence towards \nhealthy eating and activity behaviours, leading to better weight \nloss outcomes. Lifestyle modification should be recommended as \nthe primary treatment modality in midlife women with overweight \nand obesity.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 24,
          "overlap_chars": 636,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 24,
      "char_count": 636,
      "word_count": 93,
      "start_pos": 142361,
      "end_pos": 142997,
      "chunk_index": 283,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_284",
      "text": "uld be recommended as \nthe primary treatment modality in midlife women with overweight \nand obesity. The incorporation of corrective eating and activity \nbehaviour can also help in mitigating the menopausal symptom \nseverity and managing weight status.\nSection IV: Follow-up for Sustainable Weight Loss\n4.1: Which other parameters are of importance in \ndetermining the overall improvement in midlife women \nafter undergoing weight management?\nBackground\nGenerally, most weight-loss interventions are primarily aimed \nat achieving clinically significant weight loss determined by a \nreduction of 5-10% from the baseline weight.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 24,
          "overlap_chars": 626,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 24,
      "char_count": 626,
      "word_count": 86,
      "start_pos": 142897,
      "end_pos": 143523,
      "chunk_index": 284,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_285",
      "text": "ing clinically significant weight loss determined by a \nreduction of 5-10% from the baseline weight. The achievement \nof clinically significant weight loss through corrective lifestyle \nmodification techniques is associated with improvement in \ncardiometabolic risk factors, obesity-related disease, menopausal \nand overall HRQoL in midlife women.[182] It is observed \nthat a 10% reduction from body weight in an individual can\n\nRanjan, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 24,
          "overlap_chars": 427,
          "overlap_percentage": 96.3882618510158
        },
        {
          "page_number": 25,
          "overlap_chars": 14,
          "overlap_percentage": 3.160270880361174
        }
      ],
      "primary_page": 24,
      "char_count": 443,
      "word_count": 61,
      "start_pos": 143423,
      "end_pos": 143866,
      "chunk_index": 285,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_286",
      "text": "men.[182] It is observed \nthat a 10% reduction from body weight in an individual can\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\npromote significant improvement in circulating metabolic \nparameters including blood glucose, insulin, LDL, triglyceride \nand inflammatory markers such as C-reactive protein.[244]Some \ncommunity-based interventions also aim at a reduction in waist \ncircumference as an indicator for improvement in cardiometabolic \nhealth.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 24,
          "overlap_chars": 84,
          "overlap_percentage": 15.162454873646208
        },
        {
          "page_number": 25,
          "overlap_chars": 468,
          "overlap_percentage": 84.47653429602889
        }
      ],
      "primary_page": 24,
      "char_count": 554,
      "word_count": 77,
      "start_pos": 143766,
      "end_pos": 144320,
      "chunk_index": 286,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_287",
      "text": "m at a reduction in waist \ncircumference as an indicator for improvement in cardiometabolic \nhealth.[196,245] Other anthropometric parameters such as skeletal \nmuscle mass, lean muscle mass and bone mineral density are also \nimportant outcome measures for women transitioning towards \nmenopause. The improvement in menopausal symptoms such \nas vasomotor symptoms and psychological distress is associated \nwith enhanced overall HRQoL, especially in later years.[158] A \ncomprehensive assessment of health-related outcome measures \nin addition to weight change is essential for understanding holistic \nhealth benefits associated with weight loss.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 644,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 644,
      "word_count": 85,
      "start_pos": 144220,
      "end_pos": 144864,
      "chunk_index": 287,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_288",
      "text": "weight change is essential for understanding holistic \nhealth benefits associated with weight loss. However, the success \nof lifestyle modification intervention is mainly associated with \nweight loss. Hence, this clinical question was undertaken to \nidentify the relevant outcome measures that should be taken into \naccount to determine the success of a weight-loss intervention.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 380,
          "overlap_percentage": 100.26385224274405
        }
      ],
      "primary_page": 25,
      "char_count": 379,
      "word_count": 52,
      "start_pos": 144764,
      "end_pos": 145144,
      "chunk_index": 288,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_289",
      "text": "measures that should be taken into \naccount to determine the success of a weight-loss intervention.\nSummary of evidence\nAcross thirty-seven pertinent weight-loss trials, parameters such \nas anthropometric variables, cardiometabolic risk factors, bone \nmass density, menopausal symptoms, psychological distress \nand overall quality of life were assessed for improvement in \nwomen completing the lifestyle modification interventions. \nThe most commonly assessed parameters were anthropometric \nvariables including a reduction in fat mass or percentage body \nfat across 22 studies, followed by a reduction in visceral fat mass \nor waist circumference assessed in 15 studies.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 672,
          "overlap_percentage": 100.14903129657229
        }
      ],
      "primary_page": 25,
      "char_count": 671,
      "word_count": 90,
      "start_pos": 145044,
      "end_pos": 145716,
      "chunk_index": 289,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_290",
      "text": "tudies, followed by a reduction in visceral fat mass \nor waist circumference assessed in 15 studies.[66,75,196,246] The \nincrease in lean mass or muscle mass was an outcome measure \nin eleven studies.[111,247,248] The improvement in cardiometabolic \nrisk factors such as HDL, LDL, fasting blood glucose was \nconsidered in ten weight loss trials.[80,193,210] The changes in satiety \nand hunger hormones were assessed in three studies.[82,194,207] \nOther parameters such as psychological distress in the form of \nanxiety, depression, insomnia, stress and quality of life were also \nassessed.[111,212,249-251]Three studies assessed improvement in bone \nmineral density and menopausal symptoms.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 690,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 690,
      "word_count": 94,
      "start_pos": 145616,
      "end_pos": 146306,
      "chunk_index": 290,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_291",
      "text": "111,212,249-251]Three studies assessed improvement in bone \nmineral density and menopausal symptoms.[53,75,214,252]\nClinical practice recommendations\nNo.\nRecommendations\nGrade\n4.1.1\nIn addition to weight management, midlife women \nwith obesity should be appraised and sensitised \nabout the benefits of a healthy lifestyle on bone \nhealth, muscle strength and menopausal symptoms.\nII\nB\nDiscussion\nMidlife women measure successful weight loss outcomes \nmainly in terms of achieving clinically significant weight loss.[253] \nWomen should be sensitised regarding the role of weight loss \nin managing cardiometabolic, musculoskeletal, menopausal and \nmental health.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 660,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 660,
      "word_count": 84,
      "start_pos": 146206,
      "end_pos": 146866,
      "chunk_index": 291,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_292",
      "text": "he role of weight loss \nin managing cardiometabolic, musculoskeletal, menopausal and \nmental health. In addition to weight, waist circumference as an \noutcome indicator of cardiometabolic health is easier to assess \nin public health and community settings. The cut-off values \nfor biochemical parameters associated with cardiometabolic \nhealth are presented in Annexure 9. In addition to biochemical \nimprovement, the changes in the clinical signs and symptoms \nrelated to menopausal health should also be evaluated post \nintervention. The improvement in menopausal symptoms such \nas joint pain and distress has been associated with improved \ncompliance to corrective eating and activity behaviour.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 698,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 698,
      "word_count": 97,
      "start_pos": 146766,
      "end_pos": 147464,
      "chunk_index": 292,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_293",
      "text": "distress has been associated with improved \ncompliance to corrective eating and activity behaviour. Clinicians \nshould utilise improvement in health-related parameters as a \nmotivator to maintain healthy eating and activity behaviour \nin the long term.[254] Hence, healthcare practitioners should \nconsider weight management programs as an opportunity for \nimprovement in overall health and quality of life in later years.\n4.2: What should be the duration, frequency and mode \nof follow-up for midlife women during the intervention?\nBackground\nRegular and timely follow-ups is an integral component of a \nsuccessful weight loss program.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 637,
          "overlap_percentage": 100.1572327044025
        }
      ],
      "primary_page": 25,
      "char_count": 636,
      "word_count": 89,
      "start_pos": 147364,
      "end_pos": 148001,
      "chunk_index": 293,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_294",
      "text": "kground\nRegular and timely follow-ups is an integral component of a \nsuccessful weight loss program. Considering that a substantial \nproportion of adults do not adhere to weight loss programs, \nproviding supervision during intervention helps to facilitate \nadherence to corrective lifestyle-related behaviours. During the \nintervention, follow-up is an opportunity for healthcare providers \nto assess a patient’s progress, evaluate health-related outcomes, \nmitigate barriers faced during weight management and customise \nlifestyle modification strategies.[255,256]\nFollow-up meetings can be planned in individual or group \nsessions or combinations of both.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 657,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 657,
      "word_count": 84,
      "start_pos": 147901,
      "end_pos": 148558,
      "chunk_index": 294,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_295",
      "text": "255,256]\nFollow-up meetings can be planned in individual or group \nsessions or combinations of both. Use of technology such as \nweb-based follow-ups, text messages, motivational messages, \nor sending newsletters with recent updates can be utilised for \nmaintaining appropriate contact with the patients.[257-259] Factors \nsuch as target weight loss goal, type of intervention (modality, \nduration, intensity) and level of adherence are associated with \nplanning the follow-up during weight loss intervention. The \nfrequency, mode and duration of follow-up varies across different \ntypes of weight-loss interventions.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 616,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 616,
      "word_count": 83,
      "start_pos": 148458,
      "end_pos": 149074,
      "chunk_index": 295,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_296",
      "text": "equency, mode and duration of follow-up varies across different \ntypes of weight-loss interventions.[260]However, the optimum \nduration, frequency and mode of follow-up to be planned \nfor midlife women for achieving weight loss success has not \nbeen studied. Hence, this clinical question was undertaken to \nunderstand the effective combination of mode and frequency \nof follow-up during the intervention that can help in producing \nsignificant and sustainable weight loss outcomes.\nSummary of evidence\nThe duration and frequency of follow-up were mentioned across \n26 pertinent weight-loss trials; including two systematic reviews \non weight maintenance.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 655,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 655,
      "word_count": 90,
      "start_pos": 148974,
      "end_pos": 149629,
      "chunk_index": 296,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_297",
      "text": "ed across \n26 pertinent weight-loss trials; including two systematic reviews \non weight maintenance.[261,262] The total duration of follow-up \nranged from 3 - 48 months.[67,263] The most common follow-up \nduration was between 12 and 18 months reported across nine \nweight-loss trials. Long follow-up duration (≥ 30 months) was \nreported across six studies.[67,260,264,265] Similar findings were \nreported by the two systematic reviews with a total follow-up \nduration ranging from 6 - 36 months for weight maintenance \nstudies.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 527,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 25,
      "char_count": 527,
      "word_count": 75,
      "start_pos": 149529,
      "end_pos": 150056,
      "chunk_index": 297,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_298",
      "text": "reviews with a total follow-up \nduration ranging from 6 - 36 months for weight maintenance \nstudies.[261,262] As per one of the reviews, there was a vast difference \nin the frequency of contact made with the participants during the \nfollow-up phase ranging from no/minimal contact to biweekly \ncontact.[262]Similar findings were observed in independent weight-\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nloss trials. The frequency of contact ranged from biannual to \nbiweekly contact with the participants enrolled in the intervention \ngroup.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 25,
          "overlap_chars": 360,
          "overlap_percentage": 55.72755417956656
        },
        {
          "page_number": 26,
          "overlap_chars": 284,
          "overlap_percentage": 43.962848297213625
        }
      ],
      "primary_page": 25,
      "char_count": 646,
      "word_count": 97,
      "start_pos": 149956,
      "end_pos": 150602,
      "chunk_index": 298,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_299",
      "text": "ranged from biannual to \nbiweekly contact with the participants enrolled in the intervention \ngroup.[67,257] In ten studies, a monthly contact was established \nwith the participants. Some studies used a combination approach \nby establishing frequent contact at the initial intervention stage \nfollowed by limited contact at the later intervention stage.[260,266] \nIn the control groups, follow-up included no contact to web-\nbased contact, contact via untrained staff and delivery of \nelectronic health promotion material.[266,267]The most common \nmode of contact was face-to-face, individualised sessions with a \ntrained interventionist such as a dietitian, physician or behaviour \ntherapist.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 26,
          "overlap_chars": 693,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 26,
      "char_count": 693,
      "word_count": 93,
      "start_pos": 150502,
      "end_pos": 151195,
      "chunk_index": 299,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_300",
      "text": "sed sessions with a \ntrained interventionist such as a dietitian, physician or behaviour \ntherapist.[268-270] Group discussions as a mode of contact were \nopted by five studies and two studies each used telephonic, email \nand text messages as their way of maintaining follow-up contact \nwith the participants.[271-274]\nClinical practice recommendations\nNo.\nRecommendations\nGrade\n4.2.1\nThe time schedule for the intervention phase of weight \nmanagement should be decided on the basis of target \nweight loss to be achieved in the patient.\nIV\nA\n4.2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 26,
          "overlap_chars": 546,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 26,
      "char_count": 546,
      "word_count": 82,
      "start_pos": 151095,
      "end_pos": 151641,
      "chunk_index": 300,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_301",
      "text": "ement should be decided on the basis of target \nweight loss to be achieved in the patient.\nIV\nA\n4.2.2\nThe duration of the intervention phase should be \nplanned such that the patient can lose 5‑10% body weight \nevery six months till the target body weight is achieved.\nI\nA\n4.2.3\nBimonthly contact should be planned in the initial stages \nof the intervention phase that can be reduced to monthly \ncontact in the later phase.\nII\nA/B\n4.2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 26,
          "overlap_chars": 434,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 26,
      "char_count": 434,
      "word_count": 78,
      "start_pos": 151541,
      "end_pos": 151975,
      "chunk_index": 301,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_302",
      "text": "s \nof the intervention phase that can be reduced to monthly \ncontact in the later phase.\nII\nA/B\n4.2.4\nA combination of physical (face‑to‑face and/or group \ncounselling) and online meeting modalities/telephonic \ncontacts can be used for the follow-up\nII\nA\nDiscussion\nRegular contact with health care practitioners helps the patient to \nstay motivated and focused, improving the compliance towards \ncorrective eating and activity advice.[275] The adherence to lifestyle \npractices is a key factor for improved weight loss outcomes.[276] \nGenerally, the duration of the intervention is planned to achieve \nthe target weight loss of 5-10% in six months.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 26,
          "overlap_chars": 649,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 26,
      "char_count": 649,
      "word_count": 97,
      "start_pos": 151875,
      "end_pos": 152524,
      "chunk_index": 302,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_303",
      "text": "e duration of the intervention is planned to achieve \nthe target weight loss of 5-10% in six months. Follow-up is an \nimportant strategy for achieving target weight loss and long-\nterm sustenance. A follow-up of 6 to 12 months is commonly \nconsidered for achieving the optimum weight loss goal. In addition \nto target weight loss, factors such as nature of the intervention, \nreadiness to change, available social support and feasibility should \nbe kept in mind while planning the follow-up meetings.[67,268,270]\nWeight loss achieved at the initial stage of the intervention is a key \nmotivator of compliance and adherence to corrective lifestyle-\nrelated behaviours in the long term.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 26,
          "overlap_chars": 684,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 26,
      "char_count": 684,
      "word_count": 107,
      "start_pos": 152424,
      "end_pos": 153108,
      "chunk_index": 303,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_304",
      "text": "motivator of compliance and adherence to corrective lifestyle-\nrelated behaviours in the long term.[19]Frequent bimonthly \nfollow-up sessions can be planned during the initial stages of \nintervention to achieve early weight loss and improve compliance. \nFurther, frequent initial contact can help in providing information \non corrective lifestyle habits and customise lifestyle interventions \nrequired for improving weight loss efforts.[255]This information \ncan be provided using a combination of face-to-face sessions \nand technological modalities.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 26,
          "overlap_chars": 551,
          "overlap_percentage": 100.18181818181817
        }
      ],
      "primary_page": 26,
      "char_count": 550,
      "word_count": 70,
      "start_pos": 153008,
      "end_pos": 153559,
      "chunk_index": 304,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_305",
      "text": "rmation \ncan be provided using a combination of face-to-face sessions \nand technological modalities.[266,268] With advanced technologies, \nthe use of mobile applications for self-monitoring and providing \nreal-time feedback can facilitate weight loss outcomes.[264]Mostly, \na combination of individualised and technological sessions are \nplanned across weight-loss interventions. Healthcare providers \nshould identify the most feasible, interactive and sustainable \nmethod to maintain contact with midlife women enrolled for \nlifestyle modification.\n4.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 26,
          "overlap_chars": 552,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 26,
      "char_count": 552,
      "word_count": 66,
      "start_pos": 153459,
      "end_pos": 154011,
      "chunk_index": 305,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_306",
      "text": "sustainable \nmethod to maintain contact with midlife women enrolled for \nlifestyle modification.\n4.3: What should be the duration, frequency and mode \nof contact during the maintenance phase of the weight-\nmanagement program for a midlife woman?\nBackground\nThe maintenance of lost weight is more challenging than \nachieving clinically significant weight loss across treatment \nmodalities.[254] Weight maintenance is defined as a weight change \nof less than 3% for at least a period of one year.[277] Midlife \nwomen can experience fluctuations in weight status during the \nweight maintenance phase.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 26,
          "overlap_chars": 598,
          "overlap_percentage": 100.16750418760469
        }
      ],
      "primary_page": 26,
      "char_count": 597,
      "word_count": 87,
      "start_pos": 153911,
      "end_pos": 154509,
      "chunk_index": 306,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_307",
      "text": "7] Midlife \nwomen can experience fluctuations in weight status during the \nweight maintenance phase. Some common issues faced by midlife \nwomen during the maintenance phase are weight plateau, weight \ncycling, and relapse of lost weight.[278,279]Studies suggest that \nregular contact of patients with healthcare providers helps in \nweight maintenance and long-term health-related outcomes.[255] \nFollow-up meetings during the maintenance phase can act as \ncheck points for adherence, compliance and challenges faced by \nthe midlife woman. However, there are limited studies suggesting \nthe frequency and duration of follow-up for effective weight \nmaintenance.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 26,
          "overlap_chars": 660,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 26,
      "char_count": 660,
      "word_count": 89,
      "start_pos": 154409,
      "end_pos": 155069,
      "chunk_index": 307,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_308",
      "text": "mited studies suggesting \nthe frequency and duration of follow-up for effective weight \nmaintenance. Hence, it is important to understand the best \ncombination of duration, frequency and mode of follow-up for \nmidlife women undergoing lifestyle intervention programs for \nsuccessful long-term maintenance.\nSummary of evidence\nAcross weight management trials, the duration of follow-up during \nthe maintenance phase ranged from 3 to 48 months.[260,263,264] Most \nstudies had a maintenance phase for 12 months.[257,266,267,280,281] \nApart from the duration of follow-up, variation in the frequency \nand mode of contact with the patient was also observed.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 26,
          "overlap_chars": 652,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 26,
      "char_count": 652,
      "word_count": 90,
      "start_pos": 154969,
      "end_pos": 155621,
      "chunk_index": 308,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_309",
      "text": "on of follow-up, variation in the frequency \nand mode of contact with the patient was also observed. The \nfrequency of follow-up in 26 maintenance studies ranged from \nbiweekly to yearly follow-up visits. Most studies had a monthly \nfollow-up visit along with different forms of contact using \nvarious technological modalities such as biweekly transmission \nof information using newsletters, weekly website logins, and \ntelephonic calls with trained staff.[265] Group-based sessions \nwere organised in five studies and others studies planned an \nindividualised follow-up session.[67,260,266,272] A study by Leahey \net al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 26,
          "overlap_chars": 621,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 26,
      "char_count": 621,
      "word_count": 87,
      "start_pos": 155521,
      "end_pos": 156142,
      "chunk_index": 309,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_310",
      "text": "hers studies planned an \nindividualised follow-up session.[67,260,266,272] A study by Leahey \net al.[267] also used monetary rewards for better follow-up and \nreduced dropout rates.\nClinical practice recommendations\nNo.\nRecommendations\nGrade\n4.3.1\nThe weight maintenance phase should be continued \nthroughout life with sequential incorporation of \nparameters related to holistic well‑being.\nIII\nA\n4.3.2\nFace‑to‑face contact can be maintained every three \nmonths coupled with a monthly contact using \ntechnological components such as text messages, \ntelephonic calls and mobile applications.\nII\nA\n\nRanjan, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 26,
          "overlap_chars": 595,
          "overlap_percentage": 97.38134206219313
        },
        {
          "page_number": 27,
          "overlap_chars": 14,
          "overlap_percentage": 2.2913256955810146
        }
      ],
      "primary_page": 26,
      "char_count": 611,
      "word_count": 82,
      "start_pos": 156042,
      "end_pos": 156653,
      "chunk_index": 310,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_311",
      "text": "al components such as text messages, \ntelephonic calls and mobile applications.\nII\nA\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nDiscussion\nIdeally, the follow-up of a woman achieving a weight loss target \nshould be continued throughout her lifespan. The follow-up \nshould include regular monitoring of parameters including \nweight status, lifestyle-related behaviours, cardiometabolic risk \nfactors, menopausal and musculoskeletal health. Parameters \nsuch as BMI and waist circumference can be used as initial \nindicators to plan health care during maintenance.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 26,
          "overlap_chars": 84,
          "overlap_percentage": 12.631578947368421
        },
        {
          "page_number": 27,
          "overlap_chars": 579,
          "overlap_percentage": 87.06766917293233
        }
      ],
      "primary_page": 26,
      "char_count": 665,
      "word_count": 94,
      "start_pos": 156553,
      "end_pos": 157218,
      "chunk_index": 311,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_312",
      "text": "I and waist circumference can be used as initial \nindicators to plan health care during maintenance.[282] In case \nof relapse of lost weight, the BMI, waist circumference and \npresence of cardiometabolic risk factors should be referred to \nplan the intensity of future care. The action-points at different \nanthropometric and health-related parameters during weight \nmaintenance are shown in [Table 4.3.1]. Weight maintenance \nadvice should include behavioural strategies to address the \nbarriers faced by midlife women in maintaining corrective \neating and activity habits required for weight loss.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 27,
          "overlap_chars": 599,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 27,
      "char_count": 599,
      "word_count": 85,
      "start_pos": 157118,
      "end_pos": 157717,
      "chunk_index": 312,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_313",
      "text": "ced by midlife women in maintaining corrective \neating and activity habits required for weight loss. The weight \nmanagement advice can be delivered through a combination \nof individualised and long-distance technology-based sessions \nas per the availability of resources. In addition to physical \nfollow-up at three months, the use of technological modalities \nsuch as telephonic counselling, virtual counselling sessions, text \nmessages, emails and social media groups have proven effective \nfor weight maintenance.\n4.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 27,
          "overlap_chars": 519,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 27,
      "char_count": 519,
      "word_count": 71,
      "start_pos": 157617,
      "end_pos": 158136,
      "chunk_index": 313,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_314",
      "text": "ns, text \nmessages, emails and social media groups have proven effective \nfor weight maintenance.\n4.4: What advice should be given during the follow-up \nphase for maintenance of weight in midlife women?\nBackground\nWeight maintenance aims at the management of physiological, \nbehavioural, psychological and environmental factors to sustain \nweight in the long term.[283,284]Even women who lose significant \nweight during the intervention phase find maintenance of weight \nthrough corrective eating and activity habits as difficult.[254] Weight \nmaintenance counselling is an essential part of a sustainable \nweight management program.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 27,
          "overlap_chars": 633,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 27,
      "char_count": 633,
      "word_count": 86,
      "start_pos": 158036,
      "end_pos": 158669,
      "chunk_index": 314,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_315",
      "text": "4] Weight \nmaintenance counselling is an essential part of a sustainable \nweight management program.\nWeight maintenance advice includes adherence to healthy \ndietary habits, physically active routine, adequate sleep and other \nbehavioural modifications important for further weight loss \nand/or weight maintenance.[261] These lifestyle habits should \nbe reinforced to the patients at regular intervals during the \nmaintenance phase to improve compliance towards a healthy \nlifestyle that can result in weight maintenance.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 27,
          "overlap_chars": 521,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 27,
      "char_count": 521,
      "word_count": 69,
      "start_pos": 158569,
      "end_pos": 159090,
      "chunk_index": 315,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_316",
      "text": "ance phase to improve compliance towards a healthy \nlifestyle that can result in weight maintenance.[285] Behavioural \nmodification strategies such as self-monitoring, problem-solving, \nrelapse prevention, stimulus control and stress management \nshould be considered as vital components of the counselling \nplan.[254,286]Thus, a comprehensive plan should be devised to \nimpart sustainable and successful weight maintenance advice \namong midlife women.\nSummary of evidence\nWeight maintenance advice can be extended to the participants \nafter completion of the weight loss program with the aim to \nlose more weight, maintain the lost weight and prevent weight \nregain.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 27,
          "overlap_chars": 666,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 27,
      "char_count": 666,
      "word_count": 90,
      "start_pos": 158990,
      "end_pos": 159656,
      "chunk_index": 316,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_317",
      "text": "loss program with the aim to \nlose more weight, maintain the lost weight and prevent weight \nregain. The weight maintenance advice was based on dietary \nmodification, the introduction of physical activity regime, \ncognitive behavioural therapy, social support, technological \nsupport and pharmacotherapy. In a systematic review, behavioural \nmodification advice led to greater weight loss in comparison to \npharmacological intervention. Six studies reported a combination \nof lifestyle modification with cognitive behavioural techniques \nto manage the challenges experienced during the weight \nmaintenance phase.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 27,
          "overlap_chars": 612,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 27,
      "char_count": 612,
      "word_count": 80,
      "start_pos": 159556,
      "end_pos": 160168,
      "chunk_index": 317,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_318",
      "text": "e behavioural techniques \nto manage the challenges experienced during the weight \nmaintenance phase.[67,270,281] Participants involved in new healthy \nbehaviours during weight maintenance were able to maintain the \nlost weight for a longer duration in comparison to the control \ngroup following healthy dietary and activity habits.[67,268,271] Almost \nall studies included various forms of dietary modification advice \nfor weight maintenance. Dietary advice for weight maintenance \nincluded low-calorie diets, meal replacement, alternate day fasting, \nreplacing sweetened beverages with water, and reinforcement \nof healthy dietary habits.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 27,
          "overlap_chars": 639,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 27,
      "char_count": 639,
      "word_count": 82,
      "start_pos": 160068,
      "end_pos": 160707,
      "chunk_index": 318,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_319",
      "text": "ay fasting, \nreplacing sweetened beverages with water, and reinforcement \nof healthy dietary habits.[258,260,261,266,268,287] Some studies used key \nbehavioural strategies for weight loss maintenance including \nproblem-solving techniques, stimulus control, relapse prevention \nand overcoming barriers to healthy eating and physical activity \nprovided across self-directed groups.[257,265,288]In five studies, \nthe technological component was also compared with social \nsupport and positive reinforcement provided by a coach in the \nweight maintenance phase.[264,267,274] These interventions were \nassociated with greater weight maintenance and less regain.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 27,
          "overlap_chars": 656,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 27,
      "char_count": 656,
      "word_count": 77,
      "start_pos": 160607,
      "end_pos": 161263,
      "chunk_index": 319,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_320",
      "text": ".[264,267,274] These interventions were \nassociated with greater weight maintenance and less regain. The \nimprovement in cardiometabolic risk factors such as fasting \nblood glucose, triglyceride, insulin and waist circumference were \ninconsistent across dietary interventions.[263,264]\nSelf-monitoring techniques were used to track the dietary habits, \nlevel of physical activity, weight, and behavioural change goals \nduring the weight loss intervention or weight maintenance \nphase.[289-292] Across studies, the self-monitoring techniques were \nused to regulate the dietary, activity, sleep and weight-related \nTable 4.3.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 27,
          "overlap_chars": 623,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 27,
      "char_count": 623,
      "word_count": 77,
      "start_pos": 161163,
      "end_pos": 161786,
      "chunk_index": 320,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_321",
      "text": "toring techniques were \nused to regulate the dietary, activity, sleep and weight-related \nTable 4.3.1: Assessment and advice during follow‑up visits\nParameters\nCut‑off value Follow‑up actions\nBMI\n≥23 kg/m2\nTo be counselled for weight gain prevention strategies\n≥25 kg/m2\nTo be enrolled in a lifestyle intervention program for weight loss\nWaist circumference\n≥72 cm\nTo be counselled for weight gain prevention strategies\n≥80 cm\nTo be enrolled in a lifestyle intervention program for weight loss\nElevated cardiometabolic parameters\n(Blood glucose, low‑density lipoprotein, cholesterol, blood pressure)",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 27,
          "overlap_chars": 600,
          "overlap_percentage": 100.1669449081803
        }
      ],
      "primary_page": 27,
      "char_count": 599,
      "word_count": 84,
      "start_pos": 161686,
      "end_pos": 162286,
      "chunk_index": 321,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_322",
      "text": "ed cardiometabolic parameters\n(Blood glucose, low‑density lipoprotein, cholesterol, blood pressure)\nPresent\nTo be counselled for behavioural lifestyle modification\nAppropriately referred to a specialist (if required)\nOther obesity‑related disease\n(Osteoarthritis, sleep apnoea, NAFLD)\nTo be referred to a specialist for proper medical and lifestyle \nmanagement\nBMI: body mass index, NAFLD: non‑alcoholic fatty liver disease, LDL: low‑density lipoprotein\n\nRanjan, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 27,
          "overlap_chars": 453,
          "overlap_percentage": 96.58848614072495
        },
        {
          "page_number": 28,
          "overlap_chars": 14,
          "overlap_percentage": 2.9850746268656714
        }
      ],
      "primary_page": 27,
      "char_count": 469,
      "word_count": 59,
      "start_pos": 162186,
      "end_pos": 162655,
      "chunk_index": 322,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_323",
      "text": "y mass index, NAFLD: non‑alcoholic fatty liver disease, LDL: low‑density lipoprotein\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nbehaviours by providing personal feedback, health promotion \neducation, maintaining contact with interventionist, peer group \nsupport and frequent behavioural prompters.[290,293-296] Four modes \nwere identified for promoting self-monitoring techniques: digital \nplatform, minimal digital platform, wearable technologies and non-\ndigital platform or usual care.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 27,
          "overlap_chars": 84,
          "overlap_percentage": 14.18918918918919
        },
        {
          "page_number": 28,
          "overlap_chars": 506,
          "overlap_percentage": 85.47297297297297
        }
      ],
      "primary_page": 27,
      "char_count": 592,
      "word_count": 76,
      "start_pos": 162555,
      "end_pos": 163147,
      "chunk_index": 323,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_324",
      "text": "platform, minimal digital platform, wearable technologies and non-\ndigital platform or usual care.[297]Self-monitoring intervention most \ncommonly uses digital platforms including mobile and web-based \napplications, text messages, and personal digital assistants followed \nby minimally used digital platforms including health promotion \ninformation, e-consultations, e-newsletter, email, etc. for regulating \nhealthy lifestyle behaviours.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 28,
          "overlap_chars": 440,
          "overlap_percentage": 100.4566210045662
        }
      ],
      "primary_page": 28,
      "char_count": 438,
      "word_count": 49,
      "start_pos": 163047,
      "end_pos": 163487,
      "chunk_index": 324,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_325",
      "text": "nformation, e-consultations, e-newsletter, email, etc. for regulating \nhealthy lifestyle behaviours.[293,298-300] The application-based dietary \nmonitors tracked the amount of food and beverage consumed, daily \ncalorie and fat intake, photographs of food items, bite counters and \nassigned a rating to foods consumed with comments and reviews \nfrom the interventionist.[264,289,301,302] Physical activity was tracked by \nwearable technologies and applications, which provided insights \non the daily duration of moderate physical activity, number of \nsteps per day, and information on exercise plans.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 28,
          "overlap_chars": 599,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 28,
      "char_count": 599,
      "word_count": 77,
      "start_pos": 163387,
      "end_pos": 163986,
      "chunk_index": 325,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_326",
      "text": "duration of moderate physical activity, number of \nsteps per day, and information on exercise plans.[294,299,303]Across \nsystematic reviews and weight-loss trials, application-based self-\nmonitoring strategies improved adherence to healthy dietary and \nactivity advice.[290,296,297,298] The improved adherence to healthy \nlifestyle habits for a longer duration contributed to a significant \ndecrease in weight in application-based monitoring techniques in \ncomparison to traditional monitoring techniques such as pen and \npaper-based daily diet and activity logs.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 28,
          "overlap_chars": 563,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 28,
      "char_count": 563,
      "word_count": 70,
      "start_pos": 163886,
      "end_pos": 164449,
      "chunk_index": 326,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_327",
      "text": "ison to traditional monitoring techniques such as pen and \npaper-based daily diet and activity logs.[292,293,304] There is limited \nconclusive evidence on the impact of different combinations, \ndurations and frequencies of digital self-monitoring techniques \non weight loss outcomes.\nClinical practice recommendations\nNo.\nRecommendations\nGrade\n4.4.1\nAt every contact, healthcare providers should reinforce \nhealthy eating, physical activity and sleep habits and \naddress barriers and challenges faced during this phase.\nII\nA\n4.4.2  During follow‑ups, self‑monitoring through technological \ndevices should be encouraged to maintain weight, dietary, \nphysical activity and sleep routine records.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 28,
          "overlap_chars": 693,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 28,
      "char_count": 693,
      "word_count": 89,
      "start_pos": 164349,
      "end_pos": 165042,
      "chunk_index": 327,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_328",
      "text": "ices should be encouraged to maintain weight, dietary, \nphysical activity and sleep routine records. \nII\nA\n4.4.3\nThroughout weight maintenance, special attention should \nbe given to the behavioural strategies such as enhancing \nmotivation, social support, self‑efficacy, problem‑solving, \nrelapse prevention and addressing individualised barriers.\nII\nB\n4.4.4\nClinical and biochemical parameters such as blood \nglucose, lipid profile and blood pressure measurements \nshould be done as per the standard guidelines and/or \nadvice by the treating doctor.\nIV\nA\n4.4.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 28,
          "overlap_chars": 560,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 28,
      "char_count": 560,
      "word_count": 77,
      "start_pos": 164942,
      "end_pos": 165502,
      "chunk_index": 328,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_329",
      "text": "ents \nshould be done as per the standard guidelines and/or \nadvice by the treating doctor.\nIV\nA\n4.4.5\nAdequate and appropriate care of bone, muscle, joints \nand menopausal symptoms should be ensured during \nfollow‑up contacts to ensure holistic well‑being. \nIV\nB\nDiscussion\nLifestyle counselling acts as the cornerstone for sustainable weight \nmanagement during the maintenance phase. Healthcare providers \nshould reinforce compliance towards healthy dietary and activity \npractices using behavioural skills to prevent weight regain. Dietary \nstrategies such as adequate protein intake, consumption of low \nglycemic foods, high fibre diet and low-fat dairy are associated with \nmaintenance of weight.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 28,
          "overlap_chars": 700,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 28,
      "char_count": 700,
      "word_count": 98,
      "start_pos": 165402,
      "end_pos": 166102,
      "chunk_index": 329,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_330",
      "text": "f low \nglycemic foods, high fibre diet and low-fat dairy are associated with \nmaintenance of weight.[189,305]Patients should also be counselled \nto maintain an active lifestyle by including a combination of \naerobic, resistance and balance exercises for at least 150 minutes/\nweek.[306] The adherence to healthy eating and activity status should \nbe facilitated by behavioural strategies such as problem-solving, \nstimulus control, and relapse prevention.[266,268,307]\nSelf-monitoring is central to the process of weight maintenance \nand includes deliberate attention to dietary and activity \nbehaviours, associated environmental cues and immediate and \nlong-term health benefits.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 28,
          "overlap_chars": 680,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 28,
      "char_count": 680,
      "word_count": 90,
      "start_pos": 166002,
      "end_pos": 166682,
      "chunk_index": 330,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_331",
      "text": "nd activity \nbehaviours, associated environmental cues and immediate and \nlong-term health benefits.[308] Regular self-weighing is also a \nrecommended strategy for weight maintenance. Self-weighing is \ndefined as weighing oneself over a definite period of time such \nas daily, weekly or monthly.[309]Nowadays, the use of technical \nassistance through mobile and web-based applications, text \nmessages, and personal digital assistants has proven effective \nfor self-monitoring.[293,297-300] In addition to regular monitoring, \nhealthcare providers should focus on providing frequent \npersonalised feedback using technological aid.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 28,
          "overlap_chars": 629,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 28,
      "char_count": 629,
      "word_count": 78,
      "start_pos": 166582,
      "end_pos": 167211,
      "chunk_index": 331,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_332",
      "text": "lthcare providers should focus on providing frequent \npersonalised feedback using technological aid.\nIn literature, the individual and interactive impact of different \nlifestyle modification strategies in weight maintenance is lacking. \nFuture research should also focus on factors associated with the \nmanagement of overall health in association with maintenance \nof weight status.\nDiscussion\nDuring midlife, women face multiple challenges that make \nthem prone to weight gain, abdominal adiposity and poor \nHRQoL.[2,6] There is a need to address these midlife-specific \nchallenges to facilitate appropriate weight management in this \ngroup of women.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 28,
          "overlap_chars": 651,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 28,
      "char_count": 651,
      "word_count": 88,
      "start_pos": 167111,
      "end_pos": 167762,
      "chunk_index": 332,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_333",
      "text": "se midlife-specific \nchallenges to facilitate appropriate weight management in this \ngroup of women. To address these challenges, the experts from \nvarious fields came together to develop evidence and consensus-\nbased guidelines for women-centric weight management \nin midlife women. The guidelines focus on clinical practice \nrecommendations on behavioural lifestyle modification as first-\nline treatment of overweight and obesity in midlife women. In \naddition to lifestyle modification, areas specific to managing \nan adequate quality of life in midlife including metabolic, \nmenopausal and musculoskeletal health was also included to \nprovide a comprehensive treatment module.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 28,
          "overlap_chars": 680,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 28,
      "char_count": 680,
      "word_count": 91,
      "start_pos": 167662,
      "end_pos": 168342,
      "chunk_index": 333,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_334",
      "text": "enopausal and musculoskeletal health was also included to \nprovide a comprehensive treatment module.\nThe guidelines include clinical practice points for healthcare \nproviders to modify the existing dietary and activity behaviours \nin a way that promotes weight loss. The recommendations \ninclude stepwise assessment, management and monitoring of \nkey dietary and activity behaviours to facilitate effective weight \nmanagement. Dietary recommendations include counselling \nbalanced dietary intake and corrective eating behaviours, focusing \non macronutrient intake, consumption of HFSS foods and \nsugar sweetened beverages (SSBs), eating out and emotional \neating.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 28,
          "overlap_chars": 663,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 28,
      "char_count": 663,
      "word_count": 85,
      "start_pos": 168242,
      "end_pos": 168905,
      "chunk_index": 334,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_335",
      "text": ", consumption of HFSS foods and \nsugar sweetened beverages (SSBs), eating out and emotional \neating. Physical activity recommendations help in customising a \nprogressive exercise regime including aerobics, strength training, \nflexibility for managing weight, musculoskeletal and distress \nin midlife women. A mutually agreeable duration, intensity \nand frequency of exercise regime is important for long-term\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nSUMMARY OF RECOMMENDATION\nS. No.\nRecommendations\nGrade$\nInitiation of discussion for weight management\n1.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 28,
          "overlap_chars": 408,
          "overlap_percentage": 61.72465960665659
        },
        {
          "page_number": 29,
          "overlap_chars": 251,
          "overlap_percentage": 37.97276853252647
        }
      ],
      "primary_page": 28,
      "char_count": 661,
      "word_count": 91,
      "start_pos": 168805,
      "end_pos": 169466,
      "chunk_index": 335,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_336",
      "text": "RY OF RECOMMENDATION\nS. No.\nRecommendations\nGrade$\nInitiation of discussion for weight management\n1.1: When should a healthcare provider initiate structured counseling regarding weight management in midlife women?\n1.1.1 \nOpportunistic screening and management of obesity should be delivered all through the lifespan of a woman.\nIV\nA\n1.1.2\nIn the late thirties, before menopause transition, women should be counselled about the added risk of menopause‑related weight \ngain and body fat distribution. Opportunistic screening and management of obesity should be continued.\nII\nA/B\n1.1.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 29,
          "overlap_chars": 581,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 29,
      "char_count": 581,
      "word_count": 83,
      "start_pos": 169366,
      "end_pos": 169947,
      "chunk_index": 336,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_337",
      "text": "fat distribution. Opportunistic screening and management of obesity should be continued.\nII\nA/B\n1.1.3\nIn the early forties, when women experience menopausal transition, intensive customised weight management counselling should \nbe given. The emphasis should be on corrective lifestyle behaviour and handling health issues specific to menopausal transition \nsuch as menopausal symptoms, sleep disturbances, psychological distress, bone and joint health and other comorbidities. \nII\nA\n1.2: What are the components of Knowledge, Attitude and Practice (KAP) that should be evaluated to plan a personalised weight \nmanagement intervention in midlife women?\n1.2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 29,
          "overlap_chars": 656,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 29,
      "char_count": 656,
      "word_count": 90,
      "start_pos": 169847,
      "end_pos": 170503,
      "chunk_index": 337,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_338",
      "text": "at should be evaluated to plan a personalised weight \nmanagement intervention in midlife women?\n1.2.1\nAssessment of KAP related to risk factors and consequences of obesity on the holistic health of women is recommended.\nIII\nA\n1.2.2 \nDifferent modalities for weight management, barriers and facilitators in their implementation should be evaluated and accounted \nfor in the management plan. \nIII\nB\n1.3: Who are the healthcare providers that can be involved in the management of overweight and obesity in midlife women?\n1.3.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 29,
          "overlap_chars": 522,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 29,
      "char_count": 522,
      "word_count": 81,
      "start_pos": 170403,
      "end_pos": 170925,
      "chunk_index": 338,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_339",
      "text": "re providers that can be involved in the management of overweight and obesity in midlife women?\n1.3.1\nThe protocolised weight management module should be implemented by any healthcare worker who encounters a woman in her \nmidlife for routine screening or specific health conditions.\nIV\nA\n1.3.2\nWherever feasible, a multi‑disciplinary team consisting of primary care physicians, clinicians, dietitians and exercise physiologists/\nphysiotherapists should be involved in weight management of midlife women. Specialists including psychologists/psychiatrists, \nendocrinologists, orthopaedics and physiatrists should be involved, whenever indicated. \nI\nA\n1.3.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 29,
          "overlap_chars": 653,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 29,
      "char_count": 653,
      "word_count": 86,
      "start_pos": 170825,
      "end_pos": 171478,
      "chunk_index": 339,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_340",
      "text": ", \nendocrinologists, orthopaedics and physiatrists should be involved, whenever indicated. \nI\nA\n1.3.3\nAll the healthcare workers should be empowered with the knowledge and skills for prevention, diagnosis and treatment of obesity \nin midlife women.\nIV\nB\n1.4: What could be effective ways of delivering pertinent information to midlife women regarding the management of overweight and \nobesity?\n1.4.1\nA combination of face‑to‑face and technology‑supported distance counselling should be planned for the management of weight \nin midlife women with overweight and obesity.\nIV\nA\n1.4.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 29,
          "overlap_chars": 579,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 29,
      "char_count": 579,
      "word_count": 84,
      "start_pos": 171378,
      "end_pos": 171957,
      "chunk_index": 340,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_341",
      "text": "uld be planned for the management of weight \nin midlife women with overweight and obesity.\nIV\nA\n1.4.2\nInternet and mobile‑based applications should be used proactively for improving compliance by enhancing patient education, \nmotivation, self‑monitoring, personalised feedback, and managing challenges faced in appropriate weight management practices.\nII\nA\n1.4.3\nA toolkit consisting of education material apprising midlife women about menopausal transition, its impact on weight status and \nkey management strategies can be developed, distributed and utilised across healthcare settings.\nIV\nB\nScreening and risk assessment of midlife women\n2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 29,
          "overlap_chars": 643,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 29,
      "char_count": 643,
      "word_count": 89,
      "start_pos": 171857,
      "end_pos": 172500,
      "chunk_index": 341,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_342",
      "text": "uted and utilised across healthcare settings.\nIV\nB\nScreening and risk assessment of midlife women\n2.1: What BMI cut‑off and other anthropometric parameters should determine the need to initiate weight management intervention in \nmidlife women?\n2.1.1\nBMI and Waist Circumference should be used independently for population‑ and clinic‑based cardiometabolic risk stratification \nand other obesity‑related diseases.\nI\nA\n2.1.2\nFor initiating a weight management intervention, the class of generalised obesity should be identified according to the BMI‑cut‑off:\n18.5‑22.9 kg/m2: normal weight\n23.0‑24.9 kg/m2: overweight\n≥25 kg/m2: obesity\nI\nA\n2.1.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 29,
          "overlap_chars": 642,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 29,
      "char_count": 642,
      "word_count": 89,
      "start_pos": 172400,
      "end_pos": 173042,
      "chunk_index": 342,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_343",
      "text": "BMI‑cut‑off:\n18.5‑22.9 kg/m2: normal weight\n23.0‑24.9 kg/m2: overweight\n≥25 kg/m2: obesity\nI\nA\n2.1.3\nFor initiating weight management intervention, the cut‑off reference for waist circumference should be as below:\nWaist circumference less than or equal to 72 cm: normal\nWaist circumference >72 cm but <80 cm: associated with one cardiometabolic risk factor-initiate weight management advice\nWaist circumference >80 cm: associated with cardiometabolic comorbidities-initiate intensive weight management\nI\nA\n2.2: How should dietary practises of midlife women be evaluated ?\n2.2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 29,
          "overlap_chars": 577,
          "overlap_percentage": 100.17361111111111
        }
      ],
      "primary_page": 29,
      "char_count": 576,
      "word_count": 80,
      "start_pos": 172942,
      "end_pos": 173519,
      "chunk_index": 343,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_344",
      "text": "tensive weight management\nI\nA\n2.2: How should dietary practises of midlife women be evaluated ?\n2.2.1\nThe detailed dietary evaluation should include an assessment of the usual meal pattern (including the number of food items \nconsumed) and dietary habits (including skipping meals, typical frequency of consumption of HFSS foods, emotional/stress \neating). \nI\nA\n2.2.2\nTwenty‑four‑hour dietary recall and food frequency questionnaire for three days (two weekdays and one weekend) should be used \nfor dietary evaluation, if feasible. Energy, macronutrient, fibre intake should subsequently be calculated. Alternatively, a short \nvalidated questionnaire can be used.**\nII\nB\n2.2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 29,
          "overlap_chars": 675,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 29,
      "char_count": 675,
      "word_count": 97,
      "start_pos": 173419,
      "end_pos": 174094,
      "chunk_index": 344,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_345",
      "text": "subsequently be calculated. Alternatively, a short \nvalidated questionnaire can be used.**\nII\nB\n2.2.3\nDietary intake of foods rich in protein, iron, and calcium should also be assessed while taking dietary history.\nIV\nB\n2.2.4\nThe barriers faced by midlife women to maintain a healthy diet in their daily lifestyle should be evaluated. \nIV\nB\nContd...\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nContd...\nS. No.\nRecommendations\nGrade$\n2.3: How should the level of daily physical activity of midlife women be evaluated?\n2.3.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 29,
          "overlap_chars": 349,
          "overlap_percentage": 55.92948717948718
        },
        {
          "page_number": 30,
          "overlap_chars": 273,
          "overlap_percentage": 43.75
        }
      ],
      "primary_page": 29,
      "char_count": 624,
      "word_count": 100,
      "start_pos": 173994,
      "end_pos": 174618,
      "chunk_index": 345,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_346",
      "text": "ions\nGrade$\n2.3: How should the level of daily physical activity of midlife women be evaluated?\n2.3.1 \nThe detailed physical activity evaluation should include an assessment of dedicated physical exercise and domestic, work‑related, \nleisure‑related, transport‑related and sedentary activities (screen and sitting time). \nI\nB\n2.3.2\nMadras Diabetes Research Foundation‑Physical Activity Questionnaire (MPAQ) should be used to evaluate the level of physical \nactivity, if feasible. Alternatively, a short validated questionnaire can be used.** \nII\nB/C\n2.3.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 30,
          "overlap_chars": 554,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 30,
      "char_count": 554,
      "word_count": 75,
      "start_pos": 174518,
      "end_pos": 175072,
      "chunk_index": 346,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_347",
      "text": "l \nactivity, if feasible. Alternatively, a short validated questionnaire can be used.** \nII\nB/C\n2.3.3\nEvaluation of the adequacy of physical exercise should be done by assessing: type (stretching/strengthening/aerobics/balance), \nintensity (light/moderate/vigorous), frequency (number of days per week) and duration (number of minutes per day) of exercise.\nIV\nB\n2.3.4\nSpecial attention should be given to assess the number of sedentary hours (especially screen and sitting time) spent during the \nday.\nIV\nA\n2.3.5\nMidlife women should be encouraged to discuss the barriers faced by them in maintaining an active lifestyle. \nIV\nA\n2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 30,
          "overlap_chars": 630,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 30,
      "char_count": 630,
      "word_count": 93,
      "start_pos": 174972,
      "end_pos": 175602,
      "chunk_index": 347,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_348",
      "text": "uld be encouraged to discuss the barriers faced by them in maintaining an active lifestyle. \nIV\nA\n2.4: How psychological and behavioural health should be evaluated in midlife women being engaged in the management of overweight and \nobesity?\n2.4.1 \nAssessment should include inquiry into the presence of a diagnosed psychiatric disorder, especially depression, anxiety or eating \ndisorder. \nII\nA\n2.4.2\nIf there is clinical suspicion, DASS‑21 can be used as an initial screening tool for the assessment of depression, anxiety and stress. \nI\nB\n2.4.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 30,
          "overlap_chars": 545,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 30,
      "char_count": 545,
      "word_count": 85,
      "start_pos": 175502,
      "end_pos": 176047,
      "chunk_index": 348,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_349",
      "text": "be used as an initial screening tool for the assessment of depression, anxiety and stress. \nI\nB\n2.4.3\nIn case a diagnosed psychiatric disorder is present, the current condition of the psychiatric disorder and use of psychotropic \nmedications should be asked for by the weight management team.\nI\nA\n2.4.4 \nThe referral to a mental health professional should be considered if:\nDietary history reveals abnormal eating practices to cope with stress.\nThere is a sudden lack of motivation for weight reduction.\nThere are persistent interpersonal difficulties with the weight management team.\nDASS‑21 score indicates the possibility of depression, anxiety or stress.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 30,
          "overlap_chars": 658,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 30,
      "char_count": 658,
      "word_count": 101,
      "start_pos": 175947,
      "end_pos": 176605,
      "chunk_index": 349,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_350",
      "text": "he weight management team.\nDASS‑21 score indicates the possibility of depression, anxiety or stress.\nThere is a history of diagnosed psychiatric disorders.\nThere is clinical suspicion of a known psychiatric disorder.\nIV\nA\n2.5: What are the important comorbid conditions (cardio‑metabolic and other medical conditions) that should be evaluated before initiating \nmanagement of overweight and obesity?\n2.5.1\nIn midlife women, lifestyle intervention should be initiated if they have any known cardiometabolic risk factors (such as abnormal \nblood sugar, increased blood pressure, dyslipidaemia) or obesity‑related complications (such as non‑alcoholic fatty liver, sleep \napnoea, etc.). \nI\nA\n2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 30,
          "overlap_chars": 690,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 30,
      "char_count": 690,
      "word_count": 96,
      "start_pos": 176505,
      "end_pos": 177195,
      "chunk_index": 350,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_351",
      "text": ") or obesity‑related complications (such as non‑alcoholic fatty liver, sleep \napnoea, etc.). \nI\nA\n2.6: How should menopause‑related symptoms be evaluated in midlife women being engaged in the management of overweight and \nobesity?\n2.6.1 \nMenopause Rating Scale (MRS) may be used for the evaluation of menopausal symptoms, which includes physical, psychological, \nvasomotor, genitourinary and sexual domains. \nI\nB\n2.6.2\nThe impact of menopausal symptoms severity on weight‑related behaviours (diet, physical activity and sleep) should also be \nassessed.\nIV\nA\nManagement of overweight and obesity\n3.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 30,
          "overlap_chars": 597,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 30,
      "char_count": 597,
      "word_count": 85,
      "start_pos": 177095,
      "end_pos": 177692,
      "chunk_index": 351,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_352",
      "text": "physical activity and sleep) should also be \nassessed.\nIV\nA\nManagement of overweight and obesity\n3.1: How stepwise weight loss goals should be set for midlife women being engaged in the management of overweight and obesity?\n3.1.1 \nHealthcare providers should assess the readiness to engage in weight loss attempts by changing the current diet and physical \nactivity using behavioural modification.\nIV\nA\n3.1.2 \nRealistic and sustainable patient‑centric weight loss goals should be established after a detailed discussion with the midlife woman.\nIf feasible, family members should be involved and similar health goals should be planned for them. \nIV\nA\n3.1.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 30,
          "overlap_chars": 655,
          "overlap_percentage": 100.15290519877675
        }
      ],
      "primary_page": 30,
      "char_count": 654,
      "word_count": 100,
      "start_pos": 177592,
      "end_pos": 178247,
      "chunk_index": 352,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_353",
      "text": "e, family members should be involved and similar health goals should be planned for them. \nIV\nA\n3.1.3\nOverweight and obese women should be advised to reduce body weight to a normal BMI (18.5‑22.9 kg/m2). \nI\nA\n3.1.4 \nA step‑wise body‑weight loss goal should be set with a target weight loss of 0.5 kg per week attaining a weight loss of 5‑10% of \nbaseline body weight over a period of 6 months (clinically significant weight loss).\nI\nA\n3.2: What type of dietary recommendations should be advised for improving weight loss, anthropometric and metabolic health outcomes?\n3.2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 30,
          "overlap_chars": 572,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 30,
      "char_count": 572,
      "word_count": 97,
      "start_pos": 178147,
      "end_pos": 178719,
      "chunk_index": 353,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_354",
      "text": "ions should be advised for improving weight loss, anthropometric and metabolic health outcomes?\n3.2.1\nAn individualised diet plan should be recommended considering eating preferences, food habits and the health status of the \nparticipant.\nI\nA\n3.2.2\nThe meal pattern should be spread throughout the day preferably involving three major meals and two snacks. \nII\nA\n3.2.3\nThe daily dietary calorie intake should be based on the baseline caloric intake and level of physical activity of the midlife woman. \nI\nA\n3.2.4\nThe diet plan should incorporate an energy deficit of 500 kcal per day to achieve a weight loss of 0.5 kg body weight per week.\nI\nA\nContd...\n\nRanjan, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 30,
          "overlap_chars": 653,
          "overlap_percentage": 97.60837070254111
        },
        {
          "page_number": 31,
          "overlap_chars": 14,
          "overlap_percentage": 2.092675635276532
        }
      ],
      "primary_page": 30,
      "char_count": 669,
      "word_count": 112,
      "start_pos": 178619,
      "end_pos": 179288,
      "chunk_index": 354,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_355",
      "text": "0 kcal per day to achieve a weight loss of 0.5 kg body weight per week.\nI\nA\nContd...\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nContd...\nS. No.\nRecommendations\nGrade$\n3.2: What type of dietary recommendations should be advised for improving weight loss, anthropometric and metabolic health outcomes?\n3.2.5\nRestricted carbohydrate, good quality fat and a high protein diet is recommended for midlife women.\nII\nA\n3.2.6\nWomen should be counselled to consume foods rich in protein, calcium and iron in their daily diet to meet the estimated average \nrequirement (EAR).\nI\nA\n3.2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 30,
          "overlap_chars": 84,
          "overlap_percentage": 12.40768094534712
        },
        {
          "page_number": 31,
          "overlap_chars": 591,
          "overlap_percentage": 87.29689807976366
        }
      ],
      "primary_page": 30,
      "char_count": 677,
      "word_count": 112,
      "start_pos": 179188,
      "end_pos": 179865,
      "chunk_index": 355,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_356",
      "text": "ein, calcium and iron in their daily diet to meet the estimated average \nrequirement (EAR).\nI\nA\n3.2.7\nDietary fibre intake of 20‑30 g per day should be prescribed from whole grains, legumes, nuts, oilseeds, fruits and vegetables. \nI\nA\n3.2.8\nRestricted consumption of food products high in fat, sugar and salt (HFSS) should be emphasised. Salt intake should be limited to \nless than 5 g/day.\nI\nA\n3.2.9\nDietary intake of foods rich in phytoestrogen from the Indian diet should be encouraged. \nII\nC\n3.3: What type of physical activity recommendations should be advised for improving weight loss, anthropometric and metabolic health \noutcomes?\n3.3.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 31,
          "overlap_chars": 644,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 31,
      "char_count": 644,
      "word_count": 105,
      "start_pos": 179765,
      "end_pos": 180409,
      "chunk_index": 356,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_357",
      "text": "ons should be advised for improving weight loss, anthropometric and metabolic health \noutcomes?\n3.3.1\nMidlife women should be encouraged to avoid a sedentary lifestyle as far as possible by ensuring participation in dedicated \nexercise, household-related, work‑related and leisure‑related physical activities. \nII\nA\n3.3.2\nA stepwise progressive and personalised physical exercise regime based on body weight, presence of cardiometabolic risk factors, \nbone, muscle and joint health should be prescribed. \nII\nA\n3.3.3\nThe barriers and facilitators for adopting different types of physical exercises should also be considered while prescribing a \nphysical exercise regime. \nIV\nA\n3.3.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 31,
          "overlap_chars": 680,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 31,
      "char_count": 680,
      "word_count": 95,
      "start_pos": 180309,
      "end_pos": 180989,
      "chunk_index": 357,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_358",
      "text": "ysical exercises should also be considered while prescribing a \nphysical exercise regime. \nIV\nA\n3.3.4\nWomen should be encouraged to incorporate up to 300 min/week of moderate‑intensity aerobic physical activity or 150 min/\nweek of high‑intensity aerobic physical activity or an identical combination of moderate and high‑intensity exercise. \nI\nA\n3.3.5\nPreferably, daily 60 min of physical activity should be recommended including a combination of moderate‑intensity aerobic \nexercise (30 min), muscle strengthening engaging major muscle groups or balance exercise (15 min), and work‑related and/or \nhousehold‑related moderate physical activities (15 min). \nI\nB\n3.3.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 31,
          "overlap_chars": 665,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 31,
      "char_count": 665,
      "word_count": 93,
      "start_pos": 180889,
      "end_pos": 181554,
      "chunk_index": 358,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_359",
      "text": "15 min), and work‑related and/or \nhousehold‑related moderate physical activities (15 min). \nI\nB\n3.3.6\nWomen can participate in moderate‑intensity aerobic activities in short bouts (10‑15 min) throughout the day (2‑3 times). \nII\nB\n3.3.7\nThe talk test* should be used for self‑monitoring the intensity of aerobic activities.\nI\nA\n3.3.8\nYogic practices (including physically intensive yoga) can be prescribed for weight management and overall well‑being in midlife \nwomen. \nIII\nA\n3.4: What are the behaviour modification techniques that should be incorporated in weight management advice? \n3.4.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 31,
          "overlap_chars": 590,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 31,
      "char_count": 590,
      "word_count": 86,
      "start_pos": 181454,
      "end_pos": 182044,
      "chunk_index": 359,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_360",
      "text": "the behaviour modification techniques that should be incorporated in weight management advice? \n3.4.1\nBehaviour modification techniques such as realistic goal setting, motivational interviewing, and self‑monitoring strategies should be \nused.\nII\nB\n3.4.2\nWomen should be trained regarding problem‑solving skills such as defining problems, creating solutions and opting for the best \npossible choice. \nII\nB/C\n3.4.3\nCognitive restructuring skills such as identifying, challenging, and correcting the negative thoughts and emotions related to weight \nmanagement should be imparted.\nII\nB/C\n3.4.4\nFeedback on the accomplishments, achievements and scope for better progress should be given regularly.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 31,
          "overlap_chars": 693,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 31,
      "char_count": 693,
      "word_count": 93,
      "start_pos": 181944,
      "end_pos": 182637,
      "chunk_index": 360,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_361",
      "text": "edback on the accomplishments, achievements and scope for better progress should be given regularly.\nII\nB\n3.5: What is the role of menopausal hormone therapy (MHT) in a weight management program for midlife women?\n3.5.1\nMenopausal hormone therapy (MHT) is not indicated solely for weight management in midlife women.\nII\nA\n3.5.2\nWeight management by lifestyle interventions may help in improving the overall well‑being of midlife women with menopausal \nsymptoms.\nII\nA\nFollow‑up for sustainable weight loss\n4.1: What are the other important parameters in determining the overall improvement in midlife women after undergoing weight \nmanagement?\n4.1.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 31,
          "overlap_chars": 647,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 31,
      "char_count": 647,
      "word_count": 97,
      "start_pos": 182537,
      "end_pos": 183184,
      "chunk_index": 361,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_362",
      "text": "rs in determining the overall improvement in midlife women after undergoing weight \nmanagement?\n4.1.1\nIn addition to weight management, midlife women with obesity should be appraised and sensitised about the benefits of a healthy \nlifestyle on bone health, muscle strength and menopausal symptoms.\nII\nB\n4.2: What should be the duration, frequency and mode of follow‑up of midlife women during the intervention?\n4.2.1\nThe time schedule for the intervention phase of weight management should be decided on the basis of target weight loss to be \nachieved in the patient.\nIV\nA\n4.2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 31,
          "overlap_chars": 577,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 31,
      "char_count": 577,
      "word_count": 92,
      "start_pos": 183084,
      "end_pos": 183661,
      "chunk_index": 362,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_363",
      "text": "ement should be decided on the basis of target weight loss to be \nachieved in the patient.\nIV\nA\n4.2.2\nThe duration of the intervention phase should be planned such that the patient can lose 5‑10% body weight every 6 months till \nthe target body weight is achieved. \nI\nA\n4.2.3\nBimonthly contact should be planned in the initial stages of the intervention phase that can be reduced to monthly contact in the \nlater phase. \nII\nA/B\nContd...\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nContd...\nS. No.\nRecommendations\nGrade$\n4.2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 31,
          "overlap_chars": 436,
          "overlap_percentage": 69.53748006379585
        },
        {
          "page_number": 32,
          "overlap_chars": 189,
          "overlap_percentage": 30.14354066985646
        }
      ],
      "primary_page": 31,
      "char_count": 627,
      "word_count": 108,
      "start_pos": 183561,
      "end_pos": 184188,
      "chunk_index": 363,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_364",
      "text": "d Primary Care \nVolume 11  :  Issue 12  :  December 2022\nContd...\nS. No.\nRecommendations\nGrade$\n4.2.4\nA combination of physical (face‑to‑face and/or group counselling) and online meeting modalities/telephonic contacts can be used \nfor the follow-up\nII\nA\n4.3: What should be the duration, frequency and mode of contact during the maintenance phase of the weight management program for a \nmidlife woman?\n4.3.1\nWeight maintenance phase should be continued throughout life with sequential incorporation of parameters related to holistic \nwell‑being.\nIII\nA\n4.3.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 32,
          "overlap_chars": 556,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 32,
      "char_count": 556,
      "word_count": 83,
      "start_pos": 184088,
      "end_pos": 184644,
      "chunk_index": 364,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_365",
      "text": "oughout life with sequential incorporation of parameters related to holistic \nwell‑being.\nIII\nA\n4.3.2 \nFace‑to‑face contact can be maintained every three months coupled with a monthly contact using technological components such \nas text messages, telephonic calls and mobile applications.\nII\nA\n4.4: What advice should be given during the follow‑up phase for maintenance of weight in midlife women?\n4.4.1\nAt every contact, healthcare providers should reinforce healthy eating, physical activity and sleep habits and address barriers and \nchallenges faced during this phase. \nII\nA\n4.4.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 32,
          "overlap_chars": 583,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 32,
      "char_count": 583,
      "word_count": 85,
      "start_pos": 184544,
      "end_pos": 185127,
      "chunk_index": 365,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_366",
      "text": "l activity and sleep habits and address barriers and \nchallenges faced during this phase. \nII\nA\n4.4.2 \nDuring follow‑up visits, self‑monitoring through technological devices should be encouraged to maintain weight, dietary, physical \nactivity and sleep routine records.\nII\nA\n4.4.3\nThroughout weight maintenance, special attention should be given to behavioural strategies such as enhancing motivation, social \nsupport, self‑efficacy, problem‑solving, relapse prevention and addressing individualised barriers.\nII\nB\n4.4.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 32,
          "overlap_chars": 519,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 32,
      "char_count": 519,
      "word_count": 68,
      "start_pos": 185027,
      "end_pos": 185546,
      "chunk_index": 366,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.655700"
    },
    {
      "id": "chunk_367",
      "text": "self‑efficacy, problem‑solving, relapse prevention and addressing individualised barriers.\nII\nB\n4.4.4\nClinical and biochemical parameters such as blood glucose, lipid profile and blood pressure measurements should be done as per \nthe standard guidelines and/or advice by the treating doctor. \nIV\nA\n4.4.5\nAdequate and appropriate care of bone, muscle, joints and menopausal symptoms should be ensured during follow‑up contacts to \nensure holistic well‑being.\nIV\nB\n$Grade: Quality of evidence+strength of recommendation. Quality of evidence. I: High‑quality evidence; II: Moderate‑quality evidence; III: Low‑quality evidence; IV: Expert opinion. Strength of recommendation.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 32,
          "overlap_chars": 671,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 32,
      "char_count": 671,
      "word_count": 89,
      "start_pos": 185446,
      "end_pos": 186117,
      "chunk_index": 367,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_368",
      "text": "oderate‑quality evidence; III: Low‑quality evidence; IV: Expert opinion. Strength of recommendation. \nA: Strong recommendation; B: Moderate recommendation; C: Weak recommendation. *Kumari A, Chopra S, Ranjan P, Verma A, Malhotra A, Upadhyay A, Sharma AK, Vikram NK. Development and validation of \nComprehensive evaluation tool for weight management in midlife women. Under publication. **Talk test can be used to assess the intensity of aerobic exercises: comfortable speech denotes light intensity, speech with \nsome difficulty denotes moderate intensity and speech limited to phrases denotes vigorous intensity.[9]\nparticipation.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 32,
          "overlap_chars": 631,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 32,
      "char_count": 631,
      "word_count": 84,
      "start_pos": 186017,
      "end_pos": 186648,
      "chunk_index": 368,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_369",
      "text": "notes moderate intensity and speech limited to phrases denotes vigorous intensity.[9]\nparticipation.[189] The recommendations also highlight different \nbehavioural techniques including goal setting, problem-solving, \nmanaging triggers, and self-monitoring for sustainable weight \nloss. Behavioural modification can help in improving the \ncompliance to corrective dietary and activity recommendations \nrequired to maintain ideal weight in the long term.[223] In clinical \npractice, the behavioural lifestyle modifications should be \nrecommended in consideration with the maintenance of the \noverall health of midlife women.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 32,
          "overlap_chars": 622,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 32,
      "char_count": 622,
      "word_count": 76,
      "start_pos": 186548,
      "end_pos": 187170,
      "chunk_index": 369,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_370",
      "text": "hould be \nrecommended in consideration with the maintenance of the \noverall health of midlife women.\nBenefit to healthcare fraternity\nThe protocolised weight management module depicted in \n[Box 1] is a practical clinical tool for healthcare providers to \ndeliver appropriate weight management in midlife women. \nGenerally, healthcare providers encounter midlife women for \nother health-related issues such as diabetes, blood pressure, joint \npain, and distress.[10] Healthcare providers should counsel midlife \nwomen regarding the role of managing weight as an effective \nstrategy for maintaining overall health.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 32,
          "overlap_chars": 612,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 32,
      "char_count": 612,
      "word_count": 83,
      "start_pos": 187070,
      "end_pos": 187682,
      "chunk_index": 370,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_371",
      "text": "omen regarding the role of managing weight as an effective \nstrategy for maintaining overall health. They can also refer them \nto a multidisciplinary weight management team for customising a \nlifestyle modification approach.[57] The multidisciplinary team can \nuse the recommendations to facilitate a well-rounded approach \nin the management of obesity and associated adiposity-related \ncomorbidities.\nIn resource-constrained settings, the availability of experts \nfrom multidisciplinary teams might be limited.[310]The clinician \nand/or healthcare provider encountering midlife women with \nobesity are required to provide obesity care.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 32,
          "overlap_chars": 636,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 32,
      "char_count": 636,
      "word_count": 81,
      "start_pos": 187582,
      "end_pos": 188218,
      "chunk_index": 371,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_372",
      "text": "r healthcare provider encountering midlife women with \nobesity are required to provide obesity care.[311] Mostly, midlife \nwomen visit primary care physicians, family physicians, internists, \ngynaecologists, endocrinologists, and orthopaedicians for other \nhealth-related issues.[312]The recommendations provide clinical \npractice points for opportunistic screening and management of \nobesity in midlife women that can be incorporated by clinicians \nand allied healthcare providers from different healthcare \nspecialties in their daily clinical practice.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 32,
          "overlap_chars": 554,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 32,
      "char_count": 554,
      "word_count": 66,
      "start_pos": 188118,
      "end_pos": 188672,
      "chunk_index": 372,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_373",
      "text": "allied healthcare providers from different healthcare \nspecialties in their daily clinical practice.\nFurther, a significant proportion of women belonging to lower \nsocio-economic strata and/or residing in rural settings might have \naccess only to local primary healthcare centres and anganwadi. \nThese healthcare settings offer suboptimal obesity care due to \na lack of multidisciplinary teams, resources and time.[313] The \nwoman’s preference to initiate weight loss, motivation, education \nstatus, access to resources, daily lifestyle and income level becomes \nimportant in determining the appropriate weight management \napproach.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 32,
          "overlap_chars": 632,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 32,
      "char_count": 632,
      "word_count": 83,
      "start_pos": 188572,
      "end_pos": 189204,
      "chunk_index": 373,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_374",
      "text": "tyle and income level becomes \nimportant in determining the appropriate weight management \napproach. The protocolised treatment plan supplemented with \nhealth education material can help the primary care provider to \ninitiate optimum obesity care with limited resource availability.\nThe recommendations can help in capacity building by providing \nevidence and consensus-based weight management practices \nat both clinical and community level. The clinical practice \nrecommendations are simple, practical, and actionable statements \nto manage obesity in midlife women. This will ensure uniform \nand appropriate obesity treatment practices for midlife women \nwithin various healthcare settings.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 32,
          "overlap_chars": 692,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 32,
      "char_count": 692,
      "word_count": 90,
      "start_pos": 189104,
      "end_pos": 189796,
      "chunk_index": 374,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_375",
      "text": "and appropriate obesity treatment practices for midlife women \nwithin various healthcare settings.\nThe guideline promotes preventive obesity care in midlife women. \nThe current guideline highlights the following key areas: when to \ninitiate and engage midlife women for weight management, who \nshould provide obesity care, and which mode should be used to \ndeliver healthcare. These recommendations promote a proactive \napproach in managing obesity-related disorders in midlife women. \nThe practical application of these guidelines can help to manage\n\nRanjan, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 32,
          "overlap_chars": 552,
          "overlap_percentage": 97.52650176678446
        },
        {
          "page_number": 33,
          "overlap_chars": 14,
          "overlap_percentage": 2.4734982332155475
        }
      ],
      "primary_page": 32,
      "char_count": 566,
      "word_count": 79,
      "start_pos": 189696,
      "end_pos": 190264,
      "chunk_index": 375,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_376",
      "text": "in midlife women. \nThe practical application of these guidelines can help to manage\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nBox 1: Women‑centric weight management module for midlife women\nStep 1: Weight management counselling at midlife\nWHO should get it?\nOpportunistic screening and management for all women throughout the lifespan\nWomen in the late thirties before menopause transition should be made aware regarding obesity management\nWomen in the early forties experiencing menopausal tra",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 32,
          "overlap_chars": 84,
          "overlap_percentage": 14.023372287145241
        },
        {
          "page_number": 33,
          "overlap_chars": 514,
          "overlap_percentage": 85.80968280467445
        }
      ],
      "primary_page": 32,
      "char_count": 599,
      "word_count": 90,
      "start_pos": 190164,
      "end_pos": 190764,
      "chunk_index": 376,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_377",
      "text": "ld be made aware regarding obesity management\nWomen in the early forties experiencing menopausal transition\nFrom WHERE ?\nDifferent Health Clinics: Medical OPDs, Gynaecology, Community health care centres, etc.\nCommunity: Resident welfare association and institutes such as schools, colleges, corporate offices\nBy WHOM?\nPrimary Care Physicians, Family Physicians\nSpecialists: Orthopedicians, Gynaecologists, Endocrinologists, Internists\nCommunity Health Nurses\nRegistered Dietitians/Nutritionists\nBehavioural Health Specialists/Psychologists/Psychiatrists\nWHAT Type of advice?\nWeight management advice",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 33,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 33,
      "char_count": 600,
      "word_count": 68,
      "start_pos": 190664,
      "end_pos": 191264,
      "chunk_index": 377,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_378",
      "text": "vioural Health Specialists/Psychologists/Psychiatrists\nWHAT Type of advice?\nWeight management advice related to diet, physical activity and behavioural modification\nAwareness regarding appropriate weight maintenance\nBY WHAT MODE?\nMessage/advice disseminated through short videos, PowerPoint presentations, posters, booklets, diet charts, recipes etc.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 33,
          "overlap_chars": 350,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 33,
      "char_count": 350,
      "word_count": 39,
      "start_pos": 191164,
      "end_pos": 191514,
      "chunk_index": 378,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_379",
      "text": "minated through short videos, PowerPoint presentations, posters, booklets, diet charts, recipes etc.\nStep 2: Initiation of discussion\nEnsure privacy and confidentiality while initiating discussion\nIntroduce obesity as a health issue\nAsk for woman’s perception and problems associated with weight gain\nExplain benefits of weight reduction\nUse patient‑centric language\nAvoid blaming and be supportive\nStep 3: Assess the readiness and motivation to initiate weight management counselling\nIf the participant is eager to initiate:\nCounsel the woman for the next stages of lifestyle modification (screening",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 33,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 33,
      "char_count": 600,
      "word_count": 83,
      "start_pos": 191414,
      "end_pos": 192014,
      "chunk_index": 379,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_380",
      "text": "ant is eager to initiate:\nCounsel the woman for the next stages of lifestyle modification (screening, management and follow‑up)\nEvaluate the participant’s degree of obesity, associated risk factors and lifestyle‑related behaviour\nIf the participant is indecisive and reluctant to initiate lifestyle modification:\nBe supportive and invite for discussion\nReinforce the benefits of weight loss\nAssess the reason associated with unwillingness\nTry to solve the individual’s issues and motivate her to initiate lifestyle modification\nStep 4: Anthropometric assessment\nMeasure height, weight, body fat, and waist circumference.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 33,
          "overlap_chars": 620,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 33,
      "char_count": 620,
      "word_count": 85,
      "start_pos": 191914,
      "end_pos": 192534,
      "chunk_index": 380,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_381",
      "text": "ication\nStep 4: Anthropometric assessment\nMeasure height, weight, body fat, and waist circumference.\nCalculate body mass index (BMI) using the height and weight measurements,\nBMI=Weight (kg)/Height2 (m2)\nIdentify the following indications for initiating weight management:\nBMI in the overweight category (23‑24.9 kg/m2) or obese category (≥25kg/m2), and/or;\nBody fat >30%, and/or;\nWaist circumference >80 cm\nStep 5: Detailed clinical assessment\nMedical history:\nAssess the previous history of weight gain, women‑centric risk factors, previous weight loss attempts, family history, etc.\nAssess cardiometabolic risk factors (abnormal blood sugar, increased blood pressure, dyslipidaemia).",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 33,
          "overlap_chars": 686,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 33,
      "char_count": 686,
      "word_count": 90,
      "start_pos": 192434,
      "end_pos": 193120,
      "chunk_index": 381,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_382",
      "text": "Assess cardiometabolic risk factors (abnormal blood sugar, increased blood pressure, dyslipidaemia).\nIdentify obesity‑related comorbidities (non‑alcoholic fatty liver, sleep apnoea, joint issues, polycystic ovary syndrome, etc).\nBiochemical assessment: Assess biochemical parameters such as lipid profile, blood glucose level, thyroid test, C‑ reactive protein, as per indications.\nMenopausal health assessment:\nAssess the presence and severity of menopausal symptoms using the Menopause Rating Scale (MRS) to evaluate physical, psychological, vasomotor, \ngenitourinary and sexual domains.\nEvaluate the impact of menopausal symptoms severity on weight‑related lifestyle practices.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 33,
          "overlap_chars": 680,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 33,
      "char_count": 680,
      "word_count": 82,
      "start_pos": 193020,
      "end_pos": 193700,
      "chunk_index": 382,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_383",
      "text": "domains.\nEvaluate the impact of menopausal symptoms severity on weight‑related lifestyle practices.\nStep 6: Dietary, physical activity and psychosocial assessment\nDietary assessment:\nAssess dietary intake using 24‑h recall.\nAssess dietary diversity via intake of foods from various food groups.\nEvaluate dietary behaviour and barriers in maintaining a healthy diet via a validated questionnaire.\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nthe ever-growing burden of obesity and associated cardiometabolic \ndiseases in different healthcare systems of the country.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 33,
          "overlap_chars": 396,
          "overlap_percentage": 59.45945945945946
        },
        {
          "page_number": 34,
          "overlap_chars": 269,
          "overlap_percentage": 40.390390390390394
        }
      ],
      "primary_page": 33,
      "char_count": 666,
      "word_count": 93,
      "start_pos": 193600,
      "end_pos": 194267,
      "chunk_index": 383,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_384",
      "text": "of obesity and associated cardiometabolic \ndiseases in different healthcare systems of the country.\nSuggestions for policy-makers\nA substantial increase in the prevalence of overweight and \nobesity, especially in rural residents and older adults is projected \nin India by 2040.[314] The policy makers should disseminate \nrecommended clinical practice points at medical, curriculum \nand public health levels to manage the burden of obesity and \nallied comorbidities. The policy makers should ensure resources \nfor the application of the evidence-based clinical practice \npoints at different levels of healthcare settings. The clinicians \nBox 1: Contd...",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 34,
          "overlap_chars": 653,
          "overlap_percentage": 100.15337423312884
        }
      ],
      "primary_page": 34,
      "char_count": 652,
      "word_count": 90,
      "start_pos": 194167,
      "end_pos": 194820,
      "chunk_index": 384,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_385",
      "text": "linical practice \npoints at different levels of healthcare settings. The clinicians \nBox 1: Contd...\nPhysical activity assessment\nAssess detailed physical activity habits using Madras Diabetes Research Foundation ‑ Physical Activity Questionnaire (MPAQ). Assess the type, \nfrequency, duration and intensity of physical activity\nAssess the number of sedentary hours (screen and sitting time) spent in the entire day.\nValidated questionnaire to assess barriers faced in being physically active by midlife women.\nPsychological assessment:\nAssess the presence of a diagnosed psychiatric disorder (Depression, Anxiety or Eating Disorder).",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 34,
          "overlap_chars": 633,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 34,
      "char_count": 633,
      "word_count": 85,
      "start_pos": 194720,
      "end_pos": 195353,
      "chunk_index": 385,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_386",
      "text": "t:\nAssess the presence of a diagnosed psychiatric disorder (Depression, Anxiety or Eating Disorder).\nUse DASS‑21 for initial screening of depression, anxiety and stress.\nRefer to a mental health professional, if indicated.\nManagement of overweight and obesity\nStep 7: Goal setting:\nEstablish realistic, sustainable and patient‑centric weight loss goals.\nAdvice to reduce body weight to the BMI equal to or <23 kg/m2.\nStep‑wise body‑weight loss goal of 0.5 kg per week acquiring 5‑10% of clinically significant weight loss.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 34,
          "overlap_chars": 522,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 34,
      "char_count": 522,
      "word_count": 78,
      "start_pos": 195253,
      "end_pos": 195775,
      "chunk_index": 386,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_387",
      "text": "wise body‑weight loss goal of 0.5 kg per week acquiring 5‑10% of clinically significant weight loss.\nStep 8: Lifestyle management advice\nDietary management:\nCustomise diet plan considering eating preferences, food habits and health status of the patient\nPlan energy deficit diet of 500 kcal/day for 0.5 kg body weight loss per week\nAdvise a restricted carbohydrate, good quality fat and high protein diet\nSpread meal pattern throughout the day (Three major meals and Two snacks)\nCounsel women to consume foods rich in protein, calcium and iron\nPrescribe dietary fibre intake of 20‑30 g/day (whole gra",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 34,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 34,
      "char_count": 600,
      "word_count": 95,
      "start_pos": 195675,
      "end_pos": 196275,
      "chunk_index": 387,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_388",
      "text": "ume foods rich in protein, calcium and iron\nPrescribe dietary fibre intake of 20‑30 g/day (whole grains, legumes, nuts, oilseeds, fruits and vegetables)\nEncourage dietary intake of foods rich in phytoestrogen\nEmphasise restricted consumption of food products high in fat, sugar and salt (HFSS foods)\nEncourage self‑monitoring of dietary behaviour using a food diary\nPhysical activity management:\nPrescribe stepwise progressive and personalized physical activity regime based on body weight, cardio‑metabolic, bone, muscle and joint health\nEncourage to incorporate up to 300 min/week of moderate‑inten",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 34,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 34,
      "char_count": 600,
      "word_count": 84,
      "start_pos": 196175,
      "end_pos": 196775,
      "chunk_index": 388,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_389",
      "text": "tabolic, bone, muscle and joint health\nEncourage to incorporate up to 300 min/week of moderate‑intensity aerobic physical activity or 150 min/week of high‑intensity aerobic physical \nactivity\nRecommend a combination of moderate‑intensity aerobic exercise (30 min), muscle strengthening (15 min), work‑related and/or household‑related \nactivities (15 min)\nEncourage women to participate in the aerobic exercise in short bouts (10‑15 min) throughout the day (2‑3 times)\nConsider barriers and facilitators while prescribing physical activity advice\nPrescribe intensive yoga for weight management and ove",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 34,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 34,
      "char_count": 600,
      "word_count": 80,
      "start_pos": 196675,
      "end_pos": 197275,
      "chunk_index": 389,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_390",
      "text": "rs while prescribing physical activity advice\nPrescribe intensive yoga for weight management and overall well‑being\nBehavioral modification management:\nUse progressive realistic goal setting, motivational interviewing and self‑monitoring strategies\nTrain women for improving problem‑solving skills and cognitive structure skills\nGive feedback on accomplishment, achievement and scope for better progress\nStep 9: Follow‑up\nPlan duration, frequency and mode of follow‑up:\nDuration: 12 months, ranging from 6‑18 months based on the targeted weight loss.\nFrequency: Once or twice a month at initial stages followed by every 2‑3 months at a later stage.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 34,
          "overlap_chars": 648,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 34,
      "char_count": 648,
      "word_count": 89,
      "start_pos": 197175,
      "end_pos": 197823,
      "chunk_index": 390,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_391",
      "text": "s.\nFrequency: Once or twice a month at initial stages followed by every 2‑3 months at a later stage.\nMode: Face‑to‑face individualised/group counselling coupled with telephonic contacts.\nPlan advise to be provided during follow‑ups:\nReinforce advice related to a healthy diet and physically active behaviour.\nMotivate and provide support to improve adherence for maintaining healthy lifestyle behaviour.\nEncourage self‑monitoring through technological devices such as mobile applications, pedometers etc.\nFollow up checklist:\nWere you able to lose 0.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 34,
          "overlap_chars": 550,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 34,
      "char_count": 550,
      "word_count": 77,
      "start_pos": 197723,
      "end_pos": 198273,
      "chunk_index": 391,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_392",
      "text": "l devices such as mobile applications, pedometers etc.\nFollow up checklist:\nWere you able to lose 0.5‑1 kg weight per week?\nHave you followed a balanced diet comprising foods from various food groups such as fruits, vegetables, high fiber cereals and legumes and low‑fat \ndairy?\nHave you included protein‑rich foods in your diet?\nHave you restricted/avoided high fat, sugar and salt (HFSS) foods?\nHave you initiated an exercise regime including aerobic and/or strengthening exercises?\nAre you mindful of the sitting and screen time?\n\nRanjan, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 34,
          "overlap_chars": 532,
          "overlap_percentage": 97.08029197080292
        },
        {
          "page_number": 35,
          "overlap_chars": 14,
          "overlap_percentage": 2.5547445255474455
        }
      ],
      "primary_page": 34,
      "char_count": 548,
      "word_count": 86,
      "start_pos": 198173,
      "end_pos": 198721,
      "chunk_index": 392,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_393",
      "text": "obic and/or strengthening exercises?\nAre you mindful of the sitting and screen time?\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nand allied healthcare professionals should be provided with \nknowledge regarding appropriate obesity care including lifestyle \nmodification, pharmacological and surgical interventions. \nHealthcare providers in resource-constrained settings should be \nappraised about the additional challenges in managing obesity.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 34,
          "overlap_chars": 84,
          "overlap_percentage": 15.412844036697248
        },
        {
          "page_number": 35,
          "overlap_chars": 459,
          "overlap_percentage": 84.22018348623853
        }
      ],
      "primary_page": 34,
      "char_count": 545,
      "word_count": 72,
      "start_pos": 198621,
      "end_pos": 199166,
      "chunk_index": 393,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_394",
      "text": "ource-constrained settings should be \nappraised about the additional challenges in managing obesity. \nIn addition, the practitioners should empower midlife women \nwith the knowledge related to appropriate eating, physical activity \nand other lifestyle-related behaviours through providing health \neducation material (like posters, brochures, newsletters, etc.), \nproviding necessary and appropriate referrals and managing \nsupport groups at the clinical settings.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 35,
          "overlap_chars": 463,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 35,
      "char_count": 463,
      "word_count": 56,
      "start_pos": 199066,
      "end_pos": 199529,
      "chunk_index": 394,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_395",
      "text": "providing necessary and appropriate referrals and managing \nsupport groups at the clinical settings. Healthcare settings \nshould establish ‘women wellness clinics’ for multidisciplinary \nmanagement of obesity and allied health disorders and ensure \nactive and regular participation of the clinicians from different \nspecialties and allied healthcare professionals.\nIn addition to caregivers, midlife women should also be \nempowered with the correct knowledge to maintain healthy \nlifestyle-related behaviours. These women experience a number of \nbiopsychosocial changes.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 35,
          "overlap_chars": 570,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 35,
      "char_count": 570,
      "word_count": 72,
      "start_pos": 199429,
      "end_pos": 199999,
      "chunk_index": 395,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_396",
      "text": "healthy \nlifestyle-related behaviours. These women experience a number of \nbiopsychosocial changes. Poor health literacy at this stage hampers \nthe ability of midlife women to understand and implement health-\nrelated information to manage overall health.[315] The promotion \nof the use of artificial intelligence to support weight loss-related \nbehaviour change in adults through improving self-regulation, \ndecision making, problem-solving and pattern identification \ncan help in improving KAP of midlife women towards weight \nmanagement.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 35,
          "overlap_chars": 540,
          "overlap_percentage": 100.18552875695732
        }
      ],
      "primary_page": 35,
      "char_count": 539,
      "word_count": 70,
      "start_pos": 199899,
      "end_pos": 200439,
      "chunk_index": 396,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_397",
      "text": "g and pattern identification \ncan help in improving KAP of midlife women towards weight \nmanagement. The policy makers should introduce policies and \nprograms to educate midlife women experiencing menopausal \ntransitions and associated health implications including weight \ngain, musculoskeletal and cardiometabolic health. Some initiatives \nlike Club 35+, and Midlife Healthcare Clinics taken up by the \nIndian Menopausal Society can be replicated to empower midlife \nwomen with appropriate medical advice with the support of \nhealthcare professionals.\nPolicy makers should use mass-media campaigns to transform \nweight-related behaviour.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 35,
          "overlap_chars": 639,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 35,
      "char_count": 639,
      "word_count": 84,
      "start_pos": 200339,
      "end_pos": 200978,
      "chunk_index": 397,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_398",
      "text": "professionals.\nPolicy makers should use mass-media campaigns to transform \nweight-related behaviour. This will help in exposing a significant \nproportion of women with corrective weight-related information \nusing print media (leaflets, posters, brochures) and social media \n(websites, newsletters, television). These campaigns focus on \nsimple and actionable corrective eating behaviours such as \nconsumption of milk, pulses and fruits and vegetables, optimum \nwater intake and limited consumption of HFSS foods.[316] \nGenerally, campaigns promote regular participation in physical \nactivities like walking, jogging, dancing and aerobics.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 35,
          "overlap_chars": 638,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 35,
      "char_count": 638,
      "word_count": 80,
      "start_pos": 200878,
      "end_pos": 201516,
      "chunk_index": 398,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_399",
      "text": "s promote regular participation in physical \nactivities like walking, jogging, dancing and aerobics. Although \ncampaigns promote positive health behaviours in the short \nterm, often their results do not translate in the long term due \nto competing cues for unhealthy behaviours enforced by an \nobesogenic environment.[317] Hence, a more comprehensive and \nintegrated approach is required to help address overweight and \nobesity in midlife women, as has been discussed in this document.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 35,
          "overlap_chars": 485,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 35,
      "char_count": 485,
      "word_count": 70,
      "start_pos": 201416,
      "end_pos": 201901,
      "chunk_index": 399,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_400",
      "text": "ed to help address overweight and \nobesity in midlife women, as has been discussed in this document.\nStatement\nConsidering its potential for widespread public health impact \nand general interest, the guidelines in multiple versions \n(comprehensive, concise, executive summary, good clinical \npractice points) have been submitted for simultaneous publication \nand/or co-publication (either fully or a part of it) in Diabetes \nand Metabolic Syndrome: Clinical Research and Reviews, \nNational Medical Journal of India, Journal of Midlife Health, \nJournal of Family Medicine and Primary Care, JAPI: Journ",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 35,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 35,
      "char_count": 600,
      "word_count": 84,
      "start_pos": 201801,
      "end_pos": 202401,
      "chunk_index": 400,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_401",
      "text": "urnal of India, Journal of Midlife Health, \nJournal of Family Medicine and Primary Care, JAPI: Journal of \nthe Association of Physicians of India, and Indian Journal of \nMedical Specialities Journal of Obstetrics and Gynaecology of \nIndia. The guidelines can be submitted to some more journals \nfor publication. Besides, the guidelines can be published on the \ngovernment’s website and AIIMS, New Delhi’s website.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 35,
          "overlap_chars": 413,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 35,
      "char_count": 413,
      "word_count": 62,
      "start_pos": 202301,
      "end_pos": 202714,
      "chunk_index": 401,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_402",
      "text": "esides, the guidelines can be published on the \ngovernment’s website and AIIMS, New Delhi’s website.\nAcknowledgements\nThe guidelines have been developed in association with the \nfollowing National Bodies and Societies: (i) Federation of \nObstetric and Gynaecological Societies of India, (ii) Indian \nMenopause Society, (iii) Association of Physicians of India, \n(iii) Academy of Family Physicians of India, (iv) Association of \nObstetricians & Gynaecologists of Delhi and (v) Indian Dietetic \nAssociation.\nFinancial support and sponsorship\nThe study was financially supported by the SEED Division, \nDepartment of Science and Technology, Government of India.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 35,
          "overlap_chars": 657,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 35,
      "char_count": 657,
      "word_count": 90,
      "start_pos": 202614,
      "end_pos": 203271,
      "chunk_index": 402,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_403",
      "text": "ancially supported by the SEED Division, \nDepartment of Science and Technology, Government of India.\nConflicts of interest\nThere are no conflicts of interest.\nReferences\n1. \nGarawi F, Devries K, Thorogood N, Uauy R. Global \ndifferences between women and men in the prevalence of \nobesity: Is there an association with gender inequality?. Eur \nJ Clin Nutr 2014;68:1101–6.\n2. \nChopra S, Sharma KA, Ranjan P, Malhotra A, Vikram NK, \nKumari A. Weight management module for perimenopausal \nwomen: A practical guide for gynecologists. J Midlife Health \n2019;10:165-72.\n3. \nThurston RC, Ewing LJ, Low CA, Christie AJ, Levine MD.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 35,
          "overlap_chars": 621,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 35,
      "char_count": 621,
      "word_count": 95,
      "start_pos": 203171,
      "end_pos": 203792,
      "chunk_index": 403,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_404",
      "text": "ogists. J Midlife Health \n2019;10:165-72.\n3. \nThurston RC, Ewing LJ, Low CA, Christie AJ, Levine MD. \nBehavioral weight loss for the management of menopausal \nhot flashes: A pilot study. Menopause 2015;22:59-65.\n4. \nRathnayake N, Alwis G, Lenora J, Mampitiya I, \nLekamwasam S.Effect of health-promoting lifestyle \nmodification education on knowledge, attitude, and \nquality of life of postmenopausal women. Biomed Res \nInt2020;2020:3572903. doi: 10.1155/2020/3572903.\n5. \nLumsden MA, Hor K. Impact of obesity on the health of \nwomen in midlife. TOG 2015;17:201-8.\n6. \nKapoor E, Collazo-Clavell ML, Faubion SS.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 35,
          "overlap_chars": 609,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 35,
      "char_count": 609,
      "word_count": 86,
      "start_pos": 203692,
      "end_pos": 204301,
      "chunk_index": 404,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_405",
      "text": "on the health of \nwomen in midlife. TOG 2015;17:201-8.\n6. \nKapoor E, Collazo-Clavell ML, Faubion SS. Weight \ngain in women at midlife: A concise review of the \npathophysiology and strategies for management. Mayo \nClin Proc 2017;92:1552-8.\n7. \nMuzammil S, Lopes G. Lack of primary health care services \nin developing countries during pandemic: An urgent \nreminder!. J Fam Med Dis Prev 2021;7:138.\n8. \nChopra S, Ranjan P, Malhotra A, Verma A, Kumari A, \nSharma AK, et al.Perceived risk factors for weight gain, \nbarriers and facilitators related to weight loss experienced\n\nRanjan, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 35,
          "overlap_chars": 570,
          "overlap_percentage": 97.26962457337885
        },
        {
          "page_number": 36,
          "overlap_chars": 14,
          "overlap_percentage": 2.3890784982935154
        }
      ],
      "primary_page": 35,
      "char_count": 586,
      "word_count": 92,
      "start_pos": 204201,
      "end_pos": 204787,
      "chunk_index": 405,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_406",
      "text": "ctors for weight gain, \nbarriers and facilitators related to weight loss experienced\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nby perimenopausal women: Focus Group study and \nthematic analysis. Menopause 2021;29. [doi: 10.1097/\nGME.0000000000001909].\n9. \nBrunetti M, Shemilt I, Pregno S, Vale L, Oxman AD, Lord J, \net al. GRADE guidelines: 10. Considering resource use and \nrating the quality of economic evidence. JClin Epidemiol \n2013;66:140-50.\n10. Santoro N, Epperson CN, Mathews SB. Menopausal \nsymptoms and their management. Endocrinol Metab Clin \nNorth Am 2015;44:497-515.\n11.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 35,
          "overlap_chars": 84,
          "overlap_percentage": 12.209302325581394
        },
        {
          "page_number": 36,
          "overlap_chars": 602,
          "overlap_percentage": 87.5
        }
      ],
      "primary_page": 35,
      "char_count": 688,
      "word_count": 100,
      "start_pos": 204687,
      "end_pos": 205375,
      "chunk_index": 406,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_407",
      "text": "SB. Menopausal \nsymptoms and their management. Endocrinol Metab Clin \nNorth Am 2015;44:497-515.\n11. Meeta M, Digumarti L, Agarwal N, Vaze N, Shah R, Malik S. \nClinical practice guidelines on menopause: *An executive \nsummary and recommendations: Indian menopause society \n2019-2020. J Midlife Health 2020;11:55-95.\n12. Prasad JB, Tyagi NK, Verma P. Age at menopause in India: \nA systematic review. Diabetes Metab Syndr 2021;15:373-7.\n13. Greendale GA, Sternfeld B, Huang M, Han W, Karvonen-\nGutierrez C, Ruppert K, et al. Changes in body composition \nand weight during the menopause transition. JCI Insight \n2019;4:e124865.\n14.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 36,
          "overlap_chars": 628,
          "overlap_percentage": 100.15948963317385
        }
      ],
      "primary_page": 36,
      "char_count": 627,
      "word_count": 92,
      "start_pos": 205275,
      "end_pos": 205903,
      "chunk_index": 407,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_408",
      "text": "es in body composition \nand weight during the menopause transition. JCI Insight \n2019;4:e124865.\n14. Montazeri SA, Tehrani FR, Yarandi RB, Erfani H, \nMansournia MA, Azizi F. Effect of aging, menopause, and \nage at natural menopause on the trend in body mass index: A \n15-year population-based cohort. FertilSteril 2019;111:780-6.\n15. Karvonen-Gutierrez C, Kim C. Association of mid-life \nchanges in body size, body composition and obesity \nstatus with the menopausal transition. Healthcare (Basel) \n2016;4:42.\n16. Leeners B, Geary N, Tobler PN, Asarian L. Ovarian hormones \nand obesity. Hum Reprod Update 2017;23:300-21.\n17. Ko SH, Kim HS.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 36,
          "overlap_chars": 639,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 36,
      "char_count": 639,
      "word_count": 94,
      "start_pos": 205803,
      "end_pos": 206442,
      "chunk_index": 408,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_409",
      "text": "r PN, Asarian L. Ovarian hormones \nand obesity. Hum Reprod Update 2017;23:300-21.\n17. Ko SH, Kim HS. Menopause-associated lipid metabolic \ndisorders and foods beneficial for postmenopausal women. \nNutrients 2020;12:202.\n18. Anklesaria BS. The staging of menopause. J South Asian \nFeder Menopause Soc 2013;1:1-3.\n19. Chopra S, Malhotra A, Ranjan P, Vikram NK, Sarkar S, \nSiddhu A, et al. Predictors of successful weight loss \noutcomes amongst individuals with obesity undergoing \nlifestyle interventions: A systematic review. Obes Rev \n2021;22:e13148.\n20. Altmann TK. Attitude: A concept analysis2008;43:144–50.\ndoi:10.1111/j.1744-6198.2008.00106.x\n21.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 36,
          "overlap_chars": 651,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 36,
      "char_count": 651,
      "word_count": 86,
      "start_pos": 206342,
      "end_pos": 206993,
      "chunk_index": 409,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_410",
      "text": "20. Altmann TK. Attitude: A concept analysis2008;43:144–50.\ndoi:10.1111/j.1744-6198.2008.00106.x\n21. Lytle LA, Nicastro HL, Roberts SB, Evans M, Jakicic JM, \nLaposky AD, et al. Accumulating data to optimally predict \nobesity treatment (ADOPT) core measures: Behavioral \ndomain. Obesity 2018;26:S16-24.\n22. Reethesh SR, Ranjan P, Arora C, Kaloiya GS, Vikram \nNK, Dwivedi SN, et al. Development and validation of a \nquestionnaire assessing knowledge, attitude, and practices \nabout obesity among obese individuals. Indian J Endocrinol \nMetab 2019;23:102-10.\n23. De Vriendt T, Matthys C, Verbeke W, Pynaert I, De Henauw S.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 36,
          "overlap_chars": 619,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 36,
      "char_count": 619,
      "word_count": 86,
      "start_pos": 206893,
      "end_pos": 207512,
      "chunk_index": 410,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_411",
      "text": "J Endocrinol \nMetab 2019;23:102-10.\n23. De Vriendt T, Matthys C, Verbeke W, Pynaert I, De Henauw S. \nDeterminants of nutrition knowledge in young and middle-\naged Belgian women and the association with their dietary \nbehaviour. Appetite 2009;52:788-92.\n24. Su MC, Lin HR, Chu NF, Huang CH, Tsao LI. Weight loss \nexperiences of obese perimenopausal women with \nmetabolic syndrome. JClin Nurs 2015;24:1849-59.\n25. Vallance JK, Murray TC, Johnson ST, Elavsky S. Understanding \nphysical activity intentions and behavior in postmenopausal \nwomen: an application of the theory of planned behavior. \nInt J Behav Med 2011;18:139-49.\n26. Alharbi RD, Mahrus AM, Alarabi AA, Alraddadi DM.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 36,
          "overlap_chars": 678,
          "overlap_percentage": 100.14771048744461
        }
      ],
      "primary_page": 36,
      "char_count": 677,
      "word_count": 101,
      "start_pos": 207412,
      "end_pos": 208090,
      "chunk_index": 411,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_412",
      "text": "nned behavior. \nInt J Behav Med 2011;18:139-49.\n26. Alharbi RD, Mahrus AM, Alarabi AA, Alraddadi DM. \nAssessment of menopausal symptoms severity among \nfemale school teachers and their knowledge, attitudes, and \npractices. Obstet Gynecol 2021;9:299-316.\n27. Khashayar P, Qorbani M, Keshtkar A, Khashayar P, Ziaee A, \nLarijani B. Awareness of osteoporosis among female head \nof household: An Iranian experience. Arch Osteoporos \n2017;12:36.\n28. Mohd Hatta NNKN, Nurumal MS, Isa MLM, Daud A, \nIbrahim M, Sharifudin MA, et al. Knowledge and attitudes \nof maintaining bone health among post-menopausal women \nin Malaysia. Cent Asian J Glob Health 2019;8:348.\n29.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 36,
          "overlap_chars": 658,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 36,
      "char_count": 658,
      "word_count": 96,
      "start_pos": 207990,
      "end_pos": 208648,
      "chunk_index": 412,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_413",
      "text": "ining bone health among post-menopausal women \nin Malaysia. Cent Asian J Glob Health 2019;8:348.\n29. Prairie BA, Wisniewski SR, Luther J, Hess R, Thurston RC, \nWisner KL, et al. Symptoms of depressed mood, disturbed \nsleep, and sexual problems in midlife women: Cross-\nsectional data from the study of women’s health across \nthe nation. J Womens Health (Larchmt) 2015;24:119-26.\n30. El Hage C, Hallit S, Akel M, Dagher E. Osteoporosis \nawareness and health beliefs among Lebanese women aged \n40 years and above. Osteoporos Int 2019;30:771-86.\n31. McNeil J, Liepert M, Brenner DR, Courneya KS, \nFriedenreich CM.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 36,
          "overlap_chars": 610,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 36,
      "char_count": 610,
      "word_count": 95,
      "start_pos": 208548,
      "end_pos": 209158,
      "chunk_index": 413,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_414",
      "text": ". Osteoporos Int 2019;30:771-86.\n31. McNeil J, Liepert M, Brenner DR, Courneya KS, \nFriedenreich CM. Behavioral predictors of weight regain \nin postmenopausal women: Exploratory results from \nthe breast cancer and exercise trial in Alberta. Obesity \n2019;27:1451-63.\n32. Sharifi N, Mahdavi R, Ebrahimi-Mameghani M. Perceived \nbarriers to weight loss programs for overweight or obese \nwomen. Health Promot Perspect 2013;3:11–22.\n33. Ali AM, Ahmed AH, Smail L. Psychological climacteric \nsymptoms and attitudes toward menopause among Emirati \nwomen. Int J Environ Res Public Health 2020;17:5028.\n34. Kwak EK, Park HS, Kang NM.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 36,
          "overlap_chars": 624,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 36,
      "char_count": 624,
      "word_count": 89,
      "start_pos": 209058,
      "end_pos": 209682,
      "chunk_index": 414,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_415",
      "text": "e among Emirati \nwomen. Int J Environ Res Public Health 2020;17:5028.\n34. Kwak EK, Park HS, Kang NM. Menopause knowledge, \nattitude, symptom and management among midlife \nemployed women. J Menopausal Med 2014;20:118-25.\n35. Pimenta F, Leal I, Maroco J, Ramos C. Menopause Symptoms’ \nSeverity Inventory (MSISSI-38): Assessing the frequency and \nintensity of symptoms. Climacteric 2012;15:143-52.\n36. McArthur D, Dumas A, Woodend K, Beach S, Stacey D. \nFactors influencing adherence to regular exercise in middle-\naged women: A qualitative study to inform clinical practice. \nBMC Womens Health 2014;14:49.\n37. Chan CY, Subramaniam S, Chin KY, Ima-Nirwana S, \nMuhammad N, Fairus A, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 36,
          "overlap_chars": 685,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 36,
      "char_count": 685,
      "word_count": 102,
      "start_pos": 209582,
      "end_pos": 210267,
      "chunk_index": 415,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_416",
      "text": "Health 2014;14:49.\n37. Chan CY, Subramaniam S, Chin KY, Ima-Nirwana S, \nMuhammad N, Fairus A, et al. Levels of knowledge, beliefs, \nand practices regarding osteoporosis and the associations \nwith bone mineral density among populations more than \n40 years old in Malaysia. IntJEnviron ResPublic Health \n2019;16:4115.\n38. Hamid TKA. Thinking in Circles About Obesity: Applying \nSystems Thinking to Weight Management. New York: \nSpringer; 2009.\n39. Wolf AM, Woodworth KA. Obesity prevention: Recommended \nstrategies and challenges. Am J Med 2009;122(4 Suppl \n1):S19–23.\n40. Foster D, Sanchez-Collins S, Cheskin LJ.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 36,
          "overlap_chars": 611,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 36,
      "char_count": 611,
      "word_count": 87,
      "start_pos": 210167,
      "end_pos": 210778,
      "chunk_index": 416,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_417",
      "text": "s and challenges. Am J Med 2009;122(4 Suppl \n1):S19–23.\n40. Foster D, Sanchez-Collins S, Cheskin LJ. Multidisciplinary \nteam-based obesity treatment in patients with diabetes: \nCurrent practices and the state of the science. Diabetes \nSpectr 2017;30:244-9. doi: 10.2337/ds17-0045. Erratum \nin: Diabetes Spectr 2018;31:119.\n41. Cochrane AJ, Dick B, King NA, Hills AP, Kavanagh \nDJ. Developing dimensions for a multicomponent \nmultidisciplinary approach to obesity management: A \nqualitative study. BMC Public Health 2017;17:814.\n42. Pearce C, Rychetnik L, Wutzke S, Wilson A. Obesity\n\nRanjan, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 36,
          "overlap_chars": 582,
          "overlap_percentage": 97.32441471571906
        },
        {
          "page_number": 37,
          "overlap_chars": 14,
          "overlap_percentage": 2.341137123745819
        }
      ],
      "primary_page": 36,
      "char_count": 598,
      "word_count": 83,
      "start_pos": 210678,
      "end_pos": 211276,
      "chunk_index": 417,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_418",
      "text": "MC Public Health 2017;17:814.\n42. Pearce C, Rychetnik L, Wutzke S, Wilson A. Obesity\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nprevention and the role of hospital and community-based \nhealth services: A scoping review. BMC Health Serv Res \n2019;19:453.\n43. Sanchez-Ramirez DC, Long H, Mowat S, Hein C. Obesity \neducation for front-line healthcare providers. BMC Med \nEduc 2018;18:278.\n44. Johnson KM, Weinhold KR, Andridge R, Arnold K, Chu PP, \nOrchard TS.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 36,
          "overlap_chars": 84,
          "overlap_percentage": 14.973262032085561
        },
        {
          "page_number": 37,
          "overlap_chars": 475,
          "overlap_percentage": 84.67023172905526
        }
      ],
      "primary_page": 36,
      "char_count": 561,
      "word_count": 88,
      "start_pos": 211176,
      "end_pos": 211737,
      "chunk_index": 418,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_419",
      "text": ". BMC Med \nEduc 2018;18:278.\n44. Johnson KM, Weinhold KR, Andridge R, Arnold K, Chu PP, \nOrchard TS. Associations of erythrocyte polyunsaturated \nfatty acids with inflammation and quality of life in post-\nmenopausal women with obesity completing a pilot dietary \nintervention. Nutrients 2019;11:1589.\n45. Oustric P, Beaulieu K, Casanova N, O’Connor D, Gibbons C, \nHopkins M, et al. Food liking but not wanting decreases after \ncontrolled intermittent or continuous energy restriction \nto ≥5% weight loss in women with overweight/obesity. \nNutrients 2021;13:182.\n46. Kroenke CH, Caan BJ, Stefanick ML, Anderson G, Brzyski R, \nJohnson KC, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 37,
          "overlap_chars": 643,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 37,
      "char_count": 643,
      "word_count": 96,
      "start_pos": 211637,
      "end_pos": 212280,
      "chunk_index": 419,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_420",
      "text": "ients 2021;13:182.\n46. Kroenke CH, Caan BJ, Stefanick ML, Anderson G, Brzyski R, \nJohnson KC, et al. Effects of a dietary intervention and \nweight change on vasomotor symptoms in the Women’s \nHealth Initiative. Menopause 2012;19:980-8.\n47. Hintze LJ, Messier V, Lavoie MÈ, Brochu M, Lavoie JM, \nPrud’homme D, et al. A one-year resistance training program \nfollowing weight loss has no significant impact on body \ncomposition and energy expenditure in postmenopausal \nwomen living with overweight and obesity. Physiol Behav \n2018;189:99-106.\n48. Hollis JL, Williams LT, Young MD, Pollard KT, Collins CE, \nMorgan PJ.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 37,
          "overlap_chars": 614,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 37,
      "char_count": 614,
      "word_count": 92,
      "start_pos": 212180,
      "end_pos": 212794,
      "chunk_index": 420,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_421",
      "text": "ol Behav \n2018;189:99-106.\n48. Hollis JL, Williams LT, Young MD, Pollard KT, Collins CE, \nMorgan PJ. Compliance to step count and vegetable serve \nrecommendations mediates weight gain prevention in mid-\nage, premenopausal women. Findings of the 40-Something \nRCT. Appetite 2014;83:33-41.\n49. Kong A, Beresford SAA, Alfano CM, Foster-Schubert KE, \nNeuhouser ML, Johnson DB, et al. Self-monitoring and \neating-related behaviors are associated with 12-month \nweight loss in postmenopausal overweight-to-obese women. \nJ Acad Nutr Diet 2012;112:1428-35.\n50. Ilich JZ, Kelly OJ, Liu PY, Shin H, Kim Y, Chi Y, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 37,
          "overlap_chars": 609,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 37,
      "char_count": 609,
      "word_count": 89,
      "start_pos": 212694,
      "end_pos": 213303,
      "chunk_index": 421,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_422",
      "text": "en. \nJ Acad Nutr Diet 2012;112:1428-35.\n50. Ilich JZ, Kelly OJ, Liu PY, Shin H, Kim Y, Chi Y, et al. Role of \ncalcium and low-fat dairy foods in weight-loss outcomes \nrevisited: Results from the randomized trial of effects \non bone and body composition in overweight/obese \npostmenopausal women. Nutrients 2019;11:1157.\n51. Grossman JA, Arigo D, Bachman JL. Meaningful weight \nloss in obese postmenopausal women: A pilot study of \nhigh-intensity interval training and wearable technology. \nMenopause 2018;25:465-70.\n52. Shin H, Shin J, Liu PY, Dutton GR, Abood DA, Ilich JZ. \nSelf-efficacy improves weight loss in overweight/obese \npostmenopausal women during a 6-month weight loss \nintervention.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 37,
          "overlap_chars": 696,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 37,
      "char_count": 696,
      "word_count": 103,
      "start_pos": 213203,
      "end_pos": 213899,
      "chunk_index": 422,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_423",
      "text": "es weight loss in overweight/obese \npostmenopausal women during a 6-month weight loss \nintervention. Nutr Res 2011;31:822-8.\n53. Rossi AP, Muollo V, Fantin F, Masciocchi E, Urbani S, Taylor \nM, et al. Effects of diet combined with Nordic walking or \nwalking programme on weight loss and arterial stiffness \nin postmenopausal overweight and obese women: The \nWalking and Aging Verona pilot study. Eur J Prev Cardiol \n2020;27:2208-11.\n54. Perry CD, Degeneffe D, Davey C, Kollannoor-Samuel G, \nReicks M. Weight gain prevention among midlife women: A \nrandomized controlled trial to address needs related to the \nphysical and social environment. Int J Environ Res Public \nHealth 2016;13:530.\n55.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 37,
          "overlap_chars": 691,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 37,
      "char_count": 691,
      "word_count": 104,
      "start_pos": 213799,
      "end_pos": 214490,
      "chunk_index": 423,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_424",
      "text": "s related to the \nphysical and social environment. Int J Environ Res Public \nHealth 2016;13:530.\n55. Anton SD, Manini TM, Milsom VA, Dubyak P, Cesari M, \nCheng J, et al. Effects of a weight loss plus exercise program \non physical function in overweight, older women: A \nrandomized controlled trial. Clin Interv Aging 2011;6:141-9.\n56. NHaMR C. Clinical practice guidelines for the management \nof overweight and obesity in adults, adolescents and \nchildren in Australia. National Health and Medical Research \nCouncil 2013.\n57. Khandelwal S. Obesity in midlife: Lifestyle and dietary \nstrategies. Climacteric 2020;23:140-7.\n58. Jahangiry L, Farhangi MA.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 37,
          "overlap_chars": 651,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 37,
      "char_count": 651,
      "word_count": 97,
      "start_pos": 214390,
      "end_pos": 215041,
      "chunk_index": 424,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_425",
      "text": "midlife: Lifestyle and dietary \nstrategies. Climacteric 2020;23:140-7.\n58. Jahangiry L, Farhangi MA. Obesity paradigm and web-based \nweight loss programs: An updated systematic review and \nmeta-analysis of randomized controlled trials. J Health \nPopul Nutr 2021;40:16.\n59. Evert AB, Dennison M, Gardner CD, Garvey WT, Lau KH, \nMacLeod J, et al. Nutrition therapy for adults with \ndiabetes or prediabetes: A consensus report. Diabetes \nCare2019;42:731-54.\n60. Kabir SM. Essentials of Counseling. Abosar Prokashana \nSangstha; 2017.\n61. Teeriniemi AM, Salonurmi T, Jokelainen T, Vähänikkilä H, \nAlahäivälä T, Karppinen P, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 37,
          "overlap_chars": 625,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 37,
      "char_count": 625,
      "word_count": 87,
      "start_pos": 214941,
      "end_pos": 215566,
      "chunk_index": 425,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_426",
      "text": "017.\n61. Teeriniemi AM, Salonurmi T, Jokelainen T, Vähänikkilä H, \nAlahäivälä T, Karppinen P, et al. A randomized clinical \ntrial of the effectiveness of a web-based health behaviour \nchange support system and group lifestyle counselling on \nbody weight loss in overweight and obese subjects: 2-year \noutcomes. J Intern Med2018;284:534-54.\n62. Ghelani DP, Moran LJ, Johnson C, Mousa A, Naderpoor N. \nMobile apps for weight management: A review of the latest \nevidence to inform practice. FrontEndocrinol 2020;11:412.\n63. Paul-Ebhohimhen V, Avenell A. A systematic review of the \neffectiveness of group versus individual treatments for \nadult obesity. Obes Facts 2009;2:17-24.\n64.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 37,
          "overlap_chars": 679,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 37,
      "char_count": 679,
      "word_count": 99,
      "start_pos": 215466,
      "end_pos": 216145,
      "chunk_index": 426,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_427",
      "text": "effectiveness of group versus individual treatments for \nadult obesity. Obes Facts 2009;2:17-24.\n64. Hartmann-Boyce J, Johns DJ, Jebb SA, Aveyard P; Behavioural \nWeight Management Review Group. Effect of behavioural \ntechniques and delivery mode on effectiveness of weight \nmanagement: systematic review, meta-analysis and meta-\nregression. Obes Rev 2014;15:598-609.\n65. Sorgente A, Pietrabissa G, Manzoni GM, Re F, Simpson S, \nPerona S, et al. Web-based interventions for weight loss or \nweight loss maintenance in overweight and obese people: \nA systematic review of systematic reviews. J Med Internet \nRes 2017;19:e229.\n66.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 37,
          "overlap_chars": 626,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 37,
      "char_count": 626,
      "word_count": 88,
      "start_pos": 216045,
      "end_pos": 216671,
      "chunk_index": 427,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_428",
      "text": "and obese people: \nA systematic review of systematic reviews. J Med Internet \nRes 2017;19:e229.\n66. Valsdottir TD, Øvrebø B, Falck TM, Litleskare S, Johansen EI, \nHenriksen C, et al. Low-carbohydrate high-fat diet and \nexercise: Effect of a 10-week intervention on body \ncomposition and CVD risk factors in overweight and \nobese women-A randomized controlled trial. Nutrients \n2020;13:110.\n67. Vitolins MZ, Blackwell CS, Katula JA, Isom SP, Case LD. \nLong-term weight loss maintenance in the continuation of \na randomized diabetes prevention translational study: The \nHealthy Living Partnerships to Prevent Diabetes (HELP PD) \ncontinuation trial. Diabetes Care 2019;42:1653-60.\n68.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 37,
          "overlap_chars": 682,
          "overlap_percentage": 100.14684287812041
        }
      ],
      "primary_page": 37,
      "char_count": 681,
      "word_count": 96,
      "start_pos": 216571,
      "end_pos": 217253,
      "chunk_index": 428,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_429",
      "text": "g Partnerships to Prevent Diabetes (HELP PD) \ncontinuation trial. Diabetes Care 2019;42:1653-60.\n68. Walsh K, Grech C, Hill K. Health advice and education given \nto overweight patients by primary care doctors and nurses: \nA scoping literature review. Prev Med Rep 2019;14:100812.\n69. Jane M, Hagger M, Foster J, Ho S, Pal S. Social media for \nhealth promotion and weight management: A critical \ndebate. BMC Public Health 2018;18:932.\n70. Nuttall FQ. Body mass index: Obesity, BMI, and health: A \ncritical review. Nutr Today 2015;50:117-28.\n71. Borga M, West J, Bell JD, Harvey NC, Romu T, Heymsfield SB, \net al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 37,
          "overlap_chars": 611,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 37,
      "char_count": 611,
      "word_count": 98,
      "start_pos": 217153,
      "end_pos": 217764,
      "chunk_index": 429,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_430",
      "text": ". Nutr Today 2015;50:117-28.\n71. Borga M, West J, Bell JD, Harvey NC, Romu T, Heymsfield SB, \net al. Advanced body composition assessment: from body \nmass index to body composition profiling. J Investig Med \n2018;66:1-9.\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\n72. Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, \net  al. Waist circumference as a vital sign in clinical \npractice: A consensus statement from the IAS and ICCR \nworking group on visceral obesity. Nat Rev Endocrinol \n2020;16:177–89.\n73. Duren DL, Sherwood RJ, Czerwinski SA, Lee M, Choh AC, \nSiervogel RM, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 37,
          "overlap_chars": 220,
          "overlap_percentage": 31.60919540229885
        },
        {
          "page_number": 38,
          "overlap_chars": 474,
          "overlap_percentage": 68.10344827586206
        }
      ],
      "primary_page": 37,
      "char_count": 696,
      "word_count": 115,
      "start_pos": 217664,
      "end_pos": 218360,
      "chunk_index": 430,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_431",
      "text": "nol \n2020;16:177–89.\n73. Duren DL, Sherwood RJ, Czerwinski SA, Lee M, Choh AC, \nSiervogel RM, et al. Body composition methods: Comparisons \nand interpretation. J Diabetes Sci Technol 2008;2:1139-46.\n74. Misra A, Chowbey P, Makkar BM, Vikram NK, Wasir JS, \nChadha D, et al. Consensus statement for diagnosis of \nobesity, abdominal obesity and the metabolic syndrome for \nAsian Indians and recommendations for physical activity, \nmedical and surgical management. J Assoc Physicians India \n2009;57:163-70.\n75. Mu Y, Kou T, Wei B, Lu X, Liu J, Tian H, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 38,
          "overlap_chars": 554,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 38,
      "char_count": 554,
      "word_count": 87,
      "start_pos": 218260,
      "end_pos": 218814,
      "chunk_index": 431,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_432",
      "text": "ement. J Assoc Physicians India \n2009;57:163-70.\n75. Mu Y, Kou T, Wei B, Lu X, Liu J, Tian H, et al. Soy products \nameliorate obesity-related anthropometric indicators in \noverweight or obese Asian and non-menopausal women: \nA meta-analysis of randomized controlled trials. Nutrients \n2019;11:2790.\n76. Foster-Schumbert KE, Alfano CM, Duggan CR, Xiao L, \nCampbell KL, Kong A, et al. Effect of diet and exercise, \nalone or combined, on weight and body composition in \noverweight-to-obese postmenopausal women. Obesity \n(Silver Spring) 2012;20:1628-38.\n77. Lombardo M, Perrone MA, Guseva E, Aulisa G, Padua E, \nBellia C, Della-Morte D, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 38,
          "overlap_chars": 640,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 38,
      "char_count": 640,
      "word_count": 96,
      "start_pos": 218714,
      "end_pos": 219354,
      "chunk_index": 432,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_433",
      "text": "0:1628-38.\n77. Lombardo M, Perrone MA, Guseva E, Aulisa G, Padua E, \nBellia C, Della-Morte D, et al. Losing weight after menopause \nwith minimal aerobic training and mediterranean diet. \nNutrients 2020;12:2471.\n78. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, \nDonato KA, et al. 2013 AHA/ACC/TOS guideline for the \nmanagement of overweight and obesity in adults: A report \nof the American College of Cardiology/American Heart \nAssociation task force on practice guidelines and the \nObesity society. Circulation 2014;129:S102–38.\n79. Jamka M, Mądry E, Bogdański P, Kryściak J, Mądry R, \nLisowska A, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 38,
          "overlap_chars": 612,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 38,
      "char_count": 612,
      "word_count": 94,
      "start_pos": 219254,
      "end_pos": 219866,
      "chunk_index": 433,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_434",
      "text": "lation 2014;129:S102–38.\n79. Jamka M, Mądry E, Bogdański P, Kryściak J, Mądry R, \nLisowska A, et al. The effect of endurance and endurance-\nstrength training on bone mineral density and content in \nabdominally obese postmenopausal women: A randomized \ntrial. Healthcare (Basel) 2021;9:1074.\n80. Bajerska J, Chmurzynska A, Muzsik A, Krzyżanowska P, \nMądry E, Malinowska AM, et al. Weight loss and metabolic \nhealth effects from energy-restricted Mediterranean \nand Central-European diets in postmenopausal women: \nA randomized controlled trial. Sci Rep 2018;8:11170. \ndoi: 10.1038/s41598-018-29495-3. Erratum in: Sci Rep \n2019;9:16077.\n81. Brinkley TE, Ding J, Carr JJ, Nicklas BJ.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 38,
          "overlap_chars": 680,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 38,
      "char_count": 680,
      "word_count": 95,
      "start_pos": 219766,
      "end_pos": 220446,
      "chunk_index": 434,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_435",
      "text": "s41598-018-29495-3. Erratum in: Sci Rep \n2019;9:16077.\n81. Brinkley TE, Ding J, Carr JJ, Nicklas BJ. Pericardial fat loss in \npostmenopausal women under conditions of equal energy \ndeficit. Med Sci Sports Exerc 2011;43:808-14.\n82. Riesco E, Choquette S, Audet M, Lebon J, Tessier D, Dionne IJ. \nEffect of exercise training combined with phytoestrogens \non adipokines and C-reactive protein in postmenopausal \nwomen: a randomized trial. Metabolism 2012;61:273-80.\n83. Kerksick CM, Roberts MD, Campbell BI, Galbreath MM, \nTaylor LW, Wilborn CD, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 38,
          "overlap_chars": 549,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 38,
      "char_count": 549,
      "word_count": 80,
      "start_pos": 220346,
      "end_pos": 220895,
      "chunk_index": 435,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_436",
      "text": "12;61:273-80.\n83. Kerksick CM, Roberts MD, Campbell BI, Galbreath MM, \nTaylor LW, Wilborn CD, et al. Differential impact of calcium \nand vitamin D on body composition changes in post-\nmenopausal women following a restricted energy diet and \nexercise program. Nutrients 2020;12:713.\n84. Sen P, Das S, Hore S, Bhattacharjee S, Choudhuri D. Obesity \nand associated cardiometabolic risk among women from \nTripura - A Northeastern state of India. J Midlife Health \n2017;8:110-7.\n85. Lean ME, Han TS, Morrison CE. Waist circumference as a \nmeasure for indicating need for weight management. BMJ \n1995;311:158–61.\n86. Yumuk V, Tsigos C, Fried M, Schindler K, Busetto L, Micic D, \net al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 38,
          "overlap_chars": 679,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 38,
      "char_count": 679,
      "word_count": 106,
      "start_pos": 220795,
      "end_pos": 221474,
      "chunk_index": 436,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_437",
      "text": "ment. BMJ \n1995;311:158–61.\n86. Yumuk V, Tsigos C, Fried M, Schindler K, Busetto L, Micic D, \net al. European guidelines for obesity management in \nadults. Obes Facts 2015;8:402-24. doi: 10.1159/000442721. \nEpub 2015 Dec 5. Erratum in: Obes Facts 2016;9:64.\n87. FAO. Dietary assessment: A resource guide to method \nselection and application in low resource settings. Food \nand Agriculture Organization of the United Nations 2018.\n88. Batra P, Das SK, Salinardi T, Robinson L, Saltzman E, Scott  T, \net al. Eating behaviors as predictors of weight loss in a 6 \nmonth weight loss intervention: Eating behavior constructs \nand weight loss. Obesity 2013;21:2256–63.\n89.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 38,
          "overlap_chars": 665,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 38,
      "char_count": 665,
      "word_count": 102,
      "start_pos": 221374,
      "end_pos": 222039,
      "chunk_index": 437,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_438",
      "text": "weight loss intervention: Eating behavior constructs \nand weight loss. Obesity 2013;21:2256–63.\n89. Kong A, Beresford SA, Imayama I, Duggan C, Alfano CM, \nFoster-Schubert KE, et al. Adoption of diet-related self-\nmonitoring behaviors varies by race/ethnicity, education, \nand baseline binge eating score among overweight-to-obese \npostmenopausal women in a 12-month dietary weight loss \nintervention. Nutr Res 2012;32:260-5.\n90. Mason C, de Dieu Tapsoba J, Duggan C, Wang C-Y, \nAlfano  CM, McTiernan A. Eating behaviors and weight loss \noutcomes in a 12-month randomized trial of diet and/or \nexercise intervention in postmenopausal women. Int J Behav \nNutr Phys Act2019;16:113.\n91.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 38,
          "overlap_chars": 683,
          "overlap_percentage": 100.1466275659824
        }
      ],
      "primary_page": 38,
      "char_count": 682,
      "word_count": 96,
      "start_pos": 221939,
      "end_pos": 222622,
      "chunk_index": 438,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_439",
      "text": "et and/or \nexercise intervention in postmenopausal women. Int J Behav \nNutr Phys Act2019;16:113.\n91. Svetkey LP, Ard JD, Stevens VJ, Loria CM, Young DY, \nHollis JF, et al. Predictors of long-term weight loss in adults \nwith modest initial weight loss, by sex and race. Obesity \n2012;20:1820–8.\n92. Kartiko Sari I, Utari DM, Kamoshita S, Oktaviana D, Sakai S, \nNishiyama H, et al. Increasing vegetable intake 400 g/day \nto control body weight and lipid profile in overweight \nhyperlipidemia menopausal women. J Public Health Res \n2020;9:1733.\n93. Delahanty LM, Peyrot M, Shrader PJ, Williamson DA, \nMeigs JB, Nathan DM, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 38,
          "overlap_chars": 625,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 38,
      "char_count": 625,
      "word_count": 99,
      "start_pos": 222522,
      "end_pos": 223147,
      "chunk_index": 439,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_440",
      "text": "es \n2020;9:1733.\n93. Delahanty LM, Peyrot M, Shrader PJ, Williamson DA, \nMeigs JB, Nathan DM, et al. Pretreatment, psychological, and \nbehavioral predictors of weight outcomes among lifestyle \nintervention participants in the Diabetes Prevention \nProgram (DPP). Diabetes Care 2013;36:34–40.\n94. Barone Gibbs B, Kinzel LS, Pettee Gabriel K, Chang YF, \nKuller LH. Short- and long-term eating habit modification \npredicts weight change in overweight, postmenopausal \nwomen: Results from the WOMAN study. J Acad Nutr Diet \n2012;112:1347-55.e2.\n95. Urbanek JK, Metzgar CJ, Hsiao PY, Piehowski KE, Nickols-\nRichardson SM.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 38,
          "overlap_chars": 615,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 38,
      "char_count": 615,
      "word_count": 86,
      "start_pos": 223047,
      "end_pos": 223662,
      "chunk_index": 440,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_441",
      "text": "et \n2012;112:1347-55.e2.\n95. Urbanek JK, Metzgar CJ, Hsiao PY, Piehowski KE, Nickols-\nRichardson SM. Increase in cognitive eating restraint \npredicts weight loss and change in other anthropometric \nmeasurements in overweight/obese premenopausal \nwomen. Appetite 2015;87:244-50.\n96. Grave RD, Calugi S, Corica F, Di Domizio S, Marchesini G; \nQUOVADIS Study Group. Psychological variables associated \nwith weight loss in obese patients seeking treatment at \nmedical centers. J Am Diet Assoc 2009;109:2010-20.\n97. Wang J, Ye L, Zheng Y, Burke LE. Impact of perceived \nbarriers to healthy eating on diet and weight in a \n24-month behavioral weight loss trial. J Nutr Educ Behav \n2015;47:432-6.\n98.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 38,
          "overlap_chars": 693,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 38,
      "char_count": 693,
      "word_count": 101,
      "start_pos": 223562,
      "end_pos": 224255,
      "chunk_index": 441,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_442",
      "text": "n diet and weight in a \n24-month behavioral weight loss trial. J Nutr Educ Behav \n2015;47:432-6.\n98. Zheng Y, Sereika SM, Danford CA, Imes CC, Goode RW, \nMancino J, et al. Trajectories of weight change and \npredictors over 18-month weight loss treatment: Weight \nchange trajectories and predictors. J Nurs Scholarsh \n2017;49:177–84.\n99. Brończyk-Puzoń A, Piecha D, Nowak J, Koszowska A, \nKulik-Kupka K, Dittfeld A, et al. Guidelines for dietary\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nmanagement of menopausal women with simple obesity. \nPrzMenopauzalny 2015;14:48-52.\n100.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 38,
          "overlap_chars": 444,
          "overlap_percentage": 65.29411764705883
        },
        {
          "page_number": 39,
          "overlap_chars": 234,
          "overlap_percentage": 34.411764705882355
        }
      ],
      "primary_page": 38,
      "char_count": 680,
      "word_count": 103,
      "start_pos": 224155,
      "end_pos": 224835,
      "chunk_index": 442,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_443",
      "text": "cember 2022\nmanagement of menopausal women with simple obesity. \nPrzMenopauzalny 2015;14:48-52.\n100. Lambrinoudaki I, Ceasu I, Depypere H, Erel T, Rees M, \nSchenck-Gustafsson K, et al. EMAS position statement: Diet \nand health in midlife and beyond. Maturitas 2013;74:99-104.\n101. Killeen SL, Callaghan SL, Jacob CM, Hanson MA, McAuliffe   FM. \n“It only takes two minutes to ask”-A qualitative study with \nwomen on using the FIGO Nutrition Checklist in pregnancy. \nInt J Gynaecol Obstet 2020;151(Suppl 1):45-50.\n102. Johnson-Wimbley TD, Graham DY. Diagnosis and \nmanagement of iron deficiency anemia in the 21st century. \nTherap Adv Gastroenterol 2011;4:177-84.\n103. Short MW, Domagalski JE.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 39,
          "overlap_chars": 691,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 39,
      "char_count": 691,
      "word_count": 99,
      "start_pos": 224735,
      "end_pos": 225426,
      "chunk_index": 443,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_444",
      "text": "y anemia in the 21st century. \nTherap Adv Gastroenterol 2011;4:177-84.\n103. Short MW, Domagalski JE. Iron deficiency anemia: Evaluation \nand management. Am Fam Physician 2013;87:98-104.\n104. Bailey RL, Ard JD, Davis TA, Naimi TS, Schneeman BO, Stang JS, \net al. A proposed framework for identifying nutrients and \nfood components of public health relevance in the dietary \nguidelines for Americans. JNutr2021;151:1197–204.\n105. Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, \nRandall S, et al. Clinician’s guide to prevention and \ntreatment of osteoporosis. Osteoporos Int 2014;25:2359-81.\n106. Aparna P, Muthathal S, Nongkynrih B, Gupta SK. Vitamin D \ndeficiency in India.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 39,
          "overlap_chars": 682,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 39,
      "char_count": 682,
      "word_count": 101,
      "start_pos": 225326,
      "end_pos": 226008,
      "chunk_index": 444,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_445",
      "text": "2014;25:2359-81.\n106. Aparna P, Muthathal S, Nongkynrih B, Gupta SK. Vitamin D \ndeficiency in India. J Family Med Prim Care 2018;7:324-30.\n107. World Health Organization. WHO guidelines on physical \nactivity and sedentary behaviour: at a glance 2020.\n108. Caspersen CJ, Powell KE, Christenson GM. Physical \nactivity, exercise, and physical fitness: definitions and \ndistinctions for health-related research. Public Health Rep \n1985;100:126–31.\n109. Tremblay MS, Aubert S, Barnes JD, Saunders TJ, Carson V, \nLatimer-Cheung AE, et al. Sedentary Behavior Research \nNetwork (SBRN) - Terminology Consensus Project process \nand outcome. Int J Behav Nutr Phys Act2017;14:75.\n110.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 39,
          "overlap_chars": 672,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 39,
      "char_count": 672,
      "word_count": 94,
      "start_pos": 225908,
      "end_pos": 226580,
      "chunk_index": 445,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_446",
      "text": "BRN) - Terminology Consensus Project process \nand outcome. Int J Behav Nutr Phys Act2017;14:75.\n110. van Gemert WA, May AM, Schuit AJ, Oosterhof BY, \nPeeters  PH, Monninkhof EM. Effect of weight loss with \nor without exercise on inflammatory markers and \nadipokines in postmenopausal women: The SHAPE-2 trial, A \nrandomized controlled trial. Cancer Epidemiol Biomarkers \nPrev 2016;25:799-806.\n111. Seimon RV, Wild-Taylor AL, Keating SE, McClintock S, \nHarper C, Gibson AA, et al. Effect of weight loss via severe \nvs moderate energy restriction on lean mass and body \ncomposition among postmenopausal women with obesity: \nThe TEMPO diet randomized clinical trial. JAMA Netw Open \n2019;2:e1913733.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 39,
          "overlap_chars": 696,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 39,
      "char_count": 696,
      "word_count": 102,
      "start_pos": 226480,
      "end_pos": 227176,
      "chunk_index": 446,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_447",
      "text": "usal women with obesity: \nThe TEMPO diet randomized clinical trial. JAMA Netw Open \n2019;2:e1913733.\n112. Pelclová J, Štefelová N, Hodonská J, Dygrýn J, Gába A, \nZając-Gawlak I. Reallocating time from sedentary behavior \nto light and moderate-to-vigorous physical activity: What \nhas a stronger association with adiposity in older adult \nwomen? Int J Environ Res Public Health 2018;15:1444.\n113. Sadeghian M, Hosseini SA, Zare Javid A, Ahmadi Angali K, \nMashkournia A. Effect of fasting-mimicking diet or \ncontinuous energy restriction on weight loss, body \ncomposition, and appetite-regulating hormones among \nmetabolically healthy women with obesity: A randomized \ncontrolled, parallel trial.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 39,
          "overlap_chars": 694,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 39,
      "char_count": 694,
      "word_count": 96,
      "start_pos": 227076,
      "end_pos": 227770,
      "chunk_index": 447,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_448",
      "text": "hormones among \nmetabolically healthy women with obesity: A randomized \ncontrolled, parallel trial. Obes Surg 2021;31:2030-9.\n114. de Roon M, van Gemert WA, Peeters PH, Schuit AJ, \nMonninkhof EM. Long-term effects of a weight loss \nintervention with or without exercise component in \npostmenopausal women: A randomized trial. Prev Med Rep \n2016;5:118-23.\n115. Williams LT, Hollis JL, Collins CE, Morgan PJ. Can a relatively \nlow-intensity intervention by health professionals prevent \nweight gain in mid-age women? 12-Month outcomes of the \n40-Something randomised controlled trial. NutrDiabetes \n2014;4:e116.\n116. Gabriel KK, Conroy MB, Schmid KK, Storti KL, High RR, \nUnderwood DA, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 39,
          "overlap_chars": 691,
          "overlap_percentage": 100.14492753623188
        }
      ],
      "primary_page": 39,
      "char_count": 690,
      "word_count": 98,
      "start_pos": 227670,
      "end_pos": 228361,
      "chunk_index": 448,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_449",
      "text": "betes \n2014;4:e116.\n116. Gabriel KK, Conroy MB, Schmid KK, Storti KL, High RR, \nUnderwood DA, et al. The impact of weight and fat mass \nloss and increased physical activity on physical function \nin overweight, postmenopausal women: Results from the \nwomen on the move through activity and nutrition study. \nMenopause 2011;18:759-65.\n117. Yank V, Xiao L, Wilson SR, Stafford RS, Rosas LG, Ma J. \nShort-term weight loss patterns, baseline predictors, and \nlonger-term follow-up within a randomized controlled \ntrial: Short-term weight loss patterns in RCT. Obesity \n2014;22:45–51.\n118. Morgan PJ, Hollis JL, Young MD, Collins CE, Teixeira PJ.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 39,
          "overlap_chars": 640,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 39,
      "char_count": 640,
      "word_count": 96,
      "start_pos": 228261,
      "end_pos": 228901,
      "chunk_index": 449,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_450",
      "text": "tterns in RCT. Obesity \n2014;22:45–51.\n118. Morgan PJ, Hollis JL, Young MD, Collins CE, Teixeira PJ. \nWorkday sitting time and marital status: Novel pretreatment \npredictors of weight loss in overweight and obese men. Am \nJ Mens Health 2018;12:1431–8.\n119. Anjana RM, Sudha V, Lakshmipriya N, Subhashini S, \nPradeepa R, Geetha L, et al. Reliability and validity of a new \nphysical activity questionnaire for India. Int J Behav Nutr \nPhys Act 2015;12:40.\n120. Mensah K, Maire A, Oppert JM, Dugas J, Charreire H, \nWeber  C,et al. Assessment of sedentary behaviors and \ntransport-related activities by questionnaire: A validation \nstudy. BMC Public Health 2016;16:753.\n121.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 39,
          "overlap_chars": 670,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 39,
      "char_count": 670,
      "word_count": 102,
      "start_pos": 228801,
      "end_pos": 229471,
      "chunk_index": 450,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_451",
      "text": "nsport-related activities by questionnaire: A validation \nstudy. BMC Public Health 2016;16:753.\n121. Lobelo F, Rohm Young D, Sallis R, Garber MD, \nBillinger SA, Duperly J,et al. Routine assessment and \npromotion of physical activity in healthcare settings: \nA scientific statement from the American Heart \nAssociation. Circulation2018;137:e495–522.doi:10.1161/\nCIR.0000000000000559.\n122. Thivel D, Tremblay A, Genin PM, Panahi S, Rivière D, \nDuclos  M. Physical activity, inactivity, and sedentary \nbehaviors: Definitions and implications in occupational \nhealth. Front Public Health 2018;6:288.\n123. Lyons EJ, Lewis ZH, Mayrsohn BG, Rowland JL.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 39,
          "overlap_chars": 645,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 39,
      "char_count": 645,
      "word_count": 84,
      "start_pos": 229371,
      "end_pos": 230016,
      "chunk_index": 451,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_452",
      "text": "upational \nhealth. Front Public Health 2018;6:288.\n123. Lyons EJ, Lewis ZH, Mayrsohn BG, Rowland JL. Behavior \nchange techniques implemented in electronic lifestyle \nactivity monitors: A systematic content analysis. J Med \nInternet Res 2014;16:e192.\n124. Mulhall S, Andel R, Anstey KJ. Variation in symptoms of \ndepression and anxiety in midlife women by menopausal \nstatus. Maturitas 2018;108:7–12.\n125. Tamaria A, Bharti R, Sharma M, Dewan R, Kapoor G, \nAggarwal A, et al. Risk assessment for psychological disorders \nin postmenopausal women. J Clin Diagn Res 2013;7:2885-8.\n126. Whiteley J, Wagner JS, Bushmakin A, Kopenhafer L, \nDibonaventura M, Racketa J.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 39,
          "overlap_chars": 660,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 39,
      "char_count": 660,
      "word_count": 96,
      "start_pos": 229916,
      "end_pos": 230576,
      "chunk_index": 452,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_453",
      "text": "s 2013;7:2885-8.\n126. Whiteley J, Wagner JS, Bushmakin A, Kopenhafer L, \nDibonaventura M, Racketa J. Impact of the severity of \nvasomotor symptoms on health status, resource use, and \nproductivity. Menopause 2013;20:518-24.\n127. Abdel-Salam DM, Mohamed RA, Alruwaili RR, Alhablani FS, \nAldaghmi RM, ALghassab RE. Postmenopausal symptoms \nand their correlates among Saudi Women attending \ndifferent primary health centers. Int J Environ Res Public \nHealth 2021;18:6831.\n128. Lima JE, Palacios S, Wender MC. Quality of life in menopausal \nwomen: A Brazilian Portuguese version of the Cervantes \nscale. ScientificWorldJournal 2012;2012:620519. doi: \n10.1100/2012/620519.\n129.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 39,
          "overlap_chars": 672,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 39,
      "char_count": 672,
      "word_count": 90,
      "start_pos": 230476,
      "end_pos": 231148,
      "chunk_index": 453,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_454",
      "text": "on of the Cervantes \nscale. ScientificWorldJournal 2012;2012:620519. doi: \n10.1100/2012/620519.\n129. Gariepy G, Nitka D, Schmitz N. The association between \nobesity and anxiety disorders in the population: A systematic \nreview and meta-analysis. IntJObesity 2010;34:407-19.\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\n130. Blaine B. Does depression cause obesity? A meta-analysis \nof longitudinal studies of depression and weight control. \nJHealth Psychol 2008;13:1190-7.\n131. McCuen-Wurst C, Ruggieri M, Allison KC.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 39,
          "overlap_chars": 273,
          "overlap_percentage": 44.103392568659125
        },
        {
          "page_number": 40,
          "overlap_chars": 344,
          "overlap_percentage": 55.5735056542811
        }
      ],
      "primary_page": 39,
      "char_count": 619,
      "word_count": 84,
      "start_pos": 231048,
      "end_pos": 231667,
      "chunk_index": 454,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_455",
      "text": "on and weight control. \nJHealth Psychol 2008;13:1190-7.\n131. McCuen-Wurst C, Ruggieri M, Allison KC. Disordered eating \nand obesity: Associations between binge eating-disorder, \nnight-eating syndrome, and weight-related co-morbidities. \nAnn N Y AcadSci 2018;1411:96-105.\n132. Serretti A, Mandelli L, Laura M. Antidepressants and body \nweight: A comprehensive review and meta-analysis. JClin \nPsychiatry 2010;71:1259-72.\n133. Bak M, Fransen A, Janssen J, van Os J, Drukker M. Almost \nall antipsychotics result in weight gain: A meta-analysis. \nPLoS One 2014;9:e94112.\n134. Tunay M, Kurdak H, Özcan S, Özdemir Ç, Özer ZY.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 40,
          "overlap_chars": 619,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 40,
      "char_count": 619,
      "word_count": 86,
      "start_pos": 231567,
      "end_pos": 232186,
      "chunk_index": 455,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_456",
      "text": "gain: A meta-analysis. \nPLoS One 2014;9:e94112.\n134. Tunay M, Kurdak H, Özcan S, Özdemir Ç, Özer ZY. Family \nphysician-led group visits for lifestyle modification in \nwomen with weight problems: A pilot intervention and \nfollow-up study. Obesity facts 2018;11:1-4.\n135. Hageman PA, Mroz JE, Yoerger MA, Pullen CH. Weight loss \nis associated with improved quality of life among rural \nwomen completers of a web-based lifestyle intervention. \nPLoS One 2019;14:e0225446.\n136. Annesi JJ, Whitaker AC. Psychological factors discriminating \nbetween successful and unsuccessful weight loss in a \nbehavioral exercise and nutrition education treatment. \nIntJBehav Med 2010;17:168-75.\n137.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 40,
          "overlap_chars": 679,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 40,
      "char_count": 679,
      "word_count": 94,
      "start_pos": 232086,
      "end_pos": 232765,
      "chunk_index": 456,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_457",
      "text": "oss in a \nbehavioral exercise and nutrition education treatment. \nIntJBehav Med 2010;17:168-75.\n137. Carson TL, Jackson BE, Nolan TS, Williams A, Baskin ML. \nLower depression scores associated with greater weight \nloss among rural black women in a behavioral weight loss \nprogram. TranslBehav Med 2017;7:320-9.\n138. Ma J, Rosas LG, Lv N, Xiao L, Snowden MB, Venditti EM, \net al. Effect of integrated behavioral weight loss treatment \nand problem-solving therapy on body mass index and \ndepressive symptoms among patients with obesity and \ndepression: The RAINBOW randomized clinical trial. JAMA \n2019;321:869-79.\n139. Pagoto S, Schneider KL, Whited MC, Oleski JL, Merriam P, \nAppelhans B, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 40,
          "overlap_chars": 695,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 40,
      "char_count": 695,
      "word_count": 104,
      "start_pos": 232665,
      "end_pos": 233360,
      "chunk_index": 457,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_458",
      "text": "2019;321:869-79.\n139. Pagoto S, Schneider KL, Whited MC, Oleski JL, Merriam P, \nAppelhans B, et al. Randomized controlled trial of \nbehavioral treatment for comorbid obesity and depression \nin women: The Be Active Trial. IntJ Obes 2013;37:1427-34.\n140. Palmeira L, Pinto-Gouveia J, Cunha M. Exploring the \nefficacy of an acceptance, mindfulness & compassionate-\nbased group intervention for women struggling with their \nweight (Kg-Free): A randomized controlled trial. Appetite \n2017;112:107-16.\n141. ter Kuile MM, Brauer M, Laan E. The Female Sexual Function \nIndex (FSFI) and the Female Sexual Distress Scale (FSDS): \nPsychometric properties within a Dutch population.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 40,
          "overlap_chars": 671,
          "overlap_percentage": 100.1492537313433
        }
      ],
      "primary_page": 40,
      "char_count": 670,
      "word_count": 95,
      "start_pos": 233260,
      "end_pos": 233931,
      "chunk_index": 458,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_459",
      "text": "FI) and the Female Sexual Distress Scale (FSDS): \nPsychometric properties within a Dutch population. J Sex \nMarital Ther 2006;32:289-304.\n142. Kim HR, Kim HS. Optimal cutoffs of cardiometabolic \nrisk for postmenopausal Korean women. Asian Nurs Res \n2017;11:107-12.\n143. Rocha T, Crespo RP, Yance VVR, Hayashida SA, Baracat EC, \nCarvalho F, et al. Persistent poor metabolic profile in \npostmenopausal women with ovarian hyperandrogenism \nafter testosterone level normalization. J Endocr Soc \n2019;3:1087-96.\n144. Janssen I, Powell LH, Crawford S, Lasley B, Sutton-Tyrrell K. \nMenopause and the metabolic syndrome: The study \nof women’s health across the nation. Arch Intern Med \n2008;168:1568–75.\n145.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 40,
          "overlap_chars": 700,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 40,
      "char_count": 700,
      "word_count": 99,
      "start_pos": 233831,
      "end_pos": 234531,
      "chunk_index": 459,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_460",
      "text": "ic syndrome: The study \nof women’s health across the nation. Arch Intern Med \n2008;168:1568–75.\n145. Kinlen D, Cody D, O’Shea D. Complications of obesity. \nQJM2018;111:437–43.\n146. Monterrosa-Castro A, Ortiz-Banquez M, Mercado-Lara M. \nPrevalence of sarcopenia and associated factors in \nclimacteric women of the Colombian Caribbean. Menopause \n2019;26:1038-44.\n147. Orprayoon N, Wainipitapong P, Champaiboon J, \nWattanachanya L, Jaisamrarn U, Chaikittisilpa S. Prevalence \nof pre-sarcopenia among postmenopausal women younger \nthan 65 years. Menopause2021;28:1351-7.\n148. Maiello M, Zito A, Ciccone MM, Palmiero P.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 40,
          "overlap_chars": 615,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 40,
      "char_count": 615,
      "word_count": 80,
      "start_pos": 234431,
      "end_pos": 235046,
      "chunk_index": 460,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_461",
      "text": "men younger \nthan 65 years. Menopause2021;28:1351-7.\n148. Maiello M, Zito A, Ciccone MM, Palmiero P. Prevalence of co-\nmorbidities and clinical coexisting conditions among post-\nmenopausal women affected by coronary artery disease: \nData from the “Real World”. J Cardiol Clin Res 2014;2:1033.\n149. Aoi S, Miyake T, Iida T, Ikeda H, Ishizaki F, Chikamura C, \net al. Association of changes in neck circumference with \ncardiometabolic risk in postmenopausal healthy women. \nJ Atheroscler Thromb 2016;23:728-36.\n150. Liu PJ, Ma F, Lou HP, Zhu YN. Normal-weight central \nobesity is associated with metabolic disorders in Chinese \npostmenopausal women. Asia Pac J Clin Nutr 2017;26:692-7.\n151.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 40,
          "overlap_chars": 687,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 40,
      "char_count": 687,
      "word_count": 102,
      "start_pos": 234946,
      "end_pos": 235633,
      "chunk_index": 461,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_462",
      "text": "with metabolic disorders in Chinese \npostmenopausal women. Asia Pac J Clin Nutr 2017;26:692-7.\n151. Welsh P, Cezard G, Gill JM, Wallia S, Douglas A, Sheikh A, \net  al. Associations between weight change and biomarkers \nof cardiometabolic risk in South Asians: Secondary analyses \nof the PODOSA trial. Int J Obes (Lond) 2016;40:1005-11.\n152. Mongraw-Chaffin ML, Peters SAE, Huxley RR, Woodward M. \nThe sex-specific association between BMI and coronary \nheart disease: A systematic review and meta-analysis of \n95 cohorts with 1·2 million participants. Lancet Diabetes \nEndocrinol 2015;3:437-49.\n153. Larsen BA, Allison MA, Laughlin GA, Araneta MR, Barrett-\nConnor E, Wooten WJ, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 40,
          "overlap_chars": 684,
          "overlap_percentage": 100.14641288433381
        }
      ],
      "primary_page": 40,
      "char_count": 683,
      "word_count": 101,
      "start_pos": 235533,
      "end_pos": 236217,
      "chunk_index": 462,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_463",
      "text": ";3:437-49.\n153. Larsen BA, Allison MA, Laughlin GA, Araneta MR, Barrett-\nConnor E, Wooten WJ, et al. The association between \nabdominal muscle and type II diabetes across weight \ncategories in diverse post-menopausal women. J Clin \nEndocrinol Metab 2015;100:E105-9.\n154. Tohidi M, Hatami M, Hadaegh F, Azizi F. Triglycerides and \ntriglycerides to high-density lipoprotein cholesterol ratio \nare strong predictors of incident hypertension in Middle \nEastern women. J Hum Hypertens 2012;26:525–32.\n155. Thulkar J, Singh S, Sharma S, Thulkar T. Preventable risk \nfactors for osteoporosis in postmenopausal women: \nSystematic review and meta-analysis. JMidlife Health \n2016;7:108-13.\n156.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 40,
          "overlap_chars": 684,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 40,
      "char_count": 684,
      "word_count": 94,
      "start_pos": 236117,
      "end_pos": 236801,
      "chunk_index": 463,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_464",
      "text": "in postmenopausal women: \nSystematic review and meta-analysis. JMidlife Health \n2016;7:108-13.\n156. McLeod KM, Johnson CS. A systematic review of \nosteoporosis health beliefs in adult men and women. \nJOsteoporos 2011;2011.[doi: 10.4061/2011/197454].\n157. Sadeghi O, Saneei P, Nasiri M, Larijani B, Esmaillzadeh A. \nAbdominal obesity and risk of hip fracture: A systematic \nreview and meta-analysis of prospective studies. Adv Nutr \n2017;8:728-38.\n158. Davis SR, Castelo-Branco C, Chedraui P, Lumsden MA, \nNappi  RE, Shah D, et al. Understanding weight gain at \nmenopause. Climacteric 2012;15:419-29.\n159. Khadilkar SS. Musculoskeletal disorders and menopause. J \nObstet Gynecol India 2019;69:99–103.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 40,
          "overlap_chars": 700,
          "overlap_percentage": 100.14306151645206
        }
      ],
      "primary_page": 40,
      "char_count": 699,
      "word_count": 93,
      "start_pos": 236701,
      "end_pos": 237401,
      "chunk_index": 464,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_465",
      "text": "159. Khadilkar SS. Musculoskeletal disorders and menopause. J \nObstet Gynecol India 2019;69:99–103.\n160. Jull J, Stacey D, Beach S, Dumas A, Strychar I, Ufholz LA, \net  al. Lifestyle interventions targeting body weight changes \nduring the menopause transition: A systematic review. \nJObes 2014;2014:824310.\n161. Werner N, Nickenig G, Sinning JM. Complex PCI procedures: \nChallenges for the interventional cardiologist. Clin Res \nCardiol 2018;107(Suppl 2):64-73.\n162. Reginster J-Y, Beaudart C, Buckinx F, Bruyère O. \nOsteoporosis and sarcopenia: Two diseases or one?: Curr\n\nRanjan, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 40,
          "overlap_chars": 573,
          "overlap_percentage": 97.44897959183673
        },
        {
          "page_number": 41,
          "overlap_chars": 14,
          "overlap_percentage": 2.380952380952381
        }
      ],
      "primary_page": 40,
      "char_count": 588,
      "word_count": 82,
      "start_pos": 237301,
      "end_pos": 237890,
      "chunk_index": 465,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_466",
      "text": "rt C, Buckinx F, Bruyère O. \nOsteoporosis and sarcopenia: Two diseases or one?: Curr\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nOpin Clin Nutr Metab Care 2016;19:31-6. doi: 10.1097/\nMCO.0000000000000230.\n163. Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, \nIijima K, et al. Asian working group for sarcopenia: 2019 \nconsensus update on sarcopenia diagnosis and treatment. \nJ Am Med Dir Assoc 2020;21:300-7.e2.\n164. Meeta M, Harinarayan CV, Marwah R, Sahay R, Kalra S, \nBabhulkar S.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 40,
          "overlap_chars": 84,
          "overlap_percentage": 14.237288135593221
        },
        {
          "page_number": 41,
          "overlap_chars": 504,
          "overlap_percentage": 85.42372881355932
        }
      ],
      "primary_page": 40,
      "char_count": 590,
      "word_count": 94,
      "start_pos": 237790,
      "end_pos": 238380,
      "chunk_index": 466,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_467",
      "text": "Dir Assoc 2020;21:300-7.e2.\n164. Meeta M, Harinarayan CV, Marwah R, Sahay R, Kalra S, \nBabhulkar S. Clinical practice guidelines on postmenopausal \nosteoporosis: *An executive summary and recommendations \n– Update 2019–2020. J Mid-life Health 2020;11:96-112.\n165. Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, \net al. Executive summary of the stages of reproductive \naging workshop + 10: Addressing the unfinished agenda \nof staging reproductive aging. J Clin Endocrinol Metab \n2012;97:1159-68.\n166. Watt FE. Musculoskeletal pain and menopause. Post Reprod \nHealth2018.[doi:10.1177/2053369118757537].\n167. Gracia CR, Freeman EW. Onset of the menopause transition.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 41,
          "overlap_chars": 672,
          "overlap_percentage": 100.14903129657229
        }
      ],
      "primary_page": 41,
      "char_count": 671,
      "word_count": 93,
      "start_pos": 238280,
      "end_pos": 238952,
      "chunk_index": 467,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_468",
      "text": "h2018.[doi:10.1177/2053369118757537].\n167. Gracia CR, Freeman EW. Onset of the menopause transition. \nObstet Gynecol Clin North Am2018;45:585–97.\n168. Burleson MH, Todd M, Trevathan WR. Daily vasomotor \nsymptoms, sleep problems, and mood: Using daily data to \nevaluate the domino hypothesis in middle-aged women. \nMenopause 2010;17:87-95.\n169. Peeters G, Edwards KL, Brown WJ, Barker AL, Arden N, \nRedmond AC, et al. Potential effect modifiers of the \nassociation between physical activity patterns and joint \nsymptoms in middle-aged women. Arthritis Care Res \n(Hoboken) 2018;70:1012-21.\n170. Baker FC, Lampio L, Saaresranta T, Polo-Kantola P.Sleep and \nsleep disorders in the menopausal transition.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 41,
          "overlap_chars": 699,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 41,
      "char_count": 699,
      "word_count": 95,
      "start_pos": 238852,
      "end_pos": 239551,
      "chunk_index": 468,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_469",
      "text": "FC, Lampio L, Saaresranta T, Polo-Kantola P.Sleep and \nsleep disorders in the menopausal transition. Sleep Med \nClin2018;13:443–56.\n171. Avis NE, Crawford SL, Greendale G, Bromberger JT, Everson-\nRose SA, Gold EB, et al. Duration of menopausal vasomotor \nsymptoms over the menopause transition. JAMA Intern Med \n2015;175:531–9.\n172. Esposito Sorpreso IC, Laprano Vieira LH, Longoni Calió C, \nAbi Haidar M, Baracat EC, Soares JM Jr. Health education \nintervention in early and late postmenopausal Brazilian \nwomen. Climacteric 2012;15:573-80.\n173. Zhang L, Ruan X, Cui Y, Gu M, Mueck AO.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 41,
          "overlap_chars": 586,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 41,
      "char_count": 586,
      "word_count": 87,
      "start_pos": 239451,
      "end_pos": 240037,
      "chunk_index": 469,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_470",
      "text": "enopausal Brazilian \nwomen. Climacteric 2012;15:573-80.\n173. Zhang L, Ruan X, Cui Y, Gu M, Mueck AO. Menopausal \nsymptoms among Chinese peri- and postmenopausal \nwomen: A large prospective single-center cohort study. \nGynecol Endocrinol 2021;37:185-9.\n174. Chuni N, Sreeramareddy CT. Frequency of symptoms, \ndeterminants of severe symptoms, validity of and cut-off \nscore for Menopause Rating Scale (MRS) as a screening tool: \nA cross-sectional survey among midlife Nepalese women. \nBMC Womens Health 2011;11:30.\n175. Rulu P, Sievert LL, Dhall M, Bertone-Johnson ER. Symptoms \nat midlife among women in Nagaland, India. Am J Hum Biol \n2021;33:e23456.\n176.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 41,
          "overlap_chars": 655,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 41,
      "char_count": 655,
      "word_count": 93,
      "start_pos": 239937,
      "end_pos": 240592,
      "chunk_index": 470,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_471",
      "text": "Johnson ER. Symptoms \nat midlife among women in Nagaland, India. Am J Hum Biol \n2021;33:e23456.\n176. Sourouni M, Zangger M, Honermann L, Foth D, Stute P. \nAssessment of the climacteric syndrome: A narrative \nreview. Arch Gynecol Obstet 2021;304:855–62.\n177. Taşkıran G, Özgül S. Individual characteristics associated \nwith menopausal symptom severity and menopause-\nspecific quality of life: A rural perspective. Reprod Sci \n2021;28:2661-71.\n178. Malik R, Pokaria C, Singh S, Khera K. Hindi translated \nversion of menopausal rating score questionnaire: A \nmethod to evaluate post menopausal symptoms in India. \nInt J Reprod Contraception Obstet Gynecol2019;8:3102.\ndoi:10.18203/2320-1770.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 41,
          "overlap_chars": 688,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 41,
      "char_count": 688,
      "word_count": 95,
      "start_pos": 240492,
      "end_pos": 241180,
      "chunk_index": 471,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_472",
      "text": "al symptoms in India. \nInt J Reprod Contraception Obstet Gynecol2019;8:3102.\ndoi:10.18203/2320-1770.ijrcog20193519.\n179. Pearson ES. Goal setting as a health behavior change strategy \nin overweight and obese adults: A systematic literature \nreview examining intervention components. Patient Educ \nCouns2012;87:32–42.doi:10.1016/j.pec.2011.07.018.\n180. Levack WMM, Weatherall M, Hay-Smith EJC, Dean SG, \nMcPherson K, Siegert RJ. Goal setting and strategies to \nenhance goal pursuit for adults with acquired disability \nparticipating in rehabilitation. Cochrane Database Syst Rev \n2015:CD009727.doi: 10.1002/14651858.CD009727.pub2.\n181.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 41,
          "overlap_chars": 634,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 41,
      "char_count": 634,
      "word_count": 73,
      "start_pos": 241080,
      "end_pos": 241714,
      "chunk_index": 472,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_473",
      "text": "rehabilitation. Cochrane Database Syst Rev \n2015:CD009727.doi: 10.1002/14651858.CD009727.pub2.\n181. Zomer E, Gurusamy K, Leach R, Trimmer C, Lobstein T, \nMorris S, et al. Interventions that cause weight loss and the \nimpact on cardiovascular risk factors: A systematic review \nand meta-analysis. ObesRev 2016;17:1001-11.\n182. Ryan DH, Yockey SR. Weight loss and improvement in \ncomorbidity: Differences at 5%, 10%, 15%, and over. Curr \nObes Rep 2017;6:187-94.\n183. Aucott L, Gray D, Rothnie H, Thapa M, Waweru C. Effects of \nlifestyle interventions and long-term weight loss on lipid \noutcomes–A systematic review. Obes Rev 2011;12:e412-25.\n184.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 41,
          "overlap_chars": 646,
          "overlap_percentage": 100.15503875968992
        }
      ],
      "primary_page": 41,
      "char_count": 645,
      "word_count": 91,
      "start_pos": 241614,
      "end_pos": 242260,
      "chunk_index": 473,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.656695"
    },
    {
      "id": "chunk_474",
      "text": "ons and long-term weight loss on lipid \noutcomes–A systematic review. Obes Rev 2011;12:e412-25.\n184. Huang AJ, Subak LL, Wing R, West DS, Hernandez AL, \nMacer  J, et al. An intensive behavioral weight loss \nintervention and hot flushes in women. Arch Intern Med \n2010;170:1161-7. doi: 10.1001/archinternmed.2010.162. \nErratum in: Arch Intern Med 2010;170:1601.\n185. McCusker M, Gregoski MJ. Instruments to measure \nreadiness to lose weight: An integrative review. J Nurs Meas \n2015;23:142-62.\n186. Avery A, Langley-Evans SC, Harrington M, Swift JA.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 41,
          "overlap_chars": 548,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 41,
      "char_count": 548,
      "word_count": 79,
      "start_pos": 242160,
      "end_pos": 242708,
      "chunk_index": 474,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_475",
      "text": "grative review. J Nurs Meas \n2015;23:142-62.\n186. Avery A, Langley-Evans SC, Harrington M, Swift JA. \nSetting targets leads to greater long-term weight losses \nand ‘unrealistic’ targets increase the effect in a large \ncommunity-based commercial weight management group.J \nHum Nutr Diet2016;29:687–96.\n187. BehrH, HoAS, Mitchell ES, Yang Q, DeLuca L, Michealides A. \nHow do emotions during goal pursuit in weight change \nover time? Retrospective computational text analysis \nof goal setting and striving conversations with a coach \nduring a mobile weight loss program. Int J Environ Res \nPublicHealth2021;18:6600.\n188. Knittle K, Nurmi J, Crutzen R, Hankonen N, Beattie M, \nDombrowski SU.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 41,
          "overlap_chars": 687,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 41,
      "char_count": 687,
      "word_count": 99,
      "start_pos": 242608,
      "end_pos": 243295,
      "chunk_index": 475,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_476",
      "text": "PublicHealth2021;18:6600.\n188. Knittle K, Nurmi J, Crutzen R, Hankonen N, Beattie M, \nDombrowski SU. How can interventions increase motivation \nfor physical activity? A systematic review and meta-\nanalysis. Health Psychol Rev 2018;12:211–30.\n189. Chopra S, Malhotra A, Ranjan P, Vikram NK, Singh N. \nLifestyle-related advice in the management of obesity: A \nstep-wise approach. J Educ Health Promot 2020;9:239.\n190. Sharma M, Kishore A, Roy D, Joshi K. A comparison of the \nIndian diet with the EAT-Lancet reference diet.BMC Public \nHealth 2020;20:812.\n191. Rock CL, Flatt SW, Pakiz B, Barkai HS, Heath DD, Krumhar \nKC.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 41,
          "overlap_chars": 619,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 41,
      "char_count": 619,
      "word_count": 94,
      "start_pos": 243195,
      "end_pos": 243814,
      "chunk_index": 476,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_477",
      "text": "t.BMC Public \nHealth 2020;20:812.\n191. Rock CL, Flatt SW, Pakiz B, Barkai HS, Heath DD, Krumhar \nKC. Randomized clinical trial of portion-controlled \nprepackaged foods to promote weight loss. Obesity (Silver \nSpring) 2016;24:1230-7.\n192. Joseph G, Arviv-Eliashiv R, Tesler R. A comparison \nof diet versus diet + exercise programs for health \nimprovement in middle-aged overweight women. \nWomens Health (Lond) 2020;16:1745506520932372. doi: \n10.1177/1745506520932372.\n193. Cheng CC, Hsu CY, Liu JF. Effects of dietary and exercise \nintervention on weight loss and body composition in obese \npostmenopausal women: A systematic review and meta-\nanalysis. Menopause 2018;25:772-82.\n\nRanjan, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 41,
          "overlap_chars": 677,
          "overlap_percentage": 97.6911976911977
        },
        {
          "page_number": 42,
          "overlap_chars": 14,
          "overlap_percentage": 2.0202020202020203
        }
      ],
      "primary_page": 41,
      "char_count": 693,
      "word_count": 95,
      "start_pos": 243714,
      "end_pos": 244407,
      "chunk_index": 477,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_478",
      "text": "tmenopausal women: A systematic review and meta-\nanalysis. Menopause 2018;25:772-82.\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\n194. Figueroa A, Vicil F, Sanchez-Gonzalez MA, Wong A, \nOrmsbee  MJ, Hooshmand S, et al. Effects of diet and/or low-\nintensity resistance exercise training on arterial stiffness, \nadiposity, and lean mass in obese postmenopausal women. \nAm J Hypertens 2013;26:416-23.\n195. Cespedes Feliciano EM, Tinker L, Manson JE, Allison M, \nRohan T, et al. Change in dietary patterns and change in waist \ncircumference and DXA trunk fat among postmenopausal \nwomen.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 41,
          "overlap_chars": 84,
          "overlap_percentage": 12.262773722627736
        },
        {
          "page_number": 42,
          "overlap_chars": 599,
          "overlap_percentage": 87.44525547445255
        }
      ],
      "primary_page": 41,
      "char_count": 685,
      "word_count": 103,
      "start_pos": 244307,
      "end_pos": 244992,
      "chunk_index": 478,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_479",
      "text": "n dietary patterns and change in waist \ncircumference and DXA trunk fat among postmenopausal \nwomen. Obesity (Silver Spring) 2016;24:2176-84.\n196. Arguin H, Dionne IJ, Sénéchal M, Bouchard DR, \nCarpentier AC, Ardilouze JL, et al. Short- and long-term \neffects of continuous versus intermittent restrictive diet \napproaches on body composition and the metabolic profile \nin overweight and obese postmenopausal women: A pilot \nstudy. Menopause 2012;19:870-6.\n197. Koliaki C, Spinos T, Spinou Μ, Brinia ΜE, Mitsopoulou D, \nKatsilambros N. Defining the optimal dietary approach for \nsafe, effective and sustainable weight loss in overweight \nand obese adults. Healthcare (Basel) 2018;6:73.\n198.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 42,
          "overlap_chars": 690,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 42,
      "char_count": 690,
      "word_count": 97,
      "start_pos": 244892,
      "end_pos": 245582,
      "chunk_index": 479,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_480",
      "text": "tive and sustainable weight loss in overweight \nand obese adults. Healthcare (Basel) 2018;6:73.\n198. Barber TM, Hanson P, Kabisch S, Pfeiffer AFH, Weickert MO. \nThe low-carbohydrate diet: Short-term metabolic efficacy \nversus longer-term limitations. Nutrients 2021;13:1187.\n199. ICMR-NIN Expert Group on Nutrient Requirement for \nIndians, recommended Dietary Allowances (RDA) and \nEstimated Average Requirements (EAR)-2020. Available \nfrom: [URL]\nhtml. [Last accessed on2021 Dec 01].\n200. Damms-Machado A, Weser G, Bischoff SC. Micronutrient \ndeficiency in obese subjects undergoing low calorie diet. \nNutr J 2012;11:34.\n201. Gupta A, Kumar R, Mohan A, Rahi S.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 42,
          "overlap_chars": 661,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 42,
      "char_count": 661,
      "word_count": 90,
      "start_pos": 245482,
      "end_pos": 246143,
      "chunk_index": 480,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_481",
      "text": "se subjects undergoing low calorie diet. \nNutr J 2012;11:34.\n201. Gupta A, Kumar R, Mohan A, Rahi S. Guidelines for Control \nof Iron Deficiency Anaemia. New Delhi: Ministry of Health \nand Family Welfare, Government of India; 2013.\n202. Chen LR, Ko NY, Chen KH. Isoflavone supplements for \nmenopausal women: A systematic review. Nutrients \n2019;11:2649.\n203. Westerterp KR. Physical activity and physical activity \ninduced energy expenditure in humans: Measurement, \ndeterminants, and effects. Front Physiol 2013;4:90.\n204. Dasso NA. How is exercise different from physical activity? \nA concept analysis. NursForum 2019;54:45-52.\n205.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 42,
          "overlap_chars": 633,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 42,
      "char_count": 633,
      "word_count": 90,
      "start_pos": 246043,
      "end_pos": 246676,
      "chunk_index": 481,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_482",
      "text": "How is exercise different from physical activity? \nA concept analysis. NursForum 2019;54:45-52.\n205. Hintze LJ, Messier V, Lavoie MÈ, Brochu M, Lavoie JM, \nPrud’homme D, et al. A one-year resistance training program \nfollowing weight loss has no significant impact on body \ncomposition and energy expenditure in postmenopausal \nwomen living with overweight and obesity. Physiol Behav \n2018;189:99-106.\n206. Kendall KL, Fairman CM. Therapeutic physical activities for \npeople with cancer.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 42,
          "overlap_chars": 487,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 42,
      "char_count": 487,
      "word_count": 68,
      "start_pos": 246576,
      "end_pos": 247063,
      "chunk_index": 482,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_483",
      "text": "18;189:99-106.\n206. Kendall KL, Fairman CM. Therapeutic physical activities for \npeople with cancer. Available from: [URL]\nnet/profile/Ciaran-Fairman-2/publication/318207071_\nTherapeutic_Physical_Activities_for_People_with_Cancer/\nlinks/5988727645851560584f4b44/Therapeutic-Physical-\nActivities-for-People-with-Cancer.pdf. [Last accessed on \n2021 Oct 21].\n207. Kang SJ, Kim JH, Gang Z, Yook YS, Yoon JR, Ha GC, et al. \nEffects of 12-week circuit exercise program on obesity index, \nappetite regulating hormones, and insulin resistance in \nmiddle-aged obese females. J Phys Ther Sci 2018;30:169-73.\n208. Strath SJ, Kaminsky LA, Ainsworth BE, Ekelund U, \nFreedson PS, Gary RA, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 42,
          "overlap_chars": 681,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 42,
      "char_count": 681,
      "word_count": 80,
      "start_pos": 246963,
      "end_pos": 247644,
      "chunk_index": 483,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_484",
      "text": "2018;30:169-73.\n208. Strath SJ, Kaminsky LA, Ainsworth BE, Ekelund U, \nFreedson PS, Gary RA, et al. Guide to the assessment of \nphysical activity: clinical and research applications: A \nscientific statement from the American Heart Association. \nCirculation 2013;128:2259-79.\n209. Yarizadeh H, Asadi S, Baharlooi H, Setayesh L, Kakavandi NR, \nHambly C, et al. Beneficial impact of exercise on bone mass \nin individuals under calorie restriction: A systematic review \nand Meta-analysis of randomized clinical trials. Crit Rev \nFood Sci Nutr 2021;61:553-65.\n210. Rashti BA, Mehrabani J, Damirchi A, Babaei P.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 42,
          "overlap_chars": 606,
          "overlap_percentage": 100.16528925619835
        }
      ],
      "primary_page": 42,
      "char_count": 605,
      "word_count": 88,
      "start_pos": 247544,
      "end_pos": 248150,
      "chunk_index": 484,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_485",
      "text": "l trials. Crit Rev \nFood Sci Nutr 2021;61:553-65.\n210. Rashti BA, Mehrabani J, Damirchi A, Babaei P. The \ninfluence of concurrent training intensity on serum \nirisin and abdominal fat in postmenopausal women. Prz \nMenopauzalny 2019;18:166-73.\n211. Choquette S, Dion T, Brochu M, Dionne IJ. Soy isoflavones and \nexercise to improve physical capacity in postmenopausal \nwomen. Climacteric 2013;16:70-7.\n212. Luoto R, Moilanen J, Heinonen R, Mikkola T, Raitanen J, \nTomas E, et al. Effect of aerobic training on hot flushes \nand quality of life--A randomized controlled trial. Ann Med \n2012;44:616-26.\n213. David P, Buckworth J, Pennell ML, Katz ML, DeGraffinreid CR, \nPaskett ED.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 42,
          "overlap_chars": 677,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 42,
      "char_count": 677,
      "word_count": 102,
      "start_pos": 248050,
      "end_pos": 248727,
      "chunk_index": 485,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_486",
      "text": "Med \n2012;44:616-26.\n213. David P, Buckworth J, Pennell ML, Katz ML, DeGraffinreid CR, \nPaskett ED. A walking intervention for postmenopausal \nwomen using mobile phones and Interactive Voice \nResponse. J Telemed Telecare 2012;18:20-5.\n214. de Azevedo Guimarães AC, Baptista F. Influence of habitual \nphysical activity on the symptoms of climacterium/\nmenopause and the quality of life of middle-aged women. \nInt J Womens Health 2011;3:319-28.\n215. McHugh IJ, Williams AD, Fell JW. Practical application of the \nSports Medicine Australia pre-exercise screening system. J \nSci Med Sport 2008;11:182-4.\n216. Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, \nRubin RR, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 42,
          "overlap_chars": 687,
          "overlap_percentage": 100.14577259475219
        }
      ],
      "primary_page": 42,
      "char_count": 686,
      "word_count": 100,
      "start_pos": 248627,
      "end_pos": 249314,
      "chunk_index": 486,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_487",
      "text": "008;11:182-4.\n216. Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, \nRubin RR, et al. Exercise and type 2 diabetes: The American \nCollege of Sports Medicine and the American Diabetes \nAssociation joint position statement. Diabetes Care \n2010;33:e147–67.\n217. Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, \nJastreboff AM, et al. AACE/ACE comprehensive clinical \npractice guidelines for medical care of patients with obesity. \nEndocr Pract 2016;22(Suppl 3):1–203.\n218. Webster AL, Aznar-Laín S. Intensity of physical activity and \nthe “talk test”. ACSM’S Health Fitness J 2008;12:13–7.\n219. Mishra N, Mishra VN, Devanshi. Exercise beyond menopause: \nDos and Don’ts.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 42,
          "overlap_chars": 689,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 42,
      "char_count": 689,
      "word_count": 99,
      "start_pos": 249214,
      "end_pos": 249903,
      "chunk_index": 487,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_488",
      "text": "ness J 2008;12:13–7.\n219. Mishra N, Mishra VN, Devanshi. Exercise beyond menopause: \nDos and Don’ts. J Midlife Health 2011;2:51-6.\n220. Vaze N, Joshi S. Yoga and menopausal transition. J Midlife \nHealth 2010;1:56-8.\n221. Montesi L, El Ghoch M, Brodosi L, Calugi S, Marchesini G, \nDalle Grave R. Long-term weight loss maintenance for \nobesity: A multidisciplinary approach. Diabetes Metab \nSyndr Obes 2016;9:37-46.\n222. Burgess E, Hassmén P, Welvaert M, Pumpa KL. Behavioural \ntreatment strategies improve adherence to lifestyle \nintervention programmes in adults with obesity: A systematic \nreview and meta-analysis. ClinObes 2017;7:105-14.\n223. Kelley CP, Sbrocco G, Sbrocco T.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 42,
          "overlap_chars": 678,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 42,
      "char_count": 678,
      "word_count": 97,
      "start_pos": 249803,
      "end_pos": 250481,
      "chunk_index": 488,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_489",
      "text": "systematic \nreview and meta-analysis. ClinObes 2017;7:105-14.\n223. Kelley CP, Sbrocco G, Sbrocco T. Behavioral modification \nfor the management of obesity. Prim Care 2016;43:159-75.\n224. Buckworth J. Weight management behavioral strategies. \nACSM’s Health Fitness J 2018;22:45-6.\n225. Beishuizen CR, Stephan BC, van Gool WA, Brayne C, \nPeters  RJ, Andrieu S, et al. Web-based interventions \ntargeting cardiovascular risk factors in middle-aged and \nolder people: A systematic review and meta-analysis. J Med \nInternet Res 2016;18:e55.\n226. Idoate F, Ibañez J, Gorostiaga EM, García-Unciti M, Martínez-\nLabari C, Izquierdo M.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 42,
          "overlap_chars": 625,
          "overlap_percentage": 100.16025641025641
        }
      ],
      "primary_page": 42,
      "char_count": 624,
      "word_count": 86,
      "start_pos": 250381,
      "end_pos": 251006,
      "chunk_index": 489,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_490",
      "text": "16;18:e55.\n226. Idoate F, Ibañez J, Gorostiaga EM, García-Unciti M, Martínez-\nLabari C, Izquierdo M. Weight-loss diet alone or combined \nwith resistance training induces different regional\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nvisceral fat changes in obese women. Int J Obes (Lond) \n2011;35:700-13.\n227. Shin H, Shin J, Liu PY, Dutton GR, Abood DA, Ilich JZ. \nSelf-efficacy improves weight loss in overweight/obese \npostmenopausal women during a 6-month weight loss \nintervention. Nutr Res 2011;31:822-8.\n228.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 42,
          "overlap_chars": 188,
          "overlap_percentage": 30.42071197411003
        },
        {
          "page_number": 43,
          "overlap_chars": 428,
          "overlap_percentage": 69.25566343042071
        }
      ],
      "primary_page": 42,
      "char_count": 618,
      "word_count": 92,
      "start_pos": 250906,
      "end_pos": 251524,
      "chunk_index": 490,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_491",
      "text": "obese \npostmenopausal women during a 6-month weight loss \nintervention. Nutr Res 2011;31:822-8.\n228. Johns DJ, Hartmann-Boyce J, Jebb SA, Aveyard P; Behavioural \nWeight Management Review Group. Diet or exercise \ninterventions vs combined behavioral weight management \nprograms: A systematic review and meta-analysis of direct \ncomparisons. J Acad Nutr Diet 2014;114:1557-68.\n229. Imayama I, Alfano CM, Kong A, Foster-Schubert KE, \nBain CE, Xiao L, et al. Dietary weight loss and exercise \ninterventions effects on quality of life in overweight/obese \npostmenopausal women: A randomized controlled trial. Int \nJ Behav Nutr Phys Act 2011;8:118.\n230.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 43,
          "overlap_chars": 647,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 43,
      "char_count": 647,
      "word_count": 91,
      "start_pos": 251424,
      "end_pos": 252071,
      "chunk_index": 491,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_492",
      "text": "se \npostmenopausal women: A randomized controlled trial. Int \nJ Behav Nutr Phys Act 2011;8:118.\n230. Mason C, Foster-Schubert KE, Imayama I, Kong A, Xiao L, \nBain C, et al. Dietary weight loss and exercise effects on \ninsulin resistance in postmenopausal women. Am J Prev \nMed 2011;41:366-75.\n231. Durrer Schutz D, Busetto L, Dicker D, Farpour-Lambert N, \nPryke R, Toplak H, et al. European practical and patient-\ncentred guidelines for adult obesity management in primary \ncare. Obes Facts 2019;12:40-66.\n232. Hooker S, Punjabi A, Justesen K, Boyle L, Sherman MD. \nEncouraging health behavior change: eight evidence-based \nstrategies. FamPract Manag 2018;25:31-6.\n233. Fait T.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 43,
          "overlap_chars": 677,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 43,
      "char_count": 677,
      "word_count": 102,
      "start_pos": 251971,
      "end_pos": 252648,
      "chunk_index": 492,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_493",
      "text": "health behavior change: eight evidence-based \nstrategies. FamPract Manag 2018;25:31-6.\n233. Fait T. Menopause hormone therapy: Latest developments \nand clinical practice. Drugs Context 2019;8:212551. doi: \n10.7573/dic.212551.\n234. United Nations Population Division. World Population \nProspects 2019. New York: United Nations Population \nDivision; 2020. Available from: [URL]\nwpp/DataQuery/.[Last accessed on 2020 Nov 27].\n235. Papadakis GE, Hans D, Rodriguez EG, Vollenweider P, \nWaeber G, Marques-Vidal P, et al. Menopausal hormone \ntherapy is associated with reduced total and visceral \nadiposity: The OsteoLaus cohort. J Clin Endocrinol Metab \n2018;103:1948-57.\n236.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 43,
          "overlap_chars": 671,
          "overlap_percentage": 100.1492537313433
        }
      ],
      "primary_page": 43,
      "char_count": 670,
      "word_count": 85,
      "start_pos": 252548,
      "end_pos": 253219,
      "chunk_index": 493,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_494",
      "text": "total and visceral \nadiposity: The OsteoLaus cohort. J Clin Endocrinol Metab \n2018;103:1948-57.\n236. Zhang GQ, Chen JL, Luo Y, Mathur MB, Anagnostis P, Nurmatov \nU, et al. Menopausal hormone therapy and women’s health: \nAn umbrella review. PLoS Med 2021;18:e1003731.\n237. Mishra GD, Chung HF, Cano A, Chedraui P, Goulis DG, \nLopes  P, et al. EMAS position statement: Predictors of \npremature and early natural menopause. Maturitas \n2019;123:82-8.\n238. Sturdee DW, Pines A, International Menopause Society \nWriting Group, Archer DF, Baber RJ, Barlow D, et al. Updated \nIMS recommendations on postmenopausal hormone \ntherapy and preventive strategies for midlife health. \nClimacteric 2011;14:302-20.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 43,
          "overlap_chars": 697,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 43,
      "char_count": 697,
      "word_count": 99,
      "start_pos": 253119,
      "end_pos": 253816,
      "chunk_index": 494,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_495",
      "text": "nopausal hormone \ntherapy and preventive strategies for midlife health. \nClimacteric 2011;14:302-20.\n239. Casanova G, Bossardi Ramos R, Ziegelmann P, Spritzer PM. \nEffects of low-dose versus placebo or conventional-dose \npostmenopausal hormone therapy on variables related to \ncardiovascular risk: A systematic review and meta-analyses \nof randomized clinical trials. J Clin Endocrinol Metab \n2015;100:1028-37.\n240. Casanova G, Spritzer PM. Effects of micronized progesterone \nadded to non-oral estradiol on lipids and cardiovascular \nrisk factors in early postmenopause: A clinical trial. Lipids \nHealth Dis 2012;11:133.\n241. Paoletti AM, Lello S, Di Carlo C, Orrù M, Malune ME, \nNeri  M, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 43,
          "overlap_chars": 696,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 43,
      "char_count": 696,
      "word_count": 96,
      "start_pos": 253716,
      "end_pos": 254412,
      "chunk_index": 495,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_496",
      "text": "Health Dis 2012;11:133.\n241. Paoletti AM, Lello S, Di Carlo C, Orrù M, Malune ME, \nNeri  M, et al. Effect of Estradiol valerate plus dienogest \non body composition of healthy women in the menopausal \ntransition: A prospective one-year evaluation. Gynecol \nEndocrinol 2016;32:61-4.\n242. Honisett SY, Tangalakis K, Wark J, Apostolopoulos V, \nStojanovska L. The effects of hormonal therapy and exercise \non bone turnover in postmenopausal women: A randomised \ndouble-blind pilot study. Pril (Makedon Akad Nauk Umet \nOdd Med Nauki) 2016;37:23-32.\n243. Golden SH, Kim C, Barrett-Connor E, Nan B, Kong S, \nGoldberg  R, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 43,
          "overlap_chars": 621,
          "overlap_percentage": 100.32310177705976
        }
      ],
      "primary_page": 43,
      "char_count": 619,
      "word_count": 95,
      "start_pos": 254312,
      "end_pos": 254933,
      "chunk_index": 496,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_497",
      "text": "d Nauki) 2016;37:23-32.\n243. Golden SH, Kim C, Barrett-Connor E, Nan B, Kong S, \nGoldberg  R, et al. The association of elective hormone \ntherapy with changes in lipids among glucose intolerant \npostmenopausal women in the diabetes prevention \nprogram. Metabolism 2013 Sep;62:1313-22.\n244. Johnson WD, Brashear MM, Gupta AK, Rood JC, Ryan DH. \nIncremental weight loss improves cardiometabolic risk in \nextremely obese adults. Am J Med 2011;124:931–8.\n245. Wasenius NS, Isomaa BA, Östman B, Söderström J, Forsén B, \nLahti K, et al. Low-cost exercise interventions improve long-\nterm cardiometabolic health independently of a family \nhistory of type 2 diabetes: A randomized parallel group \ntrial.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 43,
          "overlap_chars": 695,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 43,
      "char_count": 695,
      "word_count": 103,
      "start_pos": 254833,
      "end_pos": 255528,
      "chunk_index": 497,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_498",
      "text": "ic health independently of a family \nhistory of type 2 diabetes: A randomized parallel group \ntrial. BMJ Open Diabetes Res Care 2020;8:e001377.\n246. Gao HL, Gao HX, Sun FM, Zhang L. Effects of walking on \nbody composition in perimenopausal and postmenopausal \nwomen: A systematic review and meta-analysis. Menopause \n2016;23:928-34.\n247. Funderburk L, Heileson J, Peterson M, Willoughby  DS. \nEfficacy of L-Leucine supplementation coupled with \na calorie-restricted diet to promote weight loss \nin mid-life women. J Am Coll Nutr 2020:1-9. doi: \n10.1080/07315724.2020.1815607.\n248. Mason C, Xiao L, Imayama I, Duggan CR, Foster-Schubert  KE, \nKong A, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 43,
          "overlap_chars": 656,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 43,
      "char_count": 656,
      "word_count": 96,
      "start_pos": 255428,
      "end_pos": 256084,
      "chunk_index": 498,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_499",
      "text": "15724.2020.1815607.\n248. Mason C, Xiao L, Imayama I, Duggan CR, Foster-Schubert  KE, \nKong A, et al. Influence of diet, exercise, and serum vitamin \nd on sarcopenia in postmenopausal women. Med Sci Sports \nExerc 2013;45:607-14.\n249. Abedi P, Nikkhah P, Najar S. Effect of pedometer-based \nwalking on depression, anxiety and insomnia among \npostmenopausal women. Climacteric 2015;18:841-5.\n250. Ponde K, Agrawal R, Hussaini SH. Effect of yoga therapy \nversus aerobic exercise on climacteric symptoms, perceived \nstress and quality of life in perimenopausal women. Int J \nYoga Physiother Phys Educ 2019;4:1-6.\n251. Subrahmanyam N, Padmaja A.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 43,
          "overlap_chars": 639,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 43,
      "char_count": 639,
      "word_count": 93,
      "start_pos": 255984,
      "end_pos": 256623,
      "chunk_index": 499,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_500",
      "text": "n perimenopausal women. Int J \nYoga Physiother Phys Educ 2019;4:1-6.\n251. Subrahmanyam N, Padmaja A. Effect of interventional \npackage on quality of life of perimenopausal women \nresiding in a rural community of Idukki District, Kerala. J \nGynecol Obstetr 2018;1:4-10.\n252. Shorey S, Ang L, Lau Y. Efficacy of mind-body therapies \nand exercise-based interventions on menopausal-related \noutcomes among Asian perimenopause women: A \nsystematic review, meta-analysis, and synthesis without a \nmeta-analysis. J Adv Nurs 2020;76:1098-110.\n253. Millstein RA. Measuring outcomes in adult weight \nloss studies that include diet and physical activity: a \nsystematic review. J Nutr Metab 2014;2014:421423.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 43,
          "overlap_chars": 696,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 43,
      "char_count": 696,
      "word_count": 96,
      "start_pos": 256523,
      "end_pos": 257219,
      "chunk_index": 500,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_501",
      "text": "tudies that include diet and physical activity: a \nsystematic review. J Nutr Metab 2014;2014:421423. [doi: \n10.1155/2014/421423].\n254. Hall KD, Kahan S. Maintenance of lost weight and \nlong-term management of obesity. Med Clin North Am \n2018;102:183-97.\n255. Lemstra M, Bird Y, Nwank Stevenwo C, Rogers M, Moraros J. \nWeight loss intervention adherence and factors promoting \nadherence: A meta-analysis. Patient Prefer Adherence \n2016;10:1547-59.\n256. Fruh SM. Obesity: Risk factors, complications, and strategies \nfor sustainable long-term weight management. J Am Assoc\n\nRanjan, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 43,
          "overlap_chars": 570,
          "overlap_percentage": 97.26962457337885
        },
        {
          "page_number": 44,
          "overlap_chars": 14,
          "overlap_percentage": 2.3890784982935154
        }
      ],
      "primary_page": 43,
      "char_count": 586,
      "word_count": 81,
      "start_pos": 257119,
      "end_pos": 257705,
      "chunk_index": 501,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_502",
      "text": "mplications, and strategies \nfor sustainable long-term weight management. J Am Assoc\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nof Nurse Pract 2017;29:S3-14.\n257. Hageman PA, Mroz JE, Yoerger MA, Pullen CH. User \nengagement associated with web-intervention features \nto attain clinically meaningful weight loss and weight \nmaintenance in rural women. JObes 2019;2019.\n258. Karimi G, Azadbakht L, Haghighatdoost F, Esmaillzadeh A. \nLow energy density diet, weight loss maintenance, and \nrisk of cardiovascular disease following a recent weight \nreduction program: A randomized control trial.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 43,
          "overlap_chars": 84,
          "overlap_percentage": 12.103746397694524
        },
        {
          "page_number": 44,
          "overlap_chars": 608,
          "overlap_percentage": 87.60806916426513
        }
      ],
      "primary_page": 43,
      "char_count": 694,
      "word_count": 99,
      "start_pos": 257605,
      "end_pos": 258299,
      "chunk_index": 502,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_503",
      "text": "of cardiovascular disease following a recent weight \nreduction program: A randomized control trial. J Res Med \nSci 2016;21:32.\n259. Milsom VA, Middleton KM, Perri MG. Successful long-term \nweight loss maintenance in a rural population. Clin Interv \nAging 2011;6:303-9.\n260. Christensen P, Henriksen M, Bartels EM, Leeds AR, Meinert \nLarsen T, Gudbergsen H, et al. Long-term weight-loss \nmaintenance in obese patients with knee osteoarthritis: A \nrandomized trial. Am J Clin Nutr 2017;106:755-63.\n261. Peirson L, Fitzpatrick-Lewis D, Ciliska D, Usman Ali M, \nRaina P, Sherifali D.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 44,
          "overlap_chars": 580,
          "overlap_percentage": 100.17271157167531
        }
      ],
      "primary_page": 44,
      "char_count": 579,
      "word_count": 85,
      "start_pos": 258199,
      "end_pos": 258779,
      "chunk_index": 503,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_504",
      "text": "2017;106:755-63.\n261. Peirson L, Fitzpatrick-Lewis D, Ciliska D, Usman Ali M, \nRaina P, Sherifali D. Strategies for weight maintenance \nin adult populations treated for overweight and obesity: \nA systematic review and meta-analysis. CMAJ Open \n2015;3:E47-54.\n262. Tussing-Humphreys LM, Fitzgibbon ML, Kong A, Odoms-\nYoung A. Weight loss maintenance in African American \nwomen: A systematic review of the behavioral lifestyle \nintervention literature. J Obes 2013;2013:437369. doi: \n10.1155/2013/437369.\n263. Wang J, Wang S, Henning SM, Qin T, Pan Y, Yang J, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 44,
          "overlap_chars": 564,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 44,
      "char_count": 564,
      "word_count": 81,
      "start_pos": 258679,
      "end_pos": 259243,
      "chunk_index": 504,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_505",
      "text": "013:437369. doi: \n10.1155/2013/437369.\n263. Wang J, Wang S, Henning SM, Qin T, Pan Y, Yang J, et al. \nMixed tree nut snacks compared to refined carbohydrate \nsnacks resulted in weight loss and increased satiety during \nboth weight loss and weight maintenance: A 24-week \nrandomized controlled trial. Nutrients 2021;13:1512.\n264. Conroy MB, Bryce CL, McTigue KM, Tudorascu D, Gibbs BB, \nComer D, et al. Promoting weight maintenance with \nelectronic health record tools in a primary care setting: \nBaseline results from the MAINTAIN-pc trial. ContempClin \nTrials 2017;54:60-7.\n265. Brantley PJ, Stewart DW, Myers VH, Matthews-Ewald MR, \nArd JD, Coughlin JW, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 44,
          "overlap_chars": 662,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 44,
      "char_count": 662,
      "word_count": 100,
      "start_pos": 259143,
      "end_pos": 259805,
      "chunk_index": 505,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_506",
      "text": "017;54:60-7.\n265. Brantley PJ, Stewart DW, Myers VH, Matthews-Ewald MR, \nArd JD, Coughlin JW, et al. Psychosocial predictors of weight \nregain in the weight loss maintenance trial. J Behav Med \n2014;37:1155-68.\n266. Dutton GR, Gowey MA, Tan F, Zhou D, Ard J, Perri MG, \net al. Comparison of an alternative schedule of extended \ncare contacts to a self-directed control: A randomized \ntrial of weight loss maintenance. Int J Behav Nutr Phys Act \n2017;14:107.\n267. Leahey TM, Fava JL, Seiden A, Fernandes D, Doyle C, Kent K, \net al. A randomized controlled trial testing an Internet \ndelivered cost-benefit approach to weight loss maintenance. \nPrev Med 2016;92:51-7.\n268.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 44,
          "overlap_chars": 670,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 44,
      "char_count": 670,
      "word_count": 106,
      "start_pos": 259705,
      "end_pos": 260375,
      "chunk_index": 506,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_507",
      "text": "n Internet \ndelivered cost-benefit approach to weight loss maintenance. \nPrev Med 2016;92:51-7.\n268. Madjd A, Taylor MA, Delavari A, Malekzadeh R, Macdonald IA, \nFarshchi HR. Effects of cognitive behavioral therapy on \nweight maintenance after successful weight loss in women; \nA randomized clinical trial. Eur J Clin Nutr 2020;74:436-44.\n269. Trepanowski JF, Kroeger CM, Barnosky A, Klempel MC, \nBhutani S, Hoddy KK, et al. Effect of alternate-day fasting \non weight loss, weight maintenance, and cardioprotection \namong metabolically healthy obese adults: A randomized \nclinical trial. JAMA Intern Med 2017;177:930-8.\n270.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 44,
          "overlap_chars": 624,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 44,
      "char_count": 624,
      "word_count": 88,
      "start_pos": 260275,
      "end_pos": 260899,
      "chunk_index": 507,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_508",
      "text": "tabolically healthy obese adults: A randomized \nclinical trial. JAMA Intern Med 2017;177:930-8.\n270. Kaikkonen KM, Saltevo SS, Korpelainen JT, Vanhala ML, \nJokelainen JJ, Korpelainen RI, et al. Effective weight loss \nand maintenance by intensive start with diet and exercise. \nMed Sci Sports Exerc 2019;51:920-9.\n271. Calugi S, Marchesini G, El Ghoch M, Gavasso I, Dalle Grave R. \nThe association between weight maintenance and session-\nby-session diet adherence, weight loss and weight-loss \nsatisfaction. Eat Weight Disord 2020;25:127-33.\n272. Zwickert K, Rieger E, Swinbourne J, Manns C, McAulay C, \nGibson AA, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 44,
          "overlap_chars": 620,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 44,
      "char_count": 620,
      "word_count": 91,
      "start_pos": 260799,
      "end_pos": 261419,
      "chunk_index": 508,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_509",
      "text": "sord 2020;25:127-33.\n272. Zwickert K, Rieger E, Swinbourne J, Manns C, McAulay C, \nGibson AA, et al. High or low intensity text-messaging \ncombined with group treatment equally promote weight \nloss maintenance in obese adults. Obes Res Clin Pract \n2016;10:680-91.\n273. Champagne CM, Broyles ST, Moran LD, Cash KC, Levy EJ, \nLin PH, et al. Dietary intakes associated with successful \nweight loss and maintenance during the weight loss \nmaintenance trial. J Am Diet Assoc 2011;111:1826-35.\n274. Gerber BS, Schiffer L, Brown AA, Berbaum ML, Rimmer JH, \nBraunschweig CL, et al. Video telehealth for weight \nmaintenance of African-American women. J Telemed \nTelecare 2013;19:266-72.\n275.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 44,
          "overlap_chars": 682,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 44,
      "char_count": 682,
      "word_count": 102,
      "start_pos": 261319,
      "end_pos": 262001,
      "chunk_index": 509,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_510",
      "text": "lehealth for weight \nmaintenance of African-American women. J Telemed \nTelecare 2013;19:266-72.\n275. Teixeira PJ, Silva MN, Mata J, Palmeira AL, Markland D. \nMotivation, self-determination, and long-term weight \ncontrol. Int J Behav Nutr Phys Act 2012;9:22.\n276. Hemmingsson E, Johansson K, Eriksson J, Sundström J, \nNeovius M, Marcus C. Weight loss and dropout during a \ncommercial weight-loss program including a very-low-\ncalorie diet, a low-calorie diet, or restricted normal food: \nObservational cohort study. Am J Clin Nutr 2012;96:953-61.\n277. Stevens J, Truesdale K, McClain J, Cai J. The definition of \nweight maintenance. Int J Obes 2006;30:391–9.\n278. Liebert KB.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 44,
          "overlap_chars": 674,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 44,
      "char_count": 674,
      "word_count": 98,
      "start_pos": 261901,
      "end_pos": 262575,
      "chunk_index": 510,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_511",
      "text": "McClain J, Cai J. The definition of \nweight maintenance. Int J Obes 2006;30:391–9.\n278. Liebert KB. Weight loss maintenance: Women’s experience \nduring perimenopause. City University of New York; 2017.\n279. Ulen CG, Huizinga MM, Beech B, Elasy TA. Weight regain \nprevention. Clin Diabetes 2008;26:100-13.\n280. Peters JC, Beck J, Cardel M, Wyatt HR, Foster GD, Pan Z, et al. \nThe effects of water and non-nutritive sweetened beverages \non weight loss and weight maintenance: A randomized \nclinical trial. Obesity (Silver Spring) 2016;24:297-304.\n281. Pekkarinen T, Kaukua J, Mustajoki P.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 44,
          "overlap_chars": 587,
          "overlap_percentage": 100.17064846416382
        }
      ],
      "primary_page": 44,
      "char_count": 586,
      "word_count": 88,
      "start_pos": 262475,
      "end_pos": 263062,
      "chunk_index": 511,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_512",
      "text": "clinical trial. Obesity (Silver Spring) 2016;24:297-304.\n281. Pekkarinen T, Kaukua J, Mustajoki P. Long-term weight \nmaintenance after a 17-week weight loss intervention \nwith or without a one-year maintenance program: A \nrandomized controlled trial. J Obes 2015;2015:651460. \ndoi: 10.1155/2015/651460.\n282. Casadei K, Kiel J. Anthropometric Measurement. In: \nStatPearls. Treasure Island (FL): StatPearls Publishing; 2021. \nAvailable from: [URL]\nNBK537315/. [Updated 2021 Oct 01].\n283. Lee A, Cardel M, Donahoo WT. Social and environmental \nfactors influencing obesity. In: Feingold KR, Anawalt  B, \nBoyce A, et al., editors. Endotext [Internet]. South \nDartmouth (MA): MDText.com, Inc.; 2000.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 44,
          "overlap_chars": 695,
          "overlap_percentage": 100.28860028860029
        }
      ],
      "primary_page": 44,
      "char_count": 693,
      "word_count": 92,
      "start_pos": 262962,
      "end_pos": 263657,
      "chunk_index": 512,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_513",
      "text": "t  B, \nBoyce A, et al., editors. Endotext [Internet]. South \nDartmouth (MA): MDText.com, Inc.; 2000. Available from: \n[URL] [Lase \naccessed on 2019 Oct 12].\n284. Greaves C, Poltawski L, Garside R, Briscoe S. Understanding \nthe challenge of weight loss maintenance: A systematic \nreview and synthesis of qualitative research on weight loss \nmaintenance. Health Psychol Rev 2017;11:145-63.\n285. Dalle Grave R, Calugi S, Centis E, El Ghoch M, Marchesini G. \nCognitive-behavioral strategies to increase the adherence \nto exercise in the management of obesity. J Obes \n2011;2011:348293. doi: 10.1155/2011/348293.\n286. Soleymani T, Daniel S, Garvey WT.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 44,
          "overlap_chars": 646,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 44,
      "char_count": 646,
      "word_count": 94,
      "start_pos": 263557,
      "end_pos": 264203,
      "chunk_index": 513,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_514",
      "text": "obesity. J Obes \n2011;2011:348293. doi: 10.1155/2011/348293.\n286. Soleymani T, Daniel S, Garvey WT. Weight maintenance: \nchallenges, tools and strategies for primary care physicians. \nObes Rev 2016;17:81-93.\n287. Arciero PJ, Edmonds R, He F, Ward E, Gumpricht E, Mohr A,\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\net al. Protein-pacing caloric-restriction enhances body \ncomposition similarly in obese men and women during \nweight loss and sustains efficacy during long-term weight \nmaintenance. Nutrients 2016;8:476.\n288. Crain AL, Sherwood NE, Martinson BC, Jeffery RW.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 44,
          "overlap_chars": 271,
          "overlap_percentage": 40.14814814814815
        },
        {
          "page_number": 45,
          "overlap_chars": 403,
          "overlap_percentage": 59.7037037037037
        }
      ],
      "primary_page": 44,
      "char_count": 675,
      "word_count": 97,
      "start_pos": 264103,
      "end_pos": 264779,
      "chunk_index": 514,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_515",
      "text": "erm weight \nmaintenance. Nutrients 2016;8:476.\n288. Crain AL, Sherwood NE, Martinson BC, Jeffery RW. Mediators \nof weight loss maintenance in the keep it off trial. Ann \nBehav Med 2018;52:9-18.\n289. Patel ML, Wakayama LN, Bennett GG. Self-monitoring via \ndigital health in weight loss interventions: A systematic \nreview among adults with overweight or obesity. Obesity \n(Silver Spring) 2021;29:478-99.\n290. Dounavi K, Tsoumani O. Mobile health applications in \nweight management: A systematic literature review. Am J \nPrev Med 2019;56:894-903.\n291. Wang Y, Min J, Khuri J, Xue H, Xie B, A Kaminsky L, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 45,
          "overlap_chars": 608,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 45,
      "char_count": 608,
      "word_count": 93,
      "start_pos": 264679,
      "end_pos": 265287,
      "chunk_index": 515,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_516",
      "text": "iew. Am J \nPrev Med 2019;56:894-903.\n291. Wang Y, Min J, Khuri J, Xue H, Xie B, A Kaminsky L, et al. \nEffectiveness of mobile health interventions on diabetes \nand obesity treatment and management: Systematic review \nof systematic reviews. JMIR Mhealth Uhealth 2020;8:e15400.\n292. Burke LE, Conroy MB, Sereika SM, Elci OU, Styn MA, \nAcharya SD, et al. The effect of electronic self-monitoring \non weight loss and dietary intake: A randomized behavioral \nweight loss trial. Obesity (Silver Spring) 2011;19:338-44.\n293. Cavero-Redondo I, Martinez-Vizcaino V, Fernandez-\nRodriguez R, Saz-Lara A, Pascual-Morena C, Álvarez-\nBueno  C.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 45,
          "overlap_chars": 629,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 45,
      "char_count": 629,
      "word_count": 94,
      "start_pos": 265187,
      "end_pos": 265816,
      "chunk_index": 516,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_517",
      "text": "ndo I, Martinez-Vizcaino V, Fernandez-\nRodriguez R, Saz-Lara A, Pascual-Morena C, Álvarez-\nBueno  C. Effect of behavioral weight management \ninterventions using lifestyle mhealth self-monitoring \non weight loss: A systematic review and meta-analysis. \nNutrients 2020;12:1977.\n294. Willmott TJ, Pang B, Rundle-Thiele S, Badejo A. Weight \nmanagement in young adults: Systematic review of \nelectronic health intervention components and outcomes. \nJ Med Internet Res 2019;21:e10265.\n295. Laitner MH, Minski SA, Perri MG. The role of self-monitoring \nin the maintenance of weight loss success. Eat Behav \n2016;21:193-7.\n296. Thomas JG, Raynor HA, Bond DS, Luke AK, Cardoso CC, \nWojtanowski AC, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 45,
          "overlap_chars": 695,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 45,
      "char_count": 695,
      "word_count": 98,
      "start_pos": 265716,
      "end_pos": 266411,
      "chunk_index": 517,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_518",
      "text": "hav \n2016;21:193-7.\n296. Thomas JG, Raynor HA, Bond DS, Luke AK, Cardoso CC, \nWojtanowski AC, et al. Weight loss and frequency of \nbody-weight self-monitoring in an online commercial \nweight management program with and without a cellular-\nconnected ‘smart’ scale: a randomized pilot study. Obes \nSci Pract 2017;3:365-72.\n297. Berry R, Kassavou A, Sutton S. Does self-monitoring diet \nand physical activity behaviors using digital technology \nsupport adults with obesity or overweight to lose weight? \nA systematic literature review with meta-analysis. Obes Rev \n2021;22:e13306.\n298. Turner-McGrievy GM, Dunn CG, Wilcox S, Boutté AK, \nHutto B, Hoover A, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 45,
          "overlap_chars": 659,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 45,
      "char_count": 659,
      "word_count": 97,
      "start_pos": 266311,
      "end_pos": 266970,
      "chunk_index": 518,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_519",
      "text": "v \n2021;22:e13306.\n298. Turner-McGrievy GM, Dunn CG, Wilcox S, Boutté AK, \nHutto B, Hoover A, et al. Defining adherence to mobile \ndietary self-monitoring and assessing tracking over time: \nTracking at least two eating occasions per day is best \nmarker of adherence within two different mobile health \nrandomized weight loss interventions. J Acad Nutr Diet \n2019;119:1516-24.\n299. Turk MW, Elci OU, Wang J, Sereika SM, Ewing LJ, Acharya SD, \net al. Self-monitoring as a mediator of weight loss in \nthe SMART randomized clinical trial. Int J Behav Med \n2013;20:556-61.\n300. Shuger SL, Barry VW, Sui X, McClain A, Hand GA, Wilcox S, \net al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 45,
          "overlap_chars": 638,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 45,
      "char_count": 638,
      "word_count": 103,
      "start_pos": 266870,
      "end_pos": 267508,
      "chunk_index": 519,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_520",
      "text": "J Behav Med \n2013;20:556-61.\n300. Shuger SL, Barry VW, Sui X, McClain A, Hand GA, Wilcox S, \net al. Electronic feedback in a diet- and physical activity-\nbased lifestyle intervention for weight loss: A randomized \ncontrolled trial. Int J Behav Nutr Phys Act 2011;8:41.\n301. Dunn CG, Turner-McGrievy GM, Wilcox S, Hutto B. Dietary \nself-monitoring through calorie tracking but not through \na digital photography app is associated with significant \nweight loss: The 2SMART pilot study-a 6-month randomized \ntrial. J Acad Nutr Diet 2019;119:1525-32.\n302. Acharya SD, Elci OU, Sereika SM, Styn MA, Burke LE.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 45,
          "overlap_chars": 604,
          "overlap_percentage": 100.16583747927032
        }
      ],
      "primary_page": 45,
      "char_count": 603,
      "word_count": 94,
      "start_pos": 267408,
      "end_pos": 268012,
      "chunk_index": 520,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_521",
      "text": "trial. J Acad Nutr Diet 2019;119:1525-32.\n302. Acharya SD, Elci OU, Sereika SM, Styn MA, Burke LE. \nUsing a personal digital assistant for self-monitoring \ninfluences diet quality in comparison to a standard paper \nrecord among overweight/obese adults. J Am Diet Assoc \n2011;111:583-8.\n303. Tronieri JS, Fabricatore AN, Wadden TA, Auerbach P, \nEndahl  L, Sugimoto D, et al. Effects of dietary self-\nmonitoring, physical activity, liraglutide 3.0 mg, and \nplacebo on weight loss in the SCALE IBT trial. Obes Facts \n2020;13:572-83.\n304. Ho TJH, Lee CCS, Wong SN, Lau Y. Internet-based self-\nmonitoring interventions for overweight and obese \nadolescents: A systematic review and meta-analysis.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 45,
          "overlap_chars": 693,
          "overlap_percentage": 100.28943560057888
        }
      ],
      "primary_page": 45,
      "char_count": 691,
      "word_count": 103,
      "start_pos": 267912,
      "end_pos": 268605,
      "chunk_index": 521,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_522",
      "text": "nitoring interventions for overweight and obese \nadolescents: A systematic review and meta-analysis. Int J \nMed Inform 2018;120:20-30.\n305. Soeliman FA, Azadbakht L. Weight loss maintenance: A review \non dietary related strategies. J Res Med Sci 2014;19:268-75.\n306. Lee PG, Jackson EA, Richardson CR. Exercise prescriptions \nin older adults. AmFam Physician 2017;95:425-32.\n307. Castelnuovo G, Pietrabissa G, Manzoni GM, Cattivelli R, \nRossi A, Novelli M, et al. Cognitive behavioral therapy to aid \nweight loss in obese patients: current perspectives. Psychol \nRes Behav Manag 2017;10:165-73.\n308. Burke LE, Wang J, Sevick MA. Self-monitoring in weight \nloss: A systematic review of the literature.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 45,
          "overlap_chars": 700,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 45,
      "char_count": 700,
      "word_count": 100,
      "start_pos": 268505,
      "end_pos": 269205,
      "chunk_index": 522,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_523",
      "text": "Burke LE, Wang J, Sevick MA. Self-monitoring in weight \nloss: A systematic review of the literature. J Am Diet Assoc \n2011;111:92-102.\n309. Zheng Y, Klem ML, Sereika SM, Danford CA, Ewing LJ, \nBurke LE. Self-weighing in weight management: a systematic \nliterature review. Obesity (Silver Spring) 2015;23:256-65.\n310. Kasthuri A. Challenges to healthcare in India - The five A’s. \nIndian J Community Med 2018;43:141-3.\n311. Dietz WH. Obesity and excessive weight gain in young \nadults: New targets for prevention. JAMA 2017;318:241-2.\n312. Berga SL, Garovic VD. Barriers to the care of menopausal \nwomen. Mayo Clin Proc 2019;94:191-3.\n313. Aboueid S, Bourgeault I, Giroux I.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 45,
          "overlap_chars": 673,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 45,
      "char_count": 673,
      "word_count": 103,
      "start_pos": 269105,
      "end_pos": 269778,
      "chunk_index": 523,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_524",
      "text": "the care of menopausal \nwomen. Mayo Clin Proc 2019;94:191-3.\n313. Aboueid S, Bourgeault I, Giroux I. Nutrition care practices \nof primary care providers for weight management in \nmultidisciplinary primary care settings in Ontario, Canada - \nA qualitative study.BMC Fam Pract2018;19:69.\n314. Luhar S, Timæus IM, Jones R, Cunningham S, Patel SA, \nKinra S, et al. Forecasting the prevalence of overweight and \nobesity in India to 2040. PLoS One 2020;15:e0229438.\n315. Seifi B, Ghanizadeh G, Seyedin H. Disaster health literacy \nof middle-aged women. J Menopausal Med 2018;24:150-4.\n316. Pomerleau J, Lock K, Knai C, McKee M.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 45,
          "overlap_chars": 621,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 45,
      "char_count": 621,
      "word_count": 95,
      "start_pos": 269678,
      "end_pos": 270299,
      "chunk_index": 524,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_525",
      "text": "cy \nof middle-aged women. J Menopausal Med 2018;24:150-4.\n316. Pomerleau J, Lock K, Knai C, McKee M. Interventions \ndesigned to increase adult fruit and vegetable intake can \nbe effective: A systematic review of the literature. J Nutr \n2005;135:2486-95.\n317. Adler NE, Stewart J. Reducing obesity: Motivating action \nwhile not blaming the victim. Milbank Q 2009;87:49-70.\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nAnnexures\nAnnexure 1: Cut‑off for haemoglobin and serum ferritin \nin the assessment of iron deficiency anaemia in women\nHemoglobin level\nAnaemia status\n12.0 to 15 g/dL\nNormal\n11‑11.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 45,
          "overlap_chars": 371,
          "overlap_percentage": 53.0
        },
        {
          "page_number": 46,
          "overlap_chars": 327,
          "overlap_percentage": 46.714285714285715
        }
      ],
      "primary_page": 45,
      "char_count": 700,
      "word_count": 107,
      "start_pos": 270199,
      "end_pos": 270899,
      "chunk_index": 525,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_526",
      "text": "nt of iron deficiency anaemia in women\nHemoglobin level\nAnaemia status\n12.0 to 15 g/dL\nNormal\n11‑11.9 g/dL\nMild anaemia\n8‑10.9 g/dL\nModerate anaemia\n<8 g/dL\nSevere anaemia\nSerum ferritin concentration\n(<15 g/L)\nDepleted iron stores\nSevere risk of iron overload\n>150\nWorld Health Organization. Serum ferritin concentrations for the assessment of iron status and iron \ndeficiency in populations.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 46,
          "overlap_chars": 393,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 46,
      "char_count": 393,
      "word_count": 59,
      "start_pos": 270799,
      "end_pos": 271192,
      "chunk_index": 526,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_527",
      "text": "Serum ferritin concentrations for the assessment of iron status and iron \ndeficiency in populations. World Health Organization; 2011\nAnnexure 2: Quick assessment of approximate dietary calcium intake per day\nSource\nCalcium (mg)\nNumber of serving*\nDairy products (Milk, curd, paneer, chhena, khoya, cheese, milk powder)\n300‑525\nNon‑dairy products (Non‑dairy milk and milk products, ragi, bengal \ngram, soy and soy products, green leafy vegetables, nuts and oilseeds)\n200‑300\nApproximate total calcium intake (mg) = (Number of servings from dairy products×300‑525) + (number of servings from non‑dairy",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 46,
          "overlap_chars": 600,
          "overlap_percentage": 100.1669449081803
        }
      ],
      "primary_page": 46,
      "char_count": 599,
      "word_count": 85,
      "start_pos": 271092,
      "end_pos": 271692,
      "chunk_index": 527,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_528",
      "text": "intake (mg) = (Number of servings from dairy products×300‑525) + (number of servings from non‑dairy products ×200‑300)\nRDA for adult Indian women: 800 mg/day; post‑menopausal woman: 1200 mg/day\n*Number of servings: To be filled according to the daily intake of the midlife woman.\nSource: Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R, National Osteoporosis Foundation et al. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. \n2014 Oct; 25 (10):2359‑81. doi: 10.1007/s00198‑014‑2794‑2. Epub 2014 Aug 15. Erratum in: Osteoporos Int.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 46,
          "overlap_chars": 590,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 46,
      "char_count": 590,
      "word_count": 88,
      "start_pos": 271592,
      "end_pos": 272182,
      "chunk_index": 528,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_529",
      "text": "Oct; 25 (10):2359‑81. doi: 10.1007/s00198‑014‑2794‑2. Epub 2014 Aug 15. Erratum in: Osteoporos Int. 2015\nAnnexure 3: Cut off for serum 25‑hydroxyvitamin D\nSerum 25‑hydroxyvitamin D (ng/mL)\nAssociated health status\n<20\nDeficiency of vitamin D\n21‑29\nInsufficient vitamin D levels\n≥30\nSufficient vitamin D levels\n>150\nToxicity\nSource: Aparna P, Muthathal S, Nongkynrih B, Gupta SK. Vitamin D deficiency in India. J Family Med \nPrim Care. 2018 Mar‑Apr; 7 (2):324‑330. doi: 10.4103/jfmpc.jfmpc_78_18. PMID: 30090772; PMCID: \nPMC6060930\n\nRanjan, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 46,
          "overlap_chars": 531,
          "overlap_percentage": 97.25274725274726
        },
        {
          "page_number": 47,
          "overlap_chars": 14,
          "overlap_percentage": 2.564102564102564
        }
      ],
      "primary_page": 46,
      "char_count": 546,
      "word_count": 78,
      "start_pos": 272082,
      "end_pos": 272629,
      "chunk_index": 529,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_530",
      "text": "r; 7 (2):324‑330. doi: 10.4103/jfmpc.jfmpc_78_18. PMID: 30090772; PMCID: \nPMC6060930\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nAnnexure 4: A comprehensive assessment tool for appropriate weight management for midlife women\nMenopause is a natural life event marked by the final menstrual period. Perimenopause is the transitional phase that leads to menopause, usually \nexperienced at the age of 43 to 55 years.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 46,
          "overlap_chars": 84,
          "overlap_percentage": 16.310679611650485
        },
        {
          "page_number": 47,
          "overlap_chars": 429,
          "overlap_percentage": 83.30097087378641
        }
      ],
      "primary_page": 46,
      "char_count": 515,
      "word_count": 77,
      "start_pos": 272529,
      "end_pos": 273044,
      "chunk_index": 530,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_531",
      "text": "s the transitional phase that leads to menopause, usually \nexperienced at the age of 43 to 55 years.\nThis questionnaire has been developed to assess the interplay of the presence and severity of menopausal changes, weight‑related perceptions and \nlifestyle practices including eating habits, physical activity and sleep patterns among women going through the menopausal transition.\nThis is a valid and reliable tool for assessment of: Dietary practices (6B-10B) and barriers associated with practicing healthy eating behavior (11B) in \neveryday life of midlife women.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 47,
          "overlap_chars": 567,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 47,
      "char_count": 567,
      "word_count": 83,
      "start_pos": 272944,
      "end_pos": 273511,
      "chunk_index": 531,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_532",
      "text": "arriers associated with practicing healthy eating behavior (11B) in \neveryday life of midlife women.\nDaily physical activity (12B-14B) and barriers associated with an inability to follow a physically active routine (15B) in everyday life of midlife women.\nMenopausal symptoms experienced by menopausal women (6B-10B).\nSection A: Sociodemographic profile\n1. Name:\n2. Age:\n3. Phone no.:\n4. House address: \n5. Marital status:\nSingle‪ Married‪ Widow‪ Divorced‪ Separated‪\n6. Education:\nProfession or Honours‪ Graduate‪ Intermediate or diploma‪ High school‪ Middle‑school certificate‪ Primary school certificate‪ Illiterate‪\n7.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 47,
          "overlap_chars": 622,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 47,
      "char_count": 622,
      "word_count": 84,
      "start_pos": 273411,
      "end_pos": 274033,
      "chunk_index": 532,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_533",
      "text": "diate or diploma‪ High school‪ Middle‑school certificate‪ Primary school certificate‪ Illiterate‪\n7.Education of the head of family:\nProfession or Honours‪ Graduate‪ Intermediate or diploma‪ High‑school certificate‪ Middle‑school certificate‪ Primary school certificate‪ \nIlliterate‪\n8. Occupation:\nUnemployed‪ Housewife‪ Working from home‪ Going to work as usual‪ Any other, please specify ……………….\n9.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 47,
          "overlap_chars": 401,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 47,
      "char_count": 401,
      "word_count": 50,
      "start_pos": 273933,
      "end_pos": 274334,
      "chunk_index": 533,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_534",
      "text": "employed‪ Housewife‪ Working from home‪ Going to work as usual‪ Any other, please specify ……………….\n9. Occupation of the head of family\nLegislators‪ Senior officials and managers‪ Professionals‪ Technicians and associate professionals‪ Clerks‪ Skilled workers, shop and market \nsales workers‪ Skilled agricultural and fishery workers‪ Craft and related trade workers‪ Plant and machine operators and assemblers‪ Elementary \noccupation/unemployed‪\n10. Total monthly income of the family:\n≥199,862 ‪ 99,931‑199,861‪ 74,756‑99,930‪ 49,962‑74,755‪ 29,973‑49,961 ‪ 10,002‑29,972‪ ≤ 10,001 ‪\n11.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 47,
          "overlap_chars": 587,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 47,
      "char_count": 587,
      "word_count": 77,
      "start_pos": 274234,
      "end_pos": 274821,
      "chunk_index": 534,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_535",
      "text": "99,862 ‪ 99,931‑199,861‪ 74,756‑99,930‪ 49,962‑74,755‪ 29,973‑49,961 ‪ 10,002‑29,972‪ ≤ 10,001 ‪\n11. Medical history (any chronic illness with which you are suffering):\nDiabetes ‪ Hypertension‪ Heart diseases‪ Hypothyroidism‪ Arthritis‪ Depression‪ Cancer‪ Any other:_______________\n12. History of operations……….\n13. Current menstrual status:\nI am having regular periods (each cycle occurs every 21 to 35 days) ‪\nI am having irregular periods, but I have not gone 12 months in a row without periods ‪\nMy periods were stopped but now having periods as I am taking hormones ‪\nMy periods have completely stopped ‪\n14.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 47,
          "overlap_chars": 614,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 47,
      "char_count": 614,
      "word_count": 94,
      "start_pos": 274721,
      "end_pos": 275335,
      "chunk_index": 535,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_536",
      "text": "re stopped but now having periods as I am taking hormones ‪\nMy periods have completely stopped ‪\n14. Status of menopause:\nNormal periods ‪ Using hormone replacement therapy‪ Surgical (removal of the ovaries/uterus)‪ Natural stopping of periods with age‪ \nMenopausal symptoms\nWith the onset of the perimenopause stage, women experience menopausal (Items 1 & 2), physical (Items 3 to 5) and psychological (Items 6 to 8) \nsymptoms. Please indicate the extent to which you are bothered by any of these symptoms:\nName of symptoms/severity\nNone\nMild\nModerate\nSevere \nVery \nsevere\n1.Irregular periods (heavy bleeding, blood clotting)\n2.Hot flushes (excessive sweating)\n3.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 47,
          "overlap_chars": 664,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 47,
      "char_count": 664,
      "word_count": 102,
      "start_pos": 275235,
      "end_pos": 275899,
      "chunk_index": 536,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_537",
      "text": "y \nsevere\n1.Irregular periods (heavy bleeding, blood clotting)\n2.Hot flushes (excessive sweating)\n3.Physical discomfort (fatigue, heaviness of body, body pain, swelling)\n4.Heart discomfort (heart racing, skipping of a beat)\n5.Joint and muscular discomfort (Pain in joints, rheumatoid complaints)\n6.Emotional volatility (feeling nervous, inner tension, aggression, depression)\nAnthropometric profile\nWeight:\nHeight: \nContd...\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nAnnexure 4: Contd...\nSection B: Lifestyle‑related behaviour \n1B.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 47,
          "overlap_chars": 424,
          "overlap_percentage": 66.66666666666666
        },
        {
          "page_number": 48,
          "overlap_chars": 210,
          "overlap_percentage": 33.0188679245283
        }
      ],
      "primary_page": 47,
      "char_count": 636,
      "word_count": 83,
      "start_pos": 275799,
      "end_pos": 276435,
      "chunk_index": 537,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_538",
      "text": "e 11  :  Issue 12  :  December 2022\nAnnexure 4: Contd...\nSection B: Lifestyle‑related behaviour \n1B. Which statement (in your opinion) does define your body weight status?\n (i) Prefer not to comment\n (ii) My weight is slightly less\n(iii) My weight is about right\n(iv) My weight is slightly more\n(v) My weight is significantly more\n2B. In the past, how many focussed attempts did you make to lose or maintain appropriate weight? \n(i) One attempt every year\n(ii) None\n(iii) 1‑2 attempts \n(iv) 3‑4 attempts \n(v) 5‑6 attempts \n3B.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 48,
          "overlap_chars": 526,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 48,
      "char_count": 526,
      "word_count": 90,
      "start_pos": 276335,
      "end_pos": 276861,
      "chunk_index": 538,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_539",
      "text": "? \n(i) One attempt every year\n(ii) None\n(iii) 1‑2 attempts \n(iv) 3‑4 attempts \n(v) 5‑6 attempts \n3B. What has been the usual outcome of the weight loss attempts that you have made in the past?\n(i) Not applicable \n(ii) Mostly unsuccessful \n(iii) Initially successful (initial weight loss followed by regain)\n(iv) Minimal success in losing weight (considerable weight loss followed by some weight regain)\n(v) Mostly successful (considerable weight loss with no weight regain)\n4B. With the onset of the perimenopausal phase, weight gain experienced by the women can be controlled by appropriate lifestyle measures.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 48,
          "overlap_chars": 611,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 48,
      "char_count": 611,
      "word_count": 96,
      "start_pos": 276761,
      "end_pos": 277372,
      "chunk_index": 539,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_540",
      "text": "sal phase, weight gain experienced by the women can be controlled by appropriate lifestyle measures.\n(i) Definitely \n(ii) Probably\n(iii) Can not say\n(iv) Probably not \n(v) Definitely not\n5B. I intend to initiate lifestyle intervention methods (diet, exercise, etc.) to keep my body weight appropriate. \n(i) Eager to initiate\n(ii) Somewhat eager to initiate\n(iii) Undecided\n(iv) Somewhat not eager to initiate \n(v) Not eager to initiate \n6B. Balanced diet consists of the right proportions of whole wheat, pulses, legumes, eggs, nuts, fruits and vegetables.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 48,
          "overlap_chars": 556,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 48,
      "char_count": 556,
      "word_count": 86,
      "start_pos": 277272,
      "end_pos": 277828,
      "chunk_index": 540,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_541",
      "text": "onsists of the right proportions of whole wheat, pulses, legumes, eggs, nuts, fruits and vegetables. How often are you able to consume \na balanced diet? \n(i) Not routinely \n(ii) One to two times per week \n(iii) Three to four times a week \n(iv) Five to six times a week \n(v) Daily\n7B. How often do you consume 2‑3 servings of protein‑rich foods (dairy, legumes, nuts and chicken)? \n(i) Not routinely \n(ii) One to two times per week \n(iii) Three to four times a week \n(iv) Five to six times a week \n(v) Daily\n8B. I snack on foods high in calories, fat, sugar and salt in between my meals.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 48,
          "overlap_chars": 586,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 48,
      "char_count": 586,
      "word_count": 109,
      "start_pos": 277728,
      "end_pos": 278314,
      "chunk_index": 541,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_542",
      "text": "es a week \n(v) Daily\n8B. I snack on foods high in calories, fat, sugar and salt in between my meals.\n(i) Not routinely\n(ii) One to two times per week\n(iii) Three to four times a week\n(iv) Five to six times a week \n(v) Daily\n9B. I believe mood swings and stress in my everyday life leads to__________\n(i) Increase in my food intake \n(ii) Somewhat increase in my food intake \n(iii) No change \n(iv) Somewhat decrease in my food intake\n(v) Decrease in my food intake\n10B. How frequently do you eat out at a canteen, restaurant or at social gatherings? \n(i) Not routinely\n(ii) One to two times every month\n(iii) One to two times every fortnight\n(iv) One to two times every week\n(v) Almost daily\nContd...",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 48,
          "overlap_chars": 698,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 48,
      "char_count": 698,
      "word_count": 132,
      "start_pos": 278214,
      "end_pos": 278912,
      "chunk_index": 542,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_543",
      "text": "th\n(iii) One to two times every fortnight\n(iv) One to two times every week\n(v) Almost daily\nContd...\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nAnnexure 4: Contd...\nSection B: Lifestyle‑related behaviour \n11B. Reasons associated with inability to follow a healthy dietary pattern.\nPlease select a response that appropriately defines the extent to which these factors impact your daily efforts to maintain a healthy diet. \nReasons\nStrongly \nagree\nAgree Neither agree \nnor disagree\nDisagree Strongly \ndisagree\n1. My food intake has increased during the perimenopausal phase.\n2.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 48,
          "overlap_chars": 100,
          "overlap_percentage": 14.727540500736378
        },
        {
          "page_number": 49,
          "overlap_chars": 577,
          "overlap_percentage": 84.97790868924889
        }
      ],
      "primary_page": 48,
      "char_count": 679,
      "word_count": 105,
      "start_pos": 278812,
      "end_pos": 279491,
      "chunk_index": 543,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_544",
      "text": "gree\nDisagree Strongly \ndisagree\n1. My food intake has increased during the perimenopausal phase.\n2. I tend to overeat due to food cravings.\n3. I often disengage from healthy eating patterns around my periods.\n5. My involvement with work and family responsibilities leaves me with less time to focus on \nhealthy eating.\n6. I feel healthy food products are either not readily available or costly.\n8. I find myself eating out of anxiousness, boredom or restlessness.\n9. I eat my favourite foods to make me feel better.\n10. I tend to eat energy‑dense food during festive and/or religious fasting.\n11.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 49,
          "overlap_chars": 597,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 49,
      "char_count": 597,
      "word_count": 100,
      "start_pos": 279391,
      "end_pos": 279988,
      "chunk_index": 544,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_545",
      "text": "ake me feel better.\n10. I tend to eat energy‑dense food during festive and/or religious fasting.\n11. My friends and family often offer me foods rich in fat, sugar and salt while eating out or \nat social gatherings.\n12B. Participation in a moderate aerobic exercise (walking, jogging, swimming, and cycling) for about 150 min/week is recommended to maintain \noptimum health. How closely do you match your weekly physical activity level with the recommendations?\n(i) 100%\n(ii) 75%\n(iii) 50%\n(iv) 25%\n(v) Not applicable\n13B. I spend………. (h) of a day on sedentary activities (sitting, desk job, using phone, watching TV) ?\n(i) <2 h\n(ii) 2‑4 h\n(iii) 4‑6 h\n(iv) 6‑8 h\n(v) More than 8 h\n14B.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 49,
          "overlap_chars": 684,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 49,
      "char_count": 684,
      "word_count": 120,
      "start_pos": 279888,
      "end_pos": 280572,
      "chunk_index": 545,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_546",
      "text": "k job, using phone, watching TV) ?\n(i) <2 h\n(ii) 2‑4 h\n(iii) 4‑6 h\n(iv) 6‑8 h\n(v) More than 8 h\n14B. I feel doing household activities (alone) contributes to an adequate amount of physical activity in a day to maintain a healthy weight for my age \ngroup. \n(i) Strongly agree\n(ii) Agree\n(iii) Neither agree nor disagree\n(iv) Disagree\n(v) Strongly disagree\n15B: Reasons associated with inability to follow a physically active routine.\nPhysically active lifestyle includes participation in exercise, household chores, commuting and leisure‑related activities.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 49,
          "overlap_chars": 556,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 49,
      "char_count": 556,
      "word_count": 90,
      "start_pos": 280472,
      "end_pos": 281028,
      "chunk_index": 546,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_547",
      "text": "tyle includes participation in exercise, household chores, commuting and leisure‑related activities. Please select a response that \nappropriately defines the extent to which these factors impact your daily efforts to maintain a physically active lifestyle. \nFactors\nStrongly \nagree\nAgree Neither agree \nnor disagree\nDisagree Strongly \ndisagree\n1. My involvement with personal and professional commitments leaves me with less time for \ndedicated physical activity.\n2. I find it difficult to engage in physical activities due to joint pain/body pain/excessive tiredness.\n3. I find it difficult to engage in physical activities around my periods.\n4.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 49,
          "overlap_chars": 646,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 49,
      "char_count": 646,
      "word_count": 92,
      "start_pos": 280928,
      "end_pos": 281574,
      "chunk_index": 547,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_548",
      "text": "n/excessive tiredness.\n3. I find it difficult to engage in physical activities around my periods.\n4. My friends and family members show little interest in maintaining an active lifestyle.\n5. I do not have access to parks, fitness centres and gyms.\n16B. On average, I am able to get a sleep of ………… h in the night. \n(i) <6\n(ii) 6 -8 \n(iii) >8\n17B. I would rate my quality of sleep as……………..\n(i) Excellent\n(ii) Very good\n(iii) Good\n(iv) Poor\n(v) Very poor\n18B: Reasons associated with an inability to follow sleep pattern.\nPlease select the appropriate response to the following factors according to the extent to which these factors contribute to disturbed sleep patterns.\nContd...\n\nRanjan, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 49,
          "overlap_chars": 680,
          "overlap_percentage": 97.70114942528735
        },
        {
          "page_number": 50,
          "overlap_chars": 14,
          "overlap_percentage": 2.0114942528735633
        }
      ],
      "primary_page": 49,
      "char_count": 696,
      "word_count": 121,
      "start_pos": 281474,
      "end_pos": 282170,
      "chunk_index": 548,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_549",
      "text": "o the extent to which these factors contribute to disturbed sleep patterns.\nContd...\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nAnnexure 4: Contd...\nSection B: Lifestyle‑related behaviour \nFactors\nStrongly \nagree\nAgree Neither agree \nnor disagree\nDisagree Strongly \ndisagree\n1. I face restlessness and discomfort during the night due to sweating and hot flashes leading \nto disturbed sleep. \n2. I face difficulty in falling asleep due to stress and anxiety.\n3. Mismatched sleep routines of family members negatively affect my sleep pattern as well.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 49,
          "overlap_chars": 84,
          "overlap_percentage": 12.883435582822086
        },
        {
          "page_number": 50,
          "overlap_chars": 566,
          "overlap_percentage": 86.80981595092024
        }
      ],
      "primary_page": 49,
      "char_count": 652,
      "word_count": 100,
      "start_pos": 282070,
      "end_pos": 282722,
      "chunk_index": 549,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_550",
      "text": "anxiety.\n3. Mismatched sleep routines of family members negatively affect my sleep pattern as well.\nSource: Kumari A, Chopra S, Ranjan P, Verma A, Malhotra A, Upadhyay AD, Sharma KA, Vikram NK. Development and validation of Comprehensive evaluation tool for weight management in midlife women. Journal \nof Mid-life Health (under publication)\nAnnexure 5: DASS‑21 for initial screening of anxiety, depression and stress\nPlease read each statement and circle a number 0, 1, 2 or 3 that indicates how much the statement applied to you over the past week. There are no right \nor wrong answers. Do not spend too much time on any statement.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 50,
          "overlap_chars": 634,
          "overlap_percentage": 100.15797788309638
        }
      ],
      "primary_page": 50,
      "char_count": 633,
      "word_count": 104,
      "start_pos": 282622,
      "end_pos": 283256,
      "chunk_index": 550,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_551",
      "text": "er the past week. There are no right \nor wrong answers. Do not spend too much time on any statement.\nThe rating scale is as follows:\n0 Did not apply to me at all\n1 Applied to me to some degree, or some of the time\n2 Applied to me to a considerable degree or a good part of time\n3 Applied to me very much or most of the time\n1 (s) I found it hard to wind down.\n1\n3\n2 (a) I was aware of the dryness of my mouth.\n3 (d) I could not seem to experience any positive feeling at all.\n4 (a) I experienced breathing difficulty (e.g. excessively rapid breathing, breathlessness in the absence of physical exertion).\n5 (d) I found it difficult to work up the initiative to do things.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 50,
          "overlap_chars": 671,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 50,
      "char_count": 671,
      "word_count": 137,
      "start_pos": 283156,
      "end_pos": 283827,
      "chunk_index": 551,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_552",
      "text": "he absence of physical exertion).\n5 (d) I found it difficult to work up the initiative to do things.\n6 (s) I tended to over‑react to situations.\n7 (a) I experienced trembling (e.g. in the hands).\n8 (s) I felt that I was using a lot of nervous energy.\n9 (a) I was worried about situations in which I might panic and make a fool of myself.\n10 (d) I felt that I had nothing to look forward to.\n11 (s) I found myself getting agitated.\n12 (s) I found it difficult to relax.\n13 (d) I felt down‑hearted and blue. \n14 (s) I was intolerant of anything that kept me from getting on with what I was doing.\n15 (a) I felt I was close to panic.\n16 (d) I was unable to become enthusiastic about anything.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 50,
          "overlap_chars": 689,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 50,
      "char_count": 689,
      "word_count": 138,
      "start_pos": 283727,
      "end_pos": 284416,
      "chunk_index": 552,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_553",
      "text": "oing.\n15 (a) I felt I was close to panic.\n16 (d) I was unable to become enthusiastic about anything.\n17 (d) I felt I was not worth much as a person.\n18 (s) I felt that I was rather touchy. \n19 (a) I was aware of the action of my heart in the absence of physical exertion (e.g. sense of heart rate increase, heart missing a beat)\n20 (a) I felt scared without any good reason.\n21 (d) I felt that life was meaningless.\nDASS‑21 scoring instructions\nThe DASS‑21 should not be used to replace a face to face clinical interview. If you are experiencing significant emotional difficulties you should \ncontact your GP for a referral to a qualified professional.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 50,
          "overlap_chars": 652,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 50,
      "char_count": 652,
      "word_count": 121,
      "start_pos": 284316,
      "end_pos": 284968,
      "chunk_index": 553,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_554",
      "text": "icant emotional difficulties you should \ncontact your GP for a referral to a qualified professional.\nDepression, Anxiety and Stress Scale‑21 Items (DASS‑21)\nThe Depression, Anxiety and Stress Scale‑21 Items (DASS‑21) is a set of three self‑report scales designed to measure the emotional states of \ndepression, anxiety and stress.\nEach of the three DASS‑21 scales contains seven items, divided into subscales with similar content. The depression scale assesses dysphoria, \nhopelessness, devaluation of life, self‑deprecation, lack of interest/involvement, anhedonia and inertia.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 50,
          "overlap_chars": 578,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 50,
      "char_count": 578,
      "word_count": 79,
      "start_pos": 284868,
      "end_pos": 285446,
      "chunk_index": 554,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_555",
      "text": "essness, devaluation of life, self‑deprecation, lack of interest/involvement, anhedonia and inertia. The anxiety scale assesses autonomic arousal, \nskeletal muscle effects, situational anxiety, and subjective experience of anxious affect. The stress scale is sensitive to levels of chronic non‑specific \narousal. It assesses difficulty relaxing, nervous arousal, and being easily upset/agitated, irritable/over‑reactive and impatient. Scores for depression, \nanxiety and stress are calculated by summing the scores for the relevant items.\nDASS‑21 is based on a dimensional rather than a categorical conception of psychological disorder.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 50,
          "overlap_chars": 636,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 50,
      "char_count": 636,
      "word_count": 82,
      "start_pos": 285346,
      "end_pos": 285982,
      "chunk_index": 555,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_556",
      "text": "s.\nDASS‑21 is based on a dimensional rather than a categorical conception of psychological disorder. The assumption on which the DASS‑21 development \nwas based (and which was confirmed by the research data) is that the differences between the depression, anxiety and stress experienced by normal \nsubjects and clinical populations are essentially differences of degree. The DASS‑21, therefore, has no direct implications for the allocation of patients to \ndiscrete diagnostic categories postulated in classificatory systems such as the DSM and ICD.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 50,
          "overlap_chars": 548,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 50,
      "char_count": 548,
      "word_count": 80,
      "start_pos": 285882,
      "end_pos": 286430,
      "chunk_index": 556,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_557",
      "text": "nts to \ndiscrete diagnostic categories postulated in classificatory systems such as the DSM and ICD.\nRecommended cut‑off scores for conventional severity labels (normal, moderate, severe) are as follows:\nNB Scores on the DASS‑21 will need to be multiplied by 2 to calculate the final score.\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nDepression\nAnxiety \nStress\nNormal \n0‑9\n0‑7\n0‑14 \nMild\n10‑13\n8‑9\n15‑18 \nModerate \n14‑20\n10‑14 \n19‑25 \nSevere\n21‑27\n15‑19\n26‑33 \nExtremely severe\n28+ \n20+\n34+\nSource: Lovibond, SH & Lovibond PF (1995). Manual for the Depression Anxiety & Stress Scales. (2nd \ned.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 50,
          "overlap_chars": 290,
          "overlap_percentage": 41.54727793696275
        },
        {
          "page_number": 51,
          "overlap_chars": 406,
          "overlap_percentage": 58.16618911174785
        }
      ],
      "primary_page": 50,
      "char_count": 698,
      "word_count": 110,
      "start_pos": 286330,
      "end_pos": 287028,
      "chunk_index": 557,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_558",
      "text": "rce: Lovibond, SH & Lovibond PF (1995). Manual for the Depression Anxiety & Stress Scales. (2nd \ned.) Sydney: Psychology Foundation\nAnnexure 6: Menopause Rating Scale: standardised scale \nto assess the severity of menopausal symptoms among \nmenopausal women\nDescription\nHot flushes, sweating (episode of sweating)\nHeart discomfort (unusual awareness of heartbeat, heart skipping, heart \nracing, and tightness)\nSleep problems (difficulty falling asleep, difficulty in sleeping through \nthe night, and waking up too early)\nDepressive mood (feeling “down” sad, on the verge of tears, lack of \nderive, an",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 51,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 51,
      "char_count": 600,
      "word_count": 86,
      "start_pos": 286928,
      "end_pos": 287528,
      "chunk_index": 558,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_559",
      "text": "waking up too early)\nDepressive mood (feeling “down” sad, on the verge of tears, lack of \nderive, and mood swings)\nIrritability (feeling nervous, inner tension, and feeling aggressive)\nAnxiety (inner restlessness, feeling “panicky”)\nPhysical and mental exhaustion (general decrease in performance, \nimpaired memory, decrease in concentration, forgetfulness, fatigue, \nheadache, and dizziness)\nSexual problems (change in sexual desire, in sexual activity, and satisfaction)\nBladder problems (difficulty in urinating, increased need to urinate, and \nbladder incontinence)\nDryness of the vagina (sensati",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 51,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 51,
      "char_count": 600,
      "word_count": 79,
      "start_pos": 287428,
      "end_pos": 288028,
      "chunk_index": 559,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_560",
      "text": "y in urinating, increased need to urinate, and \nbladder incontinence)\nDryness of the vagina (sensation of dryness or burning in the vagina, \ndifficulty with sexual intercourse)\nJoint and muscular discomfort (joint pain, muscle pain, and backache)\n(b): According to the World Health Organization (WHO) \nstandards, the degree of severity is consistent with the following:\nSymptoms\nDegree\nPercentage\nNo problem\nNone, absent, negligible\n0‑4\nMild problem\nSlight, low\n5‑24\nModerate problem\nMedium, fair\n25‑49\nSevere problem\nHigh, extreme \n50‑95\nComplete problem\nTotal\n95‑100\nSource:Heinemann LA, Potthoff P, Schneider HP. International versions of the Menopause Rating Scale \n(MRS).",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 51,
          "overlap_chars": 676,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 51,
      "char_count": 676,
      "word_count": 96,
      "start_pos": 287928,
      "end_pos": 288604,
      "chunk_index": 560,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_561",
      "text": "Heinemann LA, Potthoff P, Schneider HP. International versions of the Menopause Rating Scale \n(MRS). Health Qual Life Outcomes 2003;1:28\nAnnexure 7: Estimated average requirement for adult \nIndian women\nNutrient \nValue\nIron (mg/day)\nCalcium for non‑pregnant‑non lactating women (mg/day)\nCalcium for postmenopasual women (mg/day) \nVitamin D (IU/day)\nSource: ICMR‑NIN Expert Group on Nutrient Requirement for Indians, recommended Dietary \nAllowances (RDA) and Estimated Average Requirements (EAR)‑2020. Available From: [URL]\nnin.res.in/RDA_short_Report_2020.html. Accessed on: 1st December 2021.\n\nRanjan, et al.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 51,
          "overlap_chars": 593,
          "overlap_percentage": 97.37274220032842
        },
        {
          "page_number": 52,
          "overlap_chars": 14,
          "overlap_percentage": 2.2988505747126435
        }
      ],
      "primary_page": 51,
      "char_count": 609,
      "word_count": 76,
      "start_pos": 288504,
      "end_pos": 289113,
      "chunk_index": 561,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_562",
      "text": "e From: [URL]\nnin.res.in/RDA_short_Report_2020.html. Accessed on: 1st December 2021.\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nAnnexure 8: Dietary sources of calcium, iron and \nphytoestrogen\n(i) Dietary sources of calcium\nFood products\nServings/portion \nsize (mL/g)\nCalcium (mg) \nMilk/curd (whole, buffalo)\n1 glass (250 mL)\nMilk/curd (whole, cow)\n1 glass (250 mL)\nPaneer\n96\nKhoya\n600\nCheese\n160\nAmaranth seeds \n162\nRagi\n360\nRajma\n40.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 51,
          "overlap_chars": 84,
          "overlap_percentage": 15.613382899628252
        },
        {
          "page_number": 52,
          "overlap_chars": 452,
          "overlap_percentage": 84.01486988847584
        }
      ],
      "primary_page": 51,
      "char_count": 538,
      "word_count": 81,
      "start_pos": 289013,
      "end_pos": 289551,
      "chunk_index": 562,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_563",
      "text": "(whole, cow)\n1 glass (250 mL)\nPaneer\n96\nKhoya\n600\nCheese\n160\nAmaranth seeds \n162\nRagi\n360\nRajma\n40.2\nSoyabean \n72\nBengal gram \n45\nBlack gram/chickpeas\n30‑36\nBathua leaves\n211\nFenugreek leaves (methi leaves)\n270\nMustard leaves\n190\nRadish leaves\n234\nSpinach \n83\nLady finger\n85\nBeans\n50‑70\nCabbage\n58\nJackfruit\n45\nDates\n17.75\nFig\n20\nAlmonds\n60\nWalnuts\n52.5\nSesame seeds/flax seeds\n90\nSource: Longvah T, An̲antan̲ I, Bhaskarachary K, Venkaiah K, Longvah T. Indian food composition \ntables.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 52,
          "overlap_chars": 486,
          "overlap_percentage": 100.20618556701031
        }
      ],
      "primary_page": 52,
      "char_count": 485,
      "word_count": 79,
      "start_pos": 289451,
      "end_pos": 289937,
      "chunk_index": 563,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_564",
      "text": "ce: Longvah T, An̲antan̲ I, Bhaskarachary K, Venkaiah K, Longvah T. Indian food composition \ntables. Hyderabad: National Institute of Nutrition, Indian Council of Medical Research; 2017 May\n(ii) Dietary sources of phytoestrogen\nFood groups Food sources\nPhytoestrogen content (µg/100 g)\nOil seeds and \nnuts\nSesame seed\nFlax seed\nDried dates\nSunflower seed\nChestnuts\nOlive oil\nAlmonds\nPeanuts\n 34.5\nSoy and soy \nproducts \nSoy beans\nTofu\nSoy yogurt\nSoy milk\nBreads\nFlax bread\nMultigrain bread\nPulses and \nproducts\nHummus\nMung bean sprouts\nAlfalfa sprouts\nVegetables \nGarlic\nGreen bean\nOnion\nFruits \nDried apricots\nBlueberry\n17.5\nAdapted from Gupta C, Prakash D, Gupta S. Phytoestrogens as pharma foods.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 52,
          "overlap_chars": 699,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 52,
      "char_count": 699,
      "word_count": 105,
      "start_pos": 289837,
      "end_pos": 290536,
      "chunk_index": 564,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_565",
      "text": "ed apricots\nBlueberry\n17.5\nAdapted from Gupta C, Prakash D, Gupta S. Phytoestrogens as pharma foods. Adv Food Technol Nutr \nSci Open J. 2016;2 (1):19‑3\n\nRanjan, et al.: Guidelines for weight management in midlife\nJournal of Family Medicine and Primary Care \nVolume 11  :  Issue 12  :  December 2022\nAnnexure 9: Important metabolic parameters for \nassessment of overall improvement\nMetabolic parameters \nCut‑off points\nFasting blood glucose (mg/dL)\nInsulin (μU/mL)\nHOMA‑IR\n3.0\nCRP (mg/L)\nLow‑risk\nmedium‑risk\nHigh‑risk\n<1\n1-2.99\n≥3.0\nTotal cholesterol (mg/dL)\nLDL‑cholesterol (mg/dL)\nnon‑HDL‑C (mg/dL)\nHDL‑C (mg/dL)\nTriglycerides (mg/dL)\nWaist circumference (cm) \nWaist to height ratio\n0.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 52,
          "overlap_chars": 151,
          "overlap_percentage": 21.97962154294032
        },
        {
          "page_number": 53,
          "overlap_chars": 534,
          "overlap_percentage": 77.72925764192141
        }
      ],
      "primary_page": 52,
      "char_count": 687,
      "word_count": 98,
      "start_pos": 290436,
      "end_pos": 291123,
      "chunk_index": 565,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_566",
      "text": "HDL‑C (mg/dL)\nHDL‑C (mg/dL)\nTriglycerides (mg/dL)\nWaist circumference (cm) \nWaist to height ratio\n0.5\nBone mineral density (T‑score)\nNormal\nLow bone mass (osteopenia)\nOsteoporosis\nSevere osteoporosis\nAbove−1.0\n−1.0-−2.5\nLess than equal to−2.5\nBelow −2.5 with fragility fracture\nAppendicular skeletal muscle mass (ASM)\nDual‑energy X‑ray absorptiometry for \nfemales (kg/m2)\nBioelectrical impedance analysis for \nfemales (kg/m2)\n<5.4\n<5.7 \nSource: Dow CA, Thomson CA, Flatt SW, Sherwood NE, Pakiz B, Rock CL. Predictors of improvement \nin cardiometabolic risk factors with weight loss in women. Journal of the American Heart Association.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 634,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 634,
      "word_count": 87,
      "start_pos": 291023,
      "end_pos": 291657,
      "chunk_index": 566,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_567",
      "text": "n cardiometabolic risk factors with weight loss in women. Journal of the American Heart Association. \n2013 Dec 18;2(6):e000152; Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, \nKang L, Kim M, Kim S, Kojima T, Kuzuya M, Lee JSW, Lee SY, Lee WJ, Lee Y, Liang CK, Lim JY, Lim \nWS, Peng LN, Sugimoto K, Tanaka T, Won CW, Yamada M, Zhang T, Akishita M, Arai H. Asian Working \nGroup for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir \nAssoc. 2020 Mar;21(3):300-307.e2. doi: 10.1016/j.jamda.2019.12.012. Epub 2020 Feb 4. PMID: 32033882; \nMeeta M, Harinarayan CV, Marwah R, Sahay R, Kalra S, Babhulkar S.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 658,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 658,
      "word_count": 112,
      "start_pos": 291557,
      "end_pos": 292215,
      "chunk_index": 567,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_568",
      "text": "Epub 2020 Feb 4. PMID: 32033882; \nMeeta M, Harinarayan CV, Marwah R, Sahay R, Kalra S, Babhulkar S. Clinical Practice Guidelines on \nPostmenopausal Osteoporosis: *An Executive Summary and Recommendations - Update 2019-2020. J \nMidlife Health. 2020 Apr-Jun;11(2):96-112. doi: 10.4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 353,
          "overlap_percentage": 100.28409090909092
        }
      ],
      "primary_page": 53,
      "char_count": 352,
      "word_count": 47,
      "start_pos": 292115,
      "end_pos": 292470,
      "chunk_index": 568,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_569",
      "text": "n;11(2):96-112. doi: 10.4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 98,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 98,
      "word_count": 11,
      "start_pos": 292370,
      "end_pos": 292470,
      "chunk_index": 569,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_570",
      "text": ";11(2):96-112. doi: 10.4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 97,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 97,
      "word_count": 11,
      "start_pos": 292371,
      "end_pos": 292470,
      "chunk_index": 570,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_571",
      "text": "11(2):96-112. doi: 10.4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 96,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 96,
      "word_count": 11,
      "start_pos": 292372,
      "end_pos": 292470,
      "chunk_index": 571,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_572",
      "text": "1(2):96-112. doi: 10.4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 95,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 95,
      "word_count": 11,
      "start_pos": 292373,
      "end_pos": 292470,
      "chunk_index": 572,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_573",
      "text": "(2):96-112. doi: 10.4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 94,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 94,
      "word_count": 11,
      "start_pos": 292374,
      "end_pos": 292470,
      "chunk_index": 573,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_574",
      "text": "2):96-112. doi: 10.4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 93,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 93,
      "word_count": 11,
      "start_pos": 292375,
      "end_pos": 292470,
      "chunk_index": 574,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_575",
      "text": "):96-112. doi: 10.4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 92,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 92,
      "word_count": 11,
      "start_pos": 292376,
      "end_pos": 292470,
      "chunk_index": 575,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_576",
      "text": ":96-112. doi: 10.4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 91,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 91,
      "word_count": 11,
      "start_pos": 292377,
      "end_pos": 292470,
      "chunk_index": 576,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_577",
      "text": "96-112. doi: 10.4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 90,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 90,
      "word_count": 11,
      "start_pos": 292378,
      "end_pos": 292470,
      "chunk_index": 577,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_578",
      "text": "6-112. doi: 10.4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 89,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 89,
      "word_count": 11,
      "start_pos": 292379,
      "end_pos": 292470,
      "chunk_index": 578,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_579",
      "text": "-112. doi: 10.4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 88,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 88,
      "word_count": 11,
      "start_pos": 292380,
      "end_pos": 292470,
      "chunk_index": 579,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_580",
      "text": "112. doi: 10.4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 87,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 87,
      "word_count": 11,
      "start_pos": 292381,
      "end_pos": 292470,
      "chunk_index": 580,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_581",
      "text": "12. doi: 10.4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 86,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 86,
      "word_count": 11,
      "start_pos": 292382,
      "end_pos": 292470,
      "chunk_index": 581,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_582",
      "text": "2. doi: 10.4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 85,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 85,
      "word_count": 11,
      "start_pos": 292383,
      "end_pos": 292470,
      "chunk_index": 582,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_583",
      "text": ". doi: 10.4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 84,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 84,
      "word_count": 11,
      "start_pos": 292384,
      "end_pos": 292470,
      "chunk_index": 583,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_584",
      "text": "doi: 10.4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 83,
          "overlap_percentage": 101.21951219512195
        }
      ],
      "primary_page": 53,
      "char_count": 82,
      "word_count": 10,
      "start_pos": 292385,
      "end_pos": 292470,
      "chunk_index": 584,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_585",
      "text": "doi: 10.4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 82,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 82,
      "word_count": 10,
      "start_pos": 292386,
      "end_pos": 292470,
      "chunk_index": 585,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.657695"
    },
    {
      "id": "chunk_586",
      "text": "oi: 10.4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 81,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 81,
      "word_count": 10,
      "start_pos": 292387,
      "end_pos": 292470,
      "chunk_index": 586,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_587",
      "text": "i: 10.4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 80,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 80,
      "word_count": 10,
      "start_pos": 292388,
      "end_pos": 292470,
      "chunk_index": 587,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_588",
      "text": ": 10.4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 79,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 79,
      "word_count": 10,
      "start_pos": 292389,
      "end_pos": 292470,
      "chunk_index": 588,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_589",
      "text": "10.4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 78,
          "overlap_percentage": 101.29870129870129
        }
      ],
      "primary_page": 53,
      "char_count": 77,
      "word_count": 9,
      "start_pos": 292390,
      "end_pos": 292470,
      "chunk_index": 589,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_590",
      "text": "10.4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 77,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 77,
      "word_count": 9,
      "start_pos": 292391,
      "end_pos": 292470,
      "chunk_index": 590,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_591",
      "text": "0.4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 76,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 76,
      "word_count": 9,
      "start_pos": 292392,
      "end_pos": 292470,
      "chunk_index": 591,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_592",
      "text": ".4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 75,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 75,
      "word_count": 9,
      "start_pos": 292393,
      "end_pos": 292470,
      "chunk_index": 592,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_593",
      "text": "4103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 74,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 74,
      "word_count": 9,
      "start_pos": 292394,
      "end_pos": 292470,
      "chunk_index": 593,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_594",
      "text": "103/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 73,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 73,
      "word_count": 9,
      "start_pos": 292395,
      "end_pos": 292470,
      "chunk_index": 594,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_595",
      "text": "03/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 72,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 72,
      "word_count": 9,
      "start_pos": 292396,
      "end_pos": 292470,
      "chunk_index": 595,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_596",
      "text": "3/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 71,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 71,
      "word_count": 9,
      "start_pos": 292397,
      "end_pos": 292470,
      "chunk_index": 596,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_597",
      "text": "/jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 70,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 70,
      "word_count": 9,
      "start_pos": 292398,
      "end_pos": 292470,
      "chunk_index": 597,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_598",
      "text": "jmh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 69,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 69,
      "word_count": 9,
      "start_pos": 292399,
      "end_pos": 292470,
      "chunk_index": 598,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_599",
      "text": "mh.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 68,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 68,
      "word_count": 9,
      "start_pos": 292400,
      "end_pos": 292470,
      "chunk_index": 599,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_600",
      "text": "h.JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 67,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 67,
      "word_count": 9,
      "start_pos": 292401,
      "end_pos": 292470,
      "chunk_index": 600,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_601",
      "text": ".JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 66,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 66,
      "word_count": 9,
      "start_pos": 292402,
      "end_pos": 292470,
      "chunk_index": 601,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_602",
      "text": "JMH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 65,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 65,
      "word_count": 9,
      "start_pos": 292403,
      "end_pos": 292470,
      "chunk_index": 602,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_603",
      "text": "MH_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 64,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 64,
      "word_count": 9,
      "start_pos": 292404,
      "end_pos": 292470,
      "chunk_index": 603,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_604",
      "text": "H_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 63,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 63,
      "word_count": 9,
      "start_pos": 292405,
      "end_pos": 292470,
      "chunk_index": 604,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_605",
      "text": "_143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 62,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 62,
      "word_count": 9,
      "start_pos": 292406,
      "end_pos": 292470,
      "chunk_index": 605,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_606",
      "text": "143_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 61,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 61,
      "word_count": 9,
      "start_pos": 292407,
      "end_pos": 292470,
      "chunk_index": 606,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_607",
      "text": "43_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 60,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 60,
      "word_count": 9,
      "start_pos": 292408,
      "end_pos": 292470,
      "chunk_index": 607,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_608",
      "text": "3_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 59,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 59,
      "word_count": 9,
      "start_pos": 292409,
      "end_pos": 292470,
      "chunk_index": 608,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_609",
      "text": "_20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 58,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 58,
      "word_count": 9,
      "start_pos": 292410,
      "end_pos": 292470,
      "chunk_index": 609,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_610",
      "text": "20. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 57,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 57,
      "word_count": 9,
      "start_pos": 292411,
      "end_pos": 292470,
      "chunk_index": 610,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_611",
      "text": "0. Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 56,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 56,
      "word_count": 9,
      "start_pos": 292412,
      "end_pos": 292470,
      "chunk_index": 611,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_612",
      "text": ". Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 55,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 55,
      "word_count": 9,
      "start_pos": 292413,
      "end_pos": 292470,
      "chunk_index": 612,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_613",
      "text": "Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 54,
          "overlap_percentage": 101.88679245283019
        }
      ],
      "primary_page": 53,
      "char_count": 53,
      "word_count": 8,
      "start_pos": 292414,
      "end_pos": 292470,
      "chunk_index": 613,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_614",
      "text": "Epub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 53,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 53,
      "word_count": 8,
      "start_pos": 292415,
      "end_pos": 292470,
      "chunk_index": 614,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_615",
      "text": "pub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 52,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 52,
      "word_count": 8,
      "start_pos": 292416,
      "end_pos": 292470,
      "chunk_index": 615,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_616",
      "text": "ub 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 51,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 51,
      "word_count": 8,
      "start_pos": 292417,
      "end_pos": 292470,
      "chunk_index": 616,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_617",
      "text": "b 2020 Aug 10. PMID: \n33281419; PMCID: PMC7688018.",
      "doc_title": "ATAO:HIS:ADD:TX_1~ABS:AT/HTC:OS:TX_2~ABS:AT",
      "doc_filename": "4_Evidence_and_consensus_based_clinical_practice.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\4_Evidence_and_consensus_based_clinical_practice.pdf",
      "pages": [
        {
          "page_number": 53,
          "overlap_chars": 50,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 53,
      "char_count": 50,
      "word_count": 8,
      "start_pos": 292418,
      "end_pos": 292470,
      "chunk_index": 617,
      "total_doc_pages": 53,
      "extraction_timestamp": "2025-06-28T15:28:32.658695"
    },
    {
      "id": "chunk_0",
      "text": "Citation: Erdélyi, A.; Pálfi, E.; T˝u˝u, L.;\nNas, K.; Sz˝ucs, Z.; Török, M.; Jakab,\nA.; Várbíró, S. The Importance of\nNutrition in Menopause and\nPerimenopause—A Review. Nutrients\n2024, 16, 27. [URL]\n10.3390/nu16010027\nAcademic Editor: Yajun Xu\nReceived: 28 November 2023\nRevised: 14 December 2023\nAccepted: 19 December 2023\nPublished: 21 December 2023\nCopyright: \nLicensee MDPI, Basel, Switzerland.\nThis article is an open access article\ndistributed\nunder\nthe\nterms\nand\nconditions of the Creative Commons\nAttribution (CC BY) license (https://\ncreativecommons.org/licenses/by/\n4.0/).",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 582,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 582,
      "word_count": 81,
      "start_pos": 0,
      "end_pos": 582,
      "chunk_index": 0,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.723414"
    },
    {
      "id": "chunk_1",
      "text": "f the Creative Commons\nAttribution (CC BY) license (https://\ncreativecommons.org/licenses/by/\n4.0/).\nnutrients\nReview\nThe Importance of Nutrition in Menopause and\nPerimenopause—A Review\nAliz Erdélyi 1,2,†, Erzsébet Pálfi 3,*,†\n, László T˝u˝u 2,4\n, Katalin Nas 2,4, Zsuzsanna Sz˝ucs 1,4, Marianna Török 2,5,*\n,\nAttila Jakab 6\nand Szabolcs Várbíró 5,7\nHungarian Dietetic Association, 1034 Budapest, Hungary; aliz.erdelyi@mdosz.hu (A.E.);\nzsuzsanna.szucs@mdosz.hu (Z.S.)\nEndoCare Institute, Endocrinology Center, 1037 Budapest, Hungary; tuul68@gmail.com (L.T.);\ndrnaskatalin@yahoo.com (K.N.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 587,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 587,
      "word_count": 71,
      "start_pos": 482,
      "end_pos": 1069,
      "chunk_index": 1,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.723414"
    },
    {
      "id": "chunk_2",
      "text": "Endocrinology Center, 1037 Budapest, Hungary; tuul68@gmail.com (L.T.);\ndrnaskatalin@yahoo.com (K.N.)\nFaculty of Health Sciences, Department of Dietetics and Nutritional Sciences, Semmelweis University,\n1088 Budapest, Hungary\nSchool of PhD Studies, Semmelweis University, 1085 Budapest, Hungary\nDepartment of Obstetrics and Gynecology, Semmelweis University, 1082 Budapest, Hungary;\nvarbiro.szabolcs@med.semmelweis-univ.hu\nDepartment of Obstetrics and Gynecology, Faculty of Medicine, University of Debrecen,\n4032 Debrecen, Hungary; ja@med.unideb.hu\nDepartment of Obstetrics and Gynecology, University of Szeged, 6725 Szeged, Hungary\n*\nCorrespondence: palfi.erzsebet@semmelweis.hu (E.P.); torok.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 695,
          "overlap_percentage": 100.14409221902017
        }
      ],
      "primary_page": 1,
      "char_count": 694,
      "word_count": 75,
      "start_pos": 969,
      "end_pos": 1664,
      "chunk_index": 2,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.723414"
    },
    {
      "id": "chunk_3",
      "text": "ersity of Szeged, 6725 Szeged, Hungary\n*\nCorrespondence: palfi.erzsebet@semmelweis.hu (E.P.); torok.marianna@semmelweis.hu (M.T.)\n†\nThese authors contributed equally to this work.\nAbstract: Menopause is associated with an increased prevalence of obesity, metabolic syndrome,\ncardiovascular diseases, and osteoporosis. These diseases and unfavorable laboratory values, which\nare characteristic of this period in women, can be significantly improved by eliminating and reducing\ndietary risk factors. Changing dietary habits during perimenopause is most effectively achieved\nthrough nutrition counseling and intervention.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 618,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 618,
      "word_count": 75,
      "start_pos": 1564,
      "end_pos": 2182,
      "chunk_index": 3,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.723414"
    },
    {
      "id": "chunk_4",
      "text": "its during perimenopause is most effectively achieved\nthrough nutrition counseling and intervention. To reduce the risk factors of all these diseases, and in\nthe case of an already existing disease, dietary therapy led by a dietitian should be an integral part of\nthe treatment. The following review summarizes the recommendations for a balanced diet and fluid\nintake, the dietary prevention of cardiovascular diseases, the role of sleep, and the key preventive\nnutrients in menopause, such as vitamin D, calcium, vitamin C, B vitamins, and protein intake.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 556,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 556,
      "word_count": 86,
      "start_pos": 2082,
      "end_pos": 2638,
      "chunk_index": 4,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.723414"
    },
    {
      "id": "chunk_5",
      "text": "ntive\nnutrients in menopause, such as vitamin D, calcium, vitamin C, B vitamins, and protein intake. In\nsummary, during the period of perimenopause and menopause, many lifestyle factors can reduce the\nrisk of developing all the diseases (cardiovascular disease, insulin resistance, type 2 diabetes mellitus,\nosteoporosis, and tumors) and symptoms characteristic of this period.\nKeywords: menopause; perimenopause; dietetics; cardiovascular risk; healthy lifestyle; nutritional\nstatus; medical nutrition therapy; healthy eating guidelines\n1. Introduction\nAs life expectancy increases, the number of menopausal women worldwide is increas-\ning, with an estimated 1.2 billion worldwide by 2030 [1].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 694,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 694,
      "word_count": 94,
      "start_pos": 2538,
      "end_pos": 3232,
      "chunk_index": 5,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.723414"
    },
    {
      "id": "chunk_6",
      "text": "of menopausal women worldwide is increas-\ning, with an estimated 1.2 billion worldwide by 2030 [1]. In a woman’s life, menopause can\nbe said when menstruation no longer occurs within a year after the last period. This usually\nhappens between 45 and 55 years of age. Menstrual irregularities, including amenorrhoea,\ncan even last for years; such period is called perimenopause. Hormonal changes, which\ncause both somatic and psychological changes, begin even earlier, which is the period of\nmenopausal change associated with the loss of fertility in women over 40 (‘menopausal\ntransition’).",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 590,
          "overlap_percentage": 100.16977928692698
        }
      ],
      "primary_page": 1,
      "char_count": 589,
      "word_count": 91,
      "start_pos": 3132,
      "end_pos": 3722,
      "chunk_index": 6,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.723414"
    },
    {
      "id": "chunk_7",
      "text": "menopausal change associated with the loss of fertility in women over 40 (‘menopausal\ntransition’).\nIn the female body, estradiol is a hormone with extensive metabolic effects, so the\nabsence of the cycle and the lack of periodic exposure to estrogen and progesterone cause\nchanges in the target tissues of sex hormones, as well as the reproductive system. Estradiol\naffects the central nervous system, and increases food intake and basal energy consumption\nNutrients 2024, 16, 27. [URL]\n[URL]\n\nNutrients 2024, 16, 27\n2 of 21\n(basal metabolism). It increases gluconeogenesis in the liver, having an opposite effect to\ninsulin.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 494,
          "overlap_percentage": 78.91373801916933
        },
        {
          "page_number": 2,
          "overlap_chars": 131,
          "overlap_percentage": 20.926517571884983
        }
      ],
      "primary_page": 1,
      "char_count": 626,
      "word_count": 98,
      "start_pos": 3622,
      "end_pos": 4249,
      "chunk_index": 7,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.723414"
    },
    {
      "id": "chunk_8",
      "text": "(basal metabolism). It increases gluconeogenesis in the liver, having an opposite effect to\ninsulin. In skeletal muscles, estradiol increases insulin sensitivity and glucose uptake [2]\nand improves the function of pancreatic beta cells by increasing insulin secretion. With\nthe onset of menopause and due to the lacking effect of estrogen, basal metabolism of\nthe female body decreases significantly [3]. The hunger-suppressing effect of estrogen on\nestrogen alpha receptors in the central nervous system is also reduced, resulting in higher\ncalorie intake [4,5].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 563,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 563,
      "word_count": 82,
      "start_pos": 4149,
      "end_pos": 4712,
      "chunk_index": 8,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.723414"
    },
    {
      "id": "chunk_9",
      "text": "a receptors in the central nervous system is also reduced, resulting in higher\ncalorie intake [4,5]. Body composition changes parallel to the decrease in basal metabolism,\nas body weight increases, and fat distribution changes to an increased visceral fat, as\nmass increases [6]. The excess fat storage leads to larger adipocytes and tissue remodeling\nof visceral fat. Local growth factors are secreted, inducing adaptive angiogenesis, high\nmetabolic activity, and oxygen consumption, resulting in excess production of free oxygen\nradicals. In response to structural damage, immune cells are recruited and accumulated in\nadipose tissue.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 636,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 636,
      "word_count": 93,
      "start_pos": 4612,
      "end_pos": 5248,
      "chunk_index": 9,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.723414"
    },
    {
      "id": "chunk_10",
      "text": "als. In response to structural damage, immune cells are recruited and accumulated in\nadipose tissue. The increased secretion of pro-inflammatory signaling molecules induces\nlocal and low-grade systemic inflammation [7]. This low-grade systemic inflammation\nplays a key role in accelerating vascular damage [8].\nDuring menopause, the risk and occurrence of several chronic diseases increase in\nconnection with the decrease in estrogen levels. These are cardiovascular diseases, tumors\n(especially hormone-sensitive breast cancer), insulin resistance, type 2 diabetes (T2DM),\nand osteoporosis, the risk of which can be reduced by lifestyle modification.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 651,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 651,
      "word_count": 88,
      "start_pos": 5148,
      "end_pos": 5799,
      "chunk_index": 10,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.723414"
    },
    {
      "id": "chunk_11",
      "text": "ype 2 diabetes (T2DM),\nand osteoporosis, the risk of which can be reduced by lifestyle modification. Hormonal\nchanges during perimenopause and menopause cause several characteristic symptoms.\nThe strength, frequency, and tolerability of the symptoms can also be influenced by lifestyle.\nDuring menopause, hormone-sensitive breast cancer is more common in those whose\nmenstruation started earlier than the average and ended later. Additional risk factors are if\nthe woman has not given birth to a child or breastfed for at least 12 months [9].\nDuring perimenopause and menopause, hot flashes and night sweats are common,\nas well as headaches and joint pains may become more frequent.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 682,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 682,
      "word_count": 104,
      "start_pos": 5699,
      "end_pos": 6381,
      "chunk_index": 11,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.723414"
    },
    {
      "id": "chunk_12",
      "text": "flashes and night sweats are common,\nas well as headaches and joint pains may become more frequent. Women become more\nirritable and emotionally volatile, and their ability to concentrate deteriorates. These\nsymptoms can be of different intensity and frequency but all of them can be said to be\ninfluenced by lifestyle. Seventy-five to eighty per cent of women suffer from the symptoms\ncaused by menopause, and they are more severe in 20–30% of women [10]. In this period\nof life, the change of lifestyle, even if it does not eliminate the symptoms and associated\ndiseases, delays their development, makes them more bearable, and at the same time,\nmakes everyday life easier [11].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 680,
          "overlap_percentage": 100.14727540500736
        }
      ],
      "primary_page": 2,
      "char_count": 679,
      "word_count": 112,
      "start_pos": 6281,
      "end_pos": 6961,
      "chunk_index": 12,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.723414"
    },
    {
      "id": "chunk_13",
      "text": "their development, makes them more bearable, and at the same time,\nmakes everyday life easier [11]. In the case of obesity or overweight, losing just 5 kg of\nweight improves the tolerability of hot flashes by 30%. Regular exercise ensures metabolic\nhealth and reduces the number and intensity of hot flashes [12].\nIn a holistic approach to the care of healthy menopause, changes in the physiological\nprocesses, which occur as a result of the drop in estrogen levels, should also be followed by\nchanges in the diet. The nutrition of the population of developed countries is still far from\nfood-based dietary guidelines (FBDG) [13–20].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 634,
          "overlap_percentage": 100.15797788309638
        }
      ],
      "primary_page": 2,
      "char_count": 633,
      "word_count": 104,
      "start_pos": 6861,
      "end_pos": 7495,
      "chunk_index": 13,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.723414"
    },
    {
      "id": "chunk_14",
      "text": "he population of developed countries is still far from\nfood-based dietary guidelines (FBDG) [13–20]. The frequency of obesity is increasing every\nyear; between 1975 and 2016, the prevalence of obesity almost tripled. Based on WHO’s\ndata from 2016, 40% of women are overweight and another 15% are obese [21]. Unhealthy\nWestern nutrition is characterized by high fat (38% of energy) and salt intake (9.2 g/day in\nwomen in the age group of 50–59 years [22,23]), low vegetable and fruit consumption [24],\nand low calcium (730 ± 277 mg/day) intake [25].\nGiven all of this, significant steps must be taken with the help of dietitians to change\nthe diet of those affected by menopause and perimenopause.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 696,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 696,
      "word_count": 115,
      "start_pos": 7395,
      "end_pos": 8091,
      "chunk_index": 14,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.723414"
    },
    {
      "id": "chunk_15",
      "text": "ken with the help of dietitians to change\nthe diet of those affected by menopause and perimenopause. All those diseases and\nunfavorable laboratory values, which are characteristic of this period of women, can be\nsignificantly improved by eliminating and reducing dietary risk factors. Menopause is\nassociated with an increased prevalence of obesity, metabolic syndrome, cardiovascular\ndiseases, and osteoporosis [26]. To reduce the risk factors of all these diseases, and, in\nthe case of an already existing disease, dietary therapy should be an integral part of the\ntreatment. Nutritional intervention is an essential element of the primary prevention of\nchronic diseases [27].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 678,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 678,
      "word_count": 101,
      "start_pos": 7991,
      "end_pos": 8669,
      "chunk_index": 15,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.723414"
    },
    {
      "id": "chunk_16",
      "text": "Nutritional intervention is an essential element of the primary prevention of\nchronic diseases [27].\n\nNutrients 2024, 16, 27\n3 of 21\nThe European Menopause and Andropause Society (EMAS) also emphasizes the\nimportance of lifestyle. There is growing evidence that lifestyle factors such as diet, phys-\nical activity, smoking, and alcohol consumption have a significant impact on health and\nmenopausal symptoms. Regardless of menopause, women gain an average of 10 kg be-\ntween the ages of 40 and 60.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 100,
          "overlap_percentage": 20.12072434607646
        },
        {
          "page_number": 3,
          "overlap_chars": 395,
          "overlap_percentage": 79.47686116700201
        }
      ],
      "primary_page": 2,
      "char_count": 497,
      "word_count": 78,
      "start_pos": 8569,
      "end_pos": 9066,
      "chunk_index": 16,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.723414"
    },
    {
      "id": "chunk_17",
      "text": "l symptoms. Regardless of menopause, women gain an average of 10 kg be-\ntween the ages of 40 and 60. According to the recommendation of EMAS, women should\nbe supported, among other things, in regular exercise and in creating a diet in accordance\nwith national nutritional guidelines, to manage health risks, and prevent excessive body\nweight gain [28]. The following review summarizes the recommendations for a balanced\ndiet and fluid intake in menopause, the dietary prevention of cardiovascular diseases, the\nrole of sleep in the diet, and the key preventive nutrients in menopause, such as vitamin D,\ncalcium, vitamin C, B vitamins, and protein intake.\n2.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 658,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 3,
      "char_count": 658,
      "word_count": 106,
      "start_pos": 8966,
      "end_pos": 9624,
      "chunk_index": 17,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.723414"
    },
    {
      "id": "chunk_18",
      "text": "ve nutrients in menopause, such as vitamin D,\ncalcium, vitamin C, B vitamins, and protein intake.\n2. Balanced Nutrition Recommendation\nThe quality of the diet is a determining element of an individual’s health at every\nstage of life. Its role in the development of chronic, non-infectious diseases has now been\nsufficiently proven. Therefore, regarding nutrition, the intervention of a dietitian is an\nessential element of prevention [27]. A healthy diet can help counter the symptoms of\nperimenopause and menopause and prevent many chronic diseases, such as cardiovascular\ndisease, diabetes, and different types of malignancies.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 629,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 3,
      "char_count": 629,
      "word_count": 94,
      "start_pos": 9524,
      "end_pos": 10153,
      "chunk_index": 18,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.723414"
    },
    {
      "id": "chunk_19",
      "text": "any chronic diseases, such as cardiovascular\ndisease, diabetes, and different types of malignancies. In the Epidemiology of Obesity\nprospective cohort study of 6671 individuals aged 45 to 65 years conducted in The Nether-\nlands, dietary intake of fruits, vegetables, vegetable fats, and oils resulted in lower visceral\nfat mass. More than half of the 3576 women in the study were in menopause [29]. In Eu-\nrope, recommendations for a balanced healthy diet are described in the Food-Based Dietary\nGuidelines (FBDGs) [13–20,30].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 526,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 3,
      "char_count": 526,
      "word_count": 81,
      "start_pos": 10053,
      "end_pos": 10579,
      "chunk_index": 19,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.723414"
    },
    {
      "id": "chunk_20",
      "text": "s for a balanced healthy diet are described in the Food-Based Dietary\nGuidelines (FBDGs) [13–20,30]. There are many diets which have a positive effect on chronic\nnon-infectious diseases and weight management, such as the Mediterranean diet and the\nvery low-calorie diet (VLCD-1200 kcal/day). Diets providing less than 1200 kcal/day may\nyield micronutrient deficiencies which could negatively affect not only the nutritional status\nbut also the weight management outcome [31]. Therefore, low-calorie diets (LCDs) and\nVLCDs are used only in clinical practice. Balanced hypocaloric diets can be managed to\nindividuals and may, therefore, have better chance for long-term success [31].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 681,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 3,
      "char_count": 681,
      "word_count": 99,
      "start_pos": 10479,
      "end_pos": 11160,
      "chunk_index": 20,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.723414"
    },
    {
      "id": "chunk_21",
      "text": "ets can be managed to\nindividuals and may, therefore, have better chance for long-term success [31]. The other\npopular diet is the Mediterranean diet. The Mediterranean diet is characterized by foods\nwith anti-inflammatory and antioxidant action. There is evidence that the Mediterranean\ndiet affects weight management, blood sugar control, and cardiovascular diseases [5]. At\nthe same time, Mediterranean meal planning is not sustainable in most the European\ncountries. Summarizing the healthy, balanced diet is achievable in the long term, therefore\nit is preferred.\n2.1.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 573,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 3,
      "char_count": 573,
      "word_count": 84,
      "start_pos": 11060,
      "end_pos": 11633,
      "chunk_index": 21,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.723414"
    },
    {
      "id": "chunk_22",
      "text": "mmarizing the healthy, balanced diet is achievable in the long term, therefore\nit is preferred.\n2.1. Nutritional Status during Perimenopause\nDuring the period of perimenopause and menopause, due to the change in hormone\nlevels (decrease in sex steroids), the basal metabolism of the female body decreases signifi-\ncantly, which can mean a decrease in the basal metabolic rate (BMR) of up to 250–300 kcal\nper day. In the case of an unchanged lifestyle, it may result in an annual weight gain of\n2 kg [3]. Body composition changes parallel to the decrease in basal metabolism. During\nthis period, the most common abnormal nutritional conditions are overweight and obesity.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 670,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 3,
      "char_count": 670,
      "word_count": 108,
      "start_pos": 11533,
      "end_pos": 12203,
      "chunk_index": 22,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.723414"
    },
    {
      "id": "chunk_23",
      "text": "ism. During\nthis period, the most common abnormal nutritional conditions are overweight and obesity.\nWeight gain, typically, means an increase in abdominal (visceral) fat mass [11]. In addition,\ndue to the aforementioned hormonal changes, fat-free mass (FFM) and skeletal muscle\nmass (SMM) are characterized by a decrease, which can lead to sarcopenia and, in the case\nof two pathological body composition changes, sarcopenic obesity, in which, in addition to\nabnormal fat mass, muscle function and muscle mass decrease [10,32,33].\nThe prevalence of obesity increases with age. The incidence of abdominal obesity\nin women increases with age, and a rapid increase is observed in middle-aged women.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 696,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 3,
      "char_count": 696,
      "word_count": 105,
      "start_pos": 12103,
      "end_pos": 12799,
      "chunk_index": 23,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.723414"
    },
    {
      "id": "chunk_24",
      "text": "bdominal obesity\nin women increases with age, and a rapid increase is observed in middle-aged women.\nWeight gain is a symptom of menopause, experienced by 60–70% of middle-aged women.\nOn average, women gain about 6.8 kg per year during their midlife period (ages 50–60),\n\nNutrients 2024, 16, 27\n4 of 21\nregardless of their initial body size, race, or ethnicity [34]. According to 2016 WHO data,\n55% of women are overweight or obese [21].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 270,
          "overlap_percentage": 61.784897025171624
        },
        {
          "page_number": 4,
          "overlap_chars": 165,
          "overlap_percentage": 37.75743707093822
        }
      ],
      "primary_page": 3,
      "char_count": 437,
      "word_count": 74,
      "start_pos": 12699,
      "end_pos": 13136,
      "chunk_index": 24,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_25",
      "text": "ize, race, or ethnicity [34]. According to 2016 WHO data,\n55% of women are overweight or obese [21].\nIn menopause, due to the consequences of the hormonal changes, it is not sufficient to\nuse the body mass index (BMI) combined with the waist circumference measurement, but\nit is necessary to use body composition analyzers based on the principle of bioelectrical\nimpedance (bioelectrical impedance analysis, BIA), which are suitable for measuring body\ncomposition. Depending on the results obtained, the daily energy requirement and the\nratio of the necessary nutrients can be determined.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 588,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 588,
      "word_count": 91,
      "start_pos": 13036,
      "end_pos": 13624,
      "chunk_index": 25,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_26",
      "text": "s obtained, the daily energy requirement and the\nratio of the necessary nutrients can be determined. With individualized energy intake,\nin the case of weight reduction, the daily energy requirement cannot be less than the\nmeasured or calculated BMR. In the case of normal body weight, it can be determined\ndepending on physical activity and BMR. During individualization of energy and nutrient\nintake in menopause, it must be taken into account that with the onset of menopause and\ndue to the lack of the effect of sex steroids, the basal metabolism decreases. Even during\nmenopause, the first step in dietary care is to determine the nutritional status.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 654,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 654,
      "word_count": 107,
      "start_pos": 13524,
      "end_pos": 14178,
      "chunk_index": 26,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_27",
      "text": "eases. Even during\nmenopause, the first step in dietary care is to determine the nutritional status. The easiest\nway to determine nutritional status is the body mass index (BMI in kg/m2, calculation:\nbody weight in kilograms/height in meters squared). The mid-upper arm circumference\n(MUAC) provides an opportunity to estimate BMI [35]. BMI does not provide information\nregarding body composition. Additional measurement methods are needed to diagnose an\nabnormal nutritional status. In such cases, the waist–hip ratio, abdominal circumference,\nskinfold measurement, or performance scales are used to assess nutritional status.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 627,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 627,
      "word_count": 89,
      "start_pos": 14078,
      "end_pos": 14705,
      "chunk_index": 27,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_28",
      "text": "al circumference,\nskinfold measurement, or performance scales are used to assess nutritional status. A more\naccurate measurement is provided by the use of body composition analyzers, which, in\naddition to calculating fat mass and body fat percentage, are suitable for determining\nfat-free body mass and skeletal muscle mass, as well as for detecting edema [36–38]. The\nfollowing means overweight and obesity in women:\n•\nBody fat percentage ≥30%;\n•\nAbdominal circumference ≥88 cm (abdominal, visceral obesity);\n•\nWaist–hip ratio ≥0.8 (abdominal, visceral obesity);\n•\nMUAC ≥32 cm, then BMI ≥30 kg/m2 [39,40].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 606,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 606,
      "word_count": 92,
      "start_pos": 14605,
      "end_pos": 15211,
      "chunk_index": 28,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_29",
      "text": "y);\n•\nWaist–hip ratio ≥0.8 (abdominal, visceral obesity);\n•\nMUAC ≥32 cm, then BMI ≥30 kg/m2 [39,40].\nSarcopenia can be diagnosed in women if the following conditions are met [41–43]: if\nthe muscle mass:\n•\nFFMI ≤15 kg/m2 (fat-free mass index);\n•\nASMI ≤5.25 kg/m2 (appendicular skeletal muscle index);\nOr the muscle strength:\n•\nFor BMI ≤23 kg/m2: ≤17 kgf;\n•\nFor BMI 23.1–26 kg/m2: ≤17.3 kgf;\n•\nFor BMI ≤26.1-29 kg/m2: ≤18 kgf;\n•\nFor BMI > 29.1 kg/m2: ≤21 kgf;\n•\nShort physical performance battery (SPPB) SPPB ≤8.\n2.2.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 515,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 515,
      "word_count": 91,
      "start_pos": 15111,
      "end_pos": 15626,
      "chunk_index": 29,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_30",
      "text": "≤18 kgf;\n•\nFor BMI > 29.1 kg/m2: ≤21 kgf;\n•\nShort physical performance battery (SPPB) SPPB ≤8.\n2.2. Maintaining and Achieving a Healthy Nutritional Status\nThe symptoms of perimenopause and menopause can be significantly reduced and\nmade tolerable by achieving and maintaining a healthy nutritional status. There is no\nsingle, ideal way to achieve a healthy nutritional status. An option must be chosen that\nallows the individual to change lifestyle in the long term and form a new system of\nhabits. Complex, personalized lifestyle therapy has been proven to be more effective than\nindividual therapeutic elements in themselves.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 628,
          "overlap_percentage": 100.15948963317385
        }
      ],
      "primary_page": 4,
      "char_count": 627,
      "word_count": 99,
      "start_pos": 15526,
      "end_pos": 16154,
      "chunk_index": 30,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_31",
      "text": "yle therapy has been proven to be more effective than\nindividual therapeutic elements in themselves.\nIn reducing body weight, the energy requirement, including the energy requirement of\nbasal metabolism (basal metabolic rate, BMR), is a determining factor. Energy intake below\nBMR does not lead to weight loss in the long term and is more difficult to maintain on a\ndaily basis. Diets with an energy content of less than 1200 kcal/day are associated with\na higher risk of micronutrient deficiency. In the case of low-energy diets, after one year,\nrelapses can be observed in 45.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 578,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 578,
      "word_count": 95,
      "start_pos": 16054,
      "end_pos": 16632,
      "chunk_index": 31,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_32",
      "text": "utrient deficiency. In the case of low-energy diets, after one year,\nrelapses can be observed in 45.6% of cases, and in the case of a very low-calorie diet (VLCD,\n\nNutrients 2024, 16, 27\n5 of 21\n<800 kcal/day), gallstones are common. Diets of 800–1000 kcal do not bring long-term\nlifestyle changes and sustainable weight loss [32,44].\nDuring the dietary treatment of obesity, achieving a negative energy balance is of\ngreatest importance. The ideal rate of weight loss is 0.5–1 kg of body weight loss per week,\nwhich occurs from fat body mass while maintaining muscle mass. This means a 15–30% or\n500–1000 kcal lower energy intake than the current energy requirement.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 162,
          "overlap_percentage": 24.28785607196402
        },
        {
          "page_number": 5,
          "overlap_chars": 503,
          "overlap_percentage": 75.41229385307346
        }
      ],
      "primary_page": 4,
      "char_count": 667,
      "word_count": 111,
      "start_pos": 16532,
      "end_pos": 17199,
      "chunk_index": 32,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_33",
      "text": "mass. This means a 15–30% or\n500–1000 kcal lower energy intake than the current energy requirement. It approximately\ncorresponds to an energy intake of 25 kcal/kg/day. The actual energy requirement is\nalways calculated based on the current body weight [31,45–47].\nTo maintain or increase fat-free body weight and skeletal muscle mass, the daily\nprotein intake should be 1–1.2 g/kg body weight (20% of energy), with regular exercise\nwith free weights or against resistance. Diets with a high protein content (at least 20% of\nenergy) only result in weight loss if the energy content is low. At the same time, ensuring\nthe protein requirement (1–1.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 646,
          "overlap_percentage": 100.15503875968992
        }
      ],
      "primary_page": 5,
      "char_count": 645,
      "word_count": 104,
      "start_pos": 17099,
      "end_pos": 17745,
      "chunk_index": 33,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_34",
      "text": "n weight loss if the energy content is low. At the same time, ensuring\nthe protein requirement (1–1.2 g/kg/day) is also essential for increasing and maintaining\nskeletal muscle [48]. Body weight loss usually slows down after 12 weeks, in which case the\ngoal is to maintain the body weight achieved. It is recommended to achieve the clinically\nnecessary weight loss during more than one cycle (one cycle means a certain amount of\nweight loss and maintenance). The average weight loss should be approximately 5–10% of\nthe body weight [31,45–47].\nIn other respects, the diet should follow the guidelines of a balanced mixed diet.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 626,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 626,
      "word_count": 103,
      "start_pos": 17645,
      "end_pos": 18271,
      "chunk_index": 34,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_35",
      "text": "eight [31,45–47].\nIn other respects, the diet should follow the guidelines of a balanced mixed diet. There\nis no difference in the number of kilos lost between low-carbohydrate diets (120 g CH/day\nduring weight loss, 150 g/day during weight maintenance) and low-fat diets, but their car-\ndiometabolic effects are different. Reducing energy by 500–700 kcal per day can be achieved\nprimarily by omitting snacks between meals, incorporating small meals but reducing por-\ntion sizes, and avoiding sugar-containing liquids and alcoholic beverages [10,45,49,50].\n2.3.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 561,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 561,
      "word_count": 83,
      "start_pos": 18171,
      "end_pos": 18732,
      "chunk_index": 35,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_36",
      "text": "g por-\ntion sizes, and avoiding sugar-containing liquids and alcoholic beverages [10,45,49,50].\n2.3. Fluid Intake in Menopause\nAdequate fluid intake is also extremely important during menopause, especially con-\ncerning cellular metabolism and maintaining the optimal functioning of hemostasis. It\nhas an important role in regulating heat balance, detoxification, maintaining the proper\nfunctioning of the gastrointestinal tract and moisture of the mucous membranes, as well\nas turgor of the skin. Adequate daily fluid intake is important in the transport of nutrients\nand oxygen and contributes to the health of the skeletal system [26].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 637,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 637,
      "word_count": 92,
      "start_pos": 18632,
      "end_pos": 19269,
      "chunk_index": 36,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_37",
      "text": "in the transport of nutrients\nand oxygen and contributes to the health of the skeletal system [26]. Estrogen and proges-\nterone significantly affect not only the cardiovascular system but also fluid and electrolyte\nbalance [51]. During menopause, hormonal changes affect the thirst as well, which may\nresult in a significant decrease in fluid intake [52,53]. The individualized, appropriate\namount of fluid intake is 33 mL/kg/day, which is recommended to be evenly distributed\nover the day [54–56].\n3.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 502,
          "overlap_percentage": 100.1996007984032
        }
      ],
      "primary_page": 5,
      "char_count": 501,
      "word_count": 77,
      "start_pos": 19169,
      "end_pos": 19671,
      "chunk_index": 37,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_38",
      "text": "fluid intake is 33 mL/kg/day, which is recommended to be evenly distributed\nover the day [54–56].\n3. Dietary Intervention of Chronic Diseases in Menopause\nDuring menopause, the risk and occurrence of several chronic diseases increases in\nconnection with the decrease in estrogen levels; therefore, the dietary therapy should be an\nintegral part of the treatment and the nutritional intervention is an essential element of the\nprevention of chronic diseases [27].\n3.1. Lipids Metabolism Disorders in Menopause\nDuring perimenopause and menopause, the risk of cardiovascular diseases (CVD)\nincreases with the decrease in estrogen levels [57].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 639,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 639,
      "word_count": 94,
      "start_pos": 19571,
      "end_pos": 20210,
      "chunk_index": 38,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_39",
      "text": "ause, the risk of cardiovascular diseases (CVD)\nincreases with the decrease in estrogen levels [57]. It is a well-known fact that the population\nof women of reproductive age have a lower cardiovascular risk than the male population\nof the same age due to the protective effect of estrogen on the cardiovascular system [58].\nIn the presence of estrogen, the lipid profile is more favorable; the cholesterol level, LDL\ncholesterol fraction, and triglyceride level are also lower. With the onset of menopause,\nlipid parameters tend to deteriorate rapidly, the elasticity of blood vessels decreases, and\nthe blood supply to the organs deteriorates.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 644,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 644,
      "word_count": 101,
      "start_pos": 20110,
      "end_pos": 20754,
      "chunk_index": 39,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_40",
      "text": "rapidly, the elasticity of blood vessels decreases, and\nthe blood supply to the organs deteriorates. The increases in cholesterol levels after the\nonset of menopause already result in cholesterol values exceeding those of men of the same\n\nNutrients 2024, 16, 27\n6 of 21\nage group. In a few years, the worsening trend of LDL cholesterol and triglyceride levels\ncatches up with, and even surpasses, that of the male contemporaries [59].\nThe risk of central obesity in menopausal women is five times higher than before\nmenopause [26].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 237,
          "overlap_percentage": 44.632768361581924
        },
        {
          "page_number": 6,
          "overlap_chars": 292,
          "overlap_percentage": 54.99058380414312
        }
      ],
      "primary_page": 5,
      "char_count": 531,
      "word_count": 87,
      "start_pos": 20654,
      "end_pos": 21185,
      "chunk_index": 40,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_41",
      "text": "9].\nThe risk of central obesity in menopausal women is five times higher than before\nmenopause [26]. Epidemiological studies have shown that central obesity, dyslipidemia,\nglucose intolerance, and hypertension are the most common risk factors for CVD in\nmenopausal women. The incidence of metabolic syndrome in postmenopausal women is\n2–3 times higher than before menopause [60].\nEstrogen exerts its protective effect before menopause by the following: acting on\nestrogen receptor alpha, estradiol increases the release of vasoactive compounds promoting\nvasodilation, nitric oxide, and prostacyclin, and shifts the renin-angiotensin axis towards\nthe production of angiotensin 1–7 [61].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 685,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 6,
      "char_count": 685,
      "word_count": 96,
      "start_pos": 21085,
      "end_pos": 21770,
      "chunk_index": 41,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_42",
      "text": "prostacyclin, and shifts the renin-angiotensin axis towards\nthe production of angiotensin 1–7 [61]. Estradiol also plays a role in the regulation of the\nvascular system with local anti-inflammatory effects and epigenetic modifying effects [61].\nWith the development of estrogen deficiency, the cardiovascular risk increases significantly.\nThe increase in the risk is also influenced by the rate at which estrogen deficiency develops.\nIn general, the greater the decrease in estradiol levels and the faster the rate of change, the\ngreater the increase in cardiovascular risk [61].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 580,
          "overlap_percentage": 100.17271157167531
        }
      ],
      "primary_page": 6,
      "char_count": 579,
      "word_count": 85,
      "start_pos": 21670,
      "end_pos": 22250,
      "chunk_index": 42,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_43",
      "text": "diol levels and the faster the rate of change, the\ngreater the increase in cardiovascular risk [61]. The dietary treatment of cardiovascular\ndiseases should aim to maintain and achieve a normal nutritional status, treat high blood\npressure (one of the most important risk factors of which is currently the high salt intake),\nand manage unfavorable lipid profile changes. Strict adherence to a healthy diet can\nreduce the risk of cardiovascular death by 14–28% [62].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 465,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 6,
      "char_count": 465,
      "word_count": 74,
      "start_pos": 22150,
      "end_pos": 22615,
      "chunk_index": 43,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_44",
      "text": "nges. Strict adherence to a healthy diet can\nreduce the risk of cardiovascular death by 14–28% [62]. In the 2021 ESC Guidelines on\nCardiovascular Disease Prevention in Clinical Practice (European Society of Cardiology,\nESC), a Grade I/B recommendation is formulated; a balanced diet can be recommended to\neveryone to prevent cardiovascular diseases [63].\nThe fatty acid composition (quality) of the diet is more important than its total amount\n(grade B recommendation). The intake of saturated fatty acids (SFAs) may not exceed\n10 E%. It is recommended to be achieved by replacing SFAs with polyunsaturated fatty\nacids (PUFAs) in the diet.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 639,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 6,
      "char_count": 639,
      "word_count": 100,
      "start_pos": 22515,
      "end_pos": 23154,
      "chunk_index": 44,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_45",
      "text": "s recommended to be achieved by replacing SFAs with polyunsaturated fatty\nacids (PUFAs) in the diet. Dietary intake of omega-3 fatty acids, including eicosapentaenoic\nacid (EPA) and docosahexaenoic acid (DHA), is extremely important (grade A recommen-\ndation). The fatty acid composition of the diet (saturated fatty acids, SFAs; trans-fatty\nacids, TFAs) affects serum cholesterol levels more than dietary cholesterol intake (grade B\nrecommendation). In addition to all this, a dietary fiber intake of 30–45 g/day is recom-\nmended, mainly by consuming whole grains. It is recommended to consume at least 400 g\nof vegetables and fruits per day following WHO guidelines [64].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 673,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 6,
      "char_count": 673,
      "word_count": 102,
      "start_pos": 23054,
      "end_pos": 23727,
      "chunk_index": 45,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_46",
      "text": "ecommended to consume at least 400 g\nof vegetables and fruits per day following WHO guidelines [64].\nIn the 2021 recommendation of the American Heart Association (AHA), balancing\nenergy consumption is a priority. The guidelines encourage the consumption of fruits\nand vegetables in fresh, frozen, canned, and dried forms. Replacing refined grains with\nwhole grains is associated with a lower risk of coronary heart disease. A higher intake of\nlegumes and nuts and the consumption of 2–3 servings of fish per week are associated with\na reduction in the risk of cardiovascular diseases.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 584,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 6,
      "char_count": 584,
      "word_count": 93,
      "start_pos": 23627,
      "end_pos": 24211,
      "chunk_index": 46,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_47",
      "text": "–3 servings of fish per week are associated with\na reduction in the risk of cardiovascular diseases. Liquid vegetable oils are recommended\ninstead of tropical oils (coconut, palm, and palm kernel), animal fats (butter and lard), and\npartially hydrogenated fats. Saturated and trans fats (animal, dairy, and partially hydro-\ngenated fats) should be replaced with non-tropical liquid vegetable oils. Evidence supports\nthe cardiovascular benefits of dietary unsaturated fats, particularly polyunsaturated fats,\nprimarily from vegetable oils [62].\nSimilar principles are implemented in the menopause diet recommendations of the\nBritish Dietetic Association.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 653,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 6,
      "char_count": 653,
      "word_count": 90,
      "start_pos": 24111,
      "end_pos": 24764,
      "chunk_index": 47,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_48",
      "text": "rinciples are implemented in the menopause diet recommendations of the\nBritish Dietetic Association. Considering the special target group, it recommends consum-\ning at least four to five servings of unsalted nuts, seeds, and legumes per week and avoiding\nrefined sugars, such as sweets, cakes, and soft drinks. It highlights the heart-friendly nature\nof oats, whole grains, and whole wheat bread, as well as legumes such as lentils, chickpeas,\nand beans, in addition to being excellent sources of fiber [10]. Individualized lifestyle\nchanges are recommended for all patients with hypertension or with elevated but still\nnormal blood pressure.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 642,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 6,
      "char_count": 642,
      "word_count": 97,
      "start_pos": 24664,
      "end_pos": 25306,
      "chunk_index": 48,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_49",
      "text": "are recommended for all patients with hypertension or with elevated but still\nnormal blood pressure. The main elements of these lifestyle changes are weight control, re-\nducing alcohol and salt consumption, and increasing calcium, potassium, and magnesium\nintake [64].\n\nNutrients 2024, 16, 27\n7 of 21\nAccording to the European Society of Cardiology (ESC) and the European Society of\nHypertension (ESH) guidelines, important elements of lifestyle modification are to reduce\nsalt intake to less than 5 g per day (1A) while eating vegetables, fresh fruit, fish, seeds,\nnon-saturated fatty acids (olive oil), and low-fat dairy products and avoiding red meat\n(Grade 1A recommendation) [65].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 6,
          "overlap_chars": 268,
          "overlap_percentage": 39.12408759124087
        },
        {
          "page_number": 7,
          "overlap_chars": 415,
          "overlap_percentage": 60.58394160583942
        }
      ],
      "primary_page": 6,
      "char_count": 685,
      "word_count": 104,
      "start_pos": 25206,
      "end_pos": 25891,
      "chunk_index": 49,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_50",
      "text": "acids (olive oil), and low-fat dairy products and avoiding red meat\n(Grade 1A recommendation) [65]. In the dietary prevention of cardiovascular diseases, the\nfollowing should be emphasized in menopause:\n(a)\nBody weight control in menopause is recommended with energy intake corresponding\nto body composition measurements;\n(b)\nSalt consumption should be as close as possible to 5 g/day, preferring green and dried\nvegetable spices for seasoning;\n(c)\nThe daily recommended intake of vegetables and fruit is 5 portions (500 g/day, of\nwhich 300–400 g of vegetables and 200–100 g of fruit): 3–4 portions of vegetables,\n1–2 portions of fruit [13–20].\n3.2.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 650,
          "overlap_percentage": 100.15408320493067
        }
      ],
      "primary_page": 7,
      "char_count": 649,
      "word_count": 100,
      "start_pos": 25791,
      "end_pos": 26441,
      "chunk_index": 50,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_51",
      "text": "vegetables and 200–100 g of fruit): 3–4 portions of vegetables,\n1–2 portions of fruit [13–20].\n3.2. Carbohydrate Metabolism Disorders in Menopause\nMetabolic changes during the menopausal transition include an increase in the propor-\ntion of adipose tissue, an increase in visceral fat, and a decrease in energy expenditure [6].\nIn addition, there is an impairment of insulin secretion and insulin sensitivity, as well as an\nincrease in the risk of T2DM [66].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 459,
          "overlap_percentage": 100.21834061135371
        }
      ],
      "primary_page": 7,
      "char_count": 458,
      "word_count": 72,
      "start_pos": 26341,
      "end_pos": 26800,
      "chunk_index": 51,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_52",
      "text": "rment of insulin secretion and insulin sensitivity, as well as an\nincrease in the risk of T2DM [66].\nThe changes affecting carbohydrate metabolism during menopause are the following [67]:\n•\nIn the absence of estrogen, the insulin secretion of the pancreatic beta cells decreases;\n•\nDecreased insulin sensitivity in the muscles results in a decrease in glucose uptake;\n•\nAs a result of deteriorating insulin sensitivity in the liver, gluconeogenesis and lipoge-\nnesis increase, triglyceride accumulation increases, VLDL production increases, and\ninsulin clearance decreases;\n•\nAs a result of the reduc",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 7,
      "char_count": 600,
      "word_count": 91,
      "start_pos": 26700,
      "end_pos": 27300,
      "chunk_index": 52,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_53",
      "text": "on increases, VLDL production increases, and\ninsulin clearance decreases;\n•\nAs a result of the reduced insulin effect on adipose tissue, lipolysis increases, the size\nof fat cells increases, and inflammatory mediators accumulate;\n•\nThe resulting metabolic changes lead to the development of metabolic syndrome.\nTherefore, the risk of developing a carbohydrate metabolism disorder is related to\nthe presence or absence of sex hormones (menopause). A correlation can also be observed\nwith the date of menopause. A large Chinese study revealed a clear correlation between\nthe date of menopause and the risk of diabetes.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 616,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 7,
      "char_count": 616,
      "word_count": 94,
      "start_pos": 27200,
      "end_pos": 27816,
      "chunk_index": 53,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_54",
      "text": "e Chinese study revealed a clear correlation between\nthe date of menopause and the risk of diabetes. The risk of developing a carbohydrate\nmetabolism disorder was the lowest with menopause occurring between the ages of 45\nand 49. Menopause at both younger and older ages was associated with an increased risk\nof diabetes. Menopause occurring before the age of 40 had the highest risk [68]. The risk\nof developing diabetes was increased by weight gain and unfavorable changes in body\ncomposition (adiposity) [69]. Based on these, it can be said that menopause is associated\nwith an increased risk of T2DM.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 604,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 7,
      "char_count": 604,
      "word_count": 100,
      "start_pos": 27716,
      "end_pos": 28320,
      "chunk_index": 54,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_55",
      "text": "y) [69]. Based on these, it can be said that menopause is associated\nwith an increased risk of T2DM. Lifestyle intervention, including diet and exercise, is the\ncornerstone of diabetes prevention and management [70].\nAccording to the American Academy of Nutrition and Dietetics, for adults with\nprediabetes or type 2 diabetes, dietary therapy administered by a registered dietitian\nimproves the effectiveness of medical treatment and longevity. Dietary therapy is more\ncost-effective, successful, and essential for prediabetes and obesity, and in preventing the\nprogression of type 2 diabetes [71].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 598,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 7,
      "char_count": 598,
      "word_count": 88,
      "start_pos": 28220,
      "end_pos": 28818,
      "chunk_index": 55,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_56",
      "text": "nd essential for prediabetes and obesity, and in preventing the\nprogression of type 2 diabetes [71]. Lifestyle interventions, including dietary changes and\nregular exercise, aimed at moderate weight loss (5%) are the mainstay of treatment [72].\nIn perimenopause and menopause, if there is no impaired fasting glycaemia (IFG),\nimpaired glucose tolerance (IGT), or T2DM present, it is important to achieve and maintain\nadequate nutritional status and body composition, as well as ensure energy, nutrient, and\nfluid requirements appropriate to age, nutritional status, physical activity, and diseases.\nTreatment of overweight/obesity is of particular importance in prediabetes and diabetes.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 687,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 7,
      "char_count": 687,
      "word_count": 97,
      "start_pos": 28718,
      "end_pos": 29405,
      "chunk_index": 56,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_57",
      "text": "d diseases.\nTreatment of overweight/obesity is of particular importance in prediabetes and diabetes. Its\nelimination/reduction reduces the transition of pre-diabetes conditions to diabetes, reduces\ninsulin resistance, improves glycemic control, reduces the number and dose of blood\nsugar-lowering drugs used in already existing diabetes, and reduces the cardiovascular risk\n\nNutrients 2024, 16, 27\n8 of 21\naccompanying these conditions. In the case of weight reduction, the daily energy intake\nis 500–700 kcal less than the requirement, but it cannot be lower than the BMR [73].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 7,
          "overlap_chars": 373,
          "overlap_percentage": 64.53287197231833
        },
        {
          "page_number": 8,
          "overlap_chars": 203,
          "overlap_percentage": 35.121107266435985
        }
      ],
      "primary_page": 7,
      "char_count": 578,
      "word_count": 84,
      "start_pos": 29305,
      "end_pos": 29883,
      "chunk_index": 57,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_58",
      "text": "y energy intake\nis 500–700 kcal less than the requirement, but it cannot be lower than the BMR [73]. The\ndaily recommended amount of carbohydrates in the diet should be at least 120 g, which\nis rich in vegetable fibers, vitamins, and minerals, contains only the necessary amount of\nadded sugar, and is low in fat and salt. The WHO directive sets the recommended added\nsugar intake at no more than 10% of the daily energy intake, but an intake of less than\n5% per day would have additional benefits in achieving a healthy lifestyle [74]. Based on\nthe energy needs of an average adult woman, which means 2000 kcal, this is 200 kcal or\napproximately corresponds to a maximum of 50 g of sugar.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 689,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 8,
      "char_count": 689,
      "word_count": 125,
      "start_pos": 29783,
      "end_pos": 30472,
      "chunk_index": 58,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_59",
      "text": "which means 2000 kcal, this is 200 kcal or\napproximately corresponds to a maximum of 50 g of sugar. Taking a ratio of 5%, this is\n100 kcal, i.e., approximately 25 g of sugar [74]. Taking into account the reduction of the daily\nenergy requirement, in the case of 1600 kcal, this means only 40 g and 20 g of added sugar\ncorresponding to 160 and 80 kcal, respectively. This requires taste adjustment and better\nutilization of the natural sugar content of fruits and dairy products rather than replacing\nthe missing amount or sweet taste with intense sweeteners and sugar substitutes.\nEating carbohydrates with a low glycemic index and rich in fiber has a health-\nprotective effect.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 679,
          "overlap_percentage": 100.14749262536873
        }
      ],
      "primary_page": 8,
      "char_count": 678,
      "word_count": 117,
      "start_pos": 30372,
      "end_pos": 31051,
      "chunk_index": 59,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_60",
      "text": "s.\nEating carbohydrates with a low glycemic index and rich in fiber has a health-\nprotective effect. Regarding carbohydrate sources, preference should be given to vegetables,\nwhole-grain foods, fruits, and dairy products without added sugar. Increasing the fiber\ncontent is beneficial since it slows down the absorption of carbohydrates. In addition, due\nto fibers’ satiating value, they improve the feeling of satiety and bowel function. Regarding\nfiber intake, the European guideline recommends an intake of over 25 g per day, 35–45 g for\ncardiovascular prevention [20,63]. The European Food-Based Dietary Guidelines (FBDG)\nrecommend a minimum intake of sugar and fiber of 30 g [13–20].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 688,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 8,
      "char_count": 688,
      "word_count": 104,
      "start_pos": 30951,
      "end_pos": 31639,
      "chunk_index": 60,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_61",
      "text": "Food-Based Dietary Guidelines (FBDG)\nrecommend a minimum intake of sugar and fiber of 30 g [13–20]. A high-fiber diet has been\nshown to reduce the risk of obesity and has a protective effect against different diseases\nsuch as coronary heart diseases, intestinal malignancies, and type 2 diabetes.\nIn the case of an already existing carbohydrate metabolism disorder, the adjustment of\nthe diet is based on the energy and nutrient intake required to achieve or maintain normal\nbody weight and on a defined amount and altered composition of carbohydrate intake [75].\nThis also includes determining the frequency and timing of meals.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 630,
          "overlap_percentage": 100.15898251192368
        }
      ],
      "primary_page": 8,
      "char_count": 629,
      "word_count": 100,
      "start_pos": 31539,
      "end_pos": 32169,
      "chunk_index": 61,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_62",
      "text": "ition of carbohydrate intake [75].\nThis also includes determining the frequency and timing of meals. The individualized\ndiet promotes the preservation of health as fully as possible with particular regard to the\nachievement and maintenance of individual goals related to nutritional status, provision of\nindividual glycemic target values, and prevention or delay of complications. Establishing a\ndaily eating schedule is an important criterion. A diet divided into several parts per day\nwith defined carbohydrate content helps to limit the blood-sugar-raising effect of meals [75].\nEfforts should be made to exclude added sugars from the diet.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 643,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 8,
      "char_count": 643,
      "word_count": 95,
      "start_pos": 32069,
      "end_pos": 32712,
      "chunk_index": 62,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_63",
      "text": "od-sugar-raising effect of meals [75].\nEfforts should be made to exclude added sugars from the diet. Taking into account the\namount of fast-absorbing carbohydrates found in milk, fruits, and fermented (acidified)\nnatural products and the time of consumption, they can be included in the diet [47]. In the\ncase of already developed T2DM, adequate dietary therapy is an integral part of the toolset\nof treatment and self-management. Learning it under the guidance of an experienced\ndietitian can result in a 0.3–1.0% HbA1c reduction in type 1 diabetes and 0.5–2.0% in type 2\ndiabetes [76].\nMost people with type 2 diabetes are overweight.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 636,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 8,
      "char_count": 636,
      "word_count": 102,
      "start_pos": 32612,
      "end_pos": 33248,
      "chunk_index": 63,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_64",
      "text": "pe 1 diabetes and 0.5–2.0% in type 2\ndiabetes [76].\nMost people with type 2 diabetes are overweight. In addition to ensuring the ratio of\ndietary components and aspects of healthy nutrition, it is necessary to limit energy intake in\nthese cases. In addition to improving glycemic control, continuous and non-forced weight\nloss can contribute to regulating blood pressure and blood fat levels. In all stages of type 2\ndiabetes, it is fundamentally important to be aware of the energy content of food and follow\nand calculate carbohydrate intake.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 544,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 8,
      "char_count": 544,
      "word_count": 89,
      "start_pos": 33148,
      "end_pos": 33692,
      "chunk_index": 64,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_65",
      "text": "ly important to be aware of the energy content of food and follow\nand calculate carbohydrate intake. Regarding carbohydrate sources, preference should\nbe given to vegetables, whole-grain foods, fruits, and dairy products, while foods and\nbeverages containing added fat, sugar, or salt should be avoided. The dietary fiber ratio\nfor people living with diabetes must be at least the same as the amount recommended for\nnon-diabetic patients. Incorporating 30 to 50 g of dietary fiber into the daily carbohydrate\nintake is recommended. Increasing the fiber content is beneficial since it slows down the\nabsorption of carbohydrates.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 627,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 8,
      "char_count": 627,
      "word_count": 96,
      "start_pos": 33592,
      "end_pos": 34219,
      "chunk_index": 65,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_66",
      "text": "ded. Increasing the fiber content is beneficial since it slows down the\nabsorption of carbohydrates. In addition, due to its satiating value, it increases the feeling\nof satiety and improves bowel function [77].\n\nNutrients 2024, 16, 27\n9 of 21\nIncreasing fiber intake reduces the risk of developing metabolic syndrome. An increase\nin fiber intake of 10 g per 1000 kcal reduced the risk of metabolic syndrome by 0.1 unit [78].\nBy increasing fiber intake, the composition of the intestinal flora changes. The changes have\na positive effect on metabolism, insulin sensitivity, and insulin secretion.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 8,
          "overlap_chars": 211,
          "overlap_percentage": 35.40268456375839
        },
        {
          "page_number": 9,
          "overlap_chars": 383,
          "overlap_percentage": 64.26174496644296
        }
      ],
      "primary_page": 8,
      "char_count": 596,
      "word_count": 95,
      "start_pos": 34119,
      "end_pos": 34715,
      "chunk_index": 66,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_67",
      "text": "anges. The changes have\na positive effect on metabolism, insulin sensitivity, and insulin secretion. The increased\nfiber intake can have a positive influence on bacterial flora similar to isoflavonoids (e.g.,\nsoy), pre-, pro-, and postbiotics [79]. The intestinal flora also play a role in estrogen\nmetabolism. Bacteria with beta-glucuronidase activity can increase the level of biologically\nactive estrogen in the body, thus slowing the development of estrogen deficiency and\nreducing the symptoms accompanying menopause.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 9,
          "overlap_chars": 522,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 9,
      "char_count": 522,
      "word_count": 74,
      "start_pos": 34615,
      "end_pos": 35137,
      "chunk_index": 67,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_68",
      "text": "hus slowing the development of estrogen deficiency and\nreducing the symptoms accompanying menopause. Based on previous research, the\nfunctioning of intestinal bacteria with beta-glucuronidase activity in addition to a diet\nrich in fiber does not represent an increased risk of breast cancer [80]. When formulating\na fiber-rich diet, gradualness is important so the body can adapt to the changed diet.\nExcessive fiber intake, consuming more than 50 g of fiber per day, may have a negative\neffect because it may cause bloating, increase the binding and excretion of useful substances,\nand entail digestive problems.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 9,
          "overlap_chars": 613,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 9,
      "char_count": 613,
      "word_count": 94,
      "start_pos": 35037,
      "end_pos": 35650,
      "chunk_index": 68,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_69",
      "text": "se bloating, increase the binding and excretion of useful substances,\nand entail digestive problems. In each case, it is advisable to determine the dietary ratio of\nfats and the composition of foods containing fats on an individual basis, taking into account\nthe cardiovascular risk. In diabetes complicated by dyslipidemia, it may be beneficial to\nconsume 1.6–3.0 g of plant stanols and sterols per day. The sterols found in plants reduce\nthe absorption of dietary cholesterol by binding to their receptors. The consumption of\nfoods enriched with phytosterols is, therefore, favorable by reducing the total and LDL\ncholesterol levels of the serum.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 9,
          "overlap_chars": 648,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 9,
      "char_count": 648,
      "word_count": 101,
      "start_pos": 35550,
      "end_pos": 36198,
      "chunk_index": 69,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_70",
      "text": "phytosterols is, therefore, favorable by reducing the total and LDL\ncholesterol levels of the serum. Natural ingredients should be preferred over foods and\nbeverages containing added sugar. If necessary, energy-free and low-energy sweeteners\ncan be used to replace added sugar, as they can reduce daily carbohydrate and energy\nintake [47].\nThe organizations performing scientific evaluation and risk assessment (EFSA in\nEurope and FAO/WHO JECFA on a global level) determined the acceptable daily intake\n(ADI) amounts regarding intensive sweeteners and sugar alcohols [81]. All additives\napproved before 20 January 2009 must be re-assessed.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 9,
          "overlap_chars": 639,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 9,
      "char_count": 639,
      "word_count": 92,
      "start_pos": 36098,
      "end_pos": 36737,
      "chunk_index": 70,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_71",
      "text": "eeteners and sugar alcohols [81]. All additives\napproved before 20 January 2009 must be re-assessed. EFSA is conducting a consultation\non assessing consumer exposure to sweeteners to develop a protocol. Even for the amount\nof sweeteners used to replace sugar, the recommended maximum is approximately 5% to\n10% of the total daily energy intake, similar to that recommended in prevention [20].\n3.3. Bone Metabolism Changes in Menopause\nOsteoporosis is a chronic, progressive health problem that affects most women during\nmenopause and has serious consequences. Osteoporosis is particularly common during\nthis period in those with low serum vitamin D levels [11].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 9,
          "overlap_chars": 661,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 9,
      "char_count": 661,
      "word_count": 100,
      "start_pos": 36637,
      "end_pos": 37298,
      "chunk_index": 71,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_72",
      "text": "steoporosis is particularly common during\nthis period in those with low serum vitamin D levels [11]. The average annual rate of bone\nloss during menopause, beginning 1–3 years before menopause and lasting 5–10 years, is\napproximately 2% resulting in an average 10–12% decrease in bone mineral density (BMD)\nin the spine and hip.\nAmong nutritional factors, bone health can be adversely affected by abnormal nu-\ntritional status (overweight, obesity, malnutrition, or sarcopenia), vitamin D deficiency,\nhypercalciuria, and malabsorption disorders (e.g., celiac disease, inflammatory bowel\ndiseases, gastrectomy, chronic liver diseases, or gastrointestinal malignancies).",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 9,
          "overlap_chars": 668,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 9,
      "char_count": 668,
      "word_count": 92,
      "start_pos": 37198,
      "end_pos": 37866,
      "chunk_index": 72,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_73",
      "text": "inflammatory bowel\ndiseases, gastrectomy, chronic liver diseases, or gastrointestinal malignancies).\nA distinction must be drawn between osteoporosis (low BMD) and risk factors for\nfractures. The causes of low BMD are menopause itself, age, genetic predisposition, ab-\nnormal nutritional status, other diseases, and medications that affect bone absorption and\nmetabolism. Risk factors for bone fractures are low BMD, previous fractures, multiple\nfractures occurring in the family, old age, frailty syndrome, and other diseases (e.g., those\nassociated with dizziness and general weakness) [82].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 9,
          "overlap_chars": 593,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 9,
      "char_count": 593,
      "word_count": 81,
      "start_pos": 37766,
      "end_pos": 38359,
      "chunk_index": 73,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_74",
      "text": "ilty syndrome, and other diseases (e.g., those\nassociated with dizziness and general weakness) [82].\nBased on the above-mentioned factors, it is necessary to introduce lifestyle changes\nduring this period to reduce the risk of fractures caused by osteoporosis, which include\nmaintaining/achieving a healthy nutritional status and balanced nutrition focusing on ade-\nquate intake of vitamin D and calcium, regular exercise, smoking cessation, and stopping\nalcohol drinking [11,82].\n\nNutrients 2024, 16, 27\n10 of 21\n3.4.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 9,
          "overlap_chars": 480,
          "overlap_percentage": 92.66409266409266
        },
        {
          "page_number": 10,
          "overlap_chars": 36,
          "overlap_percentage": 6.94980694980695
        }
      ],
      "primary_page": 9,
      "char_count": 518,
      "word_count": 75,
      "start_pos": 38259,
      "end_pos": 38777,
      "chunk_index": 74,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_75",
      "text": "ise, smoking cessation, and stopping\nalcohol drinking [11,82].\n\nNutrients 2024, 16, 27\n10 of 21\n3.4. Cancer Prevention during Perimenopause and Menopause\nIn connection with female hormonal changes during perimenopause, the risk of de-\nveloping hormone-sensitive breast cancer may increase, so in this period, in addition to\nthe previously mentioned diseases (CVD, IR, T2DM, and osteoporosis), tumor preven-\ntion lifestyle changes (exercise, nutrition, avoidance of alcohol, tobacco, and coffee) are\nalso important.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 9,
          "overlap_chars": 62,
          "overlap_percentage": 12.062256809338521
        },
        {
          "page_number": 10,
          "overlap_chars": 450,
          "overlap_percentage": 87.54863813229572
        }
      ],
      "primary_page": 9,
      "char_count": 514,
      "word_count": 72,
      "start_pos": 38677,
      "end_pos": 39191,
      "chunk_index": 75,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_76",
      "text": "festyle changes (exercise, nutrition, avoidance of alcohol, tobacco, and coffee) are\nalso important.\nDuring menopause, an increase in body weight, including visceral fat weight, is\ncharacteristic, which not only increases the risk of CVD but also the risk of IR and, through\nthis, the development of tumors [11].\nThe most common cancer in women during menopause is breast cancer, for which the\nthree leading risk factors are overweight (or obesity), regular alcohol consumption, and a\nsedentary lifestyle. A weight gain of 20 kg in adulthood doubles the risk of breast cancer.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 576,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 10,
      "char_count": 576,
      "word_count": 91,
      "start_pos": 39091,
      "end_pos": 39667,
      "chunk_index": 76,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_77",
      "text": "n, and a\nsedentary lifestyle. A weight gain of 20 kg in adulthood doubles the risk of breast cancer.\nRegular alcohol consumption and a sedentary lifestyle in both the pre- and postmenopausal\nperiods increase the risk of developing breast cancer [9]. Maintaining and achieving a\nnormal nutritional status and body composition are also paramount in reducing the risk\nof cancer. In particular, the goal is to maintain and achieve a normal range of fat-free\nmass, and skeletal muscle mass.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 485,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 10,
      "char_count": 485,
      "word_count": 79,
      "start_pos": 39567,
      "end_pos": 40052,
      "chunk_index": 77,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_78",
      "text": "ular, the goal is to maintain and achieve a normal range of fat-free\nmass, and skeletal muscle mass. In addition to following the guidelines of a balanced diet,\nthe regular inclusion of cruciferous vegetables in the diet (cabbage, broccoli, cauliflower,\nradishes, and canola) and the consumption of at least half a kg of vegetables and fruits\nshould be highlighted.\nIn the case of an already developed breast cancer, the focus is on maintaining normal\nnutritional status and skeletal muscle mass. In addition to cancer treatments, the diet is\nthe same as the IR diet.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 567,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 10,
      "char_count": 567,
      "word_count": 94,
      "start_pos": 39952,
      "end_pos": 40519,
      "chunk_index": 78,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_79",
      "text": "tus and skeletal muscle mass. In addition to cancer treatments, the diet is\nthe same as the IR diet. In case of adequate energy intake or overweight or obesity, a\n500–700 kcal less energy intake and a fat intake of 30–35% of energy are recommended,\nmost of which consists of monounsaturated and polyunsaturated fatty acids, i.e., vegetable\nfats. Tumor size can be reduced with an optimized energy intake or in the case of obesity\nor overweight, with a 5–10% reduction in body weight [9].\n3.5. The Role of Micronutrients in Menopause\nMost of the vitamin D requirement is synthesized endogenously in the summer\nmonths.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 616,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 10,
      "char_count": 616,
      "word_count": 104,
      "start_pos": 40419,
      "end_pos": 41035,
      "chunk_index": 79,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_80",
      "text": "nts in Menopause\nMost of the vitamin D requirement is synthesized endogenously in the summer\nmonths. However, when there is not enough UV-B radiation, dietary vitamin D intake\nis also important (e.g., in Central Europe from October to March, or if someone does not\nspend enough time outdoors, uses sun protection creams, or wears clothing that fully\ncovers the skin). With ageing, the rate of hydroxylation of vitamin D precursors in the body\ndecreases, so the importance of exogenous vitamin D intake increases with age [83,84].\nVitamin D is a fat-soluble vitamin. Its sources are egg yolks, dairy products, offal,\nand foods supplemented with vitamin D.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 654,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 10,
      "char_count": 654,
      "word_count": 106,
      "start_pos": 40935,
      "end_pos": 41589,
      "chunk_index": 80,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_81",
      "text": "le vitamin. Its sources are egg yolks, dairy products, offal,\nand foods supplemented with vitamin D. About 80% of dietary vitamin D is absorbed in\nthe small intestine. If UV-B radiation is insufficient, routine dietary supplementation is\nrequired. Vitamin D supplementation is especially important for infants, young children,\nand the elderly population. Vitamin D preparations should be taken with meals [20].\nClinical studies have proven that osteoporosis treatments only achieve their effectiveness\nwith adequate vitamin D supplementation (more than 1000 IU per day). Without vitamin\nD supplementation, the fracture risk reduction effect of osteoporosis therapies can decrease\nby up to 30%.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 693,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 10,
      "char_count": 693,
      "word_count": 101,
      "start_pos": 41489,
      "end_pos": 42182,
      "chunk_index": 81,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_82",
      "text": "lementation, the fracture risk reduction effect of osteoporosis therapies can decrease\nby up to 30%. From October to March in Central Europe, the UV-B radiation is so low that\nnot enough vitamin D can be synthesized in the skin. Therefore, continuous vitamin D\nsupplementation is recommended in these months for preventive purposes with a dose of\n2000 IU per day. For people who do not have permanent access to sunlight, a year-round\nsupplementation is recommended [85].\nThe calcium requirements can be covered by a balanced diet. In the case of a diagnosed\ndeficiency, the appropriate intake can be ensured primarily by modifying the diet.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 640,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 10,
      "char_count": 640,
      "word_count": 104,
      "start_pos": 42082,
      "end_pos": 42722,
      "chunk_index": 82,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_83",
      "text": "se of a diagnosed\ndeficiency, the appropriate intake can be ensured primarily by modifying the diet. Routine\ncalcium supplementation is not recommended due to its cardiovascular risk [82]. The\nabsorption of calcium is primarily influenced by vitamin D status, but it can be improved\nby the acidic components of dairy products and food matrix. Dairy products contain the\nmost easily absorbable calcium, but consumption of mineral waters with high mineral\n\nNutrients 2024, 16, 27\n11 of 21\ncontent or hard water also contributes to ensuring the need.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 453,
          "overlap_percentage": 82.81535648994516
        },
        {
          "page_number": 11,
          "overlap_chars": 92,
          "overlap_percentage": 16.819012797074954
        }
      ],
      "primary_page": 10,
      "char_count": 547,
      "word_count": 87,
      "start_pos": 42622,
      "end_pos": 43169,
      "chunk_index": 83,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_84",
      "text": "ineral\n\nNutrients 2024, 16, 27\n11 of 21\ncontent or hard water also contributes to ensuring the need. Regular consumption of\nsoft-boned fish (eaten with bones), such as canned sardines, pickled herring, and anchovy,\nas well as oilseeds and foods supplemented with calcium, also contribute to calcium\nintake [86].\nIn addition to insufficient vitamin D status, the factor inhibiting calcium absorption\nand utilization is a diet rich in protein, dietary fiber, and phytates [20]. Supplements should\nonly be used if a calcium deficiency can be diagnosed. The recommended daily calcium\nintake (recommended dietary allowance, RDA) for menopausal women (from the age of\n51) is 1000–1200 mg [82].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 10,
          "overlap_chars": 6,
          "overlap_percentage": 0.8733624454148471
        },
        {
          "page_number": 11,
          "overlap_chars": 679,
          "overlap_percentage": 98.83551673944687
        }
      ],
      "primary_page": 10,
      "char_count": 687,
      "word_count": 107,
      "start_pos": 43069,
      "end_pos": 43756,
      "chunk_index": 84,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_85",
      "text": "(recommended dietary allowance, RDA) for menopausal women (from the age of\n51) is 1000–1200 mg [82]. The calcium intake recommended by the European Food Safety\nAuthority (EFSA) is 950 ug over the age of 25 [20].\nThe protein intake should be 0.8 g/kg body weight/day following a balanced diet,\nand 1–1.2 g/kg body weight/day protein intake is recommended for those who exercise\nregularly and in case of weight loss, half of which should come from vegetable sources. A\ndiet rich in protein (1.5–2 g/kg body weight/day) increases the risk of fractures [82].\nVitamin C is necessary for bone formation due to its role in collagen formation. Its\nabsorption is about 80% if the daily intake is 100 mg/day.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 698,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 11,
      "char_count": 698,
      "word_count": 118,
      "start_pos": 43656,
      "end_pos": 44354,
      "chunk_index": 85,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_86",
      "text": "ue to its role in collagen formation. Its\nabsorption is about 80% if the daily intake is 100 mg/day. RDA is 100 mg/day, which can\nbe provided through diet. Its sources are freshly eaten vegetables and fruits, especially\npeppers, currants, citrus fruits, and sauerkraut [20].\nAll menopausal women, not just those at risk of fracture, should be encouraged to\nadopt a bone-friendly lifestyle. This includes optimizing calcium and vitamin D status,\ngetting adequate physical activity, and avoiding smoking and alcohol [87]. Prevention of\nosteoporosis begins in childhood and adolescence, as this is the age when peak bone mass\nis formed.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 633,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 11,
      "char_count": 633,
      "word_count": 100,
      "start_pos": 44254,
      "end_pos": 44887,
      "chunk_index": 86,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_87",
      "text": "osteoporosis begins in childhood and adolescence, as this is the age when peak bone mass\nis formed. The two pillars of prevention are maintaining adequate calcium and vitamin D\nstatus, as well as regular exercise. According to the American guideline, phytoestrogens,\nincluding isoflavonoids, can only have a mild effect on estrogen deficiency, thus, on the\nloss of bone minerals; therefore, they do not prevent the development of osteoporosis [82].\nB vitamins also play an important role in menopause. They play a fundamental\nrole in the processing of carbohydrates and the functioning of the nervous system [88,89].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 617,
          "overlap_percentage": 100.16233766233766
        }
      ],
      "primary_page": 11,
      "char_count": 616,
      "word_count": 96,
      "start_pos": 44787,
      "end_pos": 45404,
      "chunk_index": 87,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_88",
      "text": "ndamental\nrole in the processing of carbohydrates and the functioning of the nervous system [88,89].\nAdequate B vitamin intake significantly reduces the serum homocysteine level and, in\nparallel, the risk of stroke [90]. High homocysteine levels have also been associated with\nosteoporosis and increased risk of bone fractures [91–97].\nIn the prevention and treatment of cognitive dysfunction and cognitive decline, which\nare common complaints in menopause, an adequate supply of B vitamins is extremely im-\nportant [54,98–103]. A balanced B-vitamin intake, therefore, plays an important health-\npreserving role in menopause.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 625,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 11,
      "char_count": 625,
      "word_count": 90,
      "start_pos": 45304,
      "end_pos": 45929,
      "chunk_index": 88,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_89",
      "text": "3]. A balanced B-vitamin intake, therefore, plays an important health-\npreserving role in menopause. A microbiome with the appropriate biodiversity and com-\nposition also contributes to this [104,105].\n3.6. Soy and Phytoestrogens and Menopause\nDuring perimenopause, women in question try many dietary practices. Perhaps the\nmost common and at the same time the most controversial one is the consumption of soy\nand other phytoestrogens in the diet or as dietary supplements. Many studies for and\nagainst the topic can be read.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 525,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 11,
      "char_count": 525,
      "word_count": 81,
      "start_pos": 45829,
      "end_pos": 46354,
      "chunk_index": 89,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_90",
      "text": "estrogens in the diet or as dietary supplements. Many studies for and\nagainst the topic can be read. While the isoflavone content of soy can have a positive effect\non the strength and frequency of symptoms, phytoestrogens can have a negative effect on\nthe treatment of hormone-sensitive breast tumors.\nMenopausal hot flashes are rarer in countries where regular soy consumption is a part\nof the diet. The isoflavone content of soy foods may be effective in reducing menopausal\nsymptoms. One study recommended 20 mg/day of soy isoflavones supplementation\nduring perimenopause for symptom reduction.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 597,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 11,
      "char_count": 597,
      "word_count": 93,
      "start_pos": 46254,
      "end_pos": 46851,
      "chunk_index": 90,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_91",
      "text": "recommended 20 mg/day of soy isoflavones supplementation\nduring perimenopause for symptom reduction. This corresponds to 400 mL/day of soy\ndrinks or 80 g/day of other soy products (tofu, tempeh, or fermented soy products) [106].\nAccording to another study, intake of more than 42 mg/day of soy isoflavones may have\na tumor-reducing effect [107]. According to a third publication, regular soy consumption\ndoes not increase the risk of developing breast cancer [108]. However, the effectiveness\nof anti-estrogen therapy (e.g., Tamoxifen) can be reduced by regular soy consumption\n(examined substance: Genistein).",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 610,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 11,
      "char_count": 610,
      "word_count": 89,
      "start_pos": 46751,
      "end_pos": 47361,
      "chunk_index": 91,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_92",
      "text": "therapy (e.g., Tamoxifen) can be reduced by regular soy consumption\n(examined substance: Genistein). However, according to an Asian population-level study\n\nNutrients 2024, 16, 27\n12 of 21\n(a study of isoflavones), consuming 10–15 g of soy protein (equivalent to 250 mL of soy\ndrink) with a balanced diet and a healthy lifestyle can be safe even in these cases [9,109–111].\nIn summary, it can be said that there is no consensus among the scientific community\non the effect of dietary soy on breast cancer and its treatment. It is important to point\nout that the above safe intake applies only to soy foods included in the diet and not soy\nisoflavones taken as dietary supplements [112].\n4.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 11,
          "overlap_chars": 154,
          "overlap_percentage": 22.38372093023256
        },
        {
          "page_number": 12,
          "overlap_chars": 532,
          "overlap_percentage": 77.32558139534885
        }
      ],
      "primary_page": 11,
      "char_count": 688,
      "word_count": 117,
      "start_pos": 47261,
      "end_pos": 47949,
      "chunk_index": 92,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_93",
      "text": "nly to soy foods included in the diet and not soy\nisoflavones taken as dietary supplements [112].\n4. The Role of Microbiom in Menopause\nPerimenopause and menopause are often associated with dysbiosis and gastrointesti-\nnal tract complaints. Estrogen levels can effect gut microbiota [113,114] and microbiome, in\nturn, can effect serum estrogen levels as certain microbes in the gut (called estrabolome)\nsecrete beta-glucoronidase, a bacterial enzyme that deconjugates estrogens and phytoe-\nstrogens into their active forms which can be reabsorbed in the intestine and enter the\nbloodstream [115].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 596,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 12,
      "char_count": 596,
      "word_count": 88,
      "start_pos": 47849,
      "end_pos": 48445,
      "chunk_index": 93,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_94",
      "text": "ns into their active forms which can be reabsorbed in the intestine and enter the\nbloodstream [115]. Estrabolome can be reduced by dysbiosis and, consequently, lead to\nfurther loss of circulating active estradiol metabolites [116]. This suggests that composition\nof the microbiota could determine the onset or progression of some menopause-related\nclinical conditions [117].\nProbiotic supplementation in menopausal women suggest a favorable effect on some\ncardiovascular risk factors [118] through maintaining the integrity of the intestinal barrier,\ntherefore, reducing translocation of bacteria through the gut wall and decreasing systemic\ninflammation.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 655,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 12,
      "char_count": 655,
      "word_count": 90,
      "start_pos": 48345,
      "end_pos": 49000,
      "chunk_index": 94,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_95",
      "text": "efore, reducing translocation of bacteria through the gut wall and decreasing systemic\ninflammation. Fermentation of polysaccharides and undigested proteins by some microbial\nstrains generates SCFA (i.e., acetate, propionate, and butyrate), possibly benefiting several\nmetabolic pathways. Newest studies suggest that supplementation with probiotics im-\nproves cardiometabolic risk factors in postmenopausal women [119]. Maintaining healthy\ngut biom by a balanced diet according to the needs of menopausal women might help\nprevent dysbiosis.\n5. Sleep and Menopause\nSleep difficulties are more likely to occur during menopause, with a self-reported\nrate of between 40% and 56%.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 675,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 12,
      "char_count": 675,
      "word_count": 92,
      "start_pos": 48900,
      "end_pos": 49575,
      "chunk_index": 95,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_96",
      "text": "culties are more likely to occur during menopause, with a self-reported\nrate of between 40% and 56%. For some women, sleep problems are severe, leading to\nchronic fatigue, affecting quality of life, and can have long-term consequences for mental\nand physical health [120]. In a meta-analysis, sleep disturbances during menopause were\nfound to be common and significant. According to the results of the analysis, the general\nprevalence of sleep disorders based on these studies was 51.6% [121]. Deviation from the\nrecommended 7–8 h of sleep in adults is associated with a higher risk of mortality and\ncardiovascular events [122].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 628,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 12,
      "char_count": 628,
      "word_count": 99,
      "start_pos": 49475,
      "end_pos": 50103,
      "chunk_index": 96,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_97",
      "text": "h of sleep in adults is associated with a higher risk of mortality and\ncardiovascular events [122]. Those who sleep less than 5 h a day are at the greatest risk of\ndeveloping cardiovascular diseases. Those who sleep less than 7 h are also at increased\nrisk of cardiovascular diseases and mortality [123]. Supporting this, in 2022, the American\nHeart Association increased the number of basic factors necessary to maintain optimal\ncardiovascular health from seven to eight, with the inclusion of the right amount and\nquality of sleep [124].\nThe circadian rhythm plays an important role in the regulation of metabolic processes.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 627,
          "overlap_percentage": 100.15974440894568
        }
      ],
      "primary_page": 12,
      "char_count": 626,
      "word_count": 102,
      "start_pos": 50003,
      "end_pos": 50630,
      "chunk_index": 97,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_98",
      "text": "sleep [124].\nThe circadian rhythm plays an important role in the regulation of metabolic processes.\nSleep deprivation itself affects energy intake, glucose uptake, and leptin resistance. Sleep\nand circadian factors affect appetite, nutrient absorption, and metabolism. Disturbances in\nsleep and circadian rhythms can also worsen digestive disorders [125,126]. Sleep depriva-\ntion is associated with certain chronic diseases (e.g., cardiovascular diseases, diabetes, and\ntumors) and also increases the risk of becoming overweight [127].\nFoods containing melatonin can directly affect sleep. Adequate amounts of tryptophan,\na precursor of melatonin, have a positive effect on sleep.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 681,
          "overlap_percentage": 100.1470588235294
        }
      ],
      "primary_page": 12,
      "char_count": 680,
      "word_count": 93,
      "start_pos": 50530,
      "end_pos": 51211,
      "chunk_index": 98,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_99",
      "text": "ct sleep. Adequate amounts of tryptophan,\na precursor of melatonin, have a positive effect on sleep. Thus, the different tryptophan\ncontent of foods can also cause melatonin levels to fluctuate. Improvements in sleep\nparameters (e.g., increased sleep time) were observed under the influence of tryptophan. It\nhas been found that the quality of sleep deteriorates in case of reduced intake. Vitamins\nand trace elements participating as cofactors in melatonin synthesis are the following: folic\n\nNutrients 2024, 16, 27\n13 of 21\nacid, vitamins B6 and B12, magnesium, and zinc [69]. Adequate intake of these is also\nnecessary for good sleep.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 12,
          "overlap_chars": 492,
          "overlap_percentage": 77.2370486656201
        },
        {
          "page_number": 13,
          "overlap_chars": 143,
          "overlap_percentage": 22.448979591836736
        }
      ],
      "primary_page": 12,
      "char_count": 637,
      "word_count": 100,
      "start_pos": 51111,
      "end_pos": 51748,
      "chunk_index": 99,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_100",
      "text": "ins B6 and B12, magnesium, and zinc [69]. Adequate intake of these is also\nnecessary for good sleep.\nDiet affects melatonin levels not only through tryptophan intake but also through raw\nmaterials containing melatonin in its natural form. In recent decades, melatonin has been\nwidely identified in various foods. Among animal sources, eggs and fish have a higher\nmelatonin content, while nuts have the highest melatonin content among plant-based\nfoods. Among fruits, cherries, strawberries, and wine grape skins contain the highest\namount of melatonin [128].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 558,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 13,
      "char_count": 558,
      "word_count": 85,
      "start_pos": 51648,
      "end_pos": 52206,
      "chunk_index": 100,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_101",
      "text": "fruits, cherries, strawberries, and wine grape skins contain the highest\namount of melatonin [128]. Research carried out with cherry varieties has shown an\nexceptionally high melatonin content in cherries, which suggests that cherries can be a\nnatural source of melatonin and become suitable for the development of melatonin-rich\nfunctional foods [129]. Sources of the highest tryptophan content are not typical ingredients\nof the Western diet (just for information: the fatty meat of seals, their kidneys, and the\nbeluga whale) [130].",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 536,
          "overlap_percentage": 100.18691588785047
        }
      ],
      "primary_page": 13,
      "char_count": 535,
      "word_count": 80,
      "start_pos": 52106,
      "end_pos": 52642,
      "chunk_index": 101,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_102",
      "text": "ern diet (just for information: the fatty meat of seals, their kidneys, and the\nbeluga whale) [130]. Sea fish (codfish) and shellfish, algae (including spirulina), eggs\n(especially egg whites), soy, sesame seeds, sunflower seeds, pumpkin seeds, cheeses, and\nyeast contain high levels of tryptophan (see Table 1) [131].\nTable 1. Tryptophan content of foods [131].\nFood/Raw Material\nTryptophan Content (mg/100 g)\nCheddar cheese\nTuna\nSalmon\nOat flakes\nBuckwheat\nTofu\nKidney beans\nPumpkin seeds\nSunflower seeds\nAlmond\nPeanut\nLamb (shoulders)\nChicken breast\nGround pork, lean\nTurkey breast\nEgg, whole\nA regular eating schedule plays a key role in maintaining the circadian rhythm.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 675,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 13,
      "char_count": 675,
      "word_count": 101,
      "start_pos": 52542,
      "end_pos": 53217,
      "chunk_index": 102,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_103",
      "text": "ey breast\nEgg, whole\nA regular eating schedule plays a key role in maintaining the circadian rhythm. Irregu-\nlar eating disrupts the biorhythm, thereby causing a shift in the sleep cycle and deterioration\nof sleep quality. Sleep is most affected by the timing and quality of dinner. It is recom-\nmended to have dinner at least 2 h before bedtime. Drinking a lot right before bedtime\nis not recommended. The daily fluid intake should be spread evenly throughout the day.\nDrinking water is best for thirst quenching.\nA balanced diet has a positive effect on the quality of sleep. Foods and meals containing\nsufficient protein, carbohydrates, and fat are essential for good sleep quality.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 685,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 13,
      "char_count": 685,
      "word_count": 114,
      "start_pos": 53117,
      "end_pos": 53802,
      "chunk_index": 103,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_104",
      "text": "nd meals containing\nsufficient protein, carbohydrates, and fat are essential for good sleep quality. Not only\nthe quantity of nutrients but also their quality is important. Scientific evidence points to\nthe role of omega-3 fatty acids, which can positively influence the regulation of serotonin\nsecretion. Consuming carbohydrates with low glycemic index, low glycemic load, and high\nfiber content is recommended [123]. In addition to all this, proper sleep hygiene and sleep\nself-examination also can help a lot.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 512,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 13,
      "char_count": 512,
      "word_count": 77,
      "start_pos": 53702,
      "end_pos": 54214,
      "chunk_index": 104,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_105",
      "text": "[123]. In addition to all this, proper sleep hygiene and sleep\nself-examination also can help a lot. The use of various smartwatches and smart devices\ncan also help to recognize and monitor sleep disorders, as well as to assess the effectiveness\nof the applied diet therapy and medical treatment [132,133].\n6. Conclusions\nTable 2 summarizing the main nutritional indications in menopause.\n\nNutrients 2024, 16, 27\n14 of 21\nTable 2. The main nutritional indications in menopause.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 388,
          "overlap_percentage": 81.34171907756813
        },
        {
          "page_number": 14,
          "overlap_chars": 87,
          "overlap_percentage": 18.238993710691823
        }
      ],
      "primary_page": 13,
      "char_count": 477,
      "word_count": 76,
      "start_pos": 54114,
      "end_pos": 54591,
      "chunk_index": 105,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_106",
      "text": "menopause.\n\nNutrients 2024, 16, 27\n14 of 21\nTable 2. The main nutritional indications in menopause.\nBody composition\nUse body composition analysis tools to assess nutritional status\nKeep the weight in healthy range with adequate nutrients intake\nManage overweight, obesity: reduce current energy by 500–700 kcal/day\nRegularly physical activity\nDietary recommendations\nProtein—0.8–1–1.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 13,
          "overlap_chars": 11,
          "overlap_percentage": 2.864583333333333
        },
        {
          "page_number": 14,
          "overlap_chars": 372,
          "overlap_percentage": 96.875
        }
      ],
      "primary_page": 13,
      "char_count": 384,
      "word_count": 52,
      "start_pos": 54491,
      "end_pos": 54876,
      "chunk_index": 106,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_107",
      "text": "rent energy by 500–700 kcal/day\nRegularly physical activity\nDietary recommendations\nProtein—0.8–1–1.2 g/bwkg/day\nCalcium, vitamin D, vitamin C, vitamin B\nn-3 LCPUFA, omega-3 fatty acids\nVegetables: 300–400 g/day, 3–4 portions/day\nFruits: 100–200 g, 1–2 portions/day\nLegumes: beans, peas, lentils, chickpeas, soy/at least once a week\nLow-fat dairy products, half a liter of milk—calcium\nRed meat: 350–500 g boiled/steamed/fried—per week\nDeep-sea fish: 100–120 g/occasion/at least two servings per week\n30 g unsalted nuts, oily seeds/per day\n30–45 g/day dietary fiber: whole grain, fiber-rich cereals\nT",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 600,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 14,
      "char_count": 600,
      "word_count": 83,
      "start_pos": 54776,
      "end_pos": 55376,
      "chunk_index": 107,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_108",
      "text": "30 g unsalted nuts, oily seeds/per day\n30–45 g/day dietary fiber: whole grain, fiber-rich cereals\nTo be avoided\nSimple, fast-acting sugars\nSmoking\nSugary and alcoholic beverages\nSedentary life\nSalt (max. 5 g/day)\nSaturated fat—not exceed 10% of the total energy intake\nIn summary, during the period of perimenopause and menopause, many lifestyle\nfactors can reduce the risk of developing all the diseases (CVD, IR, T2DM, osteoporo-\nsis, and tumors) and symptoms characteristic of this period. The main messages of the\nrecommendation are as follows:\n•\nAchieving/maintaining a healthy nutritional status (BMI = 18.5 −24.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 619,
          "overlap_percentage": 100.16181229773463
        }
      ],
      "primary_page": 14,
      "char_count": 618,
      "word_count": 94,
      "start_pos": 55276,
      "end_pos": 55895,
      "chunk_index": 108,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_109",
      "text": "recommendation are as follows:\n•\nAchieving/maintaining a healthy nutritional status (BMI = 18.5 −24.9 kg/m2, normal\nrange of fat mass, and skeletal muscle mass) is the goal even during the\nperimenopause period;\n•\nIn case of overweight or obesity, an energy intake less than the current energy re-\nquirement (reduced by 500–700 kcal/day) and a protein intake of 1–1.2 g/day are\nrecommended while following the recommendations of a balanced diet.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 444,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 14,
      "char_count": 444,
      "word_count": 70,
      "start_pos": 55795,
      "end_pos": 56239,
      "chunk_index": 109,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_110",
      "text": "rotein intake of 1–1.2 g/day are\nrecommended while following the recommendations of a balanced diet. Energy intake\nbelow BMR is not recommended in the long term;\n•\nDuring perimenopause, the process of dietetic care for women should be based on the\nNutrition Care Process Model (NCPM);\n•\nThe use of body composition analysis tools is ideal for assessing nutritional status;\n•\nFollowing the guidelines of a balanced diet reduces symptoms and preserves health.\nEnsuring energy, nutrient, and fluid requirements appropriate to age, nutritional\nstatus, physical activity, and diseases are required as follows:\n1.\nEstablishing a physiological eating schedule is necessary;\n2.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 669,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 14,
      "char_count": 669,
      "word_count": 101,
      "start_pos": 56139,
      "end_pos": 56808,
      "chunk_index": 110,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_111",
      "text": "d diseases are required as follows:\n1.\nEstablishing a physiological eating schedule is necessary;\n2.\nSimple, fast-acting sugars should be avoided;\n3.\nProtein intake should be 0.8–1–1.2 g/kg/day, half of which should come from\nplant sources;\n4.\nAdequate intake of calcium, vitamin D, vitamin C, and B vitamins is important;\n5.\nAdequate intake of n-3 LCPUFA and omega-3 fatty acids is necessary;\n6.\nSugary and alcoholic beverages should be avoided;\n7.\nFruits and vegetables provide vitamins, minerals, fiber, and other plant nutrients,\nsuch as antioxidants, to help protect the heart.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 582,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 14,
      "char_count": 582,
      "word_count": 90,
      "start_pos": 56708,
      "end_pos": 57290,
      "chunk_index": 111,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_112",
      "text": "tamins, minerals, fiber, and other plant nutrients,\nsuch as antioxidants, to help protect the heart. The recommended daily intake\nof vegetables and fruits is 5 portions (500 g/day: 300–400 g of vegetables and\n200–100 g of fruit), i.e., 3–4 portions of vegetables and 1–2 portions of fruit;\n\nNutrients 2024, 16, 27\n15 of 21\n8.\nEating legumes (beans, peas, lentils, chickpeas, or soy) at least once a week\nis recommended;\n9.\nRegular consumption of low-fat protein sources (e.g., poultry, low-fat dairy\nproducts) helps to cover calcium needs;\n10.\nModerate consumption of red and processed meats is recommended;\n11.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 14,
          "overlap_chars": 289,
          "overlap_percentage": 47.299509001636665
        },
        {
          "page_number": 15,
          "overlap_chars": 320,
          "overlap_percentage": 52.373158756137485
        }
      ],
      "primary_page": 14,
      "char_count": 611,
      "word_count": 98,
      "start_pos": 57190,
      "end_pos": 57801,
      "chunk_index": 112,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_113",
      "text": "elps to cover calcium needs;\n10.\nModerate consumption of red and processed meats is recommended;\n11.\nConsumption of no more than 350–500 g boiled/steamed/fried (500–700 g of\nraw meat) red meat (e.g., beef and pork) per week is recommended. Intake of\nprocessed meat products should be only occasional, in small quantities. Incorpo-\nrating at least one meat-free day per week can be useful. Meat can be replaced\nwith fish, eggs, dairy products, and the right combination of legumes, grains,\nand nuts;\n12.\nModerate consumption of fats and sweets is important. Consumption of veg-\netable fats and occasional consumption of high-fat foods is recommended.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 15,
          "overlap_chars": 649,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 15,
      "char_count": 649,
      "word_count": 103,
      "start_pos": 57701,
      "end_pos": 58350,
      "chunk_index": 113,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_114",
      "text": "ortant. Consumption of veg-\netable fats and occasional consumption of high-fat foods is recommended. Sun-\nflower oil for frying, and olive, rapeseed, linseed, soybean oil, etc., as salad\ndressing are recommended;\n13.\nUsing as little amount of sugar and salt as possible to flavor food and drinks is\nimportant. A portion of salt can be replaced with fresh or dried herbs;\n14.\nAt least two servings per week (100–120 g/occasion) of deep-sea fish with fatty\nmeat (e.g., consumption of salmon, mackerel, tuna, herring, and sardines) or\nfreshwater fish (e.g., trout and silver carp) is recommended;\n15.\nConsumption of 30 g of unsalted nuts, other oily seeds, or seeds per day can\nbe beneficial.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 15,
          "overlap_chars": 689,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 15,
      "char_count": 689,
      "word_count": 113,
      "start_pos": 58250,
      "end_pos": 58939,
      "chunk_index": 114,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_115",
      "text": "ded;\n15.\nConsumption of 30 g of unsalted nuts, other oily seeds, or seeds per day can\nbe beneficial. When it comes to frequency, it is important to take body weight\ninto account;\n16.\nIncorporation of foods and ingredients with a higher fiber content daily is rec-\nommended: whole grain bread, fiber-rich breakfast cereals without added sugar,\nand brown rice. Oats, whole grains, whole wheat bread, and legumes such as\nlentils, chickpeas, and beans are excellent sources of fiber. The daily amount of\ndietary fiber should be 30–45 g, preferably mainly whole grains. One-third of the\namount of grain consumed should be whole grains;\n17.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 15,
          "overlap_chars": 634,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 15,
      "char_count": 634,
      "word_count": 105,
      "start_pos": 58839,
      "end_pos": 59473,
      "chunk_index": 115,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_116",
      "text": "referably mainly whole grains. One-third of the\namount of grain consumed should be whole grains;\n17.\nThe amount of saturated fat should not exceed 10% of the total energy intake.\nReplacement of saturated fats with monounsaturated and polyunsaturated fatty\nacids, or carbohydrates from whole grains is recommended. The amount of TFA\nshould be reduced to the smallest possible amount so that the consumption of\nprocessed products is limited and the natural TFA intake is kept below <1E%;\n18.\nEighty per cent of salt intake comes from processed foods, and only 20% is\nconsumed in the form of added salt. It is recommended to reduce the amount and\nfrequency of processed food consumption.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 15,
          "overlap_chars": 684,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 15,
      "char_count": 684,
      "word_count": 112,
      "start_pos": 59373,
      "end_pos": 60057,
      "chunk_index": 116,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_117",
      "text": "m of added salt. It is recommended to reduce the amount and\nfrequency of processed food consumption. Salt consumption should be as close\nas possible to 5 g/day, preferring fresh and dried vegetable spices for seasoning;\n19.\nConsuming dairy products corresponding to the calcium content of half a liter\nof milk per day is recommended. It is necessary to introduce lifestyle changes\nduring this period to reduce the risk of fracture associated with osteoporosis.\nChanges should include maintaining/achieving a healthy nutritional status\nand balanced nutrition focusing on adequate intake of vitamin D and calcium,\nregular exercise, as well as quitting smoking and stopping alcohol drinking.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 15,
          "overlap_chars": 688,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 15,
      "char_count": 688,
      "word_count": 105,
      "start_pos": 59957,
      "end_pos": 60645,
      "chunk_index": 117,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_118",
      "text": "vitamin D and calcium,\nregular exercise, as well as quitting smoking and stopping alcohol drinking.\nDietary supplementation of calcium and vitamin D should be considered based\non the season and daily intake, as well as on the presence of osteoporosis and\ncardiovascular risk factors;\n20.\nA smoking-free lifestyle is recommended;\n21.\nRegular physical activity is essential.\nAuthor Contributions: Conceptualization, A.E., E.P., L.T. and S.V.; formal analysis: A.E., E.P., L.T.,\nK.N., Z.S., M.T., A.J. and S.V.; writing—original draft preparation, A.E., E.P., L.T., K.N., Z.S., M.T.,\nA.J. and S.V.; writing—review and editing, A.E., E.P., K.N., M.T. and S.V.; project administration, E.P.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 15,
          "overlap_chars": 686,
          "overlap_percentage": 100.14598540145985
        }
      ],
      "primary_page": 15,
      "char_count": 685,
      "word_count": 99,
      "start_pos": 60545,
      "end_pos": 61231,
      "chunk_index": 118,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_119",
      "text": "and S.V.; writing—review and editing, A.E., E.P., K.N., M.T. and S.V.; project administration, E.P.\n\nNutrients 2024, 16, 27\n16 of 21\nand M.T.; funding acquisition, A.E., E.P., Z.S., M.T. and S.V. All authors have read and agreed to the\npublished version of the manuscript.\nFunding: This research was funded by the Semmelweis Science and Innovation Fund (STIA-OTKA-\n2021 for S.V.), the Hungarian Hypertension Society (for S.V. and M.T.), and the Hungarian Dietetic\nAssociation (A.E., E.P. and Z.S.).\nInstitutional Review Board Statement: Not applicable.\nInformed Consent Statement: Not applicable.\nData Availability Statement: Not applicable.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 15,
          "overlap_chars": 100,
          "overlap_percentage": 15.600624024960998
        },
        {
          "page_number": 16,
          "overlap_chars": 540,
          "overlap_percentage": 84.24336973478938
        }
      ],
      "primary_page": 15,
      "char_count": 641,
      "word_count": 93,
      "start_pos": 61131,
      "end_pos": 61773,
      "chunk_index": 119,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_120",
      "text": "applicable.\nInformed Consent Statement: Not applicable.\nData Availability Statement: Not applicable.\nConflicts of Interest: The authors declare no conflict of interest.\nReferences\n1.\nHill, K. The demography of menopause. Maturitas 1996, 23, 113–127. [CrossRef] [PubMed]\n2.\nForyst-Ludwig, A.; Kintscher, U. Metabolic impact of estrogen signalling through ERalpha and ERbeta. J. Steroid. Biochem. Mol.\nBiol. 2010, 122, 74–81. [CrossRef] [PubMed]\n3.\nPoehlman, E.T. Menopause, energy expenditure, and body composition. Acta Obstet. Gynecol. Scand. 2002, 81, 603–611. [CrossRef]\n[PubMed]\n4.\nMauvais-Jarvis, F.; Clegg, D.J.; Hevener, A.L.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 632,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 16,
      "char_count": 632,
      "word_count": 84,
      "start_pos": 61673,
      "end_pos": 62305,
      "chunk_index": 120,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_121",
      "text": "col. Scand. 2002, 81, 603–611. [CrossRef]\n[PubMed]\n4.\nMauvais-Jarvis, F.; Clegg, D.J.; Hevener, A.L. The role of estrogens in control of energy balance and glucose homeostasis. Endocr.\nRev. 2013, 34, 309–338. [CrossRef] [PubMed]\n5.\nBarrea, L.; Pugliese, G.; Laudisio, D.; Colao, A.; Savastano, S.; Muscogiuri, G. Mediterranean diet as medical prescription in\nmenopausal women with obesity: A practical guide for nutritionists. Crit. Rev. Food Sci. Nutr. 2021, 61, 1201–1211. [CrossRef]\n[PubMed]\n6.\nLovejoy, J.C.; Champagne, C.M.; de Jonge, L.; Xie, H.; Smith, S.R. Increased visceral fat and decreased energy expenditure during\nthe menopausal transition. Int. J. Obes. 2008, 32, 949–958.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 687,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 16,
      "char_count": 687,
      "word_count": 100,
      "start_pos": 62205,
      "end_pos": 62892,
      "chunk_index": 121,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_122",
      "text": "and decreased energy expenditure during\nthe menopausal transition. Int. J. Obes. 2008, 32, 949–958. [CrossRef] [PubMed]\n7.\nCrewe, C.; An, Y.A.; Scherer, P.E. The ominous triad of adipose tissue dysfunction: Inflammation, fibrosis, and impaired\nangiogenesis. J. Clin. Investig. 2017, 127, 74–82. [CrossRef] [PubMed]\n8.\nAlexopoulos, N.; Katritsis, D.; Raggi, P. Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis.\nAtherosclerosis 2014, 233, 104–112. [CrossRef]\n9.\nHarvie, M. Breast cancer. In Manula of Dietetic Practic; Gandy, J., Ed.; Wiley Blackwell: Oxford, UK, 2019; pp. 842–846.\n10.\nMartin, S.; Schneider, B.; Heinemann, L.; Lodwig, V.; Kurth, H.J.; Kolb, H.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 696,
          "overlap_percentage": 100.14388489208632
        }
      ],
      "primary_page": 16,
      "char_count": 695,
      "word_count": 100,
      "start_pos": 62792,
      "end_pos": 63488,
      "chunk_index": 122,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_123",
      "text": ", 2019; pp. 842–846.\n10.\nMartin, S.; Schneider, B.; Heinemann, L.; Lodwig, V.; Kurth, H.J.; Kolb, H.; Scherbaum, W.A. Self-monitoring of blood glucose in\ntype 2 diabetes and long-term outcome: An epidemiological cohort study. Diabetologia 2006, 49, 271–278. [CrossRef]\n11.\nBussell, G. Menopause. In Manual of Dietetic Practice; Gandy, J., Ed.; Wiley Blackwell: Oxford, UK, 2019; pp. 85–87.\n12.\nHuang, A.J.; Subak, L.L.; Wing, R.; West, D.S.; Hernandez, A.L.; Macer, J.; Grady, D.; Program to Reduce Incontinence by Diet and\nExercise Investigators. An intensive behavioral weight loss intervention and hot flushes in women. Arch. Intern. Med. 2010, 170,\n1161–1167. [CrossRef]\n13.\nHerforth, A.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 691,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 16,
      "char_count": 691,
      "word_count": 103,
      "start_pos": 63388,
      "end_pos": 64079,
      "chunk_index": 123,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_124",
      "text": "ntion and hot flushes in women. Arch. Intern. Med. 2010, 170,\n1161–1167. [CrossRef]\n13.\nHerforth, A.; Arimond, M.; Álvarez-Sánchez, C.; Coates, J.; Christianson, K.; Muehlhoff, E. A Global Review of Food-Based\nDietary Guidelines. Adv. Nutr. 2019, 10, 590–605. [CrossRef]\n14.\nDaley, A.; Jolly, K.; Madigan, C.; Griffin, R.; Roalfe, A.; Lewis, A.; Nickless, A.; Aveyard, P. Public Health Research. In A Brief\nBehavioural Intervention to Promote Regular Self-Weighing to Prevent Weight Regain after Weight Loss: A RCT; NIHR Journals Library:\nSouthampton, UK, 2019. [CrossRef]\n15.\nCamara, M.; Giner, R.M.; Gonzalez-Fandos, E.; Lopez-Garcia, E.; Manes, J.; Portillo, M.P.; Rafecas, M.; Dominguez, L.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 694,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 16,
      "char_count": 694,
      "word_count": 101,
      "start_pos": 63979,
      "end_pos": 64673,
      "chunk_index": 124,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_125",
      "text": ", R.M.; Gonzalez-Fandos, E.; Lopez-Garcia, E.; Manes, J.; Portillo, M.P.; Rafecas, M.; Dominguez, L.; Martinez,\nJ.A. Food-Based Dietary Guidelines around the World: A Comparative Analysis to Update AESAN Scientific Committee Dietary\nRecommendations. Nutrients 2021, 13, 3131. [CrossRef]\n16.\nSpringmann, M.; Spajic, L.; Clark, M.A.; Poore, J.; Herforth, A.; Webb, P.; Rayner, M.; Scarborough, P. The healthiness and\nsustainability of national and global food based dietary guidelines: Modelling study. BMJ 2020, 370, m2322. [CrossRef]\n17.\nCorrêa Rezende, J.L.; de Medeiros Frazão Duarte, M.C.; Melo, G.; Dos Santos, L.C.; Toral, N. Food-based dietary guidelines for\nchildren and adolescents. Front.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 697,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 16,
      "char_count": 697,
      "word_count": 97,
      "start_pos": 64573,
      "end_pos": 65270,
      "chunk_index": 125,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_126",
      "text": ", G.; Dos Santos, L.C.; Toral, N. Food-based dietary guidelines for\nchildren and adolescents. Front. Public Health 2022, 10, 1033580. [CrossRef]\n18.\nFood-Based Dietary Guidelines. Available online: [URL]\n(accessed on 2 February 2023).\n19.\nThe Hungarian Dietetic Association. The OKOSTÁNYÉR® New Dietary Guideline for the Healthy Adult Population. Available\nonline: [URL] (accessed\non 12 February 2021).\n20.\nEuropean Food Safety Authority. Dietary Reference Values for nutrients Summary report. EFSA Support. Publ. 2017, 14, 98.\n21.\nWHO. Obesity and Overweight.\nAvailable online:\n[URL]\noverweight (accessed on 9 June 2021).\n\nNutrients 2024, 16, 27\n17 of 21\n22.\nStrohm, D.B.H.; Leschik-Bonnet, E.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 622,
          "overlap_percentage": 89.62536023054754
        },
        {
          "page_number": 17,
          "overlap_chars": 70,
          "overlap_percentage": 10.086455331412104
        }
      ],
      "primary_page": 16,
      "char_count": 694,
      "word_count": 100,
      "start_pos": 65170,
      "end_pos": 65864,
      "chunk_index": 126,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_127",
      "text": "t (accessed on 9 June 2021).\n\nNutrients 2024, 16, 27\n17 of 21\n22.\nStrohm, D.B.H.; Leschik-Bonnet, E.; Heseker, H.; Arens-Aze-vêdo, U.; Bechthold, A.; Knorpp, L.; Kroke, A.; for the German\nNutrition Society (DGE). Salt intake in Germany, health consequences, and resulting recommendations for action. A scientific\nstatement from the German Nutrition Society (DGE). Ernahr. Umsch. 2016, 63, 62–70.\n23.\nHeller, B.; Reiter, F.P.; Leicht, H.B.; Fiessler, C.; Bergheim, I.; Heuschmann, P.U.; Geier, A.; Rau, M. Salt-Intake-Related Behavior\nVaries between Sexes and Is Strongly Associated with Daily Salt Consumption in Obese Patients at High Risk for MASLD.\nNutrients 2023, 15, 3942. [CrossRef]\n24.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 16,
          "overlap_chars": 28,
          "overlap_percentage": 4.046242774566474
        },
        {
          "page_number": 17,
          "overlap_chars": 662,
          "overlap_percentage": 95.66473988439307
        }
      ],
      "primary_page": 16,
      "char_count": 692,
      "word_count": 103,
      "start_pos": 65764,
      "end_pos": 66456,
      "chunk_index": 127,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_128",
      "text": "Salt Consumption in Obese Patients at High Risk for MASLD.\nNutrients 2023, 15, 3942. [CrossRef]\n24.\nDi Rosa, C.; Di Francesco, L.; Spiezia, C.; Khazrai, Y.M. Effects of Animal and Vegetable Proteins on Gut Microbiota in Subjects\nwith Overweight or Obesity. Nutrients 2023, 15, 2675. [CrossRef]\n25.\nQuattrini, S.; Pampaloni, B.; Gronchi, G.; Giusti, F.; Brandi, M.L. The Mediterranean Diet in Osteoporosis Prevention: An Insight\nin a Peri- and Post-Menopausal Population. Nutrients 2021, 13, 531. [CrossRef]\n26.\nSilva, T.R.; Oppermann, K.; Reis, F.M.; Spritzer, P.M. Nutrition in Menopausal Women: A Narrative Review. Nutrients 2021,\n13, 2149. [CrossRef]\n27.\nOjo, O. Nutrition and Chronic Conditions.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 700,
          "overlap_percentage": 100.14306151645206
        }
      ],
      "primary_page": 17,
      "char_count": 699,
      "word_count": 104,
      "start_pos": 66356,
      "end_pos": 67056,
      "chunk_index": 128,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_129",
      "text": "Narrative Review. Nutrients 2021,\n13, 2149. [CrossRef]\n27.\nOjo, O. Nutrition and Chronic Conditions. Nutrients 2019, 11, 459. [CrossRef]\n28.\nRees, M.; Abernethy, K.; Bachmann, G.; Bretz, S.; Ceausu, I.; Durmusoglu, F.; Erkkola, R.; Fistonic, I.; Gambacciani, M.; Geukes,\nM.; et al. The essential menopause curriculum for healthcare professionals: A European Menopause and Andropause Society\n(EMAS) position statement. Maturitas 2022, 158, 70–77. [CrossRef]\n29.\nvan Eekelen, E.; Geelen, A.; Alssema, M.; Lamb, H.J.; de Roos, A.; Rosendaal, F.R.; de Mutsert, R.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 559,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 17,
      "char_count": 559,
      "word_count": 81,
      "start_pos": 66956,
      "end_pos": 67515,
      "chunk_index": 129,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_130",
      "text": ".\nvan Eekelen, E.; Geelen, A.; Alssema, M.; Lamb, H.J.; de Roos, A.; Rosendaal, F.R.; de Mutsert, R. Sweet Snacks Are Positively and\nFruits and Vegetables Are Negatively Associated with Visceral or Liver Fat Content in Middle-Aged Men and Women. J. Nutr.\n2019, 149, 304–313. [CrossRef]\n30.\nBechthold, A.; Boeing, H.; Tetens, I.; Schwingshackl, L.; Nöthlings, U. Perspective: Food-Based Dietary Guidelines in Europe-\nScientific Concepts, Current Status, and Perspectives. Adv. Nutr. 2018, 9, 544–560. [CrossRef]\n31.\nYumuk, V.; Tsigos, C.; Fried, M.; Schindler, K.; Busetto, L.; Micic, D.; Toplak, H.; Obesity Management Task Force of the European\nAssociation for the Study of Obesity.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 683,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 17,
      "char_count": 683,
      "word_count": 103,
      "start_pos": 67415,
      "end_pos": 68098,
      "chunk_index": 130,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_131",
      "text": "D.; Toplak, H.; Obesity Management Task Force of the European\nAssociation for the Study of Obesity. European Guidelines for Obesity Management in Adults. Obes. Facts 2015, 8, 402–424.\n[CrossRef]\n32.\nBurgess, N.S. Effect of a very-low-calorie diet on body composition and resting metabolic rate in obese men and women. J. Am.\nDiet. Assoc. 1991, 91, 430–434. [CrossRef]\n33.\nCederholm, T.; Barazzoni, R.; Austin, P.; Ballmer, P.; Biolo, G.; Bischoff, S.C.; Compher, C.; Correia, I.; Higashiguchi, T.; Holst, M.;\net al. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin. Nutr. 2017, 36, 49–64. [CrossRef]\n34.\nKodoth, V.; Scaccia, S.; Aggarwal, B.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 669,
          "overlap_percentage": 100.1497005988024
        }
      ],
      "primary_page": 17,
      "char_count": 668,
      "word_count": 102,
      "start_pos": 67998,
      "end_pos": 68667,
      "chunk_index": 131,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_132",
      "text": "linical nutrition. Clin. Nutr. 2017, 36, 49–64. [CrossRef]\n34.\nKodoth, V.; Scaccia, S.; Aggarwal, B. Adverse Changes in Body Composition During the Menopausal Transition and Relation to\nCardiovascular Risk: A Contemporary Review. Women’s Health Rep. 2022, 3, 573–581. [CrossRef]\n35.\nMusa, I.R.; Omar, S.M.; Adam, I. Mid-upper arm circumference as a substitute for body mass index in the assessment of nutritional\nstatus among adults in eastern Sudan. BMC Public Health 2022, 22, 2056. [CrossRef]\n36.\nKyle, U.G.; Bosaeus, I.; De Lorenzo, A.D.; Deurenberg, P.; Elia, M.; Gomez, J.M.; Heitmann, B.L.; Kent-Smith, L.; Melchior, J.C.;\nPirlich, M.; et al.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 649,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 17,
      "char_count": 649,
      "word_count": 98,
      "start_pos": 68567,
      "end_pos": 69216,
      "chunk_index": 132,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_133",
      "text": "berg, P.; Elia, M.; Gomez, J.M.; Heitmann, B.L.; Kent-Smith, L.; Melchior, J.C.;\nPirlich, M.; et al. Bioelectrical impedance analysis—Part I: Review of principles and methods. Clin. Nutr. 2004, 23, 1226–1243.\n[CrossRef]\n37.\nKyle, U.G.; Bosaeus, I.; De Lorenzo, A.D.; Deurenberg, P.; Elia, M.; Manuel Gomez, J.; Lilienthal Heitmann, B.; Kent-Smith, L.;\nMelchior, J.C.; Pirlich, M.; et al. Bioelectrical impedance analysis—Part II: Utilization in clinical practice. Clin. Nutr. 2004, 23,\n1430–1453. [CrossRef]\n38.\nBaranauskas, M.; Kupˇci¯unait˙e, I.; Stukas, R. Dietary Intake of Protein and Essential Amino Acids for Sustainable Muscle\nDevelopment in Elite Male Athletes. Nutrients 2023, 15, 4003.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 696,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 17,
      "char_count": 696,
      "word_count": 98,
      "start_pos": 69116,
      "end_pos": 69812,
      "chunk_index": 133,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_134",
      "text": "ial Amino Acids for Sustainable Muscle\nDevelopment in Elite Male Athletes. Nutrients 2023, 15, 4003. [CrossRef]\n39.\nSharma, A.M.; Kushner, R.F. A proposed clinical staging system for obesity. Int. J. Obes. 2009, 33, 289–295. [CrossRef]\n40.\nBAPEN. BAPEN The ‘MUST’ Explanatory Booklet. Available online: [URL]\nmust-toolkit/the-must-explanatory-booklet (accessed on 13 August 2023).\n41.\nCederholm, T.; Jensen, G.L.; Correia, M.; Gonzalez, M.C.; Fukushima, R.; Higashiguchi, T.; Baptista, G.; Barazzoni, R.; Blaauw,\nR.; Coats, A.J.S.; et al. GLIM criteria for the diagnosis of malnutrition—A consensus report from the global clinical nutrition\ncommunity. J. Cachexia Sarcopenia Muscle 2019, 10, 207–217.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 700,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 17,
      "char_count": 700,
      "word_count": 96,
      "start_pos": 69712,
      "end_pos": 70412,
      "chunk_index": 134,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_135",
      "text": "eport from the global clinical nutrition\ncommunity. J. Cachexia Sarcopenia Muscle 2019, 10, 207–217. [CrossRef]\n42.\nCruz-Jentoft, A.J.; Baeyens, J.P.; Bauer, J.M.; Boirie, Y.; Cederholm, T.; Landi, F.; Martin, F.C.; Michel, J.P.; Rolland, Y.; Schneider,\nS.M.; et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia\nin Older People. Age Ageing 2010, 39, 412–423. [CrossRef]\n43.\nBiolo, G.; Cederholm, T.; Muscaritoli, M. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of\naging and chronic diseases: From sarcopenic obesity to cachexia. Clin. Nutr. 2014, 33, 737–748. [CrossRef]\n44.\nFricker, J.; Rozen, R.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 697,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 17,
      "char_count": 697,
      "word_count": 101,
      "start_pos": 70312,
      "end_pos": 71009,
      "chunk_index": 135,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_136",
      "text": "sarcopenic obesity to cachexia. Clin. Nutr. 2014, 33, 737–748. [CrossRef]\n44.\nFricker, J.; Rozen, R.; Melchior, J.C.; Apfelbaum, M. Energy-metabolism adaptation in obese adults on a very-low-calorie diet. Am.\nJ. Clin. Nutr. 1991, 53, 826–830. [CrossRef]\n45.\nHassapidou, M.; Vlassopoulos, A.; Kalliostra, M.; Govers, E.; Mulrooney, H.; Ells, L.; Salas, X.R.; Muscogiuri, G.; Darleska,\nT.H.; Busetto, L.; et al. European Association for the Study of Obesity Position Statement on Medical Nutrition Therapy for the\nManagement of Overweight and Obesity in Adults Developed in Collaboration with the European Federation of the Associations\nof Dietitians. Obes. Facts 2023, 16, 11–28. [CrossRef]\n46.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 693,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 17,
      "char_count": 693,
      "word_count": 100,
      "start_pos": 70909,
      "end_pos": 71602,
      "chunk_index": 136,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_137",
      "text": "e European Federation of the Associations\nof Dietitians. Obes. Facts 2023, 16, 11–28. [CrossRef]\n46.\nSemlitsch, T.; Stigler, F.L.; Jeitler, K.; Horvath, K.; Siebenhofer, A. Management of overweight and obesity in primary care-A\nsystematic overview of international evidence-based guidelines. Obes. Rev. 2019, 20, 1218–1230. [CrossRef]\n\nNutrients 2024, 16, 27\n18 of 21\n47.\nCosentino, F.; Grant, P.J.; Aboyans, V.; Bailey, C.J.; Ceriello, A.; Delgado, V.; Federici, M.; Filippatos, G.; Grobbee, D.E.; Hansen,\nT.B.; et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.\nEur. Heart J. 2020, 41, 255–323. [CrossRef]\n48.\nThomas, D.R.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 17,
          "overlap_chars": 334,
          "overlap_percentage": 47.91965566714491
        },
        {
          "page_number": 18,
          "overlap_chars": 361,
          "overlap_percentage": 51.79340028694405
        }
      ],
      "primary_page": 17,
      "char_count": 697,
      "word_count": 100,
      "start_pos": 71502,
      "end_pos": 72199,
      "chunk_index": 137,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.724421"
    },
    {
      "id": "chunk_138",
      "text": "veloped in collaboration with the EASD.\nEur. Heart J. 2020, 41, 255–323. [CrossRef]\n48.\nThomas, D.R. Loss of skeletal muscle mass in aging: Examining the relationship of starvation, sarcopenia and cachexia. Clin.\nNutr. 2007, 26, 389–399. [CrossRef]\n49.\nRust, C.; Prior, R.M.; Stec, M. Implementation of a clinical practice guideline in a primary care setting for the prevention and\nmanagement of obesity in adults. Nurs. Forum. 2020, 55, 485–490. [CrossRef]\n50.\nWharton, S.; Lau, D.C.W.; Vallis, M.; Sharma, A.M.; Biertho, L.; Campbell-Scherer, D.; Adamo, K.; Alberga, A.; Bell, R.; Boule, N.;\net al. Obesity in adults: A clinical practice guideline. CMAJ 2020, 192, E875–E891. [CrossRef]\n51.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 692,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 18,
      "char_count": 692,
      "word_count": 106,
      "start_pos": 72099,
      "end_pos": 72791,
      "chunk_index": 138,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_139",
      "text": ";\net al. Obesity in adults: A clinical practice guideline. CMAJ 2020, 192, E875–E891. [CrossRef]\n51.\nDinh, Q.N.; Drummond, G.R.; Sobey, C.G. Estrogen: Reducing the pressure by arginine vasopressin. Cardiovasc. Res. 2021, 117,\n2143–2144. [CrossRef]\n52.\nStachenfeld, N.S. Hormonal changes during menopause and the impact on fluid regulation. Reprod. Sci. 2014, 21, 555–561.\n[CrossRef]\n53.\nStachenfeld, N.S.; DiPietro, L.; Palter, S.F.; Nadel, E.R. Estrogen influences osmotic secretion of AVP and body water balance in\npostmenopausal women. Am. J. Physiol. 1998, 274, R187–R195. [CrossRef]\n54.\nCorona, G.; Giuliani, C.; Parenti, G.; Colombo, G.L.; Sforza, A.; Maggi, M.; Forti, G.; Peri, A.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 688,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 18,
      "char_count": 688,
      "word_count": 100,
      "start_pos": 72691,
      "end_pos": 73379,
      "chunk_index": 139,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_140",
      "text": "54.\nCorona, G.; Giuliani, C.; Parenti, G.; Colombo, G.L.; Sforza, A.; Maggi, M.; Forti, G.; Peri, A. The Economic Burden of\nHyponatremia: Systematic Review and Meta-Analysis. Am. J. Med. 2016, 129, 823–835.e824. [CrossRef]\n55.\nFernando, S.; Sivagnanam, F.; Rathish, D. A compulsive act of excess water intake leading to hyponatraemia and rhabdomyolysis:\nA case report. Int. J. Emerg. Med. 2019, 12, 34. [CrossRef]\n56.\nMallett, L.J.; Premkumar, V.; Brown, L.J.; May, J.; Rollo, M.E.; Schumacher, T.L. Total water intake by kilogram of body weight:\nAnalysis of the Australian 2011 to 2013 National Nutrition and Physical Activity Survey. Nutr. Diet. 2021, 78, 496–505. [CrossRef]\n57.\nRaj, A.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 689,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 18,
      "char_count": 689,
      "word_count": 106,
      "start_pos": 73279,
      "end_pos": 73968,
      "chunk_index": 140,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_141",
      "text": "tional Nutrition and Physical Activity Survey. Nutr. Diet. 2021, 78, 496–505. [CrossRef]\n57.\nRaj, A.; Chakole, S.; Agrawal, S.; Gupta, A.; Khekade, H.; Prasad, R.; Lohakare, T.; Wanjari, M. The Impact of Menopause on\nCardiovascular Aging: A Comprehensive Review of Androgen Influences. Cureus 2023, 15, e43569. [CrossRef]\n58.\nMishra, S.R.; Chung, H.F.; Waller, M.; Mishra, G.D. Duration of estrogen exposure during reproductive years, age at menarche\nand age at menopause, and risk of cardiovascular disease events, all-cause and cardiovascular mortality: A systematic review\nand meta-analysis. BJOG 2021, 128, 809–821. [CrossRef]\n59.\nAnagnostis, P.; Stevenson, J.C.; Crook, D.; Johnston, D.G.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 693,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 18,
      "char_count": 693,
      "word_count": 99,
      "start_pos": 73868,
      "end_pos": 74561,
      "chunk_index": 141,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_142",
      "text": ". BJOG 2021, 128, 809–821. [CrossRef]\n59.\nAnagnostis, P.; Stevenson, J.C.; Crook, D.; Johnston, D.G.; Godsland, I.F. Effects of menopause, gender and age on lipids and\nhigh-density lipoprotein cholesterol subfractions. Maturitas 2015, 81, 62–68. [CrossRef]\n60.\nRyczkowska, K.; Adach, W.; Janikowski, K.; Banach, M.; Bielecka-Dabrowa, A. Menopause and women’s cardiovascular health:\nIs it really an obvious relationship? Arch. Med. Sci. 2023, 19, 458–466. [CrossRef]\n61.\nNovella, S.; Perez-Cremades, D.; Mompeon, A.; Hermenegildo, C. Mechanisms underlying the influence of oestrogen on\ncardiovascular physiology in women. J. Physiol. 2019, 597, 4873–4886. [CrossRef]\n62.\nGardner, C.D.; Vadiveloo, M.K.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 700,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 18,
      "char_count": 700,
      "word_count": 95,
      "start_pos": 74461,
      "end_pos": 75161,
      "chunk_index": 142,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_143",
      "text": "physiology in women. J. Physiol. 2019, 597, 4873–4886. [CrossRef]\n62.\nGardner, C.D.; Vadiveloo, M.K.; Petersen, K.S.; Anderson, C.A.M.; Springfield, S.; Van Horn, L.; Khera, A.; Lamendola, C.; Mayo,\nS.M.; Joseph, J.J.; et al. Popular Dietary Patterns: Alignment With American Heart Association 2021 Dietary Guidance: A Scientific\nStatement From the American Heart Association. Circulation 2023, 147, 1715–1730. [CrossRef]\n63.\nVisseren, F.L.J.; Mach, F.; Smulders, Y.M.; Carballo, D.; Koskinas, K.C.; Back, M.; Benetos, A.; Biffi, A.; Boavida, J.M.; Capodanno,\nD.; et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 2021, 42, 3227–3337.\n[CrossRef]\n64.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 699,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 18,
      "char_count": 699,
      "word_count": 98,
      "start_pos": 75061,
      "end_pos": 75760,
      "chunk_index": 143,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_144",
      "text": "ovascular disease prevention in clinical practice. Eur. Heart J. 2021, 42, 3227–3337.\n[CrossRef]\n64.\nZwart, J.J.; Richters, J.M.; Ory, F.; de Vries, J.I.; Bloemenkamp, K.W.; van Roosmalen, J. Uterine rupture in The Netherlands: A\nnationwide population-based cohort study. BJOG 2009, 116, 1069–1080. [CrossRef]\n65.\nWilliams, B.; Mancia, G.; Spiering, W.; Agabiti Rosei, E.; Azizi, M.; Burnier, M.; Clement, D.L.; Coca, A.; de Simone, G.; Dominiczak,\nA.; et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur. Heart J. 2018, 39, 3021–3104. [CrossRef]\n66.\nPaschou, S.A.; Anagnostis, P.; Pavlou, D.I.; Vryonidou, A.; Goulis, D.G.; Lambrinoudaki, I.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 670,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 18,
      "char_count": 670,
      "word_count": 97,
      "start_pos": 75660,
      "end_pos": 76330,
      "chunk_index": 144,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_145",
      "text": "Ref]\n66.\nPaschou, S.A.; Anagnostis, P.; Pavlou, D.I.; Vryonidou, A.; Goulis, D.G.; Lambrinoudaki, I. Diabetes in Menopause: Risks and\nManagement. Curr. Vasc. Pharmacol. 2019, 17, 556–563. [CrossRef]\n67.\nMauvais-Jarvis, F.; Manson, J.E.; Stevenson, J.C.; Fonseca, V.A. Menopausal Hormone Therapy and Type 2 Diabetes Prevention:\nEvidence, Mechanisms, and Clinical Implications. Endocr. Rev. 2017, 38, 173–188. [CrossRef]\n68.\nWang, M.; Gan, W.; Kartsonaki, C.; Guo, Y.; Lv, J.; Chen, Z.; Li, L.; Yang, L.; Yu, M. Menopausal status, age at natural menopause\nand risk of diabetes in China: A 10-year prospective study of 300,000 women. Nutr. Metab. 2022, 19, 7. [CrossRef]\n69.\nWainberg, M.; Mahajan, A.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 697,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 18,
      "char_count": 697,
      "word_count": 104,
      "start_pos": 76230,
      "end_pos": 76927,
      "chunk_index": 145,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_146",
      "text": "ospective study of 300,000 women. Nutr. Metab. 2022, 19, 7. [CrossRef]\n69.\nWainberg, M.; Mahajan, A.; Kundaje, A.; McCarthy, M.I.; Ingelsson, E.; Sinnott-Armstrong, N.; Rivas, M.A. Homogeneity in the\nassociation of body mass index with type 2 diabetes across the UK Biobank: A Mendelian randomization study. PLoS Med. 2019,\n16, e1002982. [CrossRef]\n70.\nSlopien, R.; Wender-Ozegowska, E.; Rogowicz-Frontczak, A.; Meczekalski, B.; Zozulinska-Ziolkiewicz, D.; Jaremek, J.D.; Cano, A.;\nChedraui, P.; Goulis, D.G.; Lopes, P.; et al. Menopause and diabetes: EMAS clinical guide. Maturitas 2018, 117, 6–10. [CrossRef]\n71.\nBriggs Early, K.; Stanley, K.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 644,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 18,
      "char_count": 644,
      "word_count": 92,
      "start_pos": 76827,
      "end_pos": 77471,
      "chunk_index": 146,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_147",
      "text": "abetes: EMAS clinical guide. Maturitas 2018, 117, 6–10. [CrossRef]\n71.\nBriggs Early, K.; Stanley, K. Position of the Academy of Nutrition and Dietetics: The Role of Medical Nutrition Therapy and\nRegistered Dietitian Nutritionists in the Prevention and Treatment of Prediabetes and Type 2 Diabetes. J. Acad. Nutr. Diet. 2018,\n118, 343–353. [CrossRef]\n72.\nPaschou, S.A.; Marina, L.V.; Spartalis, E.; Anagnostis, P.; Alexandrou, A.; Goulis, D.G.; Lambrinoudaki, I. Therapeutic strategies\nfor type 2 diabetes mellitus in women after menopause. Maturitas 2019, 126, 69–72. [CrossRef]\n\nNutrients 2024, 16, 27\n19 of 21\n73.\nCooney, C.; Daly, E.; McDonagh, M.; Ryan, L.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 578,
          "overlap_percentage": 87.57575757575758
        },
        {
          "page_number": 19,
          "overlap_chars": 80,
          "overlap_percentage": 12.121212121212121
        }
      ],
      "primary_page": 18,
      "char_count": 660,
      "word_count": 99,
      "start_pos": 77371,
      "end_pos": 78031,
      "chunk_index": 147,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_148",
      "text": "69–72. [CrossRef]\n\nNutrients 2024, 16, 27\n19 of 21\n73.\nCooney, C.; Daly, E.; McDonagh, M.; Ryan, L. Evaluation of Measured Resting Metabolic Rate for Dietary Prescription in Ageing\nAdults with Overweight and Adiposity-Based Chronic Disease. Nutrients 2021, 13, 1229. [CrossRef]\n74.\nGuideline: Sugars Intake for Adults and Children; WHO: Geneva, Switzerland, 2015.\n75.\nCobiac, L.J.; Scarborough, P.; Kaur, A.; Rayner, M. The Eatwell Guide: Modelling the Health Implications of Incorporating New\nSugar and Fibre Guidelines. PLoS ONE 2016, 11, e0167859. [CrossRef]\n76.\nAbdelsalam, S.E.; Ismaail, M.A.R.; Sultan, E.A.; Elsherif, O.E.; Salama, H.M.; Hassan, S.I.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 18,
          "overlap_chars": 18,
          "overlap_percentage": 2.73972602739726
        },
        {
          "page_number": 19,
          "overlap_chars": 638,
          "overlap_percentage": 97.10806697108066
        }
      ],
      "primary_page": 18,
      "char_count": 657,
      "word_count": 95,
      "start_pos": 77931,
      "end_pos": 78589,
      "chunk_index": 148,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_149",
      "text": "Ref]\n76.\nAbdelsalam, S.E.; Ismaail, M.A.R.; Sultan, E.A.; Elsherif, O.E.; Salama, H.M.; Hassan, S.I. The outcome of medical nutrition\ntherapy on glycemic control among type 2 diabetic patients. Pan Afr. Med. J. 2023, 45, 85. [CrossRef]\n77.\nReynolds, A.N.; Akerman, A.P.; Mann, J. Dietary fibre and whole grains in diabetes management: Systematic review and\nmeta-analyses. PLoS Med. 2020, 17, e1003053. [CrossRef]\n78.\nLepping, K.; Adams-Campbell, L.L.; Hicks, J.; Mills, M.; Dash, C. Dietary fiber intake and metabolic syndrome in postmenopausal\nAfrican American women with obesity. PLoS ONE 2022, 17, e0273911. [CrossRef]\n79.\nSingh, V.; Park, Y.J.; Lee, G.; Unno, T.; Shin, J.H.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 678,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 19,
      "char_count": 678,
      "word_count": 102,
      "start_pos": 78489,
      "end_pos": 79167,
      "chunk_index": 149,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_150",
      "text": "ty. PLoS ONE 2022, 17, e0273911. [CrossRef]\n79.\nSingh, V.; Park, Y.J.; Lee, G.; Unno, T.; Shin, J.H. Dietary regulations for microbiota dysbiosis among post-menopausal women\nwith type 2 diabetes. Crit. Rev. Food Sci. Nutr. 2023, 63, 9961–9976. [CrossRef]\n80.\nZengul, A.G.; Demark-Wahnefried, W.; Barnes, S.; Morrow, C.D.; Bertrand, B.; Berryhill, T.F.; Fruge, A.D. Associations between\nDietary Fiber, the Fecal Microbiota and Estrogen Metabolism in Postmenopausal Women with Breast Cancer. Nutr. Cancer 2021,\n73, 1108–1117. [CrossRef]\n81.\nWHO. Joint FDA/WHO Expert Committee on Food Additives. Evaluations of the Joint FAO/WHO Expert Committee on Food\nAdditives.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 662,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 19,
      "char_count": 662,
      "word_count": 95,
      "start_pos": 79067,
      "end_pos": 79729,
      "chunk_index": 150,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_151",
      "text": "rt Committee on Food Additives. Evaluations of the Joint FAO/WHO Expert Committee on Food\nAdditives. Available online: [URL] (accessed on 23 August 2018).\n82.\nManagement of osteoporosis in postmenopausal women: The 2021 position statement of The North American Menopause Society.\nMenopause 2021, 28, 973–997. [CrossRef]\n83.\nVárbíró, S.; Takács, I.; T˝u˝u, L.; Nas, K.; Sziva, R.E.; Hetthéssy, J.R.; Török, M. Effects of Vitamin D on Fertility, Pregnancy and\nPolycystic Ovary Syndrome-A Review. Nutrients 2022, 14, 1649. [CrossRef]\n84.\nAgostini, D.; Gervasi, M.; Ferrini, F.; Bartolacci, A.; Stranieri, A.; Piccoli, G.; Barbieri, E.; Sestili, P.; Patti, A.; Stocchi, V.; et al.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 676,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 19,
      "char_count": 676,
      "word_count": 100,
      "start_pos": 79629,
      "end_pos": 80305,
      "chunk_index": 151,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_152",
      "text": "artolacci, A.; Stranieri, A.; Piccoli, G.; Barbieri, E.; Sestili, P.; Patti, A.; Stocchi, V.; et al. An\nIntegrated Approach to Skeletal Muscle Health in Aging. Nutrients 2023, 15, 1802. [CrossRef]\n85.\nTakacs, I.; Dank, M.; Majnik, J.; Nagy, G.; Szabo, A.; Szabo, B.; Szekanecz, Z.; Sziller, I.; Toldy, E.; Tisler, A.; et al. Hungarian\nconsensus recommendation on the role of vitamin D in disease prevention and treatment. Orv. Hetil. 2022, 163, 575–584.\n[CrossRef]\n86.\nHodges, J.K.; Cao, S.; Cladis, D.P.; Weaver, C.M. Lactose Intolerance and Bone Health: The Challenge of Ensuring Adequate\nCalcium Intake. Nutrients 2019, 11, 718. [CrossRef]\n87.\nde Villiers, T.J.; Goldstein, S.R.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 681,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 19,
      "char_count": 681,
      "word_count": 105,
      "start_pos": 80205,
      "end_pos": 80886,
      "chunk_index": 152,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_153",
      "text": "Adequate\nCalcium Intake. Nutrients 2019, 11, 718. [CrossRef]\n87.\nde Villiers, T.J.; Goldstein, S.R. Update on bone health: The International Menopause Society White Paper 2021. Climacteric 2021,\n24, 498–504. [CrossRef]\n88.\nNutrition Working, G.; O’Connor, D.L.; Blake, J.; Bell, R.; Bowen, A.; Callum, J.; Fenton, S.; Gray-Donald, K.; Rossiter, M.; Adamo,\nK.; et al. Canadian Consensus on Female Nutrition: Adolescence, Reproduction, Menopause, and Beyond. J. Obstet. Gynaecol.\nCan. 2016, 38, 508–554.e518. [CrossRef]\n89.\nPorter, K.; Hoey, L.; Hughes, C.F.; Ward, M.; McNulty, H. Causes, Consequences and Public Health Implications of Low B-Vitamin\nStatus in Ageing. Nutrients 2016, 8, 725.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 691,
          "overlap_percentage": 100.14492753623188
        }
      ],
      "primary_page": 19,
      "char_count": 690,
      "word_count": 99,
      "start_pos": 80786,
      "end_pos": 81477,
      "chunk_index": 153,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_154",
      "text": "nsequences and Public Health Implications of Low B-Vitamin\nStatus in Ageing. Nutrients 2016, 8, 725. [CrossRef]\n90.\nHomocysteine Studies, C. Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA 2002, 288,\n2015–2022. [CrossRef] [PubMed]\n91.\nDai, Z.; Wang, R.; Ang, L.W.; Yuan, J.M.; Koh, W.P. Dietary B vitamin intake and risk of hip fracture: The Singapore Chinese\nHealth Study. Osteoporos. Int. 2013, 24, 2049–2059. [CrossRef] [PubMed]\n92.\nEnneman, A.W.; Swart, K.M.; Zillikens, M.C.; van Dijk, S.C.; van Wijngaarden, J.P.; Brouwer-Brolsma, E.M.; Dhonukshe-Rutten,\nR.A.; Hofman, A.; Rivadeneira, F.; van der Cammen, T.J.; et al.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 658,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 19,
      "char_count": 658,
      "word_count": 96,
      "start_pos": 81377,
      "end_pos": 82035,
      "chunk_index": 154,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_155",
      "text": "wer-Brolsma, E.M.; Dhonukshe-Rutten,\nR.A.; Hofman, A.; Rivadeneira, F.; van der Cammen, T.J.; et al. The association between plasma homocysteine levels and bone\nquality and bone mineral density parameters in older persons. Bone 2014, 63, 141–146. [CrossRef] [PubMed]\n93.\nGjesdal, C.G.; Vollset, S.E.; Ueland, P.M.; Refsum, H.; Drevon, C.A.; Gjessing, H.K.; Tell, G.S. Plasma total homocysteine level and\nbone mineral density: The Hordaland Homocysteine Study. Arch. Intern. Med. 2006, 166, 88–94. [CrossRef]\n94.\nMcLean, R.R.; Jacques, P.F.; Selhub, J.; Fredman, L.; Tucker, K.L.; Samelson, E.J.; Kiel, D.P.; Cupples, L.A.; Hannan, M.T.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 635,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 19,
      "char_count": 635,
      "word_count": 90,
      "start_pos": 81935,
      "end_pos": 82570,
      "chunk_index": 155,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_156",
      "text": "P.F.; Selhub, J.; Fredman, L.; Tucker, K.L.; Samelson, E.J.; Kiel, D.P.; Cupples, L.A.; Hannan, M.T. Plasma B\nvitamins, homocysteine, and their relation with bone loss and hip fracture in elderly men and women. J. Clin. Endocrinol. Metab.\n2008, 93, 2206–2212. [CrossRef] [PubMed]\n95.\nTucker, K.L.; Hannan, M.T.; Qiao, N.; Jacques, P.F.; Selhub, J.; Cupples, L.A.; Kiel, D.P. Low plasma vitamin B12 is associated with\nlower BMD: The Framingham Osteoporosis Study. J. Bone Miner Res. 2005, 20, 152–158. [CrossRef] [PubMed]\n96.\nYang, J.; Hu, X.; Zhang, Q.; Cao, H.; Wang, J.; Liu, B. Homocysteine level and risk of fracture: A meta-analysis and systematic\nreview. Bone 2012, 51, 376–382. [CrossRef]\n97.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 699,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 19,
      "char_count": 699,
      "word_count": 109,
      "start_pos": 82470,
      "end_pos": 83169,
      "chunk_index": 156,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_157",
      "text": "and risk of fracture: A meta-analysis and systematic\nreview. Bone 2012, 51, 376–382. [CrossRef]\n97.\nYazdanpanah, N.; Zillikens, M.C.; Rivadeneira, F.; de Jong, R.; Lindemans, J.; Uitterlinden, A.G.; Pols, H.A.; van Meurs, J.B. Effect\nof dietary B vitamins on BMD and risk of fracture in elderly men and women: The Rotterdam study. Bone 2007, 41, 987–994.\n[CrossRef]\n98.\nBrown, B.; Huang, M.H.; Karlamangla, A.; Seeman, T.; Kado, D. Do the effects of APOE-epsilon4 on cognitive function and\ndecline depend upon vitamin status? MacArthur Studies of Successful Aging. J. Nutr. Health Aging 2011, 15, 196–201. [CrossRef]\n99.\nHorvat, P.; Gardiner, J.; Kubinova, R.; Pajak, A.; Tamosiunas, A.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 687,
          "overlap_percentage": 100.14577259475219
        }
      ],
      "primary_page": 19,
      "char_count": 686,
      "word_count": 106,
      "start_pos": 83069,
      "end_pos": 83756,
      "chunk_index": 157,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_158",
      "text": "2011, 15, 196–201. [CrossRef]\n99.\nHorvat, P.; Gardiner, J.; Kubinova, R.; Pajak, A.; Tamosiunas, A.; Schottker, B.; Pikhart, H.; Peasey, A.; Jansen, E.; Bobak, M. Serum\nfolate, vitamin B-12 and cognitive function in middle and older age: The HAPIEE study. Exp. Gerontol. 2016, 76, 33–38. [CrossRef]\n\nNutrients 2024, 16, 27\n20 of 21\n100. Kado, D.M.; Karlamangla, A.S.; Huang, M.H.; Troen, A.; Rowe, J.W.; Selhub, J.; Seeman, T.E. Homocysteine versus the vitamins\nfolate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of\nSuccessful Aging. Am. J. Med. 2005, 118, 161–167. [CrossRef] [PubMed]\n101. Moorthy, D.; Peter, I.; Scott, T.M.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 19,
          "overlap_chars": 299,
          "overlap_percentage": 43.02158273381295
        },
        {
          "page_number": 20,
          "overlap_chars": 395,
          "overlap_percentage": 56.83453237410072
        }
      ],
      "primary_page": 19,
      "char_count": 695,
      "word_count": 107,
      "start_pos": 83656,
      "end_pos": 84352,
      "chunk_index": 158,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_159",
      "text": "Aging. Am. J. Med. 2005, 118, 161–167. [CrossRef] [PubMed]\n101. Moorthy, D.; Peter, I.; Scott, T.M.; Parnell, L.D.; Lai, C.Q.; Crott, J.W.; Ordovas, J.M.; Selhub, J.; Griffith, J.; Rosenberg, I.H.;\net al. Status of vitamins B-12 and B-6 but not of folate, homocysteine, and the methylenetetrahydrofolate reductase C677T\npolymorphism are associated with impaired cognition and depression in adults. J. Nutr. 2012, 142, 1554–1560. [CrossRef]\n[PubMed]\n102. Morris, M.S. The role of B vitamins in preventing and treating cognitive impairment and decline. Adv. Nutr. 2012, 3, 801–812.\n[CrossRef] [PubMed]\n103. Morris, M.S.; Selhub, J.; Jacques, P.F.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 645,
          "overlap_percentage": 100.15527950310559
        }
      ],
      "primary_page": 20,
      "char_count": 644,
      "word_count": 95,
      "start_pos": 84252,
      "end_pos": 84897,
      "chunk_index": 159,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_160",
      "text": "cline. Adv. Nutr. 2012, 3, 801–812.\n[CrossRef] [PubMed]\n103. Morris, M.S.; Selhub, J.; Jacques, P.F. Vitamin B-12 and folate status in relation to decline in scores on the mini-mental state\nexamination in the framingham heart study. J. Am. Geriatr. Soc. 2012, 60, 1457–1464. [CrossRef] [PubMed]\n104. Alrubaye, H.S.; Kohl, K.D. Abundance and Compositions of B-Vitamin-Producing Microbes in the Mammalian Gut Vary Based\non Feeding Strategies. mSystems 2021, 6, e0031321. [CrossRef] [PubMed]\n105. Hossain, K.S.; Amarasena, S.; Mayengbam, S. B Vitamins and Their Roles in Gut Health. Microorganisms 2022, 10, 1168. [CrossRef]\n[PubMed]\n106. Taku, K.; Melby, M.K.; Kronenberg, F.; Kurzer, M.S.; Messina, M.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 700,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 20,
      "char_count": 700,
      "word_count": 103,
      "start_pos": 84797,
      "end_pos": 85497,
      "chunk_index": 160,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_161",
      "text": "10, 1168. [CrossRef]\n[PubMed]\n106. Taku, K.; Melby, M.K.; Kronenberg, F.; Kurzer, M.S.; Messina, M. Extracted or synthesized soybean isoflavones reduce menopausal\nhot flash frequency and severity: Systematic review and meta-analysis of randomized controlled trials. Menopause 2012, 19,\n776–790. [CrossRef] [PubMed]\n107. Magee, P.J.; Rowland, I. Soy products in the management of breast cancer. Curr. Opin. Clin. Nutr. Metab. Care 2012, 15, 586–591.\n[CrossRef]\n108. Steinberg, F.M.; Murray, M.J.; Lewis, R.D.; Cramer, M.A.; Amato, P.; Young, R.L.; Barnes, S.; Konzelmann, K.L.; Fischer, J.G.; Ellis,\nK.J.; et al. Clinical outcomes of a 2-y soy isoflavone supplementation in menopausal women. Am. J.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 698,
          "overlap_percentage": 100.14347202295552
        }
      ],
      "primary_page": 20,
      "char_count": 697,
      "word_count": 100,
      "start_pos": 85397,
      "end_pos": 86095,
      "chunk_index": 161,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_162",
      "text": ",\nK.J.; et al. Clinical outcomes of a 2-y soy isoflavone supplementation in menopausal women. Am. J. Clin. Nutr. 2011, 93, 356–367.\n[CrossRef]\n109. van Duursen, M.B.; Nijmeijer, S.M.; de Morree, E.S.; de Jong, P.C.; van den Berg, M. Genistein induces breast cancer-associated\naromatase and stimulates estrogen-dependent tumor cell growth in in vitro breast cancer model. Toxicology 2011, 289, 67–73.\n[CrossRef]\n110. Guha, N.; Kwan, M.L.; Quesenberry, C.P., Jr.; Weltzien, E.K.; Castillo, A.L.; Caan, B.J. Soy isoflavones and risk of cancer recurrence\nin a cohort of breast cancer survivors: The Life After Cancer Epidemiology study. Breast Cancer Res. Treat. 2009, 118, 395–405.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 678,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 20,
      "char_count": 678,
      "word_count": 102,
      "start_pos": 85995,
      "end_pos": 86673,
      "chunk_index": 162,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_163",
      "text": "r survivors: The Life After Cancer Epidemiology study. Breast Cancer Res. Treat. 2009, 118, 395–405.\n[CrossRef] [PubMed]\n111. Shu, X.O.; Zheng, Y.; Cai, H.; Gu, K.; Chen, Z.; Zheng, W.; Lu, W. Soy food intake and breast cancer survival. JAMA 2009, 302,\n2437–2443. [CrossRef] [PubMed]\n112. Deli, T.; Orosz, M.; Jakab, A. Hormone Replacement Therapy in Cancer Survivors—Review of the Literature. Pathol. Oncol. Res.\n2020, 26, 63–78. [CrossRef] [PubMed]\n113. Huang, G.; Xu, J.; Lefever, D.E.; Glenn, T.C.; Nagy, T.; Guo, T.L.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 522,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 20,
      "char_count": 522,
      "word_count": 82,
      "start_pos": 86573,
      "end_pos": 87095,
      "chunk_index": 163,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_164",
      "text": ", 63–78. [CrossRef] [PubMed]\n113. Huang, G.; Xu, J.; Lefever, D.E.; Glenn, T.C.; Nagy, T.; Guo, T.L. Genistein prevention of hyperglycemia and improvement of\nglucose tolerance in adult non-obese diabetic mice are associated with alterations of gut microbiome and immune homeostasis.\nToxicol. Appl. Pharmacol. 2017, 332, 138–148. [CrossRef] [PubMed]\n114. Flores, R.; Shi, J.; Fuhrman, B.; Xu, X.; Veenstra, T.D.; Gail, M.H.; Gajer, P.; Ravel, J.; Goedert, J.J. Fecal microbial determinants of\nfecal and systemic estrogens and estrogen metabolites: A cross-sectional study. J. Transl. Med. 2012, 10, 253. [CrossRef] [PubMed]\n115. Zimmermann, P.; Messina, N.; Mohn, W.W.; Finlay, B.B.; Curtis, N.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 693,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 20,
      "char_count": 693,
      "word_count": 101,
      "start_pos": 86995,
      "end_pos": 87688,
      "chunk_index": 164,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_165",
      "text": "10, 253. [CrossRef] [PubMed]\n115. Zimmermann, P.; Messina, N.; Mohn, W.W.; Finlay, B.B.; Curtis, N. Association between the intestinal microbiota and allergic\nsensitization, eczema, and asthma: A systematic review. J. Allergy Clin. Immunol. 2019, 143, 467–485. [CrossRef] [PubMed]\n116. Plottel, C.S.; Blaser, M.J. Microbiome and malignancy. Cell Host Microbe 2011, 10, 324–335. [CrossRef]\n117. Vieira, A.T.; Castelo, P.M.; Ribeiro, D.A.; Ferreira, C.M. Influence of Oral and Gut Microbiota in the Health of Menopausal Women.\nFront. Microbiol. 2017, 8, 1884. [CrossRef]\n118. Szuli´nska, M.; Łoniewski, I.; van Hemert, S.; Sobieska, M.; Bogda´nski, P.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 650,
          "overlap_percentage": 100.15408320493067
        }
      ],
      "primary_page": 20,
      "char_count": 649,
      "word_count": 92,
      "start_pos": 87588,
      "end_pos": 88238,
      "chunk_index": 165,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_166",
      "text": "8, 1884. [CrossRef]\n118. Szuli´nska, M.; Łoniewski, I.; van Hemert, S.; Sobieska, M.; Bogda´nski, P. Dose-Dependent Effects of Multispecies Probiotic\nSupplementation on the Lipopolysaccharide (LPS) Level and Cardiometabolic Profile in Obese Postmenopausal Women: A\n12-Week Randomized Clinical Trial. Nutrients 2018, 10, 773. [CrossRef]\n119. Barrea, L.; Verde, L.; Auriemma, R.S.; Vetrani, C.; Cataldi, M.; Frias-Toral, E.; Pugliese, G.; Camajani, E.; Savastano, S.; Colao, A.;\net al. Probiotics and Prebiotics: Any Role in Menopause-Related Diseases? Curr. Nutr. Rep. 2023, 12, 83–97. [CrossRef]\n120. Baker, F.C.; de Zambotti, M.; Colrain, I.M.; Bei, B.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 653,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 20,
      "char_count": 653,
      "word_count": 91,
      "start_pos": 88138,
      "end_pos": 88791,
      "chunk_index": 166,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_167",
      "text": "rr. Nutr. Rep. 2023, 12, 83–97. [CrossRef]\n120. Baker, F.C.; de Zambotti, M.; Colrain, I.M.; Bei, B. Sleep problems during the menopausal transition: Prevalence, impact, and\nmanagement challenges. Nat. Sci. Sleep 2018, 10, 73–95. [CrossRef] [PubMed]\n121. Salari, N.; Hasheminezhad, R.; Hosseinian-Far, A.; Rasoulpoor, S.; Assefi, M.; Nankali, S.; Nankali, A.; Mohammadi, M. Global\nprevalence of sleep disorders during menopause: A meta-analysis. Sleep Breath 2023, 27, 1883–1897. [CrossRef] [PubMed]\n122. Kwok, C.S.; Kontopantelis, E.; Kuligowski, G.; Gray, M.; Muhyaldeen, A.; Gale, C.P.; Peat, G.M.; Cleator, J.; Chew-Graham,\nC.; Loke, Y.K.; et al.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 650,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 20,
      "char_count": 650,
      "word_count": 92,
      "start_pos": 88691,
      "end_pos": 89341,
      "chunk_index": 167,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_168",
      "text": "; Gray, M.; Muhyaldeen, A.; Gale, C.P.; Peat, G.M.; Cleator, J.; Chew-Graham,\nC.; Loke, Y.K.; et al. Self-Reported Sleep Duration and Quality and Cardiovascular Disease and Mortality: A Dose-Response\nMeta-Analysis. J. Am. Heart Assoc. 2018, 7, e008552. [CrossRef] [PubMed]\n123. Sejbuk, M.; Mironczuk-Chodakowska, I.; Witkowska, A.M. Sleep Quality: A Narrative Review on Nutrition, Stimulants, and\nPhysical Activity as Important Factors. Nutrients 2022, 14, 1912. [CrossRef] [PubMed]\n\nNutrients 2024, 16, 27\n21 of 21\n124. Lloyd-Jones, D.M.; Allen, N.B.; Anderson, C.A.M.; Black, T.; Brewer, L.C.; Foraker, R.E.; Grandner, M.A.; Lavretsky, H.; Perak,\nA.M.; Sharma, G.; et al.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 20,
          "overlap_chars": 482,
          "overlap_percentage": 71.61961367013373
        },
        {
          "page_number": 21,
          "overlap_chars": 189,
          "overlap_percentage": 28.083209509658246
        }
      ],
      "primary_page": 20,
      "char_count": 673,
      "word_count": 96,
      "start_pos": 89241,
      "end_pos": 89914,
      "chunk_index": 168,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_169",
      "text": "ack, T.; Brewer, L.C.; Foraker, R.E.; Grandner, M.A.; Lavretsky, H.; Perak,\nA.M.; Sharma, G.; et al. Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular\nHealth: A Presidential Advisory From the American Heart Association. Circulation 2022, 146, e18–e43. [CrossRef] [PubMed]\n125. Szakács, Z. The relationship between sleep and digestion. Cent. Eur. J. Gastroenterol. Hepatol. 2020, 6, 106–112. [CrossRef]\n126. Khanijow, V.; Prakash, P.; Emsellem, H.A.; Borum, M.L.; Doman, D.B. Sleep Dysfunction and Gastrointestinal Diseases. Gastroen-\nterol. Hepatol. 2015, 11, 817–825.\n127. Nagai, M.; Hoshide, S.; Kario, K.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 661,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 661,
      "word_count": 91,
      "start_pos": 89814,
      "end_pos": 90475,
      "chunk_index": 169,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_170",
      "text": "stinal Diseases. Gastroen-\nterol. Hepatol. 2015, 11, 817–825.\n127. Nagai, M.; Hoshide, S.; Kario, K. Sleep duration as a risk factor for cardiovascular disease- a review of the recent literature. Curr.\nCardiol. Rev. 2010, 6, 54–61. [CrossRef]\n128. Meng, X.; Li, Y.; Li, S.; Zhou, Y.; Gan, R.Y.; Xu, D.P.; Li, H.B. Dietary Sources and Bioactivities of Melatonin. Nutrients 2017, 9, 367.\n[CrossRef]\n129. Cortés-Montaña, D.; Bernalte-García, M.J.; Velardo-Micharet, B.; Serrano, M.; Serradilla, M.J. Impact of Pre-Storage Melatonin\nApplication on the Standard, Sensory, and Bioactive Quality of Early Sweet Cherry. Foods 2023, 12, 1723. [CrossRef]\n130. USDA. Food Data Central.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 674,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 674,
      "word_count": 100,
      "start_pos": 90375,
      "end_pos": 91049,
      "chunk_index": 170,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_171",
      "text": "active Quality of Early Sweet Cherry. Foods 2023, 12, 1723. [CrossRef]\n130. USDA. Food Data Central. Available online: [URL] (accessed on 20\nNovember 2023).\n131. Zuraikat, F.M.; Wood, R.A.; Barragán, R.; St-Onge, M.P. Sleep and Diet: Mounting Evidence of a Cyclical Relationship. Annu. Rev.\nNutr. 2021, 41, 309–332. [CrossRef] [PubMed]\n132. Asgari Mehrabadi, M.; Azimi, I.; Sarhaddi, F.; Axelin, A.; Niela-Vilen, H.; Myllyntausta, S.; Stenholm, S.; Dutt, N.; Liljeberg, P.;\nRahmani, A.M. Sleep Tracking of a Commercially Available Smart Ring and Smartwatch Against Medical-Grade Actigraphy in\nEveryday Settings: Instrument Validation Study. JMIR Mhealth Uhealth 2020, 8, e20465.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 678,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 678,
      "word_count": 97,
      "start_pos": 90949,
      "end_pos": 91627,
      "chunk_index": 171,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_172",
      "text": "Actigraphy in\nEveryday Settings: Instrument Validation Study. JMIR Mhealth Uhealth 2020, 8, e20465. [CrossRef] [PubMed]\n133. Tobin, S.Y.; Williams, P.G.; Baron, K.G.; Halliday, T.M.; Depner, C.M. Challenges and Opportunities for Applying Wearable\nTechnology to Sleep. Sleep Med. Clin. 2021, 16, 607–618. [CrossRef] [PubMed]\nDisclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual\nauthor(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to\npeople or property resulting from any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 694,
          "overlap_percentage": 100.14430014430013
        }
      ],
      "primary_page": 21,
      "char_count": 693,
      "word_count": 96,
      "start_pos": 91527,
      "end_pos": 92221,
      "chunk_index": 172,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_173",
      "text": "or property resulting from any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 100,
          "overlap_percentage": 101.01010101010101
        }
      ],
      "primary_page": 21,
      "char_count": 99,
      "word_count": 15,
      "start_pos": 92121,
      "end_pos": 92223,
      "chunk_index": 173,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_174",
      "text": "r property resulting from any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 98,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 98,
      "word_count": 15,
      "start_pos": 92123,
      "end_pos": 92223,
      "chunk_index": 174,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_175",
      "text": "property resulting from any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 97,
          "overlap_percentage": 101.04166666666667
        }
      ],
      "primary_page": 21,
      "char_count": 96,
      "word_count": 14,
      "start_pos": 92124,
      "end_pos": 92223,
      "chunk_index": 175,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_176",
      "text": "property resulting from any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 96,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 96,
      "word_count": 14,
      "start_pos": 92125,
      "end_pos": 92223,
      "chunk_index": 176,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_177",
      "text": "roperty resulting from any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 95,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 95,
      "word_count": 14,
      "start_pos": 92126,
      "end_pos": 92223,
      "chunk_index": 177,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_178",
      "text": "operty resulting from any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 94,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 94,
      "word_count": 14,
      "start_pos": 92127,
      "end_pos": 92223,
      "chunk_index": 178,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_179",
      "text": "perty resulting from any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 93,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 93,
      "word_count": 14,
      "start_pos": 92128,
      "end_pos": 92223,
      "chunk_index": 179,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_180",
      "text": "erty resulting from any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 92,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 92,
      "word_count": 14,
      "start_pos": 92129,
      "end_pos": 92223,
      "chunk_index": 180,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_181",
      "text": "rty resulting from any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 91,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 91,
      "word_count": 14,
      "start_pos": 92130,
      "end_pos": 92223,
      "chunk_index": 181,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_182",
      "text": "ty resulting from any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 90,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 90,
      "word_count": 14,
      "start_pos": 92131,
      "end_pos": 92223,
      "chunk_index": 182,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_183",
      "text": "y resulting from any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 89,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 89,
      "word_count": 14,
      "start_pos": 92132,
      "end_pos": 92223,
      "chunk_index": 183,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_184",
      "text": "resulting from any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 88,
          "overlap_percentage": 101.14942528735634
        }
      ],
      "primary_page": 21,
      "char_count": 87,
      "word_count": 13,
      "start_pos": 92133,
      "end_pos": 92223,
      "chunk_index": 184,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_185",
      "text": "resulting from any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 87,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 87,
      "word_count": 13,
      "start_pos": 92134,
      "end_pos": 92223,
      "chunk_index": 185,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_186",
      "text": "esulting from any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 86,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 86,
      "word_count": 13,
      "start_pos": 92135,
      "end_pos": 92223,
      "chunk_index": 186,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_187",
      "text": "sulting from any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 85,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 85,
      "word_count": 13,
      "start_pos": 92136,
      "end_pos": 92223,
      "chunk_index": 187,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_188",
      "text": "ulting from any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 84,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 84,
      "word_count": 13,
      "start_pos": 92137,
      "end_pos": 92223,
      "chunk_index": 188,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_189",
      "text": "lting from any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 83,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 83,
      "word_count": 13,
      "start_pos": 92138,
      "end_pos": 92223,
      "chunk_index": 189,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_190",
      "text": "ting from any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 82,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 82,
      "word_count": 13,
      "start_pos": 92139,
      "end_pos": 92223,
      "chunk_index": 190,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_191",
      "text": "ing from any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 81,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 81,
      "word_count": 13,
      "start_pos": 92140,
      "end_pos": 92223,
      "chunk_index": 191,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_192",
      "text": "ng from any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 80,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 80,
      "word_count": 13,
      "start_pos": 92141,
      "end_pos": 92223,
      "chunk_index": 192,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_193",
      "text": "g from any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 79,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 79,
      "word_count": 13,
      "start_pos": 92142,
      "end_pos": 92223,
      "chunk_index": 193,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_194",
      "text": "from any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 78,
          "overlap_percentage": 101.29870129870129
        }
      ],
      "primary_page": 21,
      "char_count": 77,
      "word_count": 12,
      "start_pos": 92143,
      "end_pos": 92223,
      "chunk_index": 194,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_195",
      "text": "from any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 77,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 77,
      "word_count": 12,
      "start_pos": 92144,
      "end_pos": 92223,
      "chunk_index": 195,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_196",
      "text": "rom any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 76,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 76,
      "word_count": 12,
      "start_pos": 92145,
      "end_pos": 92223,
      "chunk_index": 196,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_197",
      "text": "om any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 75,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 75,
      "word_count": 12,
      "start_pos": 92146,
      "end_pos": 92223,
      "chunk_index": 197,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_198",
      "text": "m any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 74,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 74,
      "word_count": 12,
      "start_pos": 92147,
      "end_pos": 92223,
      "chunk_index": 198,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_199",
      "text": "any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 73,
          "overlap_percentage": 101.38888888888889
        }
      ],
      "primary_page": 21,
      "char_count": 72,
      "word_count": 11,
      "start_pos": 92148,
      "end_pos": 92223,
      "chunk_index": 199,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_200",
      "text": "any ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 72,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 72,
      "word_count": 11,
      "start_pos": 92149,
      "end_pos": 92223,
      "chunk_index": 200,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_201",
      "text": "ny ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 71,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 71,
      "word_count": 11,
      "start_pos": 92150,
      "end_pos": 92223,
      "chunk_index": 201,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_202",
      "text": "y ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 70,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 70,
      "word_count": 11,
      "start_pos": 92151,
      "end_pos": 92223,
      "chunk_index": 202,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_203",
      "text": "ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 69,
          "overlap_percentage": 101.47058823529412
        }
      ],
      "primary_page": 21,
      "char_count": 68,
      "word_count": 10,
      "start_pos": 92152,
      "end_pos": 92223,
      "chunk_index": 203,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_204",
      "text": "ideas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 68,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 68,
      "word_count": 10,
      "start_pos": 92153,
      "end_pos": 92223,
      "chunk_index": 204,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_205",
      "text": "deas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 67,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 67,
      "word_count": 10,
      "start_pos": 92154,
      "end_pos": 92223,
      "chunk_index": 205,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_206",
      "text": "eas, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 66,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 66,
      "word_count": 10,
      "start_pos": 92155,
      "end_pos": 92223,
      "chunk_index": 206,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_207",
      "text": "as, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 65,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 65,
      "word_count": 10,
      "start_pos": 92156,
      "end_pos": 92223,
      "chunk_index": 207,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_208",
      "text": "s, methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 64,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 64,
      "word_count": 10,
      "start_pos": 92157,
      "end_pos": 92223,
      "chunk_index": 208,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_209",
      "text": ", methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 63,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 63,
      "word_count": 10,
      "start_pos": 92158,
      "end_pos": 92223,
      "chunk_index": 209,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_210",
      "text": "methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 62,
          "overlap_percentage": 101.63934426229508
        }
      ],
      "primary_page": 21,
      "char_count": 61,
      "word_count": 9,
      "start_pos": 92159,
      "end_pos": 92223,
      "chunk_index": 210,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_211",
      "text": "methods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 61,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 61,
      "word_count": 9,
      "start_pos": 92160,
      "end_pos": 92223,
      "chunk_index": 211,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_212",
      "text": "ethods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 60,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 60,
      "word_count": 9,
      "start_pos": 92161,
      "end_pos": 92223,
      "chunk_index": 212,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_213",
      "text": "thods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 59,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 59,
      "word_count": 9,
      "start_pos": 92162,
      "end_pos": 92223,
      "chunk_index": 213,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_214",
      "text": "hods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 58,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 58,
      "word_count": 9,
      "start_pos": 92163,
      "end_pos": 92223,
      "chunk_index": 214,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_215",
      "text": "ods, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 57,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 57,
      "word_count": 9,
      "start_pos": 92164,
      "end_pos": 92223,
      "chunk_index": 215,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_216",
      "text": "ds, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 56,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 56,
      "word_count": 9,
      "start_pos": 92165,
      "end_pos": 92223,
      "chunk_index": 216,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_217",
      "text": "s, instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 55,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 55,
      "word_count": 9,
      "start_pos": 92166,
      "end_pos": 92223,
      "chunk_index": 217,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_218",
      "text": ", instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 54,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 54,
      "word_count": 9,
      "start_pos": 92167,
      "end_pos": 92223,
      "chunk_index": 218,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_219",
      "text": "instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 53,
          "overlap_percentage": 101.92307692307692
        }
      ],
      "primary_page": 21,
      "char_count": 52,
      "word_count": 8,
      "start_pos": 92168,
      "end_pos": 92223,
      "chunk_index": 219,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_220",
      "text": "instructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 52,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 52,
      "word_count": 8,
      "start_pos": 92169,
      "end_pos": 92223,
      "chunk_index": 220,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_221",
      "text": "nstructions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 51,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 51,
      "word_count": 8,
      "start_pos": 92170,
      "end_pos": 92223,
      "chunk_index": 221,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_222",
      "text": "structions or products referred to in the content.",
      "doc_title": "The Importance of Nutrition in Menopause and Perimenopause—A Review",
      "doc_filename": "5_Importance_of_nutrition_in_Menopause.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\5_Importance_of_nutrition_in_Menopause.pdf",
      "pages": [
        {
          "page_number": 21,
          "overlap_chars": 50,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 21,
      "char_count": 50,
      "word_count": 8,
      "start_pos": 92171,
      "end_pos": 92223,
      "chunk_index": 222,
      "total_doc_pages": 21,
      "extraction_timestamp": "2025-06-28T15:28:32.725418"
    },
    {
      "id": "chunk_0",
      "text": "[Reddit • r/Menopause] \n \nTitle: Hot flashes at 3 AM: I started tracking them, and now I see a pattern… \n \nOriginal Post: \n“I started tracking hot flashes at night, and now I see a pattern… Estrogen tends to be lowest at \nnight, this is why night sweats are a common first symptom of perimenopause.” \n \nTop Replies: \n> “I noticed the same thing! Late‑night eating definitely makes mine worse… Have you tried \nchanging up what you eat in the evening to see if it makes a difference?” — who‑waht \n \n> “Sugar is going to affect insulin since it's a hormone...when one hormone is off balance, it will \nthrow others off; vicious cycle.",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 630,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 630,
      "word_count": 110,
      "start_pos": 0,
      "end_pos": 630,
      "chunk_index": 0,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_1",
      "text": "in since it's a hormone...when one hormone is off balance, it will \nthrow others off; vicious cycle. Cut out all carbs other than those that are keto‑friendly & your \nhot flashes will calm down.” — jenna_kay \n \n> “Blood sugar spikes were causing me mid‑sleep anxiety. I started to be more mindful of \nbalancing what I ate at night.” — Illustrious‑Film‑592 \n \n> “Mine change with time. Definitely my menstrual cycle is the biggest factor… Good fats and \nprotein seem to help — unsweetened natural yogurt… Hard boiled egg… Wild rice with extra \nvirgin olive oil.",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 560,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 1,
      "char_count": 560,
      "word_count": 94,
      "start_pos": 530,
      "end_pos": 1090,
      "chunk_index": 1,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_2",
      "text": "seem to help — unsweetened natural yogurt… Hard boiled egg… Wild rice with extra \nvirgin olive oil.” — Petulant‑Bidet \n\n[Reddit • r/Menopause] \n \nTitle: “Am I losing my mind or just in perimenopause?” \n \nOriginal Post: \n“I’m 44 and my mood is a rollercoaster. I cried in the car because a pigeon looked lonely. Then I \nscreamed at my husband for breathing too loud. Is this normal??” \n \nTop Replies: \n> “YES. Welcome to perimenopause. Emotional whiplash is real. I cried over a shampoo \ncommercial and then rage-cleaned my kitchen.” — soft_but_feral \n \n> “Estrogen messes with serotonin.",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 588,
          "overlap_percentage": 100.17035775127768
        }
      ],
      "primary_page": 1,
      "char_count": 587,
      "word_count": 94,
      "start_pos": 990,
      "end_pos": 1578,
      "chunk_index": 2,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_3",
      "text": "commercial and then rage-cleaned my kitchen.” — soft_but_feral \n \n> “Estrogen messes with serotonin. If you’ve been anxious or crying a lot lately, it might not be \n‘you’—it’s your brain chemistry being a drama queen.” — neuro_babe44\n\n> “It helps to journal the patterns. For me, it’s like PMS times 100. I warned my family and \nstarted doing yoga daily. It didn’t fix it, but I don’t want to punch walls anymore.” — \nshriekingviolet \n \n--- \n \n[Reddit • r/Menopause] \n \nTitle: “I’m gaining weight like crazy. What’s going on?!” \n \nOriginal Post: \n“Why am I gaining weight even though I haven’t changed anything in my diet?? It’s all around \nmy belly and hips, and I feel like a balloon.",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 1,
          "overlap_chars": 233,
          "overlap_percentage": 33.965014577259474
        },
        {
          "page_number": 2,
          "overlap_chars": 451,
          "overlap_percentage": 65.74344023323616
        }
      ],
      "primary_page": 1,
      "char_count": 686,
      "word_count": 115,
      "start_pos": 1478,
      "end_pos": 2164,
      "chunk_index": 3,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_4",
      "text": "haven’t changed anything in my diet?? It’s all around \nmy belly and hips, and I feel like a balloon.” \n \nTop Replies: \n> “Welcome to the cortisol–estrogen trap. You’re not eating more—but your hormones are \nstoring fat like you’re prepping for a famine.” — gut_brain_lady \n \n> “Strength training helped me more than cardio. After 40, your metabolism slows and muscle \nmass drops. Protein and weights saved my waistline.” — lift_like_linda \n \n> “Sleep quality affects weight too. I started magnesium glycinate at night and I’m sleeping \nbetter and losing bloat.",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 560,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 560,
      "word_count": 88,
      "start_pos": 2064,
      "end_pos": 2624,
      "chunk_index": 4,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_5",
      "text": "ffects weight too. I started magnesium glycinate at night and I’m sleeping \nbetter and losing bloat.” — nightflashqueen \n \n--- \n \n[Reddit • r/Menopause] \n \nTitle: “Has anyone else experienced vaginal dryness + low libido?” \n \nOriginal Post: \n“Okay, TMI, but I feel like I’m drying up inside and my sex drive has left the building. I miss \nfeeling close to my partner but also…ouch.” \n \nTop Replies: \n> “Not TMI at all, sis. You’re not alone. Estrogen decline affects lubrication and libido—totally \nnatural, but no one talks about it!” — hydrated_and_healing \n \n> “Hyaluronic acid gels helped me. Also, if you're open to HRT or vaginal estrogen creams, talk \nto your doctor. They *do* help.",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 690,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 2,
      "char_count": 690,
      "word_count": 110,
      "start_pos": 2524,
      "end_pos": 3214,
      "chunk_index": 5,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_6",
      "text": "ed me. Also, if you're open to HRT or vaginal estrogen creams, talk \nto your doctor. They *do* help.” — midlifevibecheck\n\n> “Low libido is hormonal AND emotional. I started therapy and suddenly felt more in tune with \nmy body again.” — saltysweaterseason \n \n--- \n \n[Reddit • r/Menopause] \n \nTitle: “Is it normal to feel like my memory is broken?” \n \nOriginal Post: \n“Lately I forget words mid-sentence. I walk into rooms and can’t remember why. It’s making me \npanic—like I’m getting dementia.” \n \nTop Replies: \n> “You’re not alone. Brain fog is a real, terrifying symptom of menopause. I thought I had early \nAlzheimer’s, but it was hormonal.",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 2,
          "overlap_chars": 120,
          "overlap_percentage": 18.662519440124417
        },
        {
          "page_number": 3,
          "overlap_chars": 521,
          "overlap_percentage": 81.02643856920683
        }
      ],
      "primary_page": 2,
      "char_count": 643,
      "word_count": 105,
      "start_pos": 3114,
      "end_pos": 3757,
      "chunk_index": 6,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_7",
      "text": "is a real, terrifying symptom of menopause. I thought I had early \nAlzheimer’s, but it was hormonal.” — brainfog_bandit \n \n> “B‑complex vitamins, more water, and less doomscrolling helped me get 30% of my brain \nback.” — 404memorynotfound \n \n> “Keep notes and forgive yourself. Your brain is literally rewiring under hormonal stress. Be \nkind to her.” — mindful_meno_mama \n \n[Reddit • r/Menopause] \n \nTitle: “Why does my heart randomly race?? I feel like I’m having a panic attack for no reason.” \n \nOriginal Post: \n“I’ll just be sitting, watching TV, and suddenly my heart starts pounding out of nowhere. I’ve \nhad all the tests. Doctor says I’m fine.",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 652,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 3,
      "char_count": 652,
      "word_count": 104,
      "start_pos": 3657,
      "end_pos": 4309,
      "chunk_index": 7,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_8",
      "text": "and suddenly my heart starts pounding out of nowhere. I’ve \nhad all the tests. Doctor says I’m fine. Is this just menopause???” \n \nTop Replies: \n> “YEP. Estrogen affects your cardiovascular system too. It’s wild. Palpitations are \ncommon—especially during perimenopause.” — beating_unbalanced \n \n> “Mine used to hit me while I was falling asleep. Turns out it was tied to fluctuating \nprogesterone. Yoga breathing helps a little.” — flutter_babe42\n\n> “Magnesium helped me a lot. Also cut back on caffeine. Still get them, but less scary now that \nI know I’m not dying.” — notactuallydyinglol \n\n[Reddit • r/Menopause] \n \nTitle: “My periods are chaotic. Heavy one month, nothing the next.",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 3,
          "overlap_chars": 447,
          "overlap_percentage": 65.1603498542274
        },
        {
          "page_number": 4,
          "overlap_chars": 237,
          "overlap_percentage": 34.54810495626822
        }
      ],
      "primary_page": 3,
      "char_count": 686,
      "word_count": 107,
      "start_pos": 4209,
      "end_pos": 4895,
      "chunk_index": 8,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_9",
      "text": "nglol \n\n[Reddit • r/Menopause] \n \nTitle: “My periods are chaotic. Heavy one month, nothing the next. Is this normal?” \n \nOriginal Post: \n“I’m 46 and my period has started ghosting me. Sometimes it’s early, sometimes late, sometimes \n2 weeks long. I’m stressed and confused.” \n \nTop Replies: \n> “Girl welcome to the perimenopause circus 🎪💀 It’s totally normal. Irregular periods are \nliterally the first symptom.” — cycle_slayer \n \n> “Track them but don’t panic unless you bleed *heavily* for weeks or pass large clots. Then see \na doc.” — redriver42 \n \n> “Mine were like that for 3 years before finally stopping. I kept thinking I was pregnant or \ndying. Nope. Just hormones being dramatic.",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 690,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 4,
      "char_count": 690,
      "word_count": 110,
      "start_pos": 4795,
      "end_pos": 5485,
      "chunk_index": 9,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_10",
      "text": "fore finally stopping. I kept thinking I was pregnant or \ndying. Nope. Just hormones being dramatic.” — dripdrophotflash \n\n[Reddit • r/Menopause] \n \nTitle: “No one told me menopause would make me feel invisible.” \n \nOriginal Post: \n“Ever since I turned 50, people treat me differently. I feel irrelevant at work. In my family. Even \nmy doctor talks *at* me, not to me.” \n \nTop Replies: \n> “This hit me hard. Midlife invisibility is real and no one talks about it. We need a culture \nshift.” — rageandradiance \n \n> “I dyed my hair pink and started lifting weights. I refuse to disappear. Menopause is *not* the \nend of me.” — spicyhotflashclub\n\n> “Same. But I’m done shrinking.",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 642,
          "overlap_percentage": 94.97041420118343
        },
        {
          "page_number": 5,
          "overlap_chars": 32,
          "overlap_percentage": 4.733727810650888
        }
      ],
      "primary_page": 4,
      "char_count": 676,
      "word_count": 113,
      "start_pos": 5385,
      "end_pos": 6061,
      "chunk_index": 10,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_11",
      "text": "disappear. Menopause is *not* the \nend of me.” — spicyhotflashclub\n\n> “Same. But I’m done shrinking. I'm finally living for *me* now, not for how others see me.” \n— va_va_vintage \n \n[Reddit • r/Menopause] \n \nTitle: “Dry eyes? Achy joints? Is this also menopause or am I just falling apart?” \n \nOriginal Post: \n“My eyes burn, my knees hurt, and my skin feels thinner. I feel like I aged 10 years in one.” \n \nTop Replies: \n> “Estrogen decline affects collagen production. So yes—joints, eyes, even gums can feel it.” — \nblinktwice \n \n> “My eye doctor confirmed menopause dryness is real. I use preservative-free drops now and it \nhelps.” — eyeballblues \n \n> “Add turmeric + collagen powder + hydration.",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 4,
          "overlap_chars": 66,
          "overlap_percentage": 9.428571428571429
        },
        {
          "page_number": 5,
          "overlap_chars": 632,
          "overlap_percentage": 90.28571428571428
        }
      ],
      "primary_page": 4,
      "char_count": 700,
      "word_count": 115,
      "start_pos": 5961,
      "end_pos": 6661,
      "chunk_index": 11,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_12",
      "text": "tive-free drops now and it \nhelps.” — eyeballblues \n \n> “Add turmeric + collagen powder + hydration. Helped my joints and skin bounce back.” — \nstretchymami \n\n[Reddit • r/Menopause] \n \nTitle: “Menopause is messing with my confidence.” \n \nOriginal Post: \n“I don’t recognize myself. My body looks different, I forget things, I feel exhausted. And I hate \nhow uncertain I feel all the time.” \n \nTop Replies: \n> “Same. I used to feel sharp and powerful. Now I second-guess myself constantly. It’s like my \nmojo went on vacation.” — poweroutagequeen \n \n> “Therapy and strength training helped. And finding this subreddit. Knowing I’m not alone is \neverything.",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 654,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 654,
      "word_count": 102,
      "start_pos": 6561,
      "end_pos": 7215,
      "chunk_index": 12,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_13",
      "text": "rapy and strength training helped. And finding this subreddit. Knowing I’m not alone is \neverything.” — meno_meltdown \n \n> “Hormonal shifts + society’s pressure = self-doubt storm. But this is also a rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 273,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 273,
      "word_count": 39,
      "start_pos": 7115,
      "end_pos": 7390,
      "chunk_index": 13,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_14",
      "text": "torm. But this is also a rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 98,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 98,
      "word_count": 14,
      "start_pos": 7290,
      "end_pos": 7390,
      "chunk_index": 14,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_15",
      "text": "orm. But this is also a rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 97,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 97,
      "word_count": 14,
      "start_pos": 7291,
      "end_pos": 7390,
      "chunk_index": 15,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_16",
      "text": "rm. But this is also a rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 96,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 96,
      "word_count": 14,
      "start_pos": 7292,
      "end_pos": 7390,
      "chunk_index": 16,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_17",
      "text": "m. But this is also a rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 95,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 95,
      "word_count": 14,
      "start_pos": 7293,
      "end_pos": 7390,
      "chunk_index": 17,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_18",
      "text": ". But this is also a rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 94,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 94,
      "word_count": 14,
      "start_pos": 7294,
      "end_pos": 7390,
      "chunk_index": 18,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_19",
      "text": "But this is also a rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 93,
          "overlap_percentage": 101.08695652173914
        }
      ],
      "primary_page": 5,
      "char_count": 92,
      "word_count": 13,
      "start_pos": 7295,
      "end_pos": 7390,
      "chunk_index": 19,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_20",
      "text": "But this is also a rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 92,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 92,
      "word_count": 13,
      "start_pos": 7296,
      "end_pos": 7390,
      "chunk_index": 20,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_21",
      "text": "ut this is also a rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 91,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 91,
      "word_count": 13,
      "start_pos": 7297,
      "end_pos": 7390,
      "chunk_index": 21,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_22",
      "text": "t this is also a rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 90,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 90,
      "word_count": 13,
      "start_pos": 7298,
      "end_pos": 7390,
      "chunk_index": 22,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_23",
      "text": "this is also a rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 89,
          "overlap_percentage": 101.13636363636364
        }
      ],
      "primary_page": 5,
      "char_count": 88,
      "word_count": 12,
      "start_pos": 7299,
      "end_pos": 7390,
      "chunk_index": 23,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_24",
      "text": "this is also a rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 88,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 88,
      "word_count": 12,
      "start_pos": 7300,
      "end_pos": 7390,
      "chunk_index": 24,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_25",
      "text": "his is also a rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 87,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 87,
      "word_count": 12,
      "start_pos": 7301,
      "end_pos": 7390,
      "chunk_index": 25,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_26",
      "text": "is is also a rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 86,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 86,
      "word_count": 12,
      "start_pos": 7302,
      "end_pos": 7390,
      "chunk_index": 26,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_27",
      "text": "s is also a rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 85,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 85,
      "word_count": 12,
      "start_pos": 7303,
      "end_pos": 7390,
      "chunk_index": 27,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_28",
      "text": "is also a rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 84,
          "overlap_percentage": 101.20481927710843
        }
      ],
      "primary_page": 5,
      "char_count": 83,
      "word_count": 11,
      "start_pos": 7304,
      "end_pos": 7390,
      "chunk_index": 28,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_29",
      "text": "is also a rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 83,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 83,
      "word_count": 11,
      "start_pos": 7305,
      "end_pos": 7390,
      "chunk_index": 29,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_30",
      "text": "s also a rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 82,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 82,
      "word_count": 11,
      "start_pos": 7306,
      "end_pos": 7390,
      "chunk_index": 30,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_31",
      "text": "also a rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 81,
          "overlap_percentage": 101.25
        }
      ],
      "primary_page": 5,
      "char_count": 80,
      "word_count": 10,
      "start_pos": 7307,
      "end_pos": 7390,
      "chunk_index": 31,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_32",
      "text": "also a rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 80,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 80,
      "word_count": 10,
      "start_pos": 7308,
      "end_pos": 7390,
      "chunk_index": 32,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_33",
      "text": "lso a rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 79,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 79,
      "word_count": 10,
      "start_pos": 7309,
      "end_pos": 7390,
      "chunk_index": 33,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_34",
      "text": "so a rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 78,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 78,
      "word_count": 10,
      "start_pos": 7310,
      "end_pos": 7390,
      "chunk_index": 34,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_35",
      "text": "o a rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 77,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 77,
      "word_count": 10,
      "start_pos": 7311,
      "end_pos": 7390,
      "chunk_index": 35,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_36",
      "text": "a rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 76,
          "overlap_percentage": 101.33333333333334
        }
      ],
      "primary_page": 5,
      "char_count": 75,
      "word_count": 9,
      "start_pos": 7312,
      "end_pos": 7390,
      "chunk_index": 36,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_37",
      "text": "a rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 75,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 75,
      "word_count": 9,
      "start_pos": 7313,
      "end_pos": 7390,
      "chunk_index": 37,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_38",
      "text": "rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 74,
          "overlap_percentage": 101.36986301369863
        }
      ],
      "primary_page": 5,
      "char_count": 73,
      "word_count": 8,
      "start_pos": 7314,
      "end_pos": 7390,
      "chunk_index": 38,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_39",
      "text": "rebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 73,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 73,
      "word_count": 8,
      "start_pos": 7315,
      "end_pos": 7390,
      "chunk_index": 39,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_40",
      "text": "ebirth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 72,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 72,
      "word_count": 8,
      "start_pos": 7316,
      "end_pos": 7390,
      "chunk_index": 40,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_41",
      "text": "birth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 71,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 71,
      "word_count": 8,
      "start_pos": 7317,
      "end_pos": 7390,
      "chunk_index": 41,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_42",
      "text": "irth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 70,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 70,
      "word_count": 8,
      "start_pos": 7318,
      "end_pos": 7390,
      "chunk_index": 42,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_43",
      "text": "rth phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 69,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 69,
      "word_count": 8,
      "start_pos": 7319,
      "end_pos": 7390,
      "chunk_index": 43,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_44",
      "text": "th phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 68,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 68,
      "word_count": 8,
      "start_pos": 7320,
      "end_pos": 7390,
      "chunk_index": 44,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_45",
      "text": "h phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 67,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 67,
      "word_count": 8,
      "start_pos": 7321,
      "end_pos": 7390,
      "chunk_index": 45,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_46",
      "text": "phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 66,
          "overlap_percentage": 101.53846153846153
        }
      ],
      "primary_page": 5,
      "char_count": 65,
      "word_count": 7,
      "start_pos": 7322,
      "end_pos": 7390,
      "chunk_index": 46,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_47",
      "text": "phase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 65,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 65,
      "word_count": 7,
      "start_pos": 7323,
      "end_pos": 7390,
      "chunk_index": 47,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_48",
      "text": "hase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 64,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 64,
      "word_count": 7,
      "start_pos": 7324,
      "end_pos": 7390,
      "chunk_index": 48,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_49",
      "text": "ase. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 63,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 63,
      "word_count": 7,
      "start_pos": 7325,
      "end_pos": 7390,
      "chunk_index": 49,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_50",
      "text": "se. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 62,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 62,
      "word_count": 7,
      "start_pos": 7326,
      "end_pos": 7390,
      "chunk_index": 50,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_51",
      "text": "e. \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 61,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 61,
      "word_count": 7,
      "start_pos": 7327,
      "end_pos": 7390,
      "chunk_index": 51,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_52",
      "text": ". \nYou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 60,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 60,
      "word_count": 7,
      "start_pos": 7328,
      "end_pos": 7390,
      "chunk_index": 52,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_53",
      "text": "You’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 59,
          "overlap_percentage": 103.50877192982458
        }
      ],
      "primary_page": 5,
      "char_count": 57,
      "word_count": 6,
      "start_pos": 7329,
      "end_pos": 7390,
      "chunk_index": 53,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_54",
      "text": "You’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 58,
          "overlap_percentage": 101.75438596491229
        }
      ],
      "primary_page": 5,
      "char_count": 57,
      "word_count": 6,
      "start_pos": 7330,
      "end_pos": 7390,
      "chunk_index": 54,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_55",
      "text": "You’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 57,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 57,
      "word_count": 6,
      "start_pos": 7331,
      "end_pos": 7390,
      "chunk_index": 55,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_56",
      "text": "ou’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 56,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 56,
      "word_count": 6,
      "start_pos": 7332,
      "end_pos": 7390,
      "chunk_index": 56,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_57",
      "text": "u’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 55,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 55,
      "word_count": 6,
      "start_pos": 7333,
      "end_pos": 7390,
      "chunk_index": 57,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_58",
      "text": "’re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 54,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 54,
      "word_count": 6,
      "start_pos": 7334,
      "end_pos": 7390,
      "chunk_index": 58,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_59",
      "text": "re still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 53,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 53,
      "word_count": 6,
      "start_pos": 7335,
      "end_pos": 7390,
      "chunk_index": 59,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_60",
      "text": "e still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 52,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 52,
      "word_count": 6,
      "start_pos": 7336,
      "end_pos": 7390,
      "chunk_index": 60,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_61",
      "text": "still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 51,
          "overlap_percentage": 102.0
        }
      ],
      "primary_page": 5,
      "char_count": 50,
      "word_count": 5,
      "start_pos": 7337,
      "end_pos": 7390,
      "chunk_index": 61,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    },
    {
      "id": "chunk_62",
      "text": "still powerful—just evolving.” — wisehotflashwitch",
      "doc_title": "5_Menopause_Common_Questions",
      "doc_filename": "6_Menopause_Common_Questions.pdf",
      "doc_filepath": "knowledge_base\\raw_pdfs\\vaanya\\6_Menopause_Common_Questions.pdf",
      "pages": [
        {
          "page_number": 5,
          "overlap_chars": 50,
          "overlap_percentage": 100.0
        }
      ],
      "primary_page": 5,
      "char_count": 50,
      "word_count": 5,
      "start_pos": 7338,
      "end_pos": 7390,
      "chunk_index": 62,
      "total_doc_pages": 5,
      "extraction_timestamp": "2025-06-28T15:28:32.739418"
    }
  ]
}